Citrus Sinensis ID: 042876

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------18
Protein Sequence
DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLRI
Secondary Structure (PSIPRED)
ccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEcccccccccccccccccccccccccccHHHccccccccccccccHHHHHHHHHHHccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccHccEEEcccccccHccccHHEEccccccEEEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHcccccccccccccccHHcccccHHHHccccHcccccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHcc
Coil and Loop (DISEMBL)
DAAAQELDWSQRMNTIKGVADALSylhhdcfppivhrdlssknllldlEYEAHVADFGiakflkpdssnwtefagtygyvapelAYTMkitekcdvySFGVLALEVikgkhprdflssisssslntdieldemldprlpapsrsvQEKLISIVKVAFSClnespesrptmKIVSQQLRI
Flexible Loop (DISEMBL)
daaaqeldwsqrmNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSclnespesrptmkivsqqlri
Low Complexity Region (SEG)
DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLssissssLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLRI
Disordered region (IsUnstruct)
***********RMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP***********************************KLISIVKVAFSCL*******************
Disordered Region (DISOPRED)
***AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS**NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLRI
Disordered Region (DISEMBL)
DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE*****************
Disordered Region (DISPRO)
****QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT*KIVSQQLRI
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLRI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	179	2.2.26 [Sep-21-2011]
Q8VZG8	1045	Probable LRR receptor-lik	yes	no	0.972	0.166	0.597	3e-59
Q9LP24	1120	Probable leucine-rich rep	no	no	0.966	0.154	0.586	5e-55
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.927	0.150	0.468	2e-39
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.983	0.173	0.405	1e-37
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.932	0.151	0.437	2e-37
O49318	1124	Probable leucine-rich rep	no	no	0.960	0.153	0.433	3e-37
Q9LHP4	1141	Receptor-like protein kin	no	no	0.938	0.147	0.411	1e-36
C0LGF4	591	LRR receptor-like serine/	no	no	0.960	0.291	0.458	7e-36
C0LGV1	1135	LRR receptor-like serine/	no	no	0.944	0.148	0.440	4e-35
C0LGL9	589	LRR receptor-like serine/	no	no	0.944	0.286	0.434	1e-34

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  227 bits (578), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 104/174 (59%), Positives = 135/174 (77%)

Query: 1    DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
            D  A++LDW +R+N +KGVA ALSY+HHD  P IVHRD+SS N+LL  +YEA ++DFG A
Sbjct: 868  DDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTA 927

Query: 61   KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS 120
            K LKPDSSNW+  AGTYGYVAPELAY MK+TEKCDVYSFGVL LEVIKG+HP D +S++S
Sbjct: 928  KLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLS 987

Query: 121  SSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
            SS  +  + L  + D RLP P+  ++E+++ I+KVA  CL+  P++RPTM  +S
Sbjct: 988  SSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  213 bits (542), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 102/174 (58%), Positives = 128/174 (73%), Gaps = 1/174 (0%)

Query: 1    DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
            D  A+ L W++R+N +KGVA ALSY+HHD   PIVHRD+SS N+LLD +Y A ++DFG A
Sbjct: 944  DEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTA 1003

Query: 61   KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS 120
            K LK DSSNW+  AGTYGYVAPE AYTMK+TEKCDVYSFGVL LE+I GKHP D +SS+S
Sbjct: 1004 KLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLS 1063

Query: 121  SSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
            SS     + L  + D R+  P    +EKL+ +V++A  CL  +PESRPTM  +S
Sbjct: 1064 SSP-GEALSLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  161 bits (408), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/175 (46%), Positives = 109/175 (62%), Gaps = 9/175 (5%)

Query: 7    LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
            LDW+ R     G A+ L YLHHDC P IVHRD+ S N+LLD  ++AHV DFG+AK +   
Sbjct: 895  LDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLS 954

Query: 67   -SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-------RDFLSS 118
             S + +  AG+YGY+APE AYTMK+TEKCD+YSFGV+ LE+I GK P        D ++ 
Sbjct: 955  YSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNW 1014

Query: 119  ISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
            +  S  N  I   EM D RL    +    ++  ++K+A  C + SP SRPTM+ V
Sbjct: 1015 VRRSIRNM-IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  155 bits (392), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 75/185 (40%), Positives = 115/185 (62%), Gaps = 9/185 (4%)

Query: 1   DAAAQEL-DWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGI 59
           +AA + L DW  R N   GVA  L+YLHHDC PP++HRD+ S N+LLD   +A +ADFG+
Sbjct: 793 NAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGL 852

Query: 60  AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPR--DFLS 117
           A+ +       +  AG+YGY+APE  YT+K+ EK D+YS+GV+ LE++ G+ P   +F  
Sbjct: 853 ARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGE 912

Query: 118 SIS-----SSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKI 172
           S+         +  +I L+E LDP +    R VQE+++ ++++A  C  + P+ RP+M+ 
Sbjct: 913 SVDIVEWVRRKIRDNISLEEALDPNV-GNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRD 971

Query: 173 VSQQL 177
           V   L
Sbjct: 972 VISML 976

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  154 bits (390), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 77/176 (43%), Positives = 111/176 (63%), Gaps = 9/176 (5%)

Query: 6    ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL-K 64
             LDWS+R     G A  L+YLHHDC P I HRD+ S N+LLD ++EAHV DFG+AK +  
Sbjct: 900  NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 959

Query: 65   PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-------RDFLS 117
            P S + +  AG+YGY+APE AYTMK+TEK D+YS+GV+ LE++ GK P        D ++
Sbjct: 960  PHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVN 1019

Query: 118  SISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
             +  S +  D     +LD RL      +   +++++K+A  C + SP +RP+M+ V
Sbjct: 1020 WV-RSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQV 1074

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  154 bits (389), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 78/180 (43%), Positives = 109/180 (60%), Gaps = 8/180 (4%)

Query: 2    AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK 61
              +  +DW  R     G A+ L+YLHHDC P I+HRD+ S N+L+D  +EAHV DFG+AK
Sbjct: 916  GKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAK 975

Query: 62   FL-KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RD 114
             +  P S + +  AG+YGY+APE AYTMK+TEKCD+YSFGV+ LE++ GK P        
Sbjct: 976  VIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGG 1035

Query: 115  FLSSISSSSLNTDIELDEMLDPRLPAPSRSV-QEKLISIVKVAFSCLNESPESRPTMKIV 173
             L++ + + +       E+LDP L      V    +I++ K+A  C   SP  RPTM+ V
Sbjct: 1036 DLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREV 1095

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  152 bits (383), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 77/187 (41%), Positives = 113/187 (60%), Gaps = 19/187 (10%)

Query: 4    AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
               LDW  R   + G A  L+YLHHDC PPIVHRD+ + N+L+ L++E ++ADFG+AK +
Sbjct: 885  GSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLV 944

Query: 64   -KPDSSNWTE-FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS 121
             + D    +   AG+YGY+APE  Y+MKITEK DVYS+GV+ LEV+ GK P D       
Sbjct: 945  DEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPID------- 997

Query: 122  SSLNTDIELD----------EMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             ++   I L           E+LD  L + + +  ++++ ++  A  C+N SP+ RPTMK
Sbjct: 998  PTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMK 1057

Query: 172  IVSQQLR 178
             V+  L+
Sbjct: 1058 DVAAMLK 1064

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1

 Score =  149 bits (377), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 83/181 (45%), Positives = 110/181 (60%), Gaps = 9/181 (4%)

Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
            ++LDW  R+N I G A  LSYLHHDC P I+HRD+ S N+LLD   EA V+DFG+AK L
Sbjct: 395 GEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 454

Query: 64  KPDSSNWTEF-AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS 122
           + + S+ T   AGT+GY+APE   + + TEK DVYSFGVL LEV+ GK P D  +S    
Sbjct: 455 EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTD--ASFIEK 512

Query: 123 SLNTDIELDEMLDPRLP-----APSRSVQ-EKLISIVKVAFSCLNESPESRPTMKIVSQQ 176
            LN    L  ++  + P          +Q E L +++ +A  C++ SPE RPTM  V Q 
Sbjct: 513 GLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLSIATQCVSPSPEERPTMHRVVQL 572

Query: 177 L 177
           L
Sbjct: 573 L 573

Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1

 Score =  147 bits (371), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 78/177 (44%), Positives = 105/177 (59%), Gaps = 8/177 (4%)

Query: 7    LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
            L W  R   I G A  L+YLHHDC PPIVHRD+ + N+L+  ++E ++ DFG+AK +   
Sbjct: 889  LGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDG 948

Query: 67   ----SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD--FLSSIS 120
                SSN    AG+YGY+APE  Y+MKITEK DVYS+GV+ LEV+ GK P D      + 
Sbjct: 949  DFARSSN--TIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLH 1006

Query: 121  SSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   I   +++D  L A   S  E+++  + VA  C+N  PE RPTMK V+  L
Sbjct: 1007 IVDWVKKIRDIQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAML 1063

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGL9|FEI2_ARATH LRR receptor-like serine/threonine-protein kinase FEI 2 OS=Arabidopsis thaliana GN=FEI2 PE=1 SV=1

 Score =  145 bits (366), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 80/184 (43%), Positives = 109/184 (59%), Gaps = 15/184 (8%)

Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
            ++LDW  R+N I G A  L+YLHHDC P I+HRD+ S N+LLD   EA V+DFG+AK L
Sbjct: 393 GEQLDWDSRVNIIIGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 452

Query: 64  KPDSSNWTEF-AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS 122
           + + S+ T   AGT+GY+APE   + + TEK DVYSFGVL LEV+ GK P D  +S    
Sbjct: 453 EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKLPTD--ASFIEK 510

Query: 123 SLN---------TDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
             N         ++    E++D       R   E L +++ +A  C++ SP+ RPTM  V
Sbjct: 511 GFNIVGWLNFLISENRAKEIVDLSCEGVER---ESLDALLSIATKCVSSSPDERPTMHRV 567

Query: 174 SQQL 177
            Q L
Sbjct: 568 VQLL 571

Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	179
147767326	1032	hypothetical protein VITISV_008862 [Viti	0.972	0.168	0.655	5e-66
359491509	1032	PREDICTED: probable LRR receptor-like se	0.972	0.168	0.649	5e-65
357508065	1078	Receptor protein kinase-like protein [Me	0.988	0.164	0.622	2e-62
297813345	1019	hypothetical protein ARALYDRAFT_489780 [	0.972	0.170	0.609	4e-59
356566991	1023	PREDICTED: probable LRR receptor-like se	0.988	0.173	0.602	4e-59
224073186	228	predicted protein [Populus trichocarpa]	0.955	0.75	0.586	8e-59
356577797	1204	PREDICTED: probable LRR receptor-like se	0.988	0.147	0.592	1e-58
359491512	1078	PREDICTED: probable LRR receptor-like se	0.972	0.161	0.620	1e-58
357508077	1060	Receptor protein kinase-like protein [Me	0.972	0.164	0.615	2e-58
224125418	855	predicted protein [Populus trichocarpa]	0.972	0.203	0.571	3e-58

>gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera]

 Score =  255 bits (651), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 114/174 (65%), Positives = 146/174 (83%)

Query: 4    AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
            A+E+ W  R+N IKGVA ALSYLHHDC PPIVHRD+SS N+LLD +YEAHV+DFG AKFL
Sbjct: 855  AKEVGWGTRVNIIKGVAHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFL 914

Query: 64   KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS 123
            K DSSNW+  AGTYGYVAPELAYTMK+TEKCDVYSFGVLALEV++G+HP D +SS+S+S 
Sbjct: 915  KLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSASP 974

Query: 124  LNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
               ++ L ++LDPRLP P+   + +++S++++A +CLN SP+SRPTM++VSQ L
Sbjct: 975  GKDNVVLKDVLDPRLPPPTLRDEAEVMSVIQLATACLNGSPQSRPTMQMVSQML 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  252 bits (643), Expect = 5e-65,   Method: Compositional matrix adjust.
 Identities = 113/174 (64%), Positives = 144/174 (82%)

Query: 4    AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
            A+E+ W  R+N IKGV+ ALSYLHHDC PPIVHRD+SS N+LLD +YEAHV+DFG AKFL
Sbjct: 855  AKEVGWGTRVNIIKGVSHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFL 914

Query: 64   KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS 123
            K DSSNW+  AGTYGYVAPELAYTMK+TEKCDVYSFGVLALEV++G+HP D +SS+S S 
Sbjct: 915  KLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSDSP 974

Query: 124  LNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
               ++ L ++LDPRLP P+   + ++ S++++A +CLN SP+SRPTM++VSQ L
Sbjct: 975  GKDNVVLKDVLDPRLPPPTFRDEAEVTSVIQLATACLNGSPQSRPTMQMVSQML 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357508065|ref|XP_003624321.1| Receptor protein kinase-like protein [Medicago truncatula] gi|355499336|gb|AES80539.1| Receptor protein kinase-like protein [Medicago truncatula]

 Score =  243 bits (621), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 112/180 (62%), Positives = 141/180 (78%), Gaps = 3/180 (1%)

Query: 1    DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
            D  A   DW +R+N ++GVADALSY+HHDC PPIVHRD+SSKN+LLD+ YEA ++DFG A
Sbjct: 877  DTQAIAFDWEKRVNIVRGVADALSYMHHDCIPPIVHRDISSKNVLLDISYEAQLSDFGTA 936

Query: 61   KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS 120
            KFLKPDSS+WT FAGTYGY APE A TM++TEKCDVYSFGVL  E++ GKHP DF+SS+ 
Sbjct: 937  KFLKPDSSSWTAFAGTYGYAAPEFAQTMEVTEKCDVYSFGVLCFEILLGKHPADFISSLF 996

Query: 121  SSS---LNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            SSS   +  ++ L ++LD R P P  S+ E +I I K+AFSCL+E+P SRPTM  VS++L
Sbjct: 997  SSSTAKMTYNLLLIDVLDNRPPQPINSIVEDIILITKLAFSCLSENPSSRPTMDYVSKEL 1056

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297813345|ref|XP_002874556.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata] gi|297320393|gb|EFH50815.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata]

 Score =  232 bits (592), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 106/174 (60%), Positives = 137/174 (78%)

Query: 1    DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
            D  A++LDW +R+N +KGVADALSY+HHD  P IVHRD+SS N+LL  +YEA ++DFG A
Sbjct: 842  DDEAKKLDWGKRINVVKGVADALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTA 901

Query: 61   KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS 120
            K LKPDSSNW+  AGTYGYVAPELAY MK+TEKCDVYSFGVL LEVIKG+HP D +S++S
Sbjct: 902  KLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLS 961

Query: 121  SSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
            SS  +T + L  + D RLP P+  ++E+++ I+KVA  CL+  P++RPTM  +S
Sbjct: 962  SSPPDTSLSLKTISDHRLPEPTPEIKEEVLEILKVALMCLHSDPQARPTMLSIS 1015

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356566991|ref|XP_003551708.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Glycine max]

 Score =  232 bits (592), Expect = 4e-59,   Method: Composition-based stats.
 Identities = 109/181 (60%), Positives = 142/181 (78%), Gaps = 4/181 (2%)

Query: 1    DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
            D  A   DW +R+NT+KGVA+ALSY+HHDC PPI+HRD+SSKN+LLD +YEAHV+DFG A
Sbjct: 824  DTKAVAFDWEKRVNTVKGVANALSYMHHDCSPPIIHRDISSKNVLLDSQYEAHVSDFGTA 883

Query: 61   KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL---- 116
            K LKP S NWT FAGT+GY APELA TM++TEKCDV+SFGVL+LE+I GKHP D +    
Sbjct: 884  KILKPGSHNWTTFAGTFGYAAPELAQTMEVTEKCDVFSFGVLSLEIITGKHPGDLISSLF 943

Query: 117  SSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ 176
            SS SS+++  ++ L ++LD RLP P +SV   +I +  +AFSC++E+P SRPTM  VS++
Sbjct: 944  SSSSSATMTFNLLLIDVLDQRLPQPLKSVVGDVILVASLAFSCISENPSSRPTMDQVSKK 1003

Query: 177  L 177
            L
Sbjct: 1004 L 1004

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224073186|ref|XP_002335909.1| predicted protein [Populus trichocarpa] gi|222836268|gb|EEE74689.1| predicted protein [Populus trichocarpa]

 Score =  231 bits (589), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 105/179 (58%), Positives = 137/179 (76%), Gaps = 8/179 (4%)

Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
           A +LDW++R+N +KGVA+ LSYLHHDC PPI+HRD+SS N+LLDLEYEAHV+DFG A+ L
Sbjct: 49  AMDLDWNRRLNVVKGVANGLSYLHHDCSPPIIHRDISSSNVLLDLEYEAHVSDFGTARLL 108

Query: 64  KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL------- 116
            PDS+NWT FAGT+GY APELAYTM++ EKCDVYSFGV+ +EVI G HP D +       
Sbjct: 109 MPDSTNWTSFAGTFGYTAPELAYTMRVNEKCDVYSFGVVTMEVIMGMHPGDLISSLSASA 168

Query: 117 -SSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
            SS S S +N    L +++D R+P P   V E ++SI+K+AF+CL  +P+SRPTM+ V+
Sbjct: 169 FSSSSCSQMNQHALLKDVIDQRIPLPENRVAEGVVSIIKIAFACLLANPQSRPTMRQVA 227

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356577797|ref|XP_003557009.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Glycine max]

 Score =  230 bits (587), Expect = 1e-58,   Method: Composition-based stats.
 Identities = 109/184 (59%), Positives = 138/184 (75%), Gaps = 7/184 (3%)

Query: 1    DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
            D  A   DW +R+N +K VA+AL Y+HH+C P IVHRD+SSKN+LLD EY AHV+DFG A
Sbjct: 1012 DGQAMAFDWYKRVNVVKDVANALCYMHHECSPRIVHRDISSKNVLLDSEYVAHVSDFGTA 1071

Query: 61   KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS 120
            KFL PDSSNWT F GT+GY APELAYTM++ EKCDVYSFGVLA E++ GKHP D +SS+ 
Sbjct: 1072 KFLNPDSSNWTSFVGTFGYAAPELAYTMEVNEKCDVYSFGVLAWEILVGKHPGDDISSLL 1131

Query: 121  SSSLNTDI--ELDEM-----LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
             SS +T +   LD M     LDPRLP P++ + +++ SI K+A +CL ESP SRPTM+ V
Sbjct: 1132 GSSPSTLVASTLDHMALMDKLDPRLPHPTKPIGKEVASIAKIAMACLTESPRSRPTMEQV 1191

Query: 174  SQQL 177
            + +L
Sbjct: 1192 ANEL 1195

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  230 bits (587), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 108/174 (62%), Positives = 138/174 (79%)

Query: 4    AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
            A++L W+ R+N IKGVA ALSY+HHDC PPIVHRD+SS N+LLD +YE H++DFG AK L
Sbjct: 868  AKKLGWATRINIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEPHISDFGTAKLL 927

Query: 64   KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS 123
            K DSSN +  AGT+GYVAPE AYTMK+TEK DVYSFGV+ LEVIKG+HP D + S+S S 
Sbjct: 928  KLDSSNQSALAGTFGYVAPEHAYTMKVTEKTDVYSFGVITLEVIKGRHPGDQILSLSVSP 987

Query: 124  LNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
               +I L++MLDPRLP  +   + ++ISI+ +A +CL+ +PESRPTMKI+SQ L
Sbjct: 988  EKENIVLEDMLDPRLPPLTAQDEGEVISIINLATACLSVNPESRPTMKIISQML 1041

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357508077|ref|XP_003624327.1| Receptor protein kinase-like protein [Medicago truncatula] gi|355499342|gb|AES80545.1| Receptor protein kinase-like protein [Medicago truncatula]

 Score =  230 bits (586), Expect = 2e-58,   Method: Composition-based stats.
 Identities = 109/177 (61%), Positives = 134/177 (75%), Gaps = 3/177 (1%)

Query: 4    AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
            A   DW +R+N +KGVA+ALSYLHHDC PPIVHRD+SSKN+L++L+YEAHV+DFGIAKFL
Sbjct: 863  AIAFDWEKRVNVVKGVANALSYLHHDCSPPIVHRDISSKNVLINLDYEAHVSDFGIAKFL 922

Query: 64   KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLS---SIS 120
            KPD +N T FAGT GY APELA TMK+ EKCDVYSFGVLALE+IKG+HP D +S   S S
Sbjct: 923  KPDETNRTHFAGTLGYAAPELAQTMKVNEKCDVYSFGVLALEIIKGEHPGDLISLYLSPS 982

Query: 121  SSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +L  D  L  +LD R     + + E++I I K+AFSC+N  P SRPTM  V + L
Sbjct: 983  TRTLANDTLLANVLDQRPQEVMKPIDEEVILIAKLAFSCINPEPRSRPTMDQVCKML 1039

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224125418|ref|XP_002319581.1| predicted protein [Populus trichocarpa] gi|222857957|gb|EEE95504.1| predicted protein [Populus trichocarpa]

 Score =  229 bits (585), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 104/182 (57%), Positives = 136/182 (74%), Gaps = 8/182 (4%)

Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
             +LDW++R+N +KGVA ALSYLHHDC PPI+HRD+SS N+LLD EYEAHV+DFG A+ L
Sbjct: 647 VMDLDWNRRLNVVKGVASALSYLHHDCSPPIIHRDISSSNVLLDSEYEAHVSDFGTARLL 706

Query: 64  KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSI---- 119
            PDS+NWT FAGT GY APELAYTM++ EKCDVYSFGV+ +EVI G HP D +S +    
Sbjct: 707 MPDSTNWTSFAGTLGYTAPELAYTMRVNEKCDVYSFGVVTMEVIMGMHPGDLISFLYASA 766

Query: 120 ----SSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
               S S +N    L +++D R+P P   V E ++SI+K+AF+CL  +P+SRPTM+ V+ 
Sbjct: 767 FSSSSCSQINQQALLKDVIDQRIPLPENRVAEGVVSIIKIAFACLLANPQSRPTMRQVAS 826

Query: 176 QL 177
           +L
Sbjct: 827 EL 828

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	179
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.972	0.166	0.574	9.3e-52
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.966	0.154	0.563	3.8e-47
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.932	0.151	0.459	2.8e-35
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.949	0.151	0.455	1.7e-34
TAIR|locus:2206179	592	FEI1 "FEI 1" [Arabidopsis thal	0.955	0.288	0.461	5.7e-34
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.932	0.151	0.436	7e-34
TAIR|locus:2139885	1013	AT4G28650 [Arabidopsis thalian	0.983	0.173	0.4	7.6e-34
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.960	0.150	0.423	1.2e-33
TAIR|locus:2168907	966	XIP1 "XYLEM INTERMIXED WITH PH	0.938	0.173	0.477	1.8e-33
TAIR|locus:2058759	589	FEI2 "FEI 2" [Arabidopsis thal	0.949	0.288	0.447	9.5e-33

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 546 (197.3 bits), Expect = 9.3e-52, P = 9.3e-52
 Identities = 100/174 (57%), Positives = 129/174 (74%)

Query:     1 DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
             D  A++LDW +R+N +KGVA ALSY+HHD  P IVHRD+SS N+LL  +YEA ++DFG A
Sbjct:   868 DDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTA 927

Query:    61 KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXX 120
             K LKPDSSNW+  AGTYGYVAPELAY MK+TEKCDVYSFGVL LEVIKG+HP D +    
Sbjct:   928 KLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLS 987

Query:   121 XXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
                 +  + L  + D RLP P+  ++E+++ I+KVA  CL+  P++RPTM  +S
Sbjct:   988 SSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 504 (182.5 bits), Expect = 3.8e-47, P = 3.8e-47
 Identities = 98/174 (56%), Positives = 122/174 (70%)

Query:     1 DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
             D  A+ L W++R+N +KGVA ALSY+HHD   PIVHRD+SS N+LLD +Y A ++DFG A
Sbjct:   944 DEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTA 1003

Query:    61 KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXX 120
             K LK DSSNW+  AGTYGYVAPE AYTMK+TEKCDVYSFGVL LE+I GKHP D L    
Sbjct:  1004 KLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGD-LVSSL 1062

Query:   121 XXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
                    + L  + D R+  P    +EKL+ +V++A  CL  +PESRPTM  +S
Sbjct:  1063 SSSPGEALSLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 393 (143.4 bits), Expect = 2.8e-35, P = 2.8e-35
 Identities = 80/174 (45%), Positives = 105/174 (60%)

Query:     7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
             LDW+ R     G A+ L YLHHDC P IVHRD+ S N+LLD  ++AHV DFG+AK +   
Sbjct:   895 LDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLS 954

Query:    67 -SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXX--- 122
              S + +  AG+YGY+APE AYTMK+TEKCD+YSFGV+ LE+I GK P   L         
Sbjct:   955 YSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNW 1014

Query:   123 ---XLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
                 +   I   EM D RL    +    ++  ++K+A  C + SP SRPTM+ V
Sbjct:  1015 VRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 386 (140.9 bits), Expect = 1.7e-34, P = 1.7e-34
 Identities = 81/178 (45%), Positives = 107/178 (60%)

Query:     4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
             +  +DW  R     G A+ L+YLHHDC P I+HRD+ S N+L+D  +EAHV DFG+AK +
Sbjct:   918 SHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVI 977

Query:    64 K-PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXX 122
               P S + +  AG+YGY+APE AYTMK+TEKCD+YSFGV+ LE++ GK P   L      
Sbjct:   978 DMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDL 1037

Query:   123 XLNT-----DIEL-DEMLDPRLPAPSRSV-QEKLISIVKVAFSCLNESPESRPTMKIV 173
                T     D  L  E+LDP L      V    +I++ K+A  C   SP  RPTM+ V
Sbjct:  1038 ATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREV 1095

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 373 (136.4 bits), Expect = 5.7e-34, P = 5.7e-34
 Identities = 83/180 (46%), Positives = 110/180 (61%)

Query:     5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
             ++LDW  R+N I G A  LSYLHHDC P I+HRD+ S N+LLD   EA V+DFG+AK L+
Sbjct:   397 EQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 456

Query:    65 PDSSNWTEF-AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXX 123
              + S+ T   AGT+GY+APE   + + TEK DVYSFGVL LEV+ GK P D         
Sbjct:   457 DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTD--ASFIEKG 514

Query:   124 LNTDIELDEMLDPRLPA----PS-RSVQ-EKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             LN    L  ++  + P     P+   +Q E L +++ +A  C++ SPE RPTM  V Q L
Sbjct:   515 LNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLSIATQCVSPSPEERPTMHRVVQLL 574

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0030243 "cellulose metabolic process" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 380 (138.8 bits), Expect = 7.0e-34, P = 7.0e-34
 Identities = 76/174 (43%), Positives = 109/174 (62%)

Query:     7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK-P 65
             LDWS+R     G A  L+YLHHDC P I HRD+ S N+LLD ++EAHV DFG+AK +  P
Sbjct:   901 LDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 960

Query:    66 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXX-- 123
              S + +  AG+YGY+APE AYTMK+TEK D+YS+GV+ LE++ GK P   +         
Sbjct:   961 HSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNW 1020

Query:   124 LNTDIELDEM----LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
             + + I  D +    LD RL      +   +++++K+A  C + SP +RP+M+ V
Sbjct:  1021 VRSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQV 1074

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)]

 Score = 379 (138.5 bits), Expect = 7.6e-34, P = 7.6e-34
 Identities = 74/185 (40%), Positives = 114/185 (61%)

Query:     1 DAAAQEL-DWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGI 59
             +AA + L DW  R N   GVA  L+YLHHDC PP++HRD+ S N+LLD   +A +ADFG+
Sbjct:   793 NAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGL 852

Query:    60 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD--F-- 115
             A+ +       +  AG+YGY+APE  YT+K+ EK D+YS+GV+ LE++ G+ P +  F  
Sbjct:   853 ARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGE 912

Query:   116 ---LXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKI 172
                +       +  +I L+E LDP +    R VQE+++ ++++A  C  + P+ RP+M+ 
Sbjct:   913 SVDIVEWVRRKIRDNISLEEALDPNV-GNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRD 971

Query:   173 VSQQL 177
             V   L
Sbjct:   972 VISML 976

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 378 (138.1 bits), Expect = 1.2e-33, P = 1.2e-33
 Identities = 75/177 (42%), Positives = 112/177 (63%)

Query:     7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL-KP 65
             LDW  R   + G A  L+YLHHDC PPIVHRD+ + N+L+ L++E ++ADFG+AK + + 
Sbjct:   888 LDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEG 947

Query:    66 DSSNWTE-FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXL 124
             D    +   AG+YGY+APE  Y+MKITEK DVYS+GV+ LEV+ GK P D         +
Sbjct:   948 DIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLV 1007

Query:   125 NTDIELD---EMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
             +   +     E+LD  L + + +  ++++ ++  A  C+N SP+ RPTMK V+  L+
Sbjct:  1008 DWVRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLK 1064

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 375 (137.1 bits), Expect = 1.8e-33, P = 1.8e-33
 Identities = 86/180 (47%), Positives = 108/180 (60%)

Query:     7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP- 65
             L+W  R     GVA  L+YLHHD  PPI+HRD+ S N+LLD+ Y+  VADFGIAK L+  
Sbjct:   757 LEWRTRHQIAVGVAQGLAYLHHDLSPPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 816

Query:    66 -DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXL 124
                S  T  AGTYGY+APE AY+ K T KCDVYSFGV+ +E+I GK P D         +
Sbjct:   817 GKDSTTTVMAGTYGYLAPEYAYSSKATIKCDVYSFGVVLMELITGKKPVDSCFGENKNIV 876

Query:   125 N---TDIE----LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             N   T I+    L E LD RL   S S +  +I+ ++VA  C + +P  RPTM  V Q L
Sbjct:   877 NWVSTKIDTKEGLIETLDKRL---SESSKADMINALRVAIRCTSRTPTIRPTMNEVVQLL 933

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 362 (132.5 bits), Expect = 9.5e-33, P = 9.5e-33
 Identities = 81/181 (44%), Positives = 110/181 (60%)

Query:     5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
             ++LDW  R+N I G A  L+YLHHDC P I+HRD+ S N+LLD   EA V+DFG+AK L+
Sbjct:   394 EQLDWDSRVNIIIGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 453

Query:    65 PDSSNWTEF-AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD--FLXXXXX 121
              + S+ T   AGT+GY+APE   + + TEK DVYSFGVL LEV+ GK P D  F+     
Sbjct:   454 DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKLPTDASFIEKGFN 513

Query:   122 XX--LN---TDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ 176
                 LN   ++    E++D       R   E L +++ +A  C++ SP+ RPTM  V Q 
Sbjct:   514 IVGWLNFLISENRAKEIVDLSCEGVER---ESLDALLSIATKCVSSSPDERPTMHRVVQL 570

Query:   177 L 177
             L
Sbjct:   571 L 571

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	179
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-29
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-26
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-22
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-21
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-20
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-20
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-20
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-18
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-16
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-15
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-14
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-13
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-12
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-11
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-11
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-10
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-10
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-10
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-09
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-09
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-09
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-08
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-08
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-07
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-07
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-07
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-07
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-07
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-07
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-06
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-06
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-06
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-06
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-05
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-05
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-05
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-05
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-05
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-05
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-04
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-04
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-04
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-04
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-04
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	0.001
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	0.001
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	0.001
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	0.001
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	0.003
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.003
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.003
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.004
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.004
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.004
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	0.004
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  107 bits (269), Expect = 6e-29
 Identities = 55/167 (32%), Positives = 77/167 (46%), Gaps = 11/167 (6%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L   +       +   L YLH +    I+HRDL  +N+LLD      +ADFG+AK L   
Sbjct: 95  LSEDEAKKIALQILRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKS 151

Query: 67  SSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN 125
           SS+ T F GT  Y+APE L        K DV+S GV+  E++ GK P  F    S  ++ 
Sbjct: 152 SSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP--F----SGENIL 205

Query: 126 TDIEL-DEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             ++L   +L P L                +   CLN+ P  RPT +
Sbjct: 206 DQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAE 252

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =   99 bits (250), Expect = 3e-26
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 12/153 (7%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH      IVHRDL  +N+LLD +    +ADFG+A+ L P     T F GT  
Sbjct: 106 ILSALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPE 161

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL 138
           Y+APE+       +  D++S GV+  E++ GK P           L    +      P  
Sbjct: 162 YMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFP-----GDDQLLELFKKIGKPKPPF 216

Query: 139 PAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           P P   +  +   +++     L + PE R T +
Sbjct: 217 PPPEWDISPEAKDLIR---KLLVKDPEKRLTAE 246

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 93.1 bits (232), Expect = 6e-24
 Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 5/103 (4%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD-LEYEAHVADFGIAKFL 63
            +L   + +  +  + + L YLH +    I+HRDL  +N+LLD    +  +ADFG++K L
Sbjct: 87  GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143

Query: 64  KPDSSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALE 105
             D S      GT  Y+APE L      +EK D++S GV+  E
Sbjct: 144 TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.0 bits (231), Expect = 2e-22
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 11/177 (6%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L W +R     G+A AL +LH  C P +V  +LS + +++D + E H+    +   L  D
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN- 125
           +  +   A    YVAPE   T  ITEK D+Y FG++ +E++ GK P D    +  S +  
Sbjct: 836 TKCFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891

Query: 126 -----TDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                +D  LD  +DP +       Q +++ ++ +A  C    P +RP    V + L
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 86.1 bits (214), Expect = 6e-21
 Identities = 49/184 (26%), Positives = 77/184 (41%), Gaps = 34/184 (18%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           +EL  S  ++    +A  + YL        +HRDL+++N L+       ++DFG+++ L 
Sbjct: 98  KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154

Query: 65  PDSSN----------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPR 113
            D             W          APE     K T K DV+SFGVL  E+   G+ P 
Sbjct: 155 DDDYYKVKGGKLPIRWM---------APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPY 205

Query: 114 DFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
                +S++ +   ++       RLP P     E    + K+   C  E PE RPT   +
Sbjct: 206 P---GMSNAEVLEYLKKGY----RLPKPPNCPPE----LYKLMLQCWAEDPEDRPTFSEL 254

Query: 174 SQQL 177
            + L
Sbjct: 255 VEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 85.3 bits (212), Expect = 1e-20
 Identities = 47/183 (25%), Positives = 74/183 (40%), Gaps = 34/183 (18%)

Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
           +L  S  ++    +A  + YL        +HRDL+++N L+       ++DFG+++ L  
Sbjct: 98  KLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 154

Query: 66  DSSN----------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRD 114
           D             W          APE     K T K DV+SFGVL  E+   G+ P  
Sbjct: 155 DDYYRKRGGKLPIRWM---------APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP 205

Query: 115 FLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
               +S+  +   ++       RLP P     E    +  +   C  E PE RPT   + 
Sbjct: 206 ---GMSNEEVLEYLKNGY----RLPQPPNCPPE----LYDLMLQCWAEDPEDRPTFSELV 254

Query: 175 QQL 177
           + L
Sbjct: 255 EIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 84.2 bits (209), Expect = 3e-20
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 17/157 (10%)

Query: 15  TIKGVADALSYLH--HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
             K +   L YLH        I+HRD+ + N+LL  + E  + DFG++  L  D+     
Sbjct: 103 VCKELLKGLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNT 156

Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDE 132
             GT  ++APE+        K D++S G+ A+E+ +GK P   L  + +           
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-- 214

Query: 133 MLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
              P L  P +   E     +K    CL ++PE RPT
Sbjct: 215 ---PGLRNPEKWSDE-FKDFLK---KCLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 84.5 bits (210), Expect = 3e-20
 Identities = 45/195 (23%), Positives = 69/195 (35%), Gaps = 55/195 (28%)

Query: 5   QELDWSQRMNTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
           ++L     +     +A  + YL   +     VHRDL+++N L+       ++DFG+++ +
Sbjct: 97  EKLTLKDLLQMALQIAKGMEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDI 152

Query: 64  KPDSS-----------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI----- 107
             D              W          APE     K T K DV+SFGVL  E+      
Sbjct: 153 YEDDYYRKRGGGKLPIKWM---------APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ 203

Query: 108 --KGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAP---SRSVQEKLISIVKVAFSCLNE 162
              G    + L  +                 RLP P      + E L+        C   
Sbjct: 204 PYPGMSNEEVLELLED-------------GYRLPRPENCPDELYE-LML------QCWAY 243

Query: 163 SPESRPTMKIVSQQL 177
            PE RPT   + + L
Sbjct: 244 DPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 84.1 bits (209), Expect = 3e-20
 Identities = 47/187 (25%), Positives = 76/187 (40%), Gaps = 37/187 (19%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
             L     ++    +A  + YL        VHRDL+++N L+  +    ++DFG+++ + 
Sbjct: 100 STLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156

Query: 65  PDSSN-----------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP 112
            D              W          APE       T K DV+SFGVL  E+   G  P
Sbjct: 157 DDDYYRKKTGGKLPIRWM---------APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207

Query: 113 RDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
                 +S    N ++ L+ +    RLP P     ++L  ++    SC    PE RPT  
Sbjct: 208 ---YPGLS----NEEV-LEYLRKGYRLPKPE-YCPDELYELML---SCWQLDPEDRPTFS 255

Query: 172 IVSQQLR 178
            + ++L 
Sbjct: 256 ELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 79.4 bits (196), Expect = 2e-18
 Identities = 50/178 (28%), Positives = 86/178 (48%), Gaps = 15/178 (8%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
               Q L  +  ++    VA+ ++YL        +HRDL+++N+L+  +    VADFG+A
Sbjct: 95  SPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLA 151

Query: 61  KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSI 119
           + +K D    ++    Y + APE A     + K DV+SFG+L  E+   G+ P   ++  
Sbjct: 152 RLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-- 209

Query: 120 SSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                N ++        R+P P++  QE    I K+   C    PE RP+ K + ++L
Sbjct: 210 -----NHEVYDQITAGYRMPCPAKCPQE----IYKIMLECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 78.8 bits (195), Expect = 4e-18
 Identities = 43/151 (28%), Positives = 65/151 (43%), Gaps = 9/151 (5%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +   L YLH      I+HRD+   NLL++ + E  +ADFGI+K L+        F GT  
Sbjct: 108 ILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT 165

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL 138
           Y++PE       +   D++S G+  LE   GK P       S   L   I       P  
Sbjct: 166 YMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----CDGPPP 221

Query: 139 PAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
             P+     +    +    +CL + P+ RP+
Sbjct: 222 SLPAEEFSPEFRDFIS---ACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 78.5 bits (194), Expect = 4e-18
 Identities = 39/111 (35%), Positives = 56/111 (50%), Gaps = 8/111 (7%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH      I+HRD+   N+LLD +   H+ DF IA  + PD+   T  +GT G
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-TSTSGTPG 164

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIE 129
           Y+APE+      +   D +S GV A E ++GK P        S ++   I 
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR----GHSRTIRDQIR 211

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 77.2 bits (191), Expect = 1e-17
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 7/94 (7%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE--FAGTYG 78
            L+YLH +     IVHRD+   N+L+D +    +ADFG AK L    +        GT  
Sbjct: 113 GLAYLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           ++APE+    +     D++S G   +E+  GK P
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 72.9 bits (179), Expect = 5e-16
 Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 20/163 (12%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD---SSNWTEFAG 75
           V +A+ YL  + F   +HRDL+++N L+  +    V+DFG+A+++  D   SS  T+F  
Sbjct: 109 VCEAMEYLESNGF---IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP- 164

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNTDIELDEML 134
              +  PE+    + + K DV+SFGVL  EV  +GK P +  S       N+++      
Sbjct: 165 -VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS-------NSEVVESVSA 216

Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             RL  P  +  E    +  + +SC +E PE RP  K +  QL
Sbjct: 217 GYRLYRPKLAPTE----VYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 70.6 bits (174), Expect = 4e-15
 Identities = 46/152 (30%), Positives = 66/152 (43%), Gaps = 18/152 (11%)

Query: 22  ALSYLH--HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGY 79
           AL YLH        I+HRD+  +N+ L       + DFGI+K L           GT  Y
Sbjct: 115 ALKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY 169

Query: 80  VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLP 139
           ++PEL        K D++S G +  E+   KHP  F    +   L   I    +     P
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP--FEGE-NLLELALKI----LKGQYPP 222

Query: 140 APSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            PS+   E L ++V    S L + PE RP++ 
Sbjct: 223 IPSQYSSE-LRNLVS---SLLQKDPEERPSIA 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 70.2 bits (173), Expect = 4e-15
 Identities = 36/92 (39%), Positives = 50/92 (54%), Gaps = 5/92 (5%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           AL YLH       I++RDL  +N+LLD +    + DFG+AK L  + S    F GT  Y+
Sbjct: 105 ALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160

Query: 81  APELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           APE+       +  D +S GVL  E++ GK P
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 6e-15
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 28/160 (17%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I+ V  AL Y+H      ++HRD+ + N+L+       + DFG+A  L  +SS  + F G
Sbjct: 107 IREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVG 163

Query: 76  TYGYVAPELAYTMKITE------KCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIE 129
           T  ++APE+     ITE      K D++S G+   E+  G  P   + +  +  L     
Sbjct: 164 TPYWMAPEV-----ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML----- 213

Query: 130 LDEMLDPRLPAP--SRSVQEKLISIVKVAFSCLNESPESR 167
           + +   PRL     S+ ++E +        +CL+E P+ R
Sbjct: 214 IPKSKPPRLEDNGYSKLLREFVA-------ACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 69.8 bits (171), Expect = 6e-15
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 14/146 (9%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 82
           L++LH      I+HRD+ S NL LD      + D G+AK L  +++      GT  Y++P
Sbjct: 114 LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170

Query: 83  ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPS 142
           EL       EK DV++ GV+  E   GKHP D        + N    + +++    P  S
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFD--------ANNQGALILKIIRGVFPPVS 222

Query: 143 RSVQEKLISIVKVAFSCLNESPESRP 168
           +   ++L  ++     CL +    RP
Sbjct: 223 QMYSQQLAQLID---QCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 69.9 bits (171), Expect = 6e-15
 Identities = 51/165 (30%), Positives = 83/165 (50%), Gaps = 24/165 (14%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD---SSNWTEFAG 75
           V + + YL  + F   +HRDL+++N L+       V+DFG+ +++  D   SS+  +F  
Sbjct: 109 VCEGMEYLERNSF---IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP- 164

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNTDIELDEML 134
              +  PE+    K + K DV+SFGVL  EV  +GK P  F          ++ E+ EM+
Sbjct: 165 -VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP--FEKK-------SNYEVVEMI 214

Query: 135 DPRLPAPSRSVQEKLIS--IVKVAFSCLNESPESRPTMKIVSQQL 177
                   R  + KL S  + +V +SC +E PE RPT   + + +
Sbjct: 215 S----RGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.9 bits (171), Expect = 7e-15
 Identities = 51/168 (30%), Positives = 86/168 (51%), Gaps = 20/168 (11%)

Query: 10  SQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD--- 66
           SQ +   K V + ++YL    F   +HRDL+++N L+D +    V+DFG+++++  D   
Sbjct: 100 SQLLEMCKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLN 125
           SS  ++F   +    PE+    K + K DV++FGVL  EV   GK P +  +       N
Sbjct: 157 SSVGSKFPVRWS--PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-------N 207

Query: 126 TDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
           ++         RL  P  +  EK+ +I+   +SC +E  E RPT + +
Sbjct: 208 SETVEKVSQGLRLYRPHLA-SEKVYAIM---YSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 70.1 bits (171), Expect = 8e-15
 Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 18/170 (10%)

Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
           A   D  Q    +K +   L YLH +     +HRD+ + N+LL  + +  +ADFG+A  L
Sbjct: 95  AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151

Query: 64  KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS 123
                    F GT  ++APE+        K D++S G+ A+E+ KG+ P           
Sbjct: 152 TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP----------- 200

Query: 124 LNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            N+D+    +L   P+   P+    E      +   +CLN+ P  RPT K
Sbjct: 201 -NSDMHPMRVLFLIPKNNPPTL-TGEFSKPFKEFIDACLNKDPSFRPTAK 248

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 70.5 bits (171), Expect = 1e-14
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 16/168 (9%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSN----- 69
           +  +  AL YLH      I+HRD+  +N+LLD +     + DFG+AK L    S      
Sbjct: 107 LAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA 163

Query: 70  -WTEFAGTYGYVAPELAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN 125
             +   GT GY+APE+   +     +   D++S G+   E++ G  P +   + S++S  
Sbjct: 164 LPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223

Query: 126 TDIELDEMLDPRLPAPSRSVQEKLIS--IVKVAFSCLNESPESRPTMK 171
             I + E+  P L +P      +LIS     +    L + P++R +  
Sbjct: 224 LKI-ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSS 270

Length = 384

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 69.5 bits (171), Expect = 1e-14
 Identities = 42/154 (27%), Positives = 67/154 (43%), Gaps = 24/154 (15%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L YLH      ++HRD+ S N+LL  +    +ADFG A  L  + S      GT  ++A
Sbjct: 128 GLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMA 184

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHPR-DF-----LSSISSSSLNTDIELDEMLD 135
           PE+        K D++S G++ +E+ +G+ P         L  I++  +           
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI----------- 233

Query: 136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           P L  P +   E     +     CL + PE RP+
Sbjct: 234 PPLKNPEKWSPE-FKDFLN---KCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 68.9 bits (169), Expect = 2e-14
 Identities = 53/168 (31%), Positives = 76/168 (45%), Gaps = 26/168 (15%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           VA  ++YL    F   VHRDL+++N+LL   ++A ++DFG+++ L   S  +   A T G
Sbjct: 104 VAMGMAYLESKHF---VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAG 158

Query: 79  -----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDE 132
                + APE     K + K DV+S+GV   E    G  P   +            E+  
Sbjct: 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM---------KGAEVIA 209

Query: 133 MLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           ML+   RLP P    QE    I  +  SC    PE RPT   +    R
Sbjct: 210 MLESGERLPRPEECPQE----IYSIMLSCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 68.6 bits (168), Expect = 2e-14
 Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 20/163 (12%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           VA  ++YL    +   +HRDL+++N+L+       VADFG+A+ +K D     E A    
Sbjct: 112 VASGMAYLEAQNY---IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPI 168

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP 136
            + APE A   + + K DV+SFG+L  E++  G+ P   +         T+ E+ + +D 
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM---------TNAEVLQQVDQ 219

Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             R+P P    +E    +  +   C  E P+ RPT + +  +L
Sbjct: 220 GYRMPCPPGCPKE----LYDIMLDCWKEDPDDRPTFETLQWKL 258

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.4 bits (168), Expect = 2e-14
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 25/156 (16%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L YLH +     +HRD+ + N+LL  E +  +ADFG++  L    S    F GT  ++A
Sbjct: 110 GLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMA 166

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEM----LDPR 137
           PE+       EK D++S G+ A+E+ KG+ P                +L  M    L P+
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLS--------------DLHPMRVLFLIPK 212

Query: 138 LPAPSRSVQEKLISIVKVAF--SCLNESPESRPTMK 171
              P  S++    S     F   CLN+ P+ RP+ K
Sbjct: 213 NNPP--SLEGNKFSKPFKDFVSLCLNKDPKERPSAK 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 66.9 bits (163), Expect = 8e-14
 Identities = 52/164 (31%), Positives = 80/164 (48%), Gaps = 22/164 (13%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD---SSNWTEFAG 75
           V + ++YL        +HRDL+++N L+       V+DFG+ +F+  D   SS  T+F  
Sbjct: 109 VCEGMAYLESSNV---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP- 164

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLS-SISSSSLNTDIELDEM 133
              + +PE+    K + K DV+SFGVL  EV  +GK P +  S S    ++N    L   
Sbjct: 165 -VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL--- 220

Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             PRL A          S+ ++   C  E PE RP+  ++  QL
Sbjct: 221 YKPRL-ASQ--------SVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 67.2 bits (164), Expect = 8e-14
 Identities = 34/105 (32%), Positives = 59/105 (56%), Gaps = 9/105 (8%)

Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT-- 71
           N ++ +   L+YLH+     I+HRD+   N+L+D +    ++DFGI+K L+ +S +    
Sbjct: 110 NFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166

Query: 72  ----EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                  G+  ++APE+      T K D++S G L +E++ GKHP
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.4 bits (164), Expect = 8e-14
 Identities = 50/151 (33%), Positives = 80/151 (52%), Gaps = 10/151 (6%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTY 77
           ++ AL+YLH      I++RDL   N+LLD E    + D+G+ K  L+P  +  + F GT 
Sbjct: 105 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTP 160

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-DIELDEMLDP 136
            Y+APE+          D ++ GVL  E++ G+ P D + S  +   NT D     +L+ 
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220

Query: 137 RLPAPSRSVQEKLISIVKVAFSCLNESPESR 167
           ++  P RS+  K  S++K   S LN+ P+ R
Sbjct: 221 QIRIP-RSLSVKAASVLK---SFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 1e-13
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 38/164 (23%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--------- 69
           +A+ ++YL    +   +HRDL+++N+L+       +ADFG+A+ ++ D            
Sbjct: 112 IAEGMAYLESRNY---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI 168

Query: 70  -WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNTD 127
            WT         APE A   + T K DV+SFG+L  E++  G+ P   +         T+
Sbjct: 169 KWT---------APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM---------TN 210

Query: 128 IELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            E+ E ++   R+P P    +E    +  +   C ++ PE RPT
Sbjct: 211 REVLEQVERGYRMPRPPNCPEE----LYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 66.3 bits (161), Expect = 2e-13
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 3/106 (2%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           +D  Q     +    AL +LH +    ++HRD+ S N+LL ++    + DFG    + P+
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            S  +   GT  ++APE+        K D++S G++A+E+I+G+ P
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 65.7 bits (161), Expect = 3e-13
 Identities = 36/112 (32%), Positives = 52/112 (46%), Gaps = 23/112 (20%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE-------- 72
            AL YLH      I+HRDL  +N+LLD +    + DFG AK L P+SS  +         
Sbjct: 113 LALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169

Query: 73  ------------FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                       F GT  YV+PEL       +  D+++ G +  +++ GK P
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 65.3 bits (160), Expect = 3e-13
 Identities = 41/102 (40%), Positives = 52/102 (50%), Gaps = 14/102 (13%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  V  A  YLH+     I++RDL  +NLLLD      + DFG AK LK     WT F G
Sbjct: 99  IACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCG 154

Query: 76  TYGYVAPELAYTMKITEK-----CDVYSFGVLALEVIKGKHP 112
           T  YVAPE+     I  K      D +S G+L  E++ G+ P
Sbjct: 155 TPEYVAPEI-----ILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 65.4 bits (160), Expect = 3e-13
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 17/158 (10%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
            V   L+YLH      I+HRD+   N+L++   +  + DFG++  L    +    F GT 
Sbjct: 108 AVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTS 163

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIE-LDEMLD- 135
            Y+APE       + K D++S G+  +E+  G+ P        +   +   E L  +++ 
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP----ENDPPDGIFELLQYIVNE 219

Query: 136 --PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             PRLP+   S        V +   CL + P  RP+ K
Sbjct: 220 PPPRLPSGKFS--PDFQDFVNL---CLIKDPRERPSYK 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.5 bits (159), Expect = 3e-13
 Identities = 50/171 (29%), Positives = 76/171 (44%), Gaps = 26/171 (15%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           LD +Q    ++ +   L YLH +     +HRD+ + N+LL    E  +ADFG+A  L   
Sbjct: 98  LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK------HPRDFLSSIS 120
                 F GT  ++APE+        K D++S G+ A+E+ KG+      HP   L  I 
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP 214

Query: 121 SSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            ++  T       L+     P +   E          +CLN+ P  RPT K
Sbjct: 215 KNNPPT-------LEGNYSKPLKEFVE----------ACLNKEPSFRPTAK 248

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 4e-13
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 24/178 (13%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
            +    Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++ L+
Sbjct: 101 GKFTVGQLVGMLRGIASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLE 157

Query: 65  PDSSNWTEFAGTYG--YVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSIS 120
              + +T   G     + APE +AY  K T   DV+SFG++  EV+  G+ P   +S   
Sbjct: 158 DSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMS--- 213

Query: 121 SSSLNTDIELDEMLDPRLPAPSR--SVQEKLISIVKVAFSCLNESPESRPTM-KIVSQ 175
               N D+        RLP P    S   +L         C  +    RPT  +IVS 
Sbjct: 214 ----NQDVIKAVEDGYRLPPPMDCPSALYQL------MLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 65.0 bits (159), Expect = 4e-13
 Identities = 51/160 (31%), Positives = 75/160 (46%), Gaps = 24/160 (15%)

Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEF 73
            T+KG    L YLH       +HRD+ + N+LL+ E +A +ADFG++  L    +     
Sbjct: 107 QTLKG----LEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV 159

Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEM 133
            GT  ++APE+   +    K D++S G+ A+E+ +GK P    S I        I     
Sbjct: 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP---YSDIHPMRAIFMI----- 211

Query: 134 LDPRLPAPSRSVQEK----LISIVKVAFSCLNESPESRPT 169
             P  P P+ S  EK        VK    CL + PE RP+
Sbjct: 212 --PNKPPPTLSDPEKWSPEFNDFVK---KCLVKDPEERPS 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 64.8 bits (158), Expect = 5e-13
 Identities = 51/155 (32%), Positives = 77/155 (49%), Gaps = 17/155 (10%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
           AL YLH +    IVHRDL+  N++L  + +  + DFG+AK  K   S  T   GT  Y  
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSC 181

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAP 141
           PE+       EK DV++FG +  ++   + P  F S+ +  SL T I ++ + +P     
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP--FYST-NMLSLATKI-VEAVYEP----- 232

Query: 142 SRSVQEKLIS--IVKVAFSCLNESPESRPTMKIVS 174
              + E + S  +  V  SCL    E+RP +  VS
Sbjct: 233 ---LPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 64.6 bits (157), Expect = 6e-13
 Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 22/166 (13%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V+  + YL    F   VHRDL+++N+LL  ++ A ++DFG++K L  D + +   A T+G
Sbjct: 104 VSMGMKYLEETNF---VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHG 158

Query: 79  -----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDE 132
                + APE     K + K DV+SFGVL  E    G+ P      +  + +   IE  E
Sbjct: 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP---YKGMKGNEVTQMIESGE 215

Query: 133 MLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
               R+  P R   E +  ++K+   C     + RP   +V  +LR
Sbjct: 216 ----RMECPQRCPPE-MYDLMKL---CWTYGVDERPGFAVVELRLR 253

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 64.2 bits (157), Expect = 7e-13
 Identities = 48/152 (31%), Positives = 69/152 (45%), Gaps = 13/152 (8%)

Query: 20  ADALSYLHH--DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
             AL   H+  D    ++HRDL   N+ LD      + DFG+AK L  DSS    + GT 
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTP 174

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPR 137
            Y++PE    M   EK D++S G L  E+     P  F +  +   L + I+  E    R
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP--FTAR-NQLQLASKIK--EGKFRR 229

Query: 138 LPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           +P    S   ++I       S LN  P+ RP+
Sbjct: 230 IPYRYSSELNEVIK------SMLNVDPDKRPS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.4 bits (156), Expect = 9e-13
 Identities = 31/106 (29%), Positives = 58/106 (54%), Gaps = 3/106 (2%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           +D +Q     +    AL +LH +    ++HRD+ S N+LL ++    + DFG    + P+
Sbjct: 112 MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            S  +   GT  ++APE+        K D++S G++A+E+++G+ P
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 63.9 bits (156), Expect = 1e-12
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 32/168 (19%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW----T 71
           +K V   L YLH +     +HRD+ + N+LL  +    +ADFG++  L            
Sbjct: 108 LKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164

Query: 72  EFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIKGKHP-------RDFLSSISS-- 121
            F GT  ++APE+   +     K D++SFG+ A+E+  G  P       +  + ++ +  
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP 224

Query: 122 SSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            SL T  +  +         S+S + K+IS       CL + P  RPT
Sbjct: 225 PSLETGADYKKY--------SKSFR-KMIS------LCLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 63.8 bits (155), Expect = 1e-12
 Identities = 29/91 (31%), Positives = 53/91 (58%), Gaps = 3/91 (3%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
           AL +LH +    ++HRD+ S N+LL ++    + DFG    + P+ S  +   GT  ++A
Sbjct: 127 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+        K D++S G++A+E+++G+ P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 63.6 bits (155), Expect = 1e-12
 Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 27/170 (15%)

Query: 7   LDWSQRMNTIKGVADALSYL--HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           L+W  +      +A  +SYL         +VHRDL+++N+L+       + DFG+AK L 
Sbjct: 112 LNWCVQ------IAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160

Query: 65  PDSSNWTEFAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISS 121
            D   +    G     ++A E       T K DV+S+GV   E++  G  P + + ++  
Sbjct: 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220

Query: 122 SSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             L   +E  E    RLP P        I +  V   C     ESRPT K
Sbjct: 221 PDL---LEKGE----RLPQPPICT----IDVYMVLVKCWMIDAESRPTFK 259

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 63.4 bits (154), Expect = 2e-12
 Identities = 43/137 (31%), Positives = 73/137 (53%), Gaps = 16/137 (11%)

Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++FL+ D+S+ 
Sbjct: 107 QLVGMLRGIAAGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163

Query: 71  TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSL 124
           T  +   G     + APE     K T   DV+S+G++  EV+  G+ P      +S+  +
Sbjct: 164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMSNQDV 220

Query: 125 NTDIELDEMLDPRLPAP 141
              IE D     RLP P
Sbjct: 221 INAIEQDY----RLPPP 233

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 2e-12
 Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 31/165 (18%)

Query: 15  TIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA 74
           T+KG    L+YLH       +HRD+   N+LL  + +  +ADFG++  L    +    F 
Sbjct: 110 TLKG----LAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI 162

Query: 75  GTYGYVAPELA---YTMKITEKCDVYSFGVLALEVIKGK------HPRDFLSSISSSSLN 125
           GT  ++APE+A          KCD+++ G+ A+E+ + +      HP   L  IS S+  
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP 222

Query: 126 TDIELDEMLDPRLPAPSR-SVQEKLISIVKVAFSCLNESPESRPT 169
                     P+L    + S        +K    CL + P+ RPT
Sbjct: 223 P---------PKLKDKEKWSPV--FHDFIKK---CLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.5 bits (154), Expect = 2e-12
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 14/167 (8%)

Query: 10  SQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           +Q +     +A AL YLH      I+HRDL ++N+ L       V D GIA+ L+     
Sbjct: 102 NQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158

Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIE 129
            +   GT  Y++PEL        K DV++ G    E+   KH      + ++  +N+ + 
Sbjct: 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKH------AFNAKDMNSLVY 212

Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ 176
              +++ +LP   +    +L  ++    + L++ PE RP++K + +Q
Sbjct: 213 --RIIEGKLPPMPKDYSPELGELIA---TMLSKRPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 63.2 bits (153), Expect = 3e-12
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 3/106 (2%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           +D  Q     +    AL +LH +    ++HRD+ S N+LL ++    + DFG    + P+
Sbjct: 112 MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            S  +   GT  ++APE+        K D++S G++A+E+++G+ P
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 62.3 bits (151), Expect = 6e-12
 Identities = 39/115 (33%), Positives = 53/115 (46%), Gaps = 6/115 (5%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 82
           L +LH      IV+RDL   N+LLD +    +ADFG+ K      +    F GT  Y+AP
Sbjct: 109 LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAP 165

Query: 83  ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPR 137
           E+    K     D +SFGVL  E++ G+ P           L   I +D    PR
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSP---FHGHDEEELFQSIRMDNPCYPR 217

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 6e-12
 Identities = 52/173 (30%), Positives = 75/173 (43%), Gaps = 44/173 (25%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSS----NWTE 72
           V + + YL    F   VHRDL+++N+L+  +  A V+DFG+AK      DS      WT 
Sbjct: 111 VCEGMEYLEEKNF---VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT- 166

Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI---KGKHPRDFLSSISSSSLNTDIE 129
                   APE     K + K DV+SFG+L  E+    +  +PR              I 
Sbjct: 167 --------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR--------------IP 204

Query: 130 LDEMLDP-----RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           L +++       R+ AP     E    + KV   C    P  RPT K + +QL
Sbjct: 205 LKDVVPHVEKGYRMEAPEGCPPE----VYKVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.1 bits (151), Expect = 7e-12
 Identities = 34/91 (37%), Positives = 48/91 (52%), Gaps = 3/91 (3%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L +LH      I++RDL   N+LLD +    +ADFG+ K         + F GT  Y+A
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIA 164

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+    K  E  D +SFGVL  E++ G+ P
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 61.2 bits (149), Expect = 1e-11
 Identities = 45/150 (30%), Positives = 68/150 (45%), Gaps = 17/150 (11%)

Query: 19  VADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
           +   L +LH       I++RDL   N+LLD E    +ADFG+ K         + F GT 
Sbjct: 105 IVLGLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPR 137
            Y+APE+          D ++ GVL  E++ G+ P +         L   I  DE+  P 
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDELFQSILEDEVRYP- 216

Query: 138 LPAPSRSVQEKLISIVKVAFSCLNESPESR 167
                R + ++  SI+K   S L ++PE R
Sbjct: 217 -----RWLSKEAKSILK---SFLTKNPEKR 238

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.4 bits (149), Expect = 1e-11
 Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 8/147 (5%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 80
           AL++LH      I++RDL   N+LLD E    + D+G+ K  ++P  +  T F GT  Y+
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYI 163

Query: 81  APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPA 140
           APE+          D ++ GVL  E++ G+ P D +    +   NT+  L +++  +   
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR 223

Query: 141 PSRSVQEKLISIVKVAFSCLNESPESR 167
             RS+  K  S++K     LN+ P+ R
Sbjct: 224 IPRSLSVKASSVLK---GFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.8 bits (147), Expect = 2e-11
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 26/162 (16%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++ +   L YLH +     +HRD+ + N+LL  + +  +ADFG+A  L         F G
Sbjct: 107 LREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG 163

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK------HPRDFLSSISSSSLNTDIE 129
           T  ++APE+        K D++S G+ A+E+ KG+      HP   L  I  +S  T   
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT--- 220

Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
               L+ +   P +   E          +CLN+ P  RPT K
Sbjct: 221 ----LEGQYSKPFKEFVE----------ACLNKDPRFRPTAK 248

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 60.4 bits (146), Expect = 2e-11
 Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 32/181 (17%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           D   + L     ++    VA  ++Y+    +   +HRDL S N+L+       +ADFG+A
Sbjct: 93  DGEGRALKLPNLVDMAAQVAAGMAYIERMNY---IHRDLRSANILVGDGLVCKIADFGLA 149

Query: 61  KFLKPDSSNWTEFAGT---YGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP---- 112
           + +  + + +T   G      + APE A   + T K DV+SFG+L  E++ KG+ P    
Sbjct: 150 RLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207

Query: 113 --RDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+ L  +                 R+P P    Q+  IS+ ++   C  + PE RPT 
Sbjct: 208 NNREVLEQVERGY-------------RMPCP----QDCPISLHELMLQCWKKDPEERPTF 250

Query: 171 K 171
           +
Sbjct: 251 E 251

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 3e-11
 Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 29/170 (17%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT 76
           + + +AL++LH      ++HRDL + N+LL L+ +  +ADFG++   K        F GT
Sbjct: 110 RQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGT 166

Query: 77  YGYVAPELAY--TMKITE---KCDVYSFGVLALEVIKGK------HPRDFLSSISSSSLN 125
             ++APE+    T K      K D++S G+  +E+ + +      +P   L  I  S   
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE-- 224

Query: 126 TDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
                     P L  PS+         +K   SCL + P+ RPT   + +
Sbjct: 225 ---------PPTLDQPSK-WSSSFNDFLK---SCLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 59.9 bits (145), Expect = 3e-11
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 10/92 (10%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 113 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 167

Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEV 106
              + APE LAY  K + K DV++FGVL  E+
Sbjct: 168 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 3e-11
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 3/97 (3%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           +  V   L+YLH      ++HRD+ + N+L   +    +ADFG+A  L   S +     G
Sbjct: 105 VYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVG 161

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  ++APE+      +   D++S G   +E++ G  P
Sbjct: 162 TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 59.3 bits (144), Expect = 4e-11
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 10/99 (10%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE----FAGT 76
           + L+YLH      IVHRD+   N+ LD      + DFG A  LK +++   E     AGT
Sbjct: 110 EGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166

Query: 77  YGYVAPELAYTMKITEK---CDVYSFGVLALEVIKGKHP 112
             Y+APE+    K        D++S G + LE+  GK P
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 59.4 bits (144), Expect = 4e-11
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 17/153 (11%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP--DSSNWTEFAGTYGYV 80
           L+YLH      I+HRDL + NLL+D +    ++DFGI+K      D+       G+  ++
Sbjct: 121 LAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 81  APEL--AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL 138
           APE+  +Y+   + K D++S G + LE+  G+ P     +I++       +L        
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM-----FKLGN-KRSAP 231

Query: 139 PAPSRSVQEKLISIVKVAF--SCLNESPESRPT 169
           P P        +S V + F  +C   +P++RPT
Sbjct: 232 PIPPDVSM--NLSPVALDFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 59.4 bits (144), Expect = 6e-11
 Identities = 49/163 (30%), Positives = 70/163 (42%), Gaps = 27/163 (16%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
            V   LSYLH      I+HRD+   N+LL  + +  + DFG++  L   +S    F GT 
Sbjct: 113 SVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFTGTS 167

Query: 78  GYVAPE----LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEM 133
            Y+APE      Y++      DV+S G+  LEV + + P  F            IEL   
Sbjct: 168 FYMAPERIQGKPYSI----TSDVWSLGLTLLEVAQNRFP--FPPEGEPPL--GPIELLSY 219

Query: 134 L----DPRL---PAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           +    +P L   P       E+    +K    CL + P  RPT
Sbjct: 220 IVNMPNPELKDEPGNGIKWSEEFKDFIKQ---CLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 59.0 bits (143), Expect = 6e-11
 Identities = 49/167 (29%), Positives = 75/167 (44%), Gaps = 35/167 (20%)

Query: 19  VADALSYL---HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           V + L+YL   H      I+HRD+   N+L++   +  + DFG++  L    ++   F G
Sbjct: 112 VVEGLTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVG 164

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEM-- 133
           T  Y++PE     K T K DV+S G+  +E+  GK P  F      S+++ D + D M  
Sbjct: 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF------SNIDDDGQDDPMGI 218

Query: 134 LD----------PRLPAPSRS-VQEKLISIVKVAFSCLNESPESRPT 169
           LD          PRLP+          +        CL + P  RPT
Sbjct: 219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDA------CLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 59.2 bits (143), Expect = 6e-11
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 82
           L +LH      I++RDL   N++LD +    +ADFG+ K      +  + F GT  Y+AP
Sbjct: 109 LQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165

Query: 83  ELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           E+   +K T   D +SFGVL  E++ G+ P
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 58.6 bits (142), Expect = 7e-11
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 14/161 (8%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  A+SY+H      I+HRD+ + N+ L       + DFGI+K L  + S      GT  
Sbjct: 110 IVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL 138
           Y++PEL   +K   K D+++ G +  E++  K  R F ++ +  +L   I    +     
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLK--RTFDAT-NPLNLVVKI----VQGNYT 219

Query: 139 PAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLRI 179
           P  S    E LIS+V    S L + PE RPT   V  Q  +
Sbjct: 220 PVVSVYSSE-LISLVH---SLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.1 bits (143), Expect = 8e-11
 Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 20/155 (12%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
           G    L+YLH       +HRD+ + N+LL       +ADFG A  + P +S    F GT 
Sbjct: 123 GALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTP 175

Query: 78  GYVAPELAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML 134
            ++APE+   M   +   K DV+S G+  +E+ + K P   L ++++ S    I  ++  
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQND-- 230

Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
                +P+ S  +          SCL + P+ RP+
Sbjct: 231 -----SPTLSSNDWSDYFRNFVDSCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 58.4 bits (141), Expect = 1e-10
 Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 17/156 (10%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGT 76
           +A  + YL       +VHR+L+++N+LL  +    +ADFG+A  L PD     ++E    
Sbjct: 118 IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174

Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLD 135
             ++A E     + T + DV+S+GV   E++  G  P    + +    +   +E  E   
Sbjct: 175 IKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP---YAGMRPHEVPDLLEKGE--- 228

Query: 136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            RL  P    Q   I +  V   C       RPT K
Sbjct: 229 -RLAQP----QICTIDVYMVMVKCWMIDENVRPTFK 259

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 58.6 bits (142), Expect = 1e-10
 Identities = 41/156 (26%), Positives = 62/156 (39%), Gaps = 35/156 (22%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV-----------APE 83
           +HRDL+++N+L++ E    ++DFG+AK L  D          Y YV           APE
Sbjct: 131 IHRDLAARNILVESEDLVKISDFGLAKVLPEDKD--------YYYVKEPGESPIFWYAPE 182

Query: 84  LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML--------- 134
              T K +   DV+SFGV   E+    +     S  +       I   +M+         
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELF--TYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240

Query: 135 -DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
              RLP P     E    +  +   C    P+ RP+
Sbjct: 241 EGERLPRPPSCPDE----VYDLMKLCWEAEPQDRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 58.1 bits (140), Expect = 1e-10
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 16/161 (9%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++Y+    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 112 IAEGMAYIERKNY---IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI 168

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  GK P   +S       N+D+        
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-------NSDVMSALQRGY 221

Query: 137 RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           R+P    +  ++L  I+K   +C  E  E RPT   +   L
Sbjct: 222 RMPRM-ENCPDELYDIMK---TCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 58.1 bits (140), Expect = 1e-10
 Identities = 48/180 (26%), Positives = 88/180 (48%), Gaps = 24/180 (13%)

Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
            + L   Q ++    +AD ++Y+    +   +HRDL + N+L+       +ADFG+A+ +
Sbjct: 96  GKYLKLPQLVDMAAQIADGMAYIERMNY---IHRDLRAANILVGDNLVCKIADFGLARLI 152

Query: 64  KPDSSNWTEFAGT---YGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSI 119
             + + +T   G      + APE A   + T K DV+SFG+L  E++ KG+ P   +   
Sbjct: 153 --EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--- 207

Query: 120 SSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                  + E+ E ++   R+P P +   E L  ++K+   C  + P+ RPT + +   L
Sbjct: 208 ------VNREVLEQVERGYRMPCP-QGCPESLHELMKL---CWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.4 bits (141), Expect = 1e-10
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 20/177 (11%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L+ +Q +   + + + ++YLH   +   +HRDL+++N+LLD +    + DFG+AK + P+
Sbjct: 104 LNLAQLLLFAQQICEGMAYLHSQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAV-PE 159

Query: 67  SSNWTEFA----GTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-----KGKHPRDFLS 117
              +            + A E     K +   DV+SFGV   E++     K   P+ F  
Sbjct: 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE 219

Query: 118 SIS-SSSLNTDIELDEMLD--PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            I       T + L E+L+   RLP P    QE    +  +  +C     + RPT +
Sbjct: 220 MIGPKQGQMTVVRLIELLERGMRLPCPKNCPQE----VYILMKNCWETEAKFRPTFR 272

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 57.6 bits (139), Expect = 2e-10
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 20/155 (12%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 111 IAEGMAFIERKNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI 167

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 168 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM---------TNPEVIQNLER 218

Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
             R+P P    +E    + ++   C  E PE RPT
Sbjct: 219 GYRMPRPDNCPEE----LYELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 2e-10
 Identities = 30/112 (26%), Positives = 51/112 (45%), Gaps = 6/112 (5%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGI 59
               + L  S   + +  +   L++ H H       HRDL  +NLL++ E    +ADFG+
Sbjct: 89  KDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL----HRDLKPENLLINTEGVLKLADFGL 144

Query: 60  AKFLKPDSSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGK 110
           A+        +T +  T  Y APEL    K  +   D++S G +  E++  +
Sbjct: 145 ARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.1 bits (140), Expect = 2e-10
 Identities = 43/147 (29%), Positives = 75/147 (51%), Gaps = 10/147 (6%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 80
           AL++LH      I++RDL   N+LLD +    + D+G+ K  L P  +  T F GT  Y+
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYI 163

Query: 81  APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPA 140
           APE+    +     D ++ GVL  E++ G+ P D ++   +  +NT+  L +++  +   
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT--DNPDMNTEDYLFQVILEKPIR 221

Query: 141 PSRSVQEKLISIVKVAFSCLNESPESR 167
             R +  K   ++K     LN+ P+ R
Sbjct: 222 IPRFLSVKASHVLK---GFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 57.5 bits (139), Expect = 2e-10
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 18/150 (12%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT----YGYVAPELAYTMKI 90
           +HRDL+++N L+       ++DFG+++  + +   +T   G       + APE     + 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 91  TEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKL 149
           T + DV+S+G+L  E    G  P      +S+      IE       R+PAP    +E  
Sbjct: 173 TSESDVWSYGILLWETFSLGDTP---YPGMSNQQTRERIESGY----RMPAPQLCPEE-- 223

Query: 150 ISIVKVAFSCLNESPESRPTMKIVSQQLRI 179
             I ++   C    PE+RP+   +  +L+I
Sbjct: 224 --IYRLMLQCWAYDPENRPSFSEIYNELQI 251

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 57.9 bits (140), Expect = 2e-10
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 5/95 (5%)

Query: 19  VADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
           V  AL +LH H     +++RDL   N+LLD E    +ADFG+ K    +    T F GT 
Sbjct: 105 VTLALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            Y+APE+   ++     D ++ GVL  E++ G+ P
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 57.7 bits (139), Expect = 2e-10
 Identities = 56/179 (31%), Positives = 89/179 (49%), Gaps = 23/179 (12%)

Query: 1   DAAAQELDWSQRMNTIKGVA----DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVAD 56
           DA   ELD       I+ +     +AL YLH      I+HRDL + N+LL L+ +  +AD
Sbjct: 97  DAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLAD 153

Query: 57  FGI-AKFLKPDSSNWTEFAGTYGYVAPELAY--TMKITE---KCDVYSFGVLALEVIKGK 110
           FG+ AK +K        F GT  ++APE+    TMK T    K D++S G+  +E+ + +
Sbjct: 154 FGVSAKNVKTLQRR-DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 212

Query: 111 HPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            P   L     + +   +++ +   P L  PS+   E     +K A   L++ PE+RP+
Sbjct: 213 PPHHEL-----NPMRVLLKIAKSEPPTLSQPSKWSME-FRDFLKTA---LDKHPETRPS 262

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 57.4 bits (138), Expect = 2e-10
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 22/158 (13%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ +  + + +T   G   
Sbjct: 111 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKF 165

Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLSSISSSSLNTDIELDEM- 133
              + APE A   + T K DV+SFG+L  E+  KG+ P           +N ++ LD++ 
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREV-LDQVE 217

Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
              R+P P    +    S+  +   C  + PE RPT +
Sbjct: 218 RGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 57.5 bits (139), Expect = 3e-10
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 3/94 (3%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A AL +LH      I++RDL  +N+LLD E    + DFG++K           F GT  
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+      T+  D +SFGVL  E++ G  P
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 56.9 bits (137), Expect = 3e-10
 Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 34/168 (20%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF--LKPDSS----NWTE 72
           VA+ + YL       +VHRDL+++N+L+  +  A V+DFG+A+   +  D+S     WT 
Sbjct: 109 VAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT- 164

Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELD 131
                   APE     K + K DV+S+GVL  EV   G+ P      +S   +   +E  
Sbjct: 165 --------APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP---YPKMSLKEVKECVEKG 213

Query: 132 EMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             ++P    PA    +            SC    P+ RP+   + ++L
Sbjct: 214 YRMEPPEGCPADVYVLMT----------SCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 56.9 bits (137), Expect = 3e-10
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)

Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++   E  V+DFG+++ L+ D    
Sbjct: 108 QLVGMLRGIAAGMKYLSDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164

Query: 70  WTEFAGTYG--YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + APE     K T   DV+SFG++  EV+  G+ P
Sbjct: 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 56.7 bits (137), Expect = 4e-10
 Identities = 53/156 (33%), Positives = 74/156 (47%), Gaps = 19/156 (12%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSS--NWTEFA 74
           VA  + YL    F   VHRDL+++N +LD  +   VADFG+A+  + K   S  N T   
Sbjct: 107 VAKGMEYLASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163

Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNTDIELDEM 133
               ++A E   T K T K DV+SFGVL  E++ +G  P   + S        DI +  +
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-------DITVYLL 216

Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
              RL  P          + +V  SC +  PE RPT
Sbjct: 217 QGRRLLQPEYCPD----PLYEVMLSCWHPKPEMRPT 248

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 57.0 bits (137), Expect = 4e-10
 Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 3/106 (2%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L+  Q     + V  AL YLH      ++HRD+ S ++LL L+    ++DFG    +  D
Sbjct: 114 LNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                   GT  ++APE+        + D++S G++ +E++ G+ P
Sbjct: 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.7 bits (137), Expect = 4e-10
 Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 18/156 (11%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEF----AGTYGYVAPELAYTMKI 90
           VHRDL+++N+L++ E    + DFG+ K L  D   +       +  + Y APE     K 
Sbjct: 130 VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKF 188

Query: 91  TEKCDVYSFGVLALEVI----KGKHP-RDFLSSISSSSLNTDI--ELDEMLDP--RLPAP 141
           +   DV+SFGV+  E+     K   P  +F+  + +      I   L E+L    RLPAP
Sbjct: 189 SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAP 248

Query: 142 SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                E    I  +   C N  P  RP+   ++ Q+
Sbjct: 249 PGCPAE----IYAIMKECWNNDPSQRPSFSELALQV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.0 bits (138), Expect = 4e-10
 Identities = 48/149 (32%), Positives = 67/149 (44%), Gaps = 21/149 (14%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L YLH +    IV+RDL   NLLLD E    +ADFG+ K         + F GT  ++A
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLA 169

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSSLNTDIELDEMLDPR-L 138
           PE+      T   D +  GVL  E++ G+ P   D    +  S +N     DE+  PR L
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRFL 224

Query: 139 PAPSRSVQEKLISIVKVAFSCLNESPESR 167
              + S+  +L          L  +PE R
Sbjct: 225 SREAISIMRRL----------LRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (137), Expect = 4e-10
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 7/93 (7%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA--DFGIAKFLKPDSSNWTEFAGTYGY 79
           AL  LH      +++RDL  +N+LLD  Y+ H+A  DFG+ K    D      F GT  Y
Sbjct: 105 ALENLHK---FNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159

Query: 80  VAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           +APEL      T+  D ++ GVL  E++ G  P
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 56.6 bits (136), Expect = 5e-10
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 20/155 (12%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
           G    L+YLH      ++HRD+ + N+LL    +  +ADFG A    P +S    F GT 
Sbjct: 129 GALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTP 181

Query: 78  GYVAPELAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML 134
            ++APE+   M   +   K DV+S G+  +E+ + K P   L ++++ S    I  ++  
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQND-- 236

Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
                +P+    E   S       CL + P+ RP 
Sbjct: 237 -----SPTLQSNEWTDSFRGFVDYCLQKIPQERPA 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 56.1 bits (135), Expect = 6e-10
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 22/166 (13%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V+  + YL    F   VHRDL+++N+LL  ++ A ++DFG++K L  D S +   A + G
Sbjct: 104 VSMGMKYLEGKNF---VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAG 158

Query: 79  -----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDE 132
                + APE     K + + DV+S+G+   E    G+ P      +    + + IE  +
Sbjct: 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP---YKKMKGPEVMSFIEQGK 215

Query: 133 MLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
               RL  P+    E    +  +   C     E RP    V +++R
Sbjct: 216 ----RLDCPAECPPE----MYALMKDCWIYKWEDRPNFAKVEERMR 253

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 56.4 bits (137), Expect = 6e-10
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 14/98 (14%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V  AL YLH      IV+RDL  +NLLLD +    + DFG AK +K  +  +T   GT  
Sbjct: 110 VVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT-LCGTPE 163

Query: 79  YVAPEL----AYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+     Y   +    D ++ G+L  E++ G  P
Sbjct: 164 YLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 56.0 bits (135), Expect = 7e-10
 Identities = 48/163 (29%), Positives = 68/163 (41%), Gaps = 33/163 (20%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAG----TY 77
           LSYLH +    I+HRD+   NLL+D       +ADFG A  L    +   EF G    T 
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD---------FLSSISSSSLNTDI 128
            ++APE+    +    CDV+S G + +E+   K P +          +  I+S++    I
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232

Query: 129 ELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
              E L P L                V   CL   PE RP  +
Sbjct: 233 P--EHLSPGLR--------------DVTLRCLELQPEDRPPSR 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 55.9 bits (135), Expect = 7e-10
 Identities = 38/137 (27%), Positives = 59/137 (43%), Gaps = 13/137 (9%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL S N+LL       + D GI+K LK + +  T+  GT  Y+APE+      + K
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQI-GTPHYMAPEVWKGRPYSYK 181

Query: 94  CDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIV 153
            D++S G L  E+     P     + S   L   +        + P       + L + +
Sbjct: 182 SDIWSLGCLLYEMATFAPP---FEARSMQDLRYKV-----QRGKYPPIPPIYSQDLQNFI 233

Query: 154 KVAFSCLNESPESRPTM 170
           +   S L   P+ RP  
Sbjct: 234 R---SMLQVKPKLRPNC 247

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 55.9 bits (135), Expect = 9e-10
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTY 77
           +A  L +LH      I++RDL   N++LD E    +ADFG+ K  +    +  T F GT 
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
            Y+APE+       +  D ++FGVL  E++ G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 55.9 bits (134), Expect = 1e-09
 Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 20/155 (12%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
           G    L+YLH      ++HRD+ + N+LL    +  +ADFG A    P +S    F GT 
Sbjct: 133 GALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTP 185

Query: 78  GYVAPELAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML 134
            ++APE+   M   +   K DV+S G+  +E+ + K P   L ++++ S    I  +E  
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE-- 240

Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
                +P+    E          SCL + P+ RPT
Sbjct: 241 -----SPTLQSNEWSDYFRNFVDSCLQKIPQDRPT 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 1e-09
 Identities = 35/91 (38%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
           AL YLH      IV+RDL  +N+LLD E    + DFG AK L+     WT   GT  Y+A
Sbjct: 113 ALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWT-LCGTPEYLA 166

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ G+L  E++ G  P
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 55.0 bits (132), Expect = 2e-09
 Identities = 40/142 (28%), Positives = 62/142 (43%), Gaps = 23/142 (16%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           ++HRD+ SKN+ L    +  + DFG A+ L    +    + GT  YV PE+   M    K
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNK 180

Query: 94  CDVYSFGVLALEVIKGKHP------RDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQE 147
            D++S G +  E+   KHP      ++ +  +   S               P PS    E
Sbjct: 181 SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-------------PLPSHYSYE 227

Query: 148 KLISIVKVAFSCLNESPESRPT 169
            L S++K  F     +P SRP+
Sbjct: 228 -LRSLIKQMF---KRNPRSRPS 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.0 bits (132), Expect = 2e-09
 Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 3/96 (3%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A  L +LH      I++RDL   N++LD E    +ADFG+ K    D      F GT  
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
           Y+APE+       +  D ++FGVL  E++ G+ P +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.1 bits (133), Expect = 2e-09
 Identities = 48/157 (30%), Positives = 66/157 (42%), Gaps = 27/157 (17%)

Query: 22  ALSYL--HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGY 79
           AL YL   H     ++HRD+   N+LLD      + DFGI+  L  DS   T  AG   Y
Sbjct: 126 ALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAKTRSAGCAAY 180

Query: 80  VAPELAYTMKITEK----CDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIE-LDEML 134
           +APE         K     DV+S G+  +E+  G+ P          +  T+ E L ++L
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK--------NCKTEFEVLTKIL 232

Query: 135 D---PRLPAPSRSVQEKLISIVKVAFSCLNESPESRP 168
               P LP P+        S V     CL +    RP
Sbjct: 233 QEEPPSLP-PNEGFSPDFCSFVD---LCLTKDHRKRP 265

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 54.9 bits (132), Expect = 2e-09
 Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 3/90 (3%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 82
           L +LH      I++RDL  +N+LLD +    ++D G+A  LK   S    +AGT G++AP
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAP 166

Query: 83  ELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           EL    +     D ++ GV   E+I  + P
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.0 bits (132), Expect = 2e-09
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 3/96 (3%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           ++  L +LH      I++RDL   N++LD E    +ADFG+ K    D      F GT  
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD 166

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
           Y+APE+       +  D +++GVL  E++ G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.6 bits (131), Expect = 3e-09
 Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 17/156 (10%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           +A  +SYL       +VHRDL+++N+L+       + DFG+A+ L  D + +    G   
Sbjct: 118 IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174

Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLD 135
             ++A E     + T + DV+S+GV   E++  G  P D    I +  +   +E  E   
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD---GIPAREIPDLLEKGE--- 228

Query: 136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            RLP P     +  + +VK    C     E RP  +
Sbjct: 229 -RLPQPPICTIDVYMIMVK----CWMIDSECRPRFR 259

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 3e-09
 Identities = 46/174 (26%), Positives = 71/174 (40%), Gaps = 43/174 (24%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++     L+YLH +    ++HRD+  +N+LL    E  + DFG++  L         F G
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIG 175

Query: 76  TYGYVAPELAYTMK-----ITEKCDVYSFGVLALEVIKGK------HPRDFLSSISSSSL 124
           T  ++APE+    +        + DV+S G+ A+E+  GK      HP   L  I     
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI----- 230

Query: 125 NTDIELDEMLDPRLPAPSRSVQEK-------LISIVKVAFSCLNESPESRPTMK 171
                      PR P P+    E         IS       CL ++ E RP M+
Sbjct: 231 -----------PRNPPPTLKSPENWSKKFNDFIS------ECLIKNYEQRPFME 267

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.5 bits (131), Expect = 3e-09
 Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 3/94 (3%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL +LH      I++RDL   N+LLD E    +ADFG+ K    +    + F GT  
Sbjct: 105 ITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD 161

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+   M      D ++ GVL  E++ G  P
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 54.2 bits (131), Expect = 3e-09
 Identities = 45/164 (27%), Positives = 66/164 (40%), Gaps = 25/164 (15%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF--------LKPDSSNWTEF 73
           AL YLH +    I+HRDL   N+L+D      + DFG++K         L  D       
Sbjct: 105 ALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSSLNTDIELD 131
            GT  Y+APE+      ++  D +S G +  E + G  P   +    I  + LN  IE  
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221

Query: 132 EMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
           E  D  +   +  +  KL          L   PE R   K + +
Sbjct: 222 E--DVEVSDEAIDLISKL----------LVPDPEKRLGAKSIEE 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (131), Expect = 3e-09
 Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 6/93 (6%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           AL +LH +D    IV+RDL  +N+LLD      + DFG++K    D+     F GT  Y+
Sbjct: 108 ALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYL 163

Query: 81  APELAYTMK-ITEKCDVYSFGVLALEVIKGKHP 112
           APE+    K  T+  D +S GVL  E+  G  P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 54.3 bits (131), Expect = 4e-09
 Identities = 30/90 (33%), Positives = 43/90 (47%), Gaps = 4/90 (4%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L YLH +    I+HRDL   NLLL  +    +ADFG+A+     +   T    T  Y A
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRA 176

Query: 82  PELAYTMKI-TEKCDVYSFGVLALEVIKGK 110
           PEL       T   D+++ G +  E++  K
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 54.2 bits (130), Expect = 4e-09
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 17/156 (10%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  D   +    G   
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLD 135
             ++A E       T + DV+S+GV   E++  G  P D    I +S +++ +E  E   
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEISSILEKGE--- 228

Query: 136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            RLP P     +  + +VK    C     +SRP  +
Sbjct: 229 -RLPQPPICTIDVYMIMVK----CWMIDADSRPKFR 259

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 53.8 bits (129), Expect = 4e-09
 Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 19/169 (11%)

Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 107 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163

Query: 70  WTEFAGTYG--YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNT 126
           +T   G     + APE     K T   DV+S+G++  EV+  G+ P   +S       N 
Sbjct: 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS-------NQ 216

Query: 127 DIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM-KIVS 174
           D+        RLPAP     +   ++ ++   C  +    RP   +IVS
Sbjct: 217 DVIKAIEEGYRLPAP----MDCPAALHQLMLDCWQKDRNERPKFEQIVS 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 54.3 bits (130), Expect = 4e-09
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 3/94 (3%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH      IV+RDL  +NL+LD +    + DFG+ K    D++    F GT  
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 5e-09
 Identities = 30/108 (27%), Positives = 47/108 (43%), Gaps = 13/108 (12%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK--FLK 64
            DW++    I  V   +  LH      I+HRD+  +NLL+D      + DFG+++     
Sbjct: 96  EDWAK--QYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN 150

Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                   F GT  Y+APE    +   +  D +S G +  E + G  P
Sbjct: 151 KK------FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 54.5 bits (131), Expect = 5e-09
 Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 15/103 (14%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLL---DLEYEAHVADFGIAKFLKPDSSNW----- 70
           V DAL+  H+     IVHRDL  +N+++    +   A V DFGI   L P   +      
Sbjct: 88  VLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDADVATL 143

Query: 71  ---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 110
              TE  GT  Y APE      +T   D+Y++G++ LE + G+
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.5 bits (128), Expect = 6e-09
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 2/94 (2%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH +    +V+RDL  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 104 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 161

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.2 bits (128), Expect = 8e-09
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 8/94 (8%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK--FLK-PDSSNWTEFAGTYG 78
           AL Y+H      + HRDL  KN+L + + +  + DFG+A+  F   P +  WT++  T  
Sbjct: 115 ALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 79  YVAPEL--AYTMKITEKCDVYSFGVLALEVIKGK 110
           Y APEL  ++  K T   D++S G +  EV+ GK
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 53.0 bits (127), Expect = 8e-09
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 18/159 (11%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE---- 72
           K + D ++YLH++C   +VHRD+   N++L       + DFG A+ L     + T     
Sbjct: 109 KQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165

Query: 73  --FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIEL 130
               GT  ++APE+        K D++S G    E+  GK P   L+S+   +    I  
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP---LASMDRLAAMFYIGA 222

Query: 131 DEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
              L PRLP    S     I  V    SCL      RP+
Sbjct: 223 HRGLMPRLP---DSFSAAAIDFVT---SCLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 53.2 bits (127), Expect = 8e-09
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 24/158 (15%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            LS+LH      ++HRD+  +N+LL    E  + DFG++  L         F GT  ++A
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 179

Query: 82  PELAYTMKITE-----KCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDP 136
           PE+    +  +     K D++S G+ A+E+ +G  P   +  + +            L P
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----------FLIP 229

Query: 137 RLPAP---SRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           R PAP   S+   +K  S ++   SCL ++   RPT +
Sbjct: 230 RNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPTTE 264

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 53.2 bits (128), Expect = 8e-09
 Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 32/164 (19%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
            +  AL YLH      ++HRD+   N+L++   +  + DFGI+ +L  DS   T  AG  
Sbjct: 111 SIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCK 167

Query: 78  GYVAPEL--------AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIE 129
            Y+APE          Y +    K DV+S G+  +E+  G+ P D        S  T  +
Sbjct: 168 PYMAPERINPELNQKGYDV----KSDVWSLGITMIELATGRFPYD--------SWKTPFQ 215

Query: 130 -LDEMLD---PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            L ++++   P+LPA   S +            CL ++ + RP 
Sbjct: 216 QLKQVVEEPSPQLPAEKFSPE-----FQDFVNKCLKKNYKERPN 254

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 53.1 bits (127), Expect = 9e-09
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 14/147 (9%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY--GYVAPELAYTMKIT 91
           +VHRDL+++N+L+       + DFG+A+ L+ D   +    G     ++A E  +  K T
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 92  EKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLI 150
            + DV+S+GV   E++  G  P D    I +  +   +E  E    RLP P        I
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYD---GIPTREIPDLLEKGE----RLPQPPICT----I 238

Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            +  V   C     +SRP  K ++ + 
Sbjct: 239 DVYMVMVKCWMIDADSRPKFKELAAEF 265

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 52.9 bits (128), Expect = 1e-08
 Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 13/95 (13%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYV 80
            L YLH +    I+HRD+   N+L++ +    +ADFG+A+     +S ++T    T  Y 
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR 168

Query: 81  APEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
            PEL      Y  ++    D++S G +  E+  GK
Sbjct: 169 PPELLLGATRYGPEV----DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 52.9 bits (127), Expect = 1e-08
 Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 1/79 (1%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           IV+RDL  +N+LLD      ++D G+A  L          AGT GY+APE+         
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ G    E+I G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 52.7 bits (126), Expect = 1e-08
 Identities = 39/133 (29%), Positives = 65/133 (48%), Gaps = 7/133 (5%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTY 77
           +A AL YLH      IV+RDL  +N+LLD +    + DFG+ K  ++ + +  T F GT 
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTP 160

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPR 137
            Y+APE+ +        D +  G +  E++ G  P  F S  ++   +  +     L P 
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP--FYSRNTAEMYDNILNKPLQLKPN 218

Query: 138 LPAPSRSVQEKLI 150
           +   +R + E L+
Sbjct: 219 ITNSARHLLEGLL 231

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 52.7 bits (126), Expect = 1e-08
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 20/159 (12%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
           G    L+YLH      ++HRD+ + N+LL       + DFG A  + P +     F GT 
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTP 175

Query: 78  GYVAPELAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML 134
            ++APE+   M   +   K DV+S G+  +E+ + K P   L ++++ S    I  +E  
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE-- 230

Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
            P L   S    E   + V    SCL + P+ RPT +++
Sbjct: 231 SPAL--QSGHWSEYFRNFVD---SCLQKIPQDRPTSEVL 264

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 52.7 bits (126), Expect = 1e-08
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 4/91 (4%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L  LH +    IV+RDL  +N+LLD      ++D G+A  + P+        GT GY+A
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMA 169

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+    + T   D ++ G L  E+I G+ P
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 52.3 bits (125), Expect = 1e-08
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 3/94 (3%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V  ALSYLH+     ++HRD+ S ++LL  +    ++DFG    +  +        GT  
Sbjct: 127 VLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           ++APE+   +    + D++S G++ +E+I G+ P
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 52.3 bits (125), Expect = 1e-08
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 16/161 (9%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 111 IAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 167

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L +E++  G+ P      +S+  +   +E       
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP---YPGMSNPEVIRALERGY---- 220

Query: 137 RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           R+P P    +E    +  +   C    PE RPT + +   L
Sbjct: 221 RMPRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 52.2 bits (125), Expect = 1e-08
 Identities = 36/130 (27%), Positives = 58/130 (44%), Gaps = 19/130 (14%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIA---KFLKPDSSNWTEFAGTYGYVAPE-LAYTMK 89
           +V+RDL   N+LLD      ++D G+A      KP +S      GT+GY+APE L   + 
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 172

Query: 90  ITEKCDVYSFGVLALEVIKGKHPRDFLSS-----ISSSSLNTDIELDEMLDPRLPAP--- 141
                D +S G +  ++++G  P     +     I   +L   +EL +   P L +    
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 232

Query: 142 --SRSVQEKL 149
              R V  +L
Sbjct: 233 LLQRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 52.4 bits (126), Expect = 1e-08
 Identities = 44/165 (26%), Positives = 68/165 (41%), Gaps = 37/165 (22%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT------- 71
           +A+ + YL    F   +HRDL+++N+LL  + +  + DFG+ + L  +  ++        
Sbjct: 106 IANGMRYLESKRF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162

Query: 72  EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP------RDFLSSISSSSL 124
            FA    + APE   T   +   DV+ FGV   E+   G+ P         L  I     
Sbjct: 163 PFA----WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----- 213

Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
             D E +     RL  P    Q+    I  V   C   +P  RPT
Sbjct: 214 --DKEGE-----RLERPEACPQD----IYNVMLQCWAHNPADRPT 247

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.9 bits (124), Expect = 2e-08
 Identities = 31/101 (30%), Positives = 52/101 (51%), Gaps = 2/101 (1%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           IV+RD+  +N+LLD +    ++D G+A  L  D    T+ AGT GY+APE+      +  
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSYP 174

Query: 94  CDVYSFGVLALEVIKGKHP-RDFLSSISSSSLNTDIELDEM 133
            D ++ G    E++ G+ P +D    ++   L      DE+
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 51.8 bits (125), Expect = 2e-08
 Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 4/90 (4%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L YLH   +  I+HRDL   NLL+  +    +ADFG+A+     +   T    T  Y A
Sbjct: 114 GLEYLH-SNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRA 170

Query: 82  PELAYTMKI-TEKCDVYSFGVLALEVIKGK 110
           PEL +  +      D++S G +  E++   
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 51.7 bits (124), Expect = 2e-08
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 3/91 (3%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
           AL YLH      +V+RDL  +NL+LD +    + DFG+ K    D +    F GT  Y+A
Sbjct: 107 ALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+          D +  GV+  E++ G+ P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 51.9 bits (124), Expect = 3e-08
 Identities = 27/94 (28%), Positives = 49/94 (52%), Gaps = 3/94 (3%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V  ALS LH      ++HRD+ S ++LL  +    ++DFG    +  +        GT  
Sbjct: 125 VLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 181

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           ++APEL   +    + D++S G++ +E++ G+ P
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.9 bits (124), Expect = 3e-08
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH      +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 51.5 bits (123), Expect = 3e-08
 Identities = 49/179 (27%), Positives = 73/179 (40%), Gaps = 31/179 (17%)

Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
            Q LD +     + G    L +LH++    I+HRD+   N+LL  E    + DFG++  L
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178

Query: 64  KPDSSNWTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFGVLALEVIKGK------HP 112
                      GT  ++APE+      Y      +CDV+S G+ A+E+  G       HP
Sbjct: 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238

Query: 113 RDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLI-SIVKVAFSCLNESPESRPTM 170
              L  I                PR P P+    EK   S       CL +  E+RP++
Sbjct: 239 VKTLFKI----------------PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 51.8 bits (124), Expect = 3e-08
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 2/91 (2%)

Query: 26  LHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPE 83
           +HH     ++HRD+ S N+LL       + DFG +K      S+     F GT  YVAPE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 84  LAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
           +      ++K D++S GVL  E++  K P D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.6 bits (123), Expect = 3e-08
 Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 15/145 (10%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY---GYVAPELAYTMKIT 91
           VHRDL+++N+LL       + DFG+A+ +  D SN+     T+    ++APE  +    T
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFDNLYT 317

Query: 92  EKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLI 150
              DV+S+G+L  E+   G  P  +   I  S+    I+       R+  P  + QE   
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTP--YPGMIVDSTFYNKIKSGY----RMAKPDHATQE--- 368

Query: 151 SIVKVAFSCLNESPESRPTMKIVSQ 175
            +  +   C N  PE RP+   +S 
Sbjct: 369 -VYDIMVKCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 51.2 bits (123), Expect = 4e-08
 Identities = 45/162 (27%), Positives = 68/162 (41%), Gaps = 30/162 (18%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
              AL+YL  +    I+HRD+   N+LLD      + DFGI+  L  DS   T  AG   
Sbjct: 116 TVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDAGCRP 172

Query: 79  YVAPELAYTMKITE--------KCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIEL 130
           Y+APE     +I          + DV+S G+   EV  GK P    +S+         +L
Sbjct: 173 YMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD-------QL 220

Query: 131 DEMLD---PRL-PAPSRSVQEKLISIVKVAFSCLNESPESRP 168
            +++    P L  +  R      ++ +     CL +    RP
Sbjct: 221 TQVVKGDPPILSNSEEREFSPSFVNFIN---LCLIKDESKRP 259

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 51.0 bits (122), Expect = 4e-08
 Identities = 30/82 (36%), Positives = 45/82 (54%), Gaps = 2/82 (2%)

Query: 26  LHHDCFPPIVHRDLSSKNLLLDLEYE-AHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL 84
           LHH     I+HRDL ++N+LLD       + DFGI+K L   S  +T   GT  Y++PEL
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPEL 172

Query: 85  AYTMKITEKCDVYSFGVLALEV 106
                  +K D+++ G +  E+
Sbjct: 173 CEGKPYNQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 51.0 bits (122), Expect = 4e-08
 Identities = 29/79 (36%), Positives = 43/79 (54%), Gaps = 1/79 (1%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           IV+RDL  +N+LLD      ++D G+A  + P+        GT GY+APE+    + T  
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAPEVVKNERYTFS 181

Query: 94  CDVYSFGVLALEVIKGKHP 112
            D +  G L  E+I+GK P
Sbjct: 182 PDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.2 bits (123), Expect = 4e-08
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 8/90 (8%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL--KPD--SSNWTEFAGTYG 78
           L Y+H      ++HRDL   NLL++ + E  + DFG+A+ L   P       TE+  T  
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 79  YVAPELAYTM-KITEKCDVYSFGVLALEVI 107
           Y APEL  ++ + T   D++S G +  E++
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 51.1 bits (122), Expect = 4e-08
 Identities = 40/123 (32%), Positives = 58/123 (47%), Gaps = 11/123 (8%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 80
           AL +LH      IV+RD+  +N+LLD E    + DFG++K FL  +      F GT  Y+
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 81  APELAYTMKITEKC-DVYSFGVLALEVIKGKHP------RDFLSSISSSSLNTDIELDEM 133
           APE+        K  D +S G+L  E++ G  P      R+  S +S   L  D      
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF 233

Query: 134 LDP 136
           + P
Sbjct: 234 IGP 236

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 51.2 bits (122), Expect = 4e-08
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL       + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260

Query: 93  KCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD--PRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L +     +  D E    L    R+ AP  +  E   
Sbjct: 261 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 310

Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 311 -MYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 50.8 bits (121), Expect = 5e-08
 Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 6/88 (6%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V +A+ YL  + F   VHRDL+++N+L+  +  A V+DFG+    K  SS          
Sbjct: 111 VCEAMEYLEANNF---VHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVK 164

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEV 106
           + APE     K + K DV+SFG+L  E+
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.8 bits (121), Expect = 6e-08
 Identities = 29/79 (36%), Positives = 43/79 (54%), Gaps = 1/79 (1%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           IV+RDL  +N+LLD      ++D G+A  + P+        GT GY+APE+    K T  
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKYTFS 181

Query: 94  CDVYSFGVLALEVIKGKHP 112
            D +  G L  E+I+G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 50.7 bits (121), Expect = 6e-08
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 4/91 (4%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L  LH +     V+RDL  +N+LLD      ++D G+A  + P+  +     GT GY+A
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGYMA 169

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+    + T   D +  G L  E+I+G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.8 bits (121), Expect = 6e-08
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 15/139 (10%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL       + DFG+A+  +  PD            ++APE  +    T 
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255

Query: 93  KCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLIS- 151
           + DV+SFGVL  E+           S+ +S     ++++E    RL   +R    +  + 
Sbjct: 256 QSDVWSFGVLLWEIF----------SLGASPY-PGVQINEEFCQRLKDGTRMRAPENATP 304

Query: 152 -IVKVAFSCLNESPESRPT 169
            I ++  +C    P+ RPT
Sbjct: 305 EIYRIMLACWQGDPKERPT 323

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 6e-08
 Identities = 23/65 (35%), Positives = 37/65 (56%), Gaps = 6/65 (9%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK-PDSSNWTEFAGTYGY 79
           A++Y H H+    I+HRD+  +N+L+       + DFG A+ L+   +S  T++  T  Y
Sbjct: 112 AIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWY 167

Query: 80  VAPEL 84
            APEL
Sbjct: 168 RAPEL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 50.1 bits (120), Expect = 8e-08
 Identities = 22/85 (25%), Positives = 42/85 (49%), Gaps = 5/85 (5%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGI 59
           +   + +        I     A+++ H H+C    +HRD+  +N+L+  + +  + DFG 
Sbjct: 91  EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGF 146

Query: 60  AKFLKPDSSNWTEFAGTYGYVAPEL 84
           A+ L     ++T++  T  Y APEL
Sbjct: 147 ARILTGPGDDYTDYVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 50.0 bits (119), Expect = 9e-08
 Identities = 36/142 (25%), Positives = 63/142 (44%), Gaps = 8/142 (5%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           ++HRD+   N+ +       + D G+ +F    ++      GT  Y++PE  +      K
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186

Query: 94  CDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIV 153
            D++S G L  E+   + P  +   ++  SL   IE  +   P  P P+    EKL  +V
Sbjct: 187 SDIWSLGCLLYEMAALQSPF-YGDKMNLFSLCQKIEQCDY--P--PLPTEHYSEKLRELV 241

Query: 154 KVAFSCLNESPESRPTMKIVSQ 175
            +   C+   P+ RP +  V Q
Sbjct: 242 SM---CIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 50.2 bits (120), Expect = 1e-07
 Identities = 40/139 (28%), Positives = 63/139 (45%), Gaps = 15/139 (10%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL       + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 93  KCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD--PRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L +     +  D E    L    R+ AP  +  E   
Sbjct: 255 QSDVWSFGVLLWEIFS-------LGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPE--- 304

Query: 151 SIVKVAFSCLNESPESRPT 169
            I  +   C + +PE RPT
Sbjct: 305 -IYSIMLDCWHNNPEDRPT 322

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 49.8 bits (120), Expect = 1e-07
 Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 15/98 (15%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---NWTEFAGTYG 78
            L YLH      ++HRDL   N+L++   +  + DFG+A+ + PD       TE+  T  
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 79  YVAPEL-----AYTMKITEKCDVYSFGVLALEVIKGKH 111
           Y APEL      YT  I    D++S G +  E++  K 
Sbjct: 172 YRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 49.6 bits (118), Expect = 1e-07
 Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 25/157 (15%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L+YLH       +HRD+   N+LL    +  +ADFG+A  +    +    F GT  ++A
Sbjct: 118 GLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174

Query: 82  PELAYTMK---ITEKCDVYSFGVLALEVIKGK------HPRDFLSSISSSSLNTDIELDE 132
           PE+A   K     + CD+++ G+ A+E+ + +      HP   L  +S S+         
Sbjct: 175 PEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP------ 228

Query: 133 MLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
              P+L   ++       + VK++   L ++P+ RPT
Sbjct: 229 ---PKLKDKTKW-SSTFHNFVKIS---LTKNPKKRPT 258

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.8 bits (119), Expect = 1e-07
 Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 13/127 (10%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPELAYTMKITEK 93
           VHRD+  +N+L+D      +ADFG A  L  +   N     GT  Y+APE+  TM    K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 94  ------CDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML----DPRLPAPSR 143
                 CD +S GV+A E+I G+ P  F    S+ + N  +     L    DP++ +   
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP--FHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFL 241

Query: 144 SVQEKLI 150
            + + L+
Sbjct: 242 DLIQSLL 248

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 49.8 bits (119), Expect = 1e-07
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 80
           AL +LH      I++RD+  +N+LLD E    + DFG++K FL  +      F GT  Y+
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173

Query: 81  APELAYTMKI--TEKCDVYSFGVLALEVIKGKHP 112
           APE+         +  D +S GVL  E++ G  P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.0 bits (119), Expect = 1e-07
 Identities = 33/94 (35%), Positives = 46/94 (48%), Gaps = 3/94 (3%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A AL YLH      IV+RDL  +N+LLD +    + DFG+ K     S   T F GT  
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPE 161

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  G +  E++ G  P
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 49.3 bits (118), Expect = 1e-07
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 5/93 (5%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
             L YLH       VHRD+   N+L+D      +ADFG+AK +  + S    F G+  ++
Sbjct: 113 LGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWM 168

Query: 81  APE-LAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           APE +A         D++S G   LE+  GK P
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 49.4 bits (118), Expect = 2e-07
 Identities = 40/156 (25%), Positives = 61/156 (39%), Gaps = 16/156 (10%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +   ++YLH      IVHRD+   NLL++      +ADFG+++ L           GT  
Sbjct: 177 ILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIA 233

Query: 79  YVAPE-----LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEM 133
           Y++PE     L +        D++S GV  LE   G+ P         +SL   I    M
Sbjct: 234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CM 290

Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
             P  P    +   +    +     CL   P  R +
Sbjct: 291 SQP--PEAPATASREFRHFISC---CLQREPAKRWS 321

Length = 353

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 49.4 bits (118), Expect = 2e-07
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 29/187 (15%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYL--HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFG 58
           +     LD S  ++    +A  + YL  HH      VHRDL+++N L+       ++DFG
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFG 169

Query: 59  IAKFLKPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPR 113
           +++ +   S+++            ++ PE     K T + D++SFGV+  E+   G  P 
Sbjct: 170 LSRDIY--SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227

Query: 114 DFLSSISSSSLNTDIELDEMLDPR--LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
              S         + E+ EM+  R  LP P          +  +   C NE P  RP  K
Sbjct: 228 YGFS---------NQEVIEMIRSRQLLPCPEDCPA----RVYALMIECWNEIPARRPRFK 274

Query: 172 IVSQQLR 178
            +  +LR
Sbjct: 275 DIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 2e-07
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 6/93 (6%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGY 79
           + YLH +    IVHRD+   N+L D      + DFG +K L+   S+ T      GT  +
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 80  VAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           ++PE+        K DV+S G   +E++  K P
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 49.4 bits (118), Expect = 2e-07
 Identities = 35/91 (38%), Positives = 46/91 (50%), Gaps = 6/91 (6%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
           A  YLH      I++RDL  +NLLLD +    V DFG AK  K     +T   GT  Y+A
Sbjct: 130 AFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT-LCGTPEYLA 183

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E I G  P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 49.3 bits (117), Expect = 2e-07
 Identities = 39/152 (25%), Positives = 67/152 (44%), Gaps = 11/152 (7%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
           AL ++H      ++HRD+   N+ +       + D G+ +F    ++      GT  Y++
Sbjct: 118 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAP 141
           PE  +      K D++S G L  E+   + P  +   ++  SL   IE  +      P P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEQCDY----PPLP 229

Query: 142 SRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
           S    E+L  +V +   C+N  PE RP +  V
Sbjct: 230 SDHYSEELRQLVNM---CINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 2e-07
 Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 13/108 (12%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYG 78
            L Y+H      ++HRDL   NLLL+   +  + DFG+A+   P+  +    TE+  T  
Sbjct: 118 GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 79  YVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFLSSI 119
           Y APE+    K  T+  D++S G +  E++       GK     L+ I
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI 222

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 2e-07
 Identities = 29/84 (34%), Positives = 43/84 (51%), Gaps = 6/84 (7%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA-GTYGYVAPELAYTM----- 88
           VHRD+   N+LLD      +ADFG    L  D +  +  A GT  Y++PE+   M     
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 89  KITEKCDVYSFGVLALEVIKGKHP 112
           +   +CD +S GV   E++ G+ P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.5 bits (118), Expect = 2e-07
 Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 26/169 (15%)

Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT- 76
           VA  +S+L   +C    +HRDL+++N+LL       + DFG+A+ ++ D SN+       
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRND-SNYVVKGNAR 277

Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML 134
               ++APE  +    T + DV+S+G+L  E+         L S     +  D +  +M+
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS-------LGSSPYPGMPVDSKFYKMI 330

Query: 135 DP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK----IVSQQL 177
               R+ +P  +  E +  I+K   SC +  P  RPT K    ++ QQL
Sbjct: 331 KEGYRMLSPECAPSE-MYDIMK---SCWDADPLKRPTFKQIVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 49.2 bits (117), Expect = 2e-07
 Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 9/84 (10%)

Query: 34  IVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFA----GTYGYVAPELAYTM 88
           I+HRD+ S+N+ L      A + DFGIA+ L    ++  E A    GT  Y++PE+    
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCVGTPYYLSPEICQNR 177

Query: 89  KITEKCDVYSFGVLALEVIKGKHP 112
               K D++S G +  E+   KHP
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 49.0 bits (117), Expect = 2e-07
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 11/157 (7%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL ++H      I+HRD+   N+ +       + D G+ +F    ++      GT  
Sbjct: 115 LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL 138
           Y++PE  +      K D++S G L  E+   + P  +   ++  SL   IE  +   P L
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEKCDY--PPL 228

Query: 139 PAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
           PA   S  E+L  +V     C+N  PE RP +  V Q
Sbjct: 229 PADHYS--EELRDLVSR---CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 49.2 bits (117), Expect = 2e-07
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 13/132 (9%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT 76
           K   +AL+YLH +    I+HRDL + N+L  L+ +  +ADFG++            F GT
Sbjct: 110 KQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT 166

Query: 77  YGYVAPELAYTMKITE-----KCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELD 131
             ++APE+       +     K DV+S G+  +E+ + + P   L     + +   +++ 
Sbjct: 167 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIA 221

Query: 132 EMLDPRLPAPSR 143
           +   P L  PSR
Sbjct: 222 KSEPPTLAQPSR 233

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.2 bits (117), Expect = 2e-07
 Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 6/84 (7%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA-GTYGYVAPELAYTM----- 88
           VHRD+   N+LLD+     +ADFG    +  D +  +  A GT  Y++PE+   M     
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 89  KITEKCDVYSFGVLALEVIKGKHP 112
           K   +CD +S GV   E++ G+ P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 49.1 bits (117), Expect = 2e-07
 Identities = 28/101 (27%), Positives = 50/101 (49%), Gaps = 4/101 (3%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L   Q +   K + + L YLH      I+HRD+ ++N+ ++   +  + D G A+F    
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVV 209

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
           +  +   AGT    APE+    K   K D++S G++  E++
Sbjct: 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 49.0 bits (117), Expect = 2e-07
 Identities = 26/96 (27%), Positives = 50/96 (52%), Gaps = 3/96 (3%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT 76
             V  ALS+LH      ++HRD+ S ++LL  +    ++DFG    +  +        GT
Sbjct: 122 LAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGT 178

Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             ++APE+   +    + D++S G++ +E++ G+ P
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 48.8 bits (116), Expect = 2e-07
 Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 10/112 (8%)

Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
           EL  SQ ++    +A  + YL    F   VHRDL+++N L+       + DFG+++ +  
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY- 174

Query: 66  DSSNWTEFAG----TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
            S+++    G       ++ PE     K T + DV+SFGV+  E+   GK P
Sbjct: 175 -STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.9 bits (116), Expect = 3e-07
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 12/98 (12%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA-GTYGY 79
           D++  LH+      VHRD+   N+L+D+     +ADFG    L  D +  +  A GT  Y
Sbjct: 116 DSVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 169

Query: 80  VAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHP 112
           ++PE+   M     K   +CD +S GV   E++ G+ P
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 48.8 bits (116), Expect = 3e-07
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 5/95 (5%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTY 77
           VA A+ YLH      I++RDL  +N+LLD +    + DFG+ K  ++P+ +  T F GT 
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTP 160

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            Y+APE+          D +  G +  E++ G  P
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.5 bits (115), Expect = 3e-07
 Identities = 33/116 (28%), Positives = 54/116 (46%), Gaps = 14/116 (12%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIA---KFLKPDSSNWTEFAGTYGYVAPE-LAYTMK 89
           +V+RDL   N+LLD      ++D G+A      KP +S      GT+GY+APE L     
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGTA 172

Query: 90  ITEKCDVYSFGVLALEVIKG-----KHPRDFLSSISSSSLNTDIELDEMLDPRLPA 140
                D +S G +  ++++G     +H       I   +L  ++EL +   P L +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKS 228

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 48.6 bits (116), Expect = 3e-07
 Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 3/94 (3%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A AL YLH      I++RDL  +N+LLD +    + DFG+ K     S   + F GT  
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  G +  E++ G  P
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 48.7 bits (116), Expect = 3e-07
 Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 7/89 (7%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 82
           L Y+H      +VHRDL   N+L++   +  + DFG+A   +      T +  T  Y AP
Sbjct: 121 LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLA---RIQDPQMTGYVSTRYYRAP 174

Query: 83  ELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           E+  T  K   + D++S G +  E+++GK
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 48.6 bits (116), Expect = 3e-07
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 30/149 (20%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT------YGYVAPELAYT 87
            +HRDL+++N+L+  ++   +ADFG+A+    D  +   +  T        ++APE  + 
Sbjct: 153 CIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKTTNGRLPVKWMAPEALFD 208

Query: 88  MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD-----PRLPAPS 142
              T + DV+SFGVL  E+           ++  S     I ++E+        R+  P 
Sbjct: 209 RVYTHQSDVWSFGVLLWEIF----------TLGGSPYPG-IPVEELFKLLKEGYRMEKPQ 257

Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
              QE    +  +   C +E P  RPT K
Sbjct: 258 NCTQE----LYHLMRDCWHEVPSQRPTFK 282

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 48.5 bits (115), Expect = 3e-07
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 24/156 (15%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L++LH      ++HRD+  +N+LL    E  + DFG++  L         F GT  ++A
Sbjct: 133 GLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 189

Query: 82  PELAYTMKITE-----KCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDP 136
           PE+    +  +     + D++S G+ A+E+ +G  P   +  + +            L P
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----------FLIP 239

Query: 137 RLPAP---SRSVQEKLISIVKVAFSCLNESPESRPT 169
           R P P   S+   +K I  ++    CL ++  SRP+
Sbjct: 240 RNPPPKLKSKKWSKKFIDFIE---GCLVKNYLSRPS 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 48.4 bits (115), Expect = 4e-07
 Identities = 37/147 (25%), Positives = 75/147 (51%), Gaps = 14/147 (9%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG--TYGYVAPELAYTMKIT 91
           +VHRDL+++N+L+    +  ++DFG+++ +  + S      G     ++A E  +    T
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT 207

Query: 92  EKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLI 150
            + DV+SFGVL  E++  G +P      I+   L   ++       R+  P  +  E++ 
Sbjct: 208 TQSDVWSFGVLLWEIVTLGGNP---YPGIAPERLFNLLKTGY----RMERPE-NCSEEMY 259

Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
           +++    +C  + P+ RPT   +S++L
Sbjct: 260 NLML---TCWKQEPDKRPTFADISKEL 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 47.9 bits (115), Expect = 5e-07
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 12/94 (12%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L+Y H      I+HRDL  +N+L++ +    +ADFG+A+        +T    T  Y A
Sbjct: 110 GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRA 166

Query: 82  PEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
           PE+      Y+  +    D++S G +  E+I GK
Sbjct: 167 PEILLGSKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 47.6 bits (113), Expect = 6e-07
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 11/139 (7%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRD+   N+L++   +  + DFG++  L   +S    + GT  Y+APE     +    
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 94  CDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD---PRLPAPSRSVQEKLI 150
            DV+S G+  +E+  G+ P   +     S +   + L  ++D   P LP    S  EK +
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVLPVGQFS--EKFV 230

Query: 151 SIVKVAFSCLNESPESRPT 169
             +     C+ + P+ RP 
Sbjct: 231 HFIT---QCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 47.7 bits (113), Expect = 8e-07
 Identities = 41/160 (25%), Positives = 67/160 (41%), Gaps = 24/160 (15%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
            V   L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT 
Sbjct: 111 AVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTR 166

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-----RDFLSSISSSSLNTDIELDE 132
            Y++PE       + + D++S G+  +E+  G++P        L  +    +  D    E
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE 226

Query: 133 MLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKI 172
              PR   P R +               +  P+SRP M I
Sbjct: 227 -TSPRPRPPGRPLS--------------SYGPDSRPPMAI 251

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 47.3 bits (113), Expect = 8e-07
 Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 5/91 (5%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGY 79
             ++Y+H +    I+HRDL   NLL+  +    +ADFG+A+    +    ++    T  Y
Sbjct: 110 KGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWY 166

Query: 80  VAPELAY-TMKITEKCDVYSFGVLALEVIKG 109
            APEL Y   K     D+++ G +  E++ G
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 47.4 bits (112), Expect = 8e-07
 Identities = 24/79 (30%), Positives = 44/79 (55%), Gaps = 2/79 (2%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE       + +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQ 182

Query: 94  CDVYSFGVLALEVIKGKHP 112
            D++S G+  +E+  G++P
Sbjct: 183 SDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 47.2 bits (112), Expect = 8e-07
 Identities = 25/76 (32%), Positives = 43/76 (56%), Gaps = 3/76 (3%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           VHRDL+++N+L++ E++  + DFG+ K ++ D   +T   +      + APE     K  
Sbjct: 131 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY 190

Query: 92  EKCDVYSFGVLALEVI 107
              DV+SFGV   E++
Sbjct: 191 IASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 47.2 bits (112), Expect = 8e-07
 Identities = 39/136 (28%), Positives = 63/136 (46%), Gaps = 12/136 (8%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL +KN+ L       + DFG+++ L       T F GT  Y++PE         K
Sbjct: 127 ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185

Query: 94  CDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIV 153
            D++S G +  E+    H     +    + L+  + + E   P LP    +   +L SI+
Sbjct: 186 SDIWSLGCILYEMCCLAH-----AFEGQNFLSVVLRIVEGPTPSLP---ETYSRQLNSIM 237

Query: 154 KVAFSCLNESPESRPT 169
           +   S LN+ P  RP+
Sbjct: 238 Q---SMLNKDPSLRPS 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 47.3 bits (112), Expect = 9e-07
 Identities = 28/79 (35%), Positives = 44/79 (55%), Gaps = 3/79 (3%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           IV+RDL  +NLLLD +    + DFG AK +  D+  +T   GT  Y+APE+   +   + 
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYT-LCGTPEYIAPEILLNVGHGKA 208

Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ G+   E++ G  P
Sbjct: 209 ADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 47.3 bits (112), Expect = 9e-07
 Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 7/89 (7%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 82
           L Y+H      I+HRDL   NL ++ + E  + DFG+A   +   S  T +  T  Y AP
Sbjct: 131 LKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVVTRWYRAP 184

Query: 83  ELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           E+    M  T+  D++S G +  E++ GK
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 47.1 bits (112), Expect = 9e-07
 Identities = 41/147 (27%), Positives = 69/147 (46%), Gaps = 15/147 (10%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY---GYVAPELAYTMKIT 91
           +HRDL+++N+LL       + DFG+A+ +  DS N+           ++APE  +    T
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDS-NYVVKGNARLPVKWMAPESIFNCVYT 221

Query: 92  EKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLI 150
            + DV+S+G+L  E+   G +P   +  + S       E   M  P   AP      ++ 
Sbjct: 222 FESDVWSYGILLWEIFSLGSNPYPGMP-VDSKFYKLIKEGYRMAQPEH-AP-----AEIY 274

Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            I+K   +C +  P  RPT K + Q +
Sbjct: 275 DIMK---TCWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 46.9 bits (111), Expect = 1e-06
 Identities = 44/183 (24%), Positives = 80/183 (43%), Gaps = 21/183 (11%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           D A  +L   Q +     +A  + YL    F   VHRDL+++N L+       + DFG++
Sbjct: 113 DVAPGQLTLGQMLAIASQIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMS 169

Query: 61  KFLKPDSSNWTEFAG----TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDF 115
           + +   S+++    G       ++ PE     K T + D++SFGV+  E+   GK P   
Sbjct: 170 RDIY--STDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227

Query: 116 LSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
           LS  ++ ++    +  E+  PR   P          +  +   C    P+ R  +K +  
Sbjct: 228 LS--NTEAIECITQGRELERPRTCPP---------EVYAIMQGCWQREPQQRMVIKDIHS 276

Query: 176 QLR 178
           +L+
Sbjct: 277 RLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 46.6 bits (110), Expect = 1e-06
 Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 6/99 (6%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EF 73
           + + + +SYLH +    IVHRD+   N+L D      + DFG +K L+    + T     
Sbjct: 113 RQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169

Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            GT  +++PE+        K DV+S G   +E++  K P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 46.7 bits (111), Expect = 1e-06
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 8/96 (8%)

Query: 19  VADALSYLH--HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT 76
           V   L+YL   H     I+HRD+   N+L++   E  + DFG++  L    +N   F GT
Sbjct: 108 VLRGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGT 161

Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             Y++PE       T + D++S G+  +E+  G++P
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 46.9 bits (111), Expect = 1e-06
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 80
           AL +LH      I++RD+  +N+LLD      + DFG++K F + +      F GT  Y+
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 81  APELAYTMKI--TEKCDVYSFGVLALEVIKGKHP 112
           AP++         +  D +S GVL  E++ G  P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 46.4 bits (110), Expect = 2e-06
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 30/149 (20%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE---------- 83
           I+HRD+   N+L++   +  + DFG++  L    +      G   Y+APE          
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGPNQN 181

Query: 84  LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD---PRLPA 140
             YT+    + DV+S G+  LE+  G++P         +  N   +L  ++D   P LP+
Sbjct: 182 PTYTV----QSDVWSLGLSILEMALGRYPYP-----PETYANIFAQLSAIVDGDPPTLPS 232

Query: 141 PSRSVQEKLISIVKVAFSCLNESPESRPT 169
                 +  ++       CLN+ P  RPT
Sbjct: 233 GYSDDAQDFVA------KCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 46.5 bits (111), Expect = 2e-06
 Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 7/90 (7%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L Y+H      I+HRDL   N+ ++ + E  + DFG+A   +      T +  T  Y A
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRA 183

Query: 82  PELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           PE+    M   +  D++S G +  E++ GK
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 46.3 bits (110), Expect = 2e-06
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 3/91 (3%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
           AL +LH      I++RDL  +N+LLD +    + DFG+ K    + +    F GT  Y+A
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMA 168

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+       +  D +S G L  +++ G  P
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 46.2 bits (109), Expect = 2e-06
 Identities = 33/112 (29%), Positives = 56/112 (50%), Gaps = 10/112 (8%)

Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
           EL  SQ ++  + +A  + YL    F   VHRDL+++N L+       + DFG+++ +  
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY- 171

Query: 66  DSSNWTEFAG----TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
            S+++    G       ++ PE     K T + DV+S GV+  E+   GK P
Sbjct: 172 -STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 46.0 bits (109), Expect = 2e-06
 Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 11/94 (11%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA----GTY 77
           AL ++H      I+HRD+ S+N+ L  +    + DFGIA+ L    ++  E A    GT 
Sbjct: 113 ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCIGTP 165

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKH 111
            Y++PE+        K D+++ G +  E+   KH
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 46.1 bits (109), Expect = 2e-06
 Identities = 27/78 (34%), Positives = 42/78 (53%), Gaps = 1/78 (1%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS-SNWTEFAGTYGYVAPELAYTMKITE 92
           IVHRD+  +NLL+       + DFG A+ L   S +N+TE+  T  Y +PEL       +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180

Query: 93  KCDVYSFGVLALEVIKGK 110
             D++S G +  E+  G+
Sbjct: 181 AVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 46.2 bits (110), Expect = 2e-06
 Identities = 32/93 (34%), Positives = 45/93 (48%), Gaps = 12/93 (12%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 82
           L Y+H      ++HRDL   NLLL+   +  + DFG+A+         TE+  T  Y AP
Sbjct: 121 LKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177

Query: 83  EL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
           EL      YT  I    DV+S G +  E++  K
Sbjct: 178 ELLLNCSEYTTAI----DVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 46.0 bits (110), Expect = 3e-06
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 11/96 (11%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW-----TEFAGT 76
           AL Y+H      ++HRDL   N+LL+ +    +ADFG+A+ L     N      T++  T
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 77  YGYVAPE--LAYTMKITEKCDVYSFGVLALEVIKGK 110
             Y APE  L  T + T+  D++S G +  E++ GK
Sbjct: 176 RWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 45.9 bits (109), Expect = 3e-06
 Identities = 28/98 (28%), Positives = 43/98 (43%), Gaps = 17/98 (17%)

Query: 28  HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA-KFLKPDSS-------------NWTEF 73
           H  +   +HRDLS  N+ ++ +    +ADFG+A ++  P  S               T  
Sbjct: 136 HKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193

Query: 74  AGTYGYVAPELAY-TMKITEKCDVYSFGVLALEVIKGK 110
             T  Y APEL     K     D++S G +  E++ GK
Sbjct: 194 VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 45.8 bits (108), Expect = 3e-06
 Identities = 25/78 (32%), Positives = 42/78 (53%), Gaps = 5/78 (6%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAPELAYTMKIT 91
           I+HRDL   N+++  +    + DFG+A+      +N+  T +  T  Y APE+   M   
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYK 200

Query: 92  EKCDVYSFGVLALEVIKG 109
           E  D++S G +  E++KG
Sbjct: 201 ENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 45.7 bits (109), Expect = 3e-06
 Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA-KFLKPDSSNWTEFAGTYGY 79
             +++LH +    I+HRDL + NLLL+      + DFG+A ++  P    +T+   T  Y
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLVVTLWY 172

Query: 80  VAPELAY-TMKITEKCDVYSFGVLALEVIKGK 110
            APEL     + +   D++S G +  E++  K
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.8 bits (108), Expect = 3e-06
 Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 7/89 (7%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 82
           L Y+H      I+HRDL   N+ ++ + E  + DFG+A   +      T +  T  Y AP
Sbjct: 131 LKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYRAP 184

Query: 83  ELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           E+    M   +  D++S G +  E++KGK
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.6 bits (108), Expect = 4e-06
 Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 34/169 (20%)

Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT- 76
           VA  + +L   +C    +HRD++++N+LL     A + DFG+A+ +  D SN+       
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMND-SNYVVKGNAR 275

Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP-------RDFLSSISSSSLNT 126
               ++APE  +    T + DV+S+G+L  E+   GK P         F   +       
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY--- 332

Query: 127 DIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
                +M  P    P      ++ SI+K    C N  P  RPT   +SQ
Sbjct: 333 -----QMSRPDFAPP------EIYSIMK---MCWNLEPTERPTFSQISQ 367

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.8 bits (108), Expect = 4e-06
 Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 34/165 (20%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW---TEFAGTYG 78
           AL  +H      ++HRDL S N+ L       + DFG +K    DS +    + F GT  
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVASSFCGTPY 236

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVI------KGKHPRDFLSSISSSSLNTDIELDE 132
           Y+APEL    + ++K D++S GV+  E++      KG   R+ +  +          L  
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV----------LYG 286

Query: 133 MLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             DP  P P  S  + L+  +      L+++P  RPT    +QQL
Sbjct: 287 KYDP-FPCPVSSGMKALLDPL------LSKNPALRPT----TQQL 320

Length = 478

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 45.1 bits (107), Expect = 4e-06
 Identities = 41/175 (23%), Positives = 73/175 (41%), Gaps = 31/175 (17%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
             L   Q++     +A  + +L +  F   VHRDL+++N L+  + E  V+   ++K   
Sbjct: 112 PPLSTKQKVALCTQIALGMDHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSK--D 166

Query: 65  PDSSNWTEFAGTYG---YVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP------RD 114
             +S + +         ++APE       + K DV+SFGVL  EV  +G+ P       +
Sbjct: 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226

Query: 115 FLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            L+ + +  L             LP P          + K+   C   +P+ RP+
Sbjct: 227 VLNRLQAGKL------------ELPVPEGCPS----RLYKLMTRCWAVNPKDRPS 265

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 45.2 bits (107), Expect = 4e-06
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 20/106 (18%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA--HVADFGIAKFLKPDSSNWTEFA 74
           K + + L YLH +    IVHRD+   N+L++  Y     ++DFG +K L   +     F 
Sbjct: 115 KQILEGLKYLHDN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFT 170

Query: 75  GTYGYVAPELAYTMKITEK--------CDVYSFGVLALEVIKGKHP 112
           GT  Y+APE      + +K         D++S G   +E+  GK P
Sbjct: 171 GTLQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 45.1 bits (107), Expect = 5e-06
 Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 16/98 (16%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD----SSNWTEFAGTY 77
            L Y+H      ++HRDL   NLL++ + E  + DFG+A+    +    +   TE+  T 
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 78  GYVAPEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
            Y APE+     +YT  I    DV+S G +  E++  K
Sbjct: 174 WYRAPEIMLSFQSYTKAI----DVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 45.0 bits (107), Expect = 5e-06
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 15/95 (15%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +AD ++YL    F   VHRDL+++N ++  +    + DFG+ + +       T++    G
Sbjct: 128 IADGMAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDI-----YETDYYRKGG 179

Query: 79  -------YVAPELAYTMKITEKCDVYSFGVLALEV 106
                  ++APE       T K DV+SFGV+  E+
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 45.0 bits (106), Expect = 5e-06
 Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 13/158 (8%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L YLH       +HRD+   N+LL       +ADFG++  +    +    F GT  ++A
Sbjct: 118 GLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMA 174

Query: 82  PELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL 138
           PE+A   +     + CD+++ G+ A+E+ + + P   L  + +  L T         P+L
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP---PKL 231

Query: 139 PAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ 176
               +         VK+A   L ++P+ RPT + + Q 
Sbjct: 232 KDKMKW-SNSFHHFVKMA---LTKNPKKRPTAEKLLQH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 44.7 bits (106), Expect = 6e-06
 Identities = 34/117 (29%), Positives = 58/117 (49%), Gaps = 10/117 (8%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           D+   EL  SQ +     +A  + YL    F   VHRDL+++N L+  +    + DFG++
Sbjct: 113 DSPMGELTLSQLLQIAVQIASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMS 169

Query: 61  KFLKPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           + +   ++++    G       ++ PE     K T + DV+SFGV+  E+   GK P
Sbjct: 170 RDVY--TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 44.6 bits (105), Expect = 6e-06
 Identities = 48/172 (27%), Positives = 69/172 (40%), Gaps = 30/172 (17%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +AL  L H      +HRD+   N+LL  E    + DFG++  L           GT  ++
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191

Query: 81  APEL-----AYTMKITEKCDVYSFGVLALEVIKGK------HPRDFLSSISSSSLNTDIE 129
           APE+             +CDV+S G+ A+E+  G       HP   L  I          
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI---------- 241

Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAF--SCLNESPESRPTMKIVSQQLRI 179
                 PR P P+   Q +L S     F   CL +  E RPT+  + Q + I
Sbjct: 242 ------PRNPPPTLH-QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 44.3 bits (104), Expect = 8e-06
 Identities = 44/176 (25%), Positives = 73/176 (41%), Gaps = 45/176 (25%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           +A  + YL    F   +HRDL+++N +L+      VADFG++K +         + G Y 
Sbjct: 121 IASGMEYLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKI---------YNGDYY 168

Query: 78  ----------GYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLSSISSSSLNT 126
                      ++A E       T K DV+SFGV   E+  +G+ P              
Sbjct: 169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY------------P 216

Query: 127 DIELDEMLD-----PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            +E  E+ D      RL  P     + L  +  +  SC   +P+ RP+ + +  +L
Sbjct: 217 GVENSEIYDYLRQGNRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 44.3 bits (105), Expect = 1e-05
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 13/94 (13%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVA 81
           L YLH      I+HRD+   NLL++      + DFG+A+  +PD S + T+   T  Y A
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172

Query: 82  PELA-----YTMKITEKCDVYSFGVLALEVIKGK 110
           PE+      YT  +    D++S G +  E++  +
Sbjct: 173 PEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 44.2 bits (104), Expect = 1e-05
 Identities = 26/78 (33%), Positives = 43/78 (55%), Gaps = 10/78 (12%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N   +  T        ++APE  +  
Sbjct: 159 IHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDYYKKTTNGRLPVKWMAPEALFDR 214

Query: 89  KITEKCDVYSFGVLALEV 106
             T + DV+SFGVL  E+
Sbjct: 215 VYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.4 bits (105), Expect = 1e-05
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 6/99 (6%)

Query: 11  QRMNTI-KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK--PDS 67
           ++  TI + + +AL+YLH      I+HRD+ ++N+ LD    A + DFG A  L   PD+
Sbjct: 185 EQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241

Query: 68  SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEV 106
                ++GT    +PEL        K D++S G++  E+
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 43.9 bits (104), Expect = 1e-05
 Identities = 28/104 (26%), Positives = 48/104 (46%), Gaps = 4/104 (3%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           LD S+    +  +   + + H      I+HRD+  +N+L+       + DFG A+ L   
Sbjct: 97  LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153

Query: 67  SSNWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLALEVIKG 109
              +T++  T  Y APEL     K     D+++ G L  E++ G
Sbjct: 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.8 bits (103), Expect = 1e-05
 Identities = 26/95 (27%), Positives = 49/95 (51%), Gaps = 4/95 (4%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF-LKPDSSNWTEFAG 75
           + V  A+ YLH +    I+HRD+ ++N+ ++   +  + DFG A F +  +++ +  +AG
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 110
           T    APEL          D++S G++  E+    
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.7 bits (103), Expect = 2e-05
 Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 7/89 (7%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 82
           L Y+H      I+HRDL   NL ++ + E  + DFG+A+      +  T +  T  Y AP
Sbjct: 130 LKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRAP 183

Query: 83  ELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           E+    M   +  D++S G +  E++ GK
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 43.5 bits (102), Expect = 2e-05
 Identities = 51/183 (27%), Positives = 82/183 (44%), Gaps = 32/183 (17%)

Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
           A  L   Q +     VA  + YL    F   +HRDL+++N+L+     + +ADFG+++  
Sbjct: 113 ASTLTSQQLLQFASDVATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLSR-- 167

Query: 64  KPDSSNWTEFAGTYG-----YVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFL 116
                       T G     ++A E L Y++  T K DV+SFGVL  E++  G  P   +
Sbjct: 168 ----GEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGM 222

Query: 117 SSISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
                    T  EL E L    R+  P R+  +++  +++    C  + P  RP    +S
Sbjct: 223 ---------TCAELYEKLPQGYRMEKP-RNCDDEVYELMR---QCWRDRPYERPPFAQIS 269

Query: 175 QQL 177
            QL
Sbjct: 270 VQL 272

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 43.5 bits (102), Expect = 2e-05
 Identities = 39/171 (22%), Positives = 71/171 (41%), Gaps = 37/171 (21%)

Query: 20  ADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG- 78
           A  + YL        +HRDL+++N L+  +    ++DFG+++          E  G Y  
Sbjct: 104 AAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR---------EEEDGVYAS 151

Query: 79  ----------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDI 128
                     + APE     + + + DV+SFG+L  E          L ++  ++L ++ 
Sbjct: 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS-------LGAVPYANL-SNQ 203

Query: 129 ELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           +  E ++   RLP P          + ++   C    P  RP+   V Q+L
Sbjct: 204 QTREAIEQGVRLPCPELCPDA----VYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 43.5 bits (102), Expect = 2e-05
 Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 15/95 (15%)

Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
           VA  + YL    C    +HRDL+++N+L+  +    +ADFG+A+    D  N   +  T 
Sbjct: 143 VARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDYYKKTT 194

Query: 78  G------YVAPELAYTMKITEKCDVYSFGVLALEV 106
                  ++APE  +    T + DV+SFGVL  E+
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.5 bits (102), Expect = 2e-05
 Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 7/90 (7%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  T  Y A
Sbjct: 132 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVATRWYRA 185

Query: 82  PELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           PE+    M   +  D++S G +  E++ G+
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 43.4 bits (102), Expect = 2e-05
 Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 16/113 (14%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           ++ A  L   Q ++    VA  + YL    F   +HRDL+++N+L+   Y A +ADFG++
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLS 171

Query: 61  KFLKPDSSNWTEFAGTYG-----YVAPE-LAYTMKITEKCDVYSFGVLALEVI 107
           +              T G     ++A E L Y++  T   DV+S+GVL  E++
Sbjct: 172 R------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 43.3 bits (102), Expect = 2e-05
 Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 22/167 (13%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLL-----DLEYEAHVADFGIAKFLKPDSSNWTEF 73
           VA    YL    F   +HRDL+++N L+     D +    + DFG+A+ +        E 
Sbjct: 115 VAKGCVYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171

Query: 74  AGTYG--YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIEL 130
            G     ++APE     K T + DV+SFGVL  E++  G+ P   L+       N ++  
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-------NQEVLQ 224

Query: 131 DEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                 RL  P  +  +K+  ++    +C  + P  RPT   + + L
Sbjct: 225 HVTAGGRLQKP-ENCPDKIYQLMT---NCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 42.9 bits (101), Expect = 2e-05
 Identities = 39/149 (26%), Positives = 61/149 (40%), Gaps = 32/149 (21%)

Query: 9   WSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS 68
           W+  M        AL  LH +    IV RDL+  N+LLD      +  F           
Sbjct: 90  WAAEMVV------ALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFS---------- 130

Query: 69  NWTEFAGTYG-------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS 121
            W+E   +         Y APE+    + TE CD +S G +  E++ GK     L     
Sbjct: 131 RWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKT----LVECHP 186

Query: 122 SSLNTDIELDEMLDPRLPAPSRSVQEKLI 150
           S +NT   L+  +   +   +RS+ ++L+
Sbjct: 187 SGINTHTTLN--IPEWVSEEARSLLQQLL 213

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 43.0 bits (101), Expect = 2e-05
 Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 4/89 (4%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 82
           L+Y+H      I+HRDL  +NLL+    E  +ADFG+A+     S  ++    T  Y  P
Sbjct: 116 LAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172

Query: 83  E-LAYTMKITEKCDVYSFGVLALEVIKGK 110
           + L      +   D++  G + +E+++G+
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 42.9 bits (102), Expect = 2e-05
 Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 13/102 (12%)

Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEF 73
           + I  +   L+++H   F    HRDL  +NLL+       +ADFG+A+ ++     +T++
Sbjct: 103 SIIYQILQGLAHIHKHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDY 158

Query: 74  AGTYGYVAPEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
             T  Y APE+     +Y+  +    D+++ G +  E+   +
Sbjct: 159 VSTRWYRAPEILLRSTSYSSPV----DIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 42.7 bits (100), Expect = 3e-05
 Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 6/99 (6%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP---DSSNWTEF 73
           + + + +SYLH +    IVHRD+   N+L D      + DFG +K L+      +     
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV 169

Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            GT  +++PE+        K D++S G   +E++  K P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 42.8 bits (101), Expect = 3e-05
 Identities = 35/143 (24%), Positives = 56/143 (39%), Gaps = 26/143 (18%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA----GTYGYVAPELAYTMK 89
            +HRDL  +N L+D      + DFG+       S     +A    G+  Y+APE+     
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGL-------SKGIVTYANSVVGSPDYMAPEVLRGKG 174

Query: 90  ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-TDIEL---DEMLD-PRLPAPSRS 144
                D +S G +  E + G  P       S S+ N T   L    E L  P    P  +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPP------FSGSTPNETWENLKYWKETLQRPVYDDPRFN 228

Query: 145 VQEKLISIVKVAFSCLNESPESR 167
           + ++   ++      +N+ P  R
Sbjct: 229 LSDEAWDLIT---KLIND-PSRR 247

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.5 bits (101), Expect = 3e-05
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 29/129 (22%)

Query: 14  NTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLD-LEYEAHVADFGIAKFLKPDSSNWT 71
             I+ + +AL+ LH H+    I+H D+  +N+L D  +   ++ D+G+ K +   S    
Sbjct: 113 KIIRQLVEALNDLHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC--- 165

Query: 72  EFAGTYGYVAPELAYTMKIT-EKCDVYSF-----GVLALEVIKGKHPRDFLSSISSSSLN 125
            + GT  Y +PE     KI     D  SF     GVL  E++ GKHP            +
Sbjct: 166 -YDGTLDYFSPE-----KIKGHNYD-VSFDWWAVGVLTYELLTGKHPFK-------EDED 211

Query: 126 TDIELDEML 134
            +++L+ +L
Sbjct: 212 EELDLESLL 220

Length = 267

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 42.6 bits (100), Expect = 3e-05
 Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 37/174 (21%)

Query: 19  VADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK------FLKPDSSNWT 71
           VA  + YL    C    +HRDL+++N+L+  +    +ADFG+A+      + K  S+   
Sbjct: 143 VARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198

Query: 72  EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIEL 130
                  ++APE  +    T + DV+SFG+L  E+   G  P               I +
Sbjct: 199 PVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY------------PGIPV 242

Query: 131 DEMLD-----PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLRI 179
           +E+        R+  PS    E    +  +   C +  P  RPT K + + L  
Sbjct: 243 EELFKLLREGHRMDKPSNCTHE----LYMLMRECWHAVPTQRPTFKQLVEALDK 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 42.7 bits (101), Expect = 3e-05
 Identities = 38/150 (25%), Positives = 61/150 (40%), Gaps = 26/150 (17%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV-----------APE 83
           VHRDL+++N L+   Y   +ADFG+++ L         ++  Y  V           A E
Sbjct: 152 VHRDLATRNCLVGKNYTIKIADFGMSRNL---------YSSDYYRVQGRAPLPIRWMAWE 202

Query: 84  LAYTMKITEKCDVYSFGVLALEVIK--GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAP 141
                K T K DV++FGV   E++    + P + L+             D+     LP P
Sbjct: 203 SVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRP 262

Query: 142 SRSVQEKLISIVKVAFSCLNESPESRPTMK 171
               ++    I ++   C     E RPT +
Sbjct: 263 PNCPKD----IYELMLECWRRDEEDRPTFR 288

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.7 bits (100), Expect = 4e-05
 Identities = 26/75 (34%), Positives = 43/75 (57%), Gaps = 4/75 (5%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY---GYVAPELAYTMKIT 91
           VHRDL+++N+L+       + DFG+A+ +  DS N+     T+    ++APE  +    T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDS-NYISKGSTFLPLKWMAPESIFNNLYT 319

Query: 92  EKCDVYSFGVLALEV 106
              DV+SFG+L  E+
Sbjct: 320 TLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 42.4 bits (99), Expect = 4e-05
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 32/185 (17%)

Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK 61
           + A  L   Q ++    VA  + YL    F   +HRDL+++N+L+   Y A +ADFG+++
Sbjct: 104 STASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR 160

Query: 62  FLKPDSSNWTEFAGTYG-----YVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRD 114
                         T G     ++A E L Y++  T   DV+S+GVL  E++  G  P  
Sbjct: 161 ------GQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYC 213

Query: 115 FLSSISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKI 172
            +         T  EL E L    RL  P  +  +++  +++    C  E P  RP+   
Sbjct: 214 GM---------TCAELYEKLPQGYRLEKP-LNCDDEVYDLMR---QCWREKPYERPSFAQ 260

Query: 173 VSQQL 177
           +   L
Sbjct: 261 ILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.8 bits (101), Expect = 4e-05
 Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 1/77 (1%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 197

Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+I+G 
Sbjct: 198 VDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 42.8 bits (101), Expect = 4e-05
 Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 18/87 (20%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD---------------SSNWT---EFAG 75
           ++HRDL   N+LL L  E  + D+G A F K +                S+ T   +  G
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVL 102
           T  Y+APE    +  +E  D+Y+ GV+
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVI 220

Length = 932

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 42.4 bits (100), Expect = 4e-05
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           ++ AL+YL    F   VHRD++++N+L+       + DFG++++L+ D S +    G   
Sbjct: 116 LSTALAYLESKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLP 171

Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
             ++APE     + T   DV+ FGV   E++  G  P
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 42.4 bits (99), Expect = 5e-05
 Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 4/89 (4%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            LSY+H      I+HRDL  +NLL+    E  +ADFG+A+     S  ++    T  Y  
Sbjct: 115 GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP 171

Query: 82  PELAYTMKITEKC-DVYSFGVLALEVIKG 109
           P++         C D++  G + +E+I+G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 42.2 bits (99), Expect = 5e-05
 Identities = 40/171 (23%), Positives = 76/171 (44%), Gaps = 35/171 (20%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           +A  + YL    F   +HRDL+++N +L+      VADFG++K +         ++G Y 
Sbjct: 122 IASGMEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSKKI---------YSGDYY 169

Query: 78  ----------GYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
                      ++A E       T   DV++FGV   E++ +G+ P   +        N+
Sbjct: 170 RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-------NS 222

Query: 127 DIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           +I    +   RL  P   +++    + ++   C +  P+ RP+ + +  QL
Sbjct: 223 EIYNYLIKGNRLKQPPDCLED----VYELMCQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 41.9 bits (98), Expect = 5e-05
 Identities = 40/167 (23%), Positives = 74/167 (44%), Gaps = 25/167 (14%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  + YL    F   VH+DL+++N+L+  +    ++D G+++ +   S+++        
Sbjct: 133 IAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIY--SADYYRVQPKSL 187

Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEM 133
               ++ PE     K +   D++SFGV+  E+   G  P    S         + E+ EM
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---------NQEVIEM 238

Query: 134 LDPR--LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           +  R  LP        ++ S++     C  E P  RP  K +  +LR
Sbjct: 239 VRKRQLLPCS-EDCPPRMYSLMT---ECWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 42.1 bits (99), Expect = 5e-05
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI-TE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180

Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 181 AVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 41.9 bits (98), Expect = 6e-05
 Identities = 28/88 (31%), Positives = 44/88 (50%), Gaps = 4/88 (4%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 82
           L +LH +C   IVHRDL  +N+L+    +  +ADFG+A+      +  T    T  Y AP
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAP 176

Query: 83  ELAYTMKITEKCDVYSFGVLALEVIKGK 110
           E+          D++S G +  E+ + K
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.0 bits (98), Expect = 6e-05
 Identities = 26/77 (33%), Positives = 40/77 (51%), Gaps = 1/77 (1%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205

Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+IKG 
Sbjct: 206 VDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 41.7 bits (98), Expect = 6e-05
 Identities = 45/176 (25%), Positives = 74/176 (42%), Gaps = 45/176 (25%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           +A  + YL +  F   +HRDL+++N +L  +    VADFG++K           ++G Y 
Sbjct: 122 IALGMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSK---------KIYSGDYY 169

Query: 78  --GYVAPELAYTMKI--------TEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
             G +A      + I        T K DV++FGV   E+  +G+ P              
Sbjct: 170 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY------------P 217

Query: 127 DIELDEMLD-----PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            +E  E+ D      RL  P   + E    +  + +SC    P+ RPT   + + L
Sbjct: 218 GVENHEIYDYLRHGNRLKQPEDCLDE----LYDLMYSCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 41.9 bits (98), Expect = 7e-05
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 9/92 (9%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG--- 75
           +A  + YL    F   VHRDL+++N L+   Y   +ADFG+++ L   S ++    G   
Sbjct: 138 IASGMKYLASLNF---VHRDLATRNCLVGNHYTIKIADFGMSRNLY--SGDYYRIQGRAV 192

Query: 76  -TYGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               ++A E     K T   DV++FGV   E+
Sbjct: 193 LPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 41.7 bits (98), Expect = 8e-05
 Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 13/91 (14%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFA 74
           +K + + L+Y H   F   +HRD+   N+LL+ + +  +ADFG+A+    + S  +T   
Sbjct: 122 MKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 75  GTYGYVAPEL-----AYTMKITEKCDVYSFG 100
            T  Y  PEL      Y   I    DV+S G
Sbjct: 179 ITLWYRPPELLLGEERYGPAI----DVWSCG 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 41.5 bits (97), Expect = 8e-05
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 26/152 (17%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+  +    +ADFG+A+    D  +   +  T        ++APE  +  
Sbjct: 162 IHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDR 217

Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  PS   
Sbjct: 218 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---------EELFKLLKEGHRMDKPSNCT 268

Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E L  +++    C +  P  RPT K + + L
Sbjct: 269 NE-LYMMMR---DCWHAVPSQRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 41.6 bits (97), Expect = 9e-05
 Identities = 25/92 (27%), Positives = 50/92 (54%), Gaps = 9/92 (9%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+ + F   VHRDL+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 128 IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 182

Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               +++PE       T   DV+SFGV+  E+
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 41.6 bits (97), Expect = 9e-05
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198

Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+++ K
Sbjct: 199 VDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (98), Expect = 1e-04
 Identities = 33/128 (25%), Positives = 49/128 (38%), Gaps = 38/128 (29%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAK------------------ 61
           AL  +H   F   +HRD+   N+L+D   + H+  ADFG+ K                  
Sbjct: 113 ALDSVHKLGF---IHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 62  -FLKPDSSNWTEF----------AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 110
            F         +            GT  Y+APE+        +CD +S GV+  E++ G 
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227

Query: 111 HPRDFLSS 118
            P  F S 
Sbjct: 228 PP--FYSD 233

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 41.2 bits (96), Expect = 1e-04
 Identities = 43/175 (24%), Positives = 81/175 (46%), Gaps = 29/175 (16%)

Query: 13  MNTIKGVADALSYL--HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           ++ +  +A  + +L  HH     +VH+DL+++N+L+  +    ++D G+  F +  ++++
Sbjct: 127 VHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGL--FREVYAADY 179

Query: 71  TEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLN 125
            +  G       +++PE     K +   D++S+GV+  EV   G  P    S       N
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------N 232

Query: 126 TDIELDEMLDPR--LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
            D+   EM+  R  LP P     +    +  +   C NE P  RP  K +  +LR
Sbjct: 233 QDVI--EMIRNRQVLPCPD----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 41.2 bits (96), Expect = 1e-04
 Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 4/89 (4%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP 82
           LSY H      I+HRDL  +NLL++ + E  +ADFG+A+     +  ++    T  Y  P
Sbjct: 116 LSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 172

Query: 83  E-LAYTMKITEKCDVYSFGVLALEVIKGK 110
           + L  + + +   D++  G +  E+  G+
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 41.2 bits (96), Expect = 1e-04
 Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 6/99 (6%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EF 73
           + +   +SYLH +    IVHRD+   N+L D      + DFG +K ++    + T     
Sbjct: 113 RQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169

Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            GT  +++PE+        K DV+S     +E++  K P
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 40.8 bits (95), Expect = 1e-04
 Identities = 41/188 (21%), Positives = 76/188 (40%), Gaps = 38/188 (20%)

Query: 5   QELDWSQRMNTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
            EL   Q +      A  ++YL   +C    +HRDL+++N L+       ++DFG+++  
Sbjct: 88  DELKTKQLVKFALDAAAGMAYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR-- 141

Query: 64  KPDSSNWTEFAGTYG----------YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPR 113
                   E  G Y           + APE     + + + DV+S+G+L  E        
Sbjct: 142 -------QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWET------- 187

Query: 114 DFLSSISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            F   +      T+ +  E ++   R+  P +   +    + KV   C +  PE+RP   
Sbjct: 188 -FSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDD----VYKVMQRCWDYKPENRPKFS 242

Query: 172 IVSQQLRI 179
            + ++L  
Sbjct: 243 ELQKELAA 250

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 41.0 bits (96), Expect = 1e-04
 Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 15/183 (8%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
            A    + +S  +     +A  + YL    F   VHRDL+++N L+   Y   +ADFG++
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNCLVGKNYTIKIADFGMS 177

Query: 61  KFLKPDSSNWTEFAG----TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK--GKHPRD 114
           + L   S ++    G       +++ E     K T   DV++FGV   E++    + P  
Sbjct: 178 RNLY--SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235

Query: 115 FLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
            LS         +   D+     LP P+        S+ K+  SC   + + RP+ + + 
Sbjct: 236 QLSDEQVIENTGEFFRDQGRQVYLPKPALCPD----SLYKLMLSCWRRNAKERPSFQEIH 291

Query: 175 QQL 177
             L
Sbjct: 292 ATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 36/164 (21%), Positives = 76/164 (46%), Gaps = 19/164 (11%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+   F   VHRDL+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 128 IADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 182

Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML 134
               ++APE       T   D++SFGV+  E+         L+      L+ +  L  ++
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVM 235

Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           D        +  E++  ++++   C   +P+ RPT   +   L+
Sbjct: 236 DGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 40.3 bits (95), Expect = 2e-04
 Identities = 21/62 (33%), Positives = 33/62 (53%), Gaps = 4/62 (6%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            + +LH      IVHRDL  +N+L+  + +  +ADFG+A+    + +  T    T  Y A
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRA 174

Query: 82  PE 83
           PE
Sbjct: 175 PE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 40.4 bits (94), Expect = 2e-04
 Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 8/99 (8%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA-GTY 77
           V  AL  +H   F   +HRD+   N+LLD      +ADFG    +  +     + A GT 
Sbjct: 151 VVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207

Query: 78  GYVAPELAYTMK----ITEKCDVYSFGVLALEVIKGKHP 112
            Y++PE+  +         +CD +S GV   E++ G  P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 40.2 bits (94), Expect = 3e-04
 Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 9/82 (10%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL-----AYTM 88
           ++HRDL  +NLL++   E  +ADFG+A+      + ++    T  Y AP++      Y+ 
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYST 180

Query: 89  KITEKCDVYSFGVLALEVIKGK 110
            I    D++S G +  E+I G+
Sbjct: 181 SI----DIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 40.1 bits (94), Expect = 3e-04
 Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 36/173 (20%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTEFAG 75
           VA    YL  + F   +HRD++++N LL  +     A +ADFG+A+ +    +++    G
Sbjct: 125 VAKGCKYLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKGG 179

Query: 76  T----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-------GKHPRDFLSSISSSSL 124
                  ++ PE       T K DV+SFGVL  E+         G+  ++ +  ++    
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG- 238

Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                    LDP    P          + ++   C   +PE RP    + +++
Sbjct: 239 --------RLDPPKGCPGP--------VYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 39.9 bits (93), Expect = 3e-04
 Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 23/100 (23%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           +A  + YL    F   VHRDL+++N L+       +ADFG+++ L         +AG Y 
Sbjct: 147 IASGMKYLSSLNF---VHRDLATRNCLVGENLTIKIADFGMSRNL---------YAGDYY 194

Query: 78  ----------GYVAPELAYTMKITEKCDVYSFGVLALEVI 107
                      ++A E     K T   DV++FGV   E++
Sbjct: 195 RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 39.9 bits (93), Expect = 3e-04
 Identities = 46/193 (23%), Positives = 76/193 (39%), Gaps = 36/193 (18%)

Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA- 60
           A   + D  QRM     VA  L +LH   F   +H DL+ +N  L  +    + D+G+A 
Sbjct: 94  AQMAQKDVLQRMAC--EVASGLLWLHQADF---IHSDLALRNCQLTADLSVKIGDYGLAL 148

Query: 61  -----KFLKPDSSNWTEFAGTYGYVAPELA-------YTMKITEKCDVYSFGVLALEVIK 108
                 +      +         ++APEL             T+K +++S GV   E+  
Sbjct: 149 EQYPEDYYITKDCHAVPLR----WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Query: 109 -GKHPRDFLSS---ISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP 164
               P   LS    +       DI+L +   P+L        ++   +++  F  L   P
Sbjct: 205 AADQPYPDLSDEQVLKQVVREQDIKLPK---PQLDLK---YSDRWYEVMQ--FCWL--DP 254

Query: 165 ESRPTMKIVSQQL 177
           E+RPT + V + L
Sbjct: 255 ETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 40.0 bits (93), Expect = 3e-04
 Identities = 26/86 (30%), Positives = 41/86 (47%), Gaps = 9/86 (10%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE---FAGTYGYVAPELAYTMK- 89
           ++HRD+   N+LLD      +ADFG    +K D +         GT  Y++PE+  +   
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 90  ---ITEKCDVYSFGVLALEVIKGKHP 112
                 +CD +S GV   E++ G  P
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 39.6 bits (92), Expect = 4e-04
 Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 6/90 (6%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           AL+Y+H      I HRDL  +NLL+D   +   + DFG AK L     + +     + Y 
Sbjct: 182 ALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-YR 237

Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKG 109
           APEL       T   D++S G +  E+I G
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 39.4 bits (92), Expect = 4e-04
 Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 8/99 (8%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA-GTY 77
           V  AL  +H   F   +HRD+   N+LLD      +ADFG    +  +     + A GT 
Sbjct: 151 VVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTP 207

Query: 78  GYVAPELAYTMKIT----EKCDVYSFGVLALEVIKGKHP 112
            Y++PE+  +         +CD +S GV   E++ G  P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 39.4 bits (92), Expect = 4e-04
 Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 21/146 (14%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF-LKPDSSNWTE-------- 72
           AL YLH+     IVHRDL   NLL+       + DFG++K  L   ++N  E        
Sbjct: 113 ALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 73  ------FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISSSSL 124
                   GT  Y+APE+       +  D ++ G++  E + G  P   D    +    +
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229

Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLI 150
           + DIE  E  +  LPA ++ +  +L+
Sbjct: 230 SDDIEWPEGDEA-LPADAQDLISRLL 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 39.2 bits (92), Expect = 5e-04
 Identities = 29/117 (24%), Positives = 50/117 (42%), Gaps = 23/117 (19%)

Query: 10  SQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           SQ    +  + + ++YLH +    I+HRD+ + N+L+D +    +ADFG+A+       N
Sbjct: 115 SQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171

Query: 70  WTEFAG-----------TYGYVAPELA-----YTMKITEKCDVYSFGVLALEVIKGK 110
                G           T  Y  PEL      YT  +    D++  G +  E+   +
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 38.5 bits (89), Expect = 0.001
 Identities = 30/115 (26%), Positives = 45/115 (39%), Gaps = 39/115 (33%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEF--------------------- 73
           +HRD+   NLLLD +    ++DFG+   LK   ++ TEF                     
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLK--KAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 74  ----------------AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                            GT  Y+APE+       + CD +S GV+  E++ G  P
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 38.3 bits (89), Expect = 0.001
 Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 13/96 (13%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGI------AKFLKPDSSNW 70
           K VA  ++YL    F   VHRDL+++N L+       +ADFG+      A + K   ++ 
Sbjct: 137 KQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEND- 192

Query: 71  TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEV 106
              A    ++ PE  +  + T + DV+++GV+  E+
Sbjct: 193 ---AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 38.1 bits (89), Expect = 0.001
 Identities = 16/39 (41%), Positives = 24/39 (61%), Gaps = 3/39 (7%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK 61
           L+Y H      ++HRDL  +NLL+    E  +ADFG+A+
Sbjct: 116 LAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 38.1 bits (88), Expect = 0.001
 Identities = 30/115 (26%), Positives = 45/115 (39%), Gaps = 39/115 (33%)

Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEF--------------------- 73
           +HRD+   NLLLD +    ++DFG+   LK   ++ TEF                     
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLK--KAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 74  ----------------AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                            GT  Y+APE+       + CD +S GV+  E++ G  P
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 37.9 bits (88), Expect = 0.001
 Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 2/79 (2%)

Query: 34  IVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKIT 91
           ++HRDL  +NLL+D    A  +ADFG+A+        +T    T  Y APE L  +   +
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182

Query: 92  EKCDVYSFGVLALEVIKGK 110
              D++S G +  E++  K
Sbjct: 183 TPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 37.7 bits (87), Expect = 0.001
 Identities = 24/90 (26%), Positives = 46/90 (51%), Gaps = 4/90 (4%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L+Y H      ++HRDL  +NLL++   E  +ADFG+A+     +  ++    T  Y  
Sbjct: 116 GLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172

Query: 82  PE-LAYTMKITEKCDVYSFGVLALEVIKGK 110
           P+ L  + + + + D++  G +  E+  G+
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 37.7 bits (87), Expect = 0.001
 Identities = 24/90 (26%), Positives = 45/90 (50%), Gaps = 4/90 (4%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L+Y H      ++HRDL  +NLL++   E  +ADFG+A+     +  ++    T  Y  
Sbjct: 116 GLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRP 172

Query: 82  PE-LAYTMKITEKCDVYSFGVLALEVIKGK 110
           P+ L  +   + + D++  G +  E+  G+
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 37.4 bits (86), Expect = 0.002
 Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 35/171 (20%)

Query: 22  ALSYLHHDCFPP----IVHRDLSSKNLLLDLEYE-----------------AHVADFGIA 60
           AL+Y H+    P    ++HRDL  +N+ L                      A + DFG++
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 61  KFLKPDSSNWTEFAGTYGYVAPELAY--TMKITEKCDVYSFGVLALEVIKGKHPRDFLSS 118
           K +  +S   +   GT  Y +PEL    T    +K D+++ G +  E+  GK P  F  +
Sbjct: 190 KNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP--FHKA 246

Query: 119 ISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            + S L ++++      P LP   +S  ++L  ++K   + LN S + RP+
Sbjct: 247 NNFSQLISELK----RGPDLPIKGKS--KELNILIK---NLLNLSAKERPS 288

Length = 1021

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 37.0 bits (86), Expect = 0.003
 Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 9/82 (10%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL-----AYTM 88
           ++HRDL  +NLL+D +    +ADFG+A+        +T    T  Y APE+      Y+ 
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181

Query: 89  KITEKCDVYSFGVLALEVIKGK 110
            +    D++S G +  E+   K
Sbjct: 182 PV----DIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 37.2 bits (86), Expect = 0.003
 Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 5/86 (5%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEF--AGTYGY 79
           A+ Y+H +    I+HRD+ ++N+L++   +  + DFG A F +   S    +  AGT   
Sbjct: 272 AIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328

Query: 80  VAPELAYTMKITEKCDVYSFGVLALE 105
            APE+      T   D++S G++  E
Sbjct: 329 NAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 37.0 bits (86), Expect = 0.003
 Identities = 26/98 (26%), Positives = 47/98 (47%), Gaps = 23/98 (23%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP-------DSSN-- 69
           +A  +SYLH      ++H+D++++N ++D E +  + D  +++ L P       D+ N  
Sbjct: 126 IACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182

Query: 70  --WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALE 105
             W         +A E     + +   DV+SFGVL  E
Sbjct: 183 VKW---------MALESLVNKEYSSASDVWSFGVLLWE 211

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 36.9 bits (85), Expect = 0.004
 Identities = 24/108 (22%), Positives = 42/108 (38%), Gaps = 14/108 (12%)

Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL---------K 64
           N +K +   L Y+H      I H D+  +N+++D     ++ D+GIA             
Sbjct: 130 NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186

Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            +  +     GT  Y   +      +T + D+ S G   L+    K P
Sbjct: 187 KEQKDLHR--GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 36.6 bits (85), Expect = 0.004
 Identities = 41/198 (20%), Positives = 66/198 (33%), Gaps = 58/198 (29%)

Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK------------ 61
             +K V +AL Y+H   F   +HR + + ++LL  + +  ++    +             
Sbjct: 105 FILKDVLNALDYIHSKGF---IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161

Query: 62  FLKPDSS----NWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLA------------ 103
              P SS     W          +PE+         EK D+YS G+ A            
Sbjct: 162 HDFPKSSVKNLPWL---------SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212

Query: 104 -------LEVIKGKHPR-----DFLSSISSSSLNTDIELDEMLDPRLPAPS-RSVQEKLI 150
                  LE ++G  P       +     S S +            +  P  R+  E   
Sbjct: 213 MPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFH 272

Query: 151 SIVKVAFSCLNESPESRP 168
             V++   CL   PESRP
Sbjct: 273 QFVEL---CLQRDPESRP 287

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 37.0 bits (85), Expect = 0.004
 Identities = 27/110 (24%), Positives = 52/110 (47%), Gaps = 10/110 (9%)

Query: 5   QELDWS------QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFG 58
           +  DW       Q    +K +  A+ Y+H      ++HRD+  +N+ L+ + +  + DFG
Sbjct: 256 EAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFG 312

Query: 59  IA-KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
            A  F K   +    + GT    +PE+       E  D++S G++ L+++
Sbjct: 313 TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 36.6 bits (85), Expect = 0.004
 Identities = 22/74 (29%), Positives = 37/74 (50%), Gaps = 7/74 (9%)

Query: 15  TIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEF 73
            +K + + L Y+H      I+HRD+ + N+L+  +    +ADFG+A+ F    +S    +
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 74  AG---TYGYVAPEL 84
                T  Y  PEL
Sbjct: 181 TNRVVTLWYRPPEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 36.5 bits (85), Expect = 0.004
 Identities = 25/82 (30%), Positives = 42/82 (51%), Gaps = 9/82 (10%)

Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL-----AYTM 88
           ++HRDL  +NLL+D E    +ADFG+A+        +T    T  Y APE+      Y+ 
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYST 179

Query: 89  KITEKCDVYSFGVLALEVIKGK 110
            +    D++S G +  E++  +
Sbjct: 180 PV----DIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	179
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.98
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.98
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
PHA02988	283	hypothetical protein; Provisional	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.97
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.97
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
PTZ00284	467	protein kinase; Provisional	99.97
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
PTZ00283	496	serine/threonine protein kinase; Provisional	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.96
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.96
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.96
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.96
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.96
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.96
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.96
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.96
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.96
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.96
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.96
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.96
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.96
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.96
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.96
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.96
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.96
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.96
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.96
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.96
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.96
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.96
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.96
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.96
KOG0589	426	consensus Serine/threonine protein kinase [General	99.96
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.96
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.96
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.96
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.96
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.96
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.96
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.96
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.96
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.96
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.96
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.96
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.96
PTZ00267	478	NIMA-related protein kinase; Provisional	99.96
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.96
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.96
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.96
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.96
PHA03209	357	serine/threonine kinase US3; Provisional	99.96
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.96
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.96
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.96
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.96
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.96
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.96
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.96
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.96
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.96
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.96
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.96
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.96
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.96
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.96
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.96
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.96
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.96
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.96
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.96
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.96
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.96
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.96
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.96
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.96
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.96
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.96
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.96
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.96
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.96
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.96
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.96
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.96
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.96
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.96
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.96
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.96
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.96
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.96
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.96
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.96
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.95
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.95
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.95
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.95
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.95
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.95
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.95
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.95
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.95
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.95
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.95
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.95
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.95
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.95
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.95
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.95
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.95
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.95
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.95
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.95
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.95
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.95
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.95
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.95
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.95
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.95
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.95
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.95
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.95
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.95
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.95
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.95
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.95
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.95
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.95
KOG0605	550	consensus NDR and related serine/threonine kinases	99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.95
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.95
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.95
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.95
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.95
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.95
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.95
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.95
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.95
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.95
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.95
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.95
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.95
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.95
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.95
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.95
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.95
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.95
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.95
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.95
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.95
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.95
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.95
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.95
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.95
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.95
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.95
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.95
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.95
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.95
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.95
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.95
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.95
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
PLN00009	294	cyclin-dependent kinase A; Provisional	99.95
KOG0610	459	consensus Putative serine/threonine protein kinase	99.94
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.94
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.94
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.94
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.94
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.94
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.94
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.94
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.94
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.94
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.94
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.94
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.94
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.94
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.94
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.94
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.94
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.94
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.94
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.94
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.94
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.94
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.94
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.94
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.94
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.94
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.94
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.93
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.93
KOG0586	596	consensus Serine/threonine protein kinase [General	99.93
KOG0584	632	consensus Serine/threonine protein kinase [General	99.93
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.93
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.92
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.92
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.92
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.92
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.91
KOG3653	534	consensus Transforming growth factor beta/activin	99.91
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.91
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.9
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.9
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.9
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.9
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.9
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.89
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.89
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.88
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.88
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.88
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.88
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.88
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.87
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.87
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.85
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.84
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.83
KOG1152	772	consensus Signal transduction serine/threonine kin	99.8
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.75
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.75
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.74
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.74
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.74
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.73
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.69
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.67
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.66
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.56
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.51
COG4248	637	Uncharacterized protein with protein kinase and he	99.45
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.42
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.38
PRK12274	218	serine/threonine protein kinase; Provisional	99.3
PRK09188	365	serine/threonine protein kinase; Provisional	99.28
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.26
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.25
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.23
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.16
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.14
smart00090	237	RIO RIO-like kinase.	99.0
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.9
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.85
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.83
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.78
PRK10345	210	hypothetical protein; Provisional	98.69
PRK14879	211	serine/threonine protein kinase; Provisional	98.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.63
KOG1243	690	consensus Protein kinase [General function predict	98.62
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.61
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.53
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.42
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.37
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.22
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.22
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.21
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.2
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.13
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.98
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	97.94
PRK09902	216	hypothetical protein; Provisional	97.89
KOG3087	229	consensus Serine/threonine protein kinase [General	97.89
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	97.7
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.27
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.26
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.1
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	97.03
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.0
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	96.97
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.73
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.69
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.58
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.5
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.34
PRK05231	319	homoserine kinase; Provisional	95.33
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	95.21
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.94
PF01636	239	APH: Phosphotransferase enzyme family This family	94.91
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.85
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.67
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.64
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	94.15
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.95
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	93.91
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	93.77
PRK10271	188	thiK thiamine kinase; Provisional	93.67
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	93.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	93.42
PLN02236	344	choline kinase	93.37
COG2334	331	Putative homoserine kinase type II (protein kinase	93.14
KOG2268	465	consensus Serine/threonine protein kinase [Signal	92.63
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	92.18
KOG1093	725	consensus Predicted protein kinase (contains TBC a	91.97
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.42
PRK06148	1013	hypothetical protein; Provisional	91.06
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	90.78
PRK11768	325	serine/threonine protein kinase; Provisional	90.68
KOG0576	829	consensus Mitogen-activated protein kinase kinase	90.67
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	90.63
COG4499	434	Predicted membrane protein [Function unknown]	90.57
PRK06149	972	hypothetical protein; Provisional	90.45
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	89.84
KOG2270	520	consensus Serine/threonine protein kinase involved	88.52
PRK12396	409	5-methylribose kinase; Reviewed	88.22
PF10140	359	YukC: WXG100 protein secretion system (Wss), prote	86.89
PRK09550	401	mtnK methylthioribose kinase; Reviewed	86.69
KOG1235	538	consensus Predicted unusual protein kinase [Genera	86.16
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	85.39
PHA03111	444	Ser/Thr kinase; Provisional	82.65
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	80.97
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	80.9
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	80.66

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=217.35  Aligned_cols=162  Identities=27%  Similarity=0.390  Sum_probs=129.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +.+++....+++.+|+.||.|||+ .   +|+||||||+|+|+..+|.+||+|||.+..+...  ....+.|+..||+||
T Consensus       173 g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPE  247 (364)
T KOG0581|consen  173 GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPE  247 (364)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChh
Confidence            568999999999999999999997 5   9999999999999999999999999999876654  345679999999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..|+.++||||||++++|+.+|+.||......   .......+..+++...|.....  ....++.+++..||+.|
T Consensus       248 Ri~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~---~~~~~~Ll~~Iv~~ppP~lP~~--~fS~ef~~FV~~CL~Kd  322 (364)
T KOG0581|consen  248 RISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP---YLDIFELLCAIVDEPPPRLPEG--EFSPEFRSFVSCCLRKD  322 (364)
T ss_pred             hhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC---CCCHHHHHHHHhcCCCCCCCcc--cCCHHHHHHHHHHhcCC
Confidence            999999999999999999999999999998754211   1112223333333222221111  12334788888999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |.+|||+.|+++|
T Consensus       323 p~~R~s~~qLl~H  335 (364)
T KOG0581|consen  323 PSERPSAKQLLQH  335 (364)
T ss_pred             cccCCCHHHHhcC
Confidence            9999999999987

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-36  Score=227.56  Aligned_cols=159  Identities=23%  Similarity=0.383  Sum_probs=131.3

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      +++.+++.+++.+++||++||.|||+.   +|+|||||..|+|++.+.++||+|||+|.....+.....+..|++.|.||
T Consensus       111 rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAP  187 (592)
T KOG0575|consen  111 RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAP  187 (592)
T ss_pred             hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccCh
Confidence            568899999999999999999999999   99999999999999999999999999999988776667788999999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |++.....+..+||||+||++|-|+.|+.||....-        ......+.......+.    .......+||.++|+.
T Consensus       188 EVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--------kety~~Ik~~~Y~~P~----~ls~~A~dLI~~lL~~  255 (592)
T KOG0575|consen  188 EVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV--------KETYNKIKLNEYSMPS----HLSAEAKDLIRKLLRP  255 (592)
T ss_pred             hHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH--------HHHHHHHHhcCccccc----ccCHHHHHHHHHHhcC
Confidence            999988999999999999999999999999964321        1111111111111111    1122367889999999


Q ss_pred             CCCCCCCHHHHHHH
Q 042876          163 SPESRPTMKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rps~~~~~~~  176 (179)
                      ||.+|||+++++.|
T Consensus       256 ~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  256 NPSERPSLDEVLDH  269 (592)
T ss_pred             CcccCCCHHHHhcC
Confidence            99999999999875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=221.28  Aligned_cols=162  Identities=31%  Similarity=0.520  Sum_probs=129.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC-cccCCCCCCCeeecCCC-ceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPP-IVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~-~~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      +..+++..++.++.||+.|++|||++   + |||||||++|+|++.++ .+||+|||++..............|++.|+|
T Consensus       136 ~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMA  212 (362)
T KOG0192|consen  136 KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMA  212 (362)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccC
Confidence            57899999999999999999999999   8 99999999999999997 9999999999876654333344688999999


Q ss_pred             Ccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           82 PELAY--TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        82 pe~~~--~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      ||.+.  ...++.++|+||||+++|++++|..||...........    ....  ..+.+.+..+.+    .+..+|.+|
T Consensus       213 PEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~----v~~~--~~Rp~~p~~~~~----~l~~l~~~C  282 (362)
T KOG0192|consen  213 PEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA----VVVG--GLRPPIPKECPP----HLSSLMERC  282 (362)
T ss_pred             hhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhc--CCCCCCCccCCH----HHHHHHHHh
Confidence            99999  56899999999999999999999999986643111110    1111  112221222323    378888899


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||.+||++.+++..|+
T Consensus       283 W~~dp~~RP~f~ei~~~l~  301 (362)
T KOG0192|consen  283 WLVDPSRRPSFLEIVSRLE  301 (362)
T ss_pred             CCCCCCcCCCHHHHHHHHH
Confidence            9999999999999999875

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-35  Score=216.94  Aligned_cols=164  Identities=24%  Similarity=0.310  Sum_probs=132.6

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC---CceeEccccCccccCCCCCCcccccCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE---YEAHVADFGIAKFLKPDSSNWTEFAGTYGY   79 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   79 (179)
                      +++.+.+..-+.+++|++.|+.|||++   ||+||||||+|||++.+   -.+||.|||+|+..+... ...+.+|++.|
T Consensus       269 ~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~s-fm~TlCGTpsY  344 (475)
T KOG0615|consen  269 ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGS-FMKTLCGTPSY  344 (475)
T ss_pred             hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhhccccce-ehhhhcCCccc
Confidence            346678888899999999999999999   99999999999999877   558999999999887433 34567999999


Q ss_pred             CCCcccccCCC---CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHH
Q 042876           80 VAPELAYTMKI---TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVA  156 (179)
Q Consensus        80 ~~pe~~~~~~~---~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  156 (179)
                      .|||.+.+..+   ..+.|+||+||++|-+++|..||+.....       ....+.+...+..-....+.....+..+||
T Consensus       345 vAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-------~sl~eQI~~G~y~f~p~~w~~Iseea~dlI  417 (475)
T KOG0615|consen  345 VAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-------PSLKEQILKGRYAFGPLQWDRISEEALDLI  417 (475)
T ss_pred             cChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-------ccHHHHHhcCcccccChhhhhhhHHHHHHH
Confidence            99999987653   34789999999999999999999754321       112223334455545566677777788999


Q ss_pred             hcccCcCCCCCCCHHHHHHHh
Q 042876          157 FSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       157 ~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      .+||..||++|||++|+++|=
T Consensus       418 ~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  418 NWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             HHhhEeCcccCcCHHHHhcCh
Confidence            999999999999999999874

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-34  Score=215.38  Aligned_cols=160  Identities=31%  Similarity=0.514  Sum_probs=130.9

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVA   81 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~   81 (179)
                      .+..++..+.+.++.||++|++||+++   ++|||||.+.|||++.+..+||+|||+++....+.. ......-++.|.|
T Consensus       296 ~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtA  372 (468)
T KOG0197|consen  296 EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTA  372 (468)
T ss_pred             CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecC
Confidence            356789999999999999999999999   999999999999999999999999999984443322 2333455788999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcC--CCCCCCCCccHHHHHHHHHHHHhc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      ||.+....++.++||||||+++||++| |+.|+.+....         .+.+.+  .-+++.+..|..+    +.++|..
T Consensus       373 PEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---------ev~~~le~GyRlp~P~~CP~~----vY~lM~~  439 (468)
T KOG0197|consen  373 PEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---------EVLELLERGYRLPRPEGCPDE----VYELMKS  439 (468)
T ss_pred             HHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------HHHHHHhccCcCCCCCCCCHH----HHHHHHH
Confidence            999999999999999999999999998 89998754322         222222  2356666666665    8899999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||+.+|++|||++.+...|+
T Consensus       440 CW~~~P~~RPtF~~L~~~l~  459 (468)
T KOG0197|consen  440 CWHEDPEDRPTFETLREVLE  459 (468)
T ss_pred             HhhCCcccCCCHHHHHHHHH
Confidence            99999999999999887764

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-33  Score=198.53  Aligned_cols=164  Identities=20%  Similarity=0.264  Sum_probs=129.8

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCC-CcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFP-PIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~-~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      .++.++++++|+++.|++.||.++|....+ .+.||||||.|||++.+|.+|++|||+++++..........+|+|.|++
T Consensus       117 qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMS  196 (375)
T KOG0591|consen  117 QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMS  196 (375)
T ss_pred             ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccC
Confidence            457789999999999999999999993221 3999999999999999999999999999988766555566799999999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+.+|++++|+||+||++|+|..-+.||.+.+..+        -..++-....++...  .-++.++..+|..|+.
T Consensus       197 PE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~--------L~~KI~qgd~~~~p~--~~YS~~l~~li~~ci~  266 (375)
T KOG0591|consen  197 PERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS--------LCKKIEQGDYPPLPD--EHYSTDLRELINMCIA  266 (375)
T ss_pred             HHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH--------HHHHHHcCCCCCCcH--HHhhhHHHHHHHHHcc
Confidence            999999999999999999999999999999997653211        111122222322110  2234468888999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||+.||+...+++.
T Consensus       267 vd~~~RP~t~~~v~d  281 (375)
T KOG0591|consen  267 VDPEQRPDTVPYVQD  281 (375)
T ss_pred             CCcccCCCcchHHHH
Confidence            999999985555443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=211.31  Aligned_cols=157  Identities=25%  Similarity=0.385  Sum_probs=126.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-----------c--c
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-----------W--T   71 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----------~--~   71 (179)
                      .+|++.-++.++.||+.||+|||++   |||||||||+|||++.++.++|.|||.+..+......           .  .
T Consensus       169 Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~  245 (604)
T KOG0592|consen  169 GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRS  245 (604)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCccc
Confidence            5788999999999999999999999   9999999999999999999999999999876533211           1  3


Q ss_pred             cccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHH
Q 042876           72 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLIS  151 (179)
Q Consensus        72 ~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (179)
                      .++|+..|.+||++.+...++.+|+|+|||++|+|+.|..||...+..-     .-......- =.+++..  .    ..
T Consensus       246 SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-----iFqkI~~l~-y~fp~~f--p----~~  313 (604)
T KOG0592|consen  246 SFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-----IFQKIQALD-YEFPEGF--P----ED  313 (604)
T ss_pred             ceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-----HHHHHHHhc-ccCCCCC--C----HH
Confidence            4789999999999999999999999999999999999999998665321     111111111 1122211  1    23


Q ss_pred             HHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          152 IVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       152 ~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ..+|+.++|..||.+|++..+|.+|
T Consensus       314 a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  314 ARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHHHHHccCccccccHHHHhhC
Confidence            6788889999999999999999887

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-34  Score=215.97  Aligned_cols=163  Identities=32%  Similarity=0.489  Sum_probs=132.9

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ++++++......+.++|+.|+.|||.+   +|||||||..|||++.+..+||+|||-++....- ...+.+.|+..||||
T Consensus       205 a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAP  280 (904)
T KOG4721|consen  205 AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAP  280 (904)
T ss_pred             ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCH
Confidence            467889999999999999999999999   9999999999999999999999999998766543 345668899999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |++++.+++.+.||||||+|+|+|+||..||.+.......--...-.    +  .++.+..+.    ..+.-|++.||+.
T Consensus       281 EvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNs----L--~LpvPstcP----~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  281 EVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNS----L--HLPVPSTCP----DGFKLLLKQCWNS  350 (904)
T ss_pred             HHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCc----c--cccCcccCc----hHHHHHHHHHHhc
Confidence            99999999999999999999999999999997654322111100001    1  123333332    3478889999999


Q ss_pred             CCCCCCCHHHHHHHhhC
Q 042876          163 SPESRPTMKIVSQQLRI  179 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~~  179 (179)
                      .|..|||+.+++.||.|
T Consensus       351 KpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  351 KPRNRPSFRQILLHLDI  367 (904)
T ss_pred             CCCCCccHHHHHHHHhh
Confidence            99999999999999976

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=204.87  Aligned_cols=160  Identities=27%  Similarity=0.396  Sum_probs=121.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-CCceeEccccCccccCCCC---CCcccccCCCCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-EYEAHVADFGIAKFLKPDS---SNWTEFAGTYGYVA   81 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~   81 (179)
                      +|++..++.+++|+++||+|||++   |++|+||||+|||++. ++.+||+|||.+.......   .......|++.|++
T Consensus       113 ~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~ma  189 (313)
T KOG0198|consen  113 KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMA  189 (313)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccC
Confidence            799999999999999999999999   9999999999999999 7999999999987665311   12334688999999


Q ss_pred             CcccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+. ...+++|+|||||++.+|+||..||...  ...........    .....|.....   ...+..+++.+|+
T Consensus       190 PEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig----~~~~~P~ip~~---ls~~a~~Fl~~C~  260 (313)
T KOG0198|consen  190 PEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIG----REDSLPEIPDS---LSDEAKDFLRKCF  260 (313)
T ss_pred             chhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHh----ccCCCCCCCcc---cCHHHHHHHHHHh
Confidence            9999853 3345899999999999999999999763  00001011111    11111211112   2224677888999


Q ss_pred             CcCCCCCCCHHHHHHHh
Q 042876          161 NESPESRPTMKIVSQQL  177 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l  177 (179)
                      ..||++|||++++++|-
T Consensus       261 ~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  261 KRDPEKRPTAEELLEHP  277 (313)
T ss_pred             hcCcccCcCHHHHhhCh
Confidence            99999999999999875

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-33  Score=213.99  Aligned_cols=158  Identities=27%  Similarity=0.355  Sum_probs=130.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ++++++.++.++++||+.|+.|+|..   +++||||||+|++++.+++|||+|||+|..-.+ +....+.+|.+.|++||
T Consensus       106 kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-gklLeTSCGSPHYA~PE  181 (786)
T KOG0588|consen  106 KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP-GKLLETSCGSPHYAAPE  181 (786)
T ss_pred             hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC-CccccccCCCcccCCch
Confidence            56899999999999999999999999   999999999999999999999999999965443 44567779999999999


Q ss_pred             ccccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ++.|.+| ..++||||.|+++|.+++|..||++.+-        ..-+.++..+.+..+..    ...+.++|+.+|+..
T Consensus       182 IV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--------r~LLlKV~~G~f~MPs~----Is~eaQdLLr~ml~V  249 (786)
T KOG0588|consen  182 IVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--------RVLLLKVQRGVFEMPSN----ISSEAQDLLRRMLDV  249 (786)
T ss_pred             hhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--------HHHHHHHHcCcccCCCc----CCHHHHHHHHHHhcc
Confidence            9999998 5789999999999999999999985431        12222222233332222    223488999999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 042876          163 SPESRPTMKIVSQQL  177 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l  177 (179)
                      ||++|.|.++|++|-
T Consensus       250 Dp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  250 DPSTRITTEEILKHP  264 (786)
T ss_pred             CccccccHHHHhhCc
Confidence            999999999999884

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-33  Score=209.37  Aligned_cols=160  Identities=22%  Similarity=0.367  Sum_probs=130.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.++..++++++.||+|||.+   ||+|||||.+||++..++.+||.|||++..+.........-+|++.|+|||.
T Consensus       364 ~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEV  440 (550)
T KOG0578|consen  364 TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEV  440 (550)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhh
Confidence            3578999999999999999999999   9999999999999999999999999999888776656677799999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +....|.++.||||||+.++||+-|+.||=..+  +....       ..+..+-.+...........+.+|+.+||..|+
T Consensus       441 vtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~--PlrAl-------yLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv  511 (550)
T KOG0578|consen  441 VTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN--PLRAL-------YLIATNGTPKLKNPEKLSPELKDFLDRCLVVDV  511 (550)
T ss_pred             hhhcccCccccchhhhhHHHHHhcCCCCccCCC--hHHHH-------HHHhhcCCCCcCCccccCHHHHHHHHHHhhcch
Confidence            999999999999999999999999999984321  11111       111111222222223334458888889999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+|+++.||++|
T Consensus       512 ~~RasA~eLL~H  523 (550)
T KOG0578|consen  512 EQRASAKELLEH  523 (550)
T ss_pred             hcCCCHHHHhcC
Confidence            999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-32  Score=205.11  Aligned_cols=159  Identities=23%  Similarity=0.338  Sum_probs=126.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC-CceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ..++++.++..+++|+++|++|+|+.   ||+||||||+|++++.+ +++||+|||++..............|++.|+||
T Consensus       114 ~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aP  190 (370)
T KOG0583|consen  114 KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAP  190 (370)
T ss_pred             cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCH
Confidence            46789999999999999999999999   99999999999999999 999999999998774233445668999999999


Q ss_pred             cccccCC-CC-cchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMK-IT-EKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~-~~-~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |++.+.. |+ .++|+||+|+++|.|++|..||+..+....        ...+....+..+....   ..++.+|+.+|+
T Consensus       191 Evl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l--------~~ki~~~~~~~p~~~~---S~~~~~Li~~mL  259 (370)
T KOG0583|consen  191 EVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL--------YRKIRKGEFKIPSYLL---SPEARSLIEKML  259 (370)
T ss_pred             HHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH--------HHHHhcCCccCCCCcC---CHHHHHHHHHHc
Confidence            9999877 75 789999999999999999999987321111        1111111121111110   234788999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      ..||.+|+++.+++++
T Consensus       260 ~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  260 VPDPSTRITLLEILEH  275 (370)
T ss_pred             CCCcccCCCHHHHhhC
Confidence            9999999999999865

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.2e-33  Score=197.17  Aligned_cols=168  Identities=22%  Similarity=0.380  Sum_probs=130.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.++.+.+..++.|++.|+.|+|++   +++||||||+||+++.++.+|++|||+|+.+..+....+..+.+.+|++||+
T Consensus        96 ~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPEL  172 (396)
T KOG0593|consen   96 NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPEL  172 (396)
T ss_pred             CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhh
Confidence            3567889999999999999999999   9999999999999999999999999999988766666777889999999999


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhc-------------CC-CCCCCC------Cc
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEM-------------LD-PRLPAP------SR  143 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------------~~-~~~~~~------~~  143 (179)
                      +.| .+|..+.||||+||++.||++|+.-|++.++...-.. ....+...             .. =++|.+      +.
T Consensus       173 LvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~-I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~  251 (396)
T KOG0593|consen  173 LVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYL-IRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLER  251 (396)
T ss_pred             hcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHH-HHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhh
Confidence            887 6899999999999999999999999877654321110 00111110             00 011111      12


Q ss_pred             cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          144 SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       144 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ..+....-++++++.|++.||++|++-++++.|
T Consensus       252 k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  252 KYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             hcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            222233347899999999999999999998764

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-32  Score=203.00  Aligned_cols=171  Identities=21%  Similarity=0.288  Sum_probs=131.1

Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            2 AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         2 ~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      .+++.|+++.++.++.||+.||+|+|++   |+.|||+||+|||+.++..+||+|||+|+.... ....+..+.+.+|+|
T Consensus       102 ~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S-kpPYTeYVSTRWYRA  177 (538)
T KOG0661|consen  102 DRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS-KPPYTEYVSTRWYRA  177 (538)
T ss_pred             hcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc-CCCcchhhhcccccc
Confidence            3578899999999999999999999999   999999999999999999999999999987664 334566788999999


Q ss_pred             Ccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccc------------cc-cchhhhhhhcCCCCCCCCCc----
Q 042876           82 PELAY-TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------------SS-LNTDIELDEMLDPRLPAPSR----  143 (179)
Q Consensus        82 pe~~~-~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~------------~~-~~~~~~~~~~~~~~~~~~~~----  143 (179)
                      ||++. ..-|+.+.|+|++||+++|+++-+.-|++.+....            .. ......+...+.-++|....    
T Consensus       178 PEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~  257 (538)
T KOG0661|consen  178 PEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLK  257 (538)
T ss_pred             hHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChH
Confidence            99765 45689999999999999999999888876553221            00 11112222222222222111    


Q ss_pred             -cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          144 -SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       144 -~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                       -.+....+..++|.+|+.+||.+|||++|.++|
T Consensus       258 ~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  258 DLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence             111234468889999999999999999999886

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.4e-32  Score=202.18  Aligned_cols=160  Identities=26%  Similarity=0.409  Sum_probs=122.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      .++++.+++.++.|+++||+|||+.   +++||||||+||+++.++.++++|||++.........  .....++..|++|
T Consensus       169 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  245 (338)
T cd05102         169 SPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP  245 (338)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence            4689999999999999999999999   9999999999999999999999999998765332211  1223456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |.+.+..++.++|+||||+++|++++ |..||........       ........ ........    ...+.+++.+||
T Consensus       246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~~~~~~~~~~~----~~~l~~li~~cl  314 (338)
T cd05102         246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-------FCQRLKDGTRMRAPENA----TPEIYRIMLACW  314 (338)
T ss_pred             HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-------HHHHHhcCCCCCCCCCC----CHHHHHHHHHHc
Confidence            99988889999999999999999997 9999975432110       00111111 11111111    234788999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||.+|||+.++++.|+
T Consensus       315 ~~dp~~RPs~~el~~~l~  332 (338)
T cd05102         315 QGDPKERPTFSALVEILG  332 (338)
T ss_pred             cCChhhCcCHHHHHHHHH
Confidence            999999999999999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-32  Score=203.40  Aligned_cols=173  Identities=40%  Similarity=0.716  Sum_probs=137.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccc-cCCCCCCCCcc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEF-AGTYGYVAPEL   84 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~-~~~~~~~~pe~   84 (179)
                      .++|..+++|+.+++.||+|||..+.+.|+|||||++|||++.+...||+|||++............. .++.+|++||+
T Consensus       170 ~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy  249 (361)
T KOG1187|consen  170 PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEY  249 (361)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhh
Confidence            78999999999999999999999877779999999999999999999999999995443311111112 78999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccc-------cccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHh
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS-------SSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      ......+.++||||||+++.++++|+.+.+.......       ..........+++|+++........+....+..+..
T Consensus       250 ~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~  329 (361)
T KOG1187|consen  250 ASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELAL  329 (361)
T ss_pred             hccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHH
Confidence            9888899999999999999999999988765431111       112222256777888876322221256777999999


Q ss_pred             cccCcCCCCCCCHHHHHHHhh
Q 042876          158 SCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +|++.+|.+||++.|+++.|+
T Consensus       330 ~C~~~~~~~RP~m~~Vv~~L~  350 (361)
T KOG1187|consen  330 RCLRPDPKERPTMSQVVKELE  350 (361)
T ss_pred             HHcCcCCCcCcCHHHHHHHHH
Confidence            999999999999999988874

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.98  E-value=1.6e-32  Score=192.20  Aligned_cols=161  Identities=25%  Similarity=0.368  Sum_probs=133.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++++.+++++|+.+|++|||..   +||||||||+||+++.+.+++|+|||++....+... ....+|+++|++||
T Consensus       117 ~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek-LrelCGTPgYLAPE  192 (411)
T KOG0599|consen  117 KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK-LRELCGTPGYLAPE  192 (411)
T ss_pred             heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCCchh-HHHhcCCCcccChh
Confidence            45689999999999999999999999   999999999999999999999999999988775443 35578999999999


Q ss_pred             ccccC------CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHh
Q 042876           84 LAYTM------KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        84 ~~~~~------~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      .++.+      .|+...|+|++|+++|-++.|..||...+        +..-+.-+...+..-....|.+...+..+||.
T Consensus       193 tikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------QmlMLR~ImeGkyqF~speWadis~~~KdLIs  264 (411)
T KOG0599|consen  193 TIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------QMLMLRMIMEGKYQFRSPEWADISATVKDLIS  264 (411)
T ss_pred             heeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------HHHHHHHHHhcccccCCcchhhccccHHHHHH
Confidence            98742      46788999999999999999999985322        11222233334444455667777888999999


Q ss_pred             cccCcCCCCCCCHHHHHHH
Q 042876          158 SCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~  176 (179)
                      +||+.||.+|.|++|.++|
T Consensus       265 rlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  265 RLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHeeCchhcccHHHHhcC
Confidence            9999999999999999886

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.98  E-value=4.2e-32  Score=196.08  Aligned_cols=160  Identities=26%  Similarity=0.383  Sum_probs=126.9

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      +...|+++.++.++.+|+.||.|||+.   ||+||||||+|||++.+|.+++.|||+++...........++|++.|+||
T Consensus       118 ~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAP  194 (357)
T KOG0598|consen  118 REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAP  194 (357)
T ss_pred             hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccCh
Confidence            346799999999999999999999999   99999999999999999999999999998655554455668999999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |++.+..++.++|-||||+++|+|++|..||...+.        .....++...+.+........   +..+++.++++.
T Consensus       195 Eil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~--------~~~~~~I~~~k~~~~p~~ls~---~ardll~~LL~r  263 (357)
T KOG0598|consen  195 EILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------KKMYDKILKGKLPLPPGYLSE---EARDLLKKLLKR  263 (357)
T ss_pred             HHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH--------HHHHHHHhcCcCCCCCccCCH---HHHHHHHHHhcc
Confidence            999999999999999999999999999999965432        112222222222222121122   367888899999


Q ss_pred             CCCCCC----CHHHHHHH
Q 042876          163 SPESRP----TMKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rp----s~~~~~~~  176 (179)
                      ||++|.    ++.++.+|
T Consensus       264 dp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  264 DPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             CHHHhcCCCCChHHhhcC
Confidence            999995    56666544

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-32  Score=208.05  Aligned_cols=165  Identities=23%  Similarity=0.388  Sum_probs=128.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC--CCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~   81 (179)
                      +.+|.+...+.|++|++.|+.|||.+   +|||+|||+.|||+..+++++|+|||++..-+...  .......+...|+|
T Consensus       482 etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmA  558 (678)
T KOG0193|consen  482 ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMA  558 (678)
T ss_pred             hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhc
Confidence            45788999999999999999999999   99999999999999999999999999997544322  22445677889999


Q ss_pred             Cccccc---CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           82 PELAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        82 pe~~~~---~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      ||+++.   .++++++||||||+|+|||++|..||...+..+.........    .   .+..........+++.+|+..
T Consensus       559 PEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~----l---~pd~s~~~s~~pk~mk~Ll~~  631 (678)
T KOG0193|consen  559 PEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGY----L---MPDLSKIRSNCPKAMKRLLSD  631 (678)
T ss_pred             HHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccc----c---CccchhhhccCHHHHHHHHHH
Confidence            999874   468999999999999999999999998433333222221110    0   122223333444568899999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||..++++||.+.+|+..|+
T Consensus       632 C~~~~~~eRP~F~~il~~l~  651 (678)
T KOG0193|consen  632 CWKFDREERPLFPQLLSKLE  651 (678)
T ss_pred             HHhcCcccCccHHHHHHHHH
Confidence            99999999999999998664

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=1.2e-31  Score=197.32  Aligned_cols=165  Identities=17%  Similarity=0.193  Sum_probs=124.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-------CcccccCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-------NWTEFAGTYG   78 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~   78 (179)
                      .+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++++|||++........       ......+++.
T Consensus       122 ~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~  198 (294)
T PHA02882        122 CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLY  198 (294)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCcc
Confidence            356778889999999999999999   999999999999999999999999999976542211       1123468899


Q ss_pred             CCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhh-hhcCCCCCCCCCccHHHHHHHHHHHHh
Q 042876           79 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIEL-DEMLDPRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        79 ~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      |+|||...+..++.++|+||||++++++++|..||................. .......... ..+    ...+.+++.
T Consensus       199 y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~  273 (294)
T PHA02882        199 YAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI-KNA----NKFIYDFIE  273 (294)
T ss_pred             ccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc-CCC----CHHHHHHHH
Confidence            9999999988899999999999999999999999976532221111111111 1111111111 111    234788999


Q ss_pred             cccCcCCCCCCCHHHHHHHhh
Q 042876          158 SCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      .||+.+|.+||++.++++.|.
T Consensus       274 ~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        274 CVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHhCCCCCCCCHHHHHHhhC
Confidence            999999999999999998763

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.97  E-value=8.5e-32  Score=200.49  Aligned_cols=158  Identities=23%  Similarity=0.303  Sum_probs=123.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++..+..++.||+.||+|||+.   +++||||||+||+++.++.++|+|||++..............+++.|+|||
T Consensus        89 ~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE  165 (323)
T cd05571          89 ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE  165 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChh
Confidence            35689999999999999999999999   999999999999999999999999999875433332333456889999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+||++|+|++|..||......        .............+..    ...++.+++.+||+.|
T Consensus       166 ~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~~~~~~~~~p~~----~~~~~~~li~~~L~~d  233 (323)
T cd05571         166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEEIRFPRT----LSPEAKSLLAGLLKKD  233 (323)
T ss_pred             hhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcCCCCCCCC----CCHHHHHHHHHHccCC
Confidence            998888999999999999999999999999643211        1111111111111111    1234788999999999


Q ss_pred             CCCCC-----CHHHHHHH
Q 042876          164 PESRP-----TMKIVSQQ  176 (179)
Q Consensus       164 p~~Rp-----s~~~~~~~  176 (179)
                      |++||     ++.++++|
T Consensus       234 P~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         234 PKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             HHHcCCCCCCCHHHHHcC
Confidence            99999     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=5.6e-32  Score=198.41  Aligned_cols=168  Identities=20%  Similarity=0.243  Sum_probs=123.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||||+||+++.++.++++|||++...... .......+++.|+|||.
T Consensus       105 ~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~  180 (290)
T cd07862         105 PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEV  180 (290)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEeccCC-cccccccccccccChHH
Confidence            4588999999999999999999999   9999999999999999999999999998765433 22234567889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh-------hhhh-------hcCCCCCCC-CCccHHHHH
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD-------IELD-------EMLDPRLPA-PSRSVQEKL  149 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~-------~~~~-------~~~~~~~~~-~~~~~~~~~  149 (179)
                      +.+..++.++|+||+|+++|++++|..||..............       ....       ......... .........
T Consensus       181 ~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (290)
T cd07862         181 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID  260 (290)
T ss_pred             HhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCC
Confidence            9888889999999999999999999999975432111000000       0000       000000000 000011122


Q ss_pred             HHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          150 ISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       150 ~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ..+.+++.+||+.||++|||+.++++|
T Consensus       261 ~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         261 ELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             HHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            346789999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PHA02988 hypothetical protein; Provisional

Probab=99.97  E-value=1.6e-31  Score=195.71  Aligned_cols=159  Identities=20%  Similarity=0.304  Sum_probs=122.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++..++.++.|++.||.|||+..  +++||||+|+||+++.++.++++|||++.......   ....++..|+|||.
T Consensus       117 ~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~  191 (283)
T PHA02988        117 KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FKNVNFMVYFSYKM  191 (283)
T ss_pred             CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---ccccCcccccCHHH
Confidence            56889999999999999999999842  78899999999999999999999999987654322   23456788999999


Q ss_pred             ccc--CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           85 AYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        85 ~~~--~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      +.+  ..++.++|+||||+++|++++|..||.........    ........  +.+.+..+    ...+.+++.+||+.
T Consensus       192 ~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~----~~i~~~~~--~~~~~~~~----~~~l~~li~~cl~~  261 (283)
T PHA02988        192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY----DLIINKNN--SLKLPLDC----PLEIKCIVEACTSH  261 (283)
T ss_pred             hhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcCC--CCCCCCcC----cHHHHHHHHHHhcC
Confidence            876  57899999999999999999999999754321100    00101111  11111122    22478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||++|||++++++.|+
T Consensus       262 dp~~Rps~~ell~~l~  277 (283)
T PHA02988        262 DSIKRPNIKEILYNLS  277 (283)
T ss_pred             CcccCcCHHHHHHHHH
Confidence            9999999999999886

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.2e-31  Score=201.85  Aligned_cols=170  Identities=21%  Similarity=0.310  Sum_probs=123.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC-CCcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS-SNWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~p   82 (179)
                      .+.+++.+++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++....... .......+++.|++|
T Consensus       176 ~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aP  252 (391)
T PHA03212        176 KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAP  252 (391)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCCh
Confidence            35688999999999999999999999   99999999999999999999999999986543221 122345688999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCccccccccc---------------------ccchhhhhhh-------cC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS---------------------SLNTDIELDE-------ML  134 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~---------------------~~~~~~~~~~-------~~  134 (179)
                      |.+.+..++.++|+||+|+++|++++|..||-........                     ..........       ..
T Consensus       253 E~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  332 (391)
T PHA03212        253 ELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKS  332 (391)
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhcc
Confidence            9998888999999999999999999999876322111000                     0000000000       00


Q ss_pred             --CCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          135 --DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       135 --~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                        .+...+..........++.+++.+||+.||.+|||++|+++|
T Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        333 SRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             CCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence              000001111122234568899999999999999999999876

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=1.3e-31  Score=200.32  Aligned_cols=169  Identities=25%  Similarity=0.351  Sum_probs=121.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---CcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---NWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++........   ......++..|+|
T Consensus        98 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~a  174 (338)
T cd07859          98 DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA  174 (338)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCC
Confidence            4689999999999999999999999   999999999999999999999999999875432211   1233567889999


Q ss_pred             Cccccc--CCCCcchhhHHHHHHHHHHHhCCCCCccccccccccc------------chh---hh---hhhcCCCCCCC-
Q 042876           82 PELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL------------NTD---IE---LDEMLDPRLPA-  140 (179)
Q Consensus        82 pe~~~~--~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~------------~~~---~~---~~~~~~~~~~~-  140 (179)
                      ||.+.+  ..++.++|+|||||++|++++|+.||...+.......            ...   ..   .........+. 
T Consensus       175 PE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  254 (338)
T cd07859         175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVP  254 (338)
T ss_pred             HHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCc
Confidence            998865  5678899999999999999999999965432110000            000   00   00000000000 


Q ss_pred             CCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          141 PSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       141 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ...........+.+++.+||+.||++|||++++++|
T Consensus       255 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         255 FSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000001112347889999999999999999999876

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-31  Score=182.87  Aligned_cols=166  Identities=26%  Similarity=0.352  Sum_probs=124.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---------Cccccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---------NWTEFA   74 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------~~~~~~   74 (179)
                      +..+++.+.+.++.++++||++||.... .+.|+||||.||+++.++.+++.|||.++.......         .+....
T Consensus       121 g~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~  199 (302)
T KOG2345|consen  121 GNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEER  199 (302)
T ss_pred             CCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHh
Confidence            3468999999999999999999999832 499999999999999999999999999876542211         123357


Q ss_pred             CCCCCCCCccccc---CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHH
Q 042876           75 GTYGYVAPELAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLIS  151 (179)
Q Consensus        75 ~~~~~~~pe~~~~---~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (179)
                      ++..|+|||++..   ...+.+.|+|||||++|.++.|..||+..... ............+.   +|....    ....
T Consensus       200 Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgSlaLAv~n~q~s---~P~~~~----yse~  271 (302)
T KOG2345|consen  200 CTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGSLALAVQNAQIS---IPNSSR----YSEA  271 (302)
T ss_pred             CCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCeEEEeeeccccc---cCCCCC----ccHH
Confidence            8899999999864   34678999999999999999999999754321 11111111111111   111111    3445


Q ss_pred             HHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          152 IVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       152 ~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +..++..|++.||.+||++.+++.++.
T Consensus       272 l~~lik~mlqvdP~qRP~i~~ll~~~d  298 (302)
T KOG2345|consen  272 LHQLIKSMLQVDPNQRPTIPELLSKLD  298 (302)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            888999999999999999999998874

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=2e-31  Score=196.84  Aligned_cols=169  Identities=21%  Similarity=0.250  Sum_probs=120.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++++|||++..............+++.|+|||.
T Consensus        98 ~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  174 (303)
T cd07869          98 GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV  174 (303)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHH
Confidence            4688899999999999999999999   9999999999999999999999999998754433333334567889999998


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh--------h------hhhhcCCCCCCC-CCccHH--
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD--------I------ELDEMLDPRLPA-PSRSVQ--  146 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~--------~------~~~~~~~~~~~~-~~~~~~--  146 (179)
                      +.+. .++.++|+||+||++|++++|..||....+.........        .      .........+.. ......  
T Consensus       175 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (303)
T cd07869         175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQA  254 (303)
T ss_pred             HcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHH
Confidence            7653 578899999999999999999999975432110000000        0      000000000000 000000  


Q ss_pred             ----HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          147 ----EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       147 ----~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                          ....++.+++.+||+.||.+|||++++++|
T Consensus       255 ~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         255 WNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence                012347789999999999999999999876

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=4e-31  Score=197.93  Aligned_cols=161  Identities=26%  Similarity=0.396  Sum_probs=123.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++++|||++.........  .....++..|++|
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence            4789999999999999999999999   9999999999999999999999999999765432211  1223456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+|||||+++++++ |..||........  .  ............+  ..    ...++.+++.+||+
T Consensus       245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~--~~~~~~~~~~~~~--~~----~~~~~~~l~~~cl~  314 (337)
T cd05054         245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F--CRRLKEGTRMRAP--EY----ATPEIYSIMLDCWH  314 (337)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H--HHHHhccCCCCCC--cc----CCHHHHHHHHHHcc
Confidence            99988899999999999999999997 9999865322110  0  0011111111111  11    12348889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|++||++++++++|+
T Consensus       315 ~~p~~RPs~~ell~~l~  331 (337)
T cd05054         315 NNPEDRPTFSELVEILG  331 (337)
T ss_pred             CChhhCcCHHHHHHHHH
Confidence            99999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=7.6e-31  Score=194.73  Aligned_cols=109  Identities=23%  Similarity=0.378  Sum_probs=91.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee----cCCCceeEccccCccccCCCCC---CcccccCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL----DLEYEAHVADFGIAKFLKPDSS---NWTEFAGTY   77 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~----~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~   77 (179)
                      ..+++..++.++.|++.||.|||+.   +++||||||+||++    +.++.++++|||++........   ......+++
T Consensus       103 ~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~  179 (317)
T cd07868         103 VQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF  179 (317)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccc
Confidence            3588999999999999999999999   99999999999999    4557899999999976543221   123356788


Q ss_pred             CCCCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCccc
Q 042876           78 GYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFL  116 (179)
Q Consensus        78 ~~~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~  116 (179)
                      .|+|||.+.+. .++.++|+||+||+++++++|..||...
T Consensus       180 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            99999988764 5788999999999999999999999644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.97  E-value=5.2e-31  Score=183.33  Aligned_cols=168  Identities=22%  Similarity=0.246  Sum_probs=130.5

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ....|+..+++.++.+++.||+|+|++   .|.||||||.|++++.+|.+|++|||+++.+..........+-+.+|+||
T Consensus        94 ~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAP  170 (318)
T KOG0659|consen   94 KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAP  170 (318)
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccCh
Confidence            345688999999999999999999999   99999999999999999999999999999988776665656788999999


Q ss_pred             cccccC-CCCcchhhHHHHHHHHHHHhCCCCCccccccccc-------------------ccchhhhhhhcCCCCCCCCC
Q 042876           83 ELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-------------------SLNTDIELDEMLDPRLPAPS  142 (179)
Q Consensus        83 e~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~  142 (179)
                      |++.|. .|+...|+||.||++.|++.|..-|.+.++.+.-                   .+......+...   .+...
T Consensus       171 ELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P---~~~~~  247 (318)
T KOG0659|consen  171 ELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFP---KPPLN  247 (318)
T ss_pred             HHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCC---CCccc
Confidence            998875 5899999999999999999988777654432110                   000001111011   11112


Q ss_pred             ccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          143 RSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       143 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ........+..+|+.+++..||.+|++++|++++
T Consensus       248 ~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  248 NLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            2334445567999999999999999999999875

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=3.4e-31  Score=194.28  Aligned_cols=169  Identities=20%  Similarity=0.246  Sum_probs=121.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|+++||+|||+.   +++|+||||+||+++.++.++++|||++..............++..|+|||.
T Consensus        98 ~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~  174 (288)
T cd07871          98 NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV  174 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHH
Confidence            4578899999999999999999999   9999999999999999999999999998765433333344567889999998


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccc------------c----chhhhhhhcCCCCCCC-C-CccH
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS------------L----NTDIELDEMLDPRLPA-P-SRSV  145 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~------------~----~~~~~~~~~~~~~~~~-~-~~~~  145 (179)
                      +.+ ..++.++|+||+|+++|++++|+.||..........            .    ...........+.... . ....
T Consensus       175 ~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (288)
T cd07871         175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHA  254 (288)
T ss_pred             hcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhC
Confidence            765 467899999999999999999999996543211000            0    0000000000000000 0 0000


Q ss_pred             HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .....+..+++.+|++.||.+|||++|+++|
T Consensus       255 ~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         255 PRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             CCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0112347889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=7e-31  Score=193.94  Aligned_cols=166  Identities=20%  Similarity=0.276  Sum_probs=120.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++++|||++.........  .....++..|++|
T Consensus       133 ~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (304)
T cd05096         133 PAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW  209 (304)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCH
Confidence            4578899999999999999999999   9999999999999999999999999998765432211  1223446789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh--CCCCCcccccccccccchhhhhhhcCCCC-CCCCCccHHHHHHHHHHHHhcc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK--GKHPRDFLSSISSSSLNTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      |.+.+..++.++|+||||+++|++++  +..||............. .......... ......    ....+.+++.+|
T Consensus       210 E~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~~li~~c  284 (304)
T cd05096         210 ECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAG-EFFRDQGRQVYLFRPPP----CPQGLYELMLQC  284 (304)
T ss_pred             HHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHH-HHhhhccccccccCCCC----CCHHHHHHHHHH
Confidence            99888889999999999999999986  556765433211100000 0000000000 000111    123488899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||.+|||+.++.+.|+
T Consensus       285 l~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         285 WSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             ccCCchhCcCHHHHHHHHh
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-31  Score=183.33  Aligned_cols=160  Identities=26%  Similarity=0.355  Sum_probs=124.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec---CCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD---LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +++..+....+||+++|.|+|.+   +|||||++|+|+++.   ....+|++|||++...+ .......+.|++.|++||
T Consensus       107 ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPE  182 (355)
T KOG0033|consen  107 YSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPE  182 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC-CccccccccCCCcccCHH
Confidence            57778889999999999999999   999999999999993   44568999999999888 555566789999999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .++..+++..+|+|+.|+++|-++.|..||.+.....        ..+.+...........+........+|+++||..|
T Consensus       183 vvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--------lye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~d  254 (355)
T KOG0033|consen  183 VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVN  254 (355)
T ss_pred             HhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--------HHHHHhccccCCCCcccCcCCHHHHHHHHHHhccC
Confidence            9999999999999999999999999999997632111        11111111111111122222223667888999999


Q ss_pred             CCCCCCHHHHHHHhh
Q 042876          164 PESRPTMKIVSQQLR  178 (179)
Q Consensus       164 p~~Rps~~~~~~~l~  178 (179)
                      |.+|.|++|.+.|=+
T Consensus       255 P~kRIta~EAL~HpW  269 (355)
T KOG0033|consen  255 PKKRITADEALKHPW  269 (355)
T ss_pred             hhhhccHHHHhCCch
Confidence            999999999998744

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=1.6e-30  Score=190.03  Aligned_cols=160  Identities=24%  Similarity=0.393  Sum_probs=123.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++........  ......+++.|+||
T Consensus       119 ~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05048         119 SSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP  195 (283)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCH
Confidence            5688899999999999999999999   999999999999999999999999999875432221  12233456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||.......        ....+.....+..   .......+.+++.+||+
T Consensus       196 E~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--------~~~~i~~~~~~~~---~~~~~~~~~~l~~~c~~  264 (283)
T cd05048         196 EAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--------VIEMIRSRQLLPC---PEDCPARVYALMIECWN  264 (283)
T ss_pred             HHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHcCCcCCC---cccCCHHHHHHHHHHcc
Confidence            99888888999999999999999998 999986543211        1111111111111   11223358899999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+||++.+++++|+
T Consensus       265 ~~p~~Rp~~~~i~~~l~  281 (283)
T cd05048         265 EIPARRPRFKDIHTRLR  281 (283)
T ss_pred             CChhhCcCHHHHHHHHh
Confidence            99999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.97  E-value=6.5e-31  Score=199.27  Aligned_cols=161  Identities=26%  Similarity=0.366  Sum_probs=122.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|+++||.|||+.   +++||||||+||+++.++.++|+|||++.........  .....++..|++|
T Consensus       207 ~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  283 (374)
T cd05106         207 WPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAP  283 (374)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCH
Confidence            4689999999999999999999999   9999999999999999999999999998765432211  1122345679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||........  ..  ...........+.  .    ...++.+++.+||+
T Consensus       284 E~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~--~~~~~~~~~~~~~--~----~~~~l~~li~~cl~  353 (374)
T cd05106         284 ESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY--KMVKRGYQMSRPD--F----APPEIYSIMKMCWN  353 (374)
T ss_pred             HHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH--HHHHcccCccCCC--C----CCHHHHHHHHHHcC
Confidence            99988889999999999999999997 9999875432110  00  0001111111111  1    12348889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+.++++.|+
T Consensus       354 ~dp~~RPs~~~l~~~l~  370 (374)
T cd05106         354 LEPTERPTFSQISQLIQ  370 (374)
T ss_pred             CChhhCcCHHHHHHHHH
Confidence            99999999999999885

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.97  E-value=4.9e-31  Score=192.73  Aligned_cols=162  Identities=23%  Similarity=0.292  Sum_probs=124.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+..............+++.|++||
T Consensus        91 ~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE  167 (280)
T cd05608          91 NPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPE  167 (280)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHH
Confidence            35689999999999999999999999   999999999999999999999999999876554333333456788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+|+++|++++|+.||.......    .................    .....++.+++.+||+.|
T Consensus       168 ~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~  239 (280)
T cd05608         168 LLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRILNDSVTYP----DKFSPASKSFCEALLAKD  239 (280)
T ss_pred             HhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHHhhcccCCCCc----ccCCHHHHHHHHHHhcCC
Confidence            9998889999999999999999999999996532211    01111111111111111    112334788999999999


Q ss_pred             CCCCC-----CHHHHHHH
Q 042876          164 PESRP-----TMKIVSQQ  176 (179)
Q Consensus       164 p~~Rp-----s~~~~~~~  176 (179)
                      |++||     +++++++|
T Consensus       240 P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         240 PEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             HHHhcCCCCCCHHHHhcC
Confidence            99999     77888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.97  E-value=9.1e-31  Score=191.78  Aligned_cols=159  Identities=24%  Similarity=0.284  Sum_probs=122.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++++|||++....... ......++..|+|||.
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~  172 (285)
T cd05631          97 PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRVGTVGYMAPEV  172 (285)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-eecCCCCCCCccCHhh
Confidence            4688999999999999999999999   99999999999999999999999999987654322 2233467899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC-CCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML-DPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +.+..++.++|+||+|+++|++++|..||........     .......+ .......    .....++.+|+.+||+.|
T Consensus       173 ~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~----~~~s~~~~~li~~~l~~~  243 (285)
T cd05631         173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-----REEVDRRVKEDQEEYS----EKFSEDAKSICRMLLTKN  243 (285)
T ss_pred             hcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-----HHHHHHHhhcccccCC----ccCCHHHHHHHHHHhhcC
Confidence            9988999999999999999999999999975432110     01111111 1111111    112234788999999999


Q ss_pred             CCCCCC-----HHHHHHH
Q 042876          164 PESRPT-----MKIVSQQ  176 (179)
Q Consensus       164 p~~Rps-----~~~~~~~  176 (179)
                      |.+||+     ++++++|
T Consensus       244 P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         244 PKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             HHHhcCCCCCCHHHHhcC
Confidence            999997     8888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=7.4e-31  Score=195.83  Aligned_cols=156  Identities=25%  Similarity=0.338  Sum_probs=122.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++.+++.++.||+.||+|||+.   +++|+||||+||+++.++.++++|||++..............+++.|++||
T Consensus        89 ~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE  165 (328)
T cd05593          89 ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPE  165 (328)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChh
Confidence            35689999999999999999999999   999999999999999999999999999875433222233456889999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC--CCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      .+.+..++.++|+||||+++|++++|..||.......        ......  ...++.  .    ...++.+++.+||.
T Consensus       166 ~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--------~~~~~~~~~~~~p~--~----~~~~~~~li~~~L~  231 (328)
T cd05593         166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMEDIKFPR--T----LSADAKSLLSGLLI  231 (328)
T ss_pred             hhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--------HHHHhccCCccCCC--C----CCHHHHHHHHHHcC
Confidence            9988889999999999999999999999996432111        111111  111111  1    12347889999999


Q ss_pred             cCCCCCC-----CHHHHHHH
Q 042876          162 ESPESRP-----TMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rp-----s~~~~~~~  176 (179)
                      .||.+|+     ++.++++|
T Consensus       232 ~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcC
Confidence            9999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4e-31  Score=195.14  Aligned_cols=164  Identities=26%  Similarity=0.401  Sum_probs=124.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC----cccccCCCCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN----WTEFAGTYGYVA   81 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~   81 (179)
                      .+++..+..+++++++||.|||++   |.||||+|+.|||++.+|.++++|||.+..+......    +..+.+++.|++
T Consensus       122 Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmA  198 (516)
T KOG0582|consen  122 GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMA  198 (516)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccC
Confidence            478889999999999999999999   9999999999999999999999999987665443321    256789999999


Q ss_pred             Cccccc--CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCC--CCCCccHHHHHHHHHHHHh
Q 042876           82 PELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL--PAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        82 pe~~~~--~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~  157 (179)
                      ||.+..  ..|..++||||||++..|+.+|..||..+.....-...    ++...+...  .......-...+.+..++.
T Consensus       199 PEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t----Lqn~pp~~~t~~~~~d~~k~~~ksf~e~i~  274 (516)
T KOG0582|consen  199 PEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT----LQNDPPTLLTSGLDKDEDKKFSKSFREMIA  274 (516)
T ss_pred             hHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH----hcCCCCCcccccCChHHhhhhcHHHHHHHH
Confidence            998543  45889999999999999999999999876543211111    111110000  0011112223446888999


Q ss_pred             cccCcCCCCCCCHHHHHHH
Q 042876          158 SCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~  176 (179)
                      .|++.||.+|||++++++|
T Consensus       275 ~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  275 LCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             HHhhcCcccCCCHHHHhcc
Confidence            9999999999999999876

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=6.5e-31  Score=195.53  Aligned_cols=158  Identities=25%  Similarity=0.361  Sum_probs=122.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++++|||++..............+++.|+|||
T Consensus        90 ~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE  166 (320)
T cd05590          90 SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE  166 (320)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHH
Confidence            35689999999999999999999999   999999999999999999999999999875433333334456889999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+|+++|++++|..||.......        ....+.......+..    ...++.+++.+||+.|
T Consensus       167 ~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~~~~~----~~~~~~~li~~~L~~d  234 (320)
T cd05590         167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAILNDEVVYPTW----LSQDAVDILKAFMTKN  234 (320)
T ss_pred             HHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--------HHHHHhcCCCCCCCC----CCHHHHHHHHHHcccC
Confidence            9988888999999999999999999999997543211        111111111111111    1224788999999999


Q ss_pred             CCCCCCH------HHHHHH
Q 042876          164 PESRPTM------KIVSQQ  176 (179)
Q Consensus       164 p~~Rps~------~~~~~~  176 (179)
                      |.+||++      +++++|
T Consensus       235 P~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         235 PTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             HHHCCCCCCCCCHHHHHcC
Confidence            9999998      677655

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.97  E-value=4.7e-31  Score=199.99  Aligned_cols=159  Identities=27%  Similarity=0.359  Sum_probs=132.3

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      .+.+++++.+..++.|+++||.|||++   +|.|+|+||.||++.+++.+|++|||+++.++..........|++.|++|
T Consensus        93 ~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAP  169 (808)
T KOG0597|consen   93 QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAP  169 (808)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCH
Confidence            456899999999999999999999999   99999999999999999999999999999988776667778999999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |++.+..++..+|+||+||++|++++|+.||-...        ...-...+.....+.+.    .....+..++..++..
T Consensus       170 Elv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d~v~~p~----~~S~~f~nfl~gLL~k  237 (808)
T KOG0597|consen  170 ELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKDPVKPPS----TASSSFVNFLQGLLIK  237 (808)
T ss_pred             HHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcCCCCCcc----cccHHHHHHHHHHhhc
Confidence            99999999999999999999999999999985321        11112222222222222    2233488888899999


Q ss_pred             CCCCCCCHHHHHHH
Q 042876          163 SPESRPTMKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rps~~~~~~~  176 (179)
                      ||.+|.++.+++.|
T Consensus       238 dP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  238 DPAQRLTWTDLLGH  251 (808)
T ss_pred             ChhhcccHHHHhcC
Confidence            99999999999876

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.6e-31  Score=195.21  Aligned_cols=158  Identities=25%  Similarity=0.319  Sum_probs=121.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++++|||++..............+++.|+|||
T Consensus        87 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE  163 (312)
T cd05585          87 EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPE  163 (312)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHH
Confidence            35689999999999999999999999   999999999999999999999999999875433222233456889999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+|+++|++++|..||......        ................    ....+.+++.+||+.|
T Consensus       164 ~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--------~~~~~~~~~~~~~~~~----~~~~~~~li~~~L~~d  231 (312)
T cd05585         164 LLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--------EMYRKILQEPLRFPDG----FDRDAKDLLIGLLSRD  231 (312)
T ss_pred             HHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCCCCCCCc----CCHHHHHHHHHHcCCC
Confidence            999888999999999999999999999999653211        1111111111111111    1224778899999999


Q ss_pred             CCCCCC---HHHHHHH
Q 042876          164 PESRPT---MKIVSQQ  176 (179)
Q Consensus       164 p~~Rps---~~~~~~~  176 (179)
                      |.+||+   +.+++.|
T Consensus       232 p~~R~~~~~~~e~l~h  247 (312)
T cd05585         232 PTRRLGYNGAQEIKNH  247 (312)
T ss_pred             HHHcCCCCCHHHHHcC
Confidence            999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=4.1e-31  Score=193.59  Aligned_cols=169  Identities=23%  Similarity=0.274  Sum_probs=123.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++........ ......++..|+|||
T Consensus        95 ~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  171 (287)
T cd07848          95 NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE  171 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcH
Confidence            4688999999999999999999999   999999999999999999999999999876543221 223346788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCccccccccccc-------chhhhhhh------cCCCCCCCC---C----c
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL-------NTDIELDE------MLDPRLPAP---S----R  143 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~-------~~~~~~~~------~~~~~~~~~---~----~  143 (179)
                      .+.+..++.++|+||+|+++|++++|+.||...........       ........      ......+..   .    .
T Consensus       172 ~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T cd07848         172 LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERR  251 (287)
T ss_pred             HHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHh
Confidence            99888899999999999999999999999975432110000       00000000      000000000   0    0


Q ss_pred             cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          144 SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       144 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ........+.+++.+||+.||++|||++++++|
T Consensus       252 ~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         252 YLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            001123458899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=9e-31  Score=195.00  Aligned_cols=158  Identities=23%  Similarity=0.309  Sum_probs=122.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.++++|||++..............+++.|++||
T Consensus        89 ~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE  165 (323)
T cd05595          89 ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE  165 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcc
Confidence            34689999999999999999999999   999999999999999999999999999865433222233456888999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||||+++|++++|..||.......        ............+...    ...+.+++.+||..|
T Consensus       166 ~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~~~~~~~~~p~~~----~~~~~~li~~~L~~d  233 (323)
T cd05595         166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEEIRFPRTL----SPEAKSLLAGLLKKD  233 (323)
T ss_pred             cccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCCCCCCCC----CHHHHHHHHHHccCC
Confidence            9988889999999999999999999999986432111        1111111111111111    224778999999999


Q ss_pred             CCCCC-----CHHHHHHH
Q 042876          164 PESRP-----TMKIVSQQ  176 (179)
Q Consensus       164 p~~Rp-----s~~~~~~~  176 (179)
                      |.+||     ++.++++|
T Consensus       234 P~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         234 PKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             HHHhCCCCCCCHHHHHcC
Confidence            99998     88888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=196.68  Aligned_cols=158  Identities=27%  Similarity=0.437  Sum_probs=129.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+.+.++..++++++.||.|||.+   +.+|+|||+.||+++.+|.++++|||.+..+........+++|++-|||||.
T Consensus       106 ~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEV  182 (467)
T KOG0201|consen  106 NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEV  182 (467)
T ss_pred             CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhh
Confidence            3447788888999999999999999   9999999999999999999999999999887766555577899999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..|+.++|+||||++.++|.+|..|+..........         .+.+..|+.-..  .....+.+++..||+.||
T Consensus       183 I~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf---------lIpk~~PP~L~~--~~S~~~kEFV~~CL~k~P  251 (467)
T KOG0201|consen  183 IKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF---------LIPKSAPPRLDG--DFSPPFKEFVEACLDKNP  251 (467)
T ss_pred             hccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE---------eccCCCCCcccc--ccCHHHHHHHHHHhhcCc
Confidence            998899999999999999999999999998765422111         112222221111  122237788889999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      +.|||++++++|
T Consensus       252 ~~RpsA~~LLKh  263 (467)
T KOG0201|consen  252 EFRPSAKELLKH  263 (467)
T ss_pred             ccCcCHHHHhhh
Confidence            999999999986

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=1e-30  Score=195.19  Aligned_cols=166  Identities=24%  Similarity=0.367  Sum_probs=123.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+++++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++..............++..|++||
T Consensus        90 ~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE  166 (329)
T cd05588          90 QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPE  166 (329)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHH
Confidence            35789999999999999999999999   999999999999999999999999999865332222233456788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCccccccccccc-chhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL-NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||+|+++|++++|..||+.......... ................+...    ...+.+++.+||+.
T Consensus       167 ~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~----~~~~~~li~~~L~~  242 (329)
T cd05588         167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL----SVKASSVLKGFLNK  242 (329)
T ss_pred             HHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCC----CHHHHHHHHHHhcc
Confidence            99988899999999999999999999999974332211111 11111111222221111111    22478899999999


Q ss_pred             CCCCCCC------HHHHHHH
Q 042876          163 SPESRPT------MKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rps------~~~~~~~  176 (179)
                      ||.+|++      ++++++|
T Consensus       243 dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         243 DPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CHHHcCCCCCCCCHHHHhcC
Confidence            9999997      6788765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=7.5e-31  Score=195.24  Aligned_cols=158  Identities=25%  Similarity=0.364  Sum_probs=123.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++|||++..............+++.|+|||
T Consensus        90 ~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE  166 (321)
T cd05591          90 SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE  166 (321)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHH
Confidence            35688999999999999999999999   999999999999999999999999999875433333333456788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+|+++|+|++|+.||.......        ....+.......+...    ..++.+++.+||+.|
T Consensus       167 ~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~----~~~~~~ll~~~L~~d  234 (321)
T cd05591         167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--------LFESILHDDVLYPVWL----SKEAVSILKAFMTKN  234 (321)
T ss_pred             HHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCCCCCC----CHHHHHHHHHHhccC
Confidence            9988889999999999999999999999997543211        1111111111111111    224788999999999


Q ss_pred             CCCCC-------CHHHHHHH
Q 042876          164 PESRP-------TMKIVSQQ  176 (179)
Q Consensus       164 p~~Rp-------s~~~~~~~  176 (179)
                      |++||       +++++++|
T Consensus       235 p~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         235 PNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             HHHcCCCCCCCCCHHHHhcC
Confidence            99999       88888876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=197.23  Aligned_cols=160  Identities=23%  Similarity=0.291  Sum_probs=125.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCC-----CCCcccccCCCCCCC
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-----SSNWTEFAGTYGYVA   81 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~~~~~~~   81 (179)
                      +++.+++.++++++.||+|||.+   ||+||||||+|+|++.++.+||+|||.+..+...     ........|++.|+|
T Consensus       207 ls~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~A  283 (576)
T KOG0585|consen  207 LSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFA  283 (576)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccc
Confidence            89999999999999999999999   9999999999999999999999999999766222     112334689999999


Q ss_pred             CcccccCC----CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHh
Q 042876           82 PELAYTMK----ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        82 pe~~~~~~----~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      ||++.+..    .+.+.|+||+|+++|-++.|+.||-+...        .....+++...+.-  ....+...++.+||.
T Consensus       284 PE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--------~~l~~KIvn~pL~f--P~~pe~~e~~kDli~  353 (576)
T KOG0585|consen  284 PELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--------LELFDKIVNDPLEF--PENPEINEDLKDLIK  353 (576)
T ss_pred             hHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--------HHHHHHHhcCcccC--CCcccccHHHHHHHH
Confidence            99988733    35789999999999999999999954321        12222222222211  112234456889999


Q ss_pred             cccCcCCCCCCCHHHHHHHhhC
Q 042876          158 SCLNESPESRPTMKIVSQQLRI  179 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~l~~  179 (179)
                      ++|..||++|.++.+|..|.++
T Consensus       354 ~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  354 RLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             HHhhcChhheeehhhheeccee
Confidence            9999999999999999888653

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=1.3e-30  Score=196.44  Aligned_cols=167  Identities=22%  Similarity=0.269  Sum_probs=122.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      .+++..+..++.|+++||.|||+.   +++||||||+||+++.++.++++|||++....... ......++..|+|||.+
T Consensus       115 ~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~  190 (355)
T cd07874         115 ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI  190 (355)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCcc-ccCCccccCCccCHHHH
Confidence            477888999999999999999999   99999999999999999999999999997654322 22334678899999999


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccc------------c--chhhhhhhcCC----------------
Q 042876           86 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS------------L--NTDIELDEMLD----------------  135 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~------------~--~~~~~~~~~~~----------------  135 (179)
                      .+..++.++|+||||+++|+|++|..||..........            .  ...........                
T Consensus       191 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (355)
T cd07874         191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD  270 (355)
T ss_pred             cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccc
Confidence            98889999999999999999999999996543211000            0  00000000000                


Q ss_pred             CCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ...+............+.+++.+||+.||++|||+.|+++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             cccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            00000011111123457889999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.97  E-value=1.4e-30  Score=197.56  Aligned_cols=161  Identities=26%  Similarity=0.380  Sum_probs=121.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.||++||.|||+.   +++|+||||+||+++.++.++++|||++.........  ......+..|++|
T Consensus       209 ~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  285 (375)
T cd05104         209 LALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAP  285 (375)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeCh
Confidence            4689999999999999999999999   9999999999999999999999999998765432211  1122345679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||........  ..  ...........+  ...    ..++.+++.+||+
T Consensus       286 E~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~--~~~~~~~~~~~~--~~~----~~~l~~li~~cl~  355 (375)
T cd05104         286 ESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FY--KMIKEGYRMLSP--ECA----PSEMYDIMKSCWD  355 (375)
T ss_pred             hHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HH--HHHHhCccCCCC--CCC----CHHHHHHHHHHcc
Confidence            99988889999999999999999998 8888865432110  00  000110100111  111    2348899999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++|||+.++++.|+
T Consensus       356 ~dP~~RPs~~eil~~l~  372 (375)
T cd05104         356 ADPLKRPTFKQIVQLIE  372 (375)
T ss_pred             CChhHCcCHHHHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=1.9e-30  Score=193.32  Aligned_cols=157  Identities=27%  Similarity=0.330  Sum_probs=121.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++++|||++..............+++.|++||.
T Consensus        96 ~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~  172 (324)
T cd05589          96 DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV  172 (324)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhH
Confidence            4689999999999999999999999   9999999999999999999999999998654332222334568889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|++++|..||.......        ....+.......+...    ...+.+++.+||+.||
T Consensus       173 ~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--------~~~~i~~~~~~~p~~~----~~~~~~li~~~L~~dP  240 (324)
T cd05589         173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--------VFDSIVNDEVRYPRFL----SREAISIMRRLLRRNP  240 (324)
T ss_pred             hcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCCCC----CHHHHHHHHHHhhcCH
Confidence            998889999999999999999999999996543211        1111111111111111    2247789999999999


Q ss_pred             CCCC-----CHHHHHHH
Q 042876          165 ESRP-----TMKIVSQQ  176 (179)
Q Consensus       165 ~~Rp-----s~~~~~~~  176 (179)
                      .+||     ++.+++++
T Consensus       241 ~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         241 ERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             hHcCCCCCCCHHHHhhC
Confidence            9999     67777765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=1.4e-30  Score=193.36  Aligned_cols=157  Identities=25%  Similarity=0.316  Sum_probs=120.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++++|||++..............++..|++||.
T Consensus        91 ~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  167 (316)
T cd05620          91 GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI  167 (316)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHH
Confidence            4688999999999999999999999   9999999999999999999999999998654322222334567899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|+++|+|++|..||........      ........+..+.  .    ...++.+++.+||+.||
T Consensus       168 ~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~------~~~~~~~~~~~~~--~----~~~~~~~li~~~l~~dP  235 (316)
T cd05620         168 LQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL------FESIRVDTPHYPR--W----ITKESKDILEKLFERDP  235 (316)
T ss_pred             HcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCCCC--C----CCHHHHHHHHHHccCCH
Confidence            9988899999999999999999999999965432110      0000011111111  1    12247789999999999


Q ss_pred             CCCCCH-HHHHHH
Q 042876          165 ESRPTM-KIVSQQ  176 (179)
Q Consensus       165 ~~Rps~-~~~~~~  176 (179)
                      .+||++ +++++|
T Consensus       236 ~~R~~~~~~~~~h  248 (316)
T cd05620         236 TRRLGVVGNIRGH  248 (316)
T ss_pred             HHcCCChHHHHcC
Confidence            999997 466654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.8e-31  Score=197.12  Aligned_cols=170  Identities=24%  Similarity=0.339  Sum_probs=129.6

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVA   81 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~   81 (179)
                      +..+|++.+++.+++||++||+|+|..   |+.|||||.+|||++.+|.+||+|||+|+++...... .+..+.+.+|+|
T Consensus       211 p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRp  287 (560)
T KOG0600|consen  211 PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRP  287 (560)
T ss_pred             CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccC
Confidence            456899999999999999999999999   9999999999999999999999999999987765533 667788999999


Q ss_pred             CcccccC-CCCcchhhHHHHHHHHHHHhCCCCCccccccc------------ccccchhhhhhh--cCCCCCCCCCccHH
Q 042876           82 PELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSIS------------SSSLNTDIELDE--MLDPRLPAPSRSVQ  146 (179)
Q Consensus        82 pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~------------~~~~~~~~~~~~--~~~~~~~~~~~~~~  146 (179)
                      ||++.|. .|+.+.|+||.||++.||+.|+..|.+....+            ...++....+..  ...+ .........
T Consensus       288 PELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp-~~~y~r~l~  366 (560)
T KOG0600|consen  288 PELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKP-QQPYKRRLR  366 (560)
T ss_pred             hHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCC-CCcccchHH
Confidence            9998875 68999999999999999999999986543221            122222111111  0000 011111111


Q ss_pred             HH----HHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          147 EK----LISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       147 ~~----~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      +.    ....++|+..+|..||.+|.|++++++.
T Consensus       367 E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  367 ETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             HHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            11    2246778889999999999999998753

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=1.2e-30  Score=189.62  Aligned_cols=160  Identities=26%  Similarity=0.355  Sum_probs=122.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++++|||++.........  ......+..|++|
T Consensus       107 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  183 (272)
T cd05075         107 QYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI  183 (272)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCH
Confidence            4578999999999999999999998   9999999999999999999999999998765433211  1223456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |...+..++.++|+||||+++|++++ |..||........   ..  ....  ....+....    ....+.+++.+||+
T Consensus       184 e~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~--~~~~--~~~~~~~~~----~~~~~~~li~~~l~  252 (272)
T cd05075         184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---YD--YLRQ--GNRLKQPPD----CLDGLYSLMSSCWL  252 (272)
T ss_pred             HHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH--HHHc--CCCCCCCCC----CCHHHHHHHHHHcC
Confidence            99988889999999999999999998 7889865322110   00  0000  011111111    12347889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++|||+.++++.|+
T Consensus       253 ~~p~~Rps~~~l~~~l~  269 (272)
T cd05075         253 LNPKDRPSFETLRCELE  269 (272)
T ss_pred             CCcccCcCHHHHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=7.8e-31  Score=192.12  Aligned_cols=168  Identities=23%  Similarity=0.255  Sum_probs=122.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++....... ......++..|+|||.
T Consensus       103 ~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  178 (288)
T cd07863         103 PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM-ALTPVVVTLWYRAPEV  178 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccccCcc-cCCCccccccccCchH
Confidence            4589999999999999999999999   99999999999999999999999999987654322 1223456788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-------hhhhhhh-------cCCCCCC-CCCccHHHHH
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-------TDIELDE-------MLDPRLP-APSRSVQEKL  149 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-------~~~~~~~-------~~~~~~~-~~~~~~~~~~  149 (179)
                      +.+..++.++|+||+|+++|++++|..||............       .......       ...+..+ ..........
T Consensus       179 ~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (288)
T cd07863         179 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIE  258 (288)
T ss_pred             hhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcC
Confidence            98888999999999999999999999998644321100000       0000000       0000000 0001111223


Q ss_pred             HHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          150 ISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       150 ~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ..+.+++.+|++.||.+|||+++++.|
T Consensus       259 ~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         259 ESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             HHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            347889999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=1.6e-30  Score=193.76  Aligned_cols=157  Identities=24%  Similarity=0.343  Sum_probs=121.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++++|||++..............+++.|+|||.
T Consensus        96 ~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  172 (324)
T cd05587          96 GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEI  172 (324)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhh
Confidence            4678999999999999999999999   9999999999999999999999999998654333333334568899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|+++|+|++|+.||.......        ....+.......+..    ....+.+++.+||+.||
T Consensus       173 ~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--------~~~~i~~~~~~~~~~----~~~~~~~li~~~l~~~P  240 (324)
T cd05587         173 IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQSIMEHNVSYPKS----LSKEAVSICKGLLTKHP  240 (324)
T ss_pred             hcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCCCCC----CCHHHHHHHHHHhhcCH
Confidence            998889999999999999999999999996543211        111111111111111    12247789999999999


Q ss_pred             CCCCCH-----HHHHHH
Q 042876          165 ESRPTM-----KIVSQQ  176 (179)
Q Consensus       165 ~~Rps~-----~~~~~~  176 (179)
                      .+|++.     .++++|
T Consensus       241 ~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         241 AKRLGCGPTGERDIREH  257 (324)
T ss_pred             HHcCCCCCCCHHHHhcC
Confidence            999976     666654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.97  E-value=4.9e-30  Score=188.35  Aligned_cols=160  Identities=25%  Similarity=0.393  Sum_probs=123.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||+|||++   +++|+||+|+||+++.++.++++|||++........  ......++..|++|
T Consensus       118 ~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  194 (291)
T cd05094         118 GELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  194 (291)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecCh
Confidence            4589999999999999999999999   999999999999999999999999999875543221  11223456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||.......        ..........+.....   ....+.+++.+||+
T Consensus       195 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~  263 (291)
T cd05094         195 ESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--------VIECITQGRVLERPRV---CPKEVYDIMLGCWQ  263 (291)
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhCCCCCCCCcc---CCHHHHHHHHHHcc
Confidence            99988889999999999999999998 999986543211        1111111111111111   12347889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|.+|||+.++++.|+
T Consensus       264 ~~P~~Rpt~~~v~~~l~  280 (291)
T cd05094         264 REPQQRLNIKEIYKILH  280 (291)
T ss_pred             cChhhCcCHHHHHHHHH
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=3.8e-30  Score=193.76  Aligned_cols=160  Identities=24%  Similarity=0.329  Sum_probs=117.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      ..++..+..++.||+.||+|||+.   +++|+||||+||+++.++.++|+|||++..............++..|++||.+
T Consensus       164 ~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~  240 (353)
T PLN00034        164 IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERI  240 (353)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCcccc
Confidence            356778889999999999999999   99999999999999999999999999987654332223345688899999987


Q ss_pred             cc-----CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           86 YT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        86 ~~-----~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ..     ...+.++|+|||||++|++++|+.||........    ................    ......+.++|.+||
T Consensus       241 ~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l  312 (353)
T PLN00034        241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW----ASLMCAICMSQPPEAP----ATASREFRHFISCCL  312 (353)
T ss_pred             ccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHHHHhccCCCCCC----CccCHHHHHHHHHHc
Confidence            43     2235689999999999999999999973221110    0000000010111111    112234888999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.||++|||+.|+++|
T Consensus       313 ~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        313 QREPAKRWSAMQLLQH  328 (353)
T ss_pred             cCChhhCcCHHHHhcC
Confidence            9999999999999987

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=2.7e-30  Score=194.91  Aligned_cols=168  Identities=22%  Similarity=0.288  Sum_probs=121.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++....... ......++..|+|||.+
T Consensus       119 ~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~  194 (359)
T cd07876         119 ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPYVVTRYYRAPEVI  194 (359)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccCc-cCCCCcccCCCCCchhc
Confidence            477888999999999999999999   99999999999999999999999999986543221 22334678889999999


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHhCCCCCccccccccc------------ccch--hhhhhhcC--CCCCCC---------
Q 042876           86 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS------------SLNT--DIELDEML--DPRLPA---------  140 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~------------~~~~--~~~~~~~~--~~~~~~---------  140 (179)
                      .+..++.++|+||||+++|+|++|..||.........            ....  ........  .+..+.         
T Consensus       195 ~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (359)
T cd07876         195 LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPD  274 (359)
T ss_pred             cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccc
Confidence            9888999999999999999999999999754321100            0000  00000000  000000         


Q ss_pred             -----CCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          141 -----PSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       141 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                           ...........+.+++.+||..||++|||+.|+++|-
T Consensus       275 ~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         275 WIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             cccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                 0000011123478899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=1.3e-30  Score=194.63  Aligned_cols=166  Identities=27%  Similarity=0.377  Sum_probs=123.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++..............++..|++||
T Consensus        90 ~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE  166 (329)
T cd05618          90 QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE  166 (329)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHH
Confidence            35689999999999999999999999   999999999999999999999999999875433222233456889999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhh-hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDI-ELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||+++|++++|..||............... ............+...    ...+.+++.+||+.
T Consensus       167 ~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~----~~~~~~ll~~~L~~  242 (329)
T cd05618         167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL----SVKAASVLKSFLNK  242 (329)
T ss_pred             HHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCC----CHHHHHHHHHHhcC
Confidence            999888999999999999999999999999643322111111111 1111111111111111    22377899999999


Q ss_pred             CCCCCCC------HHHHHHH
Q 042876          163 SPESRPT------MKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rps------~~~~~~~  176 (179)
                      ||.+||+      +.++++|
T Consensus       243 dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         243 DPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CHHHcCCCCCCCCHHHHhcC
Confidence            9999998      4677665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=2.3e-30  Score=192.26  Aligned_cols=157  Identities=27%  Similarity=0.358  Sum_probs=120.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++++|||++..............+++.|++||.
T Consensus        91 ~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~  167 (316)
T cd05592          91 GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEI  167 (316)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHH
Confidence            4688999999999999999999999   9999999999999999999999999998765433333334568899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+||++|+|++|..||.......        ....+.......+ ..   ...++.+++.+||+.||
T Consensus       168 ~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~~~~~-~~---~~~~~~~ll~~~l~~~P  235 (316)
T cd05592         168 LKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--------LFDSILNDRPHFP-RW---ISKEAKDCLSKLFERDP  235 (316)
T ss_pred             HcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCCC-CC---CCHHHHHHHHHHccCCH
Confidence            988889999999999999999999999997543211        1111111111101 11   12246788899999999


Q ss_pred             CCCCCHH-HHHHH
Q 042876          165 ESRPTMK-IVSQQ  176 (179)
Q Consensus       165 ~~Rps~~-~~~~~  176 (179)
                      .+||++. ++++|
T Consensus       236 ~~R~~~~~~l~~h  248 (316)
T cd05592         236 TKRLGVDGDIRQH  248 (316)
T ss_pred             HHcCCChHHHHcC
Confidence            9999865 56543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=3.7e-31  Score=207.89  Aligned_cols=159  Identities=27%  Similarity=0.429  Sum_probs=128.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe   83 (179)
                      +++..+.+.++.||+.|+.||-++   .+|||||.+.|+|++.+..+||+|||+++.....+..  ...-.-++.|||||
T Consensus       599 ~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppE  675 (774)
T KOG1026|consen  599 PLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE  675 (774)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHH
Confidence            489999999999999999999999   9999999999999999999999999999865433221  22335578999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+...+++.++||||+|+++||+++ |..||.+..+.+.......       ..-++-+..+..+    +..||..||+.
T Consensus       676 sIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~-------g~lL~~Pe~CP~~----vY~LM~~CW~~  744 (774)
T KOG1026|consen  676 SILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA-------GQLLSCPENCPTE----VYSLMLECWNE  744 (774)
T ss_pred             HhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc-------CCcccCCCCCCHH----HHHHHHHHhhc
Confidence            9999999999999999999999997 9999976654332222111       1113334445444    99999999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      +|.+||+++||-..|+
T Consensus       745 ~P~~RPsF~eI~~~L~  760 (774)
T KOG1026|consen  745 NPKRRPSFKEIHSRLQ  760 (774)
T ss_pred             CcccCCCHHHHHHHHH
Confidence            9999999999998886

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=2.2e-30  Score=192.91  Aligned_cols=157  Identities=24%  Similarity=0.321  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..............+++.|++||.
T Consensus        95 ~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  171 (323)
T cd05584          95 GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI  171 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhh
Confidence            4578888999999999999999999   9999999999999999999999999998654333322333568889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|+|++|..||......        .............+...    ..++.+++.+||+.||
T Consensus       172 ~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p  239 (323)
T cd05584         172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTIDKILKGKLNLPPYL----TPEARDLLKKLLKRNP  239 (323)
T ss_pred             ccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCCCCC----CHHHHHHHHHHcccCH
Confidence            98888889999999999999999999999654321        11111221221111111    2247889999999999


Q ss_pred             CCCC-----CHHHHHHH
Q 042876          165 ESRP-----TMKIVSQQ  176 (179)
Q Consensus       165 ~~Rp-----s~~~~~~~  176 (179)
                      ++||     ++.++++|
T Consensus       240 ~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         240 SSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             hHcCCCCCCCHHHHhcC
Confidence            9999     88888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=1.6e-30  Score=193.67  Aligned_cols=157  Identities=24%  Similarity=0.340  Sum_probs=121.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||.|||+.   +++||||||+||+++.++.++++|||++..............+++.|+|||.
T Consensus        96 ~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~  172 (323)
T cd05616          96 GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI  172 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHH
Confidence            4688999999999999999999999   9999999999999999999999999998754433333344568899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+|||||++|+|++|..||.......        ....+.......+..    ...++.+++.+|++.||
T Consensus       173 ~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--------~~~~i~~~~~~~p~~----~s~~~~~li~~~l~~~p  240 (323)
T cd05616         173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------LFQSIMEHNVAYPKS----MSKEAVAICKGLMTKHP  240 (323)
T ss_pred             hcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCCc----CCHHHHHHHHHHcccCH
Confidence            998889999999999999999999999997543211        111111111111111    12347889999999999


Q ss_pred             CCCCCH-----HHHHHH
Q 042876          165 ESRPTM-----KIVSQQ  176 (179)
Q Consensus       165 ~~Rps~-----~~~~~~  176 (179)
                      .+|++.     .++.+|
T Consensus       241 ~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         241 GKRLGCGPEGERDIKEH  257 (323)
T ss_pred             HhcCCCCCCCHHHHhcC
Confidence            999974     666554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=2.1e-30  Score=192.66  Aligned_cols=157  Identities=25%  Similarity=0.317  Sum_probs=122.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||.
T Consensus        91 ~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~  167 (318)
T cd05570          91 GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEI  167 (318)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHH
Confidence            4689999999999999999999999   9999999999999999999999999998654333222233467889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+||++|++++|..||.......        ...............    ....+.+++.+||+.||
T Consensus       168 ~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--------~~~~i~~~~~~~~~~----~~~~~~~li~~~l~~dP  235 (318)
T cd05570         168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--------LFQSILEDEVRYPRW----LSKEAKSILKSFLTKNP  235 (318)
T ss_pred             hcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCCCCCc----CCHHHHHHHHHHccCCH
Confidence            998889999999999999999999999996543211        111111111111111    12347889999999999


Q ss_pred             CCCCCH-----HHHHHH
Q 042876          165 ESRPTM-----KIVSQQ  176 (179)
Q Consensus       165 ~~Rps~-----~~~~~~  176 (179)
                      .+||++     .+++++
T Consensus       236 ~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         236 EKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             HHcCCCCCCCHHHHhcC
Confidence            999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-30  Score=190.43  Aligned_cols=156  Identities=26%  Similarity=0.315  Sum_probs=121.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.......   ....+++.|+|||
T Consensus        95 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE  168 (291)
T cd05612          95 SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT---WTLCGTPEYLAPE  168 (291)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc---ccccCChhhcCHH
Confidence            35688999999999999999999999   99999999999999999999999999987654321   2346788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||||+++|+|++|..||.......        ....+...........    ...+.+++.+||+.|
T Consensus       169 ~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~----~~~~~~li~~~l~~d  236 (291)
T cd05612         169 VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--------IYEKILAGKLEFPRHL----DLYAKDLIKKLLVVD  236 (291)
T ss_pred             HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCcCCCccC----CHHHHHHHHHHcCCC
Confidence            9988888999999999999999999999996543211        1111111111111111    223778999999999


Q ss_pred             CCCCCC-----HHHHHHHh
Q 042876          164 PESRPT-----MKIVSQQL  177 (179)
Q Consensus       164 p~~Rps-----~~~~~~~l  177 (179)
                      |.+||+     ++++++|-
T Consensus       237 p~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         237 RTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             HHHccCCccCCHHHHhcCc
Confidence            999995     99998773

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=1.2e-30  Score=203.05  Aligned_cols=166  Identities=17%  Similarity=0.225  Sum_probs=119.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCC----------------ceeEccccCccccCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEY----------------EAHVADFGIAKFLKPDS   67 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~----------------~~~l~d~~~~~~~~~~~   67 (179)
                      ..+++..++.++.||+.||.|||+ .   +|+||||||+||+++.++                .+||+|||.+.....  
T Consensus       226 ~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--  300 (467)
T PTZ00284        226 GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--  300 (467)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--
Confidence            468899999999999999999997 5   999999999999997665                489999998754322  


Q ss_pred             CCcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh---------------hhhhh
Q 042876           68 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD---------------IELDE  132 (179)
Q Consensus        68 ~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~---------------~~~~~  132 (179)
                       ......+++.|++||.+.+..++.++|+|||||++|+|++|+.||+.............               .....
T Consensus       301 -~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~  379 (467)
T PTZ00284        301 -SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARL  379 (467)
T ss_pred             -ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHH
Confidence             12345788999999999998999999999999999999999999975432110000000               00000


Q ss_pred             cC------CCCCCC---------CCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          133 ML------DPRLPA---------PSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       133 ~~------~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ..      .+...+         ...........+.+||.+||..||.+|||++|+++|
T Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        380 LYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             HhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence            00      000000         000000012347799999999999999999999986

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.97  E-value=2.9e-30  Score=186.01  Aligned_cols=169  Identities=21%  Similarity=0.201  Sum_probs=128.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.++...++.++.||+.||+|||++   +|+||||||.|++++.+|.+|++|||+|.....+.......+.+.+|+|||.
T Consensus       115 ~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEv  191 (323)
T KOG0594|consen  115 QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEV  191 (323)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHH
Confidence            4577789999999999999999999   9999999999999999999999999999988777666777889999999999


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccc------------cccchhhhhhhcCCCCCCCC---CccHH--
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------------SSLNTDIELDEMLDPRLPAP---SRSVQ--  146 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~---~~~~~--  146 (179)
                      +.+. .|+...|+||+||++.+|++++.-|++.++...            ...+.....-.-.+..++..   ..-..  
T Consensus       192 LlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~  271 (323)
T KOG0594|consen  192 LLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSIL  271 (323)
T ss_pred             hcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhc
Confidence            8876 689999999999999999999988876544211            01110000000000011100   00001  


Q ss_pred             -HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          147 -EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       147 -~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                       ....+..+++.+|++.+|.+|.|++.+++|
T Consensus       272 ~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  272 PKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence             111257889999999999999999999886

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=7.2e-30  Score=183.85  Aligned_cols=159  Identities=27%  Similarity=0.382  Sum_probs=125.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||
T Consensus        95 ~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE  171 (256)
T cd08529          95 GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE  171 (256)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHH
Confidence            35688999999999999999999998   999999999999999999999999999876654433334456778899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      ...+..++.++|+||||++++++++|..||.....        ............+....   .....+.+++.+||+.+
T Consensus       172 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~~l~~~  240 (256)
T cd08529         172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIRGVFPPVSQ---MYSQQLAQLIDQCLTKD  240 (256)
T ss_pred             HhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCcc---ccCHHHHHHHHHHccCC
Confidence            99888888999999999999999999999965431        11111111111211111   22335888999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |++||++.+++++
T Consensus       241 p~~Rp~~~~ll~~  253 (256)
T cd08529         241 YRQRPDTFQLLRN  253 (256)
T ss_pred             cccCcCHHHHhhC
Confidence            9999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=2.7e-30  Score=192.70  Aligned_cols=165  Identities=24%  Similarity=0.358  Sum_probs=122.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++..............+++.|+|||
T Consensus        90 ~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE  166 (327)
T cd05617          90 QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPE  166 (327)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHH
Confidence            35789999999999999999999999   999999999999999999999999999875432222233456889999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||||+++|+|++|..||............ ..............+...    ...+.+++.+||+.|
T Consensus       167 ~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~----~~~~~~li~~~L~~d  241 (327)
T cd05617         167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTE-DYLFQVILEKPIRIPRFL----SVKASHVLKGFLNKD  241 (327)
T ss_pred             HHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccH-HHHHHHHHhCCCCCCCCC----CHHHHHHHHHHhccC
Confidence            998888999999999999999999999999654322111111 111111111111111111    123678899999999


Q ss_pred             CCCCCC------HHHHHHH
Q 042876          164 PESRPT------MKIVSQQ  176 (179)
Q Consensus       164 p~~Rps------~~~~~~~  176 (179)
                      |.+|++      ++++++|
T Consensus       242 P~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         242 PKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             HHHcCCCCCCCCHHHHHcC
Confidence            999997      4677665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=6.1e-30  Score=187.00  Aligned_cols=160  Identities=20%  Similarity=0.336  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||||.||+++.++.++++|||++.........  .....+++.|++|
T Consensus       119 ~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05091         119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSP  195 (283)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCH
Confidence            3578889999999999999999999   9999999999999999999999999998765432211  1223456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||......        .....+..........   .....+.+++..||+
T Consensus       196 E~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~i~~~~~~~~~~---~~~~~~~~li~~cl~  264 (283)
T cd05091         196 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--------DVIEMIRNRQVLPCPD---DCPAWVYTLMLECWN  264 (283)
T ss_pred             HHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHhC
Confidence            99888888999999999999999998 88888643211        1111111111111111   122347889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|.+||++.++++.|+
T Consensus       265 ~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         265 EFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             CCcccCCCHHHHHHHhh
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.97  E-value=5.4e-30  Score=185.70  Aligned_cols=163  Identities=17%  Similarity=0.249  Sum_probs=124.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||.
T Consensus       101 ~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~  177 (267)
T cd08228         101 RLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER  177 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhh
Confidence            4578899999999999999999999   9999999999999999999999999998765543322233467788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|+++|++++|..||.......      ............++.  ........+.+++.+||+.+|
T Consensus       178 ~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p  249 (267)
T cd08228         178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------FSLCQKIEQCDYPPL--PTEHYSEKLRELVSMCIYPDP  249 (267)
T ss_pred             hccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH------HHHHHHHhcCCCCCC--ChhhcCHHHHHHHHHHCCCCc
Confidence            988888899999999999999999999985432110      000011111111111  111233458889999999999


Q ss_pred             CCCCCHHHHHHHhh
Q 042876          165 ESRPTMKIVSQQLR  178 (179)
Q Consensus       165 ~~Rps~~~~~~~l~  178 (179)
                      ++||++.++++.|+
T Consensus       250 ~~Rp~~~~vl~~~~  263 (267)
T cd08228         250 DQRPDIGYVHQIAK  263 (267)
T ss_pred             ccCcCHHHHHHHHH
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.3e-30  Score=188.03  Aligned_cols=159  Identities=25%  Similarity=0.383  Sum_probs=122.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.........  ......+..|++|
T Consensus       108 ~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05035         108 EKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  184 (273)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCH
Confidence            4689999999999999999999999   9999999999999999999999999998765433221  1122345679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |.+.+..++.++|+||||+++|++++ |..||.......        ........ .......    ....+.+++.+||
T Consensus       185 e~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~----~~~~~~~li~~~l  252 (273)
T cd05035         185 ESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--------IYDYLRHGNRLKQPED----CLDELYDLMYSCW  252 (273)
T ss_pred             hhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCCcC----CCHHHHHHHHHHc
Confidence            99888888999999999999999998 889986543211        11111111 1111111    2234888999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||.+|||+.+++++|+
T Consensus       253 ~~~p~~Rp~~~e~~~~l~  270 (273)
T cd05035         253 RADPKDRPTFTKLREVLE  270 (273)
T ss_pred             CCChhhCcCHHHHHHHHH
Confidence            999999999999999885

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=2.1e-30  Score=187.06  Aligned_cols=160  Identities=26%  Similarity=0.379  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      +.+++..++.++.|++.||++||+.   +++|+||+|.||+++.++.++++|||++.........   .....++..|++
T Consensus        90 ~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  166 (257)
T cd05116          90 KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA  166 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccC
Confidence            4688999999999999999999999   9999999999999999999999999998766443221   111223468999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..++.++|+||||+++|++++ |..||.........     ...........+  ...    ..++.++|.+||
T Consensus       167 PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-----~~i~~~~~~~~~--~~~----~~~l~~li~~~~  235 (257)
T cd05116         167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-----QMIESGERMECP--QRC----PPEMYDLMKLCW  235 (257)
T ss_pred             HhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHCCCCCCCC--CCC----CHHHHHHHHHHh
Confidence            999887788899999999999999998 99999754321110     011111111111  112    224788999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||++||++++|.+.|+
T Consensus       236 ~~~p~~Rp~~~~i~~~l~  253 (257)
T cd05116         236 TYGVDERPGFAVVELRLR  253 (257)
T ss_pred             ccCchhCcCHHHHHHHHh
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=9.3e-30  Score=184.47  Aligned_cols=164  Identities=18%  Similarity=0.261  Sum_probs=124.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||
T Consensus       100 ~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape  176 (267)
T cd08229         100 KRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE  176 (267)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHH
Confidence            35689999999999999999999999   999999999999999999999999999876654333333346778899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      ...+..++.++|+||+|+++|++++|..||........      ...........+...  .......+.+++.+||+.|
T Consensus       177 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~  248 (267)
T cd08229         177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY------SLCKKIEQCDYPPLP--SDHYSEELRQLVNMCINPD  248 (267)
T ss_pred             HhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH------HHhhhhhcCCCCCCC--cccccHHHHHHHHHhcCCC
Confidence            99888888999999999999999999999864321100      000111111111110  0112334788999999999


Q ss_pred             CCCCCCHHHHHHHhh
Q 042876          164 PESRPTMKIVSQQLR  178 (179)
Q Consensus       164 p~~Rps~~~~~~~l~  178 (179)
                      |.+|||+.+|++.++
T Consensus       249 p~~Rpt~~~i~~~~~  263 (267)
T cd08229         249 PEKRPDITYVYDVAK  263 (267)
T ss_pred             cccCCCHHHHHHHHh
Confidence            999999998888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=9.3e-31  Score=195.06  Aligned_cols=158  Identities=24%  Similarity=0.314  Sum_probs=122.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      .+.+++..++.++.||+.||.|||+ .   +++||||||+||+++.++.++|+|||++..............+++.|+||
T Consensus        89 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aP  165 (325)
T cd05594          89 ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP  165 (325)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCH
Confidence            3568999999999999999999997 6   99999999999999999999999999987543333233345688999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |.+.+..++.++|+||||+++|+|++|..||.......        ............+...    ..++.+++.+||+.
T Consensus       166 E~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~----~~~~~~li~~~L~~  233 (325)
T cd05594         166 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMEEIRFPRTL----SPEAKSLLSGLLKK  233 (325)
T ss_pred             HHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--------HHHHHhcCCCCCCCCC----CHHHHHHHHHHhhc
Confidence            99988889999999999999999999999996432110        0111111111111111    22478889999999


Q ss_pred             CCCCCC-----CHHHHHHH
Q 042876          163 SPESRP-----TMKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rp-----s~~~~~~~  176 (179)
                      ||++|+     ++.++++|
T Consensus       234 dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         234 DPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CHHHhCCCCCCCHHHHhcC
Confidence            999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=4.9e-30  Score=200.41  Aligned_cols=158  Identities=25%  Similarity=0.300  Sum_probs=123.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC--CCcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~p   82 (179)
                      ..+++..+..++.|+++||.|||+.   +++||||||+||+++.++.++|+|||++.......  .......+++.|++|
T Consensus       138 ~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aP  214 (496)
T PTZ00283        138 RTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP  214 (496)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCH
Confidence            4688999999999999999999999   99999999999999999999999999987654321  122345688899999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |.+.+..++.++|+||||+++|++++|..||......        ............+....   ...++.+++.+||+.
T Consensus       215 E~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~l~~li~~~L~~  283 (496)
T PTZ00283        215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--------EVMHKTLAGRYDPLPPS---ISPEMQEIVTALLSS  283 (496)
T ss_pred             HHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHhcCCCCCCCCC---CCHHHHHHHHHHccc
Confidence            9999888999999999999999999999999653211        11111111111111111   123478899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 042876          163 SPESRPTMKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rps~~~~~~~  176 (179)
                      ||.+||++.+++++
T Consensus       284 dP~~RPs~~ell~~  297 (496)
T PTZ00283        284 DPKRRPSSSKLLNM  297 (496)
T ss_pred             ChhhCcCHHHHHhC
Confidence            99999999999875

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=8.3e-30  Score=183.54  Aligned_cols=161  Identities=25%  Similarity=0.409  Sum_probs=124.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|+++||.|||+.   +++|+||+|.||+++.++.++++|||.+..............+...|++||
T Consensus        93 ~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE  169 (256)
T cd06612          93 NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE  169 (256)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHH
Confidence            45789999999999999999999999   999999999999999999999999999876654432333345678899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+|++++++++|..||.........     .....    ...............+.+++.+||+.|
T Consensus       170 ~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-----~~~~~----~~~~~~~~~~~~~~~~~~~i~~~l~~~  240 (256)
T cd06612         170 VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-----FMIPN----KPPPTLSDPEKWSPEFNDFVKKCLVKD  240 (256)
T ss_pred             HHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-----hhhcc----CCCCCCCchhhcCHHHHHHHHHHHhcC
Confidence            998888899999999999999999999998653321100     00000    111111111222345788999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |.+|||+++++++
T Consensus       241 P~~Rps~~~il~~  253 (256)
T cd06612         241 PEERPSAIQLLQH  253 (256)
T ss_pred             hhhCcCHHHHhcC
Confidence            9999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=2.9e-30  Score=188.34  Aligned_cols=160  Identities=26%  Similarity=0.404  Sum_probs=122.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++++|||.+........  ......++..|+||
T Consensus       117 ~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05049         117 GELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP  193 (280)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecCh
Confidence            4578999999999999999999999   999999999999999999999999999875432221  11223446789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||.......        ..........+....   .....+.+++.+||.
T Consensus       194 E~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~  262 (280)
T cd05049         194 ESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--------VIECITQGRLLQRPR---TCPSEVYDIMLGCWK  262 (280)
T ss_pred             hhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCcCCCCC---CCCHHHHHHHHHHcC
Confidence            99988889999999999999999998 999986543211        111111111111111   122347889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++||++.|+++.|+
T Consensus       263 ~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         263 RDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CCcccCCCHHHHHHHhh
Confidence            99999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=2.9e-30  Score=192.85  Aligned_cols=160  Identities=24%  Similarity=0.322  Sum_probs=121.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~p   82 (179)
                      .+.+++.+++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++........ ......++..|++|
T Consensus        99 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aP  175 (332)
T cd05614          99 RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP  175 (332)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCH
Confidence            35689999999999999999999999   999999999999999999999999999876543222 12234688999999


Q ss_pred             cccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC--CCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           83 ELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        83 e~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      |.+.+. .++.++|+||||+++|+|++|..||.........    ........  ++.++.  .    ....+.+++.+|
T Consensus       176 E~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~--~----~~~~~~~li~~~  245 (332)
T cd05614         176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILKCDPPFPS--F----IGPEAQDLLHKL  245 (332)
T ss_pred             HHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhcCCCCCCC--C----CCHHHHHHHHHH
Confidence            998765 3788999999999999999999999643221110    01111111  111111  1    122377889999


Q ss_pred             cCcCCCCCC-----CHHHHHHH
Q 042876          160 LNESPESRP-----TMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rp-----s~~~~~~~  176 (179)
                      |+.||++||     +++++++|
T Consensus       246 l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         246 LRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             cCCCHHHcCCCCCCCHHHHHcC
Confidence            999999999     78888876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=2.2e-29  Score=183.92  Aligned_cols=161  Identities=28%  Similarity=0.445  Sum_probs=122.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~   81 (179)
                      ...+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+........  ......++..|++
T Consensus       103 ~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~  179 (279)
T cd05111         103 RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA  179 (279)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccC
Confidence            34689999999999999999999999   999999999999999999999999999976543222  1223345678999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||...+..++.++|+||||+++|++++ |..||........      ...... ....+....+    ..++..++.+||
T Consensus       180 pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~-~~~~~~~~~~----~~~~~~li~~c~  248 (279)
T cd05111         180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV------PDLLEK-GERLAQPQIC----TIDVYMVMVKCW  248 (279)
T ss_pred             HHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHC-CCcCCCCCCC----CHHHHHHHHHHc
Confidence            999988889999999999999999998 9999865421110      000000 0111111112    234778899999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      ..||++|||+.++.+.|+
T Consensus       249 ~~~p~~Rps~~el~~~l~  266 (279)
T cd05111         249 MIDENVRPTFKELANEFT  266 (279)
T ss_pred             CCCcccCcCHHHHHHHHH
Confidence            999999999999998874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.5e-30  Score=196.43  Aligned_cols=154  Identities=28%  Similarity=0.420  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCCcccccC
Q 042876           11 QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTM   88 (179)
Q Consensus        11 ~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~   88 (179)
                      .++.+-.|++.++.++|++   ||||.||||.|+++- .|.+|++|||+|.....+...  .....|++.|++||.+...
T Consensus       461 ~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~  536 (677)
T KOG0596|consen  461 FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDM  536 (677)
T ss_pred             HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhc
Confidence            7889999999999999999   999999999998876 569999999999888766543  5567899999999987643


Q ss_pred             C-----------CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHh
Q 042876           89 K-----------ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        89 ~-----------~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      .           +++++|||||||++|+|+.|+.||..+.+       ....+..+.++.........++.. .++++|+
T Consensus       537 ~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~aKl~aI~~P~~~Iefp~~~~~~-~li~~mK  608 (677)
T KOG0596|consen  537 SSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIAKLHAITDPNHEIEFPDIPEND-ELIDVMK  608 (677)
T ss_pred             cccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHHHHHhhcCCCccccccCCCCch-HHHHHHH
Confidence            2           56889999999999999999999975432       223344444443322222222211 1889999


Q ss_pred             cccCcCCCCCCCHHHHHHH
Q 042876          158 SCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~  176 (179)
                      .||.+||.+||++.++++|
T Consensus       609 ~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  609 CCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HHHhcCcccCCCcHHHhcC
Confidence            9999999999999999986

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=3.2e-30  Score=189.11  Aligned_cols=160  Identities=24%  Similarity=0.376  Sum_probs=121.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.........  .....++..|++|
T Consensus       115 ~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  191 (288)
T cd05093         115 AELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  191 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCH
Confidence            3589999999999999999999999   9999999999999999999999999998755332211  1223346679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++++|++ |..||.......        ....+...........   ....+.+++.+||+
T Consensus       192 E~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--------~~~~i~~~~~~~~~~~---~~~~l~~li~~~l~  260 (288)
T cd05093         192 ESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------VIECITQGRVLQRPRT---CPKEVYDLMLGCWQ  260 (288)
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCcCCCCCC---CCHHHHHHHHHHcc
Confidence            99988888999999999999999998 898986443211        1111111111111111   12248889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+.++.+.|+
T Consensus       261 ~~p~~Rpt~~~v~~~l~  277 (288)
T cd05093         261 REPHMRLNIKEIHSLLQ  277 (288)
T ss_pred             CChhhCCCHHHHHHHHH
Confidence            99999999999988875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=1.4e-29  Score=182.92  Aligned_cols=161  Identities=29%  Similarity=0.510  Sum_probs=123.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||
T Consensus        98 ~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE  174 (261)
T cd05148          98 GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPE  174 (261)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHH
Confidence            45689999999999999999999999   999999999999999999999999999876543322222334566799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ...+..++.++|+||||++++++++ |..||.........     .......  +.+.....    ...+.+++.+||+.
T Consensus       175 ~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~-----~~~~~~~--~~~~~~~~----~~~~~~~i~~~l~~  243 (261)
T cd05148         175 AASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY-----DQITAGY--RMPCPAKC----PQEIYKIMLECWAA  243 (261)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH-----HHHHhCC--cCCCCCCC----CHHHHHHHHHHcCC
Confidence            9888888899999999999999998 89998654311100     0111111  11111111    23478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||.+|||+.++.+.|+
T Consensus       244 ~p~~Rpt~~~l~~~L~  259 (261)
T cd05148         244 EPEDRPSFKALREELD  259 (261)
T ss_pred             CchhCcCHHHHHHHHh
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-30  Score=181.61  Aligned_cols=167  Identities=25%  Similarity=0.286  Sum_probs=133.3

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec---CCCceeEccccCccccCCCCCCcccccCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD---LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGY   79 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   79 (179)
                      +.+.|++.++..+++||..|+.|||+.   +|.||||||+|+|+.   .|..+|+.|||+++....+. .......++.|
T Consensus       154 g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~-~L~TPc~TPyY  229 (400)
T KOG0604|consen  154 GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG-DLMTPCFTPYY  229 (400)
T ss_pred             ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCc-cccCCcccccc
Confidence            456799999999999999999999999   999999999999995   45668999999998766533 34556778999


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCccccccccc-ccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-SLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      .+||.+...++...+|+||+|+++|-|++|..||......... ++...+..     ....-+..-|...+.+..++|+.
T Consensus       230 vaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~-----gqy~FP~pEWs~VSe~aKdlIR~  304 (400)
T KOG0604|consen  230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT-----GQYEFPEPEWSCVSEAAKDLIRK  304 (400)
T ss_pred             cCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc-----cCccCCChhHhHHHHHHHHHHHH
Confidence            9999999999999999999999999999999999654432221 22211111     12222335566777788899999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +|..+|.+|.|+.++..|=+
T Consensus       305 LLkt~PteRlTI~~~m~hpw  324 (400)
T KOG0604|consen  305 LLKTEPTERLTIEEVMDHPW  324 (400)
T ss_pred             HhcCCchhheeHHHhhcCch
Confidence            99999999999999987643

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.97  E-value=2.2e-30  Score=185.48  Aligned_cols=169  Identities=22%  Similarity=0.207  Sum_probs=128.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .++|+..+++.+..|+++|++|||.+   .|+|||||++|+|++..|.+||+|||+|+.++.+....+..+-+.+|+|||
T Consensus       171 ~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPE  247 (419)
T KOG0663|consen  171 KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPE  247 (419)
T ss_pred             cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHH
Confidence            47899999999999999999999999   999999999999999999999999999999998777777778899999999


Q ss_pred             ccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccc------------cccchh---------hhhhhcCCCCCCCC
Q 042876           84 LAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------------SSLNTD---------IELDEMLDPRLPAP  141 (179)
Q Consensus        84 ~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~------------~~~~~~---------~~~~~~~~~~~~~~  141 (179)
                      ++.+. .|+.+.|+||+||++.+++++..-|.+......            ...+..         ..........+...
T Consensus       248 LLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~k  327 (419)
T KOG0663|consen  248 LLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKK  327 (419)
T ss_pred             HhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhh
Confidence            98875 589999999999999999999988865332110            000000         00000000001111


Q ss_pred             CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          142 SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       142 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ..+.. ....-.+|+..++.+||.+|.|+++.++|
T Consensus       328 F~~~~-lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  328 FGALS-LSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccccc-cchhHHHHHHHHhccCccccccHHHhhcc
Confidence            11111 22346788899999999999999998875

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=3.9e-30  Score=186.29  Aligned_cols=160  Identities=24%  Similarity=0.352  Sum_probs=121.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCc-ccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW-TEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.++++|||.+.......... .....+..|++||
T Consensus        99 ~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE  175 (263)
T cd05052          99 QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE  175 (263)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHH
Confidence            4578899999999999999999999   99999999999999999999999999987654332111 1122345799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ...+..++.++|+||||+++|++++ |..||........     ............+  ...    ...+.+++.+||..
T Consensus       176 ~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-----~~~~~~~~~~~~~--~~~----~~~~~~li~~cl~~  244 (263)
T cd05052         176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELLEKGYRMERP--EGC----PPKVYELMRACWQW  244 (263)
T ss_pred             HhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHHCCCCCCCC--CCC----CHHHHHHHHHHccC
Confidence            9988889999999999999999998 8889864321110     0011111111111  111    23478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||++||++.++.+.|+
T Consensus       245 ~p~~Rp~~~~l~~~l~  260 (263)
T cd05052         245 NPSDRPSFAEIHQAFE  260 (263)
T ss_pred             CcccCCCHHHHHHHHH
Confidence            9999999999999885

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=3e-30  Score=187.51  Aligned_cols=159  Identities=25%  Similarity=0.371  Sum_probs=120.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|.||+++.++.++++|||++..............++..|++||.
T Consensus       106 ~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~  182 (272)
T cd06637         106 NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV  182 (272)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhH
Confidence            4688999999999999999999999   9999999999999999999999999998765433223334567788999998


Q ss_pred             ccc-----CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           85 AYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        85 ~~~-----~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +.+     ..++.++|+||+|+++|++++|..||.........     ............. ..    ....+.+++.+|
T Consensus       183 ~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~-~~----~~~~~~~li~~~  252 (272)
T cd06637         183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FLIPRNPAPRLKS-KK----WSKKFQSFIESC  252 (272)
T ss_pred             hccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----HHHhcCCCCCCCC-CC----cCHHHHHHHHHH
Confidence            763     34678999999999999999999998643211100     0000111111111 11    122478899999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 042876          160 LNESPESRPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~  176 (179)
                      |..||.+|||+.++++|
T Consensus       253 l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         253 LVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             cCCChhhCCCHHHHhhC
Confidence            99999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=1.2e-29  Score=186.34  Aligned_cols=161  Identities=26%  Similarity=0.366  Sum_probs=122.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   81 (179)
                      ...+++..++.++.|++.||+|||+.   +++|+||+|.||+++.++.++++|||.+.........  .....++..|++
T Consensus       126 ~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  202 (293)
T cd05053         126 EETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMA  202 (293)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccC
Confidence            45689999999999999999999999   9999999999999999999999999998765432211  112234567999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..++.++|+||||+++|++++ |..||.........     ......  ........    ....+.+++.+||
T Consensus       203 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-----~~~~~~--~~~~~~~~----~~~~~~~li~~~l  271 (293)
T cd05053         203 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF-----KLLKEG--YRMEKPQN----CTQELYHLMRDCW  271 (293)
T ss_pred             HHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH-----HHHHcC--CcCCCCCC----CCHHHHHHHHHHc
Confidence            999888888999999999999999997 88898644321100     000000  11111111    1234888999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||++|||+.++++.|+
T Consensus       272 ~~~p~~Rps~~eil~~l~  289 (293)
T cd05053         272 HEVPSQRPTFKQLVEDLD  289 (293)
T ss_pred             ccCcccCcCHHHHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=2.4e-30  Score=192.68  Aligned_cols=158  Identities=23%  Similarity=0.286  Sum_probs=120.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++..+..++.||+.||.|||+.   +++||||+|+||+++.++.++++|||++..............+++.|++||
T Consensus        90 ~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE  166 (323)
T cd05575          90 ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPE  166 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChh
Confidence            35688999999999999999999999   999999999999999999999999999865433332333456888999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||||+++|+|++|..||......        .....+...........    ...+.+++.+||+.|
T Consensus       167 ~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~----~~~~~~li~~~l~~~  234 (323)
T cd05575         167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--------EMYDNILNKPLRLKPNI----SVSARHLLEGLLQKD  234 (323)
T ss_pred             hhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcCCCCCCCCC----CHHHHHHHHHHhhcC
Confidence            998888999999999999999999999999653211        11111111111111111    234788999999999


Q ss_pred             CCCCCCH----HHHHHH
Q 042876          164 PESRPTM----KIVSQQ  176 (179)
Q Consensus       164 p~~Rps~----~~~~~~  176 (179)
                      |.+||++    .++++|
T Consensus       235 p~~R~~~~~~~~~il~~  251 (323)
T cd05575         235 RTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             HHhCCCCCCCHHHHHcC
Confidence            9999987    466554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=5e-30  Score=193.80  Aligned_cols=167  Identities=23%  Similarity=0.269  Sum_probs=121.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++|||++....... ......++..|+|||.+
T Consensus       122 ~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-~~~~~~~t~~y~aPE~~  197 (364)
T cd07875         122 ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVI  197 (364)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC-cccCCcccCCcCCHHHH
Confidence            467888999999999999999999   99999999999999999999999999997654322 22334678899999999


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc------------h--hhhhhhcCCCC--------------
Q 042876           86 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN------------T--DIELDEMLDPR--------------  137 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~------------~--~~~~~~~~~~~--------------  137 (179)
                      .+..++.++|+|||||++|+|++|..||............            .  ..........+              
T Consensus       198 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (364)
T cd07875         198 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPD  277 (364)
T ss_pred             hCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcc
Confidence            9888999999999999999999999999654321100000            0  00000000000              


Q ss_pred             --CCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          138 --LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       138 --~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                        .+............+.+++.+|++.||.+|||+.++++|
T Consensus       278 ~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         278 VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             ccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              000000001112357889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=1.3e-29  Score=186.57  Aligned_cols=167  Identities=24%  Similarity=0.348  Sum_probs=120.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.........  ......+..|++|
T Consensus       125 ~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  201 (296)
T cd05095         125 VTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW  201 (296)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence            4578889999999999999999999   9999999999999999999999999998765432211  1122345679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh--CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK--GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |...+..++.++|+||||+++|++++  |..||.........................+.....    ...+.+++.+||
T Consensus       202 e~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~cl  277 (296)
T cd05095         202 ESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALC----PDSLYKLMLSCW  277 (296)
T ss_pred             HHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCC----CHHHHHHHHHHc
Confidence            98877788999999999999999998  677876443211110000000000000111111111    134788999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||.+||++.++.+.|+
T Consensus       278 ~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         278 RRNAKERPSFQEIHATLL  295 (296)
T ss_pred             CCCcccCCCHHHHHHHHh
Confidence            999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=7.4e-30  Score=189.34  Aligned_cols=109  Identities=24%  Similarity=0.385  Sum_probs=91.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee----cCCCceeEccccCccccCCCCC---CcccccCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL----DLEYEAHVADFGIAKFLKPDSS---NWTEFAGTY   77 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~----~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~   77 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||||+||++    +.++.++|+|||++........   ......++.
T Consensus       103 ~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~  179 (317)
T cd07867         103 MQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF  179 (317)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecc
Confidence            3578899999999999999999999   99999999999999    4567899999999976543321   122345678


Q ss_pred             CCCCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCccc
Q 042876           78 GYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFL  116 (179)
Q Consensus        78 ~~~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~  116 (179)
                      .|+|||.+.+. .++.++|+||+|+++|++++|..||...
T Consensus       180 ~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            89999988764 5788999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=1.5e-29  Score=187.78  Aligned_cols=160  Identities=25%  Similarity=0.425  Sum_probs=121.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCc--ccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++++|||++..........  .....+..|++|
T Consensus       104 ~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ap  180 (316)
T cd05108         104 DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL  180 (316)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecCh
Confidence            3578889999999999999999999   99999999999999999999999999998765433221  112335679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||........     .....  .....+....+    ..++.+++.+||.
T Consensus       181 E~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-----~~~~~--~~~~~~~~~~~----~~~~~~li~~cl~  249 (316)
T cd05108         181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILE--KGERLPQPPIC----TIDVYMIMVKCWM  249 (316)
T ss_pred             HHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHh--CCCCCCCCCCC----CHHHHHHHHHHcc
Confidence            99988889999999999999999997 9999865321110     00001  11112211122    2247889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++||++.+++..|.
T Consensus       250 ~~p~~Rps~~~l~~~l~  266 (316)
T cd05108         250 IDADSRPKFRELIIEFS  266 (316)
T ss_pred             CChhhCcCHHHHHHHHH
Confidence            99999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=5.3e-30  Score=190.35  Aligned_cols=157  Identities=28%  Similarity=0.379  Sum_probs=120.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|+|||.
T Consensus        91 ~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  167 (316)
T cd05619          91 HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI  167 (316)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHH
Confidence            4688999999999999999999999   9999999999999999999999999998654322222234567889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+||++|++++|..||.......   .   ........+..+.  .    ....+.+++.+||+.||
T Consensus       168 ~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~---~~~i~~~~~~~~~--~----~~~~~~~li~~~l~~~P  235 (316)
T cd05619         168 LLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---L---FQSIRMDNPCYPR--W----LTREAKDILVKLFVREP  235 (316)
T ss_pred             HcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhCCCCCCc--c----CCHHHHHHHHHHhccCH
Confidence            988889999999999999999999999996543211   0   0001111111111  1    12247788999999999


Q ss_pred             CCCCCHH-HHHHH
Q 042876          165 ESRPTMK-IVSQQ  176 (179)
Q Consensus       165 ~~Rps~~-~~~~~  176 (179)
                      .+||++. ++++|
T Consensus       236 ~~R~~~~~~l~~h  248 (316)
T cd05619         236 ERRLGVKGDIRQH  248 (316)
T ss_pred             hhcCCChHHHHcC
Confidence            9999996 67654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=6.9e-30  Score=194.80  Aligned_cols=170  Identities=25%  Similarity=0.288  Sum_probs=123.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   81 (179)
                      ...+++.+++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++.........  .....++..|++
T Consensus       179 ~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~a  255 (392)
T PHA03207        179 SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNS  255 (392)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccC
Confidence            35689999999999999999999999   9999999999999999999999999998765443221  223568899999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccc-cchh--------------------hhhhhc---CCCC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS-LNTD--------------------IELDEM---LDPR  137 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~-~~~~--------------------~~~~~~---~~~~  137 (179)
                      ||.+.+..++.++|+|||||++|+|++|..||.......... ....                    ......   ..+.
T Consensus       256 PE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (392)
T PHA03207        256 PELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPP  335 (392)
T ss_pred             HhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCC
Confidence            999998889999999999999999999999986543211000 0000                    000000   0000


Q ss_pred             CCCC-CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          138 LPAP-SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       138 ~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .... .........++.++|.+||..||.+|||+.+++.|
T Consensus       336 ~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        336 YTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000 00000112357789999999999999999999876

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=1.3e-29  Score=185.19  Aligned_cols=161  Identities=26%  Similarity=0.385  Sum_probs=120.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||
T Consensus        97 ~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE  173 (282)
T cd06643          97 ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE  173 (282)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHh
Confidence            35689999999999999999999999   999999999999999999999999999866543322233346778899999


Q ss_pred             ccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           84 LAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        84 ~~~-----~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      .+.     +..++.++|+||+|+++|++++|..||........     .........+.....    ......+.+++.+
T Consensus       174 ~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~----~~~~~~~~~li~~  244 (282)
T cd06643         174 VVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKSEPPTLAQP----SRWSSEFKDFLKK  244 (282)
T ss_pred             hccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-----HHHHhhcCCCCCCCc----cccCHHHHHHHHH
Confidence            874     34467899999999999999999999865432110     001111111111111    1122347889999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||+.||.+||++.+++++
T Consensus       245 ~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         245 CLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             HccCChhhCcCHHHHhcC
Confidence            999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=3.7e-30  Score=198.69  Aligned_cols=169  Identities=25%  Similarity=0.264  Sum_probs=120.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-ceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++ .++|+|||++........ .....+++.|+||
T Consensus       164 ~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~-~~~~~~t~~y~aP  239 (440)
T PTZ00036        164 NHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR-SVSYICSRFYRAP  239 (440)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC-cccCCCCcCccCH
Confidence            45688999999999999999999999   999999999999998665 699999999976543222 2234678889999


Q ss_pred             cccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-------hhhhhhh----cCCCCCCCCC-ccH----
Q 042876           83 ELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-------TDIELDE----MLDPRLPAPS-RSV----  145 (179)
Q Consensus        83 e~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-------~~~~~~~----~~~~~~~~~~-~~~----  145 (179)
                      |.+.+. .++.++|+|||||++|+|++|..||.+..........       .......    ..+-.++... ...    
T Consensus       240 E~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  319 (440)
T PTZ00036        240 ELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVF  319 (440)
T ss_pred             HHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHh
Confidence            987654 6889999999999999999999999754321100000       0000000    0000011100 000    


Q ss_pred             -HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 -QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 -~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                       .....++.+|+.+||..||.+|||+.++++|
T Consensus       320 p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        320 PKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence             0112357899999999999999999999876

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-30  Score=186.73  Aligned_cols=170  Identities=23%  Similarity=0.306  Sum_probs=125.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCC--CCCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD--SSNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~   81 (179)
                      ++.++...+.-++.|++.||+|+|+.   +++||||||.|++++.+...||+|||+|+.....  ....+..+.+.+|.|
T Consensus       119 ~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRA  195 (359)
T KOG0660|consen  119 QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRA  195 (359)
T ss_pred             CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecC
Confidence            44589999999999999999999998   9999999999999999999999999999877532  122355678899999


Q ss_pred             Ccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccc------------cccchh---hhhhhcCC---CCCCCC-
Q 042876           82 PELAY-TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------------SSLNTD---IELDEMLD---PRLPAP-  141 (179)
Q Consensus        82 pe~~~-~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~------------~~~~~~---~~~~~~~~---~~~~~~-  141 (179)
                      ||++. ..+|+.+.|+||.||++.+|++|+.-|.+.+....            ......   ......+.   ...+.+ 
T Consensus       196 PElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f  275 (359)
T KOG0660|consen  196 PELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPF  275 (359)
T ss_pred             HHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCH
Confidence            99765 46799999999999999999999999976543211            000000   11111111   111111 


Q ss_pred             CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          142 SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       142 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ....+......++|+.+||..||.+|+|++|+++|
T Consensus       276 ~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  276 SSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            01111112236788889999999999999999986

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.6e-30  Score=192.56  Aligned_cols=166  Identities=22%  Similarity=0.309  Sum_probs=120.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++.......   ....++..|+|||.
T Consensus       113 ~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~t~~y~aPE~  186 (343)
T cd07878         113 QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM---TGYVATRWYRAPEI  186 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCCc---CCccccccccCchH
Confidence            4689999999999999999999999   99999999999999999999999999987654322   33467889999999


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCccccccccccc---------------chhhhhhhcCC--CCCCCC--Ccc
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL---------------NTDIELDEMLD--PRLPAP--SRS  144 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~---------------~~~~~~~~~~~--~~~~~~--~~~  144 (179)
                      +.+ ..++.++|+||||+++|+|++|..||...+.......               ...........  +..+..  ...
T Consensus       187 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (343)
T cd07878         187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKI  266 (343)
T ss_pred             hcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHh
Confidence            876 4678899999999999999999999965332110000               00000000000  000000  000


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.+++.+|++.||.+|||++++++|
T Consensus       267 ~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         267 FRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00111236789999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=3.5e-30  Score=192.25  Aligned_cols=154  Identities=26%  Similarity=0.279  Sum_probs=120.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......   ....+++.|+|||.
T Consensus       113 ~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~  186 (329)
T PTZ00263        113 GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---FTLCGTPEYLAPEV  186 (329)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---ceecCChhhcCHHH
Confidence            4678899999999999999999999   99999999999999999999999999987654322   23467889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+|||||++|+|++|..||......        .....+.......+...    ...+.+++.+||+.||
T Consensus       187 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~~~~p~~~----~~~~~~li~~~L~~dP  254 (329)
T PTZ00263        187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------RIYEKILAGRLKFPNWF----DGRARDLVKGLLQTDH  254 (329)
T ss_pred             HcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--------HHHHHHhcCCcCCCCCC----CHHHHHHHHHHhhcCH
Confidence            99888899999999999999999999999643211        11111111121111111    1247789999999999


Q ss_pred             CCCCC-----HHHHHHH
Q 042876          165 ESRPT-----MKIVSQQ  176 (179)
Q Consensus       165 ~~Rps-----~~~~~~~  176 (179)
                      .+||+     ++++++|
T Consensus       255 ~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        255 TKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HHcCCCCCCCHHHHhcC
Confidence            99996     7888866

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=9.2e-30  Score=187.10  Aligned_cols=166  Identities=23%  Similarity=0.344  Sum_probs=121.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.++++|||++........  ......++..|++|
T Consensus       125 ~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (296)
T cd05051         125 KSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW  201 (296)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence            4689999999999999999999998   999999999999999999999999999875433221  11223456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh--CCCCCcccccccccccchhhhhhhcC-CCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK--GKHPRDFLSSISSSSLNTDIELDEML-DPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~--~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      |...+..++.++|+||||+++|++++  +..||........   .  ....... ................++.+++.+|
T Consensus       202 E~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~---~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  276 (296)
T cd05051         202 ESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV---I--ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLEC  276 (296)
T ss_pred             HHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH---H--HHHHhccccccccccCCCccCCCHHHHHHHHHH
Confidence            99888788999999999999999997  6677754321110   0  0000000 0000000000011123588999999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||.+|||++++++.|+
T Consensus       277 l~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         277 WRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             hccChhcCCCHHHHHHHhc
Confidence            9999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=1.1e-29  Score=183.01  Aligned_cols=160  Identities=29%  Similarity=0.432  Sum_probs=125.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC--CCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~   81 (179)
                      ...+++.+++.++.|++.||++||+.   +++|+||+|+||+++.++.++++|||.+.......  .......++..|++
T Consensus        99 ~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  175 (262)
T cd00192          99 KSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA  175 (262)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccC
Confidence            36789999999999999999999999   99999999999999999999999999997665432  11223456778999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcC-CCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEML-DPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      ||...+..++.++|+||+|++++++++ |..||........        ..... ..........    ..++.+++.+|
T Consensus       176 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~----~~~~~~li~~~  243 (262)
T cd00192         176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--------LEYLRKGYRLPKPEYC----PDELYELMLSC  243 (262)
T ss_pred             HHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH--------HHHHHcCCCCCCCccC----ChHHHHHHHHH
Confidence            999888888999999999999999998 6999876522111        11111 1111111111    33588899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |..||.+|||+.+++++|+
T Consensus       244 l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         244 WQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ccCCcccCcCHHHHHHhhC
Confidence            9999999999999999885

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=2.1e-29  Score=172.25  Aligned_cols=155  Identities=21%  Similarity=0.219  Sum_probs=116.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ++.+++.+++.++.|++.||.|||+.   +      ||+||+++.++.+++  ||.+.......     ..+++.|+|||
T Consensus        11 ~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~~~y~aPE   74 (176)
T smart00750       11 GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVDPYFMAPE   74 (176)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----CCCcccccChH
Confidence            45699999999999999999999998   6      999999999999998  99886654322     25678999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHH--HHHHHHhcccC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLI--SIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~li~~cl~  161 (179)
                      .+.+..++.++||||+|+++|++++|..||........    .............+...........  .+.+++.+||.
T Consensus        75 ~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~  150 (176)
T smart00750       75 VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA----ILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCAS  150 (176)
T ss_pred             HhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH----HHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHh
Confidence            99998999999999999999999999999864322110    0011111111111111111122222  48899999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+||++.++++++.
T Consensus       151 ~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      151 RLPQRREAANHYLAHCR  167 (176)
T ss_pred             cccccccCHHHHHHHHH
Confidence            99999999999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=5e-30  Score=185.25  Aligned_cols=161  Identities=24%  Similarity=0.352  Sum_probs=122.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~   80 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........   .....++..|+
T Consensus        89 ~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~  165 (257)
T cd05115          89 KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY  165 (257)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccC
Confidence            34689999999999999999999999   9999999999999999999999999998755433221   11122346799


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +||.+.+..++.++|+||||+++|++++ |..||........     ............+  ...    ..++.+++.+|
T Consensus       166 aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~--~~~----~~~l~~li~~c  234 (257)
T cd05115         166 APECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-----MSFIEQGKRLDCP--AEC----PPEMYALMKDC  234 (257)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-----HHHHHCCCCCCCC--CCC----CHHHHHHHHHH
Confidence            9999888888999999999999999996 9999865432110     0001111111111  111    23478899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |..+|++||++.++.+.|+
T Consensus       235 ~~~~~~~Rp~~~~i~~~l~  253 (257)
T cd05115         235 WIYKWEDRPNFAKVEERMR  253 (257)
T ss_pred             cCCChhhCcCHHHHHHHHh
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=2.7e-29  Score=183.34  Aligned_cols=160  Identities=25%  Similarity=0.430  Sum_probs=121.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCc--ccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++..........  .....+..|++|
T Consensus       104 ~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~P  180 (279)
T cd05109         104 DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL  180 (279)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCH
Confidence            4589999999999999999999999   99999999999999999999999999997665332211  112345679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |...+..++.++|+||||+++|++++ |..||.........     ......  ...+....    ...++.+++.+||.
T Consensus       181 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-----~~~~~~--~~~~~~~~----~~~~~~~li~~~l~  249 (279)
T cd05109         181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-----DLLEKG--ERLPQPPI----CTIDVYMIMVKCWM  249 (279)
T ss_pred             HHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----HHHHCC--CcCCCCcc----CCHHHHHHHHHHcC
Confidence            99988889999999999999999998 88898643211100     001110  11111111    22347889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++||++.++++.|+
T Consensus       250 ~dp~~Rp~~~~l~~~l~  266 (279)
T cd05109         250 IDSECRPRFRELVDEFS  266 (279)
T ss_pred             CChhhCcCHHHHHHHHH
Confidence            99999999999998764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=3.1e-30  Score=189.42  Aligned_cols=160  Identities=24%  Similarity=0.364  Sum_probs=129.7

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ..+.|++.+++.+++||++|+.|+|++   +++|||||.+|||++.|+++||.|||++..+.... ..++++|.+.|.+|
T Consensus       146 er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-fLqTFCGSPLYASP  221 (668)
T KOG0611|consen  146 ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-FLQTFCGSPLYASP  221 (668)
T ss_pred             HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcccc-HHHHhcCCcccCCc
Confidence            356899999999999999999999999   99999999999999999999999999998877543 45678999999999


Q ss_pred             cccccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |++.|.+| .+..|.||||+++|-++.|..||++....   .+...+...+...+..          ..+.--||++||.
T Consensus       222 EIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvrQIs~GaYrEP~~----------PSdA~gLIRwmLm  288 (668)
T KOG0611|consen  222 EIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVRQISRGAYREPET----------PSDASGLIRWMLM  288 (668)
T ss_pred             cccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHHHhhcccccCCCC----------CchHHHHHHHHHh
Confidence            99999888 47899999999999999999999875321   1111122222222211          1235568889999


Q ss_pred             cCCCCCCCHHHHHHHhhC
Q 042876          162 ESPESRPTMKIVSQQLRI  179 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~~  179 (179)
                      .||++|-|++++..|-++
T Consensus       289 VNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  289 VNPERRATIEDIASHWWV  306 (668)
T ss_pred             cCcccchhHHHHhhhhee
Confidence            999999999999988653

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.5e-30  Score=193.28  Aligned_cols=162  Identities=19%  Similarity=0.202  Sum_probs=122.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....   ......+++.|++||.
T Consensus        96 ~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~  169 (333)
T cd05600          96 GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEV  169 (333)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCCcccCccccChhH
Confidence            4688999999999999999999999   999999999999999999999999999876543   2233567889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+|||||++|+|++|..||..........  ...........  +...........++.+++.+||..+|
T Consensus       170 ~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~i~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~l~~~~  245 (333)
T cd05600         170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE--NLKYWKETLQR--PVYDDPRFNLSDEAWDLITKLINDPS  245 (333)
T ss_pred             hcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH--HHHhccccccC--CCCCccccccCHHHHHHHHHHhhChh
Confidence            998889999999999999999999999996543211100  00000111110  10000001123347889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+||+++++++|
T Consensus       246 ~rr~s~~~ll~h  257 (333)
T cd05600         246 RRFGSLEDIKNH  257 (333)
T ss_pred             hhcCCHHHHHhC
Confidence            999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=9.6e-30  Score=184.47  Aligned_cols=163  Identities=25%  Similarity=0.362  Sum_probs=121.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .++++..+..++.|++.||.|||+.   +++|+|++|.||+++.++.++++|||++..............++..|++||.
T Consensus       101 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~  177 (267)
T cd06646         101 GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV  177 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhH
Confidence            4678999999999999999999999   9999999999999999999999999999766433322233457788999998


Q ss_pred             cc---cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           85 AY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        85 ~~---~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      +.   ...++.++|+||+|++++++++|+.||..............   .....+....    .......+.+++.+||.
T Consensus       178 ~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~----~~~~~~~~~~li~~~l~  250 (267)
T cd06646         178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK---SNFQPPKLKD----KTKWSSTFHNFVKISLT  250 (267)
T ss_pred             cccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec---CCCCCCCCcc----ccccCHHHHHHHHHHhh
Confidence            74   33467889999999999999999999854432111111100   0001111111    11123357889999999


Q ss_pred             cCCCCCCCHHHHHHHh
Q 042876          162 ESPESRPTMKIVSQQL  177 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l  177 (179)
                      .+|++|||+++++++|
T Consensus       251 ~~P~~Rp~~~~il~~l  266 (267)
T cd06646         251 KNPKKRPTAERLLTHL  266 (267)
T ss_pred             CChhhCcCHHHHhcCC
Confidence            9999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.96  E-value=9.2e-30  Score=190.15  Aligned_cols=167  Identities=22%  Similarity=0.325  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+..  +++|+||+|+||+++.++.++++|||++.......  .....++..|++||.
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~g~~~y~aPE~  173 (331)
T cd06649          98 KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPER  173 (331)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc--cccCCCCcCcCCHhH
Confidence            45788999999999999999999852  69999999999999999999999999987554322  233467889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-------------------------------------hh
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-------------------------------------TD  127 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-------------------------------------~~  127 (179)
                      +.+..++.++|+||||+++|++++|+.||............                                     ..
T Consensus       174 ~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T cd06649         174 LQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAI  253 (331)
T ss_pred             hcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhH
Confidence            99888999999999999999999999999643211000000                                     00


Q ss_pred             hh-hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          128 IE-LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       128 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      .. .........+..  .......++.+|+.+||+.||++|||++++++|-
T Consensus       254 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         254 FELLDYIVNEPPPKL--PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             HHHHHHHHhCCCcCC--CCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            00 000000000000  0011234588999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=4.3e-30  Score=190.18  Aligned_cols=169  Identities=16%  Similarity=0.210  Sum_probs=121.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++++|||.+..............++..|++||.
T Consensus        99 ~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  175 (309)
T cd07872          99 NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV  175 (309)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHH
Confidence            4578899999999999999999999   9999999999999999999999999998765443333334466788999998


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-------hhhhhhc------CCCCCCCC-----CccH
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-------DIELDEM------LDPRLPAP-----SRSV  145 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-------~~~~~~~------~~~~~~~~-----~~~~  145 (179)
                      +.+ ..++.++|+||+|++++++++|..||.............       .......      .....+..     ....
T Consensus       176 ~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (309)
T cd07872         176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHA  255 (309)
T ss_pred             HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhc
Confidence            765 457889999999999999999999996543211000000       0000000      00000000     0000


Q ss_pred             HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .....++.+++.+||+.||.+|||++++++|
T Consensus       256 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         256 PRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             cCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            1122347789999999999999999999886

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=6.7e-30  Score=184.40  Aligned_cols=160  Identities=29%  Similarity=0.451  Sum_probs=121.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcc---cccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~---~~~~~~~~~~   81 (179)
                      ..+++..++.++.|++.||+|||..   +++|+||+|+||+++.++.++++|||.+...........   ...++..|++
T Consensus        90 ~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~a  166 (257)
T cd05060          90 REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA  166 (257)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccC
Confidence            3688999999999999999999998   999999999999999999999999999876644332211   1123457999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||...+..++.++|+||||+++|++++ |..||..........     .....  ...+.....    ...+.+++.+||
T Consensus       167 PE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~-----~~~~~--~~~~~~~~~----~~~l~~li~~cl  235 (257)
T cd05060         167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA-----MLESG--ERLPRPEEC----PQEIYSIMLSCW  235 (257)
T ss_pred             HHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHH-----HHHcC--CcCCCCCCC----CHHHHHHHHHHh
Confidence            999988889999999999999999997 999986543211000     00000  011111111    224788999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      ..+|++|||+.++++.|+
T Consensus       236 ~~~p~~Rp~~~~l~~~l~  253 (257)
T cd05060         236 KYRPEDRPTFSELESTFR  253 (257)
T ss_pred             cCChhhCcCHHHHHHHHH
Confidence            999999999999999885

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=3.5e-30  Score=195.18  Aligned_cols=170  Identities=24%  Similarity=0.279  Sum_probs=121.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~p   82 (179)
                      .+.+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........ ......++..|++|
T Consensus        97 ~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aP  173 (372)
T cd07853          97 PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP  173 (372)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCH
Confidence            35689999999999999999999999   999999999999999999999999999875433221 12234567889999


Q ss_pred             cccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-------hh-------hhhh-cCCCCC-CCC----
Q 042876           83 ELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-------DI-------ELDE-MLDPRL-PAP----  141 (179)
Q Consensus        83 e~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-------~~-------~~~~-~~~~~~-~~~----  141 (179)
                      |.+.+. .++.++|+||+||++++|++|+.||.............       ..       .... ...... ++.    
T Consensus       174 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (372)
T cd07853         174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVL  253 (372)
T ss_pred             HHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHh
Confidence            988764 46889999999999999999999996543211000000       00       0000 000000 000    


Q ss_pred             CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          142 SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       142 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ..........+.+++.+||+.||++|||++++++|
T Consensus       254 ~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         254 YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            00001112347889999999999999999999876

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.96  E-value=1.2e-29  Score=186.46  Aligned_cols=160  Identities=23%  Similarity=0.370  Sum_probs=123.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||.
T Consensus       113 ~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  189 (292)
T cd06658         113 TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEV  189 (292)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHH
Confidence            4688999999999999999999999   9999999999999999999999999998755433322333467788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      ..+..++.++|+||+|++++++++|..||.......     .............+...    .....+.+++.+||..||
T Consensus       190 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~P  260 (292)
T cd06658         190 ISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AMRRIRDNLPPRVKDSH----KVSSVLRGFLDLMLVREP  260 (292)
T ss_pred             HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcCCCcccccc----ccCHHHHHHHHHHccCCh
Confidence            988888999999999999999999999986432211     00111111222222111    122247788899999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+|||+++++++
T Consensus       261 ~~Rpt~~~il~~  272 (292)
T cd06658         261 SQRATAQELLQH  272 (292)
T ss_pred             hHCcCHHHHhhC
Confidence            999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.96  E-value=3e-29  Score=181.35  Aligned_cols=160  Identities=24%  Similarity=0.391  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.++++|||++......... .....++..|++||
T Consensus        98 ~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  174 (261)
T cd05072          98 GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE  174 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHH
Confidence            4678889999999999999999998   9999999999999999999999999999765432211 12233456799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ...+..++.++|+||||+++|++++ |..||.......     .........  +.+....    ....+.+++.+||+.
T Consensus       175 ~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~~~~--~~~~~~~----~~~~~~~li~~~l~~  243 (261)
T cd05072         175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-----VMSALQRGY--RMPRMEN----CPDELYDIMKTCWKE  243 (261)
T ss_pred             HhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-----HHHHHHcCC--CCCCCCC----CCHHHHHHHHHHccC
Confidence            9888888899999999999999998 999986432111     001111111  1111111    123478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      +|++||+++++.+.|+
T Consensus       244 ~p~~Rp~~~~i~~~l~  259 (261)
T cd05072         244 KAEERPTFDYLQSVLD  259 (261)
T ss_pred             CcccCcCHHHHHHHHh
Confidence            9999999999999885

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.96  E-value=5.5e-30  Score=180.69  Aligned_cols=146  Identities=26%  Similarity=0.325  Sum_probs=119.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      -++|+++.++.++.||+.||+|||+.   ++++|||||+|||++++|.+||.|||.++.....   ..+.+|++.|+|||
T Consensus       138 ~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---T~TlCGTPeYLAPE  211 (355)
T KOG0616|consen  138 SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---TWTLCGTPEYLAPE  211 (355)
T ss_pred             cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc---EEEecCCccccChH
Confidence            36899999999999999999999999   9999999999999999999999999999887654   24578999999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      ++....+..++|=|+||+++|||+.|..||...+...        ...+++.....-+.....    ++.+|+.++++.|
T Consensus       212 ii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~--------iY~KI~~~~v~fP~~fs~----~~kdLl~~LL~vD  279 (355)
T KOG0616|consen  212 IIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ--------IYEKILEGKVKFPSYFSS----DAKDLLKKLLQVD  279 (355)
T ss_pred             HhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH--------HHHHHHhCcccCCcccCH----HHHHHHHHHHhhh
Confidence            9999999999999999999999999999997554311        122222222221111112    3778888999999


Q ss_pred             CCCC
Q 042876          164 PESR  167 (179)
Q Consensus       164 p~~R  167 (179)
                      -.+|
T Consensus       280 ~t~R  283 (355)
T KOG0616|consen  280 LTKR  283 (355)
T ss_pred             hHhh
Confidence            9888

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.96  E-value=6.3e-30  Score=186.45  Aligned_cols=159  Identities=19%  Similarity=0.318  Sum_probs=119.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe   83 (179)
                      .+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++.........  .....++..|++||
T Consensus       115 ~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05062         115 PPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE  191 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChh
Confidence            467788999999999999999998   9999999999999999999999999998754432211  11224467799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||+++|++++ |..||......        ...........+.....   ....+.+++.+||+.
T Consensus       192 ~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~  260 (277)
T cd05062         192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------QVLRFVMEGGLLDKPDN---CPDMLFELMRMCWQY  260 (277)
T ss_pred             HhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHcCCcCCCCCC---CCHHHHHHHHHHcCC
Confidence            9988888999999999999999998 78888643211        11111111111111111   122478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||++|||+.++++.|+
T Consensus       261 ~p~~Rps~~e~l~~l~  276 (277)
T cd05062         261 NPKMRPSFLEIISSIK  276 (277)
T ss_pred             ChhhCcCHHHHHHHhh
Confidence            9999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.96  E-value=4.5e-30  Score=191.39  Aligned_cols=152  Identities=25%  Similarity=0.284  Sum_probs=117.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.||++||.|||+.   |++||||||+||+++.++.++++|||++..............+++.|++||.
T Consensus        91 ~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~  167 (325)
T cd05602          91 RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV  167 (325)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHH
Confidence            4678889999999999999999999   9999999999999999999999999998754433333344568899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+|||||++|+|++|..||.......        ...............    ....+.+++.+||+.||
T Consensus       168 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~----~~~~~~~li~~~l~~~p  235 (325)
T cd05602         168 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--------MYDNILNKPLQLKPN----ITNSARHLLEGLLQKDR  235 (325)
T ss_pred             HcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--------HHHHHHhCCcCCCCC----CCHHHHHHHHHHcccCH
Confidence            998889999999999999999999999996533211        011111111111111    12247788899999999


Q ss_pred             CCCCCHH
Q 042876          165 ESRPTMK  171 (179)
Q Consensus       165 ~~Rps~~  171 (179)
                      .+||++.
T Consensus       236 ~~R~~~~  242 (325)
T cd05602         236 TKRLGAK  242 (325)
T ss_pred             HHCCCCC
Confidence            9999876

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.96  E-value=5.1e-29  Score=183.51  Aligned_cols=158  Identities=25%  Similarity=0.362  Sum_probs=119.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++....... .......+..|++||.
T Consensus       114 ~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  189 (297)
T cd05089         114 STLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIES  189 (297)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchh
Confidence            3588999999999999999999998   99999999999999999999999999985432111 1111233457999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ..+..++.++|+||||+++|+|++ |..||.......        ........ ........    ...+.+++.+||..
T Consensus       190 ~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~  257 (297)
T cd05089         190 LNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQGYRMEKPRNC----DDEVYELMRQCWRD  257 (297)
T ss_pred             hccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHhcCCCCCCCCCC----CHHHHHHHHHHcCC
Confidence            888888999999999999999997 999986432211        01111111 11111111    22478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      +|.+|||++++++.|+
T Consensus       258 ~p~~Rp~~~~i~~~l~  273 (297)
T cd05089         258 RPYERPPFAQISVQLS  273 (297)
T ss_pred             ChhhCcCHHHHHHHHH
Confidence            9999999999988874

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.96  E-value=2.1e-29  Score=185.51  Aligned_cols=160  Identities=26%  Similarity=0.423  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............+++.|++||.
T Consensus       111 ~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  187 (296)
T cd06654         111 TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV  187 (296)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHH
Confidence            3578899999999999999999999   9999999999999999999999999998765433222233467788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|++++|..||..........     .......+..+..    ......+.+++.+||..+|
T Consensus       188 ~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p  258 (296)
T cd06654         188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----LIATNGTPELQNP----EKLSAIFRDFLNRCLDMDV  258 (296)
T ss_pred             HcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH-----HHhcCCCCCCCCc----cccCHHHHHHHHHHCcCCc
Confidence            988888999999999999999999999996543211000     0000001111111    1222347889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      ++||++++++++
T Consensus       259 ~~Rpt~~eil~~  270 (296)
T cd06654         259 EKRGSAKELLQH  270 (296)
T ss_pred             ccCcCHHHHhhC
Confidence            999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.96  E-value=1.3e-29  Score=188.69  Aligned_cols=157  Identities=24%  Similarity=0.347  Sum_probs=120.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|+|||.
T Consensus        96 ~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  172 (323)
T cd05615          96 GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI  172 (323)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHH
Confidence            4689999999999999999999999   9999999999999999999999999998754433322334567899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|+++|++++|..||......        .....+.......+..    ...++.+++.+||+.+|
T Consensus       173 ~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~~~~p~~----~~~~~~~li~~~l~~~p  240 (323)
T cd05615         173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHNVSYPKS----LSKEAVSICKGLMTKHP  240 (323)
T ss_pred             HcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCcc----CCHHHHHHHHHHcccCH
Confidence            98888999999999999999999999999754321        1111111111111111    12247789999999999


Q ss_pred             CCCCCH-----HHHHHH
Q 042876          165 ESRPTM-----KIVSQQ  176 (179)
Q Consensus       165 ~~Rps~-----~~~~~~  176 (179)
                      .+|++.     +++.+|
T Consensus       241 ~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         241 SKRLGCGPEGERDIREH  257 (323)
T ss_pred             hhCCCCCCCCHHHHhcC
Confidence            999974     455544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.96  E-value=2.4e-29  Score=185.28  Aligned_cols=160  Identities=25%  Similarity=0.412  Sum_probs=122.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.++..++.|++.||++||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||.
T Consensus       110 ~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  186 (296)
T cd06655         110 TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV  186 (296)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcch
Confidence            4689999999999999999999999   9999999999999999999999999988765443322333457788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|+++|++++|..||........     .........+........    ...+.++|.+||..||
T Consensus       187 ~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp  257 (296)
T cd06655         187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATNGTPELQNPEKL----SPIFRDFLNRCLEMDV  257 (296)
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcCCcccCCcccC----CHHHHHHHHHHhhcCh
Confidence            9888889999999999999999999999965432110     000111111111111111    2247788999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+||++.+++++
T Consensus       258 ~~Rpt~~~il~~  269 (296)
T cd06655         258 EKRGSAKELLQH  269 (296)
T ss_pred             hhCCCHHHHhhC
Confidence            999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.96  E-value=7e-30  Score=184.21  Aligned_cols=156  Identities=25%  Similarity=0.354  Sum_probs=119.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.......   .....+..|++||..
T Consensus        98 ~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~  171 (256)
T cd05082          98 VLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEAL  171 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---CCCccceeecCHHHH
Confidence            478899999999999999999999   99999999999999999999999999987544322   122345679999999


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           86 YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      .+..++.++|+||||+++|++++ |..||.......     .............+.      .....+.+++.+||+.+|
T Consensus       172 ~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~~p  240 (256)
T cd05082         172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVEKGYKMDAPD------GCPPVVYDVMKQCWHLDA  240 (256)
T ss_pred             ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHhcCCCCCCCC------CCCHHHHHHHHHHhcCCh
Confidence            88888999999999999999997 898986432110     000011111111111      112347889999999999


Q ss_pred             CCCCCHHHHHHHhh
Q 042876          165 ESRPTMKIVSQQLR  178 (179)
Q Consensus       165 ~~Rps~~~~~~~l~  178 (179)
                      ++|||+.++++.|+
T Consensus       241 ~~Rpt~~~l~~~l~  254 (256)
T cd05082         241 ATRPSFLQLREQLE  254 (256)
T ss_pred             hhCcCHHHHHHHHh
Confidence            99999999999885

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=1.4e-29  Score=195.75  Aligned_cols=169  Identities=20%  Similarity=0.239  Sum_probs=120.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      +.+++.+++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++........  ......++..|++|
T Consensus       255 ~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~AP  331 (461)
T PHA03211        255 RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP  331 (461)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCH
Confidence            4689999999999999999999999   999999999999999999999999999876543221  12234688999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh-----hhhhhcCCCCCCC-----------------
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD-----IELDEMLDPRLPA-----------------  140 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-----------------  140 (179)
                      |.+.+..++.++|+|||||++|++++|..++-.............     ..........++.                 
T Consensus       332 E~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  411 (461)
T PHA03211        332 EVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARN  411 (461)
T ss_pred             HHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcc
Confidence            999988899999999999999999987765422211110000000     0000000000000                 


Q ss_pred             -----CCccHH---HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          141 -----PSRSVQ---EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       141 -----~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                           ....+.   ....++.+|+.+||+.||.+|||+.|+++|
T Consensus       412 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        412 RRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 000011   112257889999999999999999999987

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.96  E-value=4.7e-29  Score=180.62  Aligned_cols=164  Identities=20%  Similarity=0.267  Sum_probs=124.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|.+||
T Consensus       100 ~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE  176 (267)
T cd08224         100 KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE  176 (267)
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHH
Confidence            35588999999999999999999999   999999999999999999999999999876544332233346778899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+|+++|++++|..||.......      ............++..  .......+.+++.+||+.+
T Consensus       177 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~cl~~~  248 (267)
T cd08224         177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIEKCDYPPLP--ADHYSEELRDLVSRCINPD  248 (267)
T ss_pred             HhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH------HHHHhhhhcCCCCCCC--hhhcCHHHHHHHHHHcCCC
Confidence            9988888999999999999999999999985432100      0000011111111110  1122334788999999999


Q ss_pred             CCCCCCHHHHHHHhh
Q 042876          164 PESRPTMKIVSQQLR  178 (179)
Q Consensus       164 p~~Rps~~~~~~~l~  178 (179)
                      |++|||+.++++.|+
T Consensus       249 p~~Rp~~~~il~~~~  263 (267)
T cd08224         249 PEKRPDISYVLQVAK  263 (267)
T ss_pred             cccCCCHHHHHHHHH
Confidence            999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.96  E-value=1e-29  Score=183.72  Aligned_cols=160  Identities=27%  Similarity=0.469  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+......... .....++..|++||
T Consensus        97 ~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  173 (260)
T cd05070          97 RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE  173 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChH
Confidence            4689999999999999999999999   9999999999999999999999999999765432211 12223456799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ...+..++.++|+||||+++|++++ |..||.......     .........  ..+...    .....+.+++.+||..
T Consensus       174 ~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----~~~~~~~~~--~~~~~~----~~~~~~~~li~~~l~~  242 (260)
T cd05070         174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-----VLEQVERGY--RMPCPQ----DCPISLHELMLQCWKK  242 (260)
T ss_pred             HHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCC--CCCCCC----cCCHHHHHHHHHHccc
Confidence            9888888999999999999999999 888986532211     001111111  111111    1223488899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      +|.+|||+.++.+.|+
T Consensus       243 ~p~~Rpt~~~l~~~l~  258 (260)
T cd05070         243 DPEERPTFEYLQSFLE  258 (260)
T ss_pred             CcccCcCHHHHHHHHh
Confidence            9999999999999885

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.96  E-value=1.7e-30  Score=187.39  Aligned_cols=165  Identities=28%  Similarity=0.438  Sum_probs=123.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++.+++.++.|+++||.+||+.   +++|+||+|+||+++.++.++++|||.+..............++..|.|||
T Consensus        92 ~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE  168 (260)
T PF00069_consen   92 NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPE  168 (260)
T ss_dssp             HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHH
T ss_pred             cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            35688999999999999999999999   999999999999999999999999999876433333344556788999999


Q ss_pred             ccc-cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAY-TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~-~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ... +...+.++|+||+|+++++|++|..||...+.................. ..    .........+.+++.+||+.
T Consensus       169 ~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~l~~li~~~l~~  243 (260)
T PF00069_consen  169 VLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS-SS----QQSREKSEELRDLIKKMLSK  243 (260)
T ss_dssp             HHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH-HT----TSHTTSHHHHHHHHHHHSSS
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc-cc----cccchhHHHHHHHHHHHccC
Confidence            988 7788999999999999999999999987541111101000000000000 00    00000014588999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 042876          163 SPESRPTMKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rps~~~~~~~  176 (179)
                      ||++|||+++++++
T Consensus       244 ~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  244 DPEQRPSAEELLKH  257 (260)
T ss_dssp             SGGGSTTHHHHHTS
T ss_pred             ChhHCcCHHHHhcC
Confidence            99999999999876

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.96  E-value=4.5e-29  Score=182.49  Aligned_cols=160  Identities=22%  Similarity=0.381  Sum_probs=121.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++...+.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++........  ......++..|++|
T Consensus       119 ~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05090         119 SSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP  195 (283)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecCh
Confidence            3578889999999999999999999   999999999999999999999999999976543321  12223445679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||++++++++ |..||.......   ..  .....  ....+.....    ...+.+++.+||+
T Consensus       196 E~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~--~~~~~--~~~~~~~~~~----~~~~~~li~~cl~  264 (283)
T cd05090         196 EAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VI--EMVRK--RQLLPCSEDC----PPRMYSLMTECWQ  264 (283)
T ss_pred             HHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HH--HHHHc--CCcCCCCCCC----CHHHHHHHHHHcc
Confidence            99888888999999999999999998 888885432110   00  00000  1111111112    2247888999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+||++.++.++|+
T Consensus       265 ~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         265 EGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             cCcccCcCHHHHHHHhh
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.2e-29  Score=180.41  Aligned_cols=162  Identities=25%  Similarity=0.382  Sum_probs=122.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .++++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||.
T Consensus        96 ~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~  172 (262)
T cd06613          96 GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV  172 (262)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchh
Confidence            5789999999999999999999998   9999999999999999999999999998765433222233456778999999


Q ss_pred             cccC---CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           85 AYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        85 ~~~~---~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ..+.   .++.++|+||+|+++++|++|..||..........   ... ......   ............+.+++.+||.
T Consensus       173 ~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~---~~~-~~~~~~---~~~~~~~~~~~~~~~li~~~l~  245 (262)
T cd06613         173 AAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF---LIS-KSNFPP---PKLKDKEKWSPVFHDFIKKCLT  245 (262)
T ss_pred             hcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH-hccCCC---ccccchhhhhHHHHHHHHHHcC
Confidence            8776   77889999999999999999999986543211000   000 000000   0111122334458899999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .+|.+|||+++++.+
T Consensus       246 ~~p~~Rpt~~~il~~  260 (262)
T cd06613         246 KDPKKRPTATKLLQH  260 (262)
T ss_pred             CChhhCCCHHHHhcC
Confidence            999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.96  E-value=7.6e-30  Score=189.84  Aligned_cols=158  Identities=23%  Similarity=0.299  Sum_probs=120.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++..+..++.||++||.|||+.   +++||||||+||+++.++.++|+|||++..............+++.|++||
T Consensus        90 ~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE  166 (321)
T cd05603          90 ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE  166 (321)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHH
Confidence            35688899999999999999999999   999999999999999999999999999875433222233456788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+|||||++|+|++|..||...+...        ....+..........    ....+.+++.+||+.|
T Consensus       167 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~----~~~~~~~li~~~l~~~  234 (321)
T cd05603         167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ--------MYDNILHKPLQLPGG----KTVAACDLLVGLLHKD  234 (321)
T ss_pred             HhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH--------HHHHHhcCCCCCCCC----CCHHHHHHHHHHccCC
Confidence            9988889999999999999999999999996542111        111111111111111    1224788999999999


Q ss_pred             CCCCCCH----HHHHHH
Q 042876          164 PESRPTM----KIVSQQ  176 (179)
Q Consensus       164 p~~Rps~----~~~~~~  176 (179)
                      |.+||++    .+++++
T Consensus       235 p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         235 QRRRLGAKADFLEIKNH  251 (321)
T ss_pred             HhhcCCCCCCHHHHhCC
Confidence            9999875    355544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.96  E-value=4.4e-29  Score=179.91  Aligned_cols=159  Identities=27%  Similarity=0.379  Sum_probs=124.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++.+++.++.|++.||++||+.   +++|+||+|+||+++.++.++++|||++..............+++.|++||
T Consensus        96 ~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE  172 (257)
T cd08223          96 GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE  172 (257)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChh
Confidence            35689999999999999999999999   999999999999999999999999999876643333334456788899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      ...+..++.++|+||+|++++++++|..||......        ...........+...   ......+.+++.+||+.|
T Consensus       173 ~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~  241 (257)
T cd08223         173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--------SLVYRIIEGKLPPMP---KDYSPELGELIATMLSKR  241 (257)
T ss_pred             HhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhcCCCCCc---cccCHHHHHHHHHHhccC
Confidence            998888899999999999999999999998643211        011111111111111   122335888999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |++||++.+++++
T Consensus       242 p~~Rp~~~~~l~~  254 (257)
T cd08223         242 PEKRPSVKSILRQ  254 (257)
T ss_pred             cccCCCHHHHhcC
Confidence            9999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.96  E-value=9.4e-30  Score=185.92  Aligned_cols=159  Identities=22%  Similarity=0.358  Sum_probs=119.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||.
T Consensus       116 ~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (282)
T cd06636         116 NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV  192 (282)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhh
Confidence            4578888999999999999999999   9999999999999999999999999998755433222334567888999998


Q ss_pred             cc-----cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           85 AY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        85 ~~-----~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +.     +..++.++|+||||+++|++++|..||.........     ............     .......+.++|.+|
T Consensus       193 l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~-----~~~~~~~~~~li~~c  262 (282)
T cd06636         193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-----FLIPRNPPPKLK-----SKKWSKKFIDFIEGC  262 (282)
T ss_pred             cCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----hhHhhCCCCCCc-----ccccCHHHHHHHHHH
Confidence            75     345678899999999999999999998643221110     001111111111     111223488899999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 042876          160 LNESPESRPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~  176 (179)
                      |+.||.+|||+.+++++
T Consensus       263 l~~~p~~Rp~~~ell~~  279 (282)
T cd06636         263 LVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hCCChhhCcCHHHHhcC
Confidence            99999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.96  E-value=9.3e-30  Score=183.72  Aligned_cols=159  Identities=27%  Similarity=0.467  Sum_probs=121.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|.||+++.++.++++|||.+......... .....++..|++||
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe  171 (256)
T cd05113          95 KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE  171 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHH
Confidence            3689999999999999999999999   9999999999999999999999999998765432211 11223456799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ...+..++.++|+||||+++|++++ |..||.......        ........ +......    ....+.+++.+||+
T Consensus       172 ~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~  239 (256)
T cd05113         172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--------TVEKVSQGLRLYRPHL----ASEKVYAIMYSCWH  239 (256)
T ss_pred             HHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHhcCCCCCCCCC----CCHHHHHHHHHHcC
Confidence            9988888899999999999999998 999986543211        01111111 1111111    12347889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+||++.++++.|+
T Consensus       240 ~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         240 EKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCcccCCCHHHHHHhhC
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.3e-30  Score=193.71  Aligned_cols=160  Identities=22%  Similarity=0.283  Sum_probs=123.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC-----------------
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS-----------------   67 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-----------------   67 (179)
                      ..+++..++.++.|++.||+|||+.   |++|+||||+||+++.++.++++|||++.......                 
T Consensus        96 ~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (350)
T cd05573          96 DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN  172 (350)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccc
Confidence            5789999999999999999999998   99999999999999999999999999987654332                 


Q ss_pred             ------------CCcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhc-C
Q 042876           68 ------------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEM-L  134 (179)
Q Consensus        68 ------------~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-~  134 (179)
                                  .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||........     ....... .
T Consensus       173 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-----~~~i~~~~~  247 (350)
T cd05573         173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET-----YNKIINWKE  247 (350)
T ss_pred             ccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH-----HHHHhccCC
Confidence                        112334678899999999988999999999999999999999999975432110     0001110 0


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCC-HHHHHHHh
Q 042876          135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT-MKIVSQQL  177 (179)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-~~~~~~~l  177 (179)
                      ....+....    ...++.++|.+|+. ||.+||+ ++++++|-
T Consensus       248 ~~~~p~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         248 SLRFPPDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             cccCCCCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            011111111    22347888889997 9999999 99999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=9.4e-30  Score=185.36  Aligned_cols=160  Identities=23%  Similarity=0.316  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........  .....++..|++|
T Consensus       114 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05032         114 GPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP  190 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCH
Confidence            3578899999999999999999998   9999999999999999999999999998765433211  1223456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||........   .....    .....+.+...    ...+.+++.+||+
T Consensus       191 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~~----~~~~~~~~~~~----~~~~~~li~~~l~  259 (277)
T cd05032         191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFVI----DGGHLDLPENC----PDKLLELMRMCWQ  259 (277)
T ss_pred             HHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHHh----cCCCCCCCCCC----CHHHHHHHHHHcC
Confidence            99888888999999999999999998 8889864322111   00000    01111111112    3348889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|++|||+.++++.|+
T Consensus       260 ~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         260 YNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CChhhCCCHHHHHHHhc
Confidence            99999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.96  E-value=9.6e-30  Score=186.69  Aligned_cols=160  Identities=23%  Similarity=0.384  Sum_probs=121.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      +.+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........  .....++..|++|
T Consensus       122 ~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap  198 (290)
T cd05045         122 RALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI  198 (290)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH
Confidence            4688999999999999999999998   9999999999999999999999999998754322211  1222445689999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |...+..++.++|+||||++++++++ |..||........   .  .......  ..+....    ...++.+++.+||+
T Consensus       199 E~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~--~~~~~~~--~~~~~~~----~~~~~~~~i~~cl~  267 (290)
T cd05045         199 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL---F--NLLKTGY--RMERPEN----CSEEMYNLMLTCWK  267 (290)
T ss_pred             HHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH---H--HHHhCCC--CCCCCCC----CCHHHHHHHHHHcc
Confidence            99888888999999999999999998 9999865321110   0  0011111  1111111    12348889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|++||++.++++.|+
T Consensus       268 ~~P~~Rp~~~~i~~~l~  284 (290)
T cd05045         268 QEPDKRPTFADISKELE  284 (290)
T ss_pred             CCcccCCCHHHHHHHHH
Confidence            99999999999999885

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=198.26  Aligned_cols=156  Identities=24%  Similarity=0.352  Sum_probs=124.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---------cccccC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---------WTEFAG   75 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---------~~~~~~   75 (179)
                      ..|++.++++|+.|+++|+++||... +.+||||||-+|+|++.++..||||||.+.........         .....-
T Consensus       139 ~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~T  217 (738)
T KOG1989|consen  139 TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYT  217 (738)
T ss_pred             ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhC
Confidence            35999999999999999999999963 36999999999999999999999999998754433311         112356


Q ss_pred             CCCCCCCccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCC--CCCCCccHHHHHH
Q 042876           76 TYGYVAPELA---YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPR--LPAPSRSVQEKLI  150 (179)
Q Consensus        76 ~~~~~~pe~~---~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  150 (179)
                      ++.|++||++   .+...+.++|||+|||++|-|+...+||+......            ++..+  +|..    +.+..
T Consensus       218 Tp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------------Ilng~Y~~P~~----p~ys~  281 (738)
T KOG1989|consen  218 TPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------------ILNGNYSFPPF----PNYSD  281 (738)
T ss_pred             CccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------------EEeccccCCCC----ccHHH
Confidence            8999999976   46778999999999999999999999997653221            11111  2222    34555


Q ss_pred             HHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          151 SIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       151 ~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      .+.+||+.||+.||.+||++-|++..+
T Consensus       282 ~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  282 RLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             HHHHHHHHHhccCcccCCCHHHHHHHH
Confidence            699999999999999999999998875

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=4.6e-29  Score=182.42  Aligned_cols=167  Identities=24%  Similarity=0.359  Sum_probs=122.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      .++++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........   .....++..|++
T Consensus       102 ~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (283)
T cd05080         102 HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA  178 (283)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeC
Confidence            4689999999999999999999999   9999999999999999999999999998765432211   122344566899


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccc------cccchhhhhhhcCCCC--CCCCCccHHHHHHHHH
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------SSLNTDIELDEMLDPR--LPAPSRSVQEKLISIV  153 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~------~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  153 (179)
                      ||...+..++.++|+||||++++++++|..|+........      ................  .+....    ....+.
T Consensus       179 PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  254 (283)
T cd05080         179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKN----CPQEVY  254 (283)
T ss_pred             HhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCC----CCHHHH
Confidence            9999888889999999999999999999999754321100      0000011111111111  111111    123488


Q ss_pred             HHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          154 KVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       154 ~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +++.+||+.+|++|||++++++.|+
T Consensus       255 ~li~~cl~~~p~~Rps~~~i~~~l~  279 (283)
T cd05080         255 ILMKNCWETEAKFRPTFRSLIPILK  279 (283)
T ss_pred             HHHHHHhccChhhCCCHHHHHHHHH
Confidence            8999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=5.8e-30  Score=191.43  Aligned_cols=159  Identities=23%  Similarity=0.309  Sum_probs=130.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +.-|+++.+..++.|++.|+.|||++   .|+|||||+.|||++.++.|+++|||+++.++.....-....|++.|++||
T Consensus       100 ~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPE  176 (426)
T KOG0589|consen  100 GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPE  176 (426)
T ss_pred             hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHH
Confidence            45689999999999999999999998   999999999999999999999999999999887763445578999999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      ++.+.+|..++|+|||||++|+|.+-+.+|...+.....        .++......+..   ..+..++..+|..|+..+
T Consensus       177 il~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li--------~ki~~~~~~Plp---~~ys~el~~lv~~~l~~~  245 (426)
T KOG0589|consen  177 ILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELI--------LKINRGLYSPLP---SMYSSELRSLVKSMLRKN  245 (426)
T ss_pred             HhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHH--------HHHhhccCCCCC---ccccHHHHHHHHHHhhcC
Confidence            999999999999999999999999999999765422111        111111111111   123334888899999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |..||++.+++.+
T Consensus       246 P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  246 PEHRPSALELLRR  258 (426)
T ss_pred             CccCCCHHHHhhC
Confidence            9999999999875

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.96  E-value=4.7e-30  Score=185.67  Aligned_cols=160  Identities=33%  Similarity=0.506  Sum_probs=117.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   81 (179)
                      ...+++..++.++.|+++||.|||+.   +++|++|++.||+++.++.+||+|||++.........  .........|++
T Consensus        97 ~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~a  173 (259)
T PF07714_consen   97 KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLA  173 (259)
T ss_dssp             TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-
T ss_pred             cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            35789999999999999999999999   9999999999999999999999999998776322211  223456678999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..++.++||||||+++|++++ |..||........     .......  .+.+......    ..+.+++..||
T Consensus       174 PE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~-----~~~~~~~--~~~~~~~~~~----~~~~~li~~C~  242 (259)
T PF07714_consen  174 PEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI-----IEKLKQG--QRLPIPDNCP----KDIYSLIQQCW  242 (259)
T ss_dssp             HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH-----HHHHHTT--EETTSBTTSB----HHHHHHHHHHT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc-----ccccccc--ccceeccchh----HHHHHHHHHHc
Confidence            999988889999999999999999999 6888765422110     0111111  1111111122    23788999999


Q ss_pred             CcCCCCCCCHHHHHHHh
Q 042876          161 NESPESRPTMKIVSQQL  177 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l  177 (179)
                      +.||.+|||+.++++.|
T Consensus       243 ~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  243 SHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -SSGGGS--HHHHHHHH
T ss_pred             CCChhhCcCHHHHHhcC
Confidence            99999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.96  E-value=2.5e-30  Score=192.20  Aligned_cols=158  Identities=25%  Similarity=0.316  Sum_probs=121.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++..............+++.|++||
T Consensus        92 ~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE  168 (318)
T cd05582          92 EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE  168 (318)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHH
Confidence            34689999999999999999999999   999999999999999999999999999876544322333456788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||||+++|+|++|..||......        .....+.......+..    ....+.+++.+||+.|
T Consensus       169 ~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~~~~~~~p~~----~~~~~~~li~~~l~~~  236 (318)
T cd05582         169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMILKAKLGMPQF----LSPEAQSLLRALFKRN  236 (318)
T ss_pred             HHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHHcCCCCCCCC----CCHHHHHHHHHHhhcC
Confidence            998888899999999999999999999999643211        1111111111111111    1234778999999999


Q ss_pred             CCCCCC-----HHHHHHH
Q 042876          164 PESRPT-----MKIVSQQ  176 (179)
Q Consensus       164 p~~Rps-----~~~~~~~  176 (179)
                      |++||+     +.+++++
T Consensus       237 P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         237 PANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             HhHcCCCCCCCHHHHhCC
Confidence            999999     5556554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.96  E-value=5.3e-29  Score=181.96  Aligned_cols=159  Identities=23%  Similarity=0.385  Sum_probs=121.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++........  ......++..|++|
T Consensus       117 ~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05092         117 GQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  193 (280)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCH
Confidence            3578999999999999999999999   999999999999999999999999999865432221  11122345789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |...+..++.++|+||||+++|++++ |..||.......        ........ ........    ...+.+++.+||
T Consensus       194 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~li~~cl  261 (280)
T cd05092         194 ESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--------AIECITQGRELERPRTC----PPEVYAIMQGCW  261 (280)
T ss_pred             HHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--------HHHHHHcCccCCCCCCC----CHHHHHHHHHHc
Confidence            99988889999999999999999998 888985432211        11111111 11111112    224778999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||.+||++.++++.|+
T Consensus       262 ~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         262 QREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             cCChhhCCCHHHHHHHHh
Confidence            999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.96  E-value=1.2e-29  Score=183.37  Aligned_cols=161  Identities=24%  Similarity=0.434  Sum_probs=123.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~p   82 (179)
                      ...+++.+++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+......... .....++..|++|
T Consensus        96 ~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~p  172 (260)
T cd05067          96 GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAP  172 (260)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCH
Confidence            34688999999999999999999998   9999999999999999999999999998765422211 1223446789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||++++++++ |..||.........     .......  +.+....    ....+.+++.+||.
T Consensus       173 e~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----~~~~~~~--~~~~~~~----~~~~~~~li~~~l~  241 (260)
T cd05067         173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-----QNLERGY--RMPRPDN----CPEELYELMRLCWK  241 (260)
T ss_pred             HHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH-----HHHHcCC--CCCCCCC----CCHHHHHHHHHHcc
Confidence            99988888999999999999999998 99999754321100     0011111  1111111    12348889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|++||+++++.+.|+
T Consensus       242 ~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         242 EKPEERPTFEYLRSVLE  258 (260)
T ss_pred             CChhhCCCHHHHHHHhh
Confidence            99999999999999886

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.4e-29  Score=183.07  Aligned_cols=161  Identities=21%  Similarity=0.309  Sum_probs=121.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      ..++...++.++.|++.||.+||+.   +++|+||+|+||+++.++.++++|||++.........   .....++..|++
T Consensus        99 ~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  175 (263)
T cd06625          99 GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS  175 (263)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccC
Confidence            4578889999999999999999999   9999999999999999999999999998754332111   123456778999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+||+|+++|++++|+.||........     ..... .........    ......+.+++.+||.
T Consensus       176 PE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~-~~~~~~~~~----~~~~~~~~~li~~~l~  245 (263)
T cd06625         176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-----IFKIA-TQPTNPQLP----SHVSPDARNFLRRTFV  245 (263)
T ss_pred             cceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-----HHHHh-ccCCCCCCC----ccCCHHHHHHHHHHhh
Confidence            9999988899999999999999999999999864321110     00000 000011111    1122347889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|.+|||+.+++++..
T Consensus       246 ~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         246 ENAKKRPSAEELLRHFF  262 (263)
T ss_pred             cCcccCCCHHHHhhCCC
Confidence            99999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.96  E-value=1.1e-29  Score=190.32  Aligned_cols=155  Identities=21%  Similarity=0.265  Sum_probs=121.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++|||++.......   ....+++.|+|||
T Consensus       125 ~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~---~~~~gt~~y~aPE  198 (340)
T PTZ00426        125 NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT---YTLCGTPEYIAPE  198 (340)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc---ceecCChhhcCHH
Confidence            35688999999999999999999999   99999999999999999999999999987654321   2346788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+||++|+|++|..||.......        ....+.......+...    ...+.+++.+|++.|
T Consensus       199 ~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~----~~~~~~li~~~l~~d  266 (340)
T PTZ00426        199 ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--------IYQKILEGIIYFPKFL----DNNCKHLMKKLLSHD  266 (340)
T ss_pred             HHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--------HHHHHhcCCCCCCCCC----CHHHHHHHHHHcccC
Confidence            9988888999999999999999999999996543211        1111111111111111    123678899999999


Q ss_pred             CCCCC-----CHHHHHHH
Q 042876          164 PESRP-----TMKIVSQQ  176 (179)
Q Consensus       164 p~~Rp-----s~~~~~~~  176 (179)
                      |.+|+     +++++++|
T Consensus       267 p~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        267 LTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHcCCCCCCCHHHHHcC
Confidence            99995     89999876

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.96  E-value=1.3e-29  Score=186.82  Aligned_cols=160  Identities=24%  Similarity=0.396  Sum_probs=122.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||.
T Consensus       112 ~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  188 (297)
T cd06659         112 TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV  188 (297)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHH
Confidence            4688999999999999999999999   9999999999999999999999999998655433222233567789999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|++++++++|..||........     ...............    ......+.+++.+||+.+|
T Consensus       189 ~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l~~~P  259 (297)
T cd06659         189 ISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-----MKRLRDSPPPKLKNA----HKISPVLRDFLERMLTREP  259 (297)
T ss_pred             HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHhccCCCCcccc----CCCCHHHHHHHHHHhcCCc
Confidence            9888889999999999999999999999864321110     000111111111111    1122347788999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+||++++++++
T Consensus       260 ~~Rps~~~ll~~  271 (297)
T cd06659         260 QERATAQELLDH  271 (297)
T ss_pred             ccCcCHHHHhhC
Confidence            999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=6e-29  Score=180.42  Aligned_cols=159  Identities=23%  Similarity=0.350  Sum_probs=120.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+......... .....++..|++||
T Consensus       102 ~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  178 (266)
T cd05064         102 GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPE  178 (266)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHH
Confidence            4689999999999999999999999   9999999999999999999999999987554322211 11223456799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      .+.+..++.++|+||+|+++|++++ |..||.......        ....+.+. ..+.....    ...+.+++.+||+
T Consensus       179 ~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~li~~c~~  246 (266)
T cd05064         179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--------VIKAVEDGFRLPAPRNC----PNLLHQLMLDCWQ  246 (266)
T ss_pred             HHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHCCCCCCCCCCC----CHHHHHHHHHHcC
Confidence            9988889999999999999999875 999986543211        01111111 11211122    2247889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|.+||+++++.+.|+
T Consensus       247 ~~p~~RP~~~~i~~~l~  263 (266)
T cd05064         247 KERGERPRFSQIHSILS  263 (266)
T ss_pred             CCchhCCCHHHHHHHHH
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.96  E-value=1.4e-29  Score=182.15  Aligned_cols=160  Identities=23%  Similarity=0.343  Sum_probs=120.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|.||+++.++.++++|||++.........  ......+..|++|
T Consensus        89 ~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  165 (252)
T cd05084          89 PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAP  165 (252)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCc
Confidence            3578999999999999999999999   9999999999999999999999999998654322111  1111234569999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||.......     .............+  .    .....+.+++.+||+
T Consensus       166 E~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~--~----~~~~~~~~li~~~l~  234 (252)
T cd05084         166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----TREAIEQGVRLPCP--E----LCPDAVYRLMERCWE  234 (252)
T ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----HHHHHHcCCCCCCc--c----cCCHHHHHHHHHHcC
Confidence            99988888999999999999999997 888886432211     00111111111111  1    112357889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|++|||++++.+.|+
T Consensus       235 ~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         235 YDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CChhhCcCHHHHHHHHh
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.96  E-value=1.5e-29  Score=184.96  Aligned_cols=169  Identities=20%  Similarity=0.201  Sum_probs=120.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||.
T Consensus        96 ~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  172 (285)
T cd07861          96 QYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV  172 (285)
T ss_pred             CcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHH
Confidence            5689999999999999999999999   9999999999999999999999999998765443333333456788999998


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccc----------------cchhhhhhhcCCCCCCC-CCccHH
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS----------------LNTDIELDEMLDPRLPA-PSRSVQ  146 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~-~~~~~~  146 (179)
                      +.+. .++.++|+||||++++++++|+.||..........                ...........+..... ......
T Consensus       173 ~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (285)
T cd07861         173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVK  252 (285)
T ss_pred             hcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcC
Confidence            7654 46889999999999999999999986432110000                00000000000000000 000000


Q ss_pred             HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          147 EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       147 ~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ....++.++|.+||+.||.+|||+.+++++
T Consensus       253 ~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         253 NLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             CCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            112346789999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=3.4e-29  Score=183.13  Aligned_cols=171  Identities=19%  Similarity=0.237  Sum_probs=121.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.||++||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||
T Consensus        93 ~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE  169 (284)
T cd07839          93 NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPD  169 (284)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChH
Confidence            35689999999999999999999999   999999999999999999999999999876554333333345678899999


Q ss_pred             ccccCC-CCcchhhHHHHHHHHHHHhCCCCCcccccccccccc--------hhh---hhhhcCC-CCCCCCC------cc
Q 042876           84 LAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN--------TDI---ELDEMLD-PRLPAPS------RS  144 (179)
Q Consensus        84 ~~~~~~-~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~--------~~~---~~~~~~~-~~~~~~~------~~  144 (179)
                      .+.+.. ++.++|+||||+++|+|++|..|+............        ...   ......+ ...+...      ..
T Consensus       170 ~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (284)
T cd07839         170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNV  249 (284)
T ss_pred             HHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhh
Confidence            886644 688999999999999999998886322211100000        000   0000000 0000000      00


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      .+....++.+++.+||+.||.+|||++++++|-
T Consensus       250 ~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         250 VPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             cccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence            011234577899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.96  E-value=7.8e-29  Score=183.04  Aligned_cols=160  Identities=26%  Similarity=0.397  Sum_probs=120.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|+++||.|||++   +++|+||+|+||+++.++.++++|||.+.........  .....++..|++|
T Consensus       132 ~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aP  208 (304)
T cd05101         132 EQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP  208 (304)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCc
Confidence            4678899999999999999999999   9999999999999999999999999998765433221  1122345679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||.......   ...  .....  ........    ....+.+++.+||+
T Consensus       209 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~--~~~~~--~~~~~~~~----~~~~~~~li~~cl~  277 (304)
T cd05101         209 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFK--LLKEG--HRMDKPAN----CTNELYMMMRDCWH  277 (304)
T ss_pred             hhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHH--HHHcC--CcCCCCCC----CCHHHHHHHHHHcc
Confidence            99988888999999999999999998 778875432111   000  00000  11111111    22347889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|.+|||+.++++.|+
T Consensus       278 ~~p~~Rps~~e~l~~l~  294 (304)
T cd05101         278 AIPSHRPTFKQLVEDLD  294 (304)
T ss_pred             cChhhCCCHHHHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=3.6e-29  Score=184.11  Aligned_cols=165  Identities=22%  Similarity=0.307  Sum_probs=119.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe   83 (179)
                      .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........  .....++..|++||
T Consensus       125 ~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  201 (295)
T cd05097         125 SVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE  201 (295)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence            468889999999999999999999   9999999999999999999999999998754332211  12234467899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh--CCCCCcccccccccccchhhhhhhcCCCC-CCCCCccHHHHHHHHHHHHhccc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK--GKHPRDFLSSISSSSLNTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ...+..++.++|+||||++++++++  +..||.............. ......... ......    ....+.+++.+||
T Consensus       202 ~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~l~~li~~~l  276 (295)
T cd05097         202 SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGE-FFRNQGRQIYLSQTPL----CPSPVFKLMMRCW  276 (295)
T ss_pred             hhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHH-hhhhccccccCCCCCC----CCHHHHHHHHHHc
Confidence            9888889999999999999999988  5667654322110000000 000000000 000111    1234889999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||++|||++++++.|+
T Consensus       277 ~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         277 SRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             CCCchhCcCHHHHHHHHh
Confidence            999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=193.67  Aligned_cols=150  Identities=27%  Similarity=0.350  Sum_probs=124.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...|++..+..++..|+.||.|||++   |||+||||.+|||++..|.+||+|||+++..-.......++.|++.|+|||
T Consensus       462 ~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPE  538 (694)
T KOG0694|consen  462 TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPE  538 (694)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChh
Confidence            46899999999999999999999999   999999999999999999999999999987654444557789999999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC--CCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ++.+..|+.+.|=|+||+++|+|+.|+.||++.+..+        ...+++  +...|.  -    ...+.+.+++++|.
T Consensus       539 il~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--------~FdsI~~d~~~yP~--~----ls~ea~~il~~ll~  604 (694)
T KOG0694|consen  539 VLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--------VFDSIVNDEVRYPR--F----LSKEAIAIMRRLLR  604 (694)
T ss_pred             hhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHhcCCCCCCC--c----ccHHHHHHHHHHhc
Confidence            9999999999999999999999999999998654322        222222  122222  1    12347888999999


Q ss_pred             cCCCCCCCH
Q 042876          162 ESPESRPTM  170 (179)
Q Consensus       162 ~~p~~Rps~  170 (179)
                      .||++|.-.
T Consensus       605 k~p~kRLG~  613 (694)
T KOG0694|consen  605 KNPEKRLGS  613 (694)
T ss_pred             cCcccccCC
Confidence            999999743

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=1.6e-29  Score=184.57  Aligned_cols=159  Identities=22%  Similarity=0.278  Sum_probs=119.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++....... ......++..|++||.
T Consensus        90 ~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  165 (277)
T cd05607          90 RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNGYMAPEI  165 (277)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCCccCHHH
Confidence            4578899999999999999999999   99999999999999999999999999987654322 2233467889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|+++|++++|..||........    .............+....   ....++.+++.+||+.||
T Consensus       166 ~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~~P  238 (277)
T cd05607         166 LKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRTLEDEVKFEHQ---NFTEESKDICRLFLAKKP  238 (277)
T ss_pred             HccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHhhccccccccc---cCCHHHHHHHHHHhccCH
Confidence            9888899999999999999999999999865322110    011111111111111111   123347889999999999


Q ss_pred             CCCCCHHHHH
Q 042876          165 ESRPTMKIVS  174 (179)
Q Consensus       165 ~~Rps~~~~~  174 (179)
                      .+||++.|++
T Consensus       239 ~~R~~~~~~~  248 (277)
T cd05607         239 EDRLGSREKN  248 (277)
T ss_pred             hhCCCCccch
Confidence            9999996544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.96  E-value=7.9e-29  Score=180.75  Aligned_cols=159  Identities=25%  Similarity=0.376  Sum_probs=119.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC---ceeEccccCccccCCCCCC--cccccCCCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY---EAHVADFGIAKFLKPDSSN--WTEFAGTYGYV   80 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~   80 (179)
                      .+++..++.++.||+.||+|||+.   +++|+||+|+||+++.++   .++++|||++.........  ......+..|+
T Consensus       112 ~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~  188 (277)
T cd05036         112 SLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM  188 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhC
Confidence            589999999999999999999999   999999999999998654   5899999998765322211  11223356799


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +||.+.+..++.++|+|||||++|++++ |..||+.......   ..  ....  ..+.......    ...+.+++.+|
T Consensus       189 aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~--~~~~--~~~~~~~~~~----~~~~~~~i~~c  257 (277)
T cd05036         189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---ME--FVTG--GGRLDPPKGC----PGPVYRIMTDC  257 (277)
T ss_pred             CHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH--HHHc--CCcCCCCCCC----CHHHHHHHHHH
Confidence            9999988889999999999999999997 9999865322110   00  0000  0111111111    23478899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.+|++|||+.+++++|+
T Consensus       258 l~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         258 WQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cCCCcccCcCHHHHHHHhh
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-29  Score=176.29  Aligned_cols=162  Identities=23%  Similarity=0.314  Sum_probs=125.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+++++..+-.+...+++||.||..+.  +++|||+||+|||++..|++|++|||++-++.... ......|-+.|++||
T Consensus       185 k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-AhtrsAGC~~YMaPE  261 (391)
T KOG0983|consen  185 KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-AHTRSAGCAAYMAPE  261 (391)
T ss_pred             cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc-ccccccCCccccCcc
Confidence            356788888889999999999999964  99999999999999999999999999998776543 334456788999999


Q ss_pred             ccccC---CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           84 LAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        84 ~~~~~---~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      .+.-.   +|.-.+||||||+.++++.||+.||.+.+. +...   -.......++.++......+    ++.+++..||
T Consensus       262 Ridp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-dFe~---ltkvln~ePP~L~~~~gFSp----~F~~fv~~CL  333 (391)
T KOG0983|consen  262 RIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-DFEV---LTKVLNEEPPLLPGHMGFSP----DFQSFVKDCL  333 (391)
T ss_pred             ccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-cHHH---HHHHHhcCCCCCCcccCcCH----HHHHHHHHHh
Confidence            88643   466789999999999999999999976431 1111   11111122344444333222    4888888999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      ..|+.+||.+.++++|
T Consensus       334 ~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  334 TKDHRKRPKYNKLLEH  349 (391)
T ss_pred             hcCcccCcchHHHhcC
Confidence            9999999999999886

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.3e-29  Score=181.99  Aligned_cols=160  Identities=28%  Similarity=0.496  Sum_probs=122.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++++|||++......... ......+..|++||
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  174 (261)
T cd05068          98 RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE  174 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCcc
Confidence            4689999999999999999999999   9999999999999999999999999999776532211 11122345799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ...+..++.++|+||||++++++++ |+.||........     ........  ..+...    .....+.+++.+|++.
T Consensus       175 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-----~~~~~~~~--~~~~~~----~~~~~~~~li~~~l~~  243 (261)
T cd05068         175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-----LQQVDQGY--RMPCPP----GCPKELYDIMLDCWKE  243 (261)
T ss_pred             ccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-----HHHHHcCC--CCCCCC----cCCHHHHHHHHHHhhc
Confidence            9988888999999999999999999 9999865421110     00111111  111111    1233588899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      +|.+||+++++.+.|+
T Consensus       244 ~P~~Rp~~~~l~~~l~  259 (261)
T cd05068         244 DPDDRPTFETLQWKLE  259 (261)
T ss_pred             CcccCCCHHHHHHHHh
Confidence            9999999999999886

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.96  E-value=1.8e-29  Score=182.09  Aligned_cols=157  Identities=28%  Similarity=0.472  Sum_probs=120.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCcc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPEL   84 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~   84 (179)
                      .+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.++++|||.+......... .....++..|++||.
T Consensus        96 ~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~  172 (256)
T cd05114          96 KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEV  172 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhh
Confidence            578999999999999999999999   9999999999999999999999999988765322211 112234567999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      +.+..++.++|+||+|+++|++++ |+.||.......        ........ .......    ....+.+++.+||..
T Consensus       173 ~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--------~~~~i~~~~~~~~~~~----~~~~~~~li~~c~~~  240 (256)
T cd05114         173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--------VVEMISRGFRLYRPKL----ASMTVYEVMYSCWHE  240 (256)
T ss_pred             cccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCCCCCCCC----CCHHHHHHHHHHccC
Confidence            988888999999999999999999 899986543211        11111111 1111111    123478999999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 042876          163 SPESRPTMKIVSQQL  177 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l  177 (179)
                      +|.+|||++++++.|
T Consensus       241 ~p~~Rps~~~l~~~l  255 (256)
T cd05114         241 KPEGRPTFAELLRAI  255 (256)
T ss_pred             CcccCcCHHHHHHhh
Confidence            999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=3.8e-29  Score=194.98  Aligned_cols=158  Identities=23%  Similarity=0.257  Sum_probs=122.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      .++++.++..++.|++.||.|||+.   +++||||||+||+++.++.++++|||++........  ......+++.|++|
T Consensus       164 ~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aP  240 (478)
T PTZ00267        164 LPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAP  240 (478)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCH
Confidence            4688999999999999999999999   999999999999999999999999999976543221  12334688999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |.+.+..++.++|+|||||++|+|++|..||......        ............+...   ....++.++|.+||+.
T Consensus       241 E~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~~~~~~~~~~---~~s~~~~~li~~~L~~  309 (478)
T PTZ00267        241 ELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVLYGKYDPFPC---PVSSGMKALLDPLLSK  309 (478)
T ss_pred             hHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCCc---cCCHHHHHHHHHHhcc
Confidence            9998888999999999999999999999999643211        1111111111111111   1123478899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 042876          163 SPESRPTMKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rps~~~~~~~  176 (179)
                      ||++||++++++.+
T Consensus       310 dP~~Rps~~~~l~~  323 (478)
T PTZ00267        310 NPALRPTTQQLLHT  323 (478)
T ss_pred             ChhhCcCHHHHHhC
Confidence            99999999998764

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.8e-30  Score=191.55  Aligned_cols=157  Identities=26%  Similarity=0.307  Sum_probs=120.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.||++||+|||+.   +++||||||+||+++.++.++|+|||++..............++..|++||
T Consensus        90 ~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE  166 (330)
T cd05586          90 EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE  166 (330)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHH
Confidence            35689999999999999999999999   999999999999999999999999999865433333334456888999999


Q ss_pred             ccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC--CCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           84 LAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        84 ~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      .+.+. .++.++|+||+|+++|+|++|..||.......        ....+.  ...++..  .   ...++.+++.+||
T Consensus       167 ~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~~--~---~~~~~~~li~~~L  233 (330)
T cd05586         167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--------MYRNIAFGKVRFPKN--V---LSDEGRQFVKGLL  233 (330)
T ss_pred             HHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--------HHHHHHcCCCCCCCc--c---CCHHHHHHHHHHc
Confidence            88654 47889999999999999999999986432111        011111  1112211  1   1224678899999


Q ss_pred             CcCCCCCC----CHHHHHHH
Q 042876          161 NESPESRP----TMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rp----s~~~~~~~  176 (179)
                      ..||.+||    ++.++++|
T Consensus       234 ~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         234 NRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CCCHHHCCCCCCCHHHHhcC
Confidence            99999998    67787765

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.96  E-value=6.8e-30  Score=190.40  Aligned_cols=153  Identities=25%  Similarity=0.310  Sum_probs=118.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..++++..+..++.||+.||.|||+.   |++|+||||+||+++.++.++++|||++..............++..|++||
T Consensus        90 ~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE  166 (325)
T cd05604          90 ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPE  166 (325)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHH
Confidence            35789999999999999999999999   999999999999999999999999999865433222233456889999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+|||||++|+|++|..||.......        ...............    ....+.+++.+|+..+
T Consensus       167 ~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--------~~~~~~~~~~~~~~~----~~~~~~~ll~~ll~~~  234 (325)
T cd05604         167 VIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--------MYDNILHKPLVLRPG----ASLTAWSILEELLEKD  234 (325)
T ss_pred             HHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--------HHHHHHcCCccCCCC----CCHHHHHHHHHHhccC
Confidence            9988889999999999999999999999996543111        111111111111111    1223778899999999


Q ss_pred             CCCCCCHH
Q 042876          164 PESRPTMK  171 (179)
Q Consensus       164 p~~Rps~~  171 (179)
                      |.+||++.
T Consensus       235 p~~R~~~~  242 (325)
T cd05604         235 RQRRLGAK  242 (325)
T ss_pred             HHhcCCCC
Confidence            99999774

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.96  E-value=3.8e-29  Score=180.20  Aligned_cols=158  Identities=21%  Similarity=0.310  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||.
T Consensus        95 ~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~  171 (255)
T cd08219          95 KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI  171 (255)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHH
Confidence            4578999999999999999999999   9999999999999999999999999998765443322334567788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|++++++++|..||.......        ...............   .....+.+++.+||+.||
T Consensus       172 ~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P  240 (255)
T cd08219         172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN--------LILKVCQGSYKPLPS---HYSYELRSLIKQMFKRNP  240 (255)
T ss_pred             HccCCcCchhhhhhhchhheehhhccCCCCCCCHHH--------HHHHHhcCCCCCCCc---ccCHHHHHHHHHHHhCCc
Confidence            988888999999999999999999999996432110        011111111111111   112347789999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+||++++++..
T Consensus       241 ~~Rp~~~~il~~  252 (255)
T cd08219         241 RSRPSATTILSR  252 (255)
T ss_pred             ccCCCHHHHhhc
Confidence            999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=1.2e-28  Score=178.73  Aligned_cols=159  Identities=27%  Similarity=0.474  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcc--cccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT--EFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++...........  ...++..|++|
T Consensus       101 ~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P  177 (266)
T cd05033         101 GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP  177 (266)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccCh
Confidence            3689999999999999999999998   999999999999999999999999999987652222111  22345679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |...+..++.++|+||||++++++++ |..||.......        ........ ..+....    ....+.+++.+||
T Consensus       178 e~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~----~~~~l~~li~~cl  245 (266)
T cd05033         178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--------VIKAVEDGYRLPPPMD----CPSALYQLMLDCW  245 (266)
T ss_pred             hhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--------HHHHHHcCCCCCCCCC----CCHHHHHHHHHHc
Confidence            99988888999999999999999997 999985432110        11111111 1111111    2234789999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.+|++||++++++++|+
T Consensus       246 ~~~p~~Rp~~~ei~~~l~  263 (266)
T cd05033         246 QKDRNERPTFSQIVSTLD  263 (266)
T ss_pred             CCCcccCcCHHHHHHHHH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.96  E-value=2.2e-29  Score=182.04  Aligned_cols=160  Identities=26%  Similarity=0.435  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+......... .....++..|++||
T Consensus        97 ~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe  173 (260)
T cd05069          97 KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE  173 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHH
Confidence            3578899999999999999999998   9999999999999999999999999998765432211 12233456799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ...+..++.++|+||||+++|++++ |..||.........     ........  .+..    ......+.+++.+||..
T Consensus       174 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-----~~~~~~~~--~~~~----~~~~~~~~~li~~~l~~  242 (260)
T cd05069         174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-----EQVERGYR--MPCP----QGCPESLHELMKLCWKK  242 (260)
T ss_pred             HhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHcCCC--CCCC----cccCHHHHHHHHHHccC
Confidence            9888888999999999999999999 89998654321100     01111111  1111    11233478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||.+||+++++.+.|+
T Consensus       243 ~p~~Rp~~~~i~~~l~  258 (260)
T cd05069         243 DPDERPTFEYIQSFLE  258 (260)
T ss_pred             CcccCcCHHHHHHHHh
Confidence            9999999999999886

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.96  E-value=7.8e-29  Score=180.91  Aligned_cols=160  Identities=25%  Similarity=0.376  Sum_probs=122.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|++.||+|||+.   +++|+||+|.||+++.++.++++|||+++.+......  .....++..|++|
T Consensus       112 ~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~ap  188 (280)
T cd05043         112 QALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL  188 (280)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCH
Confidence            5689999999999999999999999   9999999999999999999999999999765432211  1123445679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||........     ......  ....+.....    ...+.+++.+||.
T Consensus       189 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~--~~~~~~~~~~----~~~~~~li~~~l~  257 (280)
T cd05043         189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM-----AAYLKD--GYRLAQPINC----PDELFAVMACCWA  257 (280)
T ss_pred             HHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH-----HHHHHc--CCCCCCCCcC----CHHHHHHHHHHcC
Confidence            99988888999999999999999998 9999865432110     000000  0111111111    2247889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|++|||+.++++.|+
T Consensus       258 ~~p~~Rps~~~~~~~l~  274 (280)
T cd05043         258 LDPEERPSFSQLVQCLT  274 (280)
T ss_pred             CChhhCCCHHHHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=4e-29  Score=188.50  Aligned_cols=106  Identities=26%  Similarity=0.422  Sum_probs=91.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++.+++.++.||+.||.|||+.   +++||||||+||+++.++.++++|||++....... ......++..|++||
T Consensus       151 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE  226 (357)
T PHA03209        151 SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-AFLGLAGTVETNAPE  226 (357)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc-ccccccccccccCCe
Confidence            35689999999999999999999999   99999999999999999999999999986533221 223346788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPR  113 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~  113 (179)
                      .+.+..++.++|+|||||++|+++++..++
T Consensus       227 ~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        227 VLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            998888999999999999999999865543

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.96  E-value=8.7e-29  Score=181.78  Aligned_cols=160  Identities=26%  Similarity=0.411  Sum_probs=119.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||.
T Consensus       105 ~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  181 (292)
T cd06644         105 RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEV  181 (292)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCcee
Confidence            4689999999999999999999998   9999999999999999999999999988654332222234456788999998


Q ss_pred             cc-----cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           85 AY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        85 ~~-----~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +.     ...++.++|+||||+++|++++|..||.......     ..........+.....    .....++.+++.+|
T Consensus       182 ~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~  252 (292)
T cd06644         182 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSEPPTLSQP----SKWSMEFRDFLKTA  252 (292)
T ss_pred             eccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-----HHHHHhcCCCccCCCC----cccCHHHHHHHHHH
Confidence            74     3346778999999999999999999986432110     0011111111111111    11223478899999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 042876          160 LNESPESRPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~  176 (179)
                      |+.||++||++++++++
T Consensus       253 l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         253 LDKHPETRPSAAQLLEH  269 (292)
T ss_pred             hcCCcccCcCHHHHhcC
Confidence            99999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.96  E-value=1.5e-29  Score=186.90  Aligned_cols=158  Identities=25%  Similarity=0.359  Sum_probs=119.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++....... .......+..|++||.
T Consensus       119 ~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  194 (303)
T cd05088         119 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIES  194 (303)
T ss_pred             CcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCccccCcccchhh-hcccCCCcccccCHHH
Confidence            3688999999999999999999999   99999999999999999999999999985432111 1111233567999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ..+..++.++|+||||++++++++ |..||.......        ........ .......    ....+.+++.+||+.
T Consensus       195 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~  262 (303)
T cd05088         195 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQGYRLEKPLN----CDDEVYDLMRQCWRE  262 (303)
T ss_pred             HhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--------HHHHHhcCCcCCCCCC----CCHHHHHHHHHHcCC
Confidence            888788899999999999999998 999986432211        01111111 1111111    122478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      +|.+||+++++++.|+
T Consensus       263 ~p~~Rp~~~~il~~l~  278 (303)
T cd05088         263 KPYERPSFAQILVSLN  278 (303)
T ss_pred             ChhhCcCHHHHHHHHH
Confidence            9999999999998764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.8e-29  Score=182.72  Aligned_cols=158  Identities=29%  Similarity=0.441  Sum_probs=123.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||.+
T Consensus        94 ~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~  170 (274)
T cd06609          94 KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI  170 (274)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhh
Confidence            688999999999999999999999   99999999999999999999999999997765443333345677789999999


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCC
Q 042876           86 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPE  165 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  165 (179)
                      .+..++.++|+||||+++|++++|..||........     .........+..+.  .   ....++.+++.+||..+|+
T Consensus       171 ~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~--~---~~~~~~~~~l~~~l~~~p~  240 (274)
T cd06609         171 KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-----LFLIPKNNPPSLEG--N---KFSKPFKDFVSLCLNKDPK  240 (274)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-----HHHhhhcCCCCCcc--c---ccCHHHHHHHHHHhhCChh
Confidence            888899999999999999999999999965431110     00111111111111  1   0223478899999999999


Q ss_pred             CCCCHHHHHHH
Q 042876          166 SRPTMKIVSQQ  176 (179)
Q Consensus       166 ~Rps~~~~~~~  176 (179)
                      +|||+++++++
T Consensus       241 ~Rpt~~~il~~  251 (274)
T cd06609         241 ERPSAKELLKH  251 (274)
T ss_pred             hCcCHHHHhhC
Confidence            99999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.96  E-value=3.5e-29  Score=180.50  Aligned_cols=161  Identities=25%  Similarity=0.427  Sum_probs=123.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++.........   .....++..|++
T Consensus        92 ~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~  168 (257)
T cd05040          92 GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA  168 (257)
T ss_pred             ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecC
Confidence            4688999999999999999999999   9999999999999999999999999998766442211   112345678999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||...+..++.++|+||||+++++|++ |..||.........     ..... .....+...    .....+.+++.+||
T Consensus       169 pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-----~~~~~-~~~~~~~~~----~~~~~~~~li~~~l  238 (257)
T cd05040         169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL-----KKIDK-EGERLERPE----ACPQDIYNVMLQCW  238 (257)
T ss_pred             HHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHh-cCCcCCCCc----cCCHHHHHHHHHHC
Confidence            999988889999999999999999998 99998643221100     00000 111111111    12335888999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      ..+|.+|||+.++++.|.
T Consensus       239 ~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         239 AHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCcccCCCHHHHHHHhc
Confidence            999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.96  E-value=1.9e-29  Score=184.41  Aligned_cols=169  Identities=20%  Similarity=0.330  Sum_probs=122.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|.||+++.++.++++|||++..............++..|++||.
T Consensus        95 ~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~  171 (286)
T cd07847          95 RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL  171 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHH
Confidence            4689999999999999999999998   9999999999999999999999999999766543322333456778999998


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh------hhhhhcCCC-------CCCCC------Ccc
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD------IELDEMLDP-------RLPAP------SRS  144 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~------~~~~~~~~~-------~~~~~------~~~  144 (179)
                      +.+ ..++.++|+||+|++++++++|..||..............      ....+..+.       ..+..      ...
T Consensus       172 ~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (286)
T cd07847         172 LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESK  251 (286)
T ss_pred             HhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHH
Confidence            865 4578899999999999999999999975442111000000      000000000       00000      001


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.+++.+||+.+|++||++.++++|
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         252 FPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             hccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            11223458899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=1.2e-28  Score=178.56  Aligned_cols=153  Identities=23%  Similarity=0.348  Sum_probs=115.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc-------eeEccccCccccCCCCCCcccccCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE-------AHVADFGIAKFLKPDSSNWTEFAGTY   77 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~-------~~l~d~~~~~~~~~~~~~~~~~~~~~   77 (179)
                      ..+++..++.++.||++||+|||+.   +++|+||+|+||+++.++.       ++++|||++......    ....++.
T Consensus       100 ~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~  172 (262)
T cd05077         100 DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR----QECVERI  172 (262)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc----ccccccc
Confidence            4689999999999999999999999   9999999999999976654       799999988654322    2235677


Q ss_pred             CCCCCcccc-cCCCCcchhhHHHHHHHHHHH-hCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHH
Q 042876           78 GYVAPELAY-TMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKV  155 (179)
Q Consensus        78 ~~~~pe~~~-~~~~~~~~D~~slg~~~~~l~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  155 (179)
                      .|++||.+. +..++.++|+||||+++|+++ .|..|+.......      ..   .............    ..++.++
T Consensus       173 ~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~---~~~~~~~~~~~~~----~~~~~~l  239 (262)
T cd05077         173 PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------KE---RFYEGQCMLVTPS----CKELADL  239 (262)
T ss_pred             cccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------HH---HHHhcCccCCCCC----hHHHHHH
Confidence            899999876 456788999999999999997 4788875432111      00   0111111111111    2347889


Q ss_pred             HhcccCcCCCCCCCHHHHHHHh
Q 042876          156 AFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       156 i~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      +.+||+.||.+||++.++++++
T Consensus       240 i~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         240 MTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHHcCCChhhCcCHHHHHHhc
Confidence            9999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.96  E-value=1.4e-28  Score=177.79  Aligned_cols=158  Identities=30%  Similarity=0.404  Sum_probs=117.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC----CcccccCCCCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS----NWTEFAGTYGYVA   81 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~   81 (179)
                      .+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++........    ......++..|++
T Consensus        94 ~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~a  170 (262)
T cd05058          94 NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA  170 (262)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccC
Confidence            457788899999999999999998   999999999999999999999999999865432111    1112234567999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhC-CCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKG-KHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      ||.+.+..++.++|+||||+++|++++| ..||...+...        ........ ..+.....    ...+.+++.+|
T Consensus       171 PE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~li~~c  238 (262)
T cd05058         171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD--------ITVYLLQGRRLLQPEYC----PDPLYEVMLSC  238 (262)
T ss_pred             hhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHhcCCCCCCCCcC----CHHHHHHHHHH
Confidence            9998888889999999999999999995 55664322110        11111111 11111111    22478899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |..+|++||++.++++.|+
T Consensus       239 l~~~p~~Rp~~~~il~~l~  257 (262)
T cd05058         239 WHPKPEMRPTFSELVSRIE  257 (262)
T ss_pred             cCCChhhCCCHHHHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.96  E-value=9e-29  Score=182.97  Aligned_cols=160  Identities=28%  Similarity=0.411  Sum_probs=120.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCc--ccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+..........  .....+..|++|
T Consensus       135 ~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  211 (307)
T cd05098         135 EQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  211 (307)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeCh
Confidence            3588999999999999999999998   99999999999999999999999999987554322111  112234679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||.......   ...  .....  .........    ..++.+++.+||+
T Consensus       212 E~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---~~~--~~~~~--~~~~~~~~~----~~~~~~li~~~l~  280 (307)
T cd05098         212 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---LFK--LLKEG--HRMDKPSNC----TNELYMMMRDCWH  280 (307)
T ss_pred             HHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH--HHHcC--CCCCCCCcC----CHHHHHHHHHHcc
Confidence            99988888999999999999999998 888885432110   000  00010  111111111    2347889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|.+|||+.++++.|+
T Consensus       281 ~~p~~Rps~~evl~~l~  297 (307)
T cd05098         281 AVPSQRPTFKQLVEDLD  297 (307)
T ss_pred             cChhhCcCHHHHHHHHH
Confidence            99999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=184.37  Aligned_cols=109  Identities=33%  Similarity=0.554  Sum_probs=98.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC------CceeEccccCccccCCCCCCcccccCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE------YEAHVADFGIAKFLKPDSSNWTEFAGTY   77 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~------~~~~l~d~~~~~~~~~~~~~~~~~~~~~   77 (179)
                      .+.++++.++.++.||+.||++||++   +||||||||.|||++..      ..+||+|||+++.+.... ...+..|++
T Consensus       103 ~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~-~a~tlcGSp  178 (429)
T KOG0595|consen  103 RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS-MAETLCGSP  178 (429)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh-HHHHhhCCc
Confidence            45799999999999999999999999   99999999999999765      457999999999888543 345578999


Q ss_pred             CCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCccc
Q 042876           78 GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL  116 (179)
Q Consensus        78 ~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~  116 (179)
                      .|||||++...+|..++|+||+|+++|++++|..||+..
T Consensus       179 lYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  179 LYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             cccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            999999999999999999999999999999999999743

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=3.9e-29  Score=195.72  Aligned_cols=166  Identities=20%  Similarity=0.237  Sum_probs=116.2

Q ss_pred             CHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCcccc
Q 042876            8 DWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPELAY   86 (179)
Q Consensus         8 ~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~   86 (179)
                      ....++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++..+...... .....++..|++||.+.
T Consensus       265 ~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  341 (501)
T PHA03210        265 LLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA  341 (501)
T ss_pred             cHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhc
Confidence            4567788999999999999999   9999999999999999999999999999766433222 22356889999999999


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhCCC-CCcccccccccccchhhhhhhcCCCCCCC----------------CCccHHH--
Q 042876           87 TMKITEKCDVYSFGVLALEVIKGKH-PRDFLSSISSSSLNTDIELDEMLDPRLPA----------------PSRSVQE--  147 (179)
Q Consensus        87 ~~~~~~~~D~~slg~~~~~l~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~--  147 (179)
                      +..++.++|+|||||++|+|++|.. |+........................++.                .......  
T Consensus       342 ~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~  421 (501)
T PHA03210        342 GDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLI  421 (501)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHH
Confidence            8889999999999999999999765 44322111100000000000000000000                0000000  


Q ss_pred             ----HHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          148 ----KLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       148 ----~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                          ...++.+++.+||+.||.+|||+.|+++|
T Consensus       422 ~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        422 RNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                11246778889999999999999999876

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.96  E-value=9.7e-29  Score=180.85  Aligned_cols=162  Identities=24%  Similarity=0.353  Sum_probs=121.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||.
T Consensus       119 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (286)
T cd06638         119 ERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV  195 (286)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhh
Confidence            4678889999999999999999999   9999999999999999999999999998765443323334467889999998


Q ss_pred             ccc-----CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           85 AYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        85 ~~~-----~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +..     ..++.++|+||+|+++|++++|..||.........     ................    ....+.+++.+|
T Consensus       196 ~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~----~~~~~~~li~~~  266 (286)
T cd06638         196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-----FKIPRNPPPTLHQPEL----WSNEFNDFIRKC  266 (286)
T ss_pred             hchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-----hhccccCCCcccCCCC----cCHHHHHHHHHH
Confidence            753     34678999999999999999999998654321100     0000111111111111    122478899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||++|||+.+++++.-
T Consensus       267 l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         267 LTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             ccCCcccCCCHHHHhhccc
Confidence            9999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.96  E-value=3e-29  Score=186.09  Aligned_cols=160  Identities=26%  Similarity=0.402  Sum_probs=120.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++.++..++.|++.||.|||+.   |++|+||+|+||+++.++.++++|||.+.........  .....++..|++|
T Consensus       129 ~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (314)
T cd05099         129 EQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAP  205 (314)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCH
Confidence            4588999999999999999999999   9999999999999999999999999999765432211  1112334579999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||..........     ....  ..........    ..++.+++.+||+
T Consensus       206 E~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-----~~~~--~~~~~~~~~~----~~~l~~li~~cl~  274 (314)
T cd05099         206 EALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK-----LLRE--GHRMDKPSNC----THELYMLMRECWH  274 (314)
T ss_pred             HHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHc--CCCCCCCCCC----CHHHHHHHHHHcC
Confidence            99888888999999999999999998 888886432111000     0000  0011111111    2247789999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+.++++.|+
T Consensus       275 ~~p~~Rps~~~ll~~l~  291 (314)
T cd05099         275 AVPTQRPTFKQLVEALD  291 (314)
T ss_pred             CCcccCcCHHHHHHHHH
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.96  E-value=7.1e-29  Score=182.12  Aligned_cols=161  Identities=26%  Similarity=0.386  Sum_probs=120.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||
T Consensus       122 ~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE  198 (291)
T cd06639         122 GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE  198 (291)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChh
Confidence            35689999999999999999999998   999999999999999999999999999876543332223345678899999


Q ss_pred             ccccC-----CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           84 LAYTM-----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        84 ~~~~~-----~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      .+...     .++.++|+||+|+++|++++|+.||........     ...............    ......+.++|.+
T Consensus       199 ~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~----~~~~~~l~~li~~  269 (291)
T cd06639         199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-----LFKIPRNPPPTLLHP----EKWCRSFNHFISQ  269 (291)
T ss_pred             hhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-----HHHHhcCCCCCCCcc----cccCHHHHHHHHH
Confidence            87543     257899999999999999999999864321110     011111111111111    1223358889999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||+.+|++||++.++++|
T Consensus       270 ~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         270 CLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HhhcChhhCcCHHHHhcC
Confidence            999999999999999876

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.96  E-value=7e-29  Score=181.23  Aligned_cols=161  Identities=23%  Similarity=0.353  Sum_probs=122.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.......  .....++..|++||.+
T Consensus        91 ~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~  165 (279)
T cd06619          91 KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERI  165 (279)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--ccCCCCChhhcCceee
Confidence            467888999999999999999999   99999999999999999999999999987654322  2334678899999999


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC---CCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           86 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML---DPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+..++.++|+||+|+++|++++|..||............ ........   .+..+.. .    ...++.+++.+||+.
T Consensus       166 ~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~----~~~~~~~li~~~l~~  239 (279)
T cd06619         166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP-LQLLQCIVDEDPPVLPVG-Q----FSEKFVHFITQCMRK  239 (279)
T ss_pred             cCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch-HHHHHHHhccCCCCCCCC-c----CCHHHHHHHHHHhhC
Confidence            8888999999999999999999999999654322111111 11111111   1111111 1    122478899999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 042876          163 SPESRPTMKIVSQQL  177 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l  177 (179)
                      ||++||++++++++-
T Consensus       240 ~P~~Rp~~~eil~~~  254 (279)
T cd06619         240 QPKERPAPENLMDHP  254 (279)
T ss_pred             ChhhCCCHHHHhcCc
Confidence            999999999998874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-29  Score=203.55  Aligned_cols=161  Identities=28%  Similarity=0.415  Sum_probs=130.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-ccc-ccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTE-FAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~-~~~~~~~~~   81 (179)
                      ...+++.+.+.++.||+.|+.||+++   ++|||||...|+|++....+||+|||+|+........ ... -..+..|||
T Consensus       796 ~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~  872 (1025)
T KOG1095|consen  796 PSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMP  872 (1025)
T ss_pred             CCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCC
Confidence            45689999999999999999999999   9999999999999999999999999999843322211 111 245688999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+....++.++|+||||+++||+++ |..||....+.....       .-.-..+++++..|...    +.++|..||
T Consensus       873 PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~-------~~~~ggRL~~P~~CP~~----ly~lM~~CW  941 (1025)
T KOG1095|consen  873 PESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL-------DVLEGGRLDPPSYCPEK----LYQLMLQCW  941 (1025)
T ss_pred             HHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH-------HHHhCCccCCCCCCChH----HHHHHHHHc
Confidence            999999899999999999999999998 899997654322211       11223467666666665    789999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.+|++||++..+++.+.
T Consensus       942 ~~~pe~RP~F~~i~~q~~  959 (1025)
T KOG1095|consen  942 KHDPEDRPSFRTIVEQDP  959 (1025)
T ss_pred             cCChhhCccHHHHHhhhh
Confidence            999999999999988653

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=9.3e-29  Score=188.68  Aligned_cols=161  Identities=25%  Similarity=0.385  Sum_probs=122.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      +.+++.+++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++........  ......++..|++|
T Consensus       232 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  308 (400)
T cd05105         232 EGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP  308 (400)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence            4689999999999999999999999   999999999999999999999999999876543221  11223456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||........  ..  .......  ..+....    ....+.+++.+||+
T Consensus       309 E~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~--~~~~~~~--~~~~~~~----~~~~l~~li~~cl~  378 (400)
T cd05105         309 ESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY--NKIKSGY--RMAKPDH----ATQEVYDIMVKCWN  378 (400)
T ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH--HHHhcCC--CCCCCcc----CCHHHHHHHHHHCc
Confidence            99988888999999999999999997 8999865321110  00  0011101  1111111    22348889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++|||+.++.+.|+
T Consensus       379 ~dP~~RPt~~~l~~~l~  395 (400)
T cd05105         379 SEPEKRPSFLHLSDIVE  395 (400)
T ss_pred             cCHhHCcCHHHHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.8e-29  Score=181.09  Aligned_cols=159  Identities=28%  Similarity=0.439  Sum_probs=120.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+......... ......+..|++||
T Consensus        95 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe  171 (256)
T cd05059          95 GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPE  171 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHH
Confidence            3578999999999999999999999   9999999999999999999999999998765432211 11112345799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ...+..++.++|+||||+++|++++ |..||........     ............+.  .    ....+.+++.+||..
T Consensus       172 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~--~----~~~~~~~li~~cl~~  240 (256)
T cd05059         172 VFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-----VESVSAGYRLYRPK--L----APTEVYTIMYSCWHE  240 (256)
T ss_pred             HhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-----HHHHHcCCcCCCCC--C----CCHHHHHHHHHHhcC
Confidence            9988889999999999999999998 8999865432111     01111111111111  1    223488899999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 042876          163 SPESRPTMKIVSQQL  177 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l  177 (179)
                      +|++|||+.++++.|
T Consensus       241 ~p~~Rpt~~~~l~~l  255 (256)
T cd05059         241 KPEDRPAFKKLLSQL  255 (256)
T ss_pred             ChhhCcCHHHHHHHh
Confidence            999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.96  E-value=1e-28  Score=178.01  Aligned_cols=160  Identities=25%  Similarity=0.331  Sum_probs=125.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+..............++..|.+||.
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~  172 (256)
T cd08221          96 QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL  172 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhh
Confidence            4689999999999999999999998   9999999999999999999999999998765443323344567889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|++++++++|..||.....        ............+...   ......+.+++.+||..+|
T Consensus       173 ~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p  241 (256)
T cd08221         173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIVQGNYTPVV---SVYSSELISLVHSLLQQDP  241 (256)
T ss_pred             cCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCCc---cccCHHHHHHHHHHcccCc
Confidence            9888888999999999999999999999864321        1111111112221111   1223347889999999999


Q ss_pred             CCCCCHHHHHHHhh
Q 042876          165 ESRPTMKIVSQQLR  178 (179)
Q Consensus       165 ~~Rps~~~~~~~l~  178 (179)
                      ++||+++++++++.
T Consensus       242 ~~R~s~~~ll~~~~  255 (256)
T cd08221         242 EKRPTADEVLDQPL  255 (256)
T ss_pred             ccCCCHHHHhhCcC
Confidence            99999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.96  E-value=2.3e-28  Score=177.06  Aligned_cols=159  Identities=28%  Similarity=0.438  Sum_probs=122.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|+++||++||+.   +++|+||+|.||+++.++.++++|||.+......... .....++..|++||
T Consensus        97 ~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE  173 (262)
T cd05071          97 KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE  173 (262)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHh
Confidence            3578899999999999999999999   9999999999999999999999999998765433221 12234566799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ...+..++.++|+||||+++|++++ |..||.......        ........ ..+.    .......+.+++.+|++
T Consensus       174 ~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~  241 (262)
T cd05071         174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERGYRMPC----PPECPESLHDLMCQCWR  241 (262)
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--------HHHHHhcCCCCCC----ccccCHHHHHHHHHHcc
Confidence            9888888999999999999999999 888886442111        01111110 1111    12233458899999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++||++.++.+.|+
T Consensus       242 ~~p~~Rp~~~~~~~~l~  258 (262)
T cd05071         242 KEPEERPTFEYLQAFLE  258 (262)
T ss_pred             CCcccCCCHHHHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.96  E-value=2.2e-29  Score=193.18  Aligned_cols=105  Identities=25%  Similarity=0.337  Sum_probs=91.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC--CceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE--YEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      -+.|+...++.++.||+.||.+||+.   +|||+||||+|||+...  ..+||+|||.+.+......   ..+.+.-|+|
T Consensus       283 f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy---tYiQSRfYRA  356 (586)
T KOG0667|consen  283 FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY---TYIQSRFYRA  356 (586)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCCcce---eeeecccccc
Confidence            35689999999999999999999999   99999999999999433  3699999999987654332   4566778999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRD  114 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~  114 (179)
                      ||++.|.+|+.+.|||||||++.||++|..-|.
T Consensus       357 PEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  357 PEVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             chhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            999999999999999999999999999977774

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.96  E-value=2.7e-29  Score=182.60  Aligned_cols=158  Identities=25%  Similarity=0.359  Sum_probs=119.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++....... .......+..|++||.
T Consensus       107 ~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~  182 (270)
T cd05047         107 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIES  182 (270)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCCccccchhh-hccCCCCccccCChHH
Confidence            3578999999999999999999998   99999999999999999999999999985322111 1112233567999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ..+..++.++|+||||++++++++ |..||.......        ........ .......    ...++.+++.+||..
T Consensus       183 ~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~  250 (270)
T cd05047         183 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQGYRLEKPLN----CDDEVYDLMRQCWRE  250 (270)
T ss_pred             HccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--------HHHHHhCCCCCCCCCc----CCHHHHHHHHHHccc
Confidence            888888999999999999999997 999986432111        01111110 1111111    122478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||.+|||+.++++.|+
T Consensus       251 ~p~~Rps~~~il~~l~  266 (270)
T cd05047         251 KPYERPSFAQILVSLN  266 (270)
T ss_pred             ChhhCCCHHHHHHHHH
Confidence            9999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=5.7e-29  Score=180.72  Aligned_cols=161  Identities=25%  Similarity=0.407  Sum_probs=121.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||
T Consensus       107 ~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE  183 (275)
T cd06608         107 GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPE  183 (275)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHh
Confidence            45789999999999999999999999   999999999999999999999999999876543333333456778899999


Q ss_pred             cccc-----CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           84 LAYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        84 ~~~~-----~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      .+..     ..++.++|+||||++++++++|..||.......     ..........+..    .........+.+++.+
T Consensus       184 ~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~~~~~~li~~  254 (275)
T cd06608         184 VIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-----ALFKIPRNPPPTL----KSPENWSKKFNDFISE  254 (275)
T ss_pred             HhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-----HHHHhhccCCCCC----CchhhcCHHHHHHHHH
Confidence            8753     235678999999999999999999996432111     0001111111111    1112233458889999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||..||++|||+.+++++
T Consensus       255 ~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         255 CLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             HhhcChhhCcCHHHHhcC
Confidence            999999999999999876

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=8.1e-29  Score=181.48  Aligned_cols=160  Identities=21%  Similarity=0.358  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .++++.++..++.|++.||++||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||.
T Consensus       110 ~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~  186 (285)
T cd06648         110 TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEV  186 (285)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHH
Confidence            4678899999999999999999999   9999999999999999999999999987654433322333467788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      ..+..++.++|+||+|++++++++|..||.......     ..........+.....    ......+.+++.+||+.+|
T Consensus       187 ~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p  257 (285)
T cd06648         187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-----AMKRIRDNLPPKLKNL----HKVSPRLRSFLDRMLVRDP  257 (285)
T ss_pred             hcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-----HHHHHHhcCCCCCccc----ccCCHHHHHHHHHHcccCh
Confidence            988788899999999999999999999986432110     0011111111111111    1122348889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      ++||++.+++++
T Consensus       258 ~~Rpt~~~il~~  269 (285)
T cd06648         258 AQRATAAELLNH  269 (285)
T ss_pred             hhCcCHHHHccC
Confidence            999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.96  E-value=5.3e-29  Score=180.59  Aligned_cols=162  Identities=25%  Similarity=0.342  Sum_probs=119.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+..............++..|+|||.
T Consensus       101 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  177 (267)
T cd06645         101 GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV  177 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhh
Confidence            4688999999999999999999999   9999999999999999999999999998765433322334567889999998


Q ss_pred             cc---cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           85 AY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        85 ~~---~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      +.   ...++.++|+||+|+++|++++|..||..........   .........+......    .....+.+++.+||.
T Consensus       178 ~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~  250 (267)
T cd06645         178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTKSNFQPPKLKDKM----KWSNSFHHFVKMALT  250 (267)
T ss_pred             hccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH---hhhccCCCCCcccccC----CCCHHHHHHHHHHcc
Confidence            74   3457789999999999999999999985432111000   0000001111111100    112247789999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .+|++||+++++++|
T Consensus       251 ~~P~~R~~~~~ll~~  265 (267)
T cd06645         251 KNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCchhCcCHHHHhcC
Confidence            999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.96  E-value=1.6e-28  Score=184.28  Aligned_cols=161  Identities=25%  Similarity=0.390  Sum_probs=121.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++..+..++.|+++||+|||+.   +++|+||+|.||+++.++.++++|||++........  ......++..|++|
T Consensus       174 ~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  250 (343)
T cd05103         174 KVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  250 (343)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECc
Confidence            3578999999999999999999999   999999999999999999999999999876532221  11122345679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||........    ........  ...+.+...    ..++.+++..||+
T Consensus       251 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~~~~--~~~~~~~~~----~~~~~~~~~~cl~  320 (343)
T cd05103         251 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLKEG--TRMRAPDYT----TPEMYQTMLDCWH  320 (343)
T ss_pred             HHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH----HHHHHhcc--CCCCCCCCC----CHHHHHHHHHHcc
Confidence            99888888999999999999999997 8989865321110    00011111  111111111    1247889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+.+++++|+
T Consensus       321 ~~p~~Rps~~eil~~l~  337 (343)
T cd05103         321 GEPSQRPTFSELVEHLG  337 (343)
T ss_pred             CChhhCcCHHHHHHHHH
Confidence            99999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.96  E-value=2.1e-29  Score=190.79  Aligned_cols=158  Identities=22%  Similarity=0.296  Sum_probs=120.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++........ ......+++.|+|||
T Consensus       137 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE  213 (370)
T cd05596         137 YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE  213 (370)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHH
Confidence            3578889999999999999999999   999999999999999999999999999876543221 123456889999999


Q ss_pred             ccccC----CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCC----CCCCCCCccHHHHHHHHHHH
Q 042876           84 LAYTM----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD----PRLPAPSRSVQEKLISIVKV  155 (179)
Q Consensus        84 ~~~~~----~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l  155 (179)
                      .+.+.    .++.++|+|||||++|+|++|..||.......        ....+..    ..++..    ......+.++
T Consensus       214 ~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~----~~~s~~~~~l  281 (370)
T cd05596         214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMDHKNSLTFPDD----IEISKQAKDL  281 (370)
T ss_pred             HhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH--------HHHHHHcCCCcCCCCCc----CCCCHHHHHH
Confidence            88653    36789999999999999999999997543211        1111111    111111    1123347889


Q ss_pred             HhcccCcCCCC--CCCHHHHHHHh
Q 042876          156 AFSCLNESPES--RPTMKIVSQQL  177 (179)
Q Consensus       156 i~~cl~~~p~~--Rps~~~~~~~l  177 (179)
                      +.+|++.+|.+  |++++++++|-
T Consensus       282 i~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         282 ICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             HHHHccChhhccCCCCHHHHhcCc
Confidence            99999999987  99999998873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.96  E-value=4.9e-29  Score=181.80  Aligned_cols=159  Identities=26%  Similarity=0.407  Sum_probs=122.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .++++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.+++.|||++..............++..|++||.
T Consensus        96 ~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  172 (277)
T cd06642          96 GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV  172 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHH
Confidence            4688999999999999999999999   9999999999999999999999999998765543322233456788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|++++++++|..|+..........        .......+...   ......+.+++.+||+.+|
T Consensus       173 ~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p  241 (277)
T cd06642         173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--------LIPKNSPPTLE---GQYSKPFKEFVEACLNKDP  241 (277)
T ss_pred             hCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh--------hhhcCCCCCCC---cccCHHHHHHHHHHccCCc
Confidence            988888999999999999999999999986433211100        00001111110   1123347889999999999


Q ss_pred             CCCCCHHHHHHHh
Q 042876          165 ESRPTMKIVSQQL  177 (179)
Q Consensus       165 ~~Rps~~~~~~~l  177 (179)
                      ++||++.+++++-
T Consensus       242 ~~Rp~~~~il~~~  254 (277)
T cd06642         242 RFRPTAKELLKHK  254 (277)
T ss_pred             ccCcCHHHHHHhH
Confidence            9999999999863

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.96  E-value=6.3e-29  Score=183.47  Aligned_cols=159  Identities=24%  Similarity=0.374  Sum_probs=121.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe   83 (179)
                      .+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++........  ......++..|++||
T Consensus       137 ~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  213 (302)
T cd05055         137 FLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE  213 (302)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHh
Confidence            379999999999999999999999   999999999999999999999999999876543221  112234567899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCC-CCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPA-PSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~  161 (179)
                      .+.+..++.++|+||+|+++|++++ |..||.......        ............ ....   ....+.+++.+||+
T Consensus       214 ~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~~~~li~~cl~  282 (302)
T cd05055         214 SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------KFYKLIKEGYRMAQPEH---APAEIYDIMKTCWD  282 (302)
T ss_pred             hhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--------HHHHHHHcCCcCCCCCC---CCHHHHHHHHHHcC
Confidence            9888888999999999999999998 999986543211        011111111110 0011   12247889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|++|||+.++++.|+
T Consensus       283 ~~p~~Rpt~~ell~~l~  299 (302)
T cd05055         283 ADPLKRPTFKQIVQLIG  299 (302)
T ss_pred             CCchhCcCHHHHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.96  E-value=5.5e-29  Score=183.61  Aligned_cols=170  Identities=16%  Similarity=0.199  Sum_probs=121.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||
T Consensus        98 ~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE  174 (301)
T cd07873          98 GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPD  174 (301)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcH
Confidence            34688999999999999999999999   999999999999999999999999999876543333333345678899999


Q ss_pred             ccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccc------------cccchhh-hhhhcCCCCCCCCC-----cc
Q 042876           84 LAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------------SSLNTDI-ELDEMLDPRLPAPS-----RS  144 (179)
Q Consensus        84 ~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~------------~~~~~~~-~~~~~~~~~~~~~~-----~~  144 (179)
                      .+.+. .++.++|+||||+++|+|++|+.||........            ...+... ..........+...     ..
T Consensus       175 ~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (301)
T cd07873         175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNH  254 (301)
T ss_pred             HHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhh
Confidence            87653 477899999999999999999999965432100            0000000 00000000001000     00


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.++|.+|++.||.+|||++++++|
T Consensus       255 ~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         255 APRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            01123347889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3e-29  Score=183.79  Aligned_cols=160  Identities=23%  Similarity=0.269  Sum_probs=122.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++....... ......++..|++||.
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  172 (285)
T cd05605          97 PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRVGTVGYMAPEV  172 (285)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-ccccccCCCCccCcHH
Confidence            4689999999999999999999999   99999999999999999999999999987654322 1223467889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|+++|++++|..||.......     ........+.......   .......+.+++.+||+.||
T Consensus       173 ~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P  244 (285)
T cd05605         173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERRVKEDQEEY---SEKFSEAARSICRQLLTKDP  244 (285)
T ss_pred             hcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHHhhhccccc---CcccCHHHHHHHHHHccCCH
Confidence            988888999999999999999999999997543211     0011111111111111   11123347889999999999


Q ss_pred             CCCC-----CHHHHHHH
Q 042876          165 ESRP-----TMKIVSQQ  176 (179)
Q Consensus       165 ~~Rp-----s~~~~~~~  176 (179)
                      .+||     +++++++|
T Consensus       245 ~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         245 GFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             HHhcCCCCCCHHHHhcC
Confidence            9999     89899876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=5.1e-29  Score=182.55  Aligned_cols=161  Identities=28%  Similarity=0.351  Sum_probs=121.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..+..++.|++.||+|||+..  +++|+||+|+||+++.++.++++|||++........ .....++..|++||
T Consensus       101 ~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE  177 (288)
T cd06616         101 KSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-KTRDAGCRPYMAPE  177 (288)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-cccccCccCccCHH
Confidence            356899999999999999999999742  899999999999999999999999999876543221 12235677899999


Q ss_pred             ccccC---CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCC---CCCCCCCccHHHHHHHHHHHHh
Q 042876           84 LAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD---PRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        84 ~~~~~---~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      .+.+.   .++.++|+||+|+++|++++|..||.....       ..........   +..+..  ........+.+++.
T Consensus       178 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~  248 (288)
T cd06616         178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVKGDPPILSNS--EEREFSPSFVNFIN  248 (288)
T ss_pred             HhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcCCCCCcCCCc--CCCccCHHHHHHHH
Confidence            98765   578899999999999999999999865431       1111111111   111111  11123345889999


Q ss_pred             cccCcCCCCCCCHHHHHHH
Q 042876          158 SCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~  176 (179)
                      +||+.||++|||+++++++
T Consensus       249 ~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         249 LCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             HHccCChhhCcCHHHHhcC
Confidence            9999999999999999876

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-29  Score=186.93  Aligned_cols=160  Identities=28%  Similarity=0.339  Sum_probs=132.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC----CceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE----YEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      +++..+..+++|++++++|||+.   |++|||+||+|+++...    +.++++|||++..... ........|++.|+||
T Consensus       132 ~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~AP  207 (382)
T KOG0032|consen  132 YSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAP  207 (382)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCc
Confidence            89999999999999999999998   99999999999999533    4799999999988877 4456678999999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |.+.+..++..+|+||+|+++|.|++|..||.......        ....+....+.-....+........++++.++..
T Consensus       208 Evl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--------~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~  279 (382)
T KOG0032|consen  208 EVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--------IFLAILRGDFDFTSEPWDDISESAKDFIRKLLEF  279 (382)
T ss_pred             hhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--------HHHHHHcCCCCCCCCCccccCHHHHHHHHHhccc
Confidence            99998999999999999999999999999997654222        1113333333333445555566788899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||.+|+|+.++++|-+
T Consensus       280 dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  280 DPRKRLTAAQALQHPW  295 (382)
T ss_pred             CcccCCCHHHHhcCcc
Confidence            9999999999999854

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=3.5e-29  Score=180.86  Aligned_cols=159  Identities=26%  Similarity=0.343  Sum_probs=124.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLH-----HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG   78 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh-----~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~   78 (179)
                      ..++++..++.++.|++.||.+||     +.   +++|+||+|+||+++.++.++++|||++..............+...
T Consensus        99 ~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~  175 (265)
T cd08217          99 RKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY  175 (265)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCC
Confidence            457899999999999999999999     76   9999999999999999999999999998876544332334567888


Q ss_pred             CCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           79 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        79 ~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      |++||.+.+..++.++|+||||++++++++|..||.......        ..........+....   .....+.+++.+
T Consensus       176 ~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~---~~~~~~~~l~~~  244 (265)
T cd08217         176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--------LASKIKEGKFRRIPY---RYSSELNEVIKS  244 (265)
T ss_pred             ccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--------HHHHHhcCCCCCCcc---ccCHHHHHHHHH
Confidence            999999988888899999999999999999999987543111        111111111111111   122357889999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      |++.+|++||++.+++++
T Consensus       245 ~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         245 MLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HccCCcccCCCHHHHhhC
Confidence            999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.96  E-value=3.9e-29  Score=183.26  Aligned_cols=160  Identities=21%  Similarity=0.361  Sum_probs=121.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|.||+++.++.++++|||.+........  .......+..|++|
T Consensus       125 ~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (288)
T cd05050         125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP  201 (288)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCH
Confidence            3578889999999999999999999   999999999999999999999999999875432221  11223345679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |...+..++.++|+||||+++|++++ |..||......        ................   .....+.+++.+||+
T Consensus       202 E~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~--------~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~  270 (288)
T cd05050         202 ESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--------EVIYYVRDGNVLSCPD---NCPLELYNLMRLCWS  270 (288)
T ss_pred             HHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHhcCCCCCCCC---CCCHHHHHHHHHHcc
Confidence            99888889999999999999999997 88887543211        1111111111111001   112348889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|.+|||+.|+++.|+
T Consensus       271 ~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         271 KLPSDRPSFASINRILQ  287 (288)
T ss_pred             cCcccCCCHHHHHHHhh
Confidence            99999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.96  E-value=2.2e-28  Score=180.58  Aligned_cols=159  Identities=27%  Similarity=0.420  Sum_probs=120.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe   83 (179)
                      .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........  .....++..|++||
T Consensus       105 ~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE  181 (303)
T cd05110         105 NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE  181 (303)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHH
Confidence            578899999999999999999999   9999999999999999999999999999765432221  11223456899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||+++|++++ |..||........      ..... .....+.....    ..++.+++.+||..
T Consensus       182 ~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~------~~~~~-~~~~~~~~~~~----~~~~~~li~~c~~~  250 (303)
T cd05110         182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI------PDLLE-KGERLPQPPIC----TIDVYMVMVKCWMI  250 (303)
T ss_pred             HhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHH-CCCCCCCCCCC----CHHHHHHHHHHcCC
Confidence            9988888999999999999999997 8889864321110      00000 11111111111    23478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      +|++||+++++++.|+
T Consensus       251 ~p~~Rp~~~~l~~~l~  266 (303)
T cd05110         251 DADSRPKFKELAAEFS  266 (303)
T ss_pred             ChhhCcCHHHHHHHHH
Confidence            9999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.96  E-value=5.7e-29  Score=180.55  Aligned_cols=159  Identities=27%  Similarity=0.411  Sum_probs=120.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-----ceeEccccCccccCCCCC--CcccccCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-----EAHVADFGIAKFLKPDSS--NWTEFAGTY   77 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-----~~~l~d~~~~~~~~~~~~--~~~~~~~~~   77 (179)
                      ..+++.+++.++.|++.||+|||+.   +++|+||+|+||+++.++     .++++|||++........  .......+.
T Consensus       101 ~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  177 (269)
T cd05044         101 PLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV  177 (269)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCc
Confidence            3478899999999999999999998   999999999999998877     899999999865532211  112234457


Q ss_pred             CCCCCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcC-CCCCCCCCccHHHHHHHHHHH
Q 042876           78 GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEML-DPRLPAPSRSVQEKLISIVKV  155 (179)
Q Consensus        78 ~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l  155 (179)
                      .|++||.+.+..++.++|+||||+++|++++ |..||........        ..... ........    .....+.++
T Consensus       178 ~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~----~~~~~~~~l  245 (269)
T cd05044         178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV--------LQHVTAGGRLQKPE----NCPDKIYQL  245 (269)
T ss_pred             cccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH--------HHHHhcCCccCCcc----cchHHHHHH
Confidence            8999999988889999999999999999998 9999864432111        00000 01111111    123357889


Q ss_pred             HhcccCcCCCCCCCHHHHHHHhh
Q 042876          156 AFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       156 i~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +.+||..+|.+||+++++++.|+
T Consensus       246 i~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         246 MTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHHHcCCCcccCCCHHHHHHHHh
Confidence            99999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.96  E-value=7.8e-29  Score=182.56  Aligned_cols=160  Identities=24%  Similarity=0.402  Sum_probs=121.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+..............+++.|++||.
T Consensus       110 ~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  186 (297)
T cd06656         110 TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV  186 (297)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHH
Confidence            4578889999999999999999999   9999999999999999999999999998765443322333467788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|+++|++++|..||.............     ....+....    .......+.+++.+||..||
T Consensus       187 ~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~-----~~~~~~~~~----~~~~~~~~~~li~~~l~~~p  257 (297)
T cd06656         187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-----TNGTPELQN----PERLSAVFRDFLNRCLEMDV  257 (297)
T ss_pred             HcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-----cCCCCCCCC----ccccCHHHHHHHHHHccCCh
Confidence            988888999999999999999999999996543211100000     000001111    11122347788999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      ++||++++++++
T Consensus       258 ~~Rps~~~il~~  269 (297)
T cd06656         258 DRRGSAKELLQH  269 (297)
T ss_pred             hhCcCHHHHhcC
Confidence            999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=7.6e-29  Score=179.96  Aligned_cols=161  Identities=29%  Similarity=0.443  Sum_probs=123.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.+||+..  +++|+||+|.||+++.++.++++|||.+....... ......++..|++||
T Consensus       107 ~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe  183 (269)
T cd08528         107 KQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPE  183 (269)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecccceeeccccc-ccccccCcccCcChh
Confidence            346888999999999999999999631  89999999999999999999999999987655433 233456788899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCC-CCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL-PAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ...+..++.++|+||||+++|++++|..||.......        .......... +.....   ....+.+++.+||+.
T Consensus       184 ~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~  252 (269)
T cd08528         184 IVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--------LATKIVEAVYEPLPEGM---YSEDVTDVITSCLTP  252 (269)
T ss_pred             hhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--------HHHHHhhccCCcCCccc---CCHHHHHHHHHHCCC
Confidence            9988888999999999999999999999985432111        1111111111 111111   122478889999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||++||++.|+.++++
T Consensus       253 ~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         253 DAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCccCCCHHHHHHHhc
Confidence            9999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-28  Score=179.70  Aligned_cols=160  Identities=28%  Similarity=0.427  Sum_probs=120.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||.
T Consensus        98 ~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~  174 (280)
T cd06611          98 RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV  174 (280)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHH
Confidence            5689999999999999999999999   9999999999999999999999999988665443333334467788999998


Q ss_pred             cc-----cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           85 AY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        85 ~~-----~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +.     +..++.++|+||+|+++|++++|..||.......     ..........+......    .....+.+++.+|
T Consensus       175 ~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~  245 (280)
T cd06611         175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-----VLLKILKSEPPTLDQPS----KWSSSFNDFLKSC  245 (280)
T ss_pred             HhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-----HHHHHhcCCCCCcCCcc----cCCHHHHHHHHHH
Confidence            75     2346778999999999999999999986542211     01111111111111111    1223478899999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 042876          160 LNESPESRPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~  176 (179)
                      |+.+|.+||++.+++++
T Consensus       246 l~~~p~~Rps~~~il~~  262 (280)
T cd06611         246 LVKDPDDRPTAAELLKH  262 (280)
T ss_pred             hccChhhCcCHHHHhcC
Confidence            99999999999999886

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.96  E-value=1.1e-29  Score=189.60  Aligned_cols=159  Identities=23%  Similarity=0.280  Sum_probs=119.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++......... .....+++.|+|||
T Consensus        97 ~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE  173 (330)
T cd05601          97 DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE  173 (330)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHH
Confidence            4689999999999999999999999   9999999999999999999999999999766543322 22346788999999


Q ss_pred             ccc------cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC-CCCCCCCCccHHHHHHHHHHHH
Q 042876           84 LAY------TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML-DPRLPAPSRSVQEKLISIVKVA  156 (179)
Q Consensus        84 ~~~------~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li  156 (179)
                      .+.      +..++.++|+||||+++|+|++|..||........     ........ ....+....    ....+.+++
T Consensus       174 ~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~~i~~~~~~~~~~~~~~----~~~~~~~li  244 (330)
T cd05601         174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-----YNNIMNFQRFLKFPEDPK----VSSDFLDLI  244 (330)
T ss_pred             HhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-----HHHHHcCCCccCCCCCCC----CCHHHHHHH
Confidence            886      34567899999999999999999999965432110     00000000 001111111    123477888


Q ss_pred             hcccCcCCCCCCCHHHHHHH
Q 042876          157 FSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       157 ~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ..|+. +|.+||++.++++|
T Consensus       245 ~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         245 QSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HHHcc-ChhhCCCHHHHhCC
Confidence            89997 99999999999876

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.96  E-value=2.1e-28  Score=178.46  Aligned_cols=158  Identities=28%  Similarity=0.432  Sum_probs=123.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .++++..+..++.|++.||++||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||.
T Consensus        96 ~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~  172 (277)
T cd06640          96 GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV  172 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhH
Confidence            4578889999999999999999999   9999999999999999999999999998765443322233456778999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|++++|..||.........         .......++  .........+.+++.+||+.+|
T Consensus       173 ~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---------~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p  241 (277)
T cd06640         173 IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPP--TLTGEFSKPFKEFIDACLNKDP  241 (277)
T ss_pred             hccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh---------hhhhcCCCC--CCchhhhHHHHHHHHHHcccCc
Confidence            98888899999999999999999999998654321110         011111111  1122334568899999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+||++.+++++
T Consensus       242 ~~Rp~~~~il~~  253 (277)
T cd06640         242 SFRPTAKELLKH  253 (277)
T ss_pred             ccCcCHHHHHhC
Confidence            999999999887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.96  E-value=3.8e-28  Score=176.41  Aligned_cols=160  Identities=24%  Similarity=0.397  Sum_probs=121.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCc-ccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW-TEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.......... .....+..|++||
T Consensus       102 ~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE  178 (270)
T cd05056         102 YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE  178 (270)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChh
Confidence            3589999999999999999999998   99999999999999999999999999987654332111 1223346799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||++++++++ |..||.........     .....  ..+.+.....    ...+.+++.+|+..
T Consensus       179 ~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-----~~~~~--~~~~~~~~~~----~~~~~~li~~~l~~  247 (270)
T cd05056         179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-----GRIEN--GERLPMPPNC----PPTLYSLMTKCWAY  247 (270)
T ss_pred             hhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-----HHHHc--CCcCCCCCCC----CHHHHHHHHHHcCC
Confidence            9888888999999999999999986 99998654321110     00100  1111111122    23478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      +|.+|||+.++++.|+
T Consensus       248 ~P~~Rpt~~~~~~~l~  263 (270)
T cd05056         248 DPSKRPRFTELKAQLS  263 (270)
T ss_pred             ChhhCcCHHHHHHHHH
Confidence            9999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.96  E-value=5.8e-29  Score=186.01  Aligned_cols=159  Identities=25%  Similarity=0.411  Sum_probs=120.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.........  .....++..|++|
T Consensus       129 ~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (334)
T cd05100         129 EQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP  205 (334)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCH
Confidence            4578899999999999999999999   9999999999999999999999999998765432211  1112334579999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCC-CCCCCCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLD-PRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |.+.+..++.++|+||||+++|++++ |..||.......        ....... .........    ...+.+++.+||
T Consensus       206 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~----~~~l~~li~~cl  273 (334)
T cd05100         206 EALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--------LFKLLKEGHRMDKPANC----THELYMIMRECW  273 (334)
T ss_pred             HHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCCCCCCC----CHHHHHHHHHHc
Confidence            99988888999999999999999998 888886432111        0001101 111111111    224788999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.+|.+|||+.++++.|+
T Consensus       274 ~~~p~~Rps~~ell~~l~  291 (334)
T cd05100         274 HAVPSQRPTFKQLVEDLD  291 (334)
T ss_pred             ccChhhCcCHHHHHHHHH
Confidence            999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=6.3e-29  Score=179.86  Aligned_cols=162  Identities=23%  Similarity=0.366  Sum_probs=122.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..+++..+..++.|+++||+|||+ .   +++|+||+|+||+++.++.++++|||.+........  ....++..|++||
T Consensus        95 ~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~y~~PE  169 (265)
T cd06605          95 GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KTFVGTSSYMAPE  169 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--hcccCChhccCHH
Confidence            578899999999999999999999 7   999999999999999999999999998865532221  1156677899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+|++++++++|..||............   ..........+.....  .....+.++|.+||..|
T Consensus       170 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~  244 (265)
T cd06605         170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE---LLQYIVNEPPPRLPSG--KFSPDFQDFVNLCLIKD  244 (265)
T ss_pred             HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH---HHHHHhcCCCCCCChh--hcCHHHHHHHHHHcCCC
Confidence            998888899999999999999999999998654321111111   1111111111111111  13334788999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |++|||+.+++.+
T Consensus       245 p~~Rpt~~~ll~~  257 (265)
T cd06605         245 PRERPSYKELLEH  257 (265)
T ss_pred             chhCcCHHHHhhC
Confidence            9999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.96  E-value=9.6e-29  Score=177.58  Aligned_cols=161  Identities=22%  Similarity=0.325  Sum_probs=121.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||.|+|+.   +++|+||+|+||+++.++.++++|||++......... ......+..|++||
T Consensus        88 ~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE  164 (250)
T cd05085          88 DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE  164 (250)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHH
Confidence            3578999999999999999999999   9999999999999999999999999998654322111 11123356799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||+++|++++ |..||.......     .............+  ..    ...++.+++.+||..
T Consensus       165 ~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~--~~----~~~~~~~li~~~l~~  233 (250)
T cd05085         165 ALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----AREQVEKGYRMSCP--QK----CPDDVYKVMQRCWDY  233 (250)
T ss_pred             HhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHHcCCCCCCC--CC----CCHHHHHHHHHHccc
Confidence            9988888999999999999999998 899986442211     00111111111111  11    223588899999999


Q ss_pred             CCCCCCCHHHHHHHhhC
Q 042876          163 SPESRPTMKIVSQQLRI  179 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~~  179 (179)
                      +|++||++.++.+.|..
T Consensus       234 ~p~~Rp~~~~l~~~l~~  250 (250)
T cd05085         234 KPENRPKFSELQKELAA  250 (250)
T ss_pred             CcccCCCHHHHHHHhcC
Confidence            99999999999998863

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=9.3e-29  Score=178.29  Aligned_cols=156  Identities=29%  Similarity=0.440  Sum_probs=120.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+........   ....+..|++||.+
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~ape~~  171 (256)
T cd05039          98 VITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEAL  171 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---cCCCcccccCchhh
Confidence            689999999999999999999999   999999999999999999999999999876633221   23345679999998


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           86 YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      .+..++.++|+||||++++++++ |..||........     ........  +......    ....+.+++.+||..+|
T Consensus       172 ~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~~~~~~--~~~~~~~----~~~~~~~li~~~l~~~p  240 (256)
T cd05039         172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPHVEKGY--RMEAPEG----CPPEVYKVMKDCWELDP  240 (256)
T ss_pred             cCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH-----HHHHhcCC--CCCCccC----CCHHHHHHHHHHhccCh
Confidence            88788899999999999999997 9999864421110     00001100  1111111    12347889999999999


Q ss_pred             CCCCCHHHHHHHhh
Q 042876          165 ESRPTMKIVSQQLR  178 (179)
Q Consensus       165 ~~Rps~~~~~~~l~  178 (179)
                      .+|||++++++.|+
T Consensus       241 ~~Rp~~~~l~~~l~  254 (256)
T cd05039         241 AKRPTFKQLREQLA  254 (256)
T ss_pred             hhCcCHHHHHHHHh
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.96  E-value=4.7e-28  Score=175.70  Aligned_cols=159  Identities=28%  Similarity=0.456  Sum_probs=121.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCc---ccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW---TEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~~   81 (179)
                      ..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..........   .....+..|++
T Consensus       102 ~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~  178 (268)
T cd05063         102 GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA  178 (268)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecC
Confidence            4688999999999999999999999   99999999999999999999999999987654322211   11123456999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCC-CCCCCCCccHHHHHHHHHHHHhcc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLD-PRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      ||.+.+..++.++|+||||+++|++++ |..||......        .....+.. ...+....    ....+.+++.+|
T Consensus       179 PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i~~~~~~~~~~~----~~~~~~~li~~c  246 (268)
T cd05063         179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAINDGFRLPAPMD----CPSAVYQLMLQC  246 (268)
T ss_pred             HHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhcCCCCCCCCC----CCHHHHHHHHHH
Confidence            999888888999999999999999997 99998643211        01111111 11222222    233478999999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.+|++||++.++++.|+
T Consensus       247 ~~~~p~~Rp~~~~i~~~l~  265 (268)
T cd05063         247 WQQDRARRPRFVDIVNLLD  265 (268)
T ss_pred             cCCCcccCcCHHHHHHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=2.7e-28  Score=182.36  Aligned_cols=107  Identities=25%  Similarity=0.392  Sum_probs=92.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+..  +++|+||||+||+++.++.++++|||++.......  .....++..|++||.
T Consensus        98 ~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~  173 (333)
T cd06650          98 GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPER  173 (333)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--cccCCCCccccCHHH
Confidence            45788899999999999999999742  79999999999999999999999999986553221  223467889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcc
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDF  115 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~  115 (179)
                      +.+..++.++|+|||||++|++++|..||..
T Consensus       174 ~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9888889999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.96  E-value=3.3e-28  Score=174.90  Aligned_cols=160  Identities=23%  Similarity=0.360  Sum_probs=120.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.+++.||.|||++   +++|+||+|+||+++.++.++++|||.+.........  ......+..|++|
T Consensus        88 ~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~P  164 (251)
T cd05041          88 NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAP  164 (251)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCCh
Confidence            4578889999999999999999999   9999999999999999999999999998754421111  1112335679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||++++++++ |..||........     .......  ...+...    .....+.+++.+||.
T Consensus       165 E~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-----~~~~~~~--~~~~~~~----~~~~~~~~li~~~l~  233 (251)
T cd05041         165 EALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-----RERIESG--YRMPAPQ----LCPEEIYRLMLQCWA  233 (251)
T ss_pred             HhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-----HHHHhcC--CCCCCCc----cCCHHHHHHHHHHhc
Confidence            99888888999999999999999998 8888855432110     0011110  0111111    122358889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|.+|||+.++++.|+
T Consensus       234 ~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         234 YDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cChhhCcCHHHHHHHhh
Confidence            99999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=8.1e-29  Score=181.47  Aligned_cols=160  Identities=22%  Similarity=0.247  Sum_probs=120.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||+|.||+++.++.++++|||++....... ......++..|++||.
T Consensus        97 ~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g~~~~~aPE~  172 (285)
T cd05632          97 PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRVGTVGYMAPEV  172 (285)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-cccCCCCCcCccChHH
Confidence            4689999999999999999999999   99999999999999999999999999986543222 2233467899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|+++|++++|..||.........     ......+.......   .......+.+++.+||+.||
T Consensus       173 ~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P  244 (285)
T cd05632         173 LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-----EEVDRRVLETEEVY---SAKFSEEAKSICKMLLTKDP  244 (285)
T ss_pred             hcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHHhhhcccccc---CccCCHHHHHHHHHHccCCH
Confidence            98888999999999999999999999999754321100     01111110000000   01112247788999999999


Q ss_pred             CCCCC-----HHHHHHH
Q 042876          165 ESRPT-----MKIVSQQ  176 (179)
Q Consensus       165 ~~Rps-----~~~~~~~  176 (179)
                      .+||+     +.+++.+
T Consensus       245 ~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         245 KQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             hHcCCCcccChHHHHcC
Confidence            99999     7788765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.96  E-value=1.6e-28  Score=179.29  Aligned_cols=169  Identities=21%  Similarity=0.204  Sum_probs=124.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+..............+...|++||.
T Consensus        93 ~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~  169 (283)
T cd05118          93 RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL  169 (283)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHH
Confidence            4789999999999999999999999   9999999999999999999999999998766544322333456778999999


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-------hhhhhh-----------cCCCCCCCCCccH
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-------DIELDE-----------MLDPRLPAPSRSV  145 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-------~~~~~~-----------~~~~~~~~~~~~~  145 (179)
                      +.+. .++.++|+||+|++++++++|+.||...+.........       ......           .............
T Consensus       170 ~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (283)
T cd05118         170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLF  249 (283)
T ss_pred             HhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhh
Confidence            8776 67889999999999999999999986543211000000       000000           0000000111112


Q ss_pred             HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ......+.++|.+||+.||.+||++++++.+
T Consensus       250 ~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         250 PNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            2344568899999999999999999999876

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=6.2e-29  Score=180.16  Aligned_cols=158  Identities=25%  Similarity=0.440  Sum_probs=121.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC------CcccccCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS------NWTEFAGTYG   78 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~   78 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+........      ......++..
T Consensus       101 ~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (267)
T cd06628         101 GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF  177 (267)
T ss_pred             cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcC
Confidence            4678889999999999999999998   999999999999999999999999999876542211      1112346778


Q ss_pred             CCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           79 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        79 ~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      |++||.+.+..++.++|+||+|++++++++|..||.......     ..........+..+.      .....+.+++.+
T Consensus       178 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~------~~~~~~~~li~~  246 (267)
T cd06628         178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-----AIFKIGENASPEIPS------NISSEAIDFLEK  246 (267)
T ss_pred             ccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-----HHHHHhccCCCcCCc------ccCHHHHHHHHH
Confidence            999999988888889999999999999999999997543211     111111111111111      122347888999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||+.||.+||++.+++++
T Consensus       247 ~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         247 TFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             HccCCchhCcCHHHHhhC
Confidence            999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=1.9e-28  Score=176.78  Aligned_cols=153  Identities=25%  Similarity=0.393  Sum_probs=117.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-------ceeEccccCccccCCCCCCcccccCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-------EAHVADFGIAKFLKPDSSNWTEFAGTYG   78 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~   78 (179)
                      .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++       .++++|||++......    ....+...
T Consensus        97 ~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~  169 (259)
T cd05037          97 NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR----EERVERIP  169 (259)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcccccccc----cccccCCC
Confidence            578999999999999999999998   999999999999998877       7999999998765431    22345677


Q ss_pred             CCCCcccccC--CCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHH
Q 042876           79 YVAPELAYTM--KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKV  155 (179)
Q Consensus        79 ~~~pe~~~~~--~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  155 (179)
                      |++||.+.+.  .++.++|+||+|+++|++++ |..||..........     ...  .....+....      ..+.++
T Consensus       170 y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-----~~~--~~~~~~~~~~------~~~~~l  236 (259)
T cd05037         170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-----FYQ--DQHRLPMPDC------AELANL  236 (259)
T ss_pred             ccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-----HHh--cCCCCCCCCc------hHHHHH
Confidence            9999998776  67889999999999999999 577775542111000     000  0111111111      358889


Q ss_pred             HhcccCcCCCCCCCHHHHHHHhh
Q 042876          156 AFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       156 i~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +.+||..+|.+|||+.++++.|.
T Consensus       237 i~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         237 INQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHHhccChhhCCCHHHHHHhcC
Confidence            99999999999999999998773

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.96  E-value=5.1e-28  Score=174.30  Aligned_cols=157  Identities=27%  Similarity=0.412  Sum_probs=120.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+.......   .....+..|++||.
T Consensus        95 ~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~y~~pe~  168 (254)
T cd05083          95 ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---DNSKLPVKWTAPEA  168 (254)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---CCCCCCceecCHHH
Confidence            3578999999999999999999998   99999999999999999999999999986543221   12234567999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +.+..++.++|+||||++++++++ |..||........   .  .......  +.....    .....+.+++.+||+.+
T Consensus       169 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~--~~~~~~~--~~~~~~----~~~~~~~~li~~~l~~~  237 (254)
T cd05083         169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---K--ECVEKGY--RMEPPE----GCPADVYVLMTSCWETE  237 (254)
T ss_pred             hccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---H--HHHhCCC--CCCCCC----cCCHHHHHHHHHHcCCC
Confidence            888888999999999999999997 8999865432110   0  0011101  111111    12234788999999999


Q ss_pred             CCCCCCHHHHHHHhh
Q 042876          164 PESRPTMKIVSQQLR  178 (179)
Q Consensus       164 p~~Rps~~~~~~~l~  178 (179)
                      |++||++.++++.|+
T Consensus       238 p~~Rp~~~~l~~~l~  252 (254)
T cd05083         238 PKKRPSFHKLREKLE  252 (254)
T ss_pred             hhhCcCHHHHHHHHc
Confidence            999999999999886

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=3.6e-28  Score=177.84  Aligned_cols=167  Identities=21%  Similarity=0.366  Sum_probs=120.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.........   .....++..|++
T Consensus       104 ~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  180 (284)
T cd05079         104 NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA  180 (284)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccC
Confidence            3578999999999999999999999   9999999999999999999999999998765433211   123445667999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccc-------cccccchhhhhhhcC-CCCCCCCCccHHHHHHHHH
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSI-------SSSSLNTDIELDEML-DPRLPAPSRSVQEKLISIV  153 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  153 (179)
                      ||.+.+..++.++|+||||+++++++++..|.......       ............... ....+....    ....+.
T Consensus       181 pE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  256 (284)
T cd05079         181 PECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPN----CPEEVY  256 (284)
T ss_pred             HHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCC----CCHHHH
Confidence            99988888899999999999999999976654221100       000000000000011 111111111    223588


Q ss_pred             HHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          154 KVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       154 ~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +++.+||+.||.+|||+.++++.|+
T Consensus       257 ~li~~~l~~~p~~Rpt~~~il~~l~  281 (284)
T cd05079         257 QLMRKCWEFQPSKRTTFQNLIEGFE  281 (284)
T ss_pred             HHHHHHccCCcccCcCHHHHHHHHH
Confidence            8999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=3.8e-28  Score=175.50  Aligned_cols=159  Identities=27%  Similarity=0.501  Sum_probs=122.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++++|||.+......... ......+..|++||
T Consensus        98 ~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE  174 (261)
T cd05034          98 KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE  174 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHH
Confidence            4689999999999999999999999   9999999999999999999999999998765432111 11223456799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ...+..++.++|+||+|++++++++ |+.||......        ......... ..+.....    ...+.+++.+||.
T Consensus       175 ~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~~~~~i~~~l~  242 (261)
T cd05034         175 AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVERGYRMPRPPNC----PEELYDLMLQCWD  242 (261)
T ss_pred             HhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCCCCC----CHHHHHHHHHHcc
Confidence            9988888999999999999999998 99998643211        111111111 11111111    2347889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|.+||+++++.+.|+
T Consensus       243 ~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         243 KDPEERPTFEYLQSFLE  259 (261)
T ss_pred             cCcccCCCHHHHHHHHh
Confidence            99999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=3.6e-28  Score=178.17  Aligned_cols=167  Identities=25%  Similarity=0.313  Sum_probs=121.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..++...+..++.|++.||.|||+.   +++|+||+|.||+++.++.++++|||++........  ....++..|++||.
T Consensus       100 ~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~y~~pE~  174 (287)
T cd06621         100 GRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--GTFTGTSFYMAPER  174 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc--ccccCCccccCHHH
Confidence            4578889999999999999999999   999999999999999999999999999865443221  22356778999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|+++|++++|..||......................+.++............+.+++.+||+.||
T Consensus       175 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  254 (287)
T cd06621         175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDP  254 (287)
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCc
Confidence            98888899999999999999999999999755321000011011111101111111111001123357889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      ++|||+.|++++
T Consensus       255 ~~Rpt~~eil~~  266 (287)
T cd06621         255 TRRPTPWDMLEH  266 (287)
T ss_pred             ccCCCHHHHHhC
Confidence            999999999886

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.96  E-value=2.8e-29  Score=181.39  Aligned_cols=169  Identities=25%  Similarity=0.290  Sum_probs=124.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC-CceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ++.++.-.++.+..||.+||+|||+.   +|+||||||.|+|++.+ +.+||+|||.|+........ ....++.-|+||
T Consensus       119 ~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn-iSYicSRyYRaP  194 (364)
T KOG0658|consen  119 NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN-ISYICSRYYRAP  194 (364)
T ss_pred             CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc-eeEEEeccccCH
Confidence            56788888999999999999999998   99999999999999987 88999999999877654332 445677889999


Q ss_pred             cccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccc-------cccchhhhhhhc-------CCCCCCCCC---cc
Q 042876           83 ELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS-------SSLNTDIELDEM-------LDPRLPAPS---RS  144 (179)
Q Consensus        83 e~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~-------~~~~~~~~~~~~-------~~~~~~~~~---~~  144 (179)
                      |++.|. +|+.+.|+||.|||+.||+.|+.-|.+.+....       .+.-.......+       ..+.+....   -.
T Consensus       195 ELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~  274 (364)
T KOG0658|consen  195 ELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVF  274 (364)
T ss_pred             HHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeec
Confidence            988864 689999999999999999999999976443211       001111111111       111111110   01


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ......+..+|+.+++.++|.+|.++.|+++|
T Consensus       275 ~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  275 FKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             ccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            11223358899999999999999999998865

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=1e-28  Score=179.58  Aligned_cols=158  Identities=23%  Similarity=0.390  Sum_probs=120.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe   83 (179)
                      .+++...+.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+.........  .....++..|++||
T Consensus       109 ~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  185 (273)
T cd05074         109 TLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE  185 (273)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHh
Confidence            468889999999999999999999   9999999999999999999999999998765432211  12234456799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCC-CCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLD-PRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ...+..++.++|+||||+++|++++ |..||........        ...... ........    ....+.+++.+||+
T Consensus       186 ~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~----~~~~~~~l~~~~l~  253 (273)
T cd05074         186 SLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI--------YNYLIKGNRLKQPPD----CLEDVYELMCQCWS  253 (273)
T ss_pred             HHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH--------HHHHHcCCcCCCCCC----CCHHHHHHHHHHcC
Confidence            9888888899999999999999998 8888864322110        000100 11111111    22358889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|++|||+.++++.|+
T Consensus       254 ~~p~~Rps~~~~~~~l~  270 (273)
T cd05074         254 PEPKCRPSFQHLRDQLE  270 (273)
T ss_pred             CChhhCcCHHHHHHHHH
Confidence            99999999999999885

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=3.7e-28  Score=177.68  Aligned_cols=167  Identities=26%  Similarity=0.386  Sum_probs=119.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.........   ......+..|++
T Consensus       103 ~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  179 (284)
T cd05081         103 ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA  179 (284)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeC
Confidence            3588999999999999999999999   9999999999999999999999999998765432211   111123345899


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCccccccccc----c---cchhhhhhhcCC--CCCCCCCccHHHHHHHH
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS----S---LNTDIELDEMLD--PRLPAPSRSVQEKLISI  152 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~----~---~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  152 (179)
                      ||...+..++.++|+||||++++++++|..++.........    .   ............  ...+.....    ...+
T Consensus       180 PE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  255 (284)
T cd05081         180 PESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGC----PAEI  255 (284)
T ss_pred             HHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCC----CHHH
Confidence            99998888899999999999999999987665322110000    0   000000111111  111111111    2248


Q ss_pred             HHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          153 VKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       153 ~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      .+++.+||..+|++|||+.++++.|+
T Consensus       256 ~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05081         256 YAIMKECWNNDPSQRPSFSELALQVE  281 (284)
T ss_pred             HHHHHHHccCChhhCCCHHHHHHHHH
Confidence            88999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.2e-28  Score=178.19  Aligned_cols=159  Identities=25%  Similarity=0.406  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .++++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||.
T Consensus        96 ~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  172 (277)
T cd06917          96 GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV  172 (277)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHH
Confidence            3688999999999999999999999   9999999999999999999999999998776554433344467788999998


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +.+ ..++.++|+||+|+++|++++|..||...........     ......+.++..     ....++.+++.+||+.|
T Consensus       173 ~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~-----~~~~~~~~~i~~~l~~~  242 (277)
T cd06917         173 ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-----IPKSKPPRLEDN-----GYSKLLREFVAACLDEE  242 (277)
T ss_pred             hccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-----cccCCCCCCCcc-----cCCHHHHHHHHHHcCCC
Confidence            764 4568899999999999999999999965432111100     000111111111     12335888999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |++||++.+++++
T Consensus       243 p~~R~~~~~il~~  255 (277)
T cd06917         243 PKERLSAEELLKS  255 (277)
T ss_pred             cccCcCHHHHhhC
Confidence            9999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=7.5e-29  Score=183.51  Aligned_cols=170  Identities=23%  Similarity=0.195  Sum_probs=120.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+...............+..|++||.
T Consensus       103 ~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  179 (309)
T cd07845         103 TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPEL  179 (309)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhh
Confidence            5689999999999999999999999   9999999999999999999999999999776543322223345677999998


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh-------hh---h------hhc--CCCCCCCCCccH
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD-------IE---L------DEM--LDPRLPAPSRSV  145 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~-------~~---~------~~~--~~~~~~~~~~~~  145 (179)
                      +.+ ..++.++|+||+|+++|++++|..||..............       ..   .      ...  ............
T Consensus       180 ~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (309)
T cd07845         180 LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKF  259 (309)
T ss_pred             hcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhc
Confidence            865 4578899999999999999999999864332110000000       00   0      000  000000000000


Q ss_pred             HHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       146 ~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      ......+.++|.+|++.||.+|||++++++|-
T Consensus       260 ~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~  291 (309)
T cd07845         260 PWLSEAGLRLLNFLLMYDPKKRATAEEALESS  291 (309)
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            11133477899999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.96  E-value=2e-28  Score=176.46  Aligned_cols=158  Identities=21%  Similarity=0.317  Sum_probs=122.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||.
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~  172 (256)
T cd08218          96 VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI  172 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHH
Confidence            3578899999999999999999998   9999999999999999999999999998765443322233457788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      ..+..++.++|+||+|++++++++|..||.....        ............+...   .....++.++|.+||+.+|
T Consensus       173 ~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p  241 (256)
T cd08218         173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIRGSYPPVS---SHYSYDLRNLVSQLFKRNP  241 (256)
T ss_pred             hCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhcCCCCCCc---ccCCHHHHHHHHHHhhCCh
Confidence            9888888999999999999999999999864321        1111111111111111   1123348889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+||++.+++++
T Consensus       242 ~~Rp~~~~vl~~  253 (256)
T cd08218         242 RDRPSVNSILEK  253 (256)
T ss_pred             hhCcCHHHHhhC
Confidence            999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=1.6e-28  Score=180.59  Aligned_cols=160  Identities=23%  Similarity=0.347  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|.||+++.++.++++|||.+..............++..|++||.
T Consensus       111 ~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~  187 (292)
T cd06657         111 TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEL  187 (292)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHH
Confidence            4678999999999999999999999   9999999999999999999999999988765433322333456788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|++++++++|..||........     ...............    ......+.+++.+||+.||
T Consensus       188 ~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~P  258 (292)
T cd06657         188 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-----MKMIRDNLPPKLKNL----HKVSPSLKGFLDRLLVRDP  258 (292)
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhhCCcccCCc----ccCCHHHHHHHHHHHhCCc
Confidence            8887889999999999999999999999864321110     011111122222111    1122247788999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+||++.+++++
T Consensus       259 ~~R~~~~~ll~~  270 (292)
T cd06657         259 AQRATAAELLKH  270 (292)
T ss_pred             ccCcCHHHHhcC
Confidence            999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.96  E-value=1.9e-28  Score=177.15  Aligned_cols=160  Identities=24%  Similarity=0.436  Sum_probs=120.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+........ ......++..|++||
T Consensus        97 ~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE  173 (260)
T cd05073          97 SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE  173 (260)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHh
Confidence            4578889999999999999999998   999999999999999999999999999865432221 112233456799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||++++++++ |..||........   .  ......  ...+..    ......+.+++.+||+.
T Consensus       174 ~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~--~~~~~~--~~~~~~----~~~~~~~~~~i~~~l~~  242 (260)
T cd05073         174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---I--RALERG--YRMPRP----ENCPEELYNIMMRCWKN  242 (260)
T ss_pred             HhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---H--HHHhCC--CCCCCc----ccCCHHHHHHHHHHccc
Confidence            9988888899999999999999998 8999865321110   0  000000  011111    11233488899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      +|++||++.++.+.|+
T Consensus       243 ~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         243 RPEERPTFEYIQSVLD  258 (260)
T ss_pred             CcccCcCHHHHHHHHh
Confidence            9999999999999885

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.96  E-value=2.1e-28  Score=178.16  Aligned_cols=160  Identities=25%  Similarity=0.343  Sum_probs=120.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCcc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPEL   84 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~   84 (179)
                      .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++||+++........ ......++..|++||.
T Consensus       113 ~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~  189 (275)
T cd05046         113 PLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA  189 (275)
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhh
Confidence            689999999999999999999999   999999999999999999999999999865432221 1223345667999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +.+...+.++|+||||++++++++ |..||.......   .....   .......+.....    ...+.+++.+||+.+
T Consensus       190 ~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~---~~~~~~~~~~~~~----~~~l~~~i~~~l~~~  259 (275)
T cd05046         190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL---QAGKLELPVPEGC----PSRLYKLMTRCWAVN  259 (275)
T ss_pred             hccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH---HcCCcCCCCCCCC----CHHHHHHHHHHcCCC
Confidence            888788899999999999999998 788885432211   00000   0000011111111    224888999999999


Q ss_pred             CCCCCCHHHHHHHhh
Q 042876          164 PESRPTMKIVSQQLR  178 (179)
Q Consensus       164 p~~Rps~~~~~~~l~  178 (179)
                      |.+|||+.++++.|+
T Consensus       260 p~~Rp~~~~~l~~l~  274 (275)
T cd05046         260 PKDRPSFSELVSALG  274 (275)
T ss_pred             cccCCCHHHHHHHhc
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.96  E-value=1.2e-28  Score=183.76  Aligned_cols=169  Identities=17%  Similarity=0.256  Sum_probs=116.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-------CcccccCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-------NWTEFAGTY   77 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~   77 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+++.||+..........       ......++.
T Consensus        96 ~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (327)
T cd08227          96 DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL  172 (327)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccccccccccccccccee
Confidence            4588999999999999999999999   999999999999999999999999876543221110       011124556


Q ss_pred             CCCCCccccc--CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC-------------------CC
Q 042876           78 GYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML-------------------DP  136 (179)
Q Consensus        78 ~~~~pe~~~~--~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------------------~~  136 (179)
                      .|++||.+.+  ..++.++|+||+||+++++++|..||.....................                   +.
T Consensus       173 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T cd08227         173 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANS  252 (327)
T ss_pred             cccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcC
Confidence            7999999875  35788999999999999999999999643321100000000000000                   00


Q ss_pred             ----------CCCC-----CCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          137 ----------RLPA-----PSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       137 ----------~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                                ..+.     ...........+.+++.+||+.||++|||++++++|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         253 GLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             CCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                      0000     000111223357889999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=2.1e-28  Score=179.87  Aligned_cols=169  Identities=20%  Similarity=0.199  Sum_probs=119.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-CCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.||++||.|||+.   +++|+||+|+||+++. ++.++++|||.+..............+++.|++||
T Consensus       105 ~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE  181 (295)
T cd07837         105 RPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE  181 (295)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChH
Confidence            4689999999999999999999999   9999999999999998 88999999999876543322223335577899999


Q ss_pred             cccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-------hhh------hhhcC-CCCCCC--CCccHH
Q 042876           84 LAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-------DIE------LDEML-DPRLPA--PSRSVQ  146 (179)
Q Consensus        84 ~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-------~~~------~~~~~-~~~~~~--~~~~~~  146 (179)
                      .+.+ ..++.++|+||+|+++|+|++|..||.............       ...      ..... .+...+  ......
T Consensus       182 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (295)
T cd07837         182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVP  261 (295)
T ss_pred             HhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhcc
Confidence            8765 456889999999999999999999986543211000000       000      00000 000000  000001


Q ss_pred             HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          147 EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       147 ~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .....+.++|.+||..||.+||++++++.|
T Consensus       262 ~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         262 DLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             ccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            123457889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.96  E-value=9.4e-29  Score=179.30  Aligned_cols=158  Identities=23%  Similarity=0.336  Sum_probs=117.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC---CCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS---SNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.......   .......++..|++
T Consensus       101 ~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (266)
T cd06651         101 GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS  177 (266)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccC
Confidence            4578899999999999999999998   99999999999999999999999999987553221   11122356788999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+||+|+++|++++|+.||.......      ... ........+..   .......+.+++ +||.
T Consensus       178 PE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~-~~~~~~~~~~~---~~~~~~~~~~li-~~~~  246 (266)
T cd06651         178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIF-KIATQPTNPQL---PSHISEHARDFL-GCIF  246 (266)
T ss_pred             HHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHH-HHhcCCCCCCC---chhcCHHHHHHH-HHhc
Confidence            999988888999999999999999999999986432111      000 00110111111   111222355666 6888


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .+|++||+++++++|
T Consensus       247 ~~p~~Rp~~~eil~h  261 (266)
T cd06651         247 VEARHRPSAEELLRH  261 (266)
T ss_pred             CChhhCcCHHHHhcC
Confidence            999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.96  E-value=3.1e-28  Score=176.28  Aligned_cols=163  Identities=28%  Similarity=0.423  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC----cccccCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN----WTEFAGTYGYV   80 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~   80 (179)
                      ..+++..+..++.|++.||++||+.   +++|+||+|+||+++.++.++++|||++.........    .....++..|+
T Consensus        97 ~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~  173 (267)
T cd06610          97 GGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM  173 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhc
Confidence            4689999999999999999999998   9999999999999999999999999998765543221    12335678899


Q ss_pred             CCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           81 APELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        81 ~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +||.+... .++.++|+||||++++++++|..||........  .   ........+..+.. .........+.+++.+|
T Consensus       174 ~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~---~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~  247 (267)
T cd06610         174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--L---MLTLQNDPPSLETG-ADYKKYSKSFRKMISLC  247 (267)
T ss_pred             ChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--H---HHHhcCCCCCcCCc-cccccccHHHHHHHHHH
Confidence            99988766 678899999999999999999999965432110  0   00001111111111 00112234578899999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 042876          160 LNESPESRPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~  176 (179)
                      |..||++|||+.++++|
T Consensus       248 l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         248 LQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cCCChhhCcCHHHHhhC
Confidence            99999999999999876

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.96  E-value=9.7e-29  Score=187.13  Aligned_cols=161  Identities=21%  Similarity=0.273  Sum_probs=117.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      ..+++..+..++.||+.||+|||+.   +++||||||+||+++.++.++|+|||++........ ......+++.|+|||
T Consensus       137 ~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE  213 (370)
T cd05621         137 YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPE  213 (370)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHH
Confidence            3578889999999999999999999   999999999999999999999999999976543322 123456889999999


Q ss_pred             ccccCC----CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           84 LAYTMK----ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        84 ~~~~~~----~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      .+.+..    ++.++|+||+||++|+|++|..||.......        ....+..................+.+++.+|
T Consensus       214 ~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~  285 (370)
T cd05621         214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG--------TYSKIMDHKNSLNFPEDVEISKHAKNLICAF  285 (370)
T ss_pred             HHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCcccCCCCcccCCHHHHHHHHHH
Confidence            987543    6789999999999999999999996543211        1111111110000000111223367788899


Q ss_pred             cCcCCCC--CCCHHHHHHH
Q 042876          160 LNESPES--RPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~--Rps~~~~~~~  176 (179)
                      +..++.+  |+++.++++|
T Consensus       286 L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         286 LTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ccCchhccCCCCHHHHhcC
Confidence            9765543  8999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-28  Score=188.34  Aligned_cols=148  Identities=28%  Similarity=0.348  Sum_probs=117.4

Q ss_pred             HHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee-cCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccccC
Q 042876           10 SQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL-DLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM   88 (179)
Q Consensus        10 ~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~   88 (179)
                      .++..++.+|+.++.|||.+   |++||||||+|||+ +..+.++++|||.+......   .....-+..|.|||.+...
T Consensus       415 ~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~  488 (612)
T KOG0603|consen  415 SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQ  488 (612)
T ss_pred             HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccC
Confidence            67888999999999999999   99999999999999 58888999999998766544   2334557789999999988


Q ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCC
Q 042876           89 KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRP  168 (179)
Q Consensus        89 ~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp  168 (179)
                      .+++++|+||||+++|+|++|+.||......        ......+.  .+......   +....+|+.+||+.||.+||
T Consensus       489 ~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------~ei~~~i~--~~~~s~~v---S~~AKdLl~~LL~~dP~~Rl  555 (612)
T KOG0603|consen  489 EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------IEIHTRIQ--MPKFSECV---SDEAKDLLQQLLQVDPALRL  555 (612)
T ss_pred             CCCcchhhHHHHHHHHHHHhCCCccccCCch--------HHHHHhhc--CCcccccc---CHHHHHHHHHhccCChhhCc
Confidence            9999999999999999999999999765432        11111111  11111222   22366788899999999999


Q ss_pred             CHHHHHHH
Q 042876          169 TMKIVSQQ  176 (179)
Q Consensus       169 s~~~~~~~  176 (179)
                      +++++..|
T Consensus       556 ~~~~i~~h  563 (612)
T KOG0603|consen  556 GADEIGAH  563 (612)
T ss_pred             ChhhhccC
Confidence            99999876

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=6.1e-28  Score=174.40  Aligned_cols=154  Identities=24%  Similarity=0.409  Sum_probs=114.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc--------eeEccccCccccCCCCCCcccccCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE--------AHVADFGIAKFLKPDSSNWTEFAGT   76 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~   76 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.        ++++|||.+......    ....++
T Consensus        95 ~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~  167 (258)
T cd05078          95 NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK----EILLER  167 (258)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccccCCc----hhcccc
Confidence            3588999999999999999999999   9999999999999977654        689999987654422    223566


Q ss_pred             CCCCCCccccc-CCCCcchhhHHHHHHHHHHHhC-CCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHH
Q 042876           77 YGYVAPELAYT-MKITEKCDVYSFGVLALEVIKG-KHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVK  154 (179)
Q Consensus        77 ~~~~~pe~~~~-~~~~~~~D~~slg~~~~~l~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (179)
                      ..|++||.+.+ ..++.++|+||||+++|++++| ..|+.......      ....... ....+.  ..    ..++.+
T Consensus       168 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~-~~~~~~--~~----~~~~~~  234 (258)
T cd05078         168 IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KLQFYED-RHQLPA--PK----WTELAN  234 (258)
T ss_pred             CCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HHHHHHc-cccCCC--CC----cHHHHH
Confidence            78999998876 3578899999999999999998 45654332111      0000000 111121  11    124788


Q ss_pred             HHhcccCcCCCCCCCHHHHHHHhh
Q 042876          155 VAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       155 li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ++.+||+.||++|||++++++.|.
T Consensus       235 li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         235 LINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHHhccChhhCCCHHHHHHhcC
Confidence            999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=4.9e-28  Score=177.15  Aligned_cols=169  Identities=24%  Similarity=0.313  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      .++++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+........ ......++..|++||
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE  171 (288)
T cd07833          95 GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE  171 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCc
Confidence            4589999999999999999999999   999999999999999999999999999876654432 233345678899999


Q ss_pred             ccccC-CCCcchhhHHHHHHHHHHHhCCCCCccccccccccc------------chhhhhhhcCCC-CCCCCC-c-----
Q 042876           84 LAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL------------NTDIELDEMLDP-RLPAPS-R-----  143 (179)
Q Consensus        84 ~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~------------~~~~~~~~~~~~-~~~~~~-~-----  143 (179)
                      ...+. .++.++|+||+|+++|++++|..||...........            ............ ..+... .     
T Consensus       172 ~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (288)
T cd07833         172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLER  251 (288)
T ss_pred             hhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHH
Confidence            98877 788999999999999999999999864322100000            000000000000 000000 0     


Q ss_pred             -cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          144 -SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       144 -~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                       ........+.++|.+||..+|++|||+++++++
T Consensus       252 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         252 RYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             hcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence             000113458899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.96  E-value=1.9e-28  Score=179.16  Aligned_cols=170  Identities=20%  Similarity=0.211  Sum_probs=119.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||
T Consensus        94 ~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE  170 (284)
T cd07860          94 LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  170 (284)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCe
Confidence            45789999999999999999999999   999999999999999999999999999876543332233334577899999


Q ss_pred             ccccCC-CCcchhhHHHHHHHHHHHhCCCCCcccccccccccc----------------hhhhhhhcCCCCCCCC-CccH
Q 042876           84 LAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN----------------TDIELDEMLDPRLPAP-SRSV  145 (179)
Q Consensus        84 ~~~~~~-~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~-~~~~  145 (179)
                      ...+.. ++.++|+||||++++++++|..||...+........                ................ ....
T Consensus       171 ~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (284)
T cd07860         171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVV  250 (284)
T ss_pred             EEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHc
Confidence            876644 578899999999999999999998643321100000                0000000000000000 0000


Q ss_pred             HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ......+.++|.+||+.||.+||++.++++|
T Consensus       251 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         251 PPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             ccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0112346789999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.95  E-value=6.9e-28  Score=176.21  Aligned_cols=168  Identities=20%  Similarity=0.215  Sum_probs=122.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+......... ....++..|++||.
T Consensus       102 ~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~PE~  177 (287)
T cd07838         102 PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL-TSVVVTLWYRAPEV  177 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceeccCCccc-ccccccccccChHH
Confidence            3589999999999999999999999   9999999999999999999999999998766433221 22346778999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-------hhhh-------hhcCCCCC-CCCCccHHHHH
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-------DIEL-------DEMLDPRL-PAPSRSVQEKL  149 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-------~~~~-------~~~~~~~~-~~~~~~~~~~~  149 (179)
                      +.+..++.++|+||+|+++++|++|..||.............       ....       ........ ...........
T Consensus       178 ~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (287)
T cd07838         178 LLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEIC  257 (287)
T ss_pred             hccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhh
Confidence            988888999999999999999999999986543211000000       0000       00000000 00111122334


Q ss_pred             HHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          150 ISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       150 ~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ..+.+++.+||+.||.+||++.++++|
T Consensus       258 ~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         258 EEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             HHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            557889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=1e-27  Score=183.03  Aligned_cols=161  Identities=24%  Similarity=0.359  Sum_probs=121.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++........  ......++..|++|
T Consensus       234 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  310 (401)
T cd05107         234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP  310 (401)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeCh
Confidence            4688999999999999999999998   999999999999999999999999999876432221  11223456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||+|++++++++ |..||........  .  ........  +.+.+...    ...+.+++.+||.
T Consensus       311 E~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--~--~~~~~~~~--~~~~p~~~----~~~l~~li~~cl~  380 (401)
T cd05107         311 ESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--F--YNAIKRGY--RMAKPAHA----SDEIYEIMQKCWE  380 (401)
T ss_pred             HHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--H--HHHHHcCC--CCCCCCCC----CHHHHHHHHHHcC
Confidence            99988888999999999999999998 8889864321110  0  00000000  11111111    2347889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .+|.+||+++++++.|+
T Consensus       381 ~~P~~RPs~~ell~~L~  397 (401)
T cd05107         381 EKFEIRPDFSQLVHLVG  397 (401)
T ss_pred             CChhHCcCHHHHHHHHH
Confidence            99999999999999886

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=9.7e-29  Score=186.77  Aligned_cols=159  Identities=21%  Similarity=0.246  Sum_probs=118.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC----------------
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS----------------   68 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----------------   68 (179)
                      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||++........                
T Consensus        96 ~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (364)
T cd05599          96 DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL  172 (364)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccc
Confidence            4689999999999999999999999   999999999999999999999999999865432110                


Q ss_pred             ----------------------CcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch
Q 042876           69 ----------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT  126 (179)
Q Consensus        69 ----------------------~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~  126 (179)
                                            ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.........    
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~----  248 (364)
T cd05599         173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETY----  248 (364)
T ss_pred             ccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHH----
Confidence                                  001135788999999998888999999999999999999999999754321100    


Q ss_pred             hhhhhhcC-CCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCC---HHHHHHH
Q 042876          127 DIELDEML-DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT---MKIVSQQ  176 (179)
Q Consensus       127 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps---~~~~~~~  176 (179)
                       ....... ....+.....    ...+.+++.+|+. +|.+|++   +.++++|
T Consensus       249 -~~i~~~~~~~~~~~~~~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         249 -RKIINWKETLQFPDEVPL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             -HHHHcCCCccCCCCCCCC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence             0000000 0011111111    2236778889986 9999998   9998875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.95  E-value=3.8e-28  Score=183.52  Aligned_cols=110  Identities=28%  Similarity=0.375  Sum_probs=94.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---------------
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---------------   68 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------------   68 (179)
                      ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++........               
T Consensus        95 ~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~  171 (363)
T cd05628          95 KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF  171 (363)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccc
Confidence            35689999999999999999999999   999999999999999999999999999865421100               


Q ss_pred             --------------------CcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCccc
Q 042876           69 --------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL  116 (179)
Q Consensus        69 --------------------~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~  116 (179)
                                          ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                011246889999999998888999999999999999999999999654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=8.5e-28  Score=176.38  Aligned_cols=169  Identities=20%  Similarity=0.228  Sum_probs=118.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||.
T Consensus        98 ~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  174 (291)
T cd07870          98 GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV  174 (291)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCce
Confidence            3577888999999999999999999   9999999999999999999999999998754433322333456788999998


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch--------------hhhhhhcCCCCC----CCCCcc-
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT--------------DIELDEMLDPRL----PAPSRS-  144 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~--------------~~~~~~~~~~~~----~~~~~~-  144 (179)
                      +.+. .++.++|+||+|++++++++|..||.............              ............    +..... 
T Consensus       175 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (291)
T cd07870         175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVV  254 (291)
T ss_pred             eecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhh
Confidence            8653 47788999999999999999999997543210000000              000000000000    000000 


Q ss_pred             --HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 --VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 --~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                        .......+.+++.+|+..||.+|||+++++.|
T Consensus       255 ~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         255 WKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence              00012347788999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.95  E-value=1.7e-28  Score=186.55  Aligned_cols=160  Identities=21%  Similarity=0.311  Sum_probs=116.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC----------------
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS----------------   68 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----------------   68 (179)
                      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++++|||++........                
T Consensus        96 ~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~  172 (381)
T cd05626          96 EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME  172 (381)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccC
Confidence            4678899999999999999999999   999999999999999999999999998753311000                


Q ss_pred             -------------------------------CcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccc
Q 042876           69 -------------------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLS  117 (179)
Q Consensus        69 -------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~  117 (179)
                                                     ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~  252 (381)
T cd05626         173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPT  252 (381)
T ss_pred             cccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCC
Confidence                                           0012468899999999988889999999999999999999999997543


Q ss_pred             cccccccchhhhhhh-cCCCCCCCCCccHHHHHHHHHHHHhc--ccCcCCCCCCCHHHHHHH
Q 042876          118 SISSSSLNTDIELDE-MLDPRLPAPSRSVQEKLISIVKVAFS--CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       118 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~~p~~Rps~~~~~~~  176 (179)
                      ....     ...... ......+......    .++.+++.+  |+..++..||+++++++|
T Consensus       253 ~~~~-----~~~i~~~~~~~~~~~~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         253 PTET-----QLKVINWENTLHIPPQVKLS----PEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHH-----HHHHHccccccCCCCCCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            2110     000000 0011122211111    236667766  556677779999999886

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=1.5e-28  Score=180.57  Aligned_cols=169  Identities=21%  Similarity=0.185  Sum_probs=120.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||.
T Consensus       101 ~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~  177 (293)
T cd07843         101 QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPEL  177 (293)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchh
Confidence            3589999999999999999999999   9999999999999999999999999998776554333333456778999998


Q ss_pred             cccCC-CCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-------hhhh------h----hcC-CCCCCCCCccH
Q 042876           85 AYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-------DIEL------D----EML-DPRLPAPSRSV  145 (179)
Q Consensus        85 ~~~~~-~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-------~~~~------~----~~~-~~~~~~~~~~~  145 (179)
                      +.+.. .+.++|+||+|++++++++|..||.............       ....      .    ... ...........
T Consensus       178 ~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (293)
T cd07843         178 LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKF  257 (293)
T ss_pred             hcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccc
Confidence            87644 5789999999999999999999986433211000000       0000      0    000 00000000000


Q ss_pred             HH--HHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 QE--KLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ~~--~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      +.  ....+.++|.+||+.||++|||++|++++
T Consensus       258 ~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         258 PALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            10  13347789999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.95  E-value=2.2e-28  Score=176.25  Aligned_cols=160  Identities=26%  Similarity=0.414  Sum_probs=120.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||++||+.   +++|+||+|+||+++.++.++++|||.+......... ......+..|++||
T Consensus        95 ~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe  171 (256)
T cd05112          95 GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE  171 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHh
Confidence            3578899999999999999999999   9999999999999999999999999998755432211 11223456799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ...+..++.++|+||+|+++|++++ |..||........     ......... ...+ ...    ...+.+++.+||+.
T Consensus       172 ~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~~-~~~~-~~~----~~~~~~l~~~~l~~  240 (256)
T cd05112         172 VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-----VETINAGFR-LYKP-RLA----SQSVYELMQHCWKE  240 (256)
T ss_pred             HhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH-----HHHHhCCCC-CCCC-CCC----CHHHHHHHHHHccc
Confidence            9988888999999999999999998 8999864321110     000010000 0111 111    23488899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      +|++|||+.++++.|.
T Consensus       241 ~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         241 RPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ChhhCCCHHHHHHhhC
Confidence            9999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.3e-27  Score=174.45  Aligned_cols=160  Identities=28%  Similarity=0.452  Sum_probs=121.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcc--cccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT--EFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+...........  ....+..|++|
T Consensus       104 ~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~P  180 (279)
T cd05057         104 DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL  180 (279)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCH
Confidence            4588999999999999999999998   999999999999999999999999999976653332211  12234679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |...+..++.++|+||||++++++++ |..||........   .  .....  ....+.+..+.    .++.+++.+||.
T Consensus       181 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~--~~~~~--~~~~~~~~~~~----~~~~~~~~~~l~  249 (279)
T cd05057         181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---P--DLLEK--GERLPQPPICT----IDVYMVLVKCWM  249 (279)
T ss_pred             HHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---H--HHHhC--CCCCCCCCCCC----HHHHHHHHHHcC
Confidence            99887888999999999999999998 9999865432110   0  00110  11111111222    247888999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+||++.++++.|+
T Consensus       250 ~~p~~Rp~~~~l~~~l~  266 (279)
T cd05057         250 IDAESRPTFKELINEFS  266 (279)
T ss_pred             CChhhCCCHHHHHHHHH
Confidence            99999999999998774

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=5.5e-28  Score=176.47  Aligned_cols=166  Identities=24%  Similarity=0.355  Sum_probs=122.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAP   82 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~p   82 (179)
                      .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+.........   .....++..|++|
T Consensus       105 ~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~P  181 (284)
T cd05038         105 QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP  181 (284)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCc
Confidence            488999999999999999999999   9999999999999999999999999999766532211   1112344568999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCccccccccc------ccchhhhhhhcC--CCCCCCCCccHHHHHHHHHH
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS------SLNTDIELDEML--DPRLPAPSRSVQEKLISIVK  154 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  154 (179)
                      |...+..++.++|+||||++++++++|..|+.........      ...........+  ....+.....    ...+.+
T Consensus       182 e~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  257 (284)
T cd05038         182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSC----PDEVYD  257 (284)
T ss_pred             HHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccC----CHHHHH
Confidence            9988888899999999999999999999987543221100      000011111111  1111111111    234888


Q ss_pred             HHhcccCcCCCCCCCHHHHHHHhh
Q 042876          155 VAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       155 li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ++.+||+.+|.+|||+.++++.|+
T Consensus       258 li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05038         258 LMKLCWEAEPQDRPSFADLILIVD  281 (284)
T ss_pred             HHHHHhccChhhCCCHHHHHHHHh
Confidence            999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.95  E-value=4.1e-28  Score=178.42  Aligned_cols=160  Identities=25%  Similarity=0.404  Sum_probs=122.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||.
T Consensus       110 ~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~  186 (293)
T cd06647         110 TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV  186 (293)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchh
Confidence            3578889999999999999999999   9999999999999999999999999988765543333333457778999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|+++|++++|..||............     ...-.+...    ........+.+++.+||..+|
T Consensus       187 ~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-----~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p  257 (293)
T cd06647         187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----ATNGTPELQ----NPEKLSAIFRDFLNRCLEMDV  257 (293)
T ss_pred             hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-----hcCCCCCCC----CccccCHHHHHHHHHHccCCh
Confidence            98888889999999999999999999999654321110000     000001111    111123347789999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      ++||++++++.|
T Consensus       258 ~~Rp~~~~il~h  269 (293)
T cd06647         258 EKRGSAKELLQH  269 (293)
T ss_pred             hhCcCHHHHhcC
Confidence            999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.95  E-value=4.1e-28  Score=182.71  Aligned_cols=166  Identities=23%  Similarity=0.291  Sum_probs=120.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY   86 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   86 (179)
                      ++...+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+....... ......++..|++||.+.
T Consensus       115 l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~  190 (353)
T cd07850         115 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVIL  190 (353)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC-CCCCCcccccccCHHHHh
Confidence            78889999999999999999999   99999999999999999999999999997654322 122345678899999999


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhCCCCCccccccccc------------ccch--hhhhhhcCCCC---------------
Q 042876           87 TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS------------SLNT--DIELDEMLDPR---------------  137 (179)
Q Consensus        87 ~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~------------~~~~--~~~~~~~~~~~---------------  137 (179)
                      +..++.++|+||||+++++|++|..||...+.....            ....  ..........+               
T Consensus       191 ~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (353)
T cd07850         191 GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDV  270 (353)
T ss_pred             CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCccc
Confidence            888999999999999999999999999644321000            0000  00000000000               


Q ss_pred             -CCCCCc-cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          138 -LPAPSR-SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       138 -~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                       .+.... ........+.+++.+||+.||++|||+.+++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         271 LFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             ccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             000000 011123347789999999999999999999876

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=1.9e-28  Score=179.82  Aligned_cols=169  Identities=20%  Similarity=0.266  Sum_probs=118.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||.
T Consensus        98 ~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~  174 (291)
T cd07844          98 GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV  174 (291)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHH
Confidence            4678999999999999999999999   9999999999999999999999999998654432222223345778999998


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc--------hhhhh------hhcCCCCCCCCC-c----c
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN--------TDIEL------DEMLDPRLPAPS-R----S  144 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~--------~~~~~------~~~~~~~~~~~~-~----~  144 (179)
                      +.+ ..++.++|+||+|+++|++++|..||............        .....      ............ .    .
T Consensus       175 ~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (291)
T cd07844         175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINH  254 (291)
T ss_pred             hhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHh
Confidence            865 45788999999999999999999999644311000000        00000      000000000000 0    0


Q ss_pred             H--HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 V--QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~--~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .  .....++.+++.+|++.+|.+|||+++++++
T Consensus       255 ~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         255 APRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             CcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            0  0001357789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.95  E-value=1.6e-28  Score=179.52  Aligned_cols=169  Identities=22%  Similarity=0.234  Sum_probs=119.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+..............++..|++||.
T Consensus        94 ~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~  170 (283)
T cd07835          94 TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI  170 (283)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCce
Confidence            3689999999999999999999999   9999999999999999999999999998755433222233355778999998


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCccccccccccc----------------chhhhhhhcCCC-CCCCCCccHH
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL----------------NTDIELDEMLDP-RLPAPSRSVQ  146 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~----------------~~~~~~~~~~~~-~~~~~~~~~~  146 (179)
                      +.+. .++.++|+||+|+++|++++|..||...........                ............ ..+.......
T Consensus       171 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (283)
T cd07835         171 LLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVP  250 (283)
T ss_pred             eecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcC
Confidence            7654 468899999999999999999999864432110000                000000000000 0000000111


Q ss_pred             HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          147 EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       147 ~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .....+.+++.+||+.+|.+||++++++++
T Consensus       251 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         251 NLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            112357889999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=2.8e-28  Score=182.58  Aligned_cols=170  Identities=22%  Similarity=0.245  Sum_probs=122.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||
T Consensus       102 ~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE  178 (337)
T cd07858         102 SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE  178 (337)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChH
Confidence            35689999999999999999999999   999999999999999999999999999876544322223345678899999


Q ss_pred             cccc-CCCCcchhhHHHHHHHHHHHhCCCCCccccccccc---------------ccchhhhhhhcC---CCCC-CCCCc
Q 042876           84 LAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS---------------SLNTDIELDEML---DPRL-PAPSR  143 (179)
Q Consensus        84 ~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~---------------~~~~~~~~~~~~---~~~~-~~~~~  143 (179)
                      .+.+ ..++.++|+||||+++|++++|..||...+.....               ...........+   .... +....
T Consensus       179 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (337)
T cd07858         179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFAR  258 (337)
T ss_pred             HHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHH
Confidence            8764 45888999999999999999999999643211000               000000000000   0000 00000


Q ss_pred             cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          144 SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       144 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ........+.+++.+||+.+|++|||++++++|
T Consensus       259 ~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         259 LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            111223457899999999999999999999987

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.95  E-value=1.1e-27  Score=173.20  Aligned_cols=161  Identities=29%  Similarity=0.391  Sum_probs=121.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCc----ccccCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW----TEFAGTYGYV   80 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~   80 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|.||+++.++.++++|||.+..........    ....++..|+
T Consensus        94 ~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T cd06626          94 RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM  170 (264)
T ss_pred             CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCcc
Confidence            3578899999999999999999999   99999999999999999999999999987765433221    1245678899


Q ss_pred             CCcccccCC---CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHh
Q 042876           81 APELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        81 ~pe~~~~~~---~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      +||.+.+..   .+.++|+||+|++++++++|+.||........    ..........+..+...    .....+.+++.
T Consensus       171 ~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~----~~~~~~~~li~  242 (264)
T cd06626         171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ----IMFHVGAGHKPPIPDSL----QLSPEGKDFLD  242 (264)
T ss_pred             ChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH----HHHHHhcCCCCCCCccc----ccCHHHHHHHH
Confidence            999987665   78899999999999999999999965421110    00011111111222211    11234678899


Q ss_pred             cccCcCCCCCCCHHHHHHH
Q 042876          158 SCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~  176 (179)
                      +||+.+|.+||++.+++.+
T Consensus       243 ~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         243 RCLESDPKKRPTASELLQH  261 (264)
T ss_pred             HHccCCcccCCCHHHHhcC
Confidence            9999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.95  E-value=2.2e-28  Score=180.04  Aligned_cols=168  Identities=21%  Similarity=0.210  Sum_probs=119.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      .+++..++.++.||++||.|||++   +++|+||+|+||+++.++.++++|||++...............+..|++||.+
T Consensus        98 ~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  174 (298)
T cd07841          98 VLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL  174 (298)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHH
Confidence            689999999999999999999999   99999999999999999999999999997765433222333456789999987


Q ss_pred             cc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-------hh------hhhhcCCC-CC--CCCCccHHHH
Q 042876           86 YT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-------DI------ELDEMLDP-RL--PAPSRSVQEK  148 (179)
Q Consensus        86 ~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-------~~------~~~~~~~~-~~--~~~~~~~~~~  148 (179)
                      .+ ..++.++|+||+|++++++++|..+|.............       ..      ........ ..  ..........
T Consensus       175 ~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T cd07841         175 FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAA  254 (298)
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccc
Confidence            54 456889999999999999999977775433211000000       00      00000000 00  0000011112


Q ss_pred             HHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          149 LISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       149 ~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ...+.+++.+||+.||++|||+.+++++
T Consensus       255 ~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         255 SDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            3457889999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.95  E-value=4.6e-28  Score=175.82  Aligned_cols=157  Identities=24%  Similarity=0.411  Sum_probs=116.5

Q ss_pred             CHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-CCceeEccccCccccCCCCCCcccccCCCCCCCCcccc
Q 042876            8 DWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY   86 (179)
Q Consensus         8 ~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   86 (179)
                      +...+..++.|++.||+|||+.   +++|+||+|+||+++. ++.++++|||.+..............++..|++||.+.
T Consensus       106 ~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~  182 (268)
T cd06624         106 NEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID  182 (268)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhc
Confidence            7788899999999999999999   9999999999999976 67899999999876543333333345788999999886


Q ss_pred             cCC--CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           87 TMK--ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        87 ~~~--~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +..  ++.++|+||+|+++|++++|..||............  ..... ..+.++.      ....++.+++.+||+.+|
T Consensus       183 ~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~--~~~~~-~~~~~~~------~~~~~~~~li~~~l~~~p  253 (268)
T cd06624         183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK--VGMFK-IHPEIPE------SLSAEAKNFILRCFEPDP  253 (268)
T ss_pred             cccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh--hhhhc-cCCCCCc------ccCHHHHHHHHHHcCCCc
Confidence            543  678999999999999999999998643221110000  00000 0111111      122347888999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+|||+.++++|
T Consensus       254 ~~Rpt~~~ll~~  265 (268)
T cd06624         254 DKRASAHDLLQD  265 (268)
T ss_pred             hhCCCHHHHHhC
Confidence            999999999886

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.95  E-value=7.6e-28  Score=173.96  Aligned_cols=162  Identities=27%  Similarity=0.376  Sum_probs=124.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|+++||.+||+ .   +++|+||+|+||+++.++.++++|||.+..............+...|++||
T Consensus        94 ~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE  170 (264)
T cd06623          94 GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE  170 (264)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHh
Confidence            568899999999999999999999 8   999999999999999999999999999876654433333445678899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      ...+..++.++|+||||+++|++++|..||........     ............+.....  .....+.+++.+||+.+
T Consensus       171 ~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~  243 (264)
T cd06623         171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF-----FELMQAICDGPPPSLPAE--EFSPEFRDFISACLQKD  243 (264)
T ss_pred             hhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH-----HHHHHHHhcCCCCCCCcc--cCCHHHHHHHHHHccCC
Confidence            99888888999999999999999999999876542111     111111111111111111  02234888899999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |++||++.+++++
T Consensus       244 p~~R~~~~~ll~~  256 (264)
T cd06623         244 PKKRPSAAELLQH  256 (264)
T ss_pred             hhhCCCHHHHHhC
Confidence            9999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.95  E-value=1.8e-28  Score=185.76  Aligned_cols=161  Identities=20%  Similarity=0.279  Sum_probs=117.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      ..+++..+..++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++........ ......+++.|+|||
T Consensus       137 ~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE  213 (371)
T cd05622         137 YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE  213 (371)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHH
Confidence            3578889999999999999999999   999999999999999999999999999976543322 123456889999999


Q ss_pred             ccccCC----CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC-CCCCCCCCccHHHHHHHHHHHHhc
Q 042876           84 LAYTMK----ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML-DPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        84 ~~~~~~----~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      .+.+..    ++.++|+|||||++|+|++|..||...+....     ........ ...++..    ......+.++|..
T Consensus       214 ~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~i~~~~~~~~~~~~----~~~s~~~~~li~~  284 (371)
T cd05622         214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMNHKNSLTFPDD----NDISKEAKNLICA  284 (371)
T ss_pred             HHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-----HHHHHcCCCcccCCCc----CCCCHHHHHHHHH
Confidence            987543    67899999999999999999999975432110     00000000 0111211    1122346788889


Q ss_pred             ccCcCCCC--CCCHHHHHHHh
Q 042876          159 CLNESPES--RPTMKIVSQQL  177 (179)
Q Consensus       159 cl~~~p~~--Rps~~~~~~~l  177 (179)
                      |+..++.+  |++++++++|.
T Consensus       285 ~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         285 FLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HcCChhhhcCCCCHHHHhcCc
Confidence            99844433  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.95  E-value=7.3e-28  Score=172.53  Aligned_cols=159  Identities=29%  Similarity=0.444  Sum_probs=123.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|+++||.+||+.   +++|+||+|+||+++.++.++|+|||.+........ .....+...|++||.
T Consensus        93 ~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~  168 (253)
T cd05122          93 QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEV  168 (253)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccceecCCcccCHHH
Confidence            4789999999999999999999998   999999999999999999999999999876654332 234567788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+...+.++|+||+|++++++++|..||..........     .......+..+..    ......+.+++.+||+.||
T Consensus       169 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p  239 (253)
T cd05122         169 INGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-----KIATNGPPGLRNP----EKWSDEFKDFLKKCLQKNP  239 (253)
T ss_pred             HcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH-----HHHhcCCCCcCcc----cccCHHHHHHHHHHccCCh
Confidence            988888899999999999999999999986542111100     0111111111111    1112348889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+|||+.+++++
T Consensus       240 ~~R~t~~~~l~~  251 (253)
T cd05122         240 EKRPTAEQLLKH  251 (253)
T ss_pred             hhCCCHHHHhcC
Confidence            999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.95  E-value=1.2e-27  Score=172.15  Aligned_cols=157  Identities=24%  Similarity=0.261  Sum_probs=124.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +..+++..++.++.|++.||.+||+.   +++|+||+|.||+++.++.++++|||++......  ......+...|++||
T Consensus        97 ~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe  171 (256)
T cd08530          97 RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPE  171 (256)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC--CcccccCCccccCHH
Confidence            35689999999999999999999999   9999999999999999999999999998766543  222345678899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+|++++++++|..||.......        ..........+....   ....++.+++.+|++.+
T Consensus       172 ~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~  240 (256)
T cd08530         172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--------LRYKVQRGKYPPIPP---IYSQDLQNFIRSMLQVK  240 (256)
T ss_pred             HHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCCCCCch---hhCHHHHHHHHHHcCCC
Confidence            9988888899999999999999999999986543211        111111122222111   33445889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |++||++.+++++
T Consensus       241 p~~Rp~~~~~l~~  253 (256)
T cd08530         241 PKLRPNCDKILAS  253 (256)
T ss_pred             cccCCCHHHHhcC
Confidence            9999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=1.1e-27  Score=174.52  Aligned_cols=155  Identities=23%  Similarity=0.356  Sum_probs=115.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-------ceeEccccCccccCCCCCCcccccCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-------EAHVADFGIAKFLKPDSSNWTEFAGT   76 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~   76 (179)
                      ...+++..+..++.|++.||+|||+.   +++|+||+|.||+++..+       .++++|||.+......    ....++
T Consensus       111 ~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~  183 (274)
T cd05076         111 KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVER  183 (274)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc----cccccC
Confidence            35688999999999999999999999   999999999999997543       3799999987543221    223466


Q ss_pred             CCCCCCccccc-CCCCcchhhHHHHHHHHHHH-hCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHH
Q 042876           77 YGYVAPELAYT-MKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVK  154 (179)
Q Consensus        77 ~~~~~pe~~~~-~~~~~~~D~~slg~~~~~l~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (179)
                      ..|++||.+.+ ..++.++|+||||+++|+++ +|..||.........     .....  ....+.  ...    .++.+
T Consensus       184 ~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-----~~~~~--~~~~~~--~~~----~~~~~  250 (274)
T cd05076         184 IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-----RFYEK--KHRLPE--PSC----KELAT  250 (274)
T ss_pred             CcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-----HHHHh--ccCCCC--CCC----hHHHH
Confidence            78999998865 45789999999999999985 688888644221100     00000  011111  111    24788


Q ss_pred             HHhcccCcCCCCCCCHHHHHHHhh
Q 042876          155 VAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       155 li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ++.+||+.+|++|||+.++++.|.
T Consensus       251 li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         251 LISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHcccChhhCcCHHHHHHhhC
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=4e-28  Score=181.08  Aligned_cols=169  Identities=25%  Similarity=0.316  Sum_probs=122.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC---CCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS---SNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.|++.||++||+.   +++|+||+|.||+++.++.++++|||.+.......   .......++..|++
T Consensus        98 ~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  174 (330)
T cd07834          98 QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA  174 (330)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCC
Confidence            4789999999999999999999999   99999999999999999999999999998765443   11233456778999


Q ss_pred             CcccccC-CCCcchhhHHHHHHHHHHHhCCCCCccccccccccc---------------chhhhhhhcC---CCCCCCC-
Q 042876           82 PELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL---------------NTDIELDEML---DPRLPAP-  141 (179)
Q Consensus        82 pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~---------------~~~~~~~~~~---~~~~~~~-  141 (179)
                      ||.+.+. .++.++|+||+|++++++++|..||...........               .........+   ....... 
T Consensus       175 PE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (330)
T cd07834         175 PELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPL  254 (330)
T ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchh
Confidence            9998877 788999999999999999999999965432110000               0000000000   0000000 


Q ss_pred             CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          142 SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       142 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ..........+.+++.+||+.+|.+||++++++++
T Consensus       255 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         255 SKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00011123457889999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-28  Score=179.10  Aligned_cols=161  Identities=24%  Similarity=0.335  Sum_probs=133.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~   81 (179)
                      .+.++..+...++.|++.|++|||++   +++|.||...|++++..-++|+.|-.+++.+.+.+.  .......+..|++
T Consensus       390 aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMs  466 (563)
T KOG1024|consen  390 AQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMS  466 (563)
T ss_pred             ccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccC
Confidence            46788889999999999999999999   999999999999999999999999999987655432  2455677899999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      +|.+.+..++.++|+||||+++||+++ |+.|+....+.+...+.+.       .-++..+..|..+    ++.+|..||
T Consensus       467 lEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd-------GyRlaQP~NCPDe----Lf~vMacCW  535 (563)
T KOG1024|consen  467 LEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD-------GYRLAQPFNCPDE----LFTVMACCW  535 (563)
T ss_pred             HHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc-------cceecCCCCCcHH----HHHHHHHHH
Confidence            999999999999999999999999998 9999976654333222211       1245555566555    889999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      ...|++||+++|++..|.
T Consensus       536 allpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  536 ALLPEERPSFSQLVICLS  553 (563)
T ss_pred             hcCcccCCCHHHHHHHHH
Confidence            999999999999998764

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.95  E-value=1.5e-27  Score=171.84  Aligned_cols=156  Identities=31%  Similarity=0.456  Sum_probs=119.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcc-cccCCCCCCCCccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT-EFAGTYGYVAPELA   85 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~pe~~   85 (179)
                      +++..++.++.|++.||++||+.   +++|+||+|+||+++.++.++++|||.+........... ...++..|++||..
T Consensus       100 ~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~  176 (258)
T smart00219      100 LSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESL  176 (258)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHh
Confidence            89999999999999999999999   999999999999999999999999999876654322111 12356789999998


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           86 YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+..++.++|+||+|++++++++ |..||.......        ........ .......    ....+.+++.+|+..|
T Consensus       177 ~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~----~~~~~~~~i~~~l~~~  244 (258)
T smart00219      177 KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--------VLEYLKKGYRLPKPEN----CPPEIYKLMLQCWAED  244 (258)
T ss_pred             ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCCCCCCc----CCHHHHHHHHHHCcCC
Confidence            87788999999999999999998 788876422110        01111111 1111111    2335888999999999


Q ss_pred             CCCCCCHHHHHHHh
Q 042876          164 PESRPTMKIVSQQL  177 (179)
Q Consensus       164 p~~Rps~~~~~~~l  177 (179)
                      |.+|||+.++++.|
T Consensus       245 p~~Rpt~~~ll~~l  258 (258)
T smart00219      245 PEDRPTFSELVEIL  258 (258)
T ss_pred             hhhCcCHHHHHhhC
Confidence            99999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.95  E-value=2e-27  Score=174.28  Aligned_cols=159  Identities=21%  Similarity=0.327  Sum_probs=119.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe   83 (179)
                      .++...+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........  .....++..|++||
T Consensus       115 ~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE  191 (288)
T cd05061         115 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE  191 (288)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHH
Confidence            456778899999999999999999   9999999999999999999999999998754332211  12234466799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||++++++++ |..||......        .................   ....+.+++.+||+.
T Consensus       192 ~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~  260 (288)
T cd05061         192 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------QVLKFVMDGGYLDQPDN---CPERVTDLMRMCWQF  260 (288)
T ss_pred             HhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCCCC---CCHHHHHHHHHHcCC
Confidence            9988888999999999999999998 78888543211        11111111111111111   123488899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||++|||+.++++.|+
T Consensus       261 ~p~~Rps~~~ll~~l~  276 (288)
T cd05061         261 NPKMRPTFLEIVNLLK  276 (288)
T ss_pred             ChhHCcCHHHHHHHHH
Confidence            9999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=9.5e-28  Score=178.09  Aligned_cols=160  Identities=24%  Similarity=0.262  Sum_probs=121.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---------------
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---------------   68 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------------   68 (179)
                      ...+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++........               
T Consensus        97 ~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  173 (316)
T cd05574          97 GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV  173 (316)
T ss_pred             CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccc
Confidence            35789999999999999999999999   999999999999999999999999999865432111               


Q ss_pred             --------------CcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC
Q 042876           69 --------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML  134 (179)
Q Consensus        69 --------------~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~  134 (179)
                                    ......++..|++||.+.+..++.++|+||||+++|++++|..||......        .......
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--------~~~~~~~  245 (316)
T cd05574         174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD--------ETFSNIL  245 (316)
T ss_pred             cccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH--------HHHHHHh
Confidence                          011235677899999998888899999999999999999999999644321        1111112


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCC----HHHHHHH
Q 042876          135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT----MKIVSQQ  176 (179)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps----~~~~~~~  176 (179)
                      .........  ......+.+++.+||..||++||+    +.+++++
T Consensus       246 ~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         246 KKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             cCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            111111111  113345889999999999999999    8888875

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.95  E-value=1.1e-27  Score=173.45  Aligned_cols=160  Identities=23%  Similarity=0.332  Sum_probs=120.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC------CCcccccCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS------SNWTEFAGTYG   78 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~   78 (179)
                      .++++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+.......      .......++..
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (265)
T cd06631          97 GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY  173 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCcc
Confidence            4678899999999999999999999   99999999999999999999999999987543211      11223457788


Q ss_pred             CCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           79 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        79 ~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      |++||...+..++.++|+||||++++++++|..||.........     ...... ....+....   .....+.+++.+
T Consensus       174 ~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----~~~~~~-~~~~~~~~~---~~~~~~~~~i~~  244 (265)
T cd06631         174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-----FYIGAH-RGLMPRLPD---SFSAAAIDFVTS  244 (265)
T ss_pred             ccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-----HHhhhc-cCCCCCCCC---CCCHHHHHHHHH
Confidence            99999998888899999999999999999999999643221110     000000 001111111   122347889999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||+.+|.+||++.+++++
T Consensus       245 ~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         245 CLTRDQHERPSALQLLRH  262 (265)
T ss_pred             HhcCCcccCCCHHHHhcC
Confidence            999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.95  E-value=1.2e-27  Score=173.88  Aligned_cols=157  Identities=24%  Similarity=0.307  Sum_probs=120.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-ceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..+++.+++.++.|+++||.+||+.   +++|+||+|+||+++.++ .++++|||.+.......    ...++..|++||
T Consensus       104 ~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~y~aPE  176 (267)
T PHA03390        104 GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPE  176 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc----cCCCCCcccChh
Confidence            3789999999999999999999999   999999999999999888 89999999987654322    235678899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+|++++++++|..||.........    ............+..    ......+.+++.+||+.+
T Consensus       177 ~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~  248 (267)
T PHA03390        177 KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD----LESLLKRQQKKLPFI----KNVSKNANDFVQSMLKYN  248 (267)
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh----HHHHHHhhcccCCcc----cccCHHHHHHHHHHhccC
Confidence            998888899999999999999999999999743221100    011111111111111    122334888999999999


Q ss_pred             CCCCCC-HHHHHHH
Q 042876          164 PESRPT-MKIVSQQ  176 (179)
Q Consensus       164 p~~Rps-~~~~~~~  176 (179)
                      |.+||+ ++++++|
T Consensus       249 p~~R~~~~~~~l~h  262 (267)
T PHA03390        249 INYRLTNYNEIIKH  262 (267)
T ss_pred             hhhCCchHHHHhcC
Confidence            999995 6999875

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.95  E-value=4.9e-28  Score=179.40  Aligned_cols=169  Identities=19%  Similarity=0.233  Sum_probs=118.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-------CcccccCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-------NWTEFAGTY   77 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~   77 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+++.||+.+........       ......++.
T Consensus        96 ~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (314)
T cd08216          96 EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL  172 (314)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccc
Confidence            4578889999999999999999999   999999999999999999999999998864432111       112234566


Q ss_pred             CCCCCccccc--CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhh--------------------cCC
Q 042876           78 GYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDE--------------------MLD  135 (179)
Q Consensus        78 ~~~~pe~~~~--~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~--------------------~~~  135 (179)
                      .|++||.+.+  ..++.++|+||+|++++++++|..||...................                    ...
T Consensus       173 ~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (314)
T cd08216         173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEH  252 (314)
T ss_pred             cccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccc
Confidence            7999998865  357889999999999999999999996543211000000000000                    000


Q ss_pred             C--CCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          136 P--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       136 ~--~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .  ..............++.+++.+||..||++|||+++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         253 PNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0  0000111122223457889999999999999999999886

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.95  E-value=3.1e-28  Score=182.20  Aligned_cols=169  Identities=22%  Similarity=0.339  Sum_probs=120.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      +.+++..++.++.|+++||.+||+.   +++|+||+|+||+++.++.++++|||++.........   .....++..|++
T Consensus       101 ~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (336)
T cd07849         101 QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA  177 (336)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccC
Confidence            4689999999999999999999999   9999999999999999999999999998765432211   123456788999


Q ss_pred             Cccccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccc-------cchhhhhhhc-----------CCCCCCCC-
Q 042876           82 PELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS-------LNTDIELDEM-----------LDPRLPAP-  141 (179)
Q Consensus        82 pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~-------~~~~~~~~~~-----------~~~~~~~~-  141 (179)
                      ||.+.+ ..++.++|+||+|++++++++|+.||..........       ..........           .+...... 
T Consensus       178 PE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (336)
T cd07849         178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPW  257 (336)
T ss_pred             hHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccH
Confidence            998654 457889999999999999999999996432110000       0000000000           00000000 


Q ss_pred             CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          142 SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       142 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ....+.....+.+++.+||+.+|.+|||+.++++|
T Consensus       258 ~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         258 NKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00011123457899999999999999999999986

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.95  E-value=4.8e-28  Score=174.34  Aligned_cols=157  Identities=25%  Similarity=0.357  Sum_probs=119.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-ceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||+|||++   +++|+||+|.||+++.++ .++++|||.+........ .....++..|++||
T Consensus        96 ~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~y~aPE  171 (256)
T cd08220          96 SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-AYTVVGTPCYISPE  171 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-ccccccCCcccCch
Confidence            4588999999999999999999999   999999999999997554 579999999876654322 22345678899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+|++++++++|..||.......        ...............   .....+.+++.+||+.|
T Consensus       172 ~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~  240 (256)
T cd08220         172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--------LVLKIMSGTFAPISD---RYSPDLRQLILSMLNLD  240 (256)
T ss_pred             hccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--------HHHHHHhcCCCCCCC---CcCHHHHHHHHHHccCC
Confidence            9988888899999999999999999999986432111        111111111110001   11234788999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |++|||+.+++++
T Consensus       241 p~~Rpt~~~ll~~  253 (256)
T cd08220         241 PSKRPQLSQIMAQ  253 (256)
T ss_pred             hhhCCCHHHHhhC
Confidence            9999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=9.7e-28  Score=174.26  Aligned_cols=163  Identities=24%  Similarity=0.329  Sum_probs=114.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe   83 (179)
                      .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+........  ......++..|++||
T Consensus        96 ~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  172 (269)
T cd05087          96 TPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE  172 (269)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHh
Confidence            456678889999999999999999   999999999999999999999999999865432221  112234567899999


Q ss_pred             ccccC-------CCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHH
Q 042876           84 LAYTM-------KITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKV  155 (179)
Q Consensus        84 ~~~~~-------~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  155 (179)
                      .+.+.       .++.++|+||||+++|++++ |..||...........    ..... ....+..... ......+.++
T Consensus       173 ~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~-~~~~~~~~~l  246 (269)
T cd05087         173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY----TVREQ-QLKLPKPRLK-LPLSDRWYEV  246 (269)
T ss_pred             HhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH----Hhhcc-cCCCCCCccC-CCCChHHHHH
Confidence            87542       34779999999999999996 9999965432211000    00000 0111111000 0111236678


Q ss_pred             HhcccCcCCCCCCCHHHHHHHhh
Q 042876          156 AFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       156 i~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +..|| .+|++|||+++|++.|.
T Consensus       247 ~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         247 MQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHHHh-cCcccCCCHHHHHHHhc
Confidence            88999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.95  E-value=1.9e-27  Score=172.63  Aligned_cols=160  Identities=28%  Similarity=0.510  Sum_probs=119.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--ccccc---CCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFA---GTYGY   79 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~---~~~~~   79 (179)
                      ..+++.+++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+.........  .....   .+..|
T Consensus       101 ~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y  177 (269)
T cd05065         101 GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW  177 (269)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceee
Confidence            4588999999999999999999999   9999999999999999999999999998755432211  11111   13469


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      ++||...+..++.++|+||+|+++|++++ |..||.......   ..  .....  ....+.....    ...+.+++.+
T Consensus       178 ~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~--~~i~~--~~~~~~~~~~----~~~~~~li~~  246 (269)
T cd05065         178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VI--NAIEQ--DYRLPPPMDC----PTALHQLMLD  246 (269)
T ss_pred             cCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HH--HHHHc--CCcCCCcccC----CHHHHHHHHH
Confidence            99999988888999999999999999886 999986443211   00  00001  1111211122    2347889999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||..+|++||++.++++.|+
T Consensus       247 ~l~~~p~~Rp~~~~i~~~l~  266 (269)
T cd05065         247 CWQKDRNARPKFGQIVSTLD  266 (269)
T ss_pred             HcCCChhhCcCHHHHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.95  E-value=4.7e-28  Score=196.10  Aligned_cols=155  Identities=26%  Similarity=0.445  Sum_probs=116.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccC------------------CCCCCc
Q 042876            9 WSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK------------------PDSSNW   70 (179)
Q Consensus         9 ~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~------------------~~~~~~   70 (179)
                      ....++++++|++||.|+|++   |+|||||||.|||++.+..+||+|||+++...                  ......
T Consensus       696 ~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~  772 (1351)
T KOG1035|consen  696 RDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDL  772 (1351)
T ss_pred             hHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccc
Confidence            578899999999999999999   99999999999999999999999999998621                  111123


Q ss_pred             ccccCCCCCCCCcccccCC---CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHH
Q 042876           71 TEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQE  147 (179)
Q Consensus        71 ~~~~~~~~~~~pe~~~~~~---~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (179)
                      +..+|+..|+|||++.+..   |+.+.|+||||+|++||+.   ||...       +.-...+...-+..+|.+.....+
T Consensus       773 Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-------MERa~iL~~LR~g~iP~~~~f~~~  842 (1351)
T KOG1035|consen  773 TSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS-------MERASILTNLRKGSIPEPADFFDP  842 (1351)
T ss_pred             ccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch-------HHHHHHHHhcccCCCCCCcccccc
Confidence            4568999999999987654   8999999999999999975   45321       111222222333444443222223


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          148 KLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       148 ~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ....-..+|+++++.||++|||+.|++..
T Consensus       843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  843 EHPEEASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             cchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence            33334678889999999999999999863

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.95  E-value=9.4e-28  Score=175.77  Aligned_cols=159  Identities=26%  Similarity=0.419  Sum_probs=120.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      .+++..++.++.|++.||.+||+.   |++|+||+|+||+++.++.++++||+.+..............+...|++||.+
T Consensus       112 ~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~  188 (286)
T cd06614         112 RMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI  188 (286)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHh
Confidence            789999999999999999999998   99999999999999999999999999876554332222333566789999998


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCC
Q 042876           86 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPE  165 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  165 (179)
                      .+..++.++|+||||+++|++++|..||...+...        ..........+.. .........+.+++.+||+.+|.
T Consensus       189 ~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~  259 (286)
T cd06614         189 KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--------ALFLITTKGIPPL-KNPEKWSPEFKDFLNKCLVKDPE  259 (286)
T ss_pred             cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCCC-cchhhCCHHHHHHHHHHhccChh
Confidence            88888999999999999999999999986432211        0000101111110 01111233578899999999999


Q ss_pred             CCCCHHHHHHH
Q 042876          166 SRPTMKIVSQQ  176 (179)
Q Consensus       166 ~Rps~~~~~~~  176 (179)
                      +||++++++++
T Consensus       260 ~Rpt~~~il~~  270 (286)
T cd06614         260 KRPSAEELLQH  270 (286)
T ss_pred             hCcCHHHHhhC
Confidence            99999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.95  E-value=1.4e-27  Score=174.39  Aligned_cols=158  Identities=19%  Similarity=0.251  Sum_probs=119.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.......  .....++..|++||.
T Consensus        92 ~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~  166 (279)
T cd05633          92 GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEV  166 (279)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCcCCCcCccCHHH
Confidence            4689999999999999999999999   99999999999999999999999999986543221  123467889999998


Q ss_pred             cc-cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AY-TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~-~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .. +..++.++|+||+|++++++++|..||...........   ..........++      .....++.+++.+||..|
T Consensus       167 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~  237 (279)
T cd05633         167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTVNVELP------DSFSPELKSLLEGLLQRD  237 (279)
T ss_pred             hcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH---HHHhhcCCcCCc------cccCHHHHHHHHHHhcCC
Confidence            76 45578899999999999999999999965432111100   000001111111      112234788899999999


Q ss_pred             CCCCC-----CHHHHHHH
Q 042876          164 PESRP-----TMKIVSQQ  176 (179)
Q Consensus       164 p~~Rp-----s~~~~~~~  176 (179)
                      |.+||     |++++++|
T Consensus       238 p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         238 VSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             HHHhcCCCCCCHHHHHhC
Confidence            99999     69999887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.95  E-value=8e-28  Score=177.01  Aligned_cols=158  Identities=25%  Similarity=0.341  Sum_probs=119.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..+++..+..++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|||++........ .....++..|++||
T Consensus       109 ~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~y~aPE  184 (296)
T cd06618         109 GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-KTRSAGCAAYMAPE  184 (296)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-ccCCCCCccccCHh
Confidence            468899999999999999999997 5   899999999999999999999999999876543221 12234667899999


Q ss_pred             ccccCC----CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCC---CCCCCCccHHHHHHHHHHHH
Q 042876           84 LAYTMK----ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDP---RLPAPSRSVQEKLISIVKVA  156 (179)
Q Consensus        84 ~~~~~~----~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li  156 (179)
                      .+.+..    ++.++|+||||+++|++++|..||......       ..........   ..+...    .....+.+++
T Consensus       185 ~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~----~~~~~l~~li  253 (296)
T cd06618         185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEEPPSLPPNE----GFSPDFCSFV  253 (296)
T ss_pred             hcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCCCCCCCCCC----CCCHHHHHHH
Confidence            987553    678999999999999999999998643211       0111111111   111111    1223478899


Q ss_pred             hcccCcCCCCCCCHHHHHHHh
Q 042876          157 FSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       157 ~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      .+||+.||.+||++++++++-
T Consensus       254 ~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         254 DLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             HHHccCChhhCCCHHHHhcCh
Confidence            999999999999999998764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.95  E-value=1.3e-27  Score=173.67  Aligned_cols=162  Identities=21%  Similarity=0.270  Sum_probs=112.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC--CCcccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe   83 (179)
                      .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.......  .......++..|++||
T Consensus        95 ~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  171 (268)
T cd05086          95 NSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE  171 (268)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCch
Confidence            456677889999999999999998   99999999999999999999999999875432111  1112345678899999


Q ss_pred             cccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHH
Q 042876           84 LAYT-------MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKV  155 (179)
Q Consensus        84 ~~~~-------~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  155 (179)
                      .+..       ..++.++|+||||+++|++++ +..||.....................++.++.      .....+.++
T Consensus       172 ~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l  245 (268)
T cd05086         172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL------PYSERWYEV  245 (268)
T ss_pred             hcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC------CCcHHHHHH
Confidence            8753       234678999999999999997 56687543321110000000011111111111      122346778


Q ss_pred             HhcccCcCCCCCCCHHHHHHHh
Q 042876          156 AFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       156 i~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      +..|| .+|++||+++++++.|
T Consensus       246 ~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         246 LQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             HHHHh-hCcccCCCHHHHHHHh
Confidence            88999 6799999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.95  E-value=1.6e-27  Score=174.14  Aligned_cols=160  Identities=26%  Similarity=0.380  Sum_probs=119.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||++.  +++|+||+|+||+++.++.++++|||.+....... ......++..|++||.
T Consensus        98 ~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  174 (283)
T cd06617          98 LTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-AKTIDAGCKPYMAPER  174 (283)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc-ccccccCCccccChhh
Confidence            46899999999999999999999853  89999999999999999999999999987654321 1222456778999998


Q ss_pred             ccc----CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           85 AYT----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        85 ~~~----~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      +.+    ..++.++|+||+|+++|++++|..||......    ...............+.  .   ....++.+++.+||
T Consensus       175 ~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~--~---~~~~~l~~li~~~l  245 (283)
T cd06617         175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQLKQVVEEPSPQLPA--E---KFSPEFQDFVNKCL  245 (283)
T ss_pred             cCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHHHHHHHhcCCCCCCc--c---ccCHHHHHHHHHHc
Confidence            765    34578999999999999999999998642210    00000111111111111  1   12234788999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      ..+|.+||++.+++++
T Consensus       246 ~~~p~~Rp~~~~il~~  261 (283)
T cd06617         246 KKNYKERPNYPELLQH  261 (283)
T ss_pred             cCChhhCcCHHHHhcC
Confidence            9999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.95  E-value=5.7e-28  Score=175.40  Aligned_cols=162  Identities=25%  Similarity=0.317  Sum_probs=113.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCCcc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPEL   84 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~   84 (179)
                      +++...+.++.|++.||+|||+.   +++|+||||+||+++.++.++++|||++........  ......++..|++||.
T Consensus        97 ~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  173 (269)
T cd05042          97 AQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL  173 (269)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHH
Confidence            46778899999999999999999   999999999999999999999999999865432211  1122344567999998


Q ss_pred             ccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHH
Q 042876           85 AYT-------MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVA  156 (179)
Q Consensus        85 ~~~-------~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  156 (179)
                      ...       ..++.++|+||||+++|++++ |..||........    ...... ......+.. .........+..++
T Consensus       174 ~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~  247 (269)
T cd05042         174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV----LKQVVR-EQDIKLPKP-QLDLKYSDRWYEVM  247 (269)
T ss_pred             HhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH----HHHHhh-ccCccCCCC-cccccCCHHHHHHH
Confidence            642       346789999999999999998 7888864422110    000000 011111111 01111223356677


Q ss_pred             hcccCcCCCCCCCHHHHHHHhh
Q 042876          157 FSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       157 ~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ..|| .||++|||++++++.|.
T Consensus       248 ~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         248 QFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             HHHh-cCcccccCHHHHHHHhc
Confidence            8898 59999999999998863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.95  E-value=1e-27  Score=172.51  Aligned_cols=159  Identities=26%  Similarity=0.364  Sum_probs=123.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++.++..++.|++.||.+||+.   +++|+||+|+||+++.++.++++|||.+..............+++.|++||
T Consensus        97 ~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe  173 (258)
T cd08215          97 GKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE  173 (258)
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChh
Confidence            36789999999999999999999999   999999999999999999999999999876654432233346777899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      ...+..++.++|+||+|++++++++|..||......        ...........+....   .....+.+++.+||..+
T Consensus       174 ~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~~~i~~~l~~~  242 (258)
T cd08215         174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKGQYPPIPS---QYSSELRNLVSSLLQKD  242 (258)
T ss_pred             HhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcCCCCCCCC---CCCHHHHHHHHHHcCCC
Confidence            988888899999999999999999999998644311        1111111111111111   12234788999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |++|||+.+++++
T Consensus       243 p~~Rp~~~~ll~~  255 (258)
T cd08215         243 PEERPSIAQILQS  255 (258)
T ss_pred             hhhCcCHHHHhcC
Confidence            9999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.95  E-value=1.1e-27  Score=175.16  Aligned_cols=169  Identities=23%  Similarity=0.339  Sum_probs=120.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||.
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  171 (286)
T cd07846          95 NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL  171 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHH
Confidence            4589999999999999999999999   9999999999999999999999999998765443333334456788999998


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCccccccccc--------ccchh--------hhhhhcCCCCCCCC---Ccc
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS--------SLNTD--------IELDEMLDPRLPAP---SRS  144 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~--------~~~~~--------~~~~~~~~~~~~~~---~~~  144 (179)
                      ..+. .++.++|+||+|++++++++|..||.........        .....        ........+.....   ...
T Consensus       172 ~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (286)
T cd07846         172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKR  251 (286)
T ss_pred             hccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHh
Confidence            7653 4678899999999999999999888643321000        00000        00000000000000   000


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.+++.+||+.+|++||++.+++++
T Consensus       252 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         252 FPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             CCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            11123458889999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.95  E-value=7.3e-28  Score=176.45  Aligned_cols=160  Identities=23%  Similarity=0.292  Sum_probs=120.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++....... ......++..|++||.
T Consensus        97 ~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~  172 (285)
T cd05630          97 AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEV  172 (285)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cccCCCCCccccChHH
Confidence            4588899999999999999999998   99999999999999999999999999986544322 1223467889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+|+++|++++|..||........     ................   ......+.+++.+||+.||
T Consensus       173 ~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p  244 (285)
T cd05630         173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-----REEVERLVKEVQEEYS---EKFSPDARSLCKMLLCKDP  244 (285)
T ss_pred             HcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-----HHHHHhhhhhhhhhcC---ccCCHHHHHHHHHHhhcCH
Confidence            9888899999999999999999999999975432110     0011111100000000   0112247889999999999


Q ss_pred             CCCCC-----HHHHHHH
Q 042876          165 ESRPT-----MKIVSQQ  176 (179)
Q Consensus       165 ~~Rps-----~~~~~~~  176 (179)
                      .+|||     ++++++|
T Consensus       245 ~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         245 KERLGCQGGGAREVKEH  261 (285)
T ss_pred             HHccCCCCCchHHHHcC
Confidence            99999     8898875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-28  Score=190.68  Aligned_cols=156  Identities=27%  Similarity=0.385  Sum_probs=125.2

Q ss_pred             CHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee-cCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccc
Q 042876            8 DWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL-DLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY   86 (179)
Q Consensus         8 ~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   86 (179)
                      +++..-.+.+||++||.|||.+   .|||||||.+|+++ .-+|.+||+|||-++.+..-..+..++.|+..|++||++.
T Consensus       673 NEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvID  749 (1226)
T KOG4279|consen  673 NESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVID  749 (1226)
T ss_pred             chhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhc
Confidence            7788899999999999999999   99999999999999 4578899999999998877777778889999999999886


Q ss_pred             c--CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           87 T--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        87 ~--~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      .  ..|..++|+|||||++.+|.||+.||.........  +....   +.    ........+...+...+|.+|+.++|
T Consensus       750 qG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkVG---my----KvHP~iPeelsaeak~FilrcFepd~  820 (1226)
T KOG4279|consen  750 QGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKVG---MY----KVHPPIPEELSAEAKNFILRCFEPDP  820 (1226)
T ss_pred             cCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhhc---ce----ecCCCCcHHHHHHHHHHHHHHcCCCc
Confidence            4  35889999999999999999999999755432211  11111   11    11112233445568889999999999


Q ss_pred             CCCCCHHHHHH
Q 042876          165 ESRPTMKIVSQ  175 (179)
Q Consensus       165 ~~Rps~~~~~~  175 (179)
                      .+||++.++++
T Consensus       821 ~~R~sA~~LL~  831 (1226)
T KOG4279|consen  821 CDRPSAKDLLQ  831 (1226)
T ss_pred             ccCccHHHhcc
Confidence            99999999875

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.95  E-value=2.9e-27  Score=171.63  Aligned_cols=159  Identities=26%  Similarity=0.451  Sum_probs=121.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcc---cccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~---~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||++||+.   +++|+||+|+|++++.++.++++|||++...........   ....+..|++
T Consensus       101 ~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~  177 (267)
T cd05066         101 GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA  177 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecC
Confidence            4578999999999999999999999   999999999999999999999999999876654322111   1122457999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      ||.+.+..++.++|+||||++++++++ |..||........        ....... +.+....    ....+.+++.+|
T Consensus       178 pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~----~~~~~~~li~~~  245 (267)
T cd05066         178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--------IKAIEEGYRLPAPMD----CPAALHQLMLDC  245 (267)
T ss_pred             HhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--------HHHHhCCCcCCCCCC----CCHHHHHHHHHH
Confidence            999988888999999999999999886 9999865432110        1111111 1111111    123478899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.+|.+||++.++++.|+
T Consensus       246 l~~~p~~Rp~~~~i~~~l~  264 (267)
T cd05066         246 WQKDRNERPKFEQIVSILD  264 (267)
T ss_pred             cccCchhCCCHHHHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.95  E-value=3.3e-28  Score=184.97  Aligned_cols=159  Identities=19%  Similarity=0.305  Sum_probs=114.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC-----------------
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS-----------------   67 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-----------------   67 (179)
                      ..+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++.......                 
T Consensus        96 ~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~  172 (382)
T cd05625          96 GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD  172 (382)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccc
Confidence            4678899999999999999999999   99999999999999999999999999975321000                 


Q ss_pred             ------------------------------CCcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccc
Q 042876           68 ------------------------------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLS  117 (179)
Q Consensus        68 ------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~  117 (179)
                                                    .......+++.|+|||.+.+..++.++|+||+||++|+|++|..||....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~  252 (382)
T cd05625         173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQT  252 (382)
T ss_pred             ccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCC
Confidence                                          00012357889999999988889999999999999999999999996543


Q ss_pred             cccccccchhhhhhhc-CCCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCC---HHHHHHH
Q 042876          118 SISSSSLNTDIELDEM-LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT---MKIVSQQ  176 (179)
Q Consensus       118 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps---~~~~~~~  176 (179)
                      ....     ....... .....+.....    ..+..+++.+++ .+|.+|++   ++++++|
T Consensus       253 ~~~~-----~~~i~~~~~~~~~p~~~~~----s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         253 PLET-----QMKVINWQTSLHIPPQAKL----SPEASDLIIKLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             HHHH-----HHHHHccCCCcCCCCcccC----CHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence            2110     0000000 01111211111    123566666665 49999987   8888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=7.9e-28  Score=179.92  Aligned_cols=171  Identities=24%  Similarity=0.330  Sum_probs=122.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC----cccccCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN----WTEFAGTYGY   79 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~   79 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+.........    .....++..|
T Consensus       101 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y  177 (334)
T cd07855         101 DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY  177 (334)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccc
Confidence            45689999999999999999999999   9999999999999999999999999998765432211    1234677889


Q ss_pred             CCCccccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccc------------cc---hhhhhhhc---CCCCCCC
Q 042876           80 VAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS------------LN---TDIELDEM---LDPRLPA  140 (179)
Q Consensus        80 ~~pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~------------~~---~~~~~~~~---~~~~~~~  140 (179)
                      ++||.+.+ ..++.++|+||+|+++|++++|+.||..........            ..   ........   .......
T Consensus       178 ~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (334)
T cd07855         178 RAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPV  257 (334)
T ss_pred             cChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCC
Confidence            99998765 457889999999999999999999996543211000            00   00000000   0101010


Q ss_pred             C-CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          141 P-SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       141 ~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      . .........++.+++.+||+.+|.+||++++++++-
T Consensus       258 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         258 PWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             CHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence            0 001112244588999999999999999999998864

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.95  E-value=6.7e-28  Score=173.69  Aligned_cols=158  Identities=25%  Similarity=0.359  Sum_probs=120.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||++||+.   +++|+||+|+||+++.++.++++|||.+....... ......++..|++||.
T Consensus        97 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~  172 (258)
T cd06632          97 GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEV  172 (258)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-cccccCCCcceeCHHH
Confidence            3578999999999999999999999   99999999999999999999999999987654332 2233457788999998


Q ss_pred             cccCC-CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~~~-~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +.... ++.++|+||+|++++++++|..||.......     ........  ...+...   .....++.+++.+||+.+
T Consensus       173 ~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~--~~~~~~~---~~~~~~~~~li~~~l~~~  242 (258)
T cd06632         173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-----AVFKIGRS--KELPPIP---DHLSDEAKDFILKCLQRD  242 (258)
T ss_pred             hcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-----HHHHHHhc--ccCCCcC---CCcCHHHHHHHHHHhhcC
Confidence            87666 8899999999999999999999986543111     00111110  0111111   112234788899999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |++||++++++++
T Consensus       243 p~~Rp~~~~~l~~  255 (258)
T cd06632         243 PSLRPTAAELLEH  255 (258)
T ss_pred             cccCcCHHHHhcC
Confidence            9999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.95  E-value=2.2e-27  Score=171.67  Aligned_cols=158  Identities=29%  Similarity=0.349  Sum_probs=122.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||.+....... ......++..|++||.
T Consensus        88 ~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~  163 (262)
T cd05572          88 GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEI  163 (262)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCccChhH
Confidence            4578999999999999999999998   99999999999999999999999999987665432 1223456788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCC--CCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD--PRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      +.+..++.++|+||+|+++|++++|..||.......      .........  .....+...    ...+.+++.+||..
T Consensus       164 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~----~~~~~~~i~~~l~~  233 (262)
T cd05572         164 ILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP------MEIYNDILKGNGKLEFPNYI----DKAAKDLIKQLLRR  233 (262)
T ss_pred             hcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH------HHHHHHHhccCCCCCCCccc----CHHHHHHHHHHccC
Confidence            888788899999999999999999999996543211      111111111  111111111    33588999999999


Q ss_pred             CCCCCCC-----HHHHHHH
Q 042876          163 SPESRPT-----MKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rps-----~~~~~~~  176 (179)
                      ||++||+     +.|+++|
T Consensus       234 ~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         234 NPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             ChhhCcCCcccCHHHHhcC
Confidence            9999999     8998875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.95  E-value=4.6e-28  Score=182.30  Aligned_cols=161  Identities=22%  Similarity=0.286  Sum_probs=122.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCC------------------
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP------------------   65 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~------------------   65 (179)
                      ...|++..+..++.+++.||+.+|+.   |+|||||||+|+|++..|.+|+.|||++..+..                  
T Consensus       235 ~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~  311 (550)
T KOG0605|consen  235 KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLS  311 (550)
T ss_pred             cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhc
Confidence            35789999999999999999999999   999999999999999999999999999863210                  


Q ss_pred             ----CCCC-----c--------------------ccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCccc
Q 042876           66 ----DSSN-----W--------------------TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL  116 (179)
Q Consensus        66 ----~~~~-----~--------------------~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~  116 (179)
                          ....     .                    ...+|+|.|+|||++.+..+...+|-|||||++|||+.|..||...
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~  391 (550)
T KOG0605|consen  312 EAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSE  391 (550)
T ss_pred             cCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence                0000     0                    1147999999999999999999999999999999999999999765


Q ss_pred             ccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCC---CHHHHHHH
Q 042876          117 SSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRP---TMKIVSQQ  176 (179)
Q Consensus       117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~~~~~  176 (179)
                      ...+..  .....+...+.  .|......    .+..+||.+|+. ||++|.   .++||.+|
T Consensus       392 tp~~T~--rkI~nwr~~l~--fP~~~~~s----~eA~DLI~rll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  392 TPQETY--RKIVNWRETLK--FPEEVDLS----DEAKDLITRLLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             CHHHHH--HHHHHHhhhcc--CCCcCccc----HHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence            432211  11122332221  22222222    347788999998 999997   57777765

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=4.8e-28  Score=179.01  Aligned_cols=170  Identities=22%  Similarity=0.239  Sum_probs=119.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-----------ccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-----------WTE   72 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----------~~~   72 (179)
                      ...+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.++++|||++.........           ...
T Consensus       109 ~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  185 (311)
T cd07866         109 SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN  185 (311)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCccccccccc
Confidence            34689999999999999999999999   9999999999999999999999999998755432211           112


Q ss_pred             ccCCCCCCCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-------------hhhhhh----cC
Q 042876           73 FAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-------------DIELDE----ML  134 (179)
Q Consensus        73 ~~~~~~~~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-------------~~~~~~----~~  134 (179)
                      ..++..|++||.+.+. .++.++|+||+|++++++++|..||...+.........             ......    ..
T Consensus       186 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (311)
T cd07866         186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHS  265 (311)
T ss_pred             ceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhccccccccc
Confidence            2456779999987653 47889999999999999999999986543211000000             000000    00


Q ss_pred             CCCCCCC-CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          135 DPRLPAP-SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       135 ~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ....+.. ..........+.+++.+|++.||.+|||+.+++.+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         266 FTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             CCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            0001100 00011122457889999999999999999999876

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.95  E-value=5.7e-28  Score=176.31  Aligned_cols=167  Identities=20%  Similarity=0.246  Sum_probs=119.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||+|||+.   +++|+||+|.||+++. +.++++|||++........ .....++..|++||.
T Consensus        95 ~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~  169 (282)
T cd07831          95 RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-YTEYISTRWYRAPEC  169 (282)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC-cCCCCCCcccCChhH
Confidence            4689999999999999999999999   9999999999999998 9999999999876543322 223456788999997


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch------hhhhhhc------CCCCCCCCC-----ccHH
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT------DIELDEM------LDPRLPAPS-----RSVQ  146 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~------~~~~~~~------~~~~~~~~~-----~~~~  146 (179)
                      +.. ..++.++|+||+|++++++++|..||...+.........      .......      .....+...     ....
T Consensus       170 ~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (282)
T cd07831         170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLP  249 (282)
T ss_pred             hhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcc
Confidence            643 456889999999999999999999996543211000000      0000000      000000000     0011


Q ss_pred             HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          147 EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       147 ~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .....+.+++.+||+.||++||++++++++
T Consensus       250 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         250 NASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            224568899999999999999999999876

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=2e-27  Score=174.49  Aligned_cols=155  Identities=25%  Similarity=0.271  Sum_probs=120.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..+..++.|+++||.|||+.   +++|+||+|.||+++.++.++++|||++......   .....+++.|++||
T Consensus        95 ~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE  168 (290)
T cd05580          95 SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPE  168 (290)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCCCCCCccccChh
Confidence            35689999999999999999999998   9999999999999999999999999998765433   23345778899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+...+.++|+||||++++++++|..||.....        ............+.+...    ...+.+++.+||..|
T Consensus       169 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~  236 (290)
T cd05580         169 IILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEGKVRFPSFF----SPDAKDLIRNLLQVD  236 (290)
T ss_pred             hhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCccCCccC----CHHHHHHHHHHccCC
Confidence            98887888999999999999999999999864431        111111111111111111    234788999999999


Q ss_pred             CCCCC-----CHHHHHHH
Q 042876          164 PESRP-----TMKIVSQQ  176 (179)
Q Consensus       164 p~~Rp-----s~~~~~~~  176 (179)
                      |.+|+     ++.++++|
T Consensus       237 p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         237 LTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             HHHccCcccCCHHHHHcC
Confidence            99999     88888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=2.9e-27  Score=173.09  Aligned_cols=160  Identities=23%  Similarity=0.315  Sum_probs=119.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+..  +++|+||+|+||+++.++.++++|||.+.......  .....++..|++||.
T Consensus        97 ~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~aPE~  172 (286)
T cd06622          97 EGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--AKTNIGCQSYMAPER  172 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--cccCCCccCccCcch
Confidence            47899999999999999999999632  89999999999999999999999999986553221  223356778999998


Q ss_pred             cccCC------CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           85 AYTMK------ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        85 ~~~~~------~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      +.+..      ++.++|+||+|+++|++++|..||........     ............+..   ......++.+++.+
T Consensus       173 ~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~~~li~~  244 (286)
T cd06622         173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-----FAQLSAIVDGDPPTL---PSGYSDDAQDFVAK  244 (286)
T ss_pred             hcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-----HHHHHHHhhcCCCCC---CcccCHHHHHHHHH
Confidence            86543      47789999999999999999999964321110     011111111111111   11233457889999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||+.+|.+||++.+++++
T Consensus       245 ~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         245 CLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             HcccCcccCCCHHHHhcC
Confidence            999999999999999876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.95  E-value=1.7e-28  Score=186.23  Aligned_cols=159  Identities=19%  Similarity=0.277  Sum_probs=116.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC-----------------
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS-----------------   67 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-----------------   67 (179)
                      ..+++..++.++.||+.||+|||+.   +++||||||+||+++.++.++|+|||++..+....                 
T Consensus        96 ~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~  172 (376)
T cd05598          96 GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME  172 (376)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccc
Confidence            4678899999999999999999999   99999999999999999999999999975321000                 


Q ss_pred             --------------------------CCcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccc
Q 042876           68 --------------------------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS  121 (179)
Q Consensus        68 --------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~  121 (179)
                                                .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||........
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~  252 (376)
T cd05598         173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAET  252 (376)
T ss_pred             ccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHH
Confidence                                      001124688899999999988899999999999999999999999975432111


Q ss_pred             cccchhhhhhhcC-CCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCC---CHHHHHHH
Q 042876          122 SSLNTDIELDEML-DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRP---TMKIVSQQ  176 (179)
Q Consensus       122 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~~~~~  176 (179)
                      .     ....... ....+.....    ...+.+++.+|+ .+|.+|+   ++.++++|
T Consensus       253 ~-----~~i~~~~~~~~~~~~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         253 Q-----LKVINWETTLHIPSQAKL----SREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             H-----HHHhccCccccCCCCCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            0     0000000 0011111111    223566777766 5999999   89999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.95  E-value=6.2e-28  Score=173.87  Aligned_cols=158  Identities=22%  Similarity=0.284  Sum_probs=120.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc-eeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE-AHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++. ++++||+.+..............++..|++||.
T Consensus        97 ~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~  173 (257)
T cd08225          97 LFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI  173 (257)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHH
Confidence            578999999999999999999998   9999999999999988754 699999998766543322233457788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      ..+..++.++|+||+|++++++++|..||.......        ..........+....   ....++.+++.+||..+|
T Consensus       174 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~---~~~~~~~~~i~~~l~~~p  242 (257)
T cd08225         174 CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ--------LVLKICQGYFAPISP---NFSRDLRSLISQLFKVSP  242 (257)
T ss_pred             HcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHhcccCCCCCC---CCCHHHHHHHHHHhccCh
Confidence            888788899999999999999999999986432111        111111111111111   112347888999999999


Q ss_pred             CCCCCHHHHHHHh
Q 042876          165 ESRPTMKIVSQQL  177 (179)
Q Consensus       165 ~~Rps~~~~~~~l  177 (179)
                      ++|||+.+++++-
T Consensus       243 ~~Rpt~~~ll~~~  255 (257)
T cd08225         243 RDRPSITSILKRP  255 (257)
T ss_pred             hhCcCHHHHhhCC
Confidence            9999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.95  E-value=2e-27  Score=175.56  Aligned_cols=169  Identities=21%  Similarity=0.272  Sum_probs=118.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC----cccccCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN----WTEFAGTYGYV   80 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~   80 (179)
                      ..+++.+++.++.|+++||.|||++   +++|+||+|+||+++.++.++++|||.+.........    .....++..|+
T Consensus       114 ~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~  190 (310)
T cd07865         114 VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR  190 (310)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCcccc
Confidence            3689999999999999999999999   9999999999999999999999999998765432211    12334567899


Q ss_pred             CCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhh-------------hhhhcCCCCCCCCC-ccH
Q 042876           81 APELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDI-------------ELDEMLDPRLPAPS-RSV  145 (179)
Q Consensus        81 ~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~-~~~  145 (179)
                      |||.+.+. .++.++|+||+|++++++++|..||...............             ..........+... ...
T Consensus       191 aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (310)
T cd07865         191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKV  270 (310)
T ss_pred             CcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhh
Confidence            99987654 3678999999999999999999998644321000000000             00000000000000 000


Q ss_pred             H------HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 Q------EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ~------~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .      .....+.++|.+||..||.+|||++++++|
T Consensus       271 ~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         271 KERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             HHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            0      011246789999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=184.51  Aligned_cols=161  Identities=27%  Similarity=0.418  Sum_probs=127.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ++.|++.++.-+++|++.||.|||++   +|||||||.-|||+..+|.|+++|||.+-...........++|++.|++||
T Consensus       124 ~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPE  200 (1187)
T KOG0579|consen  124 GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPE  200 (1187)
T ss_pred             ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccch
Confidence            46789999999999999999999999   999999999999999999999999999866554444456689999999999


Q ss_pred             ccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           84 LAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        84 ~~~-----~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      .+.     ..+|.+++|+||||+++.+|..+..|....+......     .....-++.+..+ ..|..   .+.+++.+
T Consensus       201 VvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll-----KiaKSePPTLlqP-S~Ws~---~F~DfLk~  271 (1187)
T KOG0579|consen  201 VVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL-----KIAKSEPPTLLQP-SHWSR---SFSDFLKR  271 (1187)
T ss_pred             heeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH-----HHhhcCCCcccCc-chhhh---HHHHHHHH
Confidence            764     4578899999999999999999999987665432211     1111122222221 22222   47778889


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||..||..||++.++++|
T Consensus       272 cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  272 CLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             HHhcCCccCCCHHHHhhC
Confidence            999999999999999987

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=1.2e-27  Score=178.80  Aligned_cols=170  Identities=21%  Similarity=0.265  Sum_probs=120.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC----cccccCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN----WTEFAGTYGY   79 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~   79 (179)
                      ...+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.........    .....++..|
T Consensus        99 ~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y  175 (332)
T cd07857          99 GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY  175 (332)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccc
Confidence            45789999999999999999999999   9999999999999999999999999999765432211    1234677889


Q ss_pred             CCCccccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccc------------cccch---hhhhhh---cCCC-CCC
Q 042876           80 VAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------------SSLNT---DIELDE---MLDP-RLP  139 (179)
Q Consensus        80 ~~pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~------------~~~~~---~~~~~~---~~~~-~~~  139 (179)
                      ++||...+ ..++.++|+||+|++++++++|..||...+....            .....   ......   .... ...
T Consensus       176 ~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (332)
T cd07857         176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKK  255 (332)
T ss_pred             cCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCc
Confidence            99998765 4678899999999999999999999865431100            00000   000000   0000 000


Q ss_pred             CCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          140 APSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       140 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ............+.+++.+|++.||.+|||+++++++
T Consensus       256 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         256 PFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             chHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000001112357889999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.95  E-value=3.4e-27  Score=174.88  Aligned_cols=168  Identities=18%  Similarity=0.198  Sum_probs=119.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC----CCceeEccccCccccCCCCC---CcccccCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL----EYEAHVADFGIAKFLKPDSS---NWTEFAGTYG   78 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~----~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~   78 (179)
                      .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.    ++.++++|||++........   ......++..
T Consensus       104 ~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  180 (316)
T cd07842         104 SIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW  180 (316)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCcccccc
Confidence            688999999999999999999999   9999999999999998    89999999999876543322   1223356778


Q ss_pred             CCCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCccccccccc-ccchhhhhh-------------------------
Q 042876           79 YVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS-SLNTDIELD-------------------------  131 (179)
Q Consensus        79 ~~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~-~~~~~~~~~-------------------------  131 (179)
                      |+|||.+.+. .++.++|+||||++++++++|+.||......... .........                         
T Consensus       181 y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (316)
T cd07842         181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDT  260 (316)
T ss_pred             ccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchh
Confidence            9999987654 5788999999999999999999999654332100 000000000                         


Q ss_pred             ---hcCCCCCCCCCc-cHH----HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          132 ---EMLDPRLPAPSR-SVQ----EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       132 ---~~~~~~~~~~~~-~~~----~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                         .......+.... ...    .....+.+++.+||+.||.+|||+.++++|
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         261 LMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             hhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence               000001110000 000    122358899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.5e-28  Score=184.60  Aligned_cols=161  Identities=19%  Similarity=0.265  Sum_probs=116.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC------------C--
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS------------N--   69 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~------------~--   69 (179)
                      .+.+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++++|||+++.+.....            .  
T Consensus        95 ~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~  171 (377)
T cd05629          95 YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN  171 (377)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccc
Confidence            35688899999999999999999999   999999999999999999999999999863211000            0  


Q ss_pred             ---------------------------------cccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCccc
Q 042876           70 ---------------------------------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL  116 (179)
Q Consensus        70 ---------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~  116 (179)
                                                       .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~  251 (377)
T cd05629         172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSE  251 (377)
T ss_pred             ccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCC
Confidence                                             00135788999999998888999999999999999999999999654


Q ss_pred             ccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCCCC---CCHHHHHHH
Q 042876          117 SSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESR---PTMKIVSQQ  176 (179)
Q Consensus       117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R---ps~~~~~~~  176 (179)
                      .....  .........  ...++.....    ...+.+++.+|+. +|.+|   +++.++++|
T Consensus       252 ~~~~~--~~~i~~~~~--~~~~p~~~~~----s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         252 NSHET--YRKIINWRE--TLYFPDDIHL----SVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             CHHHH--HHHHHccCC--ccCCCCCCCC----CHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            32110  000000000  0111111111    2236788889997 66665   599999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.95  E-value=1.1e-27  Score=177.15  Aligned_cols=157  Identities=26%  Similarity=0.414  Sum_probs=119.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++..+..++.|++.||.|||+.   +++|+||+|.||+++.++.++++|||++......    ....++..|++||
T Consensus       109 ~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE  181 (307)
T cd06607         109 KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPE  181 (307)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC----CCccCCccccCce
Confidence            34689999999999999999999998   9999999999999999999999999988654432    2245677899999


Q ss_pred             ccc---cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           84 LAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        84 ~~~---~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      .+.   ...++.++|+||||+++|++++|..||.........     ........+...     .......+.+++.+||
T Consensus       182 ~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~-----~~~~~~~~~~li~~~l  251 (307)
T cd06607         182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQNDSPTLS-----SNDWSDYFRNFVDSCL  251 (307)
T ss_pred             eeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH-----HHHhcCCCCCCC-----chhhCHHHHHHHHHHh
Confidence            874   345788999999999999999999998643221100     000000001111     1112335788999999


Q ss_pred             CcCCCCCCCHHHHHHHh
Q 042876          161 NESPESRPTMKIVSQQL  177 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l  177 (179)
                      ..+|++||++.+++.+.
T Consensus       252 ~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         252 QKIPQDRPSSEELLKHR  268 (307)
T ss_pred             cCChhhCcCHHHHhcCh
Confidence            99999999999998864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.95  E-value=1e-27  Score=174.83  Aligned_cols=160  Identities=24%  Similarity=0.280  Sum_probs=120.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+...... .......+...|++||.
T Consensus        90 ~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~~PE~  165 (277)
T cd05577          90 PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPGYMAPEV  165 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCCcCCHHH
Confidence            3689999999999999999999999   9999999999999999999999999988765432 22233456778999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      ..+..++.++|+||+|++++++++|..||........    ..................    ....+.+++.+||+.||
T Consensus       166 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p  237 (277)
T cd05577         166 LQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEELKRRTLEMAVEYPDK----FSPEAKDLCEALLQKDP  237 (277)
T ss_pred             hcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHHHHhccccccccCCcc----CCHHHHHHHHHHccCCh
Confidence            8887888999999999999999999999965432110    000011111111111111    12347889999999999


Q ss_pred             CCCC-----CHHHHHHH
Q 042876          165 ESRP-----TMKIVSQQ  176 (179)
Q Consensus       165 ~~Rp-----s~~~~~~~  176 (179)
                      .+||     ++.++++|
T Consensus       238 ~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         238 EKRLGCRGGSADEVREH  254 (277)
T ss_pred             hHccCCCcccHHHHHhC
Confidence            9999     77778765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.95  E-value=1.6e-27  Score=176.46  Aligned_cols=167  Identities=22%  Similarity=0.308  Sum_probs=120.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|+++||.|||+..  +++|+||+|.||+++.++.++++|||++.......  .....++..|++||.
T Consensus        94 ~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~  169 (308)
T cd06615          94 GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPER  169 (308)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc--cccCCCCcCccChhH
Confidence            46788999999999999999999731  89999999999999999999999999886543221  233467789999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh----------------------------hhhhhcCCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD----------------------------IELDEMLDP  136 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~----------------------------~~~~~~~~~  136 (179)
                      +.+..++.++|+||+|++++++++|..||..............                            .........
T Consensus       170 ~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (308)
T cd06615         170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE  249 (308)
T ss_pred             hcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcC
Confidence            8888888999999999999999999999854321110000000                            000000000


Q ss_pred             CCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          137 RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      ..+...  ......++.+++.+||..||++||++.+++++-
T Consensus       250 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         250 PPPKLP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCccCc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            000000  001223478999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=3.8e-27  Score=171.88  Aligned_cols=169  Identities=22%  Similarity=0.270  Sum_probs=121.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.++++|||.+..................|++||.
T Consensus        93 ~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~  169 (282)
T cd07829          93 GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI  169 (282)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHH
Confidence            4689999999999999999999999   9999999999999999999999999998766544333333455678999998


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCccccccccccc-------chhhhhh---hc--CCCCCCCCC-----ccHH
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL-------NTDIELD---EM--LDPRLPAPS-----RSVQ  146 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~-------~~~~~~~---~~--~~~~~~~~~-----~~~~  146 (179)
                      +.+. .++.++|+||||++++++++|..||...........       .......   ..  .....+...     ....
T Consensus       170 ~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (282)
T cd07829         170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLP  249 (282)
T ss_pred             hcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcc
Confidence            8766 778899999999999999999999864331110000       0000000   00  000011000     0011


Q ss_pred             HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          147 EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       147 ~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .....+.+++.+||..||++||++++++.+
T Consensus       250 ~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         250 RLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            113458899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.95  E-value=1.2e-27  Score=174.92  Aligned_cols=170  Identities=20%  Similarity=0.317  Sum_probs=120.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      +.+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+........ ......++..|++||
T Consensus        94 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  170 (286)
T cd07832          94 RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE  170 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCce
Confidence            5689999999999999999999999   999999999999999999999999999876543321 233346778899999


Q ss_pred             ccccCC-CCcchhhHHHHHHHHHHHhCCCCCccccccccccc-------chhhh---------hhhcCCCCCCC-C-Ccc
Q 042876           84 LAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL-------NTDIE---------LDEMLDPRLPA-P-SRS  144 (179)
Q Consensus        84 ~~~~~~-~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~-------~~~~~---------~~~~~~~~~~~-~-~~~  144 (179)
                      .+.+.. ++.++|+||+|++++++++|..+|...........       .....         ......+.... . ...
T Consensus       171 ~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (286)
T cd07832         171 LLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEI  250 (286)
T ss_pred             eeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHh
Confidence            886543 58899999999999999999877754322110000       00000         00000000000 0 000


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      .......+.+++.+|+..||++||+++++++|-
T Consensus       251 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         251 FPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             CCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            011234588999999999999999999999873

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.95  E-value=3.3e-27  Score=172.55  Aligned_cols=169  Identities=20%  Similarity=0.238  Sum_probs=120.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||.
T Consensus        95 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~  171 (284)
T cd07836          95 GALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDV  171 (284)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHH
Confidence            4689999999999999999999999   9999999999999999999999999998765443322333456778999998


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccc------------cchhhhhhhcCCCCCCCCCc-----cHH
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS------------LNTDIELDEMLDPRLPAPSR-----SVQ  146 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~-----~~~  146 (179)
                      +.+. .++.++|+||+|++++++++|..||..........            ...............+....     ...
T Consensus       172 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (284)
T cd07836         172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFP  251 (284)
T ss_pred             hcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhh
Confidence            7654 46789999999999999999999986543211000            00000000000011111000     011


Q ss_pred             HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          147 EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       147 ~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .....+.+++.+|++.||.+||++.+++++
T Consensus       252 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         252 HADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            123457789999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.95  E-value=9.3e-28  Score=175.09  Aligned_cols=158  Identities=29%  Similarity=0.443  Sum_probs=121.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .++++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++++|||++..............+...|++||.
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~  172 (277)
T cd06641          96 GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV  172 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhh
Confidence            4688999999999999999999998   9999999999999999999999999998765443322233456778999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+...+.++|+||+|++++++++|..||.......        ..........+..   ......++.+++.+||+.+|
T Consensus       173 ~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p  241 (277)
T cd06641         173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--------VLFLIPKNNPPTL---EGNYSKPLKEFVEACLNKEP  241 (277)
T ss_pred             hccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--------HHHHHhcCCCCCC---CcccCHHHHHHHHHHccCCh
Confidence            988888899999999999999999999986432111        0001111111111   11122347888999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+||++.+++++
T Consensus       242 ~~Rp~~~~~l~~  253 (277)
T cd06641         242 SFRPTAKELLKH  253 (277)
T ss_pred             hhCcCHHHHHhC
Confidence            999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=8.6e-29  Score=188.11  Aligned_cols=158  Identities=27%  Similarity=0.413  Sum_probs=125.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      .++..++..++.+.+.||+|||++   +++||||...|+|++.++.+||+|||++..-...........-+..|+|||.+
T Consensus       258 ~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl  334 (474)
T KOG0194|consen  258 SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETL  334 (474)
T ss_pred             CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhh
Confidence            589999999999999999999999   99999999999999999999999999987654333333234568899999999


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcC--CCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           86 YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ...-++.++||||+|+++||+++ |..||.+.+..        .....++  .-+.+.+...    ...+..++.+||..
T Consensus       335 ~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~r~~~~~~~----p~~~~~~~~~c~~~  402 (474)
T KOG0194|consen  335 NTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGYRMPIPSKT----PKELAKVMKQCWKK  402 (474)
T ss_pred             ccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCccCCCCCCC----HHHHHHHHHHhccC
Confidence            98899999999999999999998 78898765432        1111121  1122222222    22367788899999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      +|++||++.++.+.|+
T Consensus       403 ~p~~R~tm~~i~~~l~  418 (474)
T KOG0194|consen  403 DPEDRPTMSTIKKKLE  418 (474)
T ss_pred             ChhhccCHHHHHHHHH
Confidence            9999999999999875

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.95  E-value=2.1e-27  Score=173.54  Aligned_cols=169  Identities=23%  Similarity=0.270  Sum_probs=120.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|+++||++||+.   +++|+||+|+||+++.++.++++|||.+........ ......++..|++||
T Consensus        95 ~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE  171 (287)
T cd07840          95 VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE  171 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCce
Confidence            4789999999999999999999999   999999999999999999999999999876654331 122335567899999


Q ss_pred             cccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh-------hhh--------hhcCCCCC--CCC-Ccc
Q 042876           84 LAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD-------IEL--------DEMLDPRL--PAP-SRS  144 (179)
Q Consensus        84 ~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~-------~~~--------~~~~~~~~--~~~-~~~  144 (179)
                      .+.+ ..++.++|+||||++++++++|..||..............       ...        ........  +.. ...
T Consensus       172 ~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T cd07840         172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREF  251 (287)
T ss_pred             eeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHH
Confidence            7765 3578899999999999999999999864432110000000       000        00000000  000 000


Q ss_pred             HHH-HHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQE-KLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~-~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ... ....+.+++.+||+.+|.+||++++++++
T Consensus       252 ~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         252 FKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            001 13458899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.4e-27  Score=172.50  Aligned_cols=157  Identities=22%  Similarity=0.261  Sum_probs=117.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||+|.||+++.++.++++|||++.....    .....+...|++||.
T Consensus        92 ~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~  164 (260)
T cd05611          92 GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPET  164 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCcCccChhh
Confidence            4688999999999999999999999   999999999999999999999999998865433    122356778999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      ..+..++.++|+||+|++++++++|..||........   ..... ....  ..+.  .........+.+++.+||+.||
T Consensus       165 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~-~~~~--~~~~--~~~~~~~~~~~~~i~~~l~~~p  236 (260)
T cd05611         165 ILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---FDNIL-SRRI--NWPE--EVKEFCSPEAVDLINRLLCMDP  236 (260)
T ss_pred             hcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHH-hccc--CCCC--cccccCCHHHHHHHHHHccCCH
Confidence            8887788999999999999999999999964432110   00000 0000  1111  0011123358899999999999


Q ss_pred             CCCCCH---HHHHHH
Q 042876          165 ESRPTM---KIVSQQ  176 (179)
Q Consensus       165 ~~Rps~---~~~~~~  176 (179)
                      ++||++   +|++.|
T Consensus       237 ~~R~~~~~~~~~l~~  251 (260)
T cd05611         237 AKRLGANGYQEIKSH  251 (260)
T ss_pred             HHccCCCcHHHHHcC
Confidence            999966   455543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=3.1e-27  Score=171.75  Aligned_cols=164  Identities=24%  Similarity=0.371  Sum_probs=120.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++++|||.+........  ......++..|++|
T Consensus       103 ~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~P  179 (272)
T cd06629         103 GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP  179 (272)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCH
Confidence            4688899999999999999999999   999999999999999999999999999865432211  11223567789999


Q ss_pred             cccccCC--CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMK--ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~--~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |...+..  ++.++|+||+|++++++++|..||..........    ...........+.  .........+.+++.+||
T Consensus       180 E~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l  253 (272)
T cd06629         180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF----KLGNKRSAPPIPP--DVSMNLSPVALDFLNACF  253 (272)
T ss_pred             HHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH----HhhccccCCcCCc--cccccCCHHHHHHHHHHh
Confidence            9887654  7889999999999999999999985432111000    0000000111111  111222345888999999


Q ss_pred             CcCCCCCCCHHHHHHHh
Q 042876          161 NESPESRPTMKIVSQQL  177 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l  177 (179)
                      ..+|.+|||++++++|-
T Consensus       254 ~~~p~~Rps~~~il~~~  270 (272)
T cd06629         254 TINPDNRPTARELLQHP  270 (272)
T ss_pred             cCChhhCCCHHHHhhCC
Confidence            99999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.4e-27  Score=179.19  Aligned_cols=166  Identities=22%  Similarity=0.306  Sum_probs=118.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++......   .....++..|++||.
T Consensus       112 ~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~  185 (342)
T cd07879         112 HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEV  185 (342)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC---CCCceeeecccChhh
Confidence            3688999999999999999999999   9999999999999999999999999998654321   122355678999998


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCccccccccccc-------chhh--------hhhhcCC--CCCCCC--Ccc
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL-------NTDI--------ELDEMLD--PRLPAP--SRS  144 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~-------~~~~--------~~~~~~~--~~~~~~--~~~  144 (179)
                      +.+ ..++.++|+||||++++++++|+.||...........       ....        .......  +..+..  ...
T Consensus       186 ~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (342)
T cd07879         186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTL  265 (342)
T ss_pred             hcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHH
Confidence            765 4578899999999999999999999975331110000       0000        0000000  000000  000


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.+++.+||+.||.+||++++++.|
T Consensus       266 ~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         266 FPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             hcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            01122347889999999999999999999876

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.95  E-value=2.4e-27  Score=171.85  Aligned_cols=162  Identities=25%  Similarity=0.396  Sum_probs=120.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-ceeEccccCccccCCCCC----CcccccCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSS----NWTEFAGTYGY   79 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~   79 (179)
                      .++++..++.++.|++.||.|||+.   +++|+||+|.||+++.++ .++++|||.+........    ......++..|
T Consensus        98 ~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  174 (268)
T cd06630          98 GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF  174 (268)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccce
Confidence            4678899999999999999999999   999999999999998765 589999999876653321    11234567789


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      ++||.+.+..++.++|+||+|++++++++|..||..........     ............  ........++.+++.+|
T Consensus       175 ~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~  247 (268)
T cd06630         175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-----LIFKIASATTAP--SIPEHLSPGLRDVTLRC  247 (268)
T ss_pred             eCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH-----HHHHHhccCCCC--CCchhhCHHHHHHHHHH
Confidence            99999988888999999999999999999999986432211111     000100000000  11122334588899999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 042876          160 LNESPESRPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~  176 (179)
                      |..+|.+||++.+++++
T Consensus       248 l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         248 LELQPEDRPPSRELLKH  264 (268)
T ss_pred             cCCCcccCcCHHHHhcC
Confidence            99999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-27  Score=179.04  Aligned_cols=157  Identities=22%  Similarity=0.358  Sum_probs=129.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee-cCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL-DLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..++++.+.+++.||+.||.|+|+.   .+|||||||+|+.+ .+-|-+|+.|||++..+.+.. ......|...|.+||
T Consensus       113 ~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-kL~TsCGSLAYSAPE  188 (864)
T KOG4717|consen  113 EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-KLTTSCGSLAYSAPE  188 (864)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc-hhhcccchhhccCch
Confidence            4688999999999999999999998   99999999999965 667889999999998888654 346678999999999


Q ss_pred             ccccCCCC-cchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKIT-EKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~-~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ++.|..|. ++.|+||||+++|.+++|+.||...++.        +.+.-+.+-+...+.    -...++.+||..||..
T Consensus       189 ILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--------ETLTmImDCKYtvPs----hvS~eCrdLI~sMLvR  256 (864)
T KOG4717|consen  189 ILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--------ETLTMIMDCKYTVPS----HVSKECRDLIQSMLVR  256 (864)
T ss_pred             hhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--------hhhhhhhcccccCch----hhhHHHHHHHHHHHhc
Confidence            99998885 6889999999999999999999765543        233334444443322    2344689999999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 042876          163 SPESRPTMKIVSQQL  177 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l  177 (179)
                      ||.+|-+.++|..+-
T Consensus       257 dPkkRAslEeI~s~~  271 (864)
T KOG4717|consen  257 DPKKRASLEEIVSTS  271 (864)
T ss_pred             CchhhccHHHHhccc
Confidence            999999999998653

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1e-28  Score=179.31  Aligned_cols=166  Identities=17%  Similarity=0.255  Sum_probs=123.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC--------------------CCceeEccccCccccC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL--------------------EYEAHVADFGIAKFLK   64 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~--------------------~~~~~l~d~~~~~~~~   64 (179)
                      .+|+.+.++.|+.|+++++++||+.   +++|.||||+||++..                    +..|+++|||.|++-.
T Consensus       187 ~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~  263 (415)
T KOG0671|consen  187 IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH  263 (415)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec
Confidence            4688999999999999999999999   9999999999999831                    3347899999997755


Q ss_pred             CCCCCcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc------------hhhhhhh
Q 042876           65 PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN------------TDIELDE  132 (179)
Q Consensus        65 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~------------~~~~~~~  132 (179)
                      .+.   ...+.+..|.|||++.+..++.++|+||+||++.|+++|..-|....+.+--.++            .....++
T Consensus       264 e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~K  340 (415)
T KOG0671|consen  264 EHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEK  340 (415)
T ss_pred             cCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHh
Confidence            443   4467788999999999999999999999999999999999988654422210000            0000000


Q ss_pred             c-------------------CCCCCCC---CCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          133 M-------------------LDPRLPA---PSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       133 ~-------------------~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .                   +...+.+   .-.....+...+++|+.++|..||.+|+|+.|+++|
T Consensus       341 yf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  341 YFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             hhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence            0                   0000111   011233345569999999999999999999999876

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.95  E-value=1.4e-27  Score=176.70  Aligned_cols=158  Identities=27%  Similarity=0.414  Sum_probs=118.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +..+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++......    ....++..|++||
T Consensus       109 ~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE  181 (308)
T cd06634         109 KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NXFVGTPYWMAPE  181 (308)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc----ccccCCccccCHH
Confidence            34688999999999999999999998   9999999999999999999999999998665432    2235677899999


Q ss_pred             ccc---cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           84 LAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        84 ~~~---~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      .+.   ...++.++|+||||+++|++++|..||.......        ..........+...  .......+.++|.+||
T Consensus       182 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl  251 (308)
T cd06634         182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPALQ--SGHWSEYFRNFVDSCL  251 (308)
T ss_pred             HHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--------HHHHHhhcCCCCcC--cccccHHHHHHHHHHh
Confidence            874   3456789999999999999999999985432111        00011111111100  0112234778899999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      ..+|.+||++++++++..
T Consensus       252 ~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         252 QKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             hCCcccCCCHHHHhhCcc
Confidence            999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.95  E-value=5.8e-27  Score=168.48  Aligned_cols=158  Identities=27%  Similarity=0.357  Sum_probs=123.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe   83 (179)
                      .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++++||+.+........  ......+...|.+||
T Consensus        97 ~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE  173 (260)
T cd06606          97 KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE  173 (260)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHh
Confidence            789999999999999999999998   999999999999999999999999999876654432  123456778899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCC-CCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD-PRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ...+...+.++|+||||++++++++|..||......       ......... ...+.....   ....+.+++.+|++.
T Consensus       174 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~---~~~~l~~~i~~~l~~  243 (260)
T cd06606         174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-------MAALYKIGSSGEPPEIPEH---LSEEAKDFLRKCLRR  243 (260)
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHhccccCCCcCCCcc---cCHHHHHHHHHhCcC
Confidence            998888899999999999999999999999765410       011111110 111111111   133588899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 042876          163 SPESRPTMKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rps~~~~~~~  176 (179)
                      ||++||++.+++++
T Consensus       244 ~p~~Rp~~~~ll~~  257 (260)
T cd06606         244 DPKKRPTADELLQH  257 (260)
T ss_pred             ChhhCCCHHHHhhC
Confidence            99999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=1.5e-27  Score=174.52  Aligned_cols=167  Identities=24%  Similarity=0.327  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++..+..++.|++.||.|||+..  +++|+||+|+||+++.++.++++|||++.......  .....++..|++||.
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--~~~~~~~~~~~aPE~  173 (284)
T cd06620          98 GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTSTYMSPER  173 (284)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--cCccccCcccCCHHH
Confidence            46789999999999999999999731  89999999999999999999999999876542211  123467889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccc---cchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS---LNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      +.+..++.++|+||+|++++++++|..||..........   ...............+...  .......+.+++.+||+
T Consensus       174 ~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~  251 (284)
T cd06620         174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP--SSDFPEDLRDFVDACLL  251 (284)
T ss_pred             HccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC--chhcCHHHHHHHHHHhc
Confidence            888788899999999999999999999997544321100   0000111111111111100  01123458889999999


Q ss_pred             cCCCCCCCHHHHHHHh
Q 042876          162 ESPESRPTMKIVSQQL  177 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l  177 (179)
                      .||++|||+++++++.
T Consensus       252 ~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         252 KDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCcccCcCHHHHhcCc
Confidence            9999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=3.4e-27  Score=192.56  Aligned_cols=159  Identities=25%  Similarity=0.351  Sum_probs=117.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCC----CCcccCCCCCCCeeecC-----------------CCceeEccccCcccc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCF----PPIVHRDLSSKNLLLDL-----------------EYEAHVADFGIAKFL   63 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~----~~~~h~dl~~~nil~~~-----------------~~~~~l~d~~~~~~~   63 (179)
                      ..+++..++.++.||+.||.|||+.+.    .+|+|+||||+|||++.                 ...++|+|||++...
T Consensus       113 g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l  192 (1021)
T PTZ00266        113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI  192 (1021)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccc
Confidence            468999999999999999999998520    15999999999999954                 234899999999765


Q ss_pred             CCCCCCcccccCCCCCCCCccccc--CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC-CCCCCC
Q 042876           64 KPDSSNWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML-DPRLPA  140 (179)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  140 (179)
                      ..... .....+++.|+|||.+.+  ..++.++|+|||||++|+|++|..||.......       .....+. .+.++.
T Consensus       193 ~~~s~-~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~-------qli~~lk~~p~lpi  264 (1021)
T PTZ00266        193 GIESM-AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS-------QLISELKRGPDLPI  264 (1021)
T ss_pred             ccccc-ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH-------HHHHHHhcCCCCCc
Confidence            43322 233568899999998864  347889999999999999999999996433211       0011111 111111


Q ss_pred             CCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          141 PSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       141 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      . .    ...++.+||..||..+|.+||++.+++.+
T Consensus       265 ~-~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        265 K-G----KSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             C-C----CCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            1 1    12348889999999999999999999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.2e-27  Score=163.11  Aligned_cols=159  Identities=26%  Similarity=0.363  Sum_probs=128.0

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      +...+++.....+..|++.||.|+|..   +++||||||+|+|++..+.+|++|||.+....  .....+..|+..|.+|
T Consensus       117 ~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~p  191 (281)
T KOG0580|consen  117 RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPP  191 (281)
T ss_pred             ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC--CCCceeeecccccCCH
Confidence            456799999999999999999999999   99999999999999999999999999986654  2334667899999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |++.+...+...|+|++|++.|+++.|..||......   .....+..   ++-.+|.      ....+..++|.+|+..
T Consensus       192 Emv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYkrI~k---~~~~~p~------~is~~a~dlI~~ll~~  259 (281)
T KOG0580|consen  192 EMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYKRIRK---VDLKFPS------TISGGAADLISRLLVK  259 (281)
T ss_pred             hhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHHHHHH---ccccCCc------ccChhHHHHHHHHhcc
Confidence            9999999999999999999999999999999754311   11111111   1112221      1122477899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      +|.+|.+..|+++|=.
T Consensus       260 ~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  260 NPIERLALTEVMDHPW  275 (281)
T ss_pred             CccccccHHHHhhhHH
Confidence            9999999999998744

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.95  E-value=5.8e-27  Score=169.81  Aligned_cols=159  Identities=21%  Similarity=0.294  Sum_probs=119.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---CcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---NWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.|++.||++||+.   +++|+||+|+||+++.++.++++|||.+........   ......++..|++
T Consensus       101 ~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (265)
T cd06652         101 GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS  177 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccC
Confidence            3578888999999999999999999   999999999999999999999999999875542211   1223456778999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+||||+++|++++|..||.......      .. ......+..+.   ........+.+++.+|+ 
T Consensus       178 PE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~-~~~~~~~~~~~---~~~~~~~~~~~~i~~~l-  246 (265)
T cd06652         178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------AI-FKIATQPTNPV---LPPHVSDHCRDFLKRIF-  246 (265)
T ss_pred             hhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------HH-HHHhcCCCCCC---CchhhCHHHHHHHHHHh-
Confidence            999988888999999999999999999999986432111      00 01111111111   11222334778888998 


Q ss_pred             cCCCCCCCHHHHHHHh
Q 042876          162 ESPESRPTMKIVSQQL  177 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l  177 (179)
                      .+|++||++++++++-
T Consensus       247 ~~p~~Rp~~~~il~~~  262 (265)
T cd06652         247 VEAKLRPSADELLRHT  262 (265)
T ss_pred             cChhhCCCHHHHhcCc
Confidence            4999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.5e-27  Score=167.59  Aligned_cols=157  Identities=27%  Similarity=0.342  Sum_probs=122.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.+||+.   +++|+||+|.||+++.++.++++|||.+..............+...|++||.
T Consensus        88 ~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~  164 (250)
T cd05123          88 GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEV  164 (250)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHH
Confidence            3688999999999999999999998   9999999999999999999999999998766543222334566778999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      ..+...+.++|+||||++++++++|..||.....        ............+.....    ...+.+++.+||..||
T Consensus       165 ~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~l~~~i~~~l~~~p  232 (250)
T cd05123         165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKDPLRFPEFL----SPEARDLISGLLQKDP  232 (250)
T ss_pred             hCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcCCCCCCCCC----CHHHHHHHHHHhcCCH
Confidence            9888888999999999999999999999964432        111111111222222121    2347889999999999


Q ss_pred             CCCCCH---HHHHHH
Q 042876          165 ESRPTM---KIVSQQ  176 (179)
Q Consensus       165 ~~Rps~---~~~~~~  176 (179)
                      ++||++   +++++|
T Consensus       233 ~~R~~~~~~~~l~~~  247 (250)
T cd05123         233 TKRLGSGGAEEIKAH  247 (250)
T ss_pred             hhCCCcccHHHHHhC
Confidence            999999   777765

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.6e-27  Score=195.53  Aligned_cols=158  Identities=16%  Similarity=0.169  Sum_probs=111.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC-------------------CceeEccccCccccC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-------------------YEAHVADFGIAKFLK   64 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~-------------------~~~~l~d~~~~~~~~   64 (179)
                      ...+++.+++.+++||++||+|||++   ||+||||||+|||++..                   +.++++|||++....
T Consensus        74 ~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~  150 (793)
T PLN00181         74 DRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREE  150 (793)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccc
Confidence            45689999999999999999999999   99999999999999654                   345566666654321


Q ss_pred             CCC----------------CCcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhh
Q 042876           65 PDS----------------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDI  128 (179)
Q Consensus        65 ~~~----------------~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~  128 (179)
                      ...                .......+++.|++||.+.+..++.++|||||||++|+|+++..|+.....     ... .
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~-~  224 (793)
T PLN00181        151 ILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMS-S  224 (793)
T ss_pred             cccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHH-H
Confidence            100                000112467779999999888999999999999999999998877642210     000 0


Q ss_pred             hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          129 ELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      ......++..       ........+++.+||+.||.+||++.|+++|-
T Consensus       225 ~~~~~~~~~~-------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        225 LRHRVLPPQI-------LLNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             HHHhhcChhh-------hhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            0011111111       01122356788899999999999999998863

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.4e-27  Score=171.53  Aligned_cols=158  Identities=25%  Similarity=0.387  Sum_probs=122.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .++++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.++++|||.+..............+...|++||.
T Consensus        94 ~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~  170 (254)
T cd06627          94 GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEV  170 (254)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhh
Confidence            5689999999999999999999999   9999999999999999999999999999776554433334467788999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      ..+..++.++|+|++|++++++++|..||.......     .............+   ..   ....+.+++.+||+.+|
T Consensus       171 ~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~---~~---~~~~~~~~i~~~l~~~p  239 (254)
T cd06627         171 IEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-----ALFRIVQDDHPPLP---EG---ISPELKDFLMQCFQKDP  239 (254)
T ss_pred             hcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHhccCCCCCC---CC---CCHHHHHHHHHHHhCCh
Confidence            887778899999999999999999999986543111     00111111111111   11   12347788999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      ++|||+.+++.+
T Consensus       240 ~~R~~~~~~l~~  251 (254)
T cd06627         240 NLRPTAKQLLKH  251 (254)
T ss_pred             hhCcCHHHHhcC
Confidence            999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.95  E-value=4.5e-28  Score=182.97  Aligned_cols=160  Identities=21%  Similarity=0.261  Sum_probs=116.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---------------
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---------------   68 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------------   68 (179)
                      ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++++|||++........               
T Consensus        95 ~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~  171 (360)
T cd05627          95 KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF  171 (360)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccc
Confidence            35689999999999999999999999   999999999999999999999999999864421100               


Q ss_pred             --------------------CcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhh
Q 042876           69 --------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDI  128 (179)
Q Consensus        69 --------------------~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~  128 (179)
                                          ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||.........     .
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~-----~  246 (360)
T cd05627         172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY-----R  246 (360)
T ss_pred             cccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHH-----H
Confidence                                011236788999999999889999999999999999999999999654321110     0


Q ss_pred             hhhhcC-CCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCC---HHHHHHH
Q 042876          129 ELDEML-DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT---MKIVSQQ  176 (179)
Q Consensus       129 ~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps---~~~~~~~  176 (179)
                      ...... ...++.....    ...+.+++.+++ .||.+|++   ++++++|
T Consensus       247 ~i~~~~~~~~~p~~~~~----s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         247 KVMNWKETLVFPPEVPI----SEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             HHHcCCCceecCCCCCC----CHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            000000 0011211111    123666777766 49999984   6777765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.95  E-value=4.1e-27  Score=174.88  Aligned_cols=156  Identities=27%  Similarity=0.417  Sum_probs=118.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..++++.++..++.|++.||.|||+.   +++|+||+|.||+++.++.++++|||++......    ....++..|++||
T Consensus       119 ~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE  191 (317)
T cd06635         119 KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----NSFVGTPYWMAPE  191 (317)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc----ccccCCccccChh
Confidence            45689999999999999999999999   9999999999999999999999999988654322    2245677899999


Q ss_pred             ccc---cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCC-CCCCccHHHHHHHHHHHHhcc
Q 042876           84 LAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL-PAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        84 ~~~---~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~c  159 (179)
                      .+.   +..++.++|+||+|++++++++|..||.......        .......... ......   ....+.+++.+|
T Consensus       192 ~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~l~~li~~~  260 (317)
T cd06635         192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPTLQSNE---WSDYFRNFVDSC  260 (317)
T ss_pred             hhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHhccCCCCCCcc---ccHHHHHHHHHH
Confidence            874   3457889999999999999999999985432111        1111111111 111111   222477889999


Q ss_pred             cCcCCCCCCCHHHHHHHh
Q 042876          160 LNESPESRPTMKIVSQQL  177 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l  177 (179)
                      |+.+|.+||++.++++++
T Consensus       261 l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         261 LQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             ccCCcccCcCHHHHHhCh
Confidence            999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.95  E-value=8.1e-27  Score=170.33  Aligned_cols=158  Identities=19%  Similarity=0.253  Sum_probs=120.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.......  .....++..|++||.
T Consensus        92 ~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE~  166 (278)
T cd05606          92 GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEV  166 (278)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCcCCCcCCcCcHH
Confidence            4689999999999999999999998   99999999999999999999999999986543221  223467889999999


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +.+ ..++.++|+||+|++++++++|..||...........   ..........++.  .    ....+.+++.+|+..+
T Consensus       167 ~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~--~----~s~~~~~li~~~l~~~  237 (278)
T cd05606         167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTMAVELPD--S----FSPELRSLLEGLLQRD  237 (278)
T ss_pred             hcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---HHHhhccCCCCCC--c----CCHHHHHHHHHHhhcC
Confidence            864 3578899999999999999999999975432111110   0001111111111  1    1234788899999999


Q ss_pred             CCCCC-----CHHHHHHH
Q 042876          164 PESRP-----TMKIVSQQ  176 (179)
Q Consensus       164 p~~Rp-----s~~~~~~~  176 (179)
                      |.+||     ++.+++++
T Consensus       238 p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         238 VNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             HHhccCCCCCCHHHHHhC
Confidence            99999     99999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.2e-28  Score=178.55  Aligned_cols=153  Identities=25%  Similarity=0.287  Sum_probs=120.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +..|+++.++.++.+|+.||++||+.   +||.|||||+|||++..|.++|+|+|+|..+..... .....|+.+|||||
T Consensus       281 ~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~-~~~rvGT~GYMAPE  356 (591)
T KOG0986|consen  281 NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP-IRGRVGTVGYMAPE  356 (591)
T ss_pred             CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc-cccccCcccccCHH
Confidence            35689999999999999999999999   999999999999999999999999999988775443 34458999999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      ++.+..|+...|-|||||++|+|+.|+.||...+..     ...+.+...+   ..........-..+..++...+|+.|
T Consensus       357 vl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-----vk~eEvdrr~---~~~~~ey~~kFS~eakslc~~LL~Kd  428 (591)
T KOG0986|consen  357 VLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-----VKREEVDRRT---LEDPEEYSDKFSEEAKSLCEGLLTKD  428 (591)
T ss_pred             HHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-----hhHHHHHHHH---hcchhhcccccCHHHHHHHHHHHccC
Confidence            999999999999999999999999999999765421     1111111111   11111222222334677888999999


Q ss_pred             CCCCC
Q 042876          164 PESRP  168 (179)
Q Consensus       164 p~~Rp  168 (179)
                      |.+|.
T Consensus       429 p~~RL  433 (591)
T KOG0986|consen  429 PEKRL  433 (591)
T ss_pred             HHHhc
Confidence            99996

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.95  E-value=2.3e-27  Score=171.25  Aligned_cols=159  Identities=30%  Similarity=0.388  Sum_probs=122.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .++++.++..++.|+++||.|||+.   +++|+||+|.||+++.++.++++|||.+....... ......+...|++||.
T Consensus        95 ~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~  170 (258)
T cd05578          95 VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEV  170 (258)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccccCCChhhcCHHH
Confidence            3788999999999999999999999   99999999999999999999999999987654432 2233456778999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      ..+..++.++|+||+|+++|++++|..||............   ..........+.      .....+.+++.+||+.||
T Consensus       171 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~i~~~l~~~p  241 (258)
T cd05578         171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR---AKQETADVLYPA------TWSTEAIDAINKLLERDP  241 (258)
T ss_pred             HcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH---HHhccccccCcc------cCcHHHHHHHHHHccCCh
Confidence            98888899999999999999999999999755422111110   000001111111      122458889999999999


Q ss_pred             CCCCCH--HHHHHH
Q 042876          165 ESRPTM--KIVSQQ  176 (179)
Q Consensus       165 ~~Rps~--~~~~~~  176 (179)
                      .+||++  ++++++
T Consensus       242 ~~R~~~~~~~l~~~  255 (258)
T cd05578         242 QKRLGDNLKDLKNH  255 (258)
T ss_pred             hHcCCccHHHHhcC
Confidence            999999  887754

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=199.90  Aligned_cols=158  Identities=27%  Similarity=0.360  Sum_probs=122.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC----CcccccCCCCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS----NWTEFAGTYGYVA   81 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~   81 (179)
                      -.++.-...+..|+++|++|||++   |||||||||.||+++.+|.+|.+|||.|.....+..    ..+...|++.|||
T Consensus      1330 i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMA 1406 (1509)
T KOG4645|consen 1330 IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMA 1406 (1509)
T ss_pred             hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcC
Confidence            345666778899999999999999   999999999999999999999999999987765532    1234578999999


Q ss_pred             CcccccCC---CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           82 PELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        82 pe~~~~~~---~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      ||.+.+.+   ...++||||||||+.||.||+.||....+.....+.    +...-.+.+|..      ....-.+++..
T Consensus      1407 PEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~----V~~gh~Pq~P~~------ls~~g~dFle~ 1476 (1509)
T KOG4645|consen 1407 PEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH----VAAGHKPQIPER------LSSEGRDFLEH 1476 (1509)
T ss_pred             chhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH----HhccCCCCCchh------hhHhHHHHHHH
Confidence            99987654   457899999999999999999999876543322221    111122222221      23345678889


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||..||.+|.+++|++++
T Consensus      1477 Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1477 CLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             HHhcCchhhhHHHHHHHh
Confidence            999999999999999886

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.95  E-value=4e-27  Score=191.24  Aligned_cols=159  Identities=25%  Similarity=0.381  Sum_probs=116.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC------------------
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS------------------   67 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------------------   67 (179)
                      .+++..++.++.|+++||+|||+.   +++||||||+||+++.++.++++|||++.......                  
T Consensus       109 ~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~  185 (932)
T PRK13184        109 KTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM  185 (932)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcceeccccccccccccccccccccccc
Confidence            456678899999999999999999   99999999999999999999999999997652110                  


Q ss_pred             CCcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHH
Q 042876           68 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQ  146 (179)
Q Consensus        68 ~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  146 (179)
                      .......+++.|+|||.+.+..++.++|+||+||++++|++|..||.........      .......+ ...+    ..
T Consensus       186 t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~------~~~~i~~P~~~~p----~~  255 (932)
T PRK13184        186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS------YRDVILSPIEVAP----YR  255 (932)
T ss_pred             ccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh------hhhhccChhhccc----cc
Confidence            0011245889999999998888999999999999999999999999653211100      00011110 0000    11


Q ss_pred             HHHHHHHHHHhcccCcCCCCCC-CHHHHHHHh
Q 042876          147 EKLISIVKVAFSCLNESPESRP-TMKIVSQQL  177 (179)
Q Consensus       147 ~~~~~~~~li~~cl~~~p~~Rp-s~~~~~~~l  177 (179)
                      .....+.+++.+|+..||++|| +++++.+.|
T Consensus       256 ~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L  287 (932)
T PRK13184        256 EIPPFLSQIAMKALAVDPAERYSSVQELKQDL  287 (932)
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            2223477889999999999996 556665544

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.95  E-value=5.8e-27  Score=169.26  Aligned_cols=158  Identities=25%  Similarity=0.337  Sum_probs=118.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--------CcccccCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--------NWTEFAGT   76 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~   76 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++........        ......+.
T Consensus        88 ~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (265)
T cd05579          88 GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT  164 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccC
Confidence            3688999999999999999999999   999999999999999999999999999875433211        12234567


Q ss_pred             CCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHH
Q 042876           77 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVA  156 (179)
Q Consensus        77 ~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  156 (179)
                      ..|++||...+...+.++|+||||++++++++|..||.......        ................  .....+.+++
T Consensus       165 ~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~--~~~~~~~~~i  234 (265)
T cd05579         165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--------IFQNILNGKIEWPEDV--EVSDEAIDLI  234 (265)
T ss_pred             ccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCcCCCccc--cCCHHHHHHH
Confidence            78999999888778899999999999999999999986443111        1111111111111111  0133478899


Q ss_pred             hcccCcCCCCCCCH---HHHHH
Q 042876          157 FSCLNESPESRPTM---KIVSQ  175 (179)
Q Consensus       157 ~~cl~~~p~~Rps~---~~~~~  175 (179)
                      .+||+.+|.+|||+   .++++
T Consensus       235 ~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         235 SKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             HHHhcCCHhhcCCCccHHHHhc
Confidence            99999999999999   55544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.95  E-value=2.1e-27  Score=177.84  Aligned_cols=168  Identities=23%  Similarity=0.291  Sum_probs=119.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-----CcccccCCCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-----NWTEFAGTYGYV   80 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~   80 (179)
                      .+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+........     ......++..|+
T Consensus       103 ~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~  179 (337)
T cd07852         103 ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR  179 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhccccccccc
Confidence            678889999999999999999999   999999999999999999999999999876543221     122345678899


Q ss_pred             CCccccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccc-------cchh--------h----hhhhcCCCCCCC
Q 042876           81 APELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS-------LNTD--------I----ELDEMLDPRLPA  140 (179)
Q Consensus        81 ~pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~-------~~~~--------~----~~~~~~~~~~~~  140 (179)
                      +||.+.+ ..++.++|+||+|+++|++++|+.||..........       ....        .    ............
T Consensus       180 aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (337)
T cd07852         180 APEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKP  259 (337)
T ss_pred             CceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccc
Confidence            9998754 456789999999999999999999986432211000       0000        0    000000000000


Q ss_pred             CCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          141 PSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       141 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ...........+.+++.+||+.||++|||+.+++++
T Consensus       260 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         260 LDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000111123357889999999999999999999876

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.95  E-value=3.3e-27  Score=181.09  Aligned_cols=161  Identities=24%  Similarity=0.372  Sum_probs=133.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~p   82 (179)
                      +.+++.-....++.||+.||+|||+.   ..|||||...||+++...-+|++|||+++.+...... .....-++.|++|
T Consensus       485 k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaP  561 (974)
T KOG4257|consen  485 KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAP  561 (974)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCc
Confidence            34677788899999999999999999   9999999999999999999999999999887654432 2234557889999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+....++.++|+|-||+++|+++. |..||.+.++........+.       .++|.+..|.+.    +..|+.+||.
T Consensus       562 ESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-------eRlP~P~nCPp~----LYslmskcWa  630 (974)
T KOG4257|consen  562 ESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG-------ERLPCPPNCPPA----LYSLMSKCWA  630 (974)
T ss_pred             cccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC-------CCCCCCCCCChH----HHHHHHHHhc
Confidence            99988899999999999999999986 99999887765544443332       255555566554    7889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      ++|.+||.+.++...|.
T Consensus       631 yeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  631 YEPSKRPRFTEIKAILS  647 (974)
T ss_pred             cCcccCCcHHHHHHHHH
Confidence            99999999999987663

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=1.4e-26  Score=167.28  Aligned_cols=158  Identities=23%  Similarity=0.328  Sum_probs=121.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++.+++.++.|+++||.|||+.   +++|+||+|+|++++. +.++++|||.+..............++..|++||
T Consensus       100 ~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe  175 (260)
T cd08222         100 GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE  175 (260)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHH
Confidence            45789999999999999999999999   9999999999999975 5699999999876654433333456778899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      ...+..++.++|+||+|++++++++|..||......        ...........+...   .....++.++|.+||+.+
T Consensus       176 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~  244 (260)
T cd08222         176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--------SVVLRIVEGPTPSLP---ETYSRQLNSIMQSMLNKD  244 (260)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHcCCCCCCc---chhcHHHHHHHHHHhcCC
Confidence            988778888999999999999999999998643211        111111111111111   122345788999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |++||++.+++++
T Consensus       245 p~~Rp~~~~il~~  257 (260)
T cd08222         245 PSLRPSAAEILRN  257 (260)
T ss_pred             hhhCcCHHHHhhC
Confidence            9999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=6.9e-27  Score=186.20  Aligned_cols=159  Identities=28%  Similarity=0.444  Sum_probs=125.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCc---ccccCCCCCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW---TEFAGTYGYVAP   82 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~~p   82 (179)
                      .++..+.+.++.||+.|++||++.   +++||||...||++..+..+||+|||+++.........   ....-+..|+||
T Consensus       414 ~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmAp  490 (609)
T KOG0200|consen  414 ALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAP  490 (609)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCH
Confidence            489999999999999999999999   99999999999999999999999999998654433221   111146779999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcC-CCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEML-DPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |.+....++.++|+||+|+++|++++ |..||.+....      ... ..-.. ..++..+..+..+    +.++|+.||
T Consensus       491 Esl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~------~~l-~~~l~~G~r~~~P~~c~~e----iY~iM~~CW  559 (609)
T KOG0200|consen  491 ESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT------EEL-LEFLKEGNRMEQPEHCSDE----IYDLMKSCW  559 (609)
T ss_pred             HHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH------HHH-HHHHhcCCCCCCCCCCCHH----HHHHHHHHh
Confidence            99999899999999999999999998 89998752210      011 11111 1244445555554    889999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.+|++||+++++.+.|+
T Consensus       560 ~~~p~~RP~F~~~~~~~~  577 (609)
T KOG0200|consen  560 NADPEDRPTFSECVEFFE  577 (609)
T ss_pred             CCCcccCCCHHHHHHHHH
Confidence            999999999999998774

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.95  E-value=1.9e-27  Score=174.79  Aligned_cols=167  Identities=22%  Similarity=0.250  Sum_probs=116.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-CCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .+++..++.++.||+.||.|||+.   +++|+||+|+||+++. ++.++++|||++..............++..|++||.
T Consensus        98 ~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~  174 (294)
T PLN00009         98 AKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEI  174 (294)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHH
Confidence            357788899999999999999999   9999999999999985 456899999999765443322333456788999998


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCccccccccccc------------ch----hhhhhhcCCCCCCCCC--ccH
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL------------NT----DIELDEMLDPRLPAPS--RSV  145 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~------------~~----~~~~~~~~~~~~~~~~--~~~  145 (179)
                      +.+. .++.++|+||+|+++|++++|..||...........            ..    ........ +..+...  ...
T Consensus       175 ~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  253 (294)
T PLN00009        175 LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF-PKWPPKDLATVV  253 (294)
T ss_pred             HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhc-ccCCCCCHHHhC
Confidence            7653 568899999999999999999999864321100000            00    00000000 0000000  000


Q ss_pred             HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ......+.+++.+|++.+|++||++.+++++
T Consensus       254 ~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        254 PTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1112347789999999999999999999875

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=9.5e-27  Score=170.70  Aligned_cols=160  Identities=22%  Similarity=0.276  Sum_probs=127.6

Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCC----------------
Q 042876            2 AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP----------------   65 (179)
Q Consensus         2 ~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~----------------   65 (179)
                      ++.+.|+++.++.++.+++.||+|||..   |||+|||||+|||+..+|.|.++||.++.....                
T Consensus       171 Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~  247 (459)
T KOG0610|consen  171 QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQ  247 (459)
T ss_pred             CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCC
Confidence            4667899999999999999999999999   999999999999999999999999999753210                


Q ss_pred             -----------------C-CC----------------------CcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHH
Q 042876           66 -----------------D-SS----------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALE  105 (179)
Q Consensus        66 -----------------~-~~----------------------~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~  105 (179)
                                       . ..                      -.+.++|+-.|+|||+++|...+.+.|=|+||+++||
T Consensus       248 ~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYE  327 (459)
T KOG0610|consen  248 PSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYE  327 (459)
T ss_pred             cccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHH
Confidence                             0 00                      0122567889999999999999999999999999999


Q ss_pred             HHhCCCCCcccccccccccchhhhhhhcCCCC--CCCCCccHHHHHHHHHHHHhcccCcCCCCCCC----HHHHHHH
Q 042876          106 VIKGKHPRDFLSSISSSSLNTDIELDEMLDPR--LPAPSRSVQEKLISIVKVAFSCLNESPESRPT----MKIVSQQ  176 (179)
Q Consensus       106 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps----~~~~~~~  176 (179)
                      |+.|..||.+.+.        .+....++.+.  ++...    ....++.+||+++|..||.+|.-    +.||.+|
T Consensus       328 mLyG~TPFKG~~~--------~~Tl~NIv~~~l~Fp~~~----~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  328 MLYGTTPFKGSNN--------KETLRNIVGQPLKFPEEP----EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HHhCCCCcCCCCc--------hhhHHHHhcCCCcCCCCC----cchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence            9999999987643        23333443332  23221    33445889999999999999998    8888765

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.94  E-value=7.2e-27  Score=170.20  Aligned_cols=157  Identities=27%  Similarity=0.425  Sum_probs=121.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC----------------
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS----------------   68 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----------------   68 (179)
                      ..+++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.++++|||++........                
T Consensus        97 ~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (280)
T cd05581          97 GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE  173 (280)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccccccc
Confidence            3689999999999999999999999   999999999999999999999999999876544321                


Q ss_pred             ----CcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCcc
Q 042876           69 ----NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRS  144 (179)
Q Consensus        69 ----~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (179)
                          ......++..|++||...+..++.++|+||||++++++++|..||......        .................
T Consensus       174 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~  245 (280)
T cd05581         174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--------LTFQKILKLEYSFPPNF  245 (280)
T ss_pred             ccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhcCCCCCCcc
Confidence                122335678899999988888889999999999999999999998754311        11111111111111111


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCH----HHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTM----KIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~----~~~~~~  176 (179)
                          ...+.+++.+||+.+|.+||++    +++++|
T Consensus       246 ----~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         246 ----PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ----CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                2347889999999999999999    998876

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-27  Score=183.51  Aligned_cols=159  Identities=26%  Similarity=0.423  Sum_probs=127.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCc---ccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW---TEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~   80 (179)
                      +..|-....-.++.||+.|+.||..+   ++|||||...|+++.....+||+|||+.+.++.....+   ....-+..|+
T Consensus       206 ~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWC  282 (1039)
T KOG0199|consen  206 KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWC  282 (1039)
T ss_pred             ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCccccc
Confidence            34567778889999999999999999   99999999999999888899999999998776554332   2234577899


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +||.++...++.++|+|++|+++||||+ |+.||.+...........       ...+++.+..|..    ++++++++|
T Consensus       283 aPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-------~~erLpRPk~cse----dIY~imk~c  351 (1039)
T KOG0199|consen  283 APESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-------AGERLPRPKYCSE----DIYQIMKNC  351 (1039)
T ss_pred             CHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-------ccccCCCCCCChH----HHHHHHHHh
Confidence            9999999999999999999999999998 899998765322211111       1234555555544    499999999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 042876          160 LNESPESRPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~  176 (179)
                      |..+|++||+++.|.+.
T Consensus       352 Wah~paDRptFsair~~  368 (1039)
T KOG0199|consen  352 WAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ccCCccccccHHHHHHh
Confidence            99999999999999754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-28  Score=190.50  Aligned_cols=161  Identities=26%  Similarity=0.473  Sum_probs=128.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-ccccc--CCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFA--GTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~--~~~~~~   80 (179)
                      +..|++-+...|++.|++|++||.++   ++|||||...|||++.+-.+|++|||+++.+..+... .....  -++.|.
T Consensus       725 DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWT  801 (996)
T KOG0196|consen  725 DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWT  801 (996)
T ss_pred             CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeec
Confidence            34588889999999999999999999   9999999999999999999999999999877554422 23332  357899


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      |||.+...+++.++|+||+|+|+||+++ |..||....+.       ......-.+=++|++-.|..    .+.+||..|
T Consensus       802 APEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-------dVIkaIe~gyRLPpPmDCP~----aL~qLMldC  870 (996)
T KOG0196|consen  802 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------DVIKAIEQGYRLPPPMDCPA----ALYQLMLDC  870 (996)
T ss_pred             ChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-------HHHHHHHhccCCCCCCCCcH----HHHHHHHHH
Confidence            9999999999999999999999999886 99998654321       11111111235555545544    499999999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.|-.+||.+.||+..|.
T Consensus       871 WqkdR~~RP~F~qiV~~lD  889 (996)
T KOG0196|consen  871 WQKDRNRRPKFAQIVSTLD  889 (996)
T ss_pred             HHHHhhcCCCHHHHHHHHH
Confidence            9999999999999998874

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.94  E-value=1.4e-27  Score=178.40  Aligned_cols=162  Identities=21%  Similarity=0.275  Sum_probs=115.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++++|||++........ ......+++.|++||
T Consensus        97 ~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE  173 (332)
T cd05623          97 DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE  173 (332)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHH
Confidence            4688999999999999999999999   999999999999999999999999999865433222 122346889999999


Q ss_pred             cccc-----CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           84 LAYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        84 ~~~~-----~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      .+.+     ..++.++|+||||+++|++++|..||..........   . ..........+...   .....++.+++.+
T Consensus       174 ~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~---~-i~~~~~~~~~p~~~---~~~s~~~~~li~~  246 (332)
T cd05623         174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---K-IMNHKERFQFPAQV---TDVSEDAKDLIRR  246 (332)
T ss_pred             HHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH---H-HhCCCccccCCCcc---ccCCHHHHHHHHH
Confidence            8862     357889999999999999999999996543211100   0 00000001111111   1122346778888


Q ss_pred             ccCcCCC--CCCCHHHHHHH
Q 042876          159 CLNESPE--SRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~--~Rps~~~~~~~  176 (179)
                      |+..++.  .|++++++++|
T Consensus       247 ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         247 LICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HccChhhhcCCCCHHHHhCC
Confidence            7755444  47899999877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.94  E-value=3.4e-27  Score=177.07  Aligned_cols=169  Identities=20%  Similarity=0.226  Sum_probs=116.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-CCceeEccccCccccCCCCC---CcccccCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-EYEAHVADFGIAKFLKPDSS---NWTEFAGTYGYV   80 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~   80 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++. ++.++++|||.+........   ......++..|+
T Consensus       109 ~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~  185 (342)
T cd07854         109 GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR  185 (342)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccceecCCcccccccccccccccccc
Confidence            4688999999999999999999999   9999999999999974 45689999999875432211   112234677899


Q ss_pred             CCccccc-CCCCcchhhHHHHHHHHHHHhCCCCCccccccccccc-------c---hhhhhh----hcCC-CCCCCC---
Q 042876           81 APELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL-------N---TDIELD----EMLD-PRLPAP---  141 (179)
Q Consensus        81 ~pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~-------~---~~~~~~----~~~~-~~~~~~---  141 (179)
                      |||.+.+ ..++.++|+|||||++|++++|+.||...........       .   ......    .... ......   
T Consensus       186 aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (342)
T cd07854         186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPL  265 (342)
T ss_pred             CHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCH
Confidence            9997654 4577899999999999999999999965432110000       0   000000    0000 000000   


Q ss_pred             CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          142 SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       142 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .........++.+++.+||..||.+|||++++++|
T Consensus       266 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         266 RDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            00001122357889999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=2.8e-26  Score=167.52  Aligned_cols=168  Identities=22%  Similarity=0.307  Sum_probs=120.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++++|.|||++   +++|+||+|.||+++.++.++++|||.+........ .....++..|++||.
T Consensus        94 ~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~aPE~  169 (283)
T cd07830          94 KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-YTDYVSTRWYRAPEI  169 (283)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-cCCCCCcccccCcee
Confidence            4689999999999999999999999   999999999999999999999999999876543222 223456778999997


Q ss_pred             cc-cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccc-------------cchhhhhhhcCCCCCCCCCc-----cH
Q 042876           85 AY-TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS-------------LNTDIELDEMLDPRLPAPSR-----SV  145 (179)
Q Consensus        85 ~~-~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~-----~~  145 (179)
                      +. +..++.++|+||||++++++++|..||..........             ...............+....     ..
T Consensus       170 ~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (283)
T cd07830         170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLI  249 (283)
T ss_pred             eecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHc
Confidence            75 3457889999999999999999999986443211000             00000000001001110000     00


Q ss_pred             HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .....++.+++.+||+.||++||+++|++.+
T Consensus       250 ~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         250 PNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0112458899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.94  E-value=5.6e-27  Score=173.91  Aligned_cols=156  Identities=27%  Similarity=0.398  Sum_probs=117.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..++++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+.....    .....++..|++||
T Consensus       115 ~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~~~~~~~~y~aPE  187 (313)
T cd06633         115 KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----ANSFVGTPYWMAPE  187 (313)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----CCCccccccccChh
Confidence            45689999999999999999999999   999999999999999999999999998854332    12345677899999


Q ss_pred             ccc---cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           84 LAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        84 ~~~---~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      .+.   +..++.++|+||+|++++++++|..||..........     .......+...  ...   ....+.+++.+||
T Consensus       188 ~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~--~~~---~~~~l~~li~~~l  257 (313)
T cd06633         188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HIAQNDSPTLQ--SNE---WTDSFRGFVDYCL  257 (313)
T ss_pred             hccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHHhcCCCCCC--ccc---cCHHHHHHHHHHc
Confidence            874   3457889999999999999999999986543211100     00000001111  111   1123778889999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.+|.+||++.+++.+
T Consensus       258 ~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         258 QKIPQERPASAELLRH  273 (313)
T ss_pred             cCChhhCcCHHHHhcC
Confidence            9999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.94  E-value=3e-27  Score=174.20  Aligned_cols=169  Identities=20%  Similarity=0.257  Sum_probs=118.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+........ .......+..|++||
T Consensus       111 ~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE  187 (302)
T cd07864         111 VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPE  187 (302)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChH
Confidence            4689999999999999999999999   999999999999999999999999999876543321 122234567899999


Q ss_pred             ccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhh-------c--------CCCCC---CCCCcc
Q 042876           84 LAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDE-------M--------LDPRL---PAPSRS  144 (179)
Q Consensus        84 ~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-------~--------~~~~~---~~~~~~  144 (179)
                      .+.+. .++.++|+||+|++++++++|+.||...+...............       .        .+...   ......
T Consensus       188 ~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd07864         188 LLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE  267 (302)
T ss_pred             HhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhh
Confidence            87643 46789999999999999999999986433211000000000000       0        00000   000000


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.+++.+||+.||.+||++++++++
T Consensus       268 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         268 FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00112347889999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.94  E-value=2.3e-27  Score=178.03  Aligned_cols=166  Identities=21%  Similarity=0.272  Sum_probs=119.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+......   .....++..|++||.
T Consensus       113 ~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~  186 (343)
T cd07851         113 QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI  186 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc---ccCCcccccccCHHH
Confidence            4689999999999999999999999   9999999999999999999999999998765432   122356778999998


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch---------------hhhhhhc---CCCCCCCC-Ccc
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT---------------DIELDEM---LDPRLPAP-SRS  144 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~---------------~~~~~~~---~~~~~~~~-~~~  144 (179)
                      +.+ ..++.++|+||||++++++++|+.||.............               .......   +....... ...
T Consensus       187 ~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (343)
T cd07851         187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEV  266 (343)
T ss_pred             HhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHH
Confidence            765 357889999999999999999999996443211000000               0000000   00000000 000


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.+++.+||+.||.+|||+.++++|
T Consensus       267 ~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         267 FSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             hccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            01113458899999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.94  E-value=4.3e-27  Score=175.94  Aligned_cols=169  Identities=24%  Similarity=0.223  Sum_probs=118.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCC--------------CCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD--------------SSNW   70 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~--------------~~~~   70 (179)
                      ..+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+......              ....
T Consensus       114 ~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (335)
T PTZ00024        114 IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM  190 (335)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccc
Confidence            4688999999999999999999999   9999999999999999999999999998765411              1111


Q ss_pred             ccccCCCCCCCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhc----------------
Q 042876           71 TEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEM----------------  133 (179)
Q Consensus        71 ~~~~~~~~~~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~----------------  133 (179)
                      ....++..|++||.+.+. .++.++|+||||++++++++|..||............. ......                
T Consensus       191 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~  269 (335)
T PTZ00024        191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF-ELLGTPNEDNWPQAKKLPLYTE  269 (335)
T ss_pred             cccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHhCCCchhhCcchhhcccccc
Confidence            223456789999988764 36889999999999999999999986543211000000 000000                


Q ss_pred             CCCCCCCC-CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          134 LDPRLPAP-SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       134 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      .....+.. ..........+.+++.+||+.+|++|||+++++.+-
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        270 FTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             cCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            00000000 000011133478899999999999999999998763

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.94  E-value=1.6e-26  Score=172.49  Aligned_cols=168  Identities=20%  Similarity=0.259  Sum_probs=115.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-------cccccCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-------WTEFAGTY   77 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~   77 (179)
                      ..+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+++.||+.+.........       .....+..
T Consensus        96 ~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (328)
T cd08226          96 EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVL  172 (328)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCcc
Confidence            3578889999999999999999998   9999999999999999999999998754322111100       01122355


Q ss_pred             CCCCCcccccC--CCCcchhhHHHHHHHHHHHhCCCCCcccccccccc-------------cchhhhhh-----------
Q 042876           78 GYVAPELAYTM--KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS-------------LNTDIELD-----------  131 (179)
Q Consensus        78 ~~~~pe~~~~~--~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~-------------~~~~~~~~-----------  131 (179)
                      .|++||.+.+.  .++.++|+||+|++++++++|..||..........             ........           
T Consensus       173 ~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (328)
T cd08226         173 PWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDS  252 (328)
T ss_pred             CccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhc
Confidence            69999998763  46789999999999999999999996432110000             00000000           


Q ss_pred             -------------hcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          132 -------------EMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       132 -------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                                   .......  ...........+.+++.+||..||++|||++++++|-
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         253 GIGESVVAAGMTQTMTSERL--RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             ccccchhccccccccccccc--cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                         0000000  0111223445688999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.94  E-value=6.2e-28  Score=171.55  Aligned_cols=163  Identities=26%  Similarity=0.397  Sum_probs=139.1

Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            2 AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         2 ~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      .++++++++++..++++.+.||.|||..   .-+|||||.-||++..+|..|+.|||.+-.+...........|++-|++
T Consensus       121 ~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMA  197 (502)
T KOG0574|consen  121 ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMA  197 (502)
T ss_pred             HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCccccc
Confidence            4678999999999999999999999998   8899999999999999999999999999877655545677899999999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+..-.|...+|+||||+...+|..|+.||.+.-......         +++.+.|+.......-..++-+++++||.
T Consensus       198 PEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------MIPT~PPPTF~KPE~WS~~F~DFi~~CLi  268 (502)
T KOG0574|consen  198 PEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------MIPTKPPPTFKKPEEWSSEFNDFIRSCLI  268 (502)
T ss_pred             HHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------eccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence            999998889999999999999999999999998765433222         23334444455555556679999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .+|++|-|+.++.+|
T Consensus       269 K~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  269 KKPEERKTALRLCEH  283 (502)
T ss_pred             CCHHHHHHHHHHhhh
Confidence            999999999999987

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.94  E-value=2.1e-26  Score=192.69  Aligned_cols=168  Identities=32%  Similarity=0.574  Sum_probs=122.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      .++|.++..++.|+++||+|||..+..+++|||+||+||+++.++..++. ++........    ....++..|+|||.+
T Consensus       776 ~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~  850 (968)
T PLN00113        776 NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETR  850 (968)
T ss_pred             cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCcccc
Confidence            47899999999999999999995433499999999999999988877664 4443322211    123567889999999


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHhCCCCCccccccccccc------chhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           86 YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL------NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      .+..++.++||||+|+++|++++|+.||+..........      .........+++.+............++.+++.+|
T Consensus       851 ~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  930 (968)
T PLN00113        851 ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHC  930 (968)
T ss_pred             cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhh
Confidence            888899999999999999999999999853221110000      00011222333433333233445566788999999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||++|||++|+++.|+
T Consensus       931 l~~~P~~RPt~~evl~~L~  949 (968)
T PLN00113        931 TATDPTARPCANDVLKTLE  949 (968)
T ss_pred             CcCCchhCcCHHHHHHHHH
Confidence            9999999999999999886

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.1e-27  Score=175.89  Aligned_cols=162  Identities=20%  Similarity=0.247  Sum_probs=114.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..+..++.||+.||+|||+.   +++|+||||+||+++.++.++++|||++......... .....+++.|++||
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE  173 (331)
T cd05597          97 DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE  173 (331)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHH
Confidence            4688999999999999999999999   9999999999999999999999999998665433221 22245788999999


Q ss_pred             cccc-----CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           84 LAYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        84 ~~~~-----~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      .+.+     ..++.++|+||+||++|+|++|+.||...+......   . ..........+.....   ....+.+++.+
T Consensus       174 ~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~---~-i~~~~~~~~~~~~~~~---~~~~~~~li~~  246 (331)
T cd05597         174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---K-IMNHKEHFQFPPDVTD---VSEEAKDLIRR  246 (331)
T ss_pred             HHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH---H-HHcCCCcccCCCccCC---CCHHHHHHHHH
Confidence            9863     346788999999999999999999996532211000   0 0000000011111111   12236667777


Q ss_pred             ccCc--CCCCCCCHHHHHHH
Q 042876          159 CLNE--SPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~--~p~~Rps~~~~~~~  176 (179)
                      |+..  ++..|++++++++|
T Consensus       247 ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         247 LICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HccCcccccCCCCHHHHhcC
Confidence            6654  44448899999876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.94  E-value=1.2e-26  Score=171.45  Aligned_cols=160  Identities=24%  Similarity=0.256  Sum_probs=115.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---------------C
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---------------N   69 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------------~   69 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||+|.||+++.++.++++|||.+........               .
T Consensus        96 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (305)
T cd05609          96 GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL  172 (305)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhcc
Confidence            4678899999999999999999999   999999999999999999999999998763211000               0


Q ss_pred             cccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHH
Q 042876           70 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKL  149 (179)
Q Consensus        70 ~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (179)
                      .....++..|++||.+.+..++.++|+||||+++|++++|..||.+....   ...........   ..+....   ...
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~~~~~~~~---~~~~~~~---~~~  243 (305)
T cd05609         173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISDDI---EWPEGDE---ALP  243 (305)
T ss_pred             ccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccc---CCCCccc---cCC
Confidence            11234567899999988888899999999999999999999998643211   00111111100   1111111   122


Q ss_pred             HHHHHHHhcccCcCCCCCCC---HHHHHHH
Q 042876          150 ISIVKVAFSCLNESPESRPT---MKIVSQQ  176 (179)
Q Consensus       150 ~~~~~li~~cl~~~p~~Rps---~~~~~~~  176 (179)
                      ..+.+++.+||+.||++||+   +.+++++
T Consensus       244 ~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         244 ADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            34788999999999999998   4555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.5e-26  Score=160.65  Aligned_cols=171  Identities=20%  Similarity=0.274  Sum_probs=123.0

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC----cccccCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN----WTEFAGTYG   78 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~   78 (179)
                      ...+|+..++.+++.++.+||.|+|++   .++|||+|+.|+++++++.++++|||+++.+......    .++++-+.+
T Consensus       117 ~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLw  193 (376)
T KOG0669|consen  117 RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLW  193 (376)
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeee
Confidence            346899999999999999999999999   9999999999999999999999999999766543322    445667899


Q ss_pred             CCCCccccc-CCCCcchhhHHHHHHHHHHHhCCCCCccccccc----------------ccccchhhhhhhcCCCCCCCC
Q 042876           79 YVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS----------------SSSLNTDIELDEMLDPRLPAP  141 (179)
Q Consensus        79 ~~~pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~  141 (179)
                      |++||.+.| ..++++.|+|..||++.+|+++.+.+.+.....                ......-.-.+++--+.++..
T Consensus       194 YrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~  273 (376)
T KOG0669|consen  194 YRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKG  273 (376)
T ss_pred             cCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcc
Confidence            999998776 468999999999999999999988875432110                000000011111100001100


Q ss_pred             -CccHHHHHH------HHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          142 -SRSVQEKLI------SIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       142 -~~~~~~~~~------~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                       ........+      +..+|+.+++..||.+|+++++++.|
T Consensus       274 ~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  274 QKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             hhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence             000111111      46788889999999999999999876

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.9e-27  Score=177.60  Aligned_cols=161  Identities=24%  Similarity=0.354  Sum_probs=128.3

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      .+.+|+...++.++.-+++|++|||++   |||.|||||+|++++.+|.+|+.|||+++..+.....+ ++.|++.|.+|
T Consensus       513 dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw-TFcGTpEYVAP  588 (732)
T KOG0614|consen  513 DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW-TFCGTPEYVAP  588 (732)
T ss_pred             hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCcee-eecCCcccccc
Confidence            456889999999999999999999999   99999999999999999999999999999988766554 47899999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |++.+.....+.|.||||++++++++|..||++.+....+.......-..-++++++          +...++|+++-..
T Consensus       589 EIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~----------k~a~~Lik~LCr~  658 (732)
T KOG0614|consen  589 EIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRIT----------KTATDLIKKLCRD  658 (732)
T ss_pred             hhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccc----------hhHHHHHHHHHhc
Confidence            999999999999999999999999999999987664433222211111111112222          2356788899999


Q ss_pred             CCCCCCC-----HHHHHHHh
Q 042876          163 SPESRPT-----MKIVSQQL  177 (179)
Q Consensus       163 ~p~~Rps-----~~~~~~~l  177 (179)
                      +|.+|.-     +.+|.+|-
T Consensus       659 ~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  659 NPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             CcHhhhccccCChHHHHhhh
Confidence            9999975     55666553

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1e-26  Score=174.62  Aligned_cols=165  Identities=23%  Similarity=0.300  Sum_probs=118.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++......   .....++..|++||.
T Consensus       115 ~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~  188 (345)
T cd07877         115 QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEI  188 (345)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccccccc---ccccccCCCccCHHH
Confidence            4688999999999999999999999   9999999999999999999999999998654322   223456778999998


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-------hhhh--------hh---hcCCCCCCCC--Cc
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-------TDIE--------LD---EMLDPRLPAP--SR  143 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-------~~~~--------~~---~~~~~~~~~~--~~  143 (179)
                      +.+ ..++.++|+||+|++++++++|..||............       ....        ..   ...+ ..+..  ..
T Consensus       189 ~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  267 (345)
T cd07877         189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT-QMPKMNFAN  267 (345)
T ss_pred             HhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhc-ccCCcchhh
Confidence            766 45788999999999999999999998643221100000       0000        00   0000 00000  00


Q ss_pred             cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          144 SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       144 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ........+.++|.+|++.||.+||++.++++|
T Consensus       268 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         268 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            000112347889999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.94  E-value=2.4e-26  Score=168.49  Aligned_cols=162  Identities=25%  Similarity=0.312  Sum_probs=118.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|.||+++.++.++++|||++......... .....++..|++||
T Consensus       100 ~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  176 (288)
T cd05583         100 EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE  176 (288)
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHH
Confidence            4688999999999999999999998   9999999999999999999999999998765433211 12235678899999


Q ss_pred             ccccCC--CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTMK--ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~~--~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ...+..  .+.++|+||+|++++++++|..||........    .............+.+..    ....+.+++.+||+
T Consensus       177 ~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~  248 (288)
T cd05583         177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----QSEISRRILKSKPPFPKT----MSAEARDFIQKLLE  248 (288)
T ss_pred             HhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----HHHHHHHHHccCCCCCcc----cCHHHHHHHHHHhc
Confidence            887654  67899999999999999999999864321110    011111111111111111    12247888999999


Q ss_pred             cCCCCCCCHHHHHHHh
Q 042876          162 ESPESRPTMKIVSQQL  177 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l  177 (179)
                      .||++|||+.++.+.|
T Consensus       249 ~~p~~R~t~~~~~~~l  264 (288)
T cd05583         249 KDPKKRLGANGADEIK  264 (288)
T ss_pred             CCHhhccCcchHHHHh
Confidence            9999999977665544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.94  E-value=1.6e-26  Score=165.12  Aligned_cols=150  Identities=22%  Similarity=0.210  Sum_probs=114.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+.......   .....+..|++||.
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aPE~  153 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAPEV  153 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCCcc
Confidence            3588999999999999999999999   99999999999999999999999999876554321   22344567999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      ..+..++.++|+||+|++++++++|..|+........          ......++.  .    ....+.+++.+|++.||
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------~~~~~~~~~--~----~~~~~~~li~~~l~~dp  217 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------THTTLNIPE--W----VSEEARSLLQQLLQFNP  217 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------cccccCCcc--c----CCHHHHHHHHHHccCCH
Confidence            8877888999999999999999999988753221100          000001111  1    12247788999999999


Q ss_pred             CCCCCH-----HHHHHH
Q 042876          165 ESRPTM-----KIVSQQ  176 (179)
Q Consensus       165 ~~Rps~-----~~~~~~  176 (179)
                      .+||++     +++++|
T Consensus       218 ~~R~~~~~~~~~~~~~h  234 (237)
T cd05576         218 TERLGAGVAGVEDIKSH  234 (237)
T ss_pred             HHhcCCCccchHHHHcC
Confidence            999986     666654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.94  E-value=7.3e-27  Score=184.56  Aligned_cols=164  Identities=20%  Similarity=0.192  Sum_probs=107.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-CCceeEccccCccccCCCC-CCcccccCCCCCCCCcccc
Q 042876            9 WSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-EYEAHVADFGIAKFLKPDS-SNWTEFAGTYGYVAPELAY   86 (179)
Q Consensus         9 ~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~   86 (179)
                      ...+..++.|++.||.|||+.   +++||||||+||+++. ++.+||+|||++....... .......+++.|++||.+.
T Consensus       254 ~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~  330 (566)
T PLN03225        254 NKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI  330 (566)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence            345678999999999999999   9999999999999985 5789999999997553221 1123456788999999654


Q ss_pred             cCC----------------------CCcchhhHHHHHHHHHHHhCCCCCccccc-----ccccccchhhhhhhcCCCCCC
Q 042876           87 TMK----------------------ITEKCDVYSFGVLALEVIKGKHPRDFLSS-----ISSSSLNTDIELDEMLDPRLP  139 (179)
Q Consensus        87 ~~~----------------------~~~~~D~~slg~~~~~l~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  139 (179)
                      ...                      +..++|+||+||++|+|+++..+++....     ...... ..........+...
T Consensus       331 ~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~~  409 (566)
T PLN03225        331 MSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDY-DLVAWRKLVEPRAS  409 (566)
T ss_pred             ccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCC-cHHHHHHhhccccc
Confidence            222                      23456999999999999987766532100     000000 00111111111111


Q ss_pred             CCCc----cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          140 APSR----SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       140 ~~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ....    ..........+|+.+||+.||.+|||++++++|
T Consensus       410 ~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        410 PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             hhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence            1000    000011124579999999999999999999987

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.7e-26  Score=165.00  Aligned_cols=159  Identities=21%  Similarity=0.293  Sum_probs=119.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC---CCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS---SNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++.......   .......++..|++
T Consensus       101 ~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (264)
T cd06653         101 GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS  177 (264)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccC
Confidence            4578889999999999999999999   99999999999999999999999999987653211   11223457788999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+||||++++++++|..||......     .. . ......+..+..   .......+.+++.+||+
T Consensus       178 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~-~-~~~~~~~~~~~~---p~~~~~~~~~~i~~~l~  247 (264)
T cd06653         178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AA-I-FKIATQPTKPML---PDGVSDACRDFLKQIFV  247 (264)
T ss_pred             HhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HH-H-HHHHcCCCCCCC---CcccCHHHHHHHHHHhc
Confidence            99998888889999999999999999999998643211     11 1 111111111111   11122347888889999


Q ss_pred             cCCCCCCCHHHHHHHh
Q 042876          162 ESPESRPTMKIVSQQL  177 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l  177 (179)
                       +|..||++.+++.|.
T Consensus       248 -~~~~r~~~~~~~~~~  262 (264)
T cd06653         248 -EEKRRPTAEFLLRHP  262 (264)
T ss_pred             -CcccCccHHHHhcCC
Confidence             579999999998874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.9e-27  Score=180.04  Aligned_cols=158  Identities=24%  Similarity=0.374  Sum_probs=126.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPELA   85 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~   85 (179)
                      ++.--.+-|+.||.+|++||...   ++|||||...|+|+..+..+|+.|||+++.+..+... .-.-.-++.|.+||.+
T Consensus       362 v~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsL  438 (1157)
T KOG4278|consen  362 VPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL  438 (1157)
T ss_pred             cchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccc
Confidence            45556688999999999999999   9999999999999999999999999999988765432 2222346789999999


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           86 YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      ..+.++-++|||+||+++|++.| |-.||.+......+.+..     .-  -++..++.|.+.    +..||+.||+++|
T Consensus       439 AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-----kg--yRM~~PeGCPpk----VYeLMraCW~WsP  507 (1157)
T KOG4278|consen  439 AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-----KG--YRMDGPEGCPPK----VYELMRACWNWSP  507 (1157)
T ss_pred             cccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-----cc--ccccCCCCCCHH----HHHHHHHHhcCCc
Confidence            99999999999999999999997 888988764322222211     11  133444455554    8899999999999


Q ss_pred             CCCCCHHHHHHHhh
Q 042876          165 ESRPTMKIVSQQLR  178 (179)
Q Consensus       165 ~~Rps~~~~~~~l~  178 (179)
                      .+||++.|+-+.|+
T Consensus       508 sDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  508 SDRPSFAEIHQAFE  521 (1157)
T ss_pred             ccCccHHHHHHHHH
Confidence            99999999988775

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.94  E-value=3.8e-27  Score=176.11  Aligned_cols=160  Identities=21%  Similarity=0.309  Sum_probs=116.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++++|||++......... .....+++.|+|||
T Consensus        97 ~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE  173 (331)
T cd05624          97 DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE  173 (331)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHH
Confidence            4688999999999999999999999   9999999999999999999999999998765433221 22346889999999


Q ss_pred             cccc-----CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC--CCCCCCCCccHHHHHHHHHHHH
Q 042876           84 LAYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVA  156 (179)
Q Consensus        84 ~~~~-----~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li  156 (179)
                      .+.+     ..++.++|+||+|+++|+|++|..||.......        ....+.  ..+.+.+ ........++.+++
T Consensus       174 ~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~~~p-~~~~~~~~~~~~li  244 (331)
T cd05624         174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHEERFQFP-SHITDVSEEAKDLI  244 (331)
T ss_pred             HHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH--------HHHHHHcCCCcccCC-CccccCCHHHHHHH
Confidence            8865     356789999999999999999999996543211        111111  1111110 11111233477788


Q ss_pred             hcccCcCCCC--CCCHHHHHHH
Q 042876          157 FSCLNESPES--RPTMKIVSQQ  176 (179)
Q Consensus       157 ~~cl~~~p~~--Rps~~~~~~~  176 (179)
                      .+|+..++.+  |++++++++|
T Consensus       245 ~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         245 QRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HHHccCchhhcCCCCHHHHhcC
Confidence            8888865544  4688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.94  E-value=2.7e-26  Score=171.27  Aligned_cols=166  Identities=25%  Similarity=0.360  Sum_probs=117.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|+++||.|||+.   +++|+||+|.||+++.++.++++|||.+......   .....++..|++||.
T Consensus       103 ~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~y~aPE~  176 (328)
T cd07856         103 RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MTGYVSTRYYRAPEI  176 (328)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC---cCCCcccccccCcee
Confidence            4578888899999999999999999   9999999999999999999999999998754322   122356778999998


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch------------------hhhhhhcCCCCCCCC-Ccc
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT------------------DIELDEMLDPRLPAP-SRS  144 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~-~~~  144 (179)
                      +.+ ..++.++|+||+|++++++++|..||.............                  ............+.. ...
T Consensus       177 ~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (328)
T cd07856         177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEK  256 (328)
T ss_pred             eeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHH
Confidence            765 567899999999999999999999996543211000000                  000000000000000 000


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.++|.+||+.+|++||++++++.+
T Consensus       257 ~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         257 FKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            01112357889999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.94  E-value=2e-26  Score=172.96  Aligned_cols=166  Identities=23%  Similarity=0.257  Sum_probs=118.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++.......   ....++..|++||.
T Consensus       113 ~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~  186 (343)
T cd07880         113 EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM---TGYVVTRWYRAPEV  186 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccCc---cccccCCcccCHHH
Confidence            4689999999999999999999999   99999999999999999999999999987554321   22356778999998


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-------hh--------hhhhh---cCCCCCCCC-Ccc
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-------TD--------IELDE---MLDPRLPAP-SRS  144 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-------~~--------~~~~~---~~~~~~~~~-~~~  144 (179)
                      +.+ ..++.++|+||||++++++++|..||............       ..        .....   .+....+.. ...
T Consensus       187 ~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (343)
T cd07880         187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSL  266 (343)
T ss_pred             HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHh
Confidence            865 45788999999999999999999999654321000000       00        00000   000000000 000


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.+++.+|++.||.+|||+.+++.+
T Consensus       267 ~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         267 LPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             ccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            01122347889999999999999999999865

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.93  E-value=3.4e-26  Score=163.00  Aligned_cols=109  Identities=26%  Similarity=0.348  Sum_probs=93.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC----CceeEccccCccccCCCCCC---cccccCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE----YEAHVADFGIAKFLKPDSSN---WTEFAGT   76 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~----~~~~l~d~~~~~~~~~~~~~---~~~~~~~   76 (179)
                      .+.++...++.++.||+.|+.|||++   =++||||||.||++..+    |.+||+|+|+++.+..+-..   ....+-+
T Consensus       126 ~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVT  202 (438)
T KOG0666|consen  126 AKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVT  202 (438)
T ss_pred             hccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEE
Confidence            45688899999999999999999999   68999999999999888    88999999999877654322   2335678


Q ss_pred             CCCCCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCcc
Q 042876           77 YGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDF  115 (179)
Q Consensus        77 ~~~~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~  115 (179)
                      .+|++||++.|. +|+++.|+|++||++.|+++-+.-|.+
T Consensus       203 iWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  203 IWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             EEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            899999988764 689999999999999999998877754

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.93  E-value=2e-25  Score=163.75  Aligned_cols=161  Identities=23%  Similarity=0.299  Sum_probs=117.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++......... .....++..|++||
T Consensus       100 ~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  176 (290)
T cd05613         100 ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD  176 (290)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChh
Confidence            4678899999999999999999999   9999999999999999999999999998765432211 22345778899999


Q ss_pred             ccccC--CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTM--KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~--~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      .+.+.  .++.++|+||+|+++|++++|..||........    .............+....    ....+.+++.+||+
T Consensus       177 ~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~----~~~~~~~ll~~~l~  248 (290)
T cd05613         177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS----QAEISRRILKSEPPYPQE----MSALAKDIIQRLLM  248 (290)
T ss_pred             hccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc----HHHHHHHhhccCCCCCcc----CCHHHHHHHHHHhc
Confidence            88653  357789999999999999999999864321110    001111111111111111    12247788999999


Q ss_pred             cCCCCCC-----CHHHHHHH
Q 042876          162 ESPESRP-----TMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rp-----s~~~~~~~  176 (179)
                      .||.+||     ++++++.+
T Consensus       249 ~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         249 KDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             CCHHHhcCCCCCCHHHHHcC
Confidence            9999997     77887765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.93  E-value=1.8e-25  Score=159.15  Aligned_cols=158  Identities=30%  Similarity=0.419  Sum_probs=120.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY   86 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   86 (179)
                      +++..++.++.+++.++.+||+.   +++|+||+|.||+++.++.++++|||.+....... ......+...|++||...
T Consensus        84 ~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~  159 (244)
T smart00220       84 LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLL  159 (244)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHc
Confidence            78899999999999999999999   99999999999999999999999999987765432 223345677899999998


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCCC
Q 042876           87 TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPES  166 (179)
Q Consensus        87 ~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~  166 (179)
                      +...+.++|+|++|++++++++|..||......       ............... .........+.+++.+||..+|++
T Consensus       160 ~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~  231 (244)
T smart00220      160 GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------LELFKKIGKPKPPFP-PPEWKISPEAKDLIRKLLVKDPEK  231 (244)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHhccCCCCc-cccccCCHHHHHHHHHHccCCchh
Confidence            878889999999999999999999998653111       111111111111110 000002235888999999999999


Q ss_pred             CCCHHHHHHH
Q 042876          167 RPTMKIVSQQ  176 (179)
Q Consensus       167 Rps~~~~~~~  176 (179)
                      ||++.+++++
T Consensus       232 Rp~~~~~~~~  241 (244)
T smart00220      232 RLTAEEALQH  241 (244)
T ss_pred             ccCHHHHhhC
Confidence            9999999874

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=2.5e-26  Score=175.37  Aligned_cols=158  Identities=24%  Similarity=0.358  Sum_probs=128.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ....+.++..+..|+++|++|+|++   +++|||||++|++++.+.++||+|||+++++... .....+.+.+.|.+||+
T Consensus       150 gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-~~lqt~cgsppyAaPEl  225 (596)
T KOG0586|consen  150 GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-LMLQTFCGSPPYAAPEL  225 (596)
T ss_pred             ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc-ccccccCCCCCccChHh
Confidence            3456689999999999999999999   9999999999999999999999999999988844 34566889999999999


Q ss_pred             cccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      ..+..+ .+.+|+|++|+++|.++.|..||++..-.....        ..+..++..+.....    ++.++|++++..+
T Consensus       226 ~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~--------rvl~gk~rIp~~ms~----dce~lLrk~lvl~  293 (596)
T KOG0586|consen  226 FNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP--------RVLRGKYRIPFYMSC----DCEDLLRKFLVLN  293 (596)
T ss_pred             hcCcccCCcceehhhhhhhheeeeecccccCCcccccccc--------hheeeeecccceeec----hhHHHHHHhhccC
Confidence            998876 588999999999999999999998654322221        122222222222222    3788999999999


Q ss_pred             CCCCCCHHHHHHHhh
Q 042876          164 PESRPTMKIVSQQLR  178 (179)
Q Consensus       164 p~~Rps~~~~~~~l~  178 (179)
                      |.+|++.+++.++-+
T Consensus       294 Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  294 PSKRGPCDQIMKDRW  308 (596)
T ss_pred             ccccCCHHHhhhhcc
Confidence            999999999987754

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=5.2e-26  Score=174.03  Aligned_cols=157  Identities=24%  Similarity=0.418  Sum_probs=120.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC-CceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +.++.+-++.+++||++||.|||++. +.|+|||||=+|||+.++ |.+||+|+|+|+.......  ...+|+|.|||||
T Consensus       138 ~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a--ksvIGTPEFMAPE  214 (632)
T KOG0584|consen  138 RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA--KSVIGTPEFMAPE  214 (632)
T ss_pred             ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcccc--ceeccCccccChH
Confidence            56788899999999999999999975 489999999999999776 7899999999987765432  2268999999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      +.. .+|....||||||+++.+|.|+..||+.-.+... .+   ..+.+.+.+ .+... + .+    ++.++|.+|+..
T Consensus       215 mYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-IY---KKV~SGiKP~sl~kV-~-dP----evr~fIekCl~~  283 (632)
T KOG0584|consen  215 MYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-IY---KKVTSGIKPAALSKV-K-DP----EVREFIEKCLAT  283 (632)
T ss_pred             HHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-HH---HHHHcCCCHHHhhcc-C-CH----HHHHHHHHHhcC
Confidence            986 7899999999999999999999999964432110 00   011111111 11110 0 11    378889999999


Q ss_pred             CCCCCCCHHHHHHH
Q 042876          163 SPESRPTMKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rps~~~~~~~  176 (179)
                       ..+|||+.|++++
T Consensus       284 -~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  284 -KSERLSAKELLKD  296 (632)
T ss_pred             -chhccCHHHHhhC
Confidence             8899999999874

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.93  E-value=6.3e-26  Score=172.76  Aligned_cols=160  Identities=24%  Similarity=0.368  Sum_probs=122.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCCcc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAPEL   84 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~   84 (179)
                      +.-+...+++.||++|++||.+-   ++||||+.+.|+|+++++.+||+|||+++.+...+.  ......-++.|+++|.
T Consensus       634 ~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEs  710 (807)
T KOG1094|consen  634 AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWES  710 (807)
T ss_pred             cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHH
Confidence            34456678999999999999998   999999999999999999999999999975433222  2233466889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHh--CCCCCcccccccccccchhhhhhhcCCCC-----CCCCCccHHHHHHHHHHHHh
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIK--GKHPRDFLSSISSSSLNTDIELDEMLDPR-----LPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~  157 (179)
                      +...+++.++|+|++|+++||+++  .+.||+...+...     .....++.+..     ++.+..+.+    .+.++|.
T Consensus       711 illgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-----ven~~~~~~~~~~~~~l~~P~~cp~----~lyelml  781 (807)
T KOG1094|consen  711 ILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-----VENAGEFFRDQGRQVVLSRPPACPQ----GLYELML  781 (807)
T ss_pred             HHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-----HHhhhhhcCCCCcceeccCCCcCcH----HHHHHHH
Confidence            998899999999999999999874  7889876543221     12222222211     122223333    4789999


Q ss_pred             cccCcCCCCCCCHHHHHHHhh
Q 042876          158 SCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +||..|..+|||++++..+|+
T Consensus       782 ~Cw~~es~~RPsFe~lh~~lq  802 (807)
T KOG1094|consen  782 RCWRRESEQRPSFEQLHLFLQ  802 (807)
T ss_pred             HHhchhhhcCCCHHHHHHHHH
Confidence            999999999999999998875

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.92  E-value=3.8e-25  Score=158.24  Aligned_cols=170  Identities=18%  Similarity=0.300  Sum_probs=130.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC---ceeEccccCccccCCCCC-------Ccccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY---EAHVADFGIAKFLKPDSS-------NWTEF   73 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~---~~~l~d~~~~~~~~~~~~-------~~~~~   73 (179)
                      .+-|++.++.+++++|+.||.+||..   ||.|||+||+|||.....   .+||+||.+.........       .....
T Consensus       170 ~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tP  246 (463)
T KOG0607|consen  170 RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTP  246 (463)
T ss_pred             hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCc
Confidence            45689999999999999999999999   999999999999995443   479999998764332211       13446


Q ss_pred             cCCCCCCCCccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCcccccc---ccc----ccchhhhhhhcCCCCCCCC
Q 042876           74 AGTYGYVAPELAYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSI---SSS----SLNTDIELDEMLDPRLPAP  141 (179)
Q Consensus        74 ~~~~~~~~pe~~~~-----~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~---~~~----~~~~~~~~~~~~~~~~~~~  141 (179)
                      .|+..||+||.+..     .-|..++|.||||+++|=|++|+.||.+.-..   +..    ..-++.-..++.+....-+
T Consensus       247 vGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFP  326 (463)
T KOG0607|consen  247 VGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFP  326 (463)
T ss_pred             ccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCC
Confidence            78889999997642     24678999999999999999999999754332   111    1223334445556666656


Q ss_pred             CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          142 SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       142 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .+.|........+++..++..++.+|.++.+++.|
T Consensus       327 dkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  327 DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            67777777778888889999999999999988775

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=8.8e-26  Score=162.02  Aligned_cols=151  Identities=25%  Similarity=0.320  Sum_probs=120.2

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      +.+.|++...+.+...|++||.|||++   +||.||||.+|++++++|.|||.|||+++.-.........+.|++.|++|
T Consensus       261 rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAP  337 (516)
T KOG0690|consen  261 RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAP  337 (516)
T ss_pred             hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCc
Confidence            346789999999999999999999999   99999999999999999999999999998766555566778999999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |.+....|..+.|-|.+|+|+|+|++|+.||..........+.   ...   +-++|.  . ..+   +...|+..+|..
T Consensus       338 EVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI---l~e---d~kFPr--~-ls~---eAktLLsGLL~k  405 (516)
T KOG0690|consen  338 EVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI---LME---DLKFPR--T-LSP---EAKTLLSGLLKK  405 (516)
T ss_pred             hhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH---Hhh---hccCCc--c-CCH---HHHHHHHHHhhc
Confidence            9999999999999999999999999999999644322111111   111   112221  1 111   245566689999


Q ss_pred             CCCCCC
Q 042876          163 SPESRP  168 (179)
Q Consensus       163 ~p~~Rp  168 (179)
                      ||.+|.
T Consensus       406 dP~kRL  411 (516)
T KOG0690|consen  406 DPKKRL  411 (516)
T ss_pred             ChHhhc
Confidence            999995

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.5e-24  Score=156.53  Aligned_cols=159  Identities=25%  Similarity=0.355  Sum_probs=123.7

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      +.++++++.++.+...|+.||.|||+.   ||+.||||.+|++++..|.+|+.|+|+++.-..+.....++.|++.|.+|
T Consensus       344 rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiap  420 (593)
T KOG0695|consen  344 RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAP  420 (593)
T ss_pred             hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccch
Confidence            457899999999999999999999999   99999999999999999999999999998766555566778999999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |++++..|....|-|+||+++++|+.|+.||+-............-..+-++.+.+..+.....    ....+++.-++.
T Consensus       421 eilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsv----kas~vlkgflnk  496 (593)
T KOG0695|consen  421 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSV----KASHVLKGFLNK  496 (593)
T ss_pred             hhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeeh----hhHHHHHHhhcC
Confidence            9999999999999999999999999999999855432222222222222223322222111111    134566688899


Q ss_pred             CCCCCC
Q 042876          163 SPESRP  168 (179)
Q Consensus       163 ~p~~Rp  168 (179)
                      ||.+|.
T Consensus       497 dp~erl  502 (593)
T KOG0695|consen  497 DPKERL  502 (593)
T ss_pred             CcHHhc
Confidence            999885

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.92  E-value=2.9e-26  Score=160.17  Aligned_cols=162  Identities=27%  Similarity=0.353  Sum_probs=119.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++...-.+..-.+.||.||-...  +++|||+||+|||++..|.+|++|||++-.+..+- ..+.-.|-..|+|||.
T Consensus       162 ~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si-AkT~daGCrpYmAPER  238 (361)
T KOG1006|consen  162 SRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI-AKTVDAGCRPYMAPER  238 (361)
T ss_pred             ccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH-HhhhccCCccccChhc
Confidence            45677777777778899999999974  89999999999999999999999999986654322 2233456778999998


Q ss_pred             cccC--CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC--CCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           85 AYTM--KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        85 ~~~~--~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      +...  .+.-++|+||||++++|+.+|..|+..-++       ....+..++  ++...............+.++|..|+
T Consensus       239 i~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl  311 (361)
T KOG1006|consen  239 IDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCL  311 (361)
T ss_pred             cCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHh
Confidence            8643  367889999999999999999999865432       111222222  22211111222233445889999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      ..|.++||.+++++++
T Consensus       312 ~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  312 IKDRSDRPKYDDLKKF  327 (361)
T ss_pred             hcccccCcchhhhhcC
Confidence            9999999999998753

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=8.9e-25  Score=167.08  Aligned_cols=156  Identities=28%  Similarity=0.427  Sum_probs=121.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ++++.+-++..++.+.+.||+|||+.   +.||||||.-||+++..|.+|++|||.+....+    -..++|+|.|++||
T Consensus       120 kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----AnsFvGTPywMAPE  192 (948)
T KOG0577|consen  120 KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----ANSFVGTPYWMAPE  192 (948)
T ss_pred             hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc----hhcccCCccccchh
Confidence            46788889999999999999999999   999999999999999999999999999865543    24579999999999


Q ss_pred             cccc---CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           84 LAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        84 ~~~~---~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      .+..   ..|+.++||||||+++.++.-.+.|+=..+..+...+     ....-.+-++  ...|.++   +..++..||
T Consensus       193 VILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-----IAQNesPtLq--s~eWS~~---F~~Fvd~CL  262 (948)
T KOG0577|consen  193 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----IAQNESPTLQ--SNEWSDY---FRNFVDSCL  262 (948)
T ss_pred             HheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-----HHhcCCCCCC--CchhHHH---HHHHHHHHH
Confidence            8764   4688999999999999999999988633322111111     1111111121  3445555   455666999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.-|.+|||.++++.|
T Consensus       263 qKipqeRptse~ll~H  278 (948)
T KOG0577|consen  263 QKIPQERPTSEELLKH  278 (948)
T ss_pred             hhCcccCCcHHHHhhc
Confidence            9999999999999886

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=5.7e-25  Score=156.82  Aligned_cols=165  Identities=23%  Similarity=0.286  Sum_probs=120.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY   86 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   86 (179)
                      ++-.....+..|++.|++|||+.   +|+||||||+||++..+...||.|||++...+.. ...+..+.+..|.+||.+-
T Consensus       115 lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil  190 (369)
T KOG0665|consen  115 LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVIL  190 (369)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc-cccCchhheeeccCchhee
Confidence            45567888999999999999999   9999999999999999999999999999876654 2223346677899999999


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhCCCCCccccccc------------c------------------cccchhhhhhh-cCC
Q 042876           87 TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS------------S------------------SSLNTDIELDE-MLD  135 (179)
Q Consensus        87 ~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~------------~------------------~~~~~~~~~~~-~~~  135 (179)
                      +..++...|+||+||++.+|++|..-|.+.....            .                  ..+.. ....+ ..|
T Consensus       191 ~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~-~~f~~~fpD  269 (369)
T KOG0665|consen  191 GMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQA-ISFSELFPD  269 (369)
T ss_pred             ccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhc-cchhhhCCc
Confidence            9889999999999999999999998875321100            0                  00000 00111 112


Q ss_pred             CCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ..++.............-+++.+||..||++|.|++++++|
T Consensus       270 ~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  270 SLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             ccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            22222222221222335678889999999999999999986

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.91  E-value=1.3e-25  Score=176.36  Aligned_cols=152  Identities=28%  Similarity=0.416  Sum_probs=115.2

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC---C--CceeEccccCccccCCCCCC---cccccCCCCCCCC
Q 042876           11 QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL---E--YEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVAP   82 (179)
Q Consensus        11 ~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~---~--~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~p   82 (179)
                      ..+....|+++||++||+-   +||||||||.|||++.   +  ..++|+|||+++.+......   .....|+.+|+||
T Consensus       607 ~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~AP  683 (903)
T KOG1027|consen  607 DPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAP  683 (903)
T ss_pred             cHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCH
Confidence            4578899999999999997   9999999999999976   3  35799999999988765543   2345788999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.....+.+.|+||+||++|++++ |.+||.+....+.........+..     +.....+      ...+||.+|++
T Consensus       684 E~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~-----L~~~~d~------eA~dLI~~ml~  752 (903)
T KOG1027|consen  684 EQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVH-----LEPLPDC------EAKDLISRMLN  752 (903)
T ss_pred             HHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceee-----eccCchH------HHHHHHHHhcC
Confidence            99998888889999999999999998 599997543222111111111111     1111111      35678889999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .+|..||++.+++.|
T Consensus       753 ~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  753 PDPQLRPSATDVLNH  767 (903)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999865

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=3.5e-24  Score=159.55  Aligned_cols=174  Identities=25%  Similarity=0.438  Sum_probs=131.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCC------CCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCF------PPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAG   75 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~------~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~   75 (179)
                      +..++|.+..+++..++.||+|||+..+      +.|+|||||+.|||+..+....|+|||++..+......  .-..+|
T Consensus       301 ~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVG  380 (534)
T KOG3653|consen  301 ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVG  380 (534)
T ss_pred             hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhh
Confidence            3578999999999999999999999543      36999999999999999999999999999877644332  233689


Q ss_pred             CCCCCCCcccccC-CCC-----cchhhHHHHHHHHHHHhCCCCCcc-------------cccccccccchhhhhhhcCCC
Q 042876           76 TYGYVAPELAYTM-KIT-----EKCDVYSFGVLALEVIKGKHPRDF-------------LSSISSSSLNTDIELDEMLDP  136 (179)
Q Consensus        76 ~~~~~~pe~~~~~-~~~-----~~~D~~slg~~~~~l~~~~~p~~~-------------~~~~~~~~~~~~~~~~~~~~~  136 (179)
                      +..|||||++.+. ++.     .+.||||+|.|+||++++-.-+..             ....+....++...+.+...+
T Consensus       381 T~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP  460 (534)
T KOG3653|consen  381 TRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRP  460 (534)
T ss_pred             hhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCC
Confidence            9999999998753 222     468999999999999986543321             111122222333344445556


Q ss_pred             CCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          137 RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      .++..+..+ .....+.+.+..||+.|++.|.|+..+.+++.
T Consensus       461 ~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~  501 (534)
T KOG3653|consen  461 KIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMA  501 (534)
T ss_pred             CChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence            666666665 44556888999999999999999999888763

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=5.7e-24  Score=156.98  Aligned_cols=149  Identities=26%  Similarity=0.350  Sum_probs=123.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .+|.+..+..++.+|+-||=+||+.   ||+.||||.+|++++.+|.+||.|||+++..-.......++.|++.|++||+
T Consensus       445 GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEI  521 (683)
T KOG0696|consen  445 GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEI  521 (683)
T ss_pred             cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccce
Confidence            4677888999999999999999999   9999999999999999999999999999877666666677899999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +..++|+.+.|-||+|+++|+|+.|+.||++....        +..+++.+....-+    ...+.+..+++...+..+|
T Consensus       522 i~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--------elF~aI~ehnvsyP----KslSkEAv~ickg~ltK~P  589 (683)
T KOG0696|consen  522 IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQAIMEHNVSYP----KSLSKEAVAICKGLLTKHP  589 (683)
T ss_pred             EEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHHccCcCc----ccccHHHHHHHHHHhhcCC
Confidence            99999999999999999999999999999865432        22333333222111    1223346778889999999


Q ss_pred             CCCC
Q 042876          165 ESRP  168 (179)
Q Consensus       165 ~~Rp  168 (179)
                      .+|.
T Consensus       590 ~kRL  593 (683)
T KOG0696|consen  590 GKRL  593 (683)
T ss_pred             cccc
Confidence            9995

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.2e-23  Score=155.85  Aligned_cols=172  Identities=26%  Similarity=0.345  Sum_probs=129.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhh-----CCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC----CCcccccC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHH-----DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----SNWTEFAG   75 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~-----~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~   75 (179)
                      ..++....++++.++++||++||.     ++.+.|.|||||+.||++..++..-|+|+|+|.......    ......+|
T Consensus       303 ~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVG  382 (513)
T KOG2052|consen  303 NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVG  382 (513)
T ss_pred             ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccc
Confidence            568889999999999999999998     344679999999999999999999999999997665432    12455789


Q ss_pred             CCCCCCCcccccC-C---C--CcchhhHHHHHHHHHHHhC----------CCCCcccc-cccccccchhhhhhhcCCCCC
Q 042876           76 TYGYVAPELAYTM-K---I--TEKCDVYSFGVLALEVIKG----------KHPRDFLS-SISSSSLNTDIELDEMLDPRL  138 (179)
Q Consensus        76 ~~~~~~pe~~~~~-~---~--~~~~D~~slg~~~~~l~~~----------~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~  138 (179)
                      +..|+|||.+... +   +  -..+||||||.|+||+..+          +.||.+.- ..+...-+........+.+.+
T Consensus       383 TKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~i  462 (513)
T KOG2052|consen  383 TKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNI  462 (513)
T ss_pred             eeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCC
Confidence            9999999998642 1   1  2358999999999998632          33553322 223333333344444555666


Q ss_pred             CCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          139 PAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       139 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      |..+...+ .+..+.++|+.||..||.-|.|+-.+.+.|
T Consensus       463 pnrW~s~~-~l~~m~klMkeCW~~Np~aRltALriKKtl  500 (513)
T KOG2052|consen  463 PNRWKSDP-ALRVMAKLMKECWYANPAARLTALRIKKTL  500 (513)
T ss_pred             CcccccCH-HHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence            66666544 566789999999999999999998887765

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=5.9e-24  Score=171.68  Aligned_cols=159  Identities=24%  Similarity=0.283  Sum_probs=121.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCcc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPEL   84 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~   84 (179)
                      +++++-++.++..|+.||..+|+.   |+|||||||+|||++.+|.++++|||.+-.+..++.. ....+|+|.|.+||+
T Consensus       171 ~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEv  247 (1317)
T KOG0612|consen  171 RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEV  247 (1317)
T ss_pred             CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHH
Confidence            588999999999999999999999   9999999999999999999999999999887755543 455789999999999


Q ss_pred             ccc-----CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           85 AYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        85 ~~~-----~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +..     ..|++.+|-||+|+++|+|+.|..||....-+..+......  ...+  .+|...    +.+....+||+..
T Consensus       248 Lqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h--k~~l--~FP~~~----~VSeeakdLI~~l  319 (1317)
T KOG0612|consen  248 LQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH--KESL--SFPDET----DVSEEAKDLIEAL  319 (1317)
T ss_pred             HHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch--hhhc--CCCccc----ccCHHHHHHHHHH
Confidence            873     35788999999999999999999999654332222211111  1111  122211    1333467777777


Q ss_pred             cCcCCCCCCC---HHHHHHH
Q 042876          160 LNESPESRPT---MKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps---~~~~~~~  176 (179)
                      + -+|+.|..   ++++..|
T Consensus       320 l-~~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  320 L-CDREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             h-cChhhhcccccHHHHHhC
Confidence            7 46778887   8888776

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=9.4e-24  Score=166.26  Aligned_cols=160  Identities=28%  Similarity=0.450  Sum_probs=128.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCccc--ccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE--FAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~--~~~~~~~~~   81 (179)
                      +..+-.+..+.++.||++|+.|||.+   .++||||-..|+|+..-..+|+.|||+++...........  ...++.|++
T Consensus       792 r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwma  868 (1177)
T KOG1025|consen  792 RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMA  868 (1177)
T ss_pred             hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHH
Confidence            34577788999999999999999999   9999999999999999999999999999887766554333  234677899


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      -|.+....++.++||||+|+++||++| |..|+.+....+......       ...+++.+.-+..    ++.-++.+||
T Consensus       869 le~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~geRLsqPpiCti----DVy~~mvkCw  937 (1177)
T KOG1025|consen  869 LESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KGERLSQPPICTI----DVYMVMVKCW  937 (1177)
T ss_pred             HHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------ccccCCCCCCccH----HHHHHHHHHh
Confidence            999998899999999999999999998 899987664333222111       1123444444433    5888899999


Q ss_pred             CcCCCCCCCHHHHHHHh
Q 042876          161 NESPESRPTMKIVSQQL  177 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l  177 (179)
                      ..|+..||+++++...+
T Consensus       938 mid~~~rp~fkel~~~f  954 (1177)
T KOG1025|consen  938 MIDADSRPTFKELAEEF  954 (1177)
T ss_pred             ccCcccCccHHHHHHHH
Confidence            99999999999998765

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.90  E-value=9.4e-24  Score=142.83  Aligned_cols=109  Identities=27%  Similarity=0.411  Sum_probs=92.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ++.+++...-+++.+++.||.|||++.  .++|||+||+|||++..|++|++|||.+-.+..+. ..+.-.|...|+|||
T Consensus       142 g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi-Akt~daGCkpYmaPE  218 (282)
T KOG0984|consen  142 GGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI-AKTMDAGCKPYMAPE  218 (282)
T ss_pred             CCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhh-HHHHhcCCCccCChh
Confidence            456788899999999999999999984  89999999999999999999999999997665432 223335667899999


Q ss_pred             cccc----CCCCcchhhHHHHHHHHHHHhCCCCCcc
Q 042876           84 LAYT----MKITEKCDVYSFGVLALEVIKGKHPRDF  115 (179)
Q Consensus        84 ~~~~----~~~~~~~D~~slg~~~~~l~~~~~p~~~  115 (179)
                      .+..    ..|+-++|+||||+.+.||.+++.||+.
T Consensus       219 ri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  219 RINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             hcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            8753    3578899999999999999999999863

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.90  E-value=1.7e-23  Score=139.16  Aligned_cols=170  Identities=21%  Similarity=0.242  Sum_probs=124.6

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      -+..++.+.++.++.|++.||.++|++   ++.|||+||.|.++..||..|+.|||+++.++.+..++....-+.+|.+|
T Consensus        94 lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrpp  170 (292)
T KOG0662|consen   94 LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPP  170 (292)
T ss_pred             cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCc
Confidence            456788899999999999999999999   99999999999999999999999999999998887777778889999999


Q ss_pred             cccccCC-CCcchhhHHHHHHHHHHHh-CCCCCcccccccc-------cccchhhhhhhc------C-CCCCCCCCccHH
Q 042876           83 ELAYTMK-ITEKCDVYSFGVLALEVIK-GKHPRDFLSSISS-------SSLNTDIELDEM------L-DPRLPAPSRSVQ  146 (179)
Q Consensus        83 e~~~~~~-~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~-------~~~~~~~~~~~~------~-~~~~~~~~~~~~  146 (179)
                      ..+.|.+ ++...|+||.||++.++.. |+.-|++..-...       ........+.++      . -+..+. ...+.
T Consensus       171 dvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypa-ttsws  249 (292)
T KOG0662|consen  171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPA-TTSWS  249 (292)
T ss_pred             ceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccc-cchHH
Confidence            9988765 7889999999999999986 5555543321100       000000011110      0 001111 11111


Q ss_pred             H----HHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          147 E----KLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       147 ~----~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .    ....--+++.+.+.-+|.+|.+++..++|
T Consensus       250 qivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  250 QIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             HHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1    12234567778999999999999998876

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.89  E-value=5.8e-23  Score=159.61  Aligned_cols=167  Identities=17%  Similarity=0.160  Sum_probs=111.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCcc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPEL   84 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~   84 (179)
                      .+++..++.++.|+++||.|||+.   +++||||||+||+++.++.++++|||++......... ......++.|++||.
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence            457788999999999999999999   9999999999999999999999999998654432211 111234678999998


Q ss_pred             cccCCC----------------------CcchhhHHHHHHHHHHHhCCC-CCcccccccccc--cchh-hhhhhcCCCCC
Q 042876           85 AYTMKI----------------------TEKCDVYSFGVLALEVIKGKH-PRDFLSSISSSS--LNTD-IELDEMLDPRL  138 (179)
Q Consensus        85 ~~~~~~----------------------~~~~D~~slg~~~~~l~~~~~-p~~~~~~~~~~~--~~~~-~~~~~~~~~~~  138 (179)
                      +.....                      ....|+||+||++++|+++.. |+..........  .... ...........
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            753221                      124699999999999999865 665332111100  0000 01111111111


Q ss_pred             CCCCccHHHHHHHHHHHHhcccCcCC---CCCCCHHHHHHHh
Q 042876          139 PAPSRSVQEKLISIVKVAFSCLNESP---ESRPTMKIVSQQL  177 (179)
Q Consensus       139 ~~~~~~~~~~~~~~~~li~~cl~~~p---~~Rps~~~~~~~l  177 (179)
                      .  ............+++.+++..+|   .+|+|++|+++|=
T Consensus       462 ~--~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp  501 (507)
T PLN03224        462 D--FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR  501 (507)
T ss_pred             C--cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence            0  11111223347788889999765   7899999999873

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.89  E-value=1.6e-24  Score=163.93  Aligned_cols=161  Identities=24%  Similarity=0.305  Sum_probs=127.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC---CCceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL---EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      +..+++...+.++.||+.||+|||-.   +|+|+||||+|+++..   -..+|++|||+++..+.... .....|++.|+
T Consensus       658 kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-RrsVVGTPAYL  733 (888)
T KOG4236|consen  658 KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-RRSVVGTPAYL  733 (888)
T ss_pred             cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh-hhhhcCCcccc
Confidence            45788888899999999999999999   9999999999999954   35689999999988775443 34568999999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      +||.+.+..|...-|+||.|+++|-.++|..||....+     ....+...+...+  +   .-|.+.....++||..+|
T Consensus       734 aPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQNAaFMyP--p---~PW~eis~~AidlIn~LL  803 (888)
T KOG4236|consen  734 APEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQNAAFMYP--P---NPWSEISPEAIDLINNLL  803 (888)
T ss_pred             CHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhhccccccC--C---CchhhcCHHHHHHHHHHH
Confidence            99999999999999999999999999999999964432     1222222222211  1   234444555788888999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +..=++|.|.++-+.|-+
T Consensus       804 qVkm~kRysvdk~lsh~W  821 (888)
T KOG4236|consen  804 QVKMRKRYSVDKSLSHPW  821 (888)
T ss_pred             HHHHHHhcchHhhccchh
Confidence            999999999998877644

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.3e-23  Score=147.89  Aligned_cols=171  Identities=23%  Similarity=0.274  Sum_probs=120.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~p   82 (179)
                      -+.++.+.++-++.||+.||+|||+.   +|.||||||-|.++..|-..||+|||+++....... ..+...-+..|.+|
T Consensus       150 PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAP  226 (449)
T KOG0664|consen  150 PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAP  226 (449)
T ss_pred             CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccH
Confidence            35688889999999999999999998   999999999999999999999999999976543322 23345567789999


Q ss_pred             cccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc------------hhh---hhhhcCCC-----CCCCC
Q 042876           83 ELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN------------TDI---ELDEMLDP-----RLPAP  141 (179)
Q Consensus        83 e~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~------------~~~---~~~~~~~~-----~~~~~  141 (179)
                      |++.|. .|+.+.|+||.||++.|++.++.-|...+..+...+.            ...   ...-++..     .++..
T Consensus       227 EiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vL  306 (449)
T KOG0664|consen  227 ELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRL  306 (449)
T ss_pred             HHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccce
Confidence            998875 6899999999999999999888877543332211100            000   00001111     11110


Q ss_pred             Cc--cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          142 SR--SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       142 ~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      ..  +....-..-.++.+.++..+|++|.+..+.++++
T Consensus       307 YtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  307 YKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             eeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            00  0011122356778899999999999999887764

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.88  E-value=2.3e-22  Score=156.10  Aligned_cols=166  Identities=27%  Similarity=0.339  Sum_probs=120.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC--Cc--eeEccccCccccCCCCCCcccccCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE--YE--AHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~--~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      ..|++.+.+.++.++..||.|||++   ||+||||||.||++...  |+  -|++|||.|+...... .....+|+..|+
T Consensus       115 ~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s-~~~S~vGT~~YL  190 (732)
T KOG4250|consen  115 YGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS-LFTSLVGTEEYL  190 (732)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC-eeeeecCchhhc
Confidence            4689999999999999999999999   99999999999988432  33  4999999998877554 566789999999


Q ss_pred             CCccccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccc-cccchhh----------------hhhhcCCCCCCCCC
Q 042876           81 APELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS-SSLNTDI----------------ELDEMLDPRLPAPS  142 (179)
Q Consensus        81 ~pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~-~~~~~~~----------------~~~~~~~~~~~~~~  142 (179)
                      +||+... ..++..+|.|||||++|++.||..||........ .......                .-.-.....+|.+.
T Consensus       191 hPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~  270 (732)
T KOG4250|consen  191 HPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPN  270 (732)
T ss_pred             ChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcc
Confidence            9999984 6788899999999999999999999954322110 0000000                00000111233333


Q ss_pred             ccHHHHHHHHHHHHhcccCcCCCCCC--CHHHHH
Q 042876          143 RSVQEKLISIVKVAFSCLNESPESRP--TMKIVS  174 (179)
Q Consensus       143 ~~~~~~~~~~~~li~~cl~~~p~~Rp--s~~~~~  174 (179)
                      .-.+.....+-.++..+|..+|++|-  .+.+..
T Consensus       271 ~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~F  304 (732)
T KOG4250|consen  271 HLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFF  304 (732)
T ss_pred             cccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHH
Confidence            33444555677888899999999997  444433

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.9e-23  Score=153.88  Aligned_cols=164  Identities=29%  Similarity=0.372  Sum_probs=118.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec---CCCceeEccccCccccCCCCCC-------cccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD---LEYEAHVADFGIAKFLKPDSSN-------WTEF   73 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~-------~~~~   73 (179)
                      .+.+++++++.|+.||+.||.||..... .|+|.||||.|||+.   .-|.|||.|||+++.+......       ....
T Consensus       562 hklmSEKEARSIiMQiVnAL~YLNEikp-PIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQg  640 (775)
T KOG1151|consen  562 HKLMSEKEARSIIMQIVNALKYLNEIKP-PIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQG  640 (775)
T ss_pred             hhhhhHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeeccc
Confidence            3567999999999999999999999643 899999999999984   3467999999999876543221       3446


Q ss_pred             cCCCCCCCCcccccC----CCCcchhhHHHHHHHHHHHhCCCCCcccccccc-cccchhhhhhhcCCCCCCCCCccHHHH
Q 042876           74 AGTYGYVAPELAYTM----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS-SSLNTDIELDEMLDPRLPAPSRSVQEK  148 (179)
Q Consensus        74 ~~~~~~~~pe~~~~~----~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (179)
                      .|+.+|++||++...    +.+.+.||||.|+++|+++.|+.||........ ..........++.   +|+-    +..
T Consensus       641 AGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVq---FP~K----PvV  713 (775)
T KOG1151|consen  641 AGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQ---FPPK----PVV  713 (775)
T ss_pred             CceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceecc---CCCC----Ccc
Confidence            789999999987643    357899999999999999999999964322111 1111111111111   1111    112


Q ss_pred             HHHHHHHHhcccCcCCCCCCCHHHHHH
Q 042876          149 LISIVKVAFSCLNESPESRPTMKIVSQ  175 (179)
Q Consensus       149 ~~~~~~li~~cl~~~p~~Rps~~~~~~  175 (179)
                      ..+..++|++||.+.-++|.+.-++..
T Consensus       714 sseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  714 SSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             CHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            234678899999999999998877653

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.88  E-value=1.4e-22  Score=160.21  Aligned_cols=161  Identities=21%  Similarity=0.358  Sum_probs=128.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +.++.|..+.-+++.++.|+.+||++   .++|||+|..||++..++.+|++|||.+..+........+..|++.|+|||
T Consensus       117 g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPE  193 (953)
T KOG0587|consen  117 GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPE  193 (953)
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccce
Confidence            45788899999999999999999999   999999999999999999999999999977665555567789999999999


Q ss_pred             ccccC-----CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           84 LAYTM-----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        84 ~~~~~-----~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      .+...     .+...+|+||||++..+|--|..|+.+.-.+..-.         .+.++.|+--..+..-.+.+.++|..
T Consensus       194 Viac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF---------~IpRNPPPkLkrp~kWs~~FndFIs~  264 (953)
T KOG0587|consen  194 VIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPPPKLKRPKKWSKKFNDFIST  264 (953)
T ss_pred             eeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc---------cCCCCCCccccchhhHHHHHHHHHHH
Confidence            98754     35678999999999999999999986543211110         11222222223334445568889999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      |+..|..+||+..++++|
T Consensus       265 cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  265 CLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             HHhhccccCcchhhhccC
Confidence            999999999999999876

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.88  E-value=4e-22  Score=160.88  Aligned_cols=94  Identities=22%  Similarity=0.316  Sum_probs=66.1

Q ss_pred             CCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHH
Q 042876           75 GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVK  154 (179)
Q Consensus        75 ~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (179)
                      +++.|++||.+.+..++.++|+||+||++|++++|..||.......        ....++....+.... .......+.+
T Consensus       542 GT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~--------~~~~il~~~~~~p~~-~~~~~~~~~~  612 (669)
T cd05610         542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQ--------VFQNILNRDIPWPEG-EEKLSVNAQN  612 (669)
T ss_pred             eCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhcCCCCCcc-cccCCHHHHH
Confidence            3678999999988889999999999999999999999996532111        111111111111100 0112234678


Q ss_pred             HHhcccCcCCCCCCCHHHHHHHh
Q 042876          155 VAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       155 li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      ++..||..||.+||++.++++|-
T Consensus       613 ~l~~lL~~dP~~R~ta~e~l~h~  635 (669)
T cd05610         613 AIEILLTMDPTKRAGLKELKQHP  635 (669)
T ss_pred             HHHHHcccChhHCcCHHHHHhCH
Confidence            88899999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.87  E-value=8.6e-22  Score=137.01  Aligned_cols=126  Identities=33%  Similarity=0.575  Sum_probs=109.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-CCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .++...++.++.+++.++.+||+.   +++|+||+|.||+++. ++.++++||+.+..................|++||.
T Consensus        88 ~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~  164 (215)
T cd00180          88 KLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEV  164 (215)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhH
Confidence            578899999999999999999999   9999999999999998 889999999998766543322233456778999999


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .... ..+.+.|+|++|++++++                                           ..+.+++..|+..|
T Consensus       165 ~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~~~~l~~~l~~~  201 (215)
T cd00180         165 LLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PELKDLIRKMLQKD  201 (215)
T ss_pred             hcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHHHHHHHHHhhCC
Confidence            8776 778899999999999998                                           23788899999999


Q ss_pred             CCCCCCHHHHHHHh
Q 042876          164 PESRPTMKIVSQQL  177 (179)
Q Consensus       164 p~~Rps~~~~~~~l  177 (179)
                      |++||++.++++++
T Consensus       202 p~~R~~~~~l~~~~  215 (215)
T cd00180         202 PEKRPSAKEILEHL  215 (215)
T ss_pred             cccCcCHHHHhhCC
Confidence            99999999998864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.87  E-value=6.9e-23  Score=154.66  Aligned_cols=167  Identities=18%  Similarity=0.170  Sum_probs=120.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-ceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..|..+.+..++.|+.-||..|-+.   |++|.||||+|||+..+- .+||||||.|.+........  ..-+-.|.+||
T Consensus       531 vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitP--YLVSRFYRaPE  605 (752)
T KOG0670|consen  531 VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASENEITP--YLVSRFYRAPE  605 (752)
T ss_pred             cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccccccccccH--HHHHHhccCcc
Confidence            4466778899999999999999997   999999999999997554 46999999998776544321  23345699999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccc------------------------------cccchh------
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------------------------------SSLNTD------  127 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~------------------------------~~~~~~------  127 (179)
                      ++.|.+|....|+||.||++|+++||+..|++..+-..                              ..+...      
T Consensus       606 IiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~  685 (752)
T KOG0670|consen  606 IILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTE  685 (752)
T ss_pred             eeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEecccccc
Confidence            99999999999999999999999999999854221100                              000000      


Q ss_pred             ---hhhhhcCCC---------CCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          128 ---IELDEMLDP---------RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       128 ---~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                         ......+.+         ..+............+.+|+.+|+..||++|.|..++++|
T Consensus       686 r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  686 REKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             ceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence               000000100         0011122234456678889999999999999999999886

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=7e-21  Score=146.98  Aligned_cols=111  Identities=24%  Similarity=0.372  Sum_probs=95.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---------------C
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---------------N   69 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------------~   69 (179)
                      .-|.++.++.++.++..|+++.|+.   |+|||||||+|||++.+|.||+.|||+++.+.+...               .
T Consensus       724 gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSme  800 (1034)
T KOG0608|consen  724 GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSME  800 (1034)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCC
Confidence            3578899999999999999999999   999999999999999999999999999975421100               0


Q ss_pred             ---------------------------cccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCccccc
Q 042876           70 ---------------------------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSS  118 (179)
Q Consensus        70 ---------------------------~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~  118 (179)
                                                 -...+|++.|++||.+....++..+|-||.|+++|+|+.|+.||.....
T Consensus       801 p~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  801 PSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP  876 (1034)
T ss_pred             CchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence                                       0114689999999999988999999999999999999999999965443

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.84  E-value=8.9e-21  Score=130.47  Aligned_cols=165  Identities=20%  Similarity=0.266  Sum_probs=114.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-ceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +|+-.++.-++.+++.||.|+|+.   ||.|||+||.|++++... ..+++|+|+|.++.+.. ....+..+.-|-.||+
T Consensus       128 tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~-eYnVRVASRyfKGPEL  203 (338)
T KOG0668|consen  128 TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL  203 (338)
T ss_pred             hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCc-eeeeeeehhhcCCchh
Confidence            566778899999999999999999   999999999999998654 47999999998876533 3444566666779998


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCccc-ccccc-------------------cccchhhhhhhcCCC-------
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFL-SSISS-------------------SSLNTDIELDEMLDP-------  136 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~-~~~~~-------------------~~~~~~~~~~~~~~~-------  136 (179)
                      +... .+..+-|+|||||.+..|+..+.||=.. .+...                   ...........++..       
T Consensus       204 LVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~  283 (338)
T KOG0668|consen  204 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWS  283 (338)
T ss_pred             eeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHH
Confidence            8764 4678899999999999999999887211 11000                   000000001111110       


Q ss_pred             -CCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          137 -RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       137 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                       ..+.. .... ...+.++++.++|..|-.+|+|+.|...|
T Consensus       284 ~Fi~~~-n~hl-~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  284 RFINSE-NQHL-VSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HhCCcc-cccc-CChHHHHHHHHHHhhccccccchHHHhcC
Confidence             01111 1110 11246778889999999999999998765

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.84  E-value=4.1e-21  Score=134.97  Aligned_cols=157  Identities=20%  Similarity=0.311  Sum_probs=107.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec--CCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD--LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+-+.-.++++.|+++||.|+|+.   ++||||||.+|||+-  ...++|++|||+++..+.....   ......|.+||
T Consensus       117 GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~---~~~~~~y~~pe  190 (378)
T KOG1345|consen  117 GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY---LEYVNNYHAPE  190 (378)
T ss_pred             cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceehh---hhhhcccCCcH
Confidence            345566789999999999999999   999999999999993  3457999999998766543211   12234577888


Q ss_pred             ccc---cC--CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           84 LAY---TM--KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        84 ~~~---~~--~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      .+.   +.  ...+..|+|+||++++.+++|..||..... ....+..-........++.|.......+   ..+++.++
T Consensus       191 ~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~~rk~~~~P~~F~~fs~---~a~r~Fkk  266 (378)
T KOG1345|consen  191 LCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWLKRKNPALPKKFNPFSE---KALRLFKK  266 (378)
T ss_pred             HHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHhcccCccCchhhcccCH---HHHHHHHH
Confidence            653   22  246788999999999999999999973321 1222333333333333344443333333   35666669


Q ss_pred             ccCcCCCCCCCHHH
Q 042876          159 CLNESPESRPTMKI  172 (179)
Q Consensus       159 cl~~~p~~Rps~~~  172 (179)
                      -+..++++|=-+.+
T Consensus       267 ~lt~~~~drcki~~  280 (378)
T KOG1345|consen  267 SLTPRFKDRCKIWT  280 (378)
T ss_pred             hcCCcccccchhHH
Confidence            99999988843333

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=7.2e-21  Score=150.78  Aligned_cols=166  Identities=21%  Similarity=0.263  Sum_probs=126.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC----CcccccCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS----NWTEFAGTYGYV   80 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~   80 (179)
                      ..++..++-.+.+|++.|++|+|..   |+.|||+|++|+++..++.+|++|||.+..+.....    ......|...|+
T Consensus       415 ~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~  491 (601)
T KOG0590|consen  415 GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYL  491 (601)
T ss_pred             cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCc
Confidence            3688899999999999999999999   999999999999999999999999999976654322    234568899999


Q ss_pred             CCcccccCCCCc-chhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           81 APELAYTMKITE-KCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        81 ~pe~~~~~~~~~-~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      |||.+.+..+.+ ..|+||.|+++..|.+|+.||...........   ................-..........+|.++
T Consensus       492 apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~  568 (601)
T KOG0590|consen  492 APEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRM  568 (601)
T ss_pred             CcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---hhccccccccccChHHHHHhchhhHHHHHHHH
Confidence            999999888854 67999999999999999999965432211110   00000000111112233444555678899999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 042876          160 LNESPESRPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~  176 (179)
                      |+.||.+|.|+++|++-
T Consensus       569 l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  569 LQLDPTKRITIEQILND  585 (601)
T ss_pred             ccCChhheecHHHHhhC
Confidence            99999999999999863

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=2.8e-20  Score=139.50  Aligned_cols=104  Identities=20%  Similarity=0.192  Sum_probs=69.3

Q ss_pred             cCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccc---cccch--hhhhhh--------------cC
Q 042876           74 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS---SSLNT--DIELDE--------------ML  134 (179)
Q Consensus        74 ~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~---~~~~~--~~~~~~--------------~~  134 (179)
                      +.+..|++||.+.+..|+..+|+||++|++++|.||..-|+..+....   ..+..  .+.+..              .+
T Consensus       412 IQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFF  491 (590)
T KOG1290|consen  412 IQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFF  491 (590)
T ss_pred             hhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhh
Confidence            345679999999999999999999999999999999998854322111   00000  000000              00


Q ss_pred             CC--------C---CCC------CCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          135 DP--------R---LPA------PSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       135 ~~--------~---~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      .+        +   ++-      -..-..+...++.+++.-||+.+|++|||+.+.++|=
T Consensus       492 nr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hP  551 (590)
T KOG1290|consen  492 NRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHP  551 (590)
T ss_pred             ccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCc
Confidence            00        0   000      0112344566799999999999999999999998763

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.80  E-value=1.9e-20  Score=143.05  Aligned_cols=106  Identities=27%  Similarity=0.454  Sum_probs=95.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +..+++.+++.+.+|++.|+++||+.   ||||||||-+|+.++.+|-+|++|||.+-.....  .+..++|+..|.|||
T Consensus       664 kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~ksg--pfd~f~gtv~~aape  738 (772)
T KOG1152|consen  664 KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG--PFDVFVGTVDYAAPE  738 (772)
T ss_pred             cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhcCC--Ccceeeeeccccchh
Confidence            45789999999999999999999999   9999999999999999999999999998665543  356789999999999


Q ss_pred             ccccCCC-CcchhhHHHHHHHHHHHhCCCCCc
Q 042876           84 LAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD  114 (179)
Q Consensus        84 ~~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~  114 (179)
                      .+.|.+| ....|+|+||+++|-++....||.
T Consensus       739 vl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  739 VLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999887 456799999999999999888873

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.80  E-value=4.1e-20  Score=136.14  Aligned_cols=106  Identities=28%  Similarity=0.462  Sum_probs=86.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC-CceeEccccCccccCCC---------------C-
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPD---------------S-   67 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~---------------~-   67 (179)
                      ..++..++..+++.++.||+++|.+   ||+|||+||.|++++.. ++-.++|||++.....+               . 
T Consensus       127 ~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~  203 (418)
T KOG1167|consen  127 RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPA  203 (418)
T ss_pred             hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCcc
Confidence            3578899999999999999999999   99999999999999765 45689999999721000               0 


Q ss_pred             ---------------C-------------CcccccCCCCCCCCccccc-CCCCcchhhHHHHHHHHHHHhCCCCC
Q 042876           68 ---------------S-------------NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPR  113 (179)
Q Consensus        68 ---------------~-------------~~~~~~~~~~~~~pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~  113 (179)
                                     .             ..-...|+++|.+||.+.. ...+.+.|+||.|+++..++++..||
T Consensus       204 ~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PF  278 (418)
T KOG1167|consen  204 MGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPF  278 (418)
T ss_pred             ccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcccccc
Confidence                           0             0012468999999998764 45688999999999999999999998

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=6.4e-20  Score=132.47  Aligned_cols=135  Identities=20%  Similarity=0.232  Sum_probs=91.6

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccccC--
Q 042876           11 QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM--   88 (179)
Q Consensus        11 ~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--   88 (179)
                      -++.+..|++..+++||..   |++|+||+|+|++++.+|.+.++||+.....+....   ....+..|.|||.....  
T Consensus       146 arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~  219 (288)
T PF14531_consen  146 ARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQ  219 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTS
T ss_pred             HHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcc
Confidence            3456679999999999999   999999999999999999999999987765443221   12344678899976432  


Q ss_pred             ------CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           89 ------KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        89 ------~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                            .++.+.|.|+||+++|.++++..||...........               ....|. ..+..+.+||..+|+.
T Consensus       220 ~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------~f~~C~-~~Pe~v~~LI~~lL~~  283 (288)
T PF14531_consen  220 FGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---------------DFSRCR-DMPEPVQFLIRGLLQR  283 (288)
T ss_dssp             CHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------------GGTTSS----HHHHHHHHHHT-S
T ss_pred             cCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---------------cchhcC-CcCHHHHHHHHHHccC
Confidence                  467899999999999999999999975433222211               011222 4445588899999999


Q ss_pred             CCCCC
Q 042876          163 SPESR  167 (179)
Q Consensus       163 ~p~~R  167 (179)
                      ||.+|
T Consensus       284 ~~~~R  288 (288)
T PF14531_consen  284 NPEDR  288 (288)
T ss_dssp             SGGGS
T ss_pred             CcccC
Confidence            99988

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=2.3e-18  Score=128.37  Aligned_cols=165  Identities=21%  Similarity=0.246  Sum_probs=119.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC-----CceeEccccCccccC--CCC--------C
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-----YEAHVADFGIAKFLK--PDS--------S   68 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~-----~~~~l~d~~~~~~~~--~~~--------~   68 (179)
                      .+.|+..++++++.|++.+|+++|+.   |++||||||.|+.+...     ..+.+.|||+++...  ...        .
T Consensus       116 ~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~  192 (322)
T KOG1164|consen  116 PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRP  192 (322)
T ss_pred             CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCC
Confidence            47899999999999999999999999   99999999999999765     358999999998322  111        1


Q ss_pred             CcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHH
Q 042876           69 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEK  148 (179)
Q Consensus        69 ~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (179)
                      ....+.|+..|+++....+...+++.|+||++.++.+++.|..||.......................    .....+.+
T Consensus       193 ~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  268 (322)
T KOG1164|consen  193 QKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR----FGDLKPEE  268 (322)
T ss_pred             CccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcccc----ccCCChHH
Confidence            12345689999999999999999999999999999999999999976553322111111111111111    11222232


Q ss_pred             HHHHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          149 LISIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       149 ~~~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                         +..+...+-..+...+|.+..+...|+
T Consensus       269 ---~~~~~~~~~~~~~~~~Pdy~~~~~~l~  295 (322)
T KOG1164|consen  269 ---FAKILEYIDSLDYEDKPDYEKLAELLK  295 (322)
T ss_pred             ---HHHHHHHhhccCCcCCCCHHHHHHHHH
Confidence               444444555589999999999887753

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=7.5e-19  Score=134.49  Aligned_cols=172  Identities=23%  Similarity=0.376  Sum_probs=121.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCC--CCCCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP--DSSNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~~~~~~~   81 (179)
                      ...+++.....++++++.||.|+|..-  ...|+.+++.|++++.+..+|+.|||+......  .............|.+
T Consensus        42 ~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~a  119 (484)
T KOG1023|consen   42 DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTA  119 (484)
T ss_pred             ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccC
Confidence            456788899999999999999999972  239999999999999999999999999876532  1111222334567899


Q ss_pred             CcccccCC-------CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHH
Q 042876           82 PELAYTMK-------ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVK  154 (179)
Q Consensus        82 pe~~~~~~-------~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (179)
                      ||.+++..       .+.+.|+||+|++++++++...||+........ ............+.+.+......+...++..
T Consensus       120 Pellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~  198 (484)
T KOG1023|consen  120 PELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP-DEIILRVKKGGSNPFRPSIELLNELPPELLL  198 (484)
T ss_pred             HHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCCh-HHHHHHHHhcCCCCcCcchhhhhhcchHHHH
Confidence            99988642       356799999999999999999999865433322 0011111110111111111111123335889


Q ss_pred             HHhcccCcCCCCCCCHHHHHHHhh
Q 042876          155 VAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       155 li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ++..||..+|.+||+++++...++
T Consensus       199 l~~~cw~e~P~~rPs~~~i~~~~~  222 (484)
T KOG1023|consen  199 LVARCWEEIPEKRPSIEQIRSKLL  222 (484)
T ss_pred             HHHHhcccChhhCccHHHHHhhhh
Confidence            999999999999999999988765

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.75  E-value=6.2e-18  Score=119.18  Aligned_cols=106  Identities=34%  Similarity=0.509  Sum_probs=91.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC-CCcccccCCCCCCCCccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS-SNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~   85 (179)
                      +++..++.++.+++.++.+||+.   +++|+|+++.|++++.++.++++|||.+....... .......+...|++||..
T Consensus        95 ~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~  171 (225)
T smart00221       95 LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVL  171 (225)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHh
Confidence            78899999999999999999999   99999999999999999999999999987665432 112234566789999998


Q ss_pred             -ccCCCCcchhhHHHHHHHHHHHhCCCCCcc
Q 042876           86 -YTMKITEKCDVYSFGVLALEVIKGKHPRDF  115 (179)
Q Consensus        86 -~~~~~~~~~D~~slg~~~~~l~~~~~p~~~  115 (179)
                       ....++.++|+|++|++++++++|+.||..
T Consensus       172 ~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      172 LGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence             566777899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.75  E-value=3.1e-18  Score=120.97  Aligned_cols=154  Identities=22%  Similarity=0.295  Sum_probs=114.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEc--cccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA--DFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .+..++.+++.+++.|++|||+... -+....|++..++++.+-..+|+  |..++  ++..     .....+.|++||.
T Consensus       286 vd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfs--fqe~-----gr~y~pawmspea  357 (448)
T KOG0195|consen  286 VDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFS--FQEV-----GRAYSPAWMSPEA  357 (448)
T ss_pred             EecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceee--eecc-----ccccCcccCCHHH
Confidence            4667899999999999999999631 34555689999999988776653  33322  2211     1345678999998


Q ss_pred             cccCC---CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           85 AYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        85 ~~~~~---~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      +...+   .-.++|+|||++++|++.|...||....+.+......-+.++-.+++.+..          .+.+||.-|+.
T Consensus       358 lqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~----------hm~klm~icmn  427 (448)
T KOG0195|consen  358 LQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISR----------HMNKLMNICMN  427 (448)
T ss_pred             HhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccH----------HHHHHHHHHhc
Confidence            87543   246899999999999999999999988877766655544444444433322          37789999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+||.+++++..|+
T Consensus       428 edpgkrpkfdmivpile  444 (448)
T KOG0195|consen  428 EDPGKRPKFDMIVPILE  444 (448)
T ss_pred             CCCCcCCCcceehhhHH
Confidence            99999999999887764

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=2.2e-17  Score=122.01  Aligned_cols=159  Identities=26%  Similarity=0.368  Sum_probs=107.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC----CceeEccccCccccCCC------CCCcccccC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE----YEAHVADFGIAKFLKPD------SSNWTEFAG   75 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~----~~~~l~d~~~~~~~~~~------~~~~~~~~~   75 (179)
                      ..+.-...-++.|+++|+.|||++   |+.|||+|++||++.-+    .+..++|||.+---...      ........|
T Consensus       337 ~~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GG  413 (598)
T KOG4158|consen  337 HRSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGG  413 (598)
T ss_pred             CCchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCC
Confidence            345567788999999999999999   99999999999999432    33678999987422111      111233456


Q ss_pred             CCCCCCCcccccCCC------CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHH
Q 042876           76 TYGYVAPELAYTMKI------TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKL  149 (179)
Q Consensus        76 ~~~~~~pe~~~~~~~------~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (179)
                      +...++||+....+-      -.++|.|+.|.+.||++....||...........       ......+|......+.  
T Consensus       414 Na~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r-------~Yqe~qLPalp~~vpp--  484 (598)
T KOG4158|consen  414 NAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR-------TYQESQLPALPSRVPP--  484 (598)
T ss_pred             cceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh-------hhhhhhCCCCcccCCh--
Confidence            777899998764321      2478999999999999999999965332211111       1111222222222222  


Q ss_pred             HHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          150 ISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       150 ~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                       .+.+++...++.||++|+|..-....|
T Consensus       485 -~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  485 -VARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             -HHHHHHHHHhcCCccccCCccHHHhHH
Confidence             267788899999999999987655544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.74  E-value=6.9e-18  Score=137.08  Aligned_cols=153  Identities=20%  Similarity=0.221  Sum_probs=111.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCC--CCCC-----cccccCCCCC
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP--DSSN-----WTEFAGTYGY   79 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~--~~~~-----~~~~~~~~~~   79 (179)
                      ++.-+++.++=|++.||..+|+.   ||+|||||.+|||++.=.++.+.||...+....  +...     +.+...-..|
T Consensus       117 L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCY  193 (1431)
T KOG1240|consen  117 LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCY  193 (1431)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeee
Confidence            46678999999999999999999   999999999999999888999999998764321  1111     2333445679


Q ss_pred             CCCcccccC----------C-CCcchhhHHHHHHHHHHHh-CCCCCcccccccc--c-ccchhhhhhhcCCCCCCCCCcc
Q 042876           80 VAPELAYTM----------K-ITEKCDVYSFGVLALEVIK-GKHPRDFLSSISS--S-SLNTDIELDEMLDPRLPAPSRS  144 (179)
Q Consensus        80 ~~pe~~~~~----------~-~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~  144 (179)
                      .|||.+...          . .+++.|+||+||++.|+++ |+.+|....-...  . .......++.+-+.        
T Consensus       194 iAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ied~--------  265 (1431)
T KOG1240|consen  194 IAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKIEDV--------  265 (1431)
T ss_pred             cChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhCcCc--------
Confidence            999976531          1 4688999999999999998 7888853221111  1 11111222222222        


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                            .+..++..|++.||.+|.|+++.++.
T Consensus       266 ------~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  266 ------SLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ------cHHHHHHHHHccCchhccCHHHHHHh
Confidence                  26788899999999999999999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.74  E-value=1.2e-17  Score=120.67  Aligned_cols=168  Identities=14%  Similarity=0.216  Sum_probs=123.0

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC-----CceeEccccCccccCCCCCC-------c
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-----YEAHVADFGIAKFLKPDSSN-------W   70 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~-----~~~~l~d~~~~~~~~~~~~~-------~   70 (179)
                      .+++|+.+++..+++|++.-++++|++   .+|.|||||+|+|+...     ..|.++|||+++.+..+.+.       .
T Consensus       117 CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~  193 (449)
T KOG1165|consen  117 CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREH  193 (449)
T ss_pred             hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccc
Confidence            467899999999999999999999999   99999999999999644     34789999999987655432       3


Q ss_pred             ccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHH
Q 042876           71 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLI  150 (179)
Q Consensus        71 ~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (179)
                      ....|+..||+.-...|...|...|+-|||.++++.+-|..||.+.+........+.+.-.+.. ..+...+...+++  
T Consensus       194 KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~-T~i~~Lc~g~P~e--  270 (449)
T KOG1165|consen  194 KSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS-TPIEVLCEGFPEE--  270 (449)
T ss_pred             cccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc-CCHHHHHhcCHHH--
Confidence            3457888999999888999999999999999999999999999988765433322222111100 0111112223444  


Q ss_pred             HHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          151 SIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       151 ~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                       +..-+.-.-..+..+-|+++-+...|
T Consensus       271 -fa~Yl~yvR~L~F~E~PDYdylr~Lf  296 (449)
T KOG1165|consen  271 -FATYLRYVRRLDFFETPDYDYLRKLF  296 (449)
T ss_pred             -HHHHHHHHHhcCcccCCCHHHHHHHH
Confidence             44444445556777888888776654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.73  E-value=2.9e-18  Score=132.96  Aligned_cols=163  Identities=25%  Similarity=0.346  Sum_probs=121.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..++++.++.-+++..+.||+|||+.   |-+|||||..||+++..+.+|+.|||.+-.++........+.|++.|++||
T Consensus       106 TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapE  182 (829)
T KOG0576|consen  106 TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPE  182 (829)
T ss_pred             cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchh
Confidence            45788899999999999999999999   889999999999999999999999999877765555566789999999999


Q ss_pred             ccc---cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           84 LAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        84 ~~~---~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ...   ...+...+|+|++|+...++---+.|.-..-......++    ..+..++.-......+.+   .+.+|++.|+
T Consensus       183 vaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm----TkS~~qpp~lkDk~kws~---~fh~fvK~al  255 (829)
T KOG0576|consen  183 VAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM----TKSGFQPPTLKDKTKWSE---FFHNFVKGAL  255 (829)
T ss_pred             HHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh----hccCCCCCcccCCccchH---HHHHHHHHHh
Confidence            753   335778999999999999987666663222111111111    111222222222233333   3677888999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      ..||.+||+++.+++|
T Consensus       256 tknpKkRptaeklL~h  271 (829)
T KOG0576|consen  256 TKNPKKRPTAEKLLQH  271 (829)
T ss_pred             cCCCccCCChhhheec
Confidence            9999999999988764

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.69  E-value=3e-17  Score=124.43  Aligned_cols=149  Identities=26%  Similarity=0.404  Sum_probs=111.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC------CCcccccCCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS------SNWTEFAGTYGY   79 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~~   79 (179)
                      +-++...+.+..|++.|++|   .   +.+|+|++|.||+...+..++|+|||+.+......      .......++..|
T Consensus       355 ~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~Y  428 (516)
T KOG1033|consen  355 ERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLY  428 (516)
T ss_pred             ccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhccccccc
Confidence            45777889999999999999   5   89999999999999999999999999987654332      124557899999


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      ++||-+.+..++.++|+|+||+++++++. ....+...           .....+-+..+|+.  ...++.. =..|+.+
T Consensus       429 msPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------~t~~d~r~g~ip~~--~~~d~p~-e~~ll~~  494 (516)
T KOG1033|consen  429 MSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----------ATLTDIRDGIIPPE--FLQDYPE-EYTLLQQ  494 (516)
T ss_pred             CCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------HhhhhhhcCCCChH--HhhcCcH-HHHHHHH
Confidence            99999999999999999999999999987 44444221           12222233334321  1122222 2467779


Q ss_pred             ccCcCCCCCCCHHHHH
Q 042876          159 CLNESPESRPTMKIVS  174 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~  174 (179)
                      ++..+|.+||++.+..
T Consensus       495 lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  495 LLSPSPEERPSAIEVA  510 (516)
T ss_pred             hcCCCcccCchHHHHh
Confidence            9999999999655443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.67  E-value=5e-17  Score=112.86  Aligned_cols=169  Identities=18%  Similarity=0.275  Sum_probs=121.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC---CceeEccccCccccCCCCC-------Ccccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE---YEAHVADFGIAKFLKPDSS-------NWTEF   73 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~---~~~~l~d~~~~~~~~~~~~-------~~~~~   73 (179)
                      .+.|+.++++.++-|++.-++|+|..   +.+||||||+|++...+   .++.++|||+++.+.....       .....
T Consensus       105 ~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~l  181 (341)
T KOG1163|consen  105 SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNL  181 (341)
T ss_pred             hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCcc
Confidence            46789999999999999999999999   99999999999999644   4578999999987653322       12345


Q ss_pred             cCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHH
Q 042876           74 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIV  153 (179)
Q Consensus        74 ~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (179)
                      .|+..|.+.-..-+...+...|+-|+|.++.+..-|..||.+............+.-.++- ..+...+.-.+.   ++.
T Consensus       182 tGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s-~~ie~LC~G~P~---EF~  257 (341)
T KOG1163|consen  182 TGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS-TPIEVLCKGFPA---EFA  257 (341)
T ss_pred             ceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC-CCHHHHhCCCcH---HHH
Confidence            6788888887777777889999999999999999999999887654432222222111111 111111222222   344


Q ss_pred             HHHhcccCcCCCCCCCHHHHHHHhhC
Q 042876          154 KVAFSCLNESPESRPTMKIVSQQLRI  179 (179)
Q Consensus       154 ~li~~cl~~~p~~Rps~~~~~~~l~~  179 (179)
                      -.+.-|-...-++-|+...+.+.+++
T Consensus       258 myl~Y~R~L~F~E~Pdy~ylrqlFri  283 (341)
T KOG1163|consen  258 MYLNYCRGLGFEEKPDYMYLRQLFRI  283 (341)
T ss_pred             HHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence            55557878888888998888887764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.66  E-value=1.8e-15  Score=111.53  Aligned_cols=166  Identities=27%  Similarity=0.335  Sum_probs=118.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-ceeEccccCccccCCCCC------CcccccCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSS------NWTEFAGTYG   78 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~------~~~~~~~~~~   78 (179)
                      .++......+..|++.++.++|+.   +++|||+||+|++++..+ .+++.|||.+........      ......++..
T Consensus        97 ~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~  173 (384)
T COG0515          97 PLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG  173 (384)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccc
Confidence            678899999999999999999999   999999999999999888 699999999875544332      2355678899


Q ss_pred             CCCCccccc---CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCC-CCCCCCcc-HHHHHHHHH
Q 042876           79 YVAPELAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRS-VQEKLISIV  153 (179)
Q Consensus        79 ~~~pe~~~~---~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~  153 (179)
                      |.+||...+   ...+...|+|++|+++++++++..||....... ..............+ ........ .......+.
T Consensus       174 ~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (384)
T COG0515         174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-ATSQTLKIILELPTPSLASPLSPSNPELISKAAS  252 (384)
T ss_pred             cCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc-cHHHHHHHHHhcCCcccccccCccccchhhHHHH
Confidence            999999987   467889999999999999999999975543210 000000001111111 00000000 011123467


Q ss_pred             HHHhcccCcCCCCCCCHHHHHH
Q 042876          154 KVAFSCLNESPESRPTMKIVSQ  175 (179)
Q Consensus       154 ~li~~cl~~~p~~Rps~~~~~~  175 (179)
                      +++..++..+|..|.+..+...
T Consensus       253 ~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         253 DLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             HHHHHHHhcCchhcCCHHHHhh
Confidence            8888999999999998876554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.56  E-value=2.5e-15  Score=116.18  Aligned_cols=141  Identities=29%  Similarity=0.334  Sum_probs=108.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.....+...++-+++++|+.   +++++|+|++||+++.+|.+++.|||+++..-....    ..|+..|++||+
T Consensus        92 ~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~cgt~eymApEI  164 (612)
T KOG0603|consen   92 VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----ACGTYEYRAPEI  164 (612)
T ss_pred             CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh----cccchhhhhhHh
Confidence            3466777888889999999999999   999999999999999999999999999876554332    277899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      ..  ....+.|.||+|++.+++++|..||..            .....+.......    .+.......+++..++..+|
T Consensus       165 ~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~~~----p~~l~~~a~~~~~~l~~r~p  226 (612)
T KOG0603|consen  165 IN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAELEM----PRELSAEARSLFRQLFKRNP  226 (612)
T ss_pred             hh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhccCC----chhhhHHHHHHHHHHHhhCH
Confidence            87  456788999999999999999999864            1222222212222    22333346777778999999


Q ss_pred             CCCCCH
Q 042876          165 ESRPTM  170 (179)
Q Consensus       165 ~~Rps~  170 (179)
                      ..|.-.
T Consensus       227 ~nrLg~  232 (612)
T KOG0603|consen  227 ENRLGA  232 (612)
T ss_pred             HHHhcc
Confidence            888643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.51  E-value=1.3e-14  Score=118.03  Aligned_cols=137  Identities=25%  Similarity=0.261  Sum_probs=100.5

Q ss_pred             HHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC---------------CCcccccCCCCCCCCc
Q 042876           19 VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS---------------SNWTEFAGTYGYVAPE   83 (179)
Q Consensus        19 i~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---------------~~~~~~~~~~~~~~pe   83 (179)
                      ++.+++|||+.   +|+|+|+||+|.++..-|.+|+.|||+++.-....               ....+.++++.|.+||
T Consensus       152 mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe  228 (1205)
T KOG0606|consen  152 MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE  228 (1205)
T ss_pred             hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence            47789999999   99999999999999999999999999987432111               0123458899999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCC-CCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPA-PSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      ++..+.|....|=|++|+++|+.+-|..||.+....+....  .+.-..    .++. .+....    +..+++.++|..
T Consensus       229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~--visd~i----~wpE~dea~p~----Ea~dli~~LL~q  298 (1205)
T KOG0606|consen  229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ--VISDDI----EWPEEDEALPP----EAQDLIEQLLRQ  298 (1205)
T ss_pred             hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh--hhhhhc----cccccCcCCCH----HHHHHHHHHHHh
Confidence            99999999999999999999999999999865422111111  010000    1111 111122    377788899999


Q ss_pred             CCCCCC
Q 042876          163 SPESRP  168 (179)
Q Consensus       163 ~p~~Rp  168 (179)
                      +|..|.
T Consensus       299 np~~Rl  304 (1205)
T KOG0606|consen  299 NPLCRL  304 (1205)
T ss_pred             ChHhhc
Confidence            999995

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.45  E-value=3.9e-12  Score=95.44  Aligned_cols=167  Identities=20%  Similarity=0.272  Sum_probs=116.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY   86 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   86 (179)
                      ++|...++.++.++.+.+.||..   |.+-+|++++|+++++.+.+.+.|-...... .....+-+..+...|++||...
T Consensus       114 ~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~-~ng~~~~cpVg~~eftPPElQ~  189 (637)
T COG4248         114 CAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN-ANGTLHLCPVGVSEFTPPELQT  189 (637)
T ss_pred             cccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec-cCCceEecccCccccCCHHHhc
Confidence            58899999999999999999999   8899999999999999999999885543322 3344566678899999999765


Q ss_pred             -----cCCCCcchhhHHHHHHHHHHHhC-CCCCcccccccc--cccchhhhhhh-------cCCCCCCCCCccHHHHHHH
Q 042876           87 -----TMKITEKCDVYSFGVLALEVIKG-KHPRDFLSSISS--SSLNTDIELDE-------MLDPRLPAPSRSVQEKLIS  151 (179)
Q Consensus        87 -----~~~~~~~~D~~slg~~~~~l~~~-~~p~~~~~~~~~--~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~  151 (179)
                           +..-+...|.|.||+++++++.| ++||++......  .-+...+....       ...-+.++..--+.-...+
T Consensus       190 ~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~  269 (637)
T COG4248         190 LPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPD  269 (637)
T ss_pred             cccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHH
Confidence                 23345678999999999999875 999987653221  11111111111       1111111111122222334


Q ss_pred             HHHHHhcccCc--CCCCCCCHHHHHHHh
Q 042876          152 IVKVAFSCLNE--SPESRPTMKIVSQQL  177 (179)
Q Consensus       152 ~~~li~~cl~~--~p~~Rps~~~~~~~l  177 (179)
                      +..+..+|+..  ++.-|||++-++..|
T Consensus       270 vqAlF~qaF~~~~~~~~RP~a~aW~aAl  297 (637)
T COG4248         270 VQALFQQAFTESGVATPRPTAKAWVAAL  297 (637)
T ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence            67777788876  467899999888765

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.42  E-value=5.8e-13  Score=109.33  Aligned_cols=106  Identities=20%  Similarity=0.146  Sum_probs=91.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec-------CCCceeEccccCccccCC--CCCCccccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD-------LEYEAHVADFGIAKFLKP--DSSNWTEFA   74 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~-------~~~~~~l~d~~~~~~~~~--~~~~~~~~~   74 (179)
                      .+.+++.....++.|++..++.||..   +|||+||||+|+++.       .+..++|+|||.+..+..  ....+....
T Consensus       788 ~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~  864 (974)
T KOG1166|consen  788 NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVW  864 (974)
T ss_pred             CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeee
Confidence            35678889999999999999999999   999999999999993       344589999999986643  333456667


Q ss_pred             CCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 042876           75 GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP  112 (179)
Q Consensus        75 ~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p  112 (179)
                      .+-.+-.+|+..|..++++.|.|.++.+++-|+.|+..
T Consensus       865 ~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  865 HTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            78888999999999999999999999999999998755

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=1.7e-13  Score=109.12  Aligned_cols=160  Identities=23%  Similarity=0.309  Sum_probs=115.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHh-hCCCCCcccCCCCCCCeeecCCC-ceeEccccCccccCC-CCCC--cccccC-CCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKP-DSSN--WTEFAG-TYGY   79 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh-~~~~~~~~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~-~~~~--~~~~~~-~~~~   79 (179)
                      ..+...+..+..|+..++.|+| ..   ++.|+|++|+|.+++.++ .+++.||++++.+.. ....  .....+ .+.|
T Consensus       119 ~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y  195 (601)
T KOG0590|consen  119 GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPY  195 (601)
T ss_pred             CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCC
Confidence            4556678899999999999999 76   999999999999999999 899999999988765 3222  334566 8999


Q ss_pred             CCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           80 VAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        80 ~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      .+||...+. ...+..|+||.|+++..+++|..||............    ....-.......   +........+++.+
T Consensus       196 ~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~l~k  268 (601)
T KOG0590|consen  196 GAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS----WKSNKGRFTQLP---WNSISDQAHDLLHK  268 (601)
T ss_pred             CCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee----ecccccccccCc---cccCChhhhhcccc
Confidence            999998874 3467889999999999999999998754432211110    111000000111   11112236677779


Q ss_pred             ccCcCCCCCCCHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQ  175 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~  175 (179)
                      ++..+|..|.+.+++..
T Consensus       269 ~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  269 ILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccCCchhccccccccc
Confidence            99999999999988754

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.30  E-value=8.7e-12  Score=86.52  Aligned_cols=100  Identities=15%  Similarity=0.110  Sum_probs=73.5

Q ss_pred             HHHHHHHHHHHHHHhhCCCCCcccCCC-CCCCeeecCCCceeEccccCccccCCCCCC-------------cccccCCCC
Q 042876           13 MNTIKGVADALSYLHHDCFPPIVHRDL-SSKNLLLDLEYEAHVADFGIAKFLKPDSSN-------------WTEFAGTYG   78 (179)
Q Consensus        13 ~~~~~qi~~~l~~lh~~~~~~~~h~dl-~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-------------~~~~~~~~~   78 (179)
                      ..+..|++.+|.++|+.   |++|+|| +|.||+++.++.++|+|||++.........             .......+.
T Consensus        94 ~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~  170 (218)
T PRK12274         94 LAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPA  170 (218)
T ss_pred             HHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCC
Confidence            45788999999999999   9999999 799999999999999999999854433310             011124556


Q ss_pred             CCCCcccccC-CCC-cchhhHHHHHHHHHHHhCCCCCcc
Q 042876           79 YVAPELAYTM-KIT-EKCDVYSFGVLALEVIKGKHPRDF  115 (179)
Q Consensus        79 ~~~pe~~~~~-~~~-~~~D~~slg~~~~~l~~~~~p~~~  115 (179)
                      ++.|+-..-. ..+ ...+-++.|+-+|.++|+..+.-.
T Consensus       171 ~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        171 ALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             CCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            6667643322 233 345566899999999999888643

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.28  E-value=5.4e-12  Score=95.01  Aligned_cols=72  Identities=25%  Similarity=0.318  Sum_probs=57.7

Q ss_pred             HHHHHHHHHHHHHHhhCCCCCcccCCC-CCCCeeecCCCceeEccccCccccCCCCCCc--------ccccCCCCCCCCc
Q 042876           13 MNTIKGVADALSYLHHDCFPPIVHRDL-SSKNLLLDLEYEAHVADFGIAKFLKPDSSNW--------TEFAGTYGYVAPE   83 (179)
Q Consensus        13 ~~~~~qi~~~l~~lh~~~~~~~~h~dl-~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--------~~~~~~~~~~~pe   83 (179)
                      ..++.|++++|.|||+.   |++|||| ||+||+++.++.++|+|||++..........        ....++..|.+||
T Consensus       114 ~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe  190 (365)
T PRK09188        114 PAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD  190 (365)
T ss_pred             HHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence            56789999999999999   9999999 9999999988999999999998665432111        2234566788898


Q ss_pred             cccc
Q 042876           84 LAYT   87 (179)
Q Consensus        84 ~~~~   87 (179)
                      .+..
T Consensus       191 ~~~~  194 (365)
T PRK09188        191 ALTP  194 (365)
T ss_pred             cCCh
Confidence            8753

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.26  E-value=1e-11  Score=85.96  Aligned_cols=55  Identities=24%  Similarity=0.192  Sum_probs=49.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHH-hhCCCCCcccCCCCCCCeeecCCCceeEccccCcccc
Q 042876            5 QELDWSQRMNTIKGVADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL   63 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~l-h~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~   63 (179)
                      ..++..++..++.|++.+|.++ |+.   |++||||||.||+++ ++.++++|||++...
T Consensus       112 ~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         112 APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            4678889999999999999999 688   999999999999998 578999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=3.1e-11  Score=87.88  Aligned_cols=156  Identities=20%  Similarity=0.273  Sum_probs=104.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccC----CCCCCcccccCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK----PDSSNWTEFAGTYGYV   80 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~----~~~~~~~~~~~~~~~~   80 (179)
                      +.+..+.-.+++.||++||.|||+.. +.++|+++.-..+++..++-||++...-.....    ..........+.++|.
T Consensus       171 ~a~~~~~wkkw~tqIlsal~yLhs~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~  249 (458)
T KOG1266|consen  171 KALFQKAWKKWCTQILSALSYLHSCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFS  249 (458)
T ss_pred             hhhhHHHHHHHHHHHHhhhhhhhccC-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccc
Confidence            34566677889999999999999965 489999999999999999999986533221110    0111123345678899


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCC-CcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHP-RDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +||.....+.+.++|+|++|+...++-.+..- -....     .....+.....+...-..    .      -..++.+|
T Consensus       250 a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS-----~~~~ee~ia~~i~~len~----l------qr~~i~kc  314 (458)
T KOG1266|consen  250 APESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSES-----KVEVEENIANVIIGLENG----L------QRGSITKC  314 (458)
T ss_pred             cCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcc-----eeehhhhhhhheeeccCc----c------ccCcCccc
Confidence            99988777788899999999999998776543 11111     111111111111110000    0      12467799


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 042876          160 LNESPESRPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~  176 (179)
                      ++-+|..||++..++.|
T Consensus       315 l~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  315 LEGEPNGRPDARLLLFH  331 (458)
T ss_pred             ccCCCCCCcchhhhhcC
Confidence            99999999999998876

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.23  E-value=1.9e-11  Score=84.66  Aligned_cols=56  Identities=23%  Similarity=0.256  Sum_probs=50.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCCceeEccccCccccC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK   64 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~   64 (179)
                      ..++..+...++.|++.++.++|. .   |++|+||+|.||+++ ++.++++|||++....
T Consensus       112 ~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         112 VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            356778899999999999999999 8   999999999999999 7899999999986654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.16  E-value=1.2e-11  Score=87.19  Aligned_cols=77  Identities=12%  Similarity=0.174  Sum_probs=57.8

Q ss_pred             HHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccccCCCCcc
Q 042876           14 NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK   93 (179)
Q Consensus        14 ~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~   93 (179)
                      ....+++.+|..+|+.   |++|+|++|.|++++.++ ++++|||........... .           .......+..+
T Consensus       139 ~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~-d-----------~~vler~y~~~  202 (232)
T PRK10359        139 DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK-D-----------RIDLERHYGIK  202 (232)
T ss_pred             HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH-H-----------HHHHHhHhccc
Confidence            3466999999999999   999999999999999888 999999987544322111 0           02223344568


Q ss_pred             hhhHHHHHHHHHH
Q 042876           94 CDVYSFGVLALEV  106 (179)
Q Consensus        94 ~D~~slg~~~~~l  106 (179)
                      +|+|+||+.+...
T Consensus       203 ~di~~lg~~~~~~  215 (232)
T PRK10359        203 NEIKDLGYYLLIY  215 (232)
T ss_pred             ccccceeEeehHH
Confidence            9999999987754

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=2.1e-11  Score=95.95  Aligned_cols=151  Identities=21%  Similarity=0.282  Sum_probs=99.6

Q ss_pred             HHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---------CcccccCCCCCCCCccc
Q 042876           15 TIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---------NWTEFAGTYGYVAPELA   85 (179)
Q Consensus        15 ~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------~~~~~~~~~~~~~pe~~   85 (179)
                      =+.+++.|+.|+|+.+  ++||++|.|++|.+..++.+|++.|+.+........         ..........|.+||++
T Consensus       104 nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  104 NLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            3456678999999997  999999999999999999999999998764433111         01112345679999999


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           86 YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      .+...+.++|+||+|+++|.++. |+.-+...+.......     .....+........   ....++.+=+.+++..++
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-----~~~~~~~~~~~~s~---~~p~el~~~l~k~l~~~~  253 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-----SRNLLNAGAFGYSN---NLPSELRESLKKLLNGDS  253 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-----hhcccccccccccc---cCcHHHHHHHHHHhcCCc
Confidence            88888899999999999999995 5544433321111100     00000000000011   112235555668899999


Q ss_pred             CCCCCHHHHHH
Q 042876          165 ESRPTMKIVSQ  175 (179)
Q Consensus       165 ~~Rps~~~~~~  175 (179)
                      ..||++.++..
T Consensus       254 ~~rp~~~~l~~  264 (700)
T KOG2137|consen  254 AVRPTLDLLLS  264 (700)
T ss_pred             ccCcchhhhhc
Confidence            99998776653

>smart00090 RIO RIO-like kinase

Probab=99.00  E-value=6.8e-10  Score=79.39  Aligned_cols=55  Identities=20%  Similarity=0.294  Sum_probs=48.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCC-cccCCCCCCCeeecCCCceeEccccCccccC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPP-IVHRDLSSKNLLLDLEYEAHVADFGIAKFLK   64 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~-~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~   64 (179)
                      .+...+...++.|++++|.+||+.   | ++|+||+|+||+++ ++.++++|||.+....
T Consensus       144 ~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      144 EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            345556789999999999999999   8 99999999999999 7889999999886544

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.90  E-value=2.6e-09  Score=82.91  Aligned_cols=155  Identities=25%  Similarity=0.242  Sum_probs=109.3

Q ss_pred             CCCHHHHHHHHHHHHH----HHHHHhhCCCCCcccCCCCCCCeeecCC-CceeEccccCccccCCCCCCcccc-----cC
Q 042876            6 ELDWSQRMNTIKGVAD----ALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEF-----AG   75 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~----~l~~lh~~~~~~~~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~-----~~   75 (179)
                      .++....+....+...    ||.++|..   +++|-|++|.|++...+ ...++.||++...++.........     .+
T Consensus       214 ~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~  290 (524)
T KOG0601|consen  214 FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEG  290 (524)
T ss_pred             cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCC
Confidence            3566778888888888    99999999   99999999999999988 778999999988777655432222     56


Q ss_pred             CCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCccccc-ccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHH
Q 042876           76 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSS-ISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVK  154 (179)
Q Consensus        76 ~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (179)
                      ...|++||...+ -++...|+|++|.++.+..++.......+. .+.......     +.+..+...       ..++-.
T Consensus       291 ~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----ip~e~~~~~-------s~~l~~  357 (524)
T KOG0601|consen  291 DCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----IPLEFCEGG-------SSSLRS  357 (524)
T ss_pred             CceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----CchhhhcCc-------chhhhh
Confidence            778999998765 567789999999999999988766543322 121111100     000111111       111333


Q ss_pred             HHhcccCcCCCCCCCHHHHHHH
Q 042876          155 VAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       155 li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .+..+++.+|..|++...+..+
T Consensus       358 ~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  358 VTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             HHHHhcCcchhhhhHHHHHhcc
Confidence            7778999999999998776643

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.85  E-value=6.5e-09  Score=72.39  Aligned_cols=52  Identities=17%  Similarity=0.221  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccC
Q 042876           10 SQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK   64 (179)
Q Consensus        10 ~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~   64 (179)
                      .....++.++++++.++|+.   +++|+||+|.||+++.++.++++|||.+....
T Consensus       125 ~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         125 EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            34567889999999999998   99999999999999999999999999985443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.83  E-value=5.7e-09  Score=74.75  Aligned_cols=45  Identities=22%  Similarity=0.436  Sum_probs=41.4

Q ss_pred             HHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccc
Q 042876           15 TIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF   62 (179)
Q Consensus        15 ~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~   62 (179)
                      .+.+++.+|.+||+.   |++|+||+|.||+++.++.++++|||.+..
T Consensus       147 ~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        147 QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            467899999999999   999999999999999888999999998755

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.78  E-value=1.1e-08  Score=70.52  Aligned_cols=51  Identities=22%  Similarity=0.262  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCCceeEccccCccccC
Q 042876           10 SQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK   64 (179)
Q Consensus        10 ~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~   64 (179)
                      .++..++.+++.++.++|. .   +++|+||+|+||+++ ++.++++|||.+....
T Consensus       114 ~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         114 EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            5678899999999999999 7   999999999999999 8899999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK10345 hypothetical protein; Provisional

Probab=98.69  E-value=2.5e-08  Score=69.98  Aligned_cols=45  Identities=24%  Similarity=0.286  Sum_probs=36.7

Q ss_pred             HHHHHHHHHHH-HHHhhCCCCCcccCCCCCCCeeecC----CCceeEccccCc
Q 042876           13 MNTIKGVADAL-SYLHHDCFPPIVHRDLSSKNLLLDL----EYEAHVADFGIA   60 (179)
Q Consensus        13 ~~~~~qi~~~l-~~lh~~~~~~~~h~dl~~~nil~~~----~~~~~l~d~~~~   60 (179)
                      ...+.|++.++ +|||++   +|+|+||||+||+++.    +..++|+|++.+
T Consensus       107 ~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        107 VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            35577888777 999999   9999999999999974    347999995444

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.67  E-value=4.3e-08  Score=68.75  Aligned_cols=48  Identities=27%  Similarity=0.547  Sum_probs=44.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccc
Q 042876           11 QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF   62 (179)
Q Consensus        11 ~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~   62 (179)
                      ++..++.+++.+|.++|+.   +++|+|++|.||+++ ++.++++|||.+..
T Consensus        96 ~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         96 EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            5678999999999999999   999999999999999 78899999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.63  E-value=5.2e-08  Score=67.74  Aligned_cols=45  Identities=27%  Similarity=0.585  Sum_probs=42.1

Q ss_pred             HHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccc
Q 042876           14 NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF   62 (179)
Q Consensus        14 ~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~   62 (179)
                      .++.+++.+|.+||+.   +++|+|++|.|++++ ++.++++|||.+..
T Consensus        94 ~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        94 ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            7899999999999999   999999999999999 78999999998755

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.62  E-value=1.1e-07  Score=75.26  Aligned_cols=95  Identities=17%  Similarity=0.236  Sum_probs=70.0

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccccCCC
Q 042876           11 QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI   90 (179)
Q Consensus        11 ~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~   90 (179)
                      ..-.-+.||+.||.|||+.+  +++|++++...++++..|..++++|.+...................|..|+...... 
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc-
Confidence            44556789999999999876  899999999999999999999999998754332221111222333455666543322 


Q ss_pred             CcchhhHHHHHHHHHHHhC
Q 042876           91 TEKCDVYSFGVLALEVIKG  109 (179)
Q Consensus        91 ~~~~D~~slg~~~~~l~~~  109 (179)
                       -..|.|.||+++++++.|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             246999999999999998

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.61  E-value=4.3e-08  Score=78.15  Aligned_cols=47  Identities=28%  Similarity=0.552  Sum_probs=43.2

Q ss_pred             HHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccc
Q 042876           12 RMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF   62 (179)
Q Consensus        12 ~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~   62 (179)
                      ...++.+++.+|.+||+.   +++|||++|.||++ .++.++++|||++..
T Consensus       430 ~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        430 NPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             HHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            577899999999999999   99999999999999 577899999999855

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.53  E-value=1.9e-07  Score=64.64  Aligned_cols=54  Identities=22%  Similarity=0.190  Sum_probs=45.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHH-hhCCCCCcccCCCCCCCeeecCCCceeEccccCccccC
Q 042876            7 LDWSQRMNTIKGVADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK   64 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~l-h~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~   64 (179)
                      ++.++...+..+++.+|..+ |+.   +++|+||++.||++. ++.+.++||+.+....
T Consensus       121 ~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         121 LNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            44456677889999999999 787   999999999999997 4689999999886654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.42  E-value=5.8e-07  Score=59.09  Aligned_cols=54  Identities=22%  Similarity=0.257  Sum_probs=46.4

Q ss_pred             CHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCcc
Q 042876            8 DWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus         8 ~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      +......++.+++++++.+|.....+++|+|++|.|++++..+.+++.||+.+.
T Consensus        84 ~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          84 SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            346778889999999999999532369999999999999988899999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.37  E-value=6.6e-07  Score=74.25  Aligned_cols=148  Identities=24%  Similarity=0.287  Sum_probs=102.9

Q ss_pred             HHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCC-----------------------
Q 042876           10 SQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-----------------------   66 (179)
Q Consensus        10 ~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~-----------------------   66 (179)
                      .-++.....+..++++||..   .+.|+|++|.|.+...++..++.+|+.....+.-                       
T Consensus       904 epaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~  980 (1205)
T KOG0606|consen  904 EPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSER  980 (1205)
T ss_pred             ccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCcccccccccc
Confidence            34455566778899999997   7899999999999999999999998733221100                       


Q ss_pred             --C------CCcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCC-
Q 042876           67 --S------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPR-  137 (179)
Q Consensus        67 --~------~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  137 (179)
                        .      .......+++.|.+||...+......+|.|+.|+++++.++|..||.........        +.+.... 
T Consensus       981 ~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f--------~ni~~~~~ 1052 (1205)
T KOG0606|consen  981 RPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIF--------ENILNRDI 1052 (1205)
T ss_pred             ccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhh--------hccccCCC
Confidence              0      0022346789999999999998889999999999999999999998654322111        2222111 


Q ss_pred             -CCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHH
Q 042876          138 -LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK  171 (179)
Q Consensus       138 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~  171 (179)
                       ++....   +......+++...+..+|.+|..+.
T Consensus      1053 ~~p~g~~---~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1053 PWPEGPE---EGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcc---ccChhhhhhhhhhhccCchhccCcc
Confidence             211111   1122366777799999999997654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.22  E-value=3.1e-06  Score=61.59  Aligned_cols=53  Identities=30%  Similarity=0.297  Sum_probs=45.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-------CCceeEccccCccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-------EYEAHVADFGIAKF   62 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-------~~~~~l~d~~~~~~   62 (179)
                      .+...+..++.+++..+.-||..   |++|+|+++.||+++.       +..+.++||+.+..
T Consensus       135 ~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        135 PDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            45567788999999999999999   9999999999999975       45789999997743

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.22  E-value=1.4e-06  Score=68.01  Aligned_cols=152  Identities=20%  Similarity=0.227  Sum_probs=99.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC-CceeEccccCccccCCCCCCcccccCCCCC-CCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTYGY-VAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~-~~pe   83 (179)
                      .+.+..++++..|++.++.++|+.   ..+|.|++|+||++..+ +..+++||+.++.+.......  ......| .++.
T Consensus       362 ~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~~--~~~~r~~p~~~~  436 (524)
T KOG0601|consen  362 MLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGVF--HHIDRLYPIAEI  436 (524)
T ss_pred             hcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceecccc--cccccccccchh
Confidence            356678899999999999999999   99999999999999876 677889999886533222111  0111122 3444


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      ......+-.+.|+++||..+.+..++..--....           .+..+....++......    ..++.+...+...+
T Consensus       437 ~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----------~~~~i~~~~~p~~~~~~----~~~q~~~kv~~~~~  501 (524)
T KOG0601|consen  437 LLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----------QSLTIRSGDTPNLPGLK----LQLQVLLKVMINPD  501 (524)
T ss_pred             hccccccccccccccccccccccccCcccCcccc-----------cceeeecccccCCCchH----HhhhhhhhhhcCCc
Confidence            5555566788999999999999887654321111           00011111121111111    23566777889999


Q ss_pred             CCCCCCHHHHHHHh
Q 042876          164 PESRPTMKIVSQQL  177 (179)
Q Consensus       164 p~~Rps~~~~~~~l  177 (179)
                      +..||++-++..+.
T Consensus       502 ~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  502 RKRRPSAVELSLHS  515 (524)
T ss_pred             cccchhhhhhcccc
Confidence            99999988776543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.21  E-value=2.7e-06  Score=57.47  Aligned_cols=48  Identities=27%  Similarity=0.290  Sum_probs=39.4

Q ss_pred             HHHHHHHHHHHHHHhhCC--CCCcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           13 MNTIKGVADALSYLHHDC--FPPIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        13 ~~~~~qi~~~l~~lh~~~--~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      ...+.+++++|+.||...  ..+++|+|+++.||+++ ++.++++||+.+.
T Consensus        86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            346789999999999982  11259999999999999 6689999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.20  E-value=3.4e-06  Score=59.18  Aligned_cols=53  Identities=32%  Similarity=0.461  Sum_probs=47.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC---ceeEccccCccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY---EAHVADFGIAKF   62 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~---~~~l~d~~~~~~   62 (179)
                      .+......++.+++..++-||..   |++|+|+++.|||+..++   .+.++||+.+..
T Consensus       115 ~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  115 LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            45667889999999999999999   999999999999998887   789999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.13  E-value=4.8e-06  Score=56.66  Aligned_cols=46  Identities=30%  Similarity=0.535  Sum_probs=39.2

Q ss_pred             HHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccc
Q 042876           13 MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF   62 (179)
Q Consensus        13 ~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~   62 (179)
                      ..+++.+=.-+.-||..   |++|+||.++|+.++.. .+.++|||++.+
T Consensus        95 ~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          95 PDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             hHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCC-cEEEEECCcccc
Confidence            34667777778899999   99999999999999865 499999999854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.98  E-value=1.1e-05  Score=55.67  Aligned_cols=51  Identities=29%  Similarity=0.395  Sum_probs=38.7

Q ss_pred             HHHHHHHHHHHHHHHH-HhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccC
Q 042876           10 SQRMNTIKGVADALSY-LHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK   64 (179)
Q Consensus        10 ~~~~~~~~qi~~~l~~-lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~   64 (179)
                      .....++.+++..+.. +|..   |++|+||++.||+++.+ .+.++||+.+....
T Consensus       106 ~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  106 EEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             STHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             hhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            4566778888885555 5677   99999999999999977 99999999886544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=97.94  E-value=2e-05  Score=61.47  Aligned_cols=49  Identities=24%  Similarity=0.293  Sum_probs=41.5

Q ss_pred             HHHHHHHHH-HHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccC
Q 042876           13 MNTIKGVAD-ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK   64 (179)
Q Consensus        13 ~~~~~qi~~-~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~   64 (179)
                      ..++.+++. .+..+|..   |++|+|++|.||++..++.++++|||++..+.
T Consensus       259 ~~ia~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       259 KALAENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            456666665 47888998   99999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK09902 hypothetical protein; Provisional

Probab=97.89  E-value=3.8e-05  Score=53.72  Aligned_cols=54  Identities=19%  Similarity=0.114  Sum_probs=46.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc--eeEccccCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE--AHVADFGIAKF   62 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~--~~l~d~~~~~~   62 (179)
                      +.+..++..+..+++..++-||+.   |+.|+|+.+.||+++.++.  +.++||.-+..
T Consensus       124 ~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        124 PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            446677789999999999999999   9999999999999986666  88999886643

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=97.89  E-value=2.5e-05  Score=53.30  Aligned_cols=47  Identities=26%  Similarity=0.533  Sum_probs=40.0

Q ss_pred             HHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc---eeEccccCccc
Q 042876           13 MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKF   62 (179)
Q Consensus        13 ~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~---~~l~d~~~~~~   62 (179)
                      ..+++.+-+.+.-||.+   +++|+||.++||++..++.   +.++|||++..
T Consensus       116 ~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  116 AELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            67889999999999999   9999999999999854432   47899999854

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=97.70  E-value=0.00019  Score=56.25  Aligned_cols=87  Identities=20%  Similarity=0.289  Sum_probs=69.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +.++++...|.++.|+..||.++|+.   |+..+-|.+.+|++.++.+++|+..|.......++.              +
T Consensus       387 ~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~--------------~  449 (655)
T KOG3741|consen  387 NLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT--------------E  449 (655)
T ss_pred             CCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCCCC--------------c
Confidence            45678899999999999999999999   999999999999999999999988887766554431              0


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGK  110 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~  110 (179)
                      .+.+   ..+-|.-.||.++..+.+|.
T Consensus       450 ~le~---~Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  450 PLES---QQQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             chhH---HhhhhHHHHHHHHHHHhhcc
Confidence            1111   13568888999999999874

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.27  E-value=0.00056  Score=48.23  Aligned_cols=42  Identities=19%  Similarity=0.249  Sum_probs=36.1

Q ss_pred             HHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCc
Q 042876           15 TIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA   60 (179)
Q Consensus        15 ~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~   60 (179)
                      +...+.+++.-+|+.   |+.|+|+.|.|++++.+ .++++|++..
T Consensus       140 ~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k  181 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGK  181 (229)
T ss_pred             HHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECccc
Confidence            446678889999999   99999999999999854 5899998865

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.26  E-value=0.00076  Score=48.91  Aligned_cols=53  Identities=21%  Similarity=0.203  Sum_probs=40.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccC
Q 042876            9 WSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK   64 (179)
Q Consensus         9 ~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~   64 (179)
                      ......++..|++-+.-.-..   |+||+|++.-||+++.++.+.++||-.+....
T Consensus       201 ~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         201 VENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             ccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEEEeCcccccCC
Confidence            444555566666656555566   99999999999999999999999998765444

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.10  E-value=0.0015  Score=46.81  Aligned_cols=55  Identities=24%  Similarity=0.332  Sum_probs=46.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccC
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK   64 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~   64 (179)
                      ++..++..+..++++.+.-|-..+  ++||+||+.-|||+. ++.+.++|++.+....
T Consensus       163 ~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         163 LELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            334467888889999999988854  999999999999999 7799999999886655

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=97.03  E-value=0.00056  Score=54.61  Aligned_cols=38  Identities=24%  Similarity=0.413  Sum_probs=32.1

Q ss_pred             HHHhhCCCCCcccCCCCCCCeeecCCC----ceeEccccCccccC
Q 042876           24 SYLHHDCFPPIVHRDLSSKNLLLDLEY----EAHVADFGIAKFLK   64 (179)
Q Consensus        24 ~~lh~~~~~~~~h~dl~~~nil~~~~~----~~~l~d~~~~~~~~   64 (179)
                      ..+...   |++|+|++|.||+++.++    .+++.|||+.....
T Consensus       274 ~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        274 TQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            344556   999999999999999887    89999999987654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.00  E-value=0.0037  Score=53.62  Aligned_cols=148  Identities=18%  Similarity=0.169  Sum_probs=92.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCC---CeeecCCCceeEc--cccCccccCCCCCCcccccCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSK---NLLLDLEYEAHVA--DFGIAKFLKPDSSNWTEFAGTYGY   79 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~---nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~   79 (179)
                      ..++....+.+..+..+|++++|+.   ...|.-+..+   +--.+..+...+.  +|+............. ...+..+
T Consensus       281 ~~i~~~~~r~~~~~~~~GL~~~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~-~~~~~~~  356 (1351)
T KOG1035|consen  281 GSIPLETLRILHQKLLEGLAYLHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS-DLLAEIR  356 (1351)
T ss_pred             cccCHHHHHHHHHHHhhhHHHHHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh-hcCcccc
Confidence            3567788899999999999999998   6666655544   2223334444444  7776655544332222 2344456


Q ss_pred             CCCcccccCCCCc--chhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHh
Q 042876           80 VAPELAYTMKITE--KCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        80 ~~pe~~~~~~~~~--~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      .++|.......+.  ..|+|.+|.....+..+..+-...           .......+....      .    .+.+...
T Consensus       357 ~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~-----------~~~~~~l~~~~~------~----~~~d~~~  415 (1351)
T KOG1035|consen  357 NADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS-----------AVPVSLLDVLST------S----ELLDALP  415 (1351)
T ss_pred             ccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc-----------cchhhhhccccc------h----hhhhhhh
Confidence            6777665554443  469999999999988766542110           011111111110      0    2667788


Q ss_pred             cccCcCCCCCCCHHHHHHHh
Q 042876          158 SCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~l  177 (179)
                      +|+..++++|+++.+++.+.
T Consensus       416 ~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  416 KCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhcchhhhhccchhhhhhch
Confidence            99999999999999998763

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=96.97  E-value=0.0026  Score=44.57  Aligned_cols=28  Identities=29%  Similarity=0.366  Sum_probs=24.5

Q ss_pred             CcccCCCCCCCeeecC--CCceeEccccCc
Q 042876           33 PIVHRDLSSKNLLLDL--EYEAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~--~~~~~l~d~~~~   60 (179)
                      .++|+|+.+.|++++.  ++.+.++||+.+
T Consensus       175 ~l~HgD~~~~Nil~~~~~~~~~~iID~e~~  204 (223)
T cd05154         175 GLVHGDYRLGNVLFHPDEPRVVAVLDWELA  204 (223)
T ss_pred             EEEECCCCcccEEEcCCCCcEEEEEecccc
Confidence            6899999999999988  556789999876

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.73  E-value=0.0029  Score=43.78  Aligned_cols=55  Identities=18%  Similarity=0.173  Sum_probs=47.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCcc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      -+|..+.+++.++++.+.+++..-.-.+...|++++|+.++.++++++.|.....
T Consensus        56 ~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   56 SPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence            4899999999999999999999422268889999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.69  E-value=0.012  Score=41.87  Aligned_cols=39  Identities=18%  Similarity=0.110  Sum_probs=32.9

Q ss_pred             HHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccC
Q 042876           20 ADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGI   59 (179)
Q Consensus        20 ~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~   59 (179)
                      +.+|.-.|+..+ +.+|+|..|+||+-+..|.+|+.|-+.
T Consensus       151 i~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhh
Confidence            456778886443 899999999999999999999999663

The function of this family is unknown.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.58  E-value=0.024  Score=40.35  Aligned_cols=28  Identities=25%  Similarity=0.391  Sum_probs=25.4

Q ss_pred             CcccCCCCCCCeeecC-CCceeEccccCc
Q 042876           33 PIVHRDLSSKNLLLDL-EYEAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~-~~~~~l~d~~~~   60 (179)
                      +++|+|+.+.||+++. ++.+.++||..+
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a  199 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYA  199 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence            7999999999999997 477999999876

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.50  E-value=0.037  Score=41.05  Aligned_cols=29  Identities=31%  Similarity=0.327  Sum_probs=25.9

Q ss_pred             CCcccCCCCCCCeeecCC----CceeEccccCc
Q 042876           32 PPIVHRDLSSKNLLLDLE----YEAHVADFGIA   60 (179)
Q Consensus        32 ~~~~h~dl~~~nil~~~~----~~~~l~d~~~~   60 (179)
                      .+++|+|+.+.||+++.+    +.+.++||..+
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya  211 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYA  211 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence            379999999999999874    78999999977

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.34  E-value=0.047  Score=41.76  Aligned_cols=53  Identities=23%  Similarity=0.413  Sum_probs=47.4

Q ss_pred             CHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCcccc
Q 042876            8 DWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL   63 (179)
Q Consensus         8 ~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~   63 (179)
                      .++++..++.+++..+.-+..+-  ..-||++.-.||+++ +|++.++||.+++.-
T Consensus       319 ~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         319 RSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             cHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecc
Confidence            67899999999999888888863  789999999999999 999999999999743

>PRK05231 homoserine kinase; Provisional

Probab=95.33  E-value=0.053  Score=40.54  Aligned_cols=29  Identities=28%  Similarity=0.363  Sum_probs=25.3

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      +++|+|+.+.|++++.+....++||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            89999999999999976556899999763

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=95.21  E-value=0.027  Score=40.19  Aligned_cols=28  Identities=36%  Similarity=0.413  Sum_probs=24.4

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~   60 (179)
                      +++|+|+.+.|++++.+....++||+.+
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a  192 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCL  192 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCccc
Confidence            6999999999999987655679999976

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.94  E-value=0.09  Score=39.17  Aligned_cols=29  Identities=34%  Similarity=0.445  Sum_probs=25.9

Q ss_pred             CCcccCCCCCCCeeecCCCceeEccccCc
Q 042876           32 PPIVHRDLSSKNLLLDLEYEAHVADFGIA   60 (179)
Q Consensus        32 ~~~~h~dl~~~nil~~~~~~~~l~d~~~~   60 (179)
                      .+++|+|+.+.|++++.++...++||+.+
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeecccc
Confidence            38999999999999998876789999976

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=94.91  E-value=0.027  Score=39.62  Aligned_cols=28  Identities=32%  Similarity=0.484  Sum_probs=20.0

Q ss_pred             CcccCCCCCCCeeec-CCCceeEccccCc
Q 042876           33 PIVHRDLSSKNLLLD-LEYEAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~~-~~~~~~l~d~~~~   60 (179)
                      .++|+|+.+.||+++ .++.+.++||+.+
T Consensus       167 ~~~HgD~~~~Nil~~~~~~~i~iID~e~a  195 (239)
T PF01636_consen  167 VLIHGDLHPGNILVDPSDGRIGIIDFEDA  195 (239)
T ss_dssp             EEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred             EEEEeccccccceeeeccceeEEEecccc
Confidence            799999999999999 5666689999865

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.85  E-value=0.063  Score=39.34  Aligned_cols=50  Identities=26%  Similarity=0.220  Sum_probs=37.9

Q ss_pred             HHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           11 QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        11 ~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      .....+..+-.++.-.+..- ..++|+|+.+.|++.+..+.++++||..|.
T Consensus       133 ~~~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         133 LLRKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            33445555666666666641 158999999999999998999999999874

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.67  E-value=0.087  Score=39.16  Aligned_cols=27  Identities=33%  Similarity=0.455  Sum_probs=24.1

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~   60 (179)
                      +++|+|+.+.|++++. +.+.++||+.+
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            8999999999999987 57889999965

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.64  E-value=0.066  Score=39.55  Aligned_cols=29  Identities=34%  Similarity=0.414  Sum_probs=25.8

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      +++|+|+.|.|++++.+..+.|+||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            79999999999999987777899998763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=94.15  E-value=0.036  Score=39.75  Aligned_cols=28  Identities=21%  Similarity=0.272  Sum_probs=25.2

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~   60 (179)
                      .++|+|+.+.|++++.+....|+||+.+
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a  191 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRL  191 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEcccc
Confidence            7999999999999998777789999866

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.95  E-value=0.076  Score=37.23  Aligned_cols=28  Identities=32%  Similarity=0.530  Sum_probs=20.4

Q ss_pred             CcccCCCCCCCeee-cCCCceeEccccCc
Q 042876           33 PIVHRDLSSKNLLL-DLEYEAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~-~~~~~~~l~d~~~~   60 (179)
                      .++|+|+.+.||++ ..++.++++||..+
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya  172 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYA  172 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHH
Confidence            68999999999999 78889999999987

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=93.91  E-value=0.11  Score=38.73  Aligned_cols=29  Identities=28%  Similarity=0.311  Sum_probs=26.5

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      +++|+|+.+.|++++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            89999999999999988889999998763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=93.77  E-value=0.048  Score=39.44  Aligned_cols=28  Identities=21%  Similarity=0.306  Sum_probs=24.6

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      .++|+|+.+.|++++.++ +.++||..+.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            689999999999998776 7899999773

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.67  E-value=0.062  Score=37.09  Aligned_cols=28  Identities=21%  Similarity=0.261  Sum_probs=24.5

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      ..+|+|+.|.|++++.++ ++++||+.+.
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence            579999999999998766 8899999874

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=93.57  E-value=0.057  Score=38.48  Aligned_cols=27  Identities=22%  Similarity=0.182  Sum_probs=24.4

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~   60 (179)
                      .++|+|+.|.|++++.++ +.++||+.+
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a  180 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDF  180 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhc
Confidence            679999999999999877 999999876

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=93.42  E-value=0.24  Score=39.84  Aligned_cols=39  Identities=31%  Similarity=0.389  Sum_probs=33.0

Q ss_pred             HHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccC
Q 042876           23 LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK   64 (179)
Q Consensus        23 l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~   64 (179)
                      +..+-..   |+.|+|..|-|+++..++.+.+.|||+.....
T Consensus       278 ~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         278 LRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            4445556   89999999999999999999999999976543

>PLN02236 choline kinase

Probab=93.37  E-value=0.15  Score=38.82  Aligned_cols=29  Identities=24%  Similarity=0.413  Sum_probs=25.3

Q ss_pred             CcccCCCCCCCeeecC-CCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDL-EYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~-~~~~~l~d~~~~~   61 (179)
                      .++|+|+++.||+++. ++.+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            7899999999999976 4679999998874

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=93.14  E-value=0.25  Score=37.40  Aligned_cols=27  Identities=37%  Similarity=0.577  Sum_probs=24.3

Q ss_pred             cccCCCCCCCeeecCCCc-eeEccccCc
Q 042876           34 IVHRDLSSKNLLLDLEYE-AHVADFGIA   60 (179)
Q Consensus        34 ~~h~dl~~~nil~~~~~~-~~l~d~~~~   60 (179)
                      +||+|+.+.|++++.+.. +.+.||+-+
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa  226 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA  226 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccc
Confidence            899999999999998874 889999976

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=92.63  E-value=0.24  Score=37.59  Aligned_cols=49  Identities=14%  Similarity=0.177  Sum_probs=38.6

Q ss_pred             HHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccC
Q 042876           13 MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK   64 (179)
Q Consensus        13 ~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~   64 (179)
                      -.+...+..-|--|-++   |+||+|.+--||++..++.++++||-......
T Consensus       205 ~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  205 PTLYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             HHHHHHHHHHHHHHHHc---CceecccchheeEEecCCCEEEeechHhhccC
Confidence            34445555566677777   99999999999999999999999998765444

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=92.18  E-value=0.11  Score=38.16  Aligned_cols=29  Identities=31%  Similarity=0.473  Sum_probs=24.3

Q ss_pred             CcccCCCCCCCeeecCCCc-eeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYE-AHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~-~~l~d~~~~~   61 (179)
                      .++|+|+.+.|++++.++. ..|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            6899999999999987455 4699999763

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=91.97  E-value=0.026  Score=44.94  Aligned_cols=80  Identities=23%  Similarity=0.154  Sum_probs=44.5

Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC--CCCCCC---CCccHHHHHHHHHHHHhcccCcCCC
Q 042876           91 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML--DPRLPA---PSRSVQEKLISIVKVAFSCLNESPE  165 (179)
Q Consensus        91 ~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~  165 (179)
                      .+++|||++|.++.++..|..-+.........     .......  +.....   ......+....+.++..+|+...|.
T Consensus       109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l-----~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~  183 (725)
T KOG1093|consen  109 GPKSDVWSLGFIILELYLGISLEAELTESEYL-----EILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPI  183 (725)
T ss_pred             CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHH-----HHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccc
Confidence            36999999999999998887655322111100     0000000  000000   0011122334477888899999999


Q ss_pred             CCCCHHHHHH
Q 042876          166 SRPTMKIVSQ  175 (179)
Q Consensus       166 ~Rps~~~~~~  175 (179)
                      .||...+..+
T Consensus       184 ir~l~~~~~k  193 (725)
T KOG1093|consen  184 IRPLPMELSK  193 (725)
T ss_pred             cccchhHHhc
Confidence            9997666543

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.42  E-value=0.18  Score=35.05  Aligned_cols=28  Identities=21%  Similarity=0.483  Sum_probs=23.7

Q ss_pred             CcccCCCCCCCeeecCCC-----ceeEccccCc
Q 042876           33 PIVHRDLSSKNLLLDLEY-----EAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~-----~~~l~d~~~~   60 (179)
                      .++|||+.+.|+++..++     .+.++||..+
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~  153 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLS  153 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccC
Confidence            799999999999997543     5788999876

subfamily of choline kinases

>PRK06148 hypothetical protein; Provisional

Probab=91.06  E-value=0.61  Score=40.80  Aligned_cols=30  Identities=30%  Similarity=0.503  Sum_probs=25.2

Q ss_pred             CcccCCCCCCCeeecCCC--ce-eEccccCccc
Q 042876           33 PIVHRDLSSKNLLLDLEY--EA-HVADFGIAKF   62 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~--~~-~l~d~~~~~~   62 (179)
                      ++||+|+.+.||+++.+.  .+ -|+|||.+..
T Consensus       204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            799999999999998775  44 5999998753

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=90.78  E-value=0.47  Score=35.89  Aligned_cols=29  Identities=34%  Similarity=0.401  Sum_probs=25.2

Q ss_pred             CcccCCCCCCCeeecC-CCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDL-EYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~-~~~~~l~d~~~~~   61 (179)
                      ..+|+|+.+.||+++. ++.++++||..+-
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            4899999999999974 4679999999874

>PRK11768 serine/threonine protein kinase; Provisional

Probab=90.68  E-value=0.61  Score=35.18  Aligned_cols=27  Identities=26%  Similarity=0.378  Sum_probs=23.3

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      +++|+|+.+.|+++. + .+.++||+.+.
T Consensus       197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             cceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            789999999999995 4 57899999774

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=90.67  E-value=0.18  Score=41.39  Aligned_cols=93  Identities=29%  Similarity=0.315  Sum_probs=68.5

Q ss_pred             HHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccccCCCCc
Q 042876           13 MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITE   92 (179)
Q Consensus        13 ~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~   92 (179)
                      ...++.-+++++++|+.   .-+|+|    ||+.+ ++..+..+|+....+.... ......+++.+++||......+..
T Consensus       339 ~~~~r~et~~l~~l~~~---~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~  409 (829)
T KOG0576|consen  339 AYPLRKETRPLAELHSS---YKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTIDG  409 (829)
T ss_pred             hhhhhhhcccccccccc---cccCcc----ccccc-ccccccccccCCcccCccc-ccccCCCCCCCCCchhhccccccc
Confidence            44556667789999997   457887    55544 3577888988876655432 234467889999999988888888


Q ss_pred             chhhHHHHHHHHHHHhCCCCCc
Q 042876           93 KCDVYSFGVLALEVIKGKHPRD  114 (179)
Q Consensus        93 ~~D~~slg~~~~~l~~~~~p~~  114 (179)
                      ..|.|++|.-..++--|..|..
T Consensus       410 ~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  410 CPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCccCCCcchhhcCCCCCCCC
Confidence            9999999987667766766653

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=90.63  E-value=0.22  Score=37.42  Aligned_cols=31  Identities=32%  Similarity=0.535  Sum_probs=27.9

Q ss_pred             CCcccCCCCCCCeeecCCCceeEccccCccc
Q 042876           32 PPIVHRDLSSKNLLLDLEYEAHVADFGIAKF   62 (179)
Q Consensus        32 ~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~   62 (179)
                      ..++|+|+.+.|++++.+..+-|.||+++..
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            3699999999999999998899999998854

>COG4499 Predicted membrane protein [Function unknown]

Probab=90.57  E-value=1.9  Score=33.07  Aligned_cols=85  Identities=19%  Similarity=0.224  Sum_probs=58.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY   86 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   86 (179)
                      +.....++++.|.+..|.-+...    -.|-=+.|+||+++++..+.+..+|+-....+..            +.||   
T Consensus        82 ~~k~~Klr~a~~~I~~l~e~~~t----r~~~~laPeNilf~~~l~p~~vH~Glk~~lpPye------------~tee---  142 (434)
T COG4499          82 KEKTRKLRLALQNIATLSELNNT----RYTFFLAPENILFDGGLTPFFVHRGLKNSLPPYE------------MTEE---  142 (434)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcc----ceeEEecchheEEcCCCceEEEecchhccCCCCC------------CCHH---
Confidence            44456677777777777655443    3666788999999999999999999764433322            2333   


Q ss_pred             cCCCCcchhhH-HHHHHHHHHHhCCCCCccccc
Q 042876           87 TMKITEKCDVY-SFGVLALEVIKGKHPRDFLSS  118 (179)
Q Consensus        87 ~~~~~~~~D~~-slg~~~~~l~~~~~p~~~~~~  118 (179)
                              ++| .+-+++..++.|..+|+..-.
T Consensus       143 --------~f~~~ykA~~~~~fn~k~~Fe~l~~  167 (434)
T COG4499         143 --------RFLKEYKALAIYAFNGKFSFESLVN  167 (434)
T ss_pred             --------HHHHHHHHHHHHHHcCCccHHHHhc
Confidence                    233 467778888889999975543

>PRK06149 hypothetical protein; Provisional

Probab=90.45  E-value=0.56  Score=40.83  Aligned_cols=29  Identities=28%  Similarity=0.357  Sum_probs=24.1

Q ss_pred             CcccCCCCCCCeeecCCC--c---eeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEY--E---AHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~--~---~~l~d~~~~~   61 (179)
                      ++||+|+.+.||+++.+.  .   ..|+|||.+.
T Consensus       209 g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        209 QAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             cccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            899999999999998652  2   3789999864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=89.84  E-value=0.043  Score=49.35  Aligned_cols=81  Identities=16%  Similarity=0.117  Sum_probs=62.6

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP  112 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p  112 (179)
                      ..+|.++++.|.++..+.+++++++|+.+-..+.........+++.|+.+++.....++.++|+|..|+.+|....|..+
T Consensus      1360 T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~ 1439 (2724)
T KOG1826|consen 1360 TNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAY 1439 (2724)
T ss_pred             cchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHH
Confidence            36899999999999999999999999987222222223445667777788877666777779999999999988777777


Q ss_pred             C
Q 042876          113 R  113 (179)
Q Consensus       113 ~  113 (179)
                      |
T Consensus      1440 f 1440 (2724)
T KOG1826|consen 1440 F 1440 (2724)
T ss_pred             H
Confidence            6

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=88.52  E-value=1.1  Score=34.82  Aligned_cols=56  Identities=23%  Similarity=0.258  Sum_probs=47.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCcccc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL   63 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~   63 (179)
                      -.++...+..+-.|++.-+.-|-+.|  ++||.||+--|+++. +|.+.++|.+.+...
T Consensus       259 ~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  259 ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DGKLYIIDVSQSVEH  314 (520)
T ss_pred             ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CCEEEEEEccccccC
Confidence            35777889999999999999999987  899999999999887 568899998887543

>PRK12396 5-methylribose kinase; Reviewed

Probab=88.22  E-value=0.92  Score=35.31  Aligned_cols=27  Identities=22%  Similarity=0.425  Sum_probs=23.9

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~   60 (179)
                      .++|||+.|.|||++.+ .++++|...+
T Consensus       228 aLlHGDlHtGSI~v~~~-~~kvIDpEFA  254 (409)
T PRK12396        228 ALIHGDLHTGSVFVKND-STKVIDPEFA  254 (409)
T ss_pred             hhccCcCCCCCEEecCC-ceEEEccccc
Confidence            79999999999999975 6899997776

>PF10140 YukC: WXG100 protein secretion system (Wss), protein YukC; InterPro: IPR018778 Members of this family are associated with type VII secretion of WXG100 family targets in the Firmicutes, but not in the Actinobacteria

Probab=86.89  E-value=0.56  Score=35.85  Aligned_cols=53  Identities=21%  Similarity=0.268  Sum_probs=33.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF   62 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~   62 (179)
                      +.++..++++++.+|..--.++++     -+|--+.|+|++++.++.+++.-.|+-..
T Consensus        54 ~~~~~~eklr~~~ni~~l~~~~~~-----~~~f~l~P~Nl~fd~~~~p~i~hrGi~~~  106 (359)
T PF10140_consen   54 KKLDKSEKLRLLINIAALKEHLNS-----RYTFILHPENLVFDKNLMPKILHRGIKEI  106 (359)
T ss_dssp             GGS-HHHHHHHHHHGGGGGGGGGS-----SEE---SGGGEEE-TTS-EEES--EETTT
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhcC-----ceeEEEechheEEcCCCCEEEEEcCCcCC
Confidence            456788999999995543333333     38899999999999999999988876543

This protein is designated YukC in Bacillus subtilis and EssB is Staphylococcus aureus. ; PDB: 4ANN_A.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=86.69  E-value=1.4  Score=34.42  Aligned_cols=28  Identities=29%  Similarity=0.414  Sum_probs=24.5

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      .++|||+.+.||++..+ .++++||..+.
T Consensus       224 ~l~HgDl~~gni~~~~~-~~~viD~E~a~  251 (401)
T PRK09550        224 ALLHGDLHTGSIFVTEE-ETKVIDPEFAF  251 (401)
T ss_pred             ceeeccCCcccEEeeCC-CcEEEeccccc
Confidence            79999999999999765 68999998763

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=86.16  E-value=2.4  Score=34.37  Aligned_cols=32  Identities=22%  Similarity=0.313  Sum_probs=27.5

Q ss_pred             CcccCCCCCCCeeec----CCCceeEccccCccccC
Q 042876           33 PIVHRDLSSKNLLLD----LEYEAHVADFGIAKFLK   64 (179)
Q Consensus        33 ~~~h~dl~~~nil~~----~~~~~~l~d~~~~~~~~   64 (179)
                      |.+|+|-.|-||++.    .++.+.+.|+|+.....
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            899999999999998    46778999999876544

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=85.39  E-value=1.6  Score=32.22  Aligned_cols=28  Identities=25%  Similarity=0.505  Sum_probs=23.2

Q ss_pred             CcccCCCCCCCeeecCCC-----ceeEccccCc
Q 042876           33 PIVHRDLSSKNLLLDLEY-----EAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~-----~~~l~d~~~~   60 (179)
                      .++|||+...|+++..++     .+.+.||..+
T Consensus       216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~  248 (294)
T PF02958_consen  216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLA  248 (294)
T ss_pred             EEEcCccCHHhEeEccccccccccceeeccccc
Confidence            699999999999996542     4788898876

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PHA03111 Ser/Thr kinase; Provisional

Probab=82.65  E-value=3.9  Score=31.39  Aligned_cols=41  Identities=17%  Similarity=0.114  Sum_probs=26.0

Q ss_pred             HHHHHHHHHHHHHHHHH-hhCCCCCcccCCCCCCCeeecCCC
Q 042876           10 SQRMNTIKGVADALSYL-HHDCFPPIVHRDLSSKNLLLDLEY   50 (179)
Q Consensus        10 ~~~~~~~~qi~~~l~~l-h~~~~~~~~h~dl~~~nil~~~~~   50 (179)
                      +-.+.+..|++.-.-.. .--+-.+.+|.||||.|||+-.+.
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~  320 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD  320 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence            35567788886433222 111111799999999999995443

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=80.97  E-value=2.5  Score=32.45  Aligned_cols=36  Identities=25%  Similarity=0.300  Sum_probs=24.0

Q ss_pred             HHHHHHHHHHHHHHHHhh----CCCCCcccCCCCCCCeeecCC
Q 042876           11 QRMNTIKGVADALSYLHH----DCFPPIVHRDLSSKNLLLDLE   49 (179)
Q Consensus        11 ~~~~~~~qi~~~l~~lh~----~~~~~~~h~dl~~~nil~~~~   49 (179)
                      -.+.+..|++  |-|+--    .+. +.+|.||||+|||+-.+
T Consensus       276 YvkfifLQia--LLyikIYelp~c~-nF~H~DLKPdNILiFds  315 (434)
T PF05445_consen  276 YVKFIFLQIA--LLYIKIYELPCCT-NFLHVDLKPDNILIFDS  315 (434)
T ss_pred             HHHHHHHHHH--HHHeeeecCCCcc-eeeecccCcCcEEEecC
Confidence            4566677776  444222    122 79999999999999544

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=80.90  E-value=1.2  Score=34.20  Aligned_cols=28  Identities=29%  Similarity=0.388  Sum_probs=23.8

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      .++|||+.+.||+++.+ .++++|+..+.
T Consensus       193 ~llHGDl~~gNi~~~~~-~~~~iD~e~~~  220 (370)
T TIGR01767       193 TLLHGDLHSGSIFVSEH-ETKVIDPEFAF  220 (370)
T ss_pred             eeeeccCCcccEEEcCC-CCEEEcCcccc
Confidence            79999999999999765 47799988663

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=80.66  E-value=4.2  Score=28.44  Aligned_cols=38  Identities=26%  Similarity=0.396  Sum_probs=26.4

Q ss_pred             HHHHHHHHhhCCCCCcccCCCCCCCeeecCCC----ceeEcc-ccC
Q 042876           19 VADALSYLHHDCFPPIVHRDLSSKNLLLDLEY----EAHVAD-FGI   59 (179)
Q Consensus        19 i~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~----~~~l~d-~~~   59 (179)
                      +-+-..+|-++   +|+.+|++|.||++..+.    .+.++| ||.
T Consensus       127 L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  127 LDEFKRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             HHHHHHHHHHc---CCeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence            33445677788   899999999999995432    355555 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	179
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-24
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-24
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-18
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-18
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-17
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-17
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-17
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-09
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-08
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-07
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-07
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-07
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-07
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-07
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-07
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-06
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		2e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-06
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-06
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-06
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-06
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-06
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-06
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-06
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-06
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-06
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-06
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-06
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-06
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-06
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-06
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-05
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-05
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-05
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-05
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-05
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-05
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-04
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-04
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-04
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-04
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-04
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-04
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-04
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-04
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-04
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-04
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-04
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-04
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-04
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-04
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-04
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-04
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-04
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-04
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-04
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-04
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-04
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-04
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-04
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-04
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-04
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-04
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-04
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		4e-04
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		4e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-04
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-04
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-04
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-04
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-04
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  107 bits (268), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 64/181 (35%), Positives = 94/181 (51%), Gaps = 12/181 (6%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK-P 65
           LDW +R     G A  L+YLH  C P I+HRD+ + N+LLD E+EA V DFG+AK +   
Sbjct: 136 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 195
Query: 66  DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDF---------L 116
           D        GT G++APE   T K +EK DV+ +GV+ LE+I G+   D          +
Sbjct: 196 DXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 255
Query: 117 XXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ 176
                  L  + +L+ ++D  L    +   E++  +++VA  C   SP  RP M  V + 
Sbjct: 256 LLDWVKGLLKEKKLEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRM 313
Query: 177 L 177
           L
Sbjct: 314 L 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  106 bits (264), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 63/181 (34%), Positives = 93/181 (51%), Gaps = 12/181 (6%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK-P 65
           LDW +R     G A  L+YLH  C P I+HRD+ + N+LLD E+EA V DFG+AK +   
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 66  DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDF---------L 116
           D        G  G++APE   T K +EK DV+ +GV+ LE+I G+   D          +
Sbjct: 188 DXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 117 XXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ 176
                  L  + +L+ ++D  L    +   E++  +++VA  C   SP  RP M  V + 
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 177 L 177
           L
Sbjct: 306 L 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/188 (33%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           D     + W QR+    G A  L YLH      I+HRD+ S N+LLD  +   + DFGI+
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186
Query: 61  KFLKPDSSNWTEFA----GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKH----- 111
           K  K    + T       GT GY+ PE     ++TEK DVYSFGV+  EV+  +      
Sbjct: 187 K--KGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244
Query: 112 -PRDFLXXXX-XXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            PR+ +         + + +L++++DP L    R   E L      A  CL  S E RP+
Sbjct: 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPS 302
Query: 170 MKIVSQQL 177
           M  V  +L
Sbjct: 303 MGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/188 (33%), Positives = 88/188 (46%), Gaps = 18/188 (9%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           D     + W QR+    G A  L YLH      I+HRD+ S N+LLD  +   + DFGI+
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186
Query: 61  KFLKPDSSNWTEFA----GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKH----- 111
           K  K      T       GT GY+ PE     ++TEK DVYSFGV+  EV+  +      
Sbjct: 187 K--KGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244
Query: 112 -PRDFLXXXX-XXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            PR+ +         + + +L++++DP L    R   E L      A  CL  S E RP+
Sbjct: 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPS 302
Query: 170 MKIVSQQL 177
           M  V  +L
Sbjct: 303 MGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 89/181 (49%), Gaps = 17/181 (9%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK-- 64
           L W  R    +G A+ +++LH +     +HRD+ S N+LLD  + A ++DFG+A+  +  
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG-------KHPRDFLX 117
             +   +   GT  Y+APE A   +IT K D+YSFGV+ LE+I G       + P+  L 
Sbjct: 187 AQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245
Query: 118 XXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                        D +      A S SV+    ++  VA  CL+E    RP +K V Q L
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVE----AMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 178 R 178
           +
Sbjct: 302 Q 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 88/181 (48%), Gaps = 17/181 (9%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK-- 64
           L W  R    +G A+ +++LH +     +HRD+ S N+LLD  + A ++DFG+A+  +  
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG-------KHPRDFLX 117
             +       GT  Y+APE A   +IT K D+YSFGV+ LE+I G       + P+  L 
Sbjct: 187 AQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245
Query: 118 XXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                        D +      A S SV+    ++  VA  CL+E    RP +K V Q L
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVE----AMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 178 R 178
           +
Sbjct: 302 Q 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 88/181 (48%), Gaps = 17/181 (9%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L W  R    +G A+ +++LH +     +HRD+ S N+LLD  + A ++DFG+A+  +  
Sbjct: 124 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 67  SSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG-------KHPRDFLX 117
           +         GT  Y+APE A   +IT K D+YSFGV+ LE+I G       + P+  L 
Sbjct: 181 AQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 239
Query: 118 XXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                        D +      A S SV+    ++  VA  CL+E    RP +K V Q L
Sbjct: 240 IKEEIEDEEKTIEDYIDKKMNDADSTSVE----AMYSVASQCLHEKKNKRPDIKKVQQLL 295
Query: 178 R 178
           +
Sbjct: 296 Q 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/181 (32%), Positives = 86/181 (47%), Gaps = 17/181 (9%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK-- 64
           L W  R    +G A+ +++LH +     +HRD+ S N+LLD  + A ++DFG+A+  +  
Sbjct: 121 LSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG-------KHPRDFLX 117
                 +   GT  Y APE A   +IT K D+YSFGV+ LE+I G       + P+  L 
Sbjct: 178 AQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 236
Query: 118 XXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                        D +      A S SV+    +   VA  CL+E    RP +K V Q L
Sbjct: 237 IKEEIEDEEKTIEDYIDKKXNDADSTSVE----AXYSVASQCLHEKKNKRPDIKKVQQLL 292
Query: 178 R 178
           +
Sbjct: 293 Q 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 85/177 (48%), Gaps = 11/177 (6%)
Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK 61
            A ++LD  +R++    VA  ++YLH+   PPIVHRDL S NLL+D +Y   V DFG+++
Sbjct: 129 GAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 62  FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXX 121
                       AGT  ++APE+       EK DVYSFGV+  E+   + P   L     
Sbjct: 188 LKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV 247
Query: 122 XXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
                 +        RL  P R++  ++ +I++    C    P  RP+   +   LR
Sbjct: 248 ------VAAVGFKCKRLEIP-RNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 86/177 (48%), Gaps = 11/177 (6%)
Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK 61
            A ++LD  +R++    VA  ++YLH+   PPIVHR+L S NLL+D +Y   V DFG+++
Sbjct: 129 GAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 62  FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXX 121
                  +    AGT  ++APE+       EK DVYSFGV+  E+   + P   L     
Sbjct: 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV 247
Query: 122 XXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
                 +        RL  P R++  ++ +I++    C    P  RP+   +   LR
Sbjct: 248 ------VAAVGFKCKRLEIP-RNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 76/177 (42%), Gaps = 28/177 (15%)
Query: 9   WSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL----- 63
           WSQR++  K +A  ++YLH      I+HRDL+S N L+       VADFG+A+ +     
Sbjct: 107 WSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163
Query: 64  ---------KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPR 113
                    KPD        G   ++APE+       EK DV+SFG++  E+I +     
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223
Query: 114 DFLXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
           D+L       LN    LD    P  P           S   +   C +  PE RP+ 
Sbjct: 224 DYLPRTMDFGLNVRGFLDRYCPPNCPP----------SFFPITVRCCDLDPEKRPSF 270

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 20/174 (11%)
Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK 61
           +  + L+ SQ +     V + +++L    F   +HRDL+++N L+D +    V+DFG+ +
Sbjct: 96  SHGKGLEPSQLLEMCYDVCEGMAFLESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTR 152
Query: 62  FLKPD---SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLX 117
           ++  D   SS  T+F   +   APE+ +  K + K DV++FG+L  EV   GK P D   
Sbjct: 153 YVLDDQYVSSVGTKFPVKWS--APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210
Query: 118 XXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
                  N+++ L      RL  P  +      +I ++ +SC +E PE RPT +
Sbjct: 211 -------NSEVVLKVSQGHRLYRPHLASD----TIYQIMYSCWHELPEKRPTFQ 253

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 58/106 (54%), Gaps = 3/106 (2%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           +D  Q     +    AL +LH +    ++HRD+ S N+LL ++    + DFG    + P+
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            S  +E  GT  ++APE+        K D++S G++A+E+I+G+ P
Sbjct: 170 QSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA--------HVADFGIAKFLKPDSSNW 70
           +A  ++YLH +   PI+HRDL S N+L+  + E          + DFG+A+     +   
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-- 171
Query: 71  TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIEL 130
              AG Y ++APE+      ++  DV+S+GVL  E++ G+ P           +   + +
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP---FRGIDGLAVAYGVAM 228
Query: 131 DEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           +++    LP PS   +       K+   C N  P SRP+   +  QL
Sbjct: 229 NKL---ALPIPSTCPE----PFAKLMEDCWNPDPHSRPSFTNILDQL 268

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           +D  Q     +    AL +LH +    ++HRD+ S N+LL ++    + DFG    + P+
Sbjct: 114 MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 170
Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            S  +   GT  ++APE+        K D++S G++A+E+I+G+ P
Sbjct: 171 QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           +D  Q     +    AL +LH +    ++HRD+ S N+LL ++    + DFG    + P+
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            S  +   GT  ++APE+        K D++S G++A+E+I+G+ P
Sbjct: 170 QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           +D  Q     +    AL +LH +    ++HRD+ S N+LL ++    + DFG    + P+
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            S  +   GT  ++APE+        K D++S G++A+E+I+G+ P
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 80
           AL+YLH      I++RDL   N+LLD E    + D+G+ K  L+P  +  T F GT  Y+
Sbjct: 165 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYI 220
Query: 81  APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNT-DIELDEMLDPRLP 139
           APE+          D ++ GVL  E++ G+ P D +        NT D     +L+ ++ 
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280
Query: 140 APSRSVQEKLISIVKVAFSCLNESPESR 167
            P RS+  K  S++K   S LN+ P+ R
Sbjct: 281 IP-RSLSVKAASVLK---SFLNKDPKER 304

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 18/170 (10%)
Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
           A   D  Q    +K +   L YLH +     +HRD+ + N+LL  + +  +ADFG+A  L
Sbjct: 114 AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQL 170
Query: 64  KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXX 123
                    F GT  ++APE+        K D++S G+ A+E+ KG+ P           
Sbjct: 171 TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP----------- 219
Query: 124 LNTDIELDEM--LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            N+D+    +  L P+   P+  V +   S  +   +CLN+ P  RPT K
Sbjct: 220 -NSDMHPMRVLFLIPKNNPPTL-VGDFTKSFKEFIDACLNKDPSFRPTAK 267

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 14/165 (8%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           LD +Q    ++ +   L YLH +     +HRD+ + N+LL    E  +ADFG+A  L   
Sbjct: 116 LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172
Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNT 126
                 F GT  ++APE+        K D++S G+ A+E+ +G+ P   L       L  
Sbjct: 173 QIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-- 230
Query: 127 DIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
                 +     P    +  + L   V+   +CLN+ P  RPT K
Sbjct: 231 ------IPKNNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPTAK 266

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 18/167 (10%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           LD +Q    ++ +   L YLH +     +HRD+ + N+LL    E  +ADFG+A  L   
Sbjct: 101 LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNT 126
                 F GT  ++APE+        K D++S G+ A+E+ +G+ P   L          
Sbjct: 158 QIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---- 213
Query: 127 DIELDEMLDPRLPAPS--RSVQEKLISIVKVAFSCLNESPESRPTMK 171
                  L P+   P+   +  + L   V+   +CLN+ P  RPT K
Sbjct: 214 ------FLIPKNNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPTAK 251

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 18/167 (10%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           LD +Q    ++ +   L YLH +     +HRD+ + N+LL    E  +ADFG+A  L   
Sbjct: 101 LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNT 126
                 F GT  ++APE+        K D++S G+ A+E+ +G+ P   L          
Sbjct: 158 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---- 213
Query: 127 DIELDEMLDPRLPAPS--RSVQEKLISIVKVAFSCLNESPESRPTMK 171
                  L P+   P+   +  + L   V+   +CLN+ P  RPT K
Sbjct: 214 ------FLIPKNNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPTAK 251

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 18/167 (10%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           LD +Q    ++ +   L YLH +     +HRD+ + N+LL    E  +ADFG+A  L   
Sbjct: 121 LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 177
Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNT 126
                 F GT  ++APE+        K D++S G+ A+E+ +G+ P   L          
Sbjct: 178 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---- 233
Query: 127 DIELDEMLDPRLPAPS--RSVQEKLISIVKVAFSCLNESPESRPTMK 171
                  L P+   P+   +  + L   V+   +CLN+ P  RPT K
Sbjct: 234 ------FLIPKNNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPTAK 271

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 80
           AL+YLH      I++RDL   N+LLD E    + D+G+ K  L+P  +  + F GT  Y+
Sbjct: 133 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYI 188
Query: 81  APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNT-DIELDEMLDPRLP 139
           APE+          D ++ GVL  E++ G+ P D +        NT D     +L+ ++ 
Sbjct: 189 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 248
Query: 140 APSRSVQEKLISIVKVAFSCLNESPESR 167
            P RS+  K  S++K   S LN+ P+ R
Sbjct: 249 IP-RSMSVKAASVLK---SFLNKDPKER 272

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 80
           AL+YLH      I++RDL   N+LLD E    + D+G+ K  L+P  +  + F GT  Y+
Sbjct: 122 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYI 177
Query: 81  APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNT-DIELDEMLDPRLP 139
           APE+          D ++ GVL  E++ G+ P D +        NT D     +L+ ++ 
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 237
Query: 140 APSRSVQEKLISIVKVAFSCLNESPESR 167
            P RS+  K  S++K   S LN+ P+ R
Sbjct: 238 IP-RSLSVKAASVLK---SFLNKDPKER 261

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 20/173 (11%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++FL+ +SS+ 
Sbjct: 119 QLVGMLRGIASGMRYLAEMSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP 175
Query: 71  TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           TE +   G     + APE     K T   D +S+G++  EV+  G+ P  +        +
Sbjct: 176 TETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP--YWDMSNQDVI 233
Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           N  IE D  L P    P+        S+ ++   C  +   +RP    V   L
Sbjct: 234 NA-IEQDYRLPPPPDCPT--------SLHQLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           +D  Q     +    AL +LH +    ++HR++ S N+LL ++    + DFG    + P+
Sbjct: 114 MDEGQIAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE 170
Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            S  +   GT  ++APE+        K D++S G++A+E+I+G+ P
Sbjct: 171 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 80
           AL+YLH      I++RDL   N+LLD E    + D+G+ K  L+P  +  + F GT  Y+
Sbjct: 118 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYI 173
Query: 81  APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNT-DIELDEMLDPRLP 139
           APE+          D ++ GVL  E++ G+ P D +        NT D     +L+ ++ 
Sbjct: 174 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 233
Query: 140 APSRSVQEKLISIVKVAFSCLNESPESR 167
            P RS+  K  S++K   S LN+ P+ R
Sbjct: 234 IP-RSLSVKAASVLK---SFLNKDPKER 257

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/103 (40%), Positives = 56/103 (54%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 108 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 162
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            TE  GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 163 RTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 20/173 (11%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++FL+ D+S+ 
Sbjct: 136 QLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 192
Query: 71  TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           T  +   G     + APE     K T   DV+S+G++  EV+  G+ P  +        +
Sbjct: 193 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTNQDVI 250
Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           N  IE D  L P +  PS        ++ ++   C  +    RP    +   L
Sbjct: 251 NA-IEQDYRLPPPMDCPS--------ALHQLMLDCWQKDRNHRPKFGQIVNTL 294

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 20/163 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD---SSNWTEFAG 75
           V + ++YL   C   ++HRDL+++N L+       V+DFG+ +F+  D   SS  T+F  
Sbjct: 115 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP- 170
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLXXXXXXXLNTDIELDEML 134
              + +PE+    + + K DV+SFGVL  EV  +GK P +          N+++  D   
Sbjct: 171 -VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDIST 222
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             RL  P  +       + ++   C  E PE RP    + +QL
Sbjct: 223 GFRLYKPRLASTH----VYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 20/163 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD---SSNWTEFAG 75
           V + ++YL   C   ++HRDL+++N L+       V+DFG+ +F+  D   SS  T+F  
Sbjct: 113 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP- 168
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLXXXXXXXLNTDIELDEML 134
              + +PE+    + + K DV+SFGVL  EV  +GK P +          N+++  D   
Sbjct: 169 -VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDIST 220
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             RL  P  +       + ++   C  E PE RP    + +QL
Sbjct: 221 GFRLYKPRLASTH----VYQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 20/163 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD---SSNWTEFAG 75
           V + ++YL   C   ++HRDL+++N L+       V+DFG+ +F+  D   SS  T+F  
Sbjct: 112 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP- 167
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLXXXXXXXLNTDIELDEML 134
              + +PE+    + + K DV+SFGVL  EV  +GK P +          N+++  D   
Sbjct: 168 -VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDIST 219
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             RL  P  +       + ++   C  E PE RP    + +QL
Sbjct: 220 GFRLYKPRLASTH----VYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 20/163 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD---SSNWTEFAG 75
           V + ++YL   C   ++HRDL+++N L+       V+DFG+ +F+  D   SS  T+F  
Sbjct: 110 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP- 165
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLXXXXXXXLNTDIELDEML 134
              + +PE+    + + K DV+SFGVL  EV  +GK P +          N+++  D   
Sbjct: 166 -VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDIST 217
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             RL  P  +       + ++   C  E PE RP    + +QL
Sbjct: 218 GFRLYKPRLASTH----VYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 20/163 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD---SSNWTEFAG 75
           V + ++YL   C   ++HRDL+++N L+       V+DFG+ +F+  D   SS  T+F  
Sbjct: 132 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP- 187
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLXXXXXXXLNTDIELDEML 134
              + +PE+    + + K DV+SFGVL  EV  +GK P +          N+++  D   
Sbjct: 188 -VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDIST 239
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             RL  P  +       + ++   C  E PE RP    + +QL
Sbjct: 240 GFRLYKPRLASTH----VYQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 56/103 (54%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 108 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 162
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T+  GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 163 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 56/103 (54%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 109 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 163
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T+  GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 56/103 (54%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 108 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 162
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T+  GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 163 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 23/175 (13%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           LD S     ++ V + L YLH +     +HRD+ + N+LL  +    +ADFG++ FL   
Sbjct: 118 LDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174
Query: 67  -----SSNWTEFAGTYGYVAPELAYTMKITE-KCDVYSFGVLALEVIKGKHPRDFLXXXX 120
                +     F GT  ++APE+   ++  + K D++SFG+ A+E+  G  P        
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234
Query: 121 XXXLNTDIELDEMLDPRLPAPSRSVQEKLI------SIVKVAFSCLNESPESRPT 169
              L          DP  P+    VQ+K +      S  K+   CL + PE RPT
Sbjct: 235 VLMLTLQN------DP--PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 56/103 (54%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 113 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 167
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T+  GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 168 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 23/175 (13%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           LD S     ++ V + L YLH +     +HRD+ + N+LL  +    +ADFG++ FL   
Sbjct: 113 LDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 169
Query: 67  -----SSNWTEFAGTYGYVAPELAYTMKITE-KCDVYSFGVLALEVIKGKHPRDFLXXXX 120
                +     F GT  ++APE+   ++  + K D++SFG+ A+E+  G  P        
Sbjct: 170 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 229
Query: 121 XXXLNTDIELDEMLDPRLPAPSRSVQEKLI------SIVKVAFSCLNESPESRPT 169
              L          DP  P+    VQ+K +      S  K+   CL + PE RPT
Sbjct: 230 VLMLTLQN------DP--PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 276

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 134 QRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 188
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 189 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 19/181 (10%)
Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE-----AHVADFG 58
           A  + WS ++  +  +A  + Y+ +   PPIVHRDL S N+ L    E     A VADFG
Sbjct: 116 AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 59  IAKFLKPDSSNWTEFAGTYGYVAPEL--AYTMKITEKCDVYSFGVLALEVIKGKHPRDFL 116
           ++   +    + +   G + ++APE   A     TEK D YSF ++   ++ G+ P D  
Sbjct: 175 LS---QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
Query: 117 XXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ 176
                  +N   E  E L P +P        +L +++++   C +  P+ RP    + ++
Sbjct: 232 SYGKIKFINMIRE--EGLRPTIP---EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKE 283
Query: 177 L 177
           L
Sbjct: 284 L 284

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 20/164 (12%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++FL+ +SS+ 
Sbjct: 117 QLVGMLRGIASGMRYLAEMSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP 173
Query: 71  TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           T  +   G     + APE     K T   D +S+G++  EV+  G+ P  +        +
Sbjct: 174 TYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP--YWDMSNQDVI 231
Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRP 168
           N  IE D  L P    P+        S+ ++   C  +   +RP
Sbjct: 232 NA-IEQDYRLPPPPDCPT--------SLHQLMLDCWQKDRNARP 266

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 66/136 (48%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL      ++  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 255
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 256 KFFPKARDLVEKLLVL 271

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++ +   L YLH +     +HRD+ + N+LL  + +  +ADFG+A  L         F G
Sbjct: 122 LREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVG 178
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEM-- 133
           T  ++APE+        K D++S G+ A+E+ KG+ P            N+D+    +  
Sbjct: 179 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP------------NSDLHPMRVLF 226
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           L P+   P+   Q       +   +CLN+ P  RPT K
Sbjct: 227 LIPKNSPPTLEGQHSK-PFKEFVEACLNKDPRFRPTAK 263

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 125 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 179
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 180 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 111 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 165
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 166 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 113 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 167
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 168 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 108 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 162
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 163 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 113 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 167
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 168 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L +LH      IV+RDL   N+LLD +    +ADFG+ K      +   EF GT  Y+A
Sbjct: 131 GLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIA 187
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+    K     D +SFGVL  E++ G+ P
Sbjct: 188 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ +  + + WT   G   
Sbjct: 120 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKF 174
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM- 133
              + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++ 
Sbjct: 175 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVE 226
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
              R+P P    +    S+  +   C  + PE RPT + + 
Sbjct: 227 RGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQ 263

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 87/169 (51%), Gaps = 24/169 (14%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD---S 67
           Q +   K V +A+ YL    F   +HRDL+++N L++ +    V+DFG+++++  D   S
Sbjct: 106 QLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 162
Query: 68  SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNT 126
           S  ++F   +    PE+    K + K D+++FGVL  E+   GK P +           T
Sbjct: 163 SRGSKFPVRWS--PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---------T 211
Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
           + E  E +    RL  P  +  EK+ +I+   +SC +E  + RPT KI+
Sbjct: 212 NSETAEHIAQGLRLYRPHLA-SEKVYTIM---YSCWHEKADERPTFKIL 256

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 107 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 161
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 162 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 108 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 162
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 163 RTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 111 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 165
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 166 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 16/173 (9%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           D   + L     ++    VA  ++Y+    +   +HRDL S N+L+       +ADFG+A
Sbjct: 96  DGEGRALKLPNLVDMAAQVAAGMAYIERMNY---IHRDLRSANILVGNGLICKIADFGLA 152
Query: 61  KFLKPDSSNWTEFAG-TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLXX 118
           + ++ +     + A     + APE A   + T K DV+SFG+L  E++ KG+ P   +  
Sbjct: 153 RLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN- 211
Query: 119 XXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
                 N ++        R+P P    Q+  IS+ ++   C  + PE RPT +
Sbjct: 212 ------NREVLEQVERGYRMPCP----QDCPISLHELMIHCWKKDPEERPTFE 254

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 112 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 166
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 167 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +      SS 
Sbjct: 109 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSR 163
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T  +GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 164 RTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 105 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 159
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 160 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 72/138 (52%), Gaps = 12/138 (8%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           Q +  ++G+A  + YL    +   VHR L+++N+L++      V+DFG+++FL+ D+S+ 
Sbjct: 110 QLVGMLRGIAAGMKYLADMNY---VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 166
Query: 71  TEFAGTYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           T  +   G     + APE     K T   DV+S+G++  EV+  G+ P  +        +
Sbjct: 167 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTNQDVI 224
Query: 125 NTDIELDEMLDPRLPAPS 142
           N  IE D  L P +  PS
Sbjct: 225 NA-IEQDYRLPPPMDCPS 241

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 30/172 (17%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           Q +   K V +A+ YL    F   +HRDL+++N L++ +    V+DFG+++++  D    
Sbjct: 105 QLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---- 157
Query: 71  TEFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXX 123
            E+  + G      +  PE+    K + K D+++FGVL  E+   GK P +         
Sbjct: 158 -EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------- 209
Query: 124 LNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
             T+ E  E +    RL  P  +  EK+ +I+   +SC +E  + RPT KI+
Sbjct: 210 --TNSETAEHIAQGLRLYRPHLA-SEKVYTIM---YSCWHEKADERPTFKIL 255

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 30/172 (17%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           Q +   K V +A+ YL    F   +HRDL+++N L++ +    V+DFG+++++  D    
Sbjct: 106 QLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---- 158
Query: 71  TEFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXX 123
            E+  + G      +  PE+    K + K D+++FGVL  E+   GK P +         
Sbjct: 159 -EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------- 210
Query: 124 LNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
             T+ E  E +    RL  P  +  EK+ +I+   +SC +E  + RPT KI+
Sbjct: 211 --TNSETAEHIAQGLRLYRPHLA-SEKVYTIM---YSCWHEKADERPTFKIL 256

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 119 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 233
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 234 KFFPKARDLVEKLLVL 249

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 30/172 (17%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           Q +   K V +A+ YL    F   +HRDL+++N L++ +    V+DFG+++++  D    
Sbjct: 112 QLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---- 164
Query: 71  TEFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXX 123
            E+  + G      +  PE+    K + K D+++FGVL  E+   GK P +         
Sbjct: 165 -EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------- 216
Query: 124 LNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
             T+ E  E +    RL  P  +  EK+ +I+   +SC +E  + RPT KI+
Sbjct: 217 --TNSETAEHIAQGLRLYRPHLA-SEKVYTIM---YSCWHEKADERPTFKIL 262

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 256
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 257 KFFPKARDLVEKLLVL 272

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 118 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 232
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 233 KFFPKARDLVEKLLVL 248

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/97 (40%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA---HVADFGIAKFLKPDSSNWTEFAG 75
           ++ AL YLH +    I+HRDL  +N++L    +     + D G AK L       TEF G
Sbjct: 131 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVG 186
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  Y+APEL    K T   D +SFG LA E I G  P
Sbjct: 187 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 231
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 232 KFFPKARDLVEKLLVL 247

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/97 (40%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA---HVADFGIAKFLKPDSSNWTEFAG 75
           ++ AL YLH +    I+HRDL  +N++L    +     + D G AK L       TEF G
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVG 185
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  Y+APEL    K T   D +SFG LA E I G  P
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 30/172 (17%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           Q +   K V +A+ YL    F   +HRDL+++N L++ +    V+DFG+++++  D    
Sbjct: 121 QLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---- 173
Query: 71  TEFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXX 123
            E+  + G      +  PE+    K + K D+++FGVL  E+   GK P +         
Sbjct: 174 -EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------- 225
Query: 124 LNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
             T+ E  E +    RL  P  +  EK+ +I+   +SC +E  + RPT KI+
Sbjct: 226 --TNSETAEHIAQGLRLYRPHLA-SEKVYTIM---YSCWHEKADERPTFKIL 271

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 116 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 230
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 231 KFFPKARDLVEKLLVL 246

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 19/181 (10%)
Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE-----AHVADFG 58
           A  + WS ++  +  +A  + Y+ +   PPIVHRDL S N+ L    E     A VADFG
Sbjct: 116 AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 59  IAKFLKPDSSNWTEFAGTYGYVAPEL--AYTMKITEKCDVYSFGVLALEVIKGKHPRDFL 116
            +   +    + +   G + ++APE   A     TEK D YSF ++   ++ G+ P D  
Sbjct: 175 TS---QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
Query: 117 XXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ 176
                  +N   E  E L P +P        +L +++++   C +  P+ RP    + ++
Sbjct: 232 SYGKIKFINMIRE--EGLRPTIP---EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKE 283
Query: 177 L 177
           L
Sbjct: 284 L 284

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 86/172 (50%), Gaps = 30/172 (17%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           Q +   K V +A+ YL    F   +HRDL+++N L++ +    V+DFG+++++  D    
Sbjct: 101 QLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---- 153
Query: 71  TEFAGTYG------YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXX 123
            E+  + G      +  PE+    K + K D+++FGVL  E+   GK P +         
Sbjct: 154 -EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------- 205
Query: 124 LNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
             T+ E  E +    RL  P  +  EK+ +I+   +SC +E  + RPT KI+
Sbjct: 206 --TNSETAEHIAQGLRLYRPHLA-SEKVYTIM---YSCWHEKADERPTFKIL 251

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 255
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 256 KFFPKARDLVEKLLVL 271

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 253
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 254 KFFPKARDLVEKLLVL 269

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 255
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 256 KFFPKARDLVEKLLVL 271

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 253
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 254 KFFPKARDLVEKLLVL 269

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 253
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 254 KFFPKARDLVEKLLVL 269

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 146 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 260
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 261 KFFPKARDLVEKLLVL 276

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
           AL YL +     I+HRD+   N+LLD     H+ DF IA  L P  +  T  AGT  Y+A
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITTMAGTKPYMA 182
Query: 82  PELAYTMK---ITEKCDVYSFGVLALEVIKGKHP 112
           PE+  + K    +   D +S GV A E+++G+ P
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 256
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 257 KFFPKARDLVEKLLVL 272

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 255
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 256 KFFPKARDLVEKLLVL 271

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 253
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 254 KFFPKARDLVEKLLVL 269

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 252
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 253 KFFPKARDLVEKLLVL 268

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 113 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 167
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE        EK D++S GVL  E + GK P
Sbjct: 168 RTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 123 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 237
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 238 KFFPKARDLVEKLLVL 253

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V+  + YL    F   VHRDL+++N+LL  ++ A ++DFG++K L+ D + +   A T+G
Sbjct: 120 VSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK--AQTHG 174
Query: 79  -----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDE 132
                + APE     K + K DV+SFGVL  E    G+ P   +            E+  
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------EVTA 225
Query: 133 MLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           ML+   R+  P+   +E    +  +   C     E+RP    V  +LR
Sbjct: 226 MLEKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 269

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 144 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 7/136 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             YV+PEL       +  D+++ G +  +++ G  P  F            I+L+     
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 252
Query: 137 RLPAPSRSVQEKLISI 152
           +    +R + EKL+ +
Sbjct: 253 KFFPKARDLVEKLLVL 268

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGT 76
           +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 7/99 (7%)
Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEF 73
           +T+KG    L YLH   F   +HRD+ + N+LL+ E  A +ADFG+A  L    +     
Sbjct: 133 STLKG----LEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXV 185
Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            GT  ++APE+   +      D++S G+ A+E+ +GK P
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 134 QRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 188
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             +  GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 189 RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V+  + YL    F   VHRDL+++N+LL  ++ A ++DFG++K L+ D + +   A T+G
Sbjct: 114 VSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHG 168
Query: 79  -----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDE 132
                + APE     K + K DV+SFGVL  E    G+ P   +            E+  
Sbjct: 169 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------EVTA 219
Query: 133 MLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           ML+   R+  P+   +E    +  +   C     E+RP    V  +LR
Sbjct: 220 MLEKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 263

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V+  + YL    F   VHRDL+++N+LL  ++ A ++DFG++K L+ D + +   A T+G
Sbjct: 120 VSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHG 174
Query: 79  -----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDE 132
                + APE     K + K DV+SFGVL  E    G+ P   +            E+  
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------EVTA 225
Query: 133 MLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           ML+   R+  P+   +E    +  +   C     E+RP    V  +LR
Sbjct: 226 MLEKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 269

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +A+FG +  +   SS 
Sbjct: 110 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSR 164
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 165 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 87/169 (51%), Gaps = 24/169 (14%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD---S 67
           Q +   K V +A+ YL    F   +HRDL+++N L++ +    V+DFG+++++  D   S
Sbjct: 121 QLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS 177
Query: 68  SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNT 126
           S  ++F   +    PE+    K + K D+++FGVL  E+   GK P +           T
Sbjct: 178 SVGSKFPVRWS--PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---------T 226
Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
           + E  E +    RL  P  +  EK+ +I+   +SC +E  + RPT KI+
Sbjct: 227 NSETAEHIAQGLRLYRPHLA-SEKVYTIM---YSCWHEKADERPTFKIL 271

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V+  + YL    F   VHRDL+++N+LL  ++ A ++DFG++K L+ D + +   A T+G
Sbjct: 116 VSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHG 170
Query: 79  -----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDE 132
                + APE     K + K DV+SFGVL  E    G+ P   +            E+  
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------EVTA 221
Query: 133 MLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           ML+   R+  P+   +E    +  +   C     E+RP    V  +LR
Sbjct: 222 MLEKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 265

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V+  + YL    F   VHRDL+++N+LL  ++ A ++DFG++K L+ D + +   A T+G
Sbjct: 126 VSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHG 180
Query: 79  -----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDE 132
                + APE     K + K DV+SFGVL  E    G+ P   +            E+  
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------EVTA 231
Query: 133 MLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           ML+   R+  P+   +E    +  +   C     E+RP    V  +LR
Sbjct: 232 MLEKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 275

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           +  V+  + YL    F   VHRDL+++N+LL  ++ A ++DFG++K L+ D + +   A 
Sbjct: 133 VHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQ 187
Query: 76  TYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
           T+G     + APE     K + K DV+SFGVL  E    G+ P   +            E
Sbjct: 188 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------E 238
Query: 130 LDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           +  ML+   R+  P+   +E    +  +   C     E+RP    V  +LR
Sbjct: 239 VTAMLEKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 285

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           +  V+  + YL    F   VHRDL+++N+LL  ++ A ++DFG++K L+ D + +   A 
Sbjct: 133 VHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQ 187
Query: 76  TYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
           T+G     + APE     K + K DV+SFGVL  E    G+ P   +            E
Sbjct: 188 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------E 238
Query: 130 LDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           +  ML+   R+  P+   +E    +  +   C     E+RP    V  +LR
Sbjct: 239 VTAMLEKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 285

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           +  V+  + YL    F   VHRDL+++N+LL  ++ A ++DFG++K L+ D + +   A 
Sbjct: 131 VHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQ 185
Query: 76  TYG-----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
           T+G     + APE     K + K DV+SFGVL  E    G+ P   +            E
Sbjct: 186 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------E 236
Query: 130 LDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           +  ML+   R+  P+   +E    +  +   C     E+RP    V  +LR
Sbjct: 237 VTAMLEKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 283

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +A+FG +  +   SS 
Sbjct: 111 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSR 165
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 166 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 110 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 164
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 165 RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 55/103 (53%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 111 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 165
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             +  GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 166 RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD---SSNWTEFAG 75
           V + ++YL       ++HRDL+++N L+       V+DFG+ +F+  D   SS  T+F  
Sbjct: 112 VCEGMAYLEE---ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP- 167
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLXXXXXXXLNTDIELDEML 134
              + +PE+    + + K DV+SFGVL  EV  +GK P +          N+++  D   
Sbjct: 168 -VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDIST 219
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             RL  P  +       + ++   C  E PE RP    + +QL
Sbjct: 220 GFRLYKPRLASTH----VYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 108 QRTATYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 162
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 163 RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 111 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 165
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 166 RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V+  + YL    F   VHRDL+++N+LL  ++ A ++DFG++K L+ D + +   A T+G
Sbjct: 478 VSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHG 532
Query: 79  -----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDE 132
                + APE     K + K DV+SFGVL  E    G+ P   +            E+  
Sbjct: 533 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------EVTA 583
Query: 133 MLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           ML+   R+  P+   +E    +  +   C     E+RP    V  +LR
Sbjct: 584 MLEKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 627

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V+  + YL    F   VHRDL+++N+LL  ++ A ++DFG++K L+ D + +   A T+G
Sbjct: 479 VSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHG 533
Query: 79  -----YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDE 132
                + APE     K + K DV+SFGVL  E    G+ P   +            E+  
Sbjct: 534 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---------EVTA 584
Query: 133 MLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           ML+   R+  P+   +E    +  +   C     E+RP    V  +LR
Sbjct: 585 MLEKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 628

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 108 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 162
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 163 RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V  AL YLH      I++RDL  +N+LLD      + DFG AK++ PD +      GT  
Sbjct: 115 VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVT--YXLCGTPD 168
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+  T    +  D +SFG+L  E++ G  P
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 111 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 165
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 166 RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 113 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 167
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 168 RXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 47/91 (51%), Gaps = 3/91 (3%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L +LH      IV+RDL   N+LLD +    +ADFG+ K      +    F GT  Y+A
Sbjct: 130 GLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIA 186
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+    K     D +SFGVL  E++ G+ P
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 108 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 162
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 163 RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 19/181 (10%)
Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE-----AHVADFG 58
           A  + WS ++  +  +A  + Y+ +   PPIVHRDL S N+ L    E     A VADF 
Sbjct: 116 AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFS 174
Query: 59  IAKFLKPDSSNWTEFAGTYGYVAPEL--AYTMKITEKCDVYSFGVLALEVIKGKHPRDFL 116
           ++   +    + +   G + ++APE   A     TEK D YSF ++   ++ G+ P D  
Sbjct: 175 LS---QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
Query: 117 XXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ 176
                  +N   E  E L P +P        +L +++++   C +  P+ RP    + ++
Sbjct: 232 SYGKIKFINMIRE--EGLRPTIP---EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKE 283
Query: 177 L 177
           L
Sbjct: 284 L 284

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 109 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR 163
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                GT  Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 164 RDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 112 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSR 166
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T   GT  Y+ PE+       EK D++S GVL  E + G  P
Sbjct: 167 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           ++  L +LH      I++RDL   N++LD E    +ADFG+ K    D     EF GT  
Sbjct: 129 ISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPD 185
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
           Y+APE+       +  D +++GVL  E++ G+ P D
Sbjct: 186 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 2/104 (1%)
Query: 5   QELDWSQRMNTIKGVADALSYLHH--DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF 62
           Q LD    +  +  +  AL   H   D    ++HRDL   N+ LD +    + DFG+A+ 
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 63  LKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEV 106
           L  D+S    F GT  Y++PE    M   EK D++S G L  E+
Sbjct: 166 LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA- 74
           I+ +ADA   L+      I+HRD+   N+++       V DFGIA+ +    ++ T+ A 
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 75  --GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y++PE A    +  + DVYS G +  EV+ G+ P
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA- 74
           I+ +ADA   L+      I+HRD+   N+++       V DFGIA+ +    ++ T+ A 
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 75  --GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y++PE A    +  + DVYS G +  EV+ G+ P
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA- 74
           I+ +ADA   L+      I+HRD+   N+++       V DFGIA+ +    ++ T+ A 
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 75  --GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y++PE A    +  + DVYS G +  EV+ G+ P
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 2/104 (1%)
Query: 5   QELDWSQRMNTIKGVADALSYLHH--DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF 62
           Q LD    +  +  +  AL   H   D    ++HRDL   N+ LD +    + DFG+A+ 
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 63  LKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEV 106
           L  D+S    F GT  Y++PE    M   EK D++S G L  E+
Sbjct: 166 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA- 74
           I+ +ADA   L+      I+HRD+   N+++       V DFGIA+ +    ++ T+ A 
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 75  --GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y++PE A    +  + DVYS G +  EV+ G+ P
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 60/106 (56%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL +  +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + APE     K T   DV+SFG++  EV+  G+ P
Sbjct: 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 22/161 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  ++Y+    +   VHRDL++ N+L+       VADFG+A+ +  + + +T   G   
Sbjct: 123 IASGMAYVERMNY---VHRDLAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKF 177
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM- 133
              + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++ 
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVE 229
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
              R+P P    +    S+  +   C  + PE RPT + + 
Sbjct: 230 RGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQ 266

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 28/73 (38%), Positives = 40/73 (54%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           ++HRDL   N+ LD +    + DFG+A+ L  D     EF GT  Y++PE    M   EK
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEK 196
Query: 94  CDVYSFGVLALEV 106
            D++S G L  E+
Sbjct: 197 SDIWSLGCLLYEL 209

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 3/100 (3%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA- 74
           I+ +ADA   L+      I+HRD+   N+++       V DFGIA+ +    ++ T+ A 
Sbjct: 136 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 195
Query: 75  --GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y++PE A    +  + DVYS G +  EV+ G+ P
Sbjct: 196 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 54/106 (50%), Gaps = 3/106 (2%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L+  Q     + V  AL+YLH      ++HRD+ S ++LL L+    ++DFG    +  D
Sbjct: 138 LNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 194
Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                   GT  ++APE+        + D++S G++ +E++ G+ P
Sbjct: 195 VPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ +  + + +T   G   
Sbjct: 120 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKF 174
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM- 133
              + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++ 
Sbjct: 175 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVE 226
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
              R+P P    +    S+  +   C  + PE RPT + + 
Sbjct: 227 RGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQ 263

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 18/156 (11%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ ++ +     + A    
Sbjct: 113 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPI 169
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM-LD 135
            + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++   
Sbjct: 170 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVERG 221
Query: 136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            R+P P    +    S+  +   C  + PE RPT +
Sbjct: 222 YRMPCPPECPE----SLHDLMCQCWRKEPEERPTFE 253

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ +  + + +T   G   
Sbjct: 116 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKF 170
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM- 133
              + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++ 
Sbjct: 171 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVE 222
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
              R+P P    +    S+  +   C  + PE RPT + + 
Sbjct: 223 RGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQ 259

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ ++ +     + A    
Sbjct: 123 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPI 179
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM-LD 135
            + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++   
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVERG 231
Query: 136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
            R+P P    +    S+  +   C  + PE RPT + + 
Sbjct: 232 YRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQ 266

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ +  + + +T   G   
Sbjct: 123 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKF 177
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM- 133
              + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++ 
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVE 229
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
              R+P P    +    S+  +   C  + PE RPT + + 
Sbjct: 230 RGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQ 266

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ +  + + +T   G   
Sbjct: 123 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKF 177
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM- 133
              + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++ 
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVE 229
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
              R+P P    +    S+  +   C  + PE RPT + + 
Sbjct: 230 RGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQ 266

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 73/161 (45%), Gaps = 16/161 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 120 IAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 176
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L +E++  G+ P   +        N ++        
Sbjct: 177 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-------NPEVIRALERGY 229
Query: 137 RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           R+P P    +E    +  +   C    PE RPT + +   L
Sbjct: 230 RMPRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ +  + + +T   G   
Sbjct: 123 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKF 177
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM- 133
              + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++ 
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVE 229
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
              R+P P    +    S+  +   C  + PE RPT + + 
Sbjct: 230 RGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQ 266

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A AL +LH      I++RDL  +N+LLD E    + DFG++K           F GT  
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+      T+  D +SFGVL  E++ G  P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ +  + + +T   G   
Sbjct: 123 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKF 177
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM- 133
              + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++ 
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVE 229
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
              R+P P    +    S+  +   C  + PE RPT + + 
Sbjct: 230 RGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQ 266

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ +  + + +T   G   
Sbjct: 123 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKF 177
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM- 133
              + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++ 
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVE 229
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
              R+P P    +    S+  +   C  + PE RPT + + 
Sbjct: 230 RGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQ 266

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ +  + + +T   G   
Sbjct: 123 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKF 177
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM- 133
              + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++ 
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVE 229
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
              R+P P    +    S+  +   C  + PE RPT + + 
Sbjct: 230 RGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQ 266

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A AL +LH      I++RDL  +N+LLD E    + DFG++K           F GT  
Sbjct: 136 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 192
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+      T+  D +SFGVL  E++ G  P
Sbjct: 193 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A AL +LH      I++RDL  +N+LLD E    + DFG++K           F GT  
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+      T+  D +SFGVL  E++ G  P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 28/163 (17%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ ++ +     E+    G
Sbjct: 289 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQG 340
Query: 79  ------YVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELD 131
                 + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD
Sbjct: 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LD 392
Query: 132 EM-LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
           ++    R+P P    +    S+  +   C  + PE RPT + +
Sbjct: 393 QVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYL 431

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 28/163 (17%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ ++ +     E+    G
Sbjct: 289 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQG 340
Query: 79  ------YVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELD 131
                 + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD
Sbjct: 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LD 392
Query: 132 EM-LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
           ++    R+P P    +    S+  +   C  + PE RPT + +
Sbjct: 393 QVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYL 431

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ +  + + +T   G   
Sbjct: 114 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKF 168
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM- 133
              + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++ 
Sbjct: 169 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVE 220
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
              R+P P    +    S+  +   C  + PE RPT + + 
Sbjct: 221 RGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQ 257

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ +  + + +T   G   
Sbjct: 112 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKF 166
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEM- 133
              + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD++ 
Sbjct: 167 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LDQVE 218
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
              R+P P    +    S+  +   C  + PE RPT + + 
Sbjct: 219 RGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYLQ 255

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 28/163 (17%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ ++ +     E+    G
Sbjct: 289 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQG 340
Query: 79  ------YVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELD 131
                 + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD
Sbjct: 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LD 392
Query: 132 EM-LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
           ++    R+P P    +    S+  +   C  + PE RPT + +
Sbjct: 393 QVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYL 431

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA- 74
           I+ +ADA   L+      I+HRD+   N+L+       V DFGIA+ +    ++  + A 
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAA 178
Query: 75  --GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y++PE A    +  + DVYS G +  EV+ G+ P
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 73/161 (45%), Gaps = 16/161 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 293 IAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 349
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L +E++  G+ P   +        N ++        
Sbjct: 350 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-------NPEVIRALERGY 402
Query: 137 RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           R+P P    +E    +  +   C    PE RPT + +   L
Sbjct: 403 RMPRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 28/163 (17%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ ++ +     E+    G
Sbjct: 372 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQG 423
Query: 79  ------YVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELD 131
                 + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD
Sbjct: 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LD 475
Query: 132 EM-LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
           ++    R+P P    +    S+  +   C  + PE RPT + +
Sbjct: 476 QVERGYRMPCPPECPE----SLHDLMCQCWRKEPEERPTFEYL 514

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 53/103 (51%), Gaps = 6/103 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +  +   SS 
Sbjct: 112 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSR 166
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                GT  Y+ PE+       EK D++S GVL  E + G  P
Sbjct: 167 RDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 81/182 (44%), Gaps = 25/182 (13%)
Query: 3   AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAK 61
           AA  + W   +   +GVA    YLH      ++HRDL   NLLL        + DFG A 
Sbjct: 102 AAHAMSWC--LQCSQGVA----YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 155
Query: 62  FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXX 121
            ++   ++ T   G+  ++APE+      +EKCDV+S+G++  EVI  + P D +     
Sbjct: 156 DIQ---THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 212
Query: 122 XXL-NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM----KIVSQQ 176
             +          L   LP P  S+  +          C ++ P  RP+M    KI++  
Sbjct: 213 RIMWAVHNGTRPPLIKNLPKPIESLMTR----------CWSKDPSQRPSMEEIVKIMTHL 262
Query: 177 LR 178
           +R
Sbjct: 263 MR 264

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    F   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGF---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 81/182 (44%), Gaps = 25/182 (13%)
Query: 3   AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAK 61
           AA  + W   +   +GVA    YLH      ++HRDL   NLLL        + DFG A 
Sbjct: 101 AAHAMSWC--LQCSQGVA----YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154
Query: 62  FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXX 121
            ++   ++ T   G+  ++APE+      +EKCDV+S+G++  EVI  + P D +     
Sbjct: 155 DIQ---THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211
Query: 122 XXL-NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM----KIVSQQ 176
             +          L   LP P  S+  +          C ++ P  RP+M    KI++  
Sbjct: 212 RIMWAVHNGTRPPLIKNLPKPIESLMTR----------CWSKDPSQRPSMEEIVKIMTHL 261
Query: 177 LR 178
           +R
Sbjct: 262 MR 263

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEF 73
            TI+GV     YLH++    ++HRDL   NL L+ + +  + DFG+A  ++ D     + 
Sbjct: 134 QTIQGV----QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL 186
Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            GT  Y+APE+      + + D++S G +   ++ GK P
Sbjct: 187 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+A+ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA 204
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEF 73
            TI+GV     YLH++    ++HRDL   NL L+ + +  + DFG+A  ++ D     + 
Sbjct: 150 QTIQGV----QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL 202
Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            GT  Y+APE+      + + D++S G +   ++ GK P
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-------FLKPDSS- 68
           + + +ALSY+H      I+HRDL   N+ +D      + DFG+AK        LK DS  
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 69  ------NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI 107
                 N T   GT  YVA E L  T    EK D+YS G++  E+I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-------FLKPDSS- 68
           + + +ALSY+H      I+HRDL   N+ +D      + DFG+AK        LK DS  
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 69  ------NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI 107
                 N T   GT  YVA E L  T    EK D+YS G++  E+I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 10/103 (9%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++ + +A+S+LH +    IVHRDL  +N+LLD   +  ++DFG +  L+P      E  G
Sbjct: 206 MRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELCG 261
Query: 76  TYGYVAPE-LAYTMKIT-----EKCDVYSFGVLALEVIKGKHP 112
           T GY+APE L  +M  T     ++ D+++ GV+   ++ G  P
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 24/160 (15%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+        WT       
Sbjct: 287 IAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT------- 336
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDPR 137
             APE       T K DV+SFG+L +E++  G+ P   +        N ++        R
Sbjct: 337 --APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-------NPEVIRALERGYR 387
Query: 138 LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           +P P    +E    +  +   C    PE RPT + +   L
Sbjct: 388 MPRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 28/163 (17%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A  ++Y+    +   VHRDL + N+L+       VADFG+ + ++ +     E+    G
Sbjct: 290 IASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLGRLIEDN-----EYTARQG 341
Query: 79  ------YVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELD 131
                 + APE A   + T K DV+SFG+L  E+  KG+ P   +       +N ++ LD
Sbjct: 342 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREV-LD 393
Query: 132 EM-LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
           ++    R+P P    +    S+  +   C  + PE RPT + +
Sbjct: 394 QVERGYRMPCPPECPE----SLHDLMCQCWRKDPEERPTFEYL 432

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++ +     YLH +    ++HRDL   NL L+ + E  + DFG+A  ++ D        G
Sbjct: 127 LRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCG 183
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  Y+APE+      + + DV+S G +   ++ GK P
Sbjct: 184 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++ +     YLH +    ++HRDL   NL L+ + E  + DFG+A  ++ D        G
Sbjct: 123 LRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCG 179
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  Y+APE+      + + DV+S G +   ++ GK P
Sbjct: 180 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+   + YL    +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 117 QLVGMLRGIGSGMKYLSDMSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAA 173
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + APE     K T   DV+S+G++  EV+  G+ P
Sbjct: 174 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++ +     YLH +    ++HRDL   NL L+ + E  + DFG+A  ++ D        G
Sbjct: 123 LRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCG 179
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  Y+APE+      + + DV+S G +   ++ GK P
Sbjct: 180 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 119 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 136 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 192
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 193 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+   + YL    +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 111 QLVGMLRGIGSGMKYLSDMSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAA 167
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + APE     K T   DV+S+G++  EV+  G+ P
Sbjct: 168 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 119 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLL---LDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           V DA+ YLH      IVHRDL  +NLL   LD + +  ++DFG++K   P S   T   G
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CG 180
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T GYVAPE+      ++  D +S GV+A  ++ G  P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 43/79 (54%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I++RDL   N++LD E    +ADFG+ K    D      F GT  Y+APE+       + 
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 522
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++FGVL  E++ G+ P
Sbjct: 523 VDWWAFGVLLYEMLAGQAP 541

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 50/101 (49%), Gaps = 4/101 (3%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    + D + + H      IVHRD+  +N+L+D      + DFGIAK L   S   T 
Sbjct: 114 INFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170
Query: 73  FA-GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
              GT  Y +PE A      E  D+YS G++  E++ G+ P
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLL---LDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           V DA+ YLH      IVHRDL  +NLL   LD + +  ++DFG++K   P S   T   G
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CG 180
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T GYVAPE+      ++  D +S GV+A  ++ G  P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLL---LDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           V DA+ YLH      IVHRDL  +NLL   LD + +  ++DFG++K   P S   T   G
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CG 180
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T GYVAPE+      ++  D +S GV+A  ++ G  P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEF 73
            TI+GV     YLH++    ++HRDL   NL L+ + +  + DFG+A  ++ D       
Sbjct: 150 QTIQGV----QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL 202
Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            GT  Y+APE+      + + D++S G +   ++ GK P
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEF 73
            TI+GV     YLH++    ++HRDL   NL L+ + +  + DFG+A  ++ D       
Sbjct: 150 QTIQGV----QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL 202
Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            GT  Y+APE+      + + D++S G +   ++ GK P
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 18/162 (11%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G++  + YL    +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 125 QLVGMLRGISAGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 181
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNT 126
           +T   G     + APE     K T   DV+S+G++  EV+  G+ P            N 
Sbjct: 182 YTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP-------YWEMTNQ 234
Query: 127 DIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRP 168
           D+        RLP+P     +   ++ ++   C  +   SRP
Sbjct: 235 DVIKAVEEGYRLPSP----MDCPAALYQLMLDCWQKERNSRP 272

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 7/97 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLL---LDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           V DA+ YLH      IVHRDL  +NLL   LD + +  ++DFG++K   P S   T   G
Sbjct: 125 VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CG 180
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T GYVAPE+      ++  D +S GV+A  ++ G  P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 43/79 (54%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I++RDL   N++LD E    +ADFG+ K    D      F GT  Y+APE+       + 
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 201
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++FGVL  E++ G+ P
Sbjct: 202 VDWWAFGVLLYEMLAGQAP 220

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++ +     YLH +    ++HRDL   NL L+ + E  + DFG+A  ++ D        G
Sbjct: 147 LRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 203
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  Y+APE+      + + DV+S G +   ++ GK P
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+ + L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 146 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 202
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 203 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++ +     YLH +    ++HRDL   NL L+ + E  + DFG+A  ++ D        G
Sbjct: 145 LRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 201
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  Y+APE+      + + DV+S G +   ++ GK P
Sbjct: 202 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++ +     YLH +    ++HRDL   NL L+ + E  + DFG+A  ++ D        G
Sbjct: 121 LRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 177
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  Y+APE+      + + DV+S G +   ++ GK P
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 91/179 (50%), Gaps = 23/179 (12%)
Query: 1   DAAAQELDWS----QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVAD 56
           DA   ELD      Q     + + +AL++LH      I+HRDL + N+L+ LE +  +AD
Sbjct: 96  DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLAD 152
Query: 57  FGI-AKFLKPDSSNWTEFAGTYGYVAPELAY--TMKITE---KCDVYSFGVLALEVIKGK 110
           FG+ AK LK        F GT  ++APE+    TMK T    K D++S G+  +E+ + +
Sbjct: 153 FGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 211
Query: 111 HPRDFLXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            P   L       +   +++ +   P L  PS+   E     +K+A   L+++PE+RP+
Sbjct: 212 PPHHEL-----NPMRVLLKIAKSDPPTLLTPSKWSVE-FRDFLKIA---LDKNPETRPS 261

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 91/179 (50%), Gaps = 23/179 (12%)
Query: 1   DAAAQELDWS----QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVAD 56
           DA   ELD      Q     + + +AL++LH      I+HRDL + N+L+ LE +  +AD
Sbjct: 104 DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLAD 160
Query: 57  FGI-AKFLKPDSSNWTEFAGTYGYVAPELAY--TMKITE---KCDVYSFGVLALEVIKGK 110
           FG+ AK LK        F GT  ++APE+    TMK T    K D++S G+  +E+ + +
Sbjct: 161 FGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
Query: 111 HPRDFLXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            P   L       +   +++ +   P L  PS+   E     +K+A   L+++PE+RP+
Sbjct: 220 PPHHEL-----NPMRVLLKIAKSDPPTLLTPSKWSVE-FRDFLKIA---LDKNPETRPS 269

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 124 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 178
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 179 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 231
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 232 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 268

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH +    +V+RDL  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 257 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 314
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH +    +V+RDL  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 260 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 317
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 318 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 120 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 174
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 175 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 227
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 228 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +   L +LH      I++RDL  +N+LLD +    ++D G+A  LK   +    +AGT G
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           ++APEL    +     D ++ GV   E+I  + P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 133 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 187
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 188 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 240
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 241 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 277

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +   L +LH      I++RDL  +N+LLD +    ++D G+A  LK   +    +AGT G
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           ++APEL    +     D ++ GV   E+I  + P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +   L +LH      I++RDL  +N+LLD +    ++D G+A  LK   +    +AGT G
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           ++APEL    +     D ++ GV   E+I  + P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +   L +LH      I++RDL  +N+LLD +    ++D G+A  LK   +    +AGT G
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           ++APEL    +     D ++ GV   E+I  + P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 125 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 179
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 180 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 232
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 233 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 122 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 176
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 177 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 229
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 230 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 266

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT-EFAGTY 77
           V+  + YL    F   VHRDL+++N+LL   + A ++DFG++K L  D S +T   AG +
Sbjct: 119 VSMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 78  --GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
              + APE     K + + DV+S+GV   E +  G+ P
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 120 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 174
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 175 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 227
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 228 -DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V  ALSYLH+     ++HRD+ S ++LL  +    ++DFG    +  +        GT  
Sbjct: 150 VLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPY 206
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           ++APE+   +    + D++S G++ +E+I G+ P
Sbjct: 207 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 125 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 179
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 180 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 232
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 233 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 125 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 179
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 180 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 232
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 233 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 120 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 174
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 175 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 227
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 228 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 122 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 176
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 177 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 229
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 230 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 266

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 120 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 174
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 175 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 227
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 228 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 125 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 179
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 180 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 232
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 233 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 120 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 174
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 175 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 227
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 228 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 120 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 174
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 175 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 227
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 228 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++GV   + YL    +   VHRDL+++N+L+D      V+DFG+++ L+ D  + 
Sbjct: 152 QLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNT 126
           +T   G     + APE       +   DV+SFGV+  EV+  G+ P            N 
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP-------YWNMTNR 261
Query: 127 DIELDEMLDPRLPAP 141
           D+        RLPAP
Sbjct: 262 DVISSVEEGYRLPAP 276

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLD-LEYEA--HVADFGIAKFLKPDSSNWTE 72
           IK V   ++YLH      IVHRDL  +NLLL+  E +A   + DFG++   + +     E
Sbjct: 142 IKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKE 197
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y+APE+    K  EKCDV+S GV+   ++ G  P
Sbjct: 198 RLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH +    +V+RDL  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 117 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE 174
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 175 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH +    +V+RDL  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 119 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE 176
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 177 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 2/94 (2%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH +    +V+RDL  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 118 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE 175
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+   T  AG   
Sbjct: 125 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKF 179
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 180 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 232
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 233 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 50/100 (50%), Gaps = 5/100 (5%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
            + +  A+ Y H      IVHRDL ++NLLLD +    +ADFG +       +   EF G
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDEFCG 174
Query: 76  TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 114
           +  Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+   T  AG   
Sbjct: 121 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKF 175
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 176 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 228
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 229 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 265

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 21/164 (12%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  + YL       +VHRDL+++N+L+       + DFG+A+ L+ D   +  
Sbjct: 120 LNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 176
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E  +  K T + DV+S+GV   E++  G  P D +            E
Sbjct: 177 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---------E 227
Query: 130 LDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           + ++L+   RLP P        I +  V   C     +SRP  K
Sbjct: 228 IPDLLEKGERLPQPPICT----IDVYMVMVKCWMIDADSRPKFK 267

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+   + YL        VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 132 QLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAA 188
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + APE     K T   DV+S+G++  EV+  G+ P
Sbjct: 189 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL +LH      I++RDL   N+LLD E    +ADFG+ K    +      F GT  
Sbjct: 133 IISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPD 189
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+   M      D ++ GVL  E++ G  P
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK--PDSS 68
           Q +  ++GV   + YL    +   VHRDL+++N+L+D      V+DFG+++ L+  PD++
Sbjct: 152 QLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208
Query: 69  NWTEFAGT-YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNT 126
             T        + APE       +   DV+SFGV+  EV+  G+ P            N 
Sbjct: 209 XTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP-------YWNMTNR 261
Query: 127 DIELDEMLDPRLPAP 141
           D+        RLPAP
Sbjct: 262 DVISSVEEGYRLPAP 276

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 21/164 (12%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  + YL       +VHRDL+++N+L+       + DFG+A+ L+ D   +  
Sbjct: 143 LNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 199
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E  +  K T + DV+S+GV   E++  G  P D +            E
Sbjct: 200 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---------E 250
Query: 130 LDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           + ++L+   RLP P        I +  V   C     +SRP  K
Sbjct: 251 IPDLLEKGERLPQPPICT----IDVYMVMVKCWMIDADSRPKFK 290

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+++ ++ D  + 
Sbjct: 146 QLVGMLRGIAAGMRYLADMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAV 202
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + APE     K T   DV+S+G++  EV+  G+ P
Sbjct: 203 YTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLL---DLEYEAHVADFGIAKFLKPDSSNWTE 72
           I+ V DA+ YLH      IVHRDL  +NLL    D E +  ++DFG++K ++      + 
Sbjct: 126 IRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMST 181
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT GYVAPE+      ++  D +S GV+A  ++ G  P
Sbjct: 182 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
            V  ALS LH      ++HRD+ S ++LL  +    ++DFG    +  +        GT 
Sbjct: 255 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTP 311
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            ++APEL   +    + D++S G++ +E++ G+ P
Sbjct: 312 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 124 IAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 180
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 181 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 231
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 232 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 263

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 7/106 (6%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-SSN 69
           Q +  ++G+A  + YL        VHRDL+++N+L++      V+DFG+++ L+ D  + 
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 70  WTEFAGT--YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +T   G     + +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 126 IAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 182
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 183 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 233
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 234 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 265

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 127 IAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 183
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 184 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 234
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 235 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 266

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 121 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKF 175
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 176 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 228
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 229 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 265

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 4/95 (4%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V   L+YL       I+HRD+   N+L++   E  + DFG++  L  + +N  EF GT  
Sbjct: 116 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN--EFVGTRS 171
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPR 113
           Y++PE       + + D++S G+  +E+  G++PR
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPR 206

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 50/106 (47%), Gaps = 18/106 (16%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-------FLKPDSS- 68
           + + +ALSY+H      I+HR+L   N+ +D      + DFG+AK        LK DS  
Sbjct: 123 RQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 69  ------NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI 107
                 N T   GT  YVA E L  T    EK D YS G++  E I
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 118 IAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 174
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 225
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 226 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 257

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 119 IAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 175
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 176 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 226
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 227 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 258

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 120 IAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 176
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 177 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 227
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 228 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 259

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 122 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAKF 176
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 177 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 229
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 230 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 266

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE---YEAHVADFGIAKFLKPDSSNWTE 72
           ++ +  A+S++H      +VHRDL  +NLL   E    E  + DFG A+   PD+     
Sbjct: 112 MRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
              T  Y APEL       E CD++S GV+   ++ G+ P
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 31/164 (18%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH----VADFGIAKFLKPDSSNWT 71
           +K + +AL+Y H      +VH+DL  +N+L   +   H    + DFG+A+  K D  + T
Sbjct: 130 MKQMMNALAYFHSQ---HVVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKSDEHS-T 184
Query: 72  EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELD 131
             AGT  Y+APE+ +   +T KCD++S GV+   ++ G  P             T   L+
Sbjct: 185 NAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCLPF------------TGTSLE 231
Query: 132 EML------DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           E+       +P      R +  + + ++K     L + PE RP+
Sbjct: 232 EVQQKATYKEPNYAVECRPLTPQAVDLLK---QMLTKDPERRPS 272

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I++RDL  +N+LLD E    + DFG++K           F GT  Y+APE+      +  
Sbjct: 151 IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHS 210
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D +S+GVL  E++ G  P
Sbjct: 211 ADWWSYGVLMFEMLTGSLP 229

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 118 IAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI 174
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 225
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 226 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 257

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 3/97 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA---HVADFGIAKFLKPDSSNWTEFAG 75
           +   L  ++H     IVHRDL  +NLLL  + +     +ADFG+A  ++ D   W  FAG
Sbjct: 109 IQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAG 168
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T GY++PE+       +  D+++ GV+   ++ G  P
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK-PDSSNWTEFAGTY 77
           +   + YLH      I+HRDL+  NLLL       +ADFG+A  LK P   ++T   GT 
Sbjct: 121 IITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTP 176
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
            Y++PE+A       + DV+S G +   ++ G+ P D
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HR+L+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 327 ISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 381
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 382 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 434
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 435 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 471

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 59/103 (57%), Gaps = 8/103 (7%)
Query: 14  NTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEA---HVADFGIAKFLKPDSSN 69
           + I  + ++++++H HD    IVHRDL  +NLLL  + +     +ADFG+A  ++ +   
Sbjct: 134 HCIHQILESVNHIHQHD----IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQA 189
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           W  FAGT GY++PE+       +  D+++ GV+   ++ G  P
Sbjct: 190 WFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 3/97 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA---HVADFGIAKFLKPDSSNWTEFAG 75
           +   L  ++H     IVHRDL  +NLLL  + +     +ADFG+A  ++ D   W  FAG
Sbjct: 109 IQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAG 168
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T GY++PE+       +  D+++ GV+   ++ G  P
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V  ALS LH      ++HRD+ S ++LL  +    ++DFG    +  +        GT  
Sbjct: 179 VLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 235
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           ++APEL   +    + D++S G++ +E++ G+ P
Sbjct: 236 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
            V  ALS LH      ++HRD+ S ++LL  +    ++DFG    +  +        GT 
Sbjct: 133 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTP 189
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            ++APEL   +    + D++S G++ +E++ G+ P
Sbjct: 190 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSS--NWTEFA 74
           VA  + YL    F   VHRDL+++N +LD ++   VADFG+A+  + K   S  N T   
Sbjct: 141 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAK 197
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
            V  ALS LH      ++HRD+ S ++LL  +    ++DFG    +  +        GT 
Sbjct: 135 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTP 191
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            ++APEL   +    + D++S G++ +E++ G+ P
Sbjct: 192 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 124 IAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 180
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 181 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 231
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 232 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 263

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA---HVADFGIAKFLKPDSSNW 70
           + I+ + +A+ + H      +VHRDL  +NLLL  + +     +ADFG+A  ++ D   W
Sbjct: 107 HCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW 163
Query: 71  TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             FAGT GY++PE+       +  D+++ GV+   ++ G  P
Sbjct: 164 FGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 25/163 (15%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           VA  + YL    F   VHRDL+++N +LD  +   VADFG+A+ +  D   ++     + 
Sbjct: 133 VARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHRHA 188
Query: 79  -----YVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLXXXXXXXLNTDIELDE 132
                + A E   T + T K DV+SFGVL  E++ +G  P   +            +L  
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI---------DPFDLTH 239
Query: 133 ML--DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
            L    RLP P         S+ +V   C    P  RPT +++
Sbjct: 240 FLAQGRRLPQPEYCPD----SLYQVMQQCWEADPAVRPTFRVL 278

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 128 IAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 184
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 185 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 235
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 236 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 267

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 123 IAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 179
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 180 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 230
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 231 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 262

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HR+L+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 366 ISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKF 420
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L+   EL E 
Sbjct: 421 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEK 473
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 474 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 510

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH      +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 119 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 175
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH      +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 60/112 (53%), Gaps = 7/112 (6%)
Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           +E+  S     +  V+  + YL    F   VHR+L+++N+LL   + A ++DFG++K L 
Sbjct: 431 EEIPVSNVAELLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALG 487
Query: 65  PDSSNWT-EFAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
            D S +T   AG +   + APE     K + + DV+S+GV   E +  G+ P
Sbjct: 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 58/100 (58%), Gaps = 7/100 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA---HVADFGIAKFLKPDSSNWTE 72
           I+ + ++++Y H +    IVHR+L  +NLLL  + +     +ADFG+A  +  DS  W  
Sbjct: 134 IQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHG 189
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           FAGT GY++PE+      ++  D+++ GV+   ++ G  P
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
            V  ALS LH      ++HRD+ S ++LL  +    ++DFG    +  +        GT 
Sbjct: 124 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTP 180
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            ++APEL   +    + D++S G++ +E++ G+ P
Sbjct: 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 118 IAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 225
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 226 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 257

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+   T  AG   
Sbjct: 118 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKF 172
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L     L++ 
Sbjct: 173 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYEL-----LEK- 225
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 226 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 262

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH      +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 113 IAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 169
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 170 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 220
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 221 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 252

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 62/120 (51%), Gaps = 15/120 (12%)
Query: 5   QELDWSQR----MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL--DLEYEAHVADFG 58
           + LD+ QR     N ++ +  AL YLH+     I HRD+  +N L   +  +E  + DFG
Sbjct: 159 ESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFG 215
Query: 59  IAK-FLKPDSSNW---TEFAGTYGYVAPELAYTMK--ITEKCDVYSFGVLALEVIKGKHP 112
           ++K F K ++  +   T  AGT  +VAPE+  T       KCD +S GVL   ++ G  P
Sbjct: 216 LSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+   T  AG   
Sbjct: 118 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKF 172
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L     L++ 
Sbjct: 173 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYEL-----LEK- 225
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 226 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 262

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH      +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH      +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH      +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 117 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 173
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 174 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YLH      +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T ++ +ADAL Y H      ++HRD+  +NLL+  + E  +ADFG +  +   S  
Sbjct: 114 QRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLR 168
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
                GT  Y+ PE+       EK D++  GVL  E + G  P D
Sbjct: 169 RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 22/162 (13%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 118 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--FTAHAGAKF 172
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEM 133
              + APE LAY  K + K DV++FGVL  E+   G  P   +       L     L++ 
Sbjct: 173 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYEL-----LEK- 225
Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
            D R+  P     EK+  +++   +C   +P  RP+   + Q
Sbjct: 226 -DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 262

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 11  QRMNT-IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  T ++ +ADAL Y H      ++HRD+  +NLL+  + E  +ADFG +  +   S  
Sbjct: 115 QRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLR 169
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
                GT  Y+ PE+       EK D++  GVL  E + G  P D
Sbjct: 170 RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE---YEAHVADFGIAKFLKPDSSNW 70
           N +K +   + YLH      IVHRD+  +N+LL+ +       + DFG++ F   D    
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-L 205
Query: 71  TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            +  GT  Y+APE+    K  EKCDV+S GV+   ++ G  P
Sbjct: 206 RDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 7/102 (6%)
Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA---HVADFGIAKFLKPDSSNW 70
           + I+ + ++++Y H +    IVHR+L  +NLLL  + +     +ADFG+A  +  DS  W
Sbjct: 109 HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAW 164
Query: 71  TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             FAGT GY++PE+      ++  D+++ GV+   ++ G  P
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----SNWTEFA 74
           VA  + YL    F   VHRDL+++N +LD ++   VADFG+A+ +         N T   
Sbjct: 160 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 216
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 217 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----SNWTEFA 74
           VA  + YL    F   VHRDL+++N +LD ++   VADFG+A+ +         N T   
Sbjct: 161 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 217
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 218 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----SNWTEFA 74
           VA  + YL    F   VHRDL+++N +LD ++   VADFG+A+ +         N T   
Sbjct: 142 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----SNWTEFA 74
           VA  + YL    F   VHRDL+++N +LD ++   VADFG+A+ +         N T   
Sbjct: 134 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 190
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 191 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
            V  ALS LH      ++HRD+ S ++LL  +    ++DFG    +  +        GT 
Sbjct: 128 AVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTP 184
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            ++APEL   +    + D++S G++ +E++ G+ P
Sbjct: 185 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 7/102 (6%)
Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA---HVADFGIAKFLKPDSSNW 70
           + I+ + ++++Y H +    IVHR+L  +NLLL  + +     +ADFG+A  +  DS  W
Sbjct: 108 HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAW 163
Query: 71  TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             FAGT GY++PE+      ++  D+++ GV+   ++ G  P
Sbjct: 164 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----SNWTEFA 74
           VA  + YL    F   VHRDL+++N +LD ++   VADFG+A+ +         N T   
Sbjct: 139 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 195
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 7/102 (6%)
Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA---HVADFGIAKFLKPDSSNW 70
           + I+ + ++++Y H +    IVHR+L  +NLLL  + +     +ADFG+A  +  DS  W
Sbjct: 109 HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAW 164
Query: 71  TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             FAGT GY++PE+      ++  D+++ GV+   ++ G  P
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++Y+    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 119 IAEGMAYIERKNY---IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI 175
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  GK P            N D+        
Sbjct: 176 KWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIP-------YPGRTNADVMTALSQGY 228
Query: 137 RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
           R+P    +  ++L  I+K+   C  E  E RPT 
Sbjct: 229 RMPR-VENCPDELYDIMKM---CWKEKAEERPTF 258

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 5/97 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  A+ Y H      IVHRDL ++NLLLD +    +ADFG +            F G+  
Sbjct: 120 IVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDTFCGSPP 175
Query: 79  YVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 114
           Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 176 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 5/91 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGT 76
           +A  + YL       +VHR+L+++N+LL    +  VADFG+A  L PD     ++E    
Sbjct: 142 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 198
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
             ++A E  +  K T + DV+S+GV   E++
Sbjct: 199 IKWMALESIHFGKYTHQSDVWSYGVTVWELM 229

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----SNWTEFA 74
           VA  + YL    F   VHRDL+++N +LD ++   VADFG+A+ +         N T   
Sbjct: 142 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++       E A    
Sbjct: 118 IAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPI 174
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 225
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 226 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 257

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----SNWTEFA 74
           VA  + YL    F   VHRDL+++N +LD ++   VADFG+A+ +         N T   
Sbjct: 141 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 197
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----SNWTEFA 74
           VA  + YL    F   VHRDL+++N +LD ++   VADFG+A+ +         N T   
Sbjct: 140 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 196
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----SNWTEFA 74
           VA  + YL    F   VHRDL+++N +LD ++   VADFG+A+ +         N T   
Sbjct: 137 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 17/155 (10%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAG 75
           VA+ + YL    F   +HRDL+++NLLL       + DFG+ + L  +  ++        
Sbjct: 124 VAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEML 134
            + + APE   T   +   D + FGV   E+   G+ P  ++       L+   +  E  
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE-- 236
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
             RLP P    Q+    I  V   C    PE RPT
Sbjct: 237 --RLPRPEDCPQD----IYNVMVQCWAHKPEDRPT 265

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 1/79 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           IV+RDL  +N+LLD      ++D G+A  + P+        GT GY+APE+    + T  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ G L  E+I G+ P
Sbjct: 366 PDWWALGCLLYEMIAGQSP 384

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 1/79 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           IV+RDL  +N+LLD      ++D G+A  + P+        GT GY+APE+    + T  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMAPEVVKNERYTFS 365
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ G L  E+I G+ P
Sbjct: 366 PDWWALGCLLYEMIAGQSP 384

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 5/91 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGT 76
           +A  + YL       +VHR+L+++N+LL    +  VADFG+A  L PD     ++E    
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
             ++A E  +  K T + DV+S+GV   E++
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELM 211

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 5/100 (5%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
            + +  A+ Y H      IVHRDL ++NLLLD +    +ADFG +       +    F G
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCG 174
Query: 76  TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 114
           +  Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 5/100 (5%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
            + +  A+ Y H      IVHRDL ++NLLLD +    +ADFG +       +    F G
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCG 174
Query: 76  TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 114
           +  Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 5/100 (5%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
            + +  A+ Y H      IVHRDL ++NLLLD +    +ADFG +       +    F G
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCG 174
Query: 76  TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 114
           +  Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 47/99 (47%), Gaps = 5/99 (5%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT 76
           + +  A+ Y H      IVHRDL ++NLLLD +    +ADFG +            F G 
Sbjct: 121 RQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFCGA 176
Query: 77  YGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 114
             Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT 76
           + +  A+ Y H      IVHRDL ++NLLLD +    +ADFG +       +    F G+
Sbjct: 121 RQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTV-GNKLDTFCGS 176
Query: 77  YGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 114
             Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 7/146 (4%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           ++ AL +LH      I++RDL  +N++L+ +    + DFG+ K    D +    F GT  
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDPRL 138
           Y+APE+          D +S G L  +++ G  P  F        ++  ++    L P L
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP--FTGENRKKTIDKILKCKLNLPPYL 244
Query: 139 PAPSRSVQEKLISIVKVAFSCLNESP 164
              +R + +KL+   + A S L   P
Sbjct: 245 TQEARDLLKKLLK--RNAASRLGAGP 268

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 17/155 (10%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAG 75
           VA+ + YL    F   +HRDL+++NLLL       + DFG+ + L  +  ++        
Sbjct: 120 VAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEML 134
            + + APE   T   +   D + FGV   E+   G+ P  ++       L+   +  E  
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE-- 232
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
             RLP P    Q+    I  V   C    PE RPT
Sbjct: 233 --RLPRPEDCPQD----IYNVMVQCWAHKPEDRPT 261

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 24/161 (14%)
Query: 18  GVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT 76
           G    L+YLH H+    ++HRD+ + N+LL       + DFG A  + P +     F GT
Sbjct: 162 GALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGT 213
Query: 77  YGYVAPELAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEM 133
             ++APE+   M   +   K DV+S G+  +E+ + K P           +N    L  +
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--------LFNMNAMSALYHI 265
Query: 134 LDPRLPA-PSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
                PA  S    E   + V    SCL + P+ RPT +++
Sbjct: 266 AQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVL 303

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 5/100 (5%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
            + +  A+ Y H      IVHRDL ++NLLLD +    +ADFG +       +    F G
Sbjct: 112 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCG 167
Query: 76  TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 114
           +  Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 168 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 7/146 (4%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           ++ AL +LH      I++RDL  +N++L+ +    + DFG+ K    D +    F GT  
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDPRL 138
           Y+APE+          D +S G L  +++ G  P  F        ++  ++    L P L
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP--FTGENRKKTIDKILKCKLNLPPYL 244
Query: 139 PAPSRSVQEKLISIVKVAFSCLNESP 164
              +R + +KL+   + A S L   P
Sbjct: 245 TQEARDLLKKLLK--RNAASRLGAGP 268

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 153 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 257

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 17/155 (10%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAG 75
           VA+ + YL    F   +HRDL+++NLLL       + DFG+ + L  +  ++        
Sbjct: 124 VAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEML 134
            + + APE   T   +   D + FGV   E+   G+ P  ++       L+   +  E  
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE-- 236
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
             RLP P    Q+    I  V   C    PE RPT
Sbjct: 237 --RLPRPEDCPQD----IYNVMVQCWAHKPEDRPT 265

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 17/155 (10%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAG 75
           VA+ + YL    F   +HRDL+++NLLL       + DFG+ + L  +  ++        
Sbjct: 130 VAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEML 134
            + + APE   T   +   D + FGV   E+   G+ P  ++       L+   +  E  
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE-- 242
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
             RLP P    Q+    I  V   C    PE RPT
Sbjct: 243 --RLPRPEDCPQD----IYNVMVQCWAHKPEDRPT 271

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 36/161 (22%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            LS+LH      ++HRD+  +N+LL    E  + DFG++  L         F GT  ++A
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 82  PELAYTMKITE-----KCDVYSFGVLALEVIKGK------HPRDFLXXXXXXXLNTDIEL 130
           PE+    +  +     K D++S G+ A+E+ +G       HP   L              
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------------- 243
Query: 131 DEMLDPRLPAP---SRSVQEKLISIVKVAFSCLNESPESRP 168
              L PR PAP   S+   +K  S ++   SCL ++   RP
Sbjct: 244 --FLIPRNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRP 279

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 17/155 (10%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAG 75
           VA+ + YL    F   +HRDL+++NLLL       + DFG+ + L  +  ++        
Sbjct: 120 VAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEML 134
            + + APE   T   +   D + FGV   E+   G+ P  ++       L+   +  E  
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE-- 232
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
             RLP P    Q+    I  V   C    PE RPT
Sbjct: 233 --RLPRPEDCPQD----IYNVMVQCWAHKPEDRPT 261

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 239

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 57/116 (49%), Gaps = 15/116 (12%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDC--------FPPIVHRDLSSKNLLLDLEYEAHVADFG 58
           + W++  +  + ++  LSYLH D          P I HRD  SKN+LL  +  A +ADFG
Sbjct: 109 ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFG 168
Query: 59  IAKFLKPDS--SNWTEFAGTYGYVAPE-----LAYTMKITEKCDVYSFGVLALEVI 107
           +A   +P     +     GT  Y+APE     + +      + D+Y+ G++  E++
Sbjct: 169 LAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 24/161 (14%)
Query: 18  GVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT 76
           G    L+YLH H+    ++HRD+ + N+LL       + DFG A  + P +     F GT
Sbjct: 123 GALQGLAYLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGT 174
Query: 77  YGYVAPELAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEM 133
             ++APE+   M   +   K DV+S G+  +E+ + K P           +N    L  +
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP--------LFNMNAMSALYHI 226
Query: 134 LDPRLPA-PSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
                PA  S    E   + V    SCL + P+ RPT +++
Sbjct: 227 AQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVL 264

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 141 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 245

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 239

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 14/117 (11%)
Query: 4   AQELDWSQRMNTIKGVADALSYLHHDC-------FPPIVHRDLSSKNLLLDLEYEAHVAD 56
           A  + W++  +  + +A  L+YLH D         P I HRD+ SKN+LL     A +AD
Sbjct: 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 57  FGIA-KFLKPDSSNWTEF-AGTYGYVAPE-----LAYTMKITEKCDVYSFGVLALEV 106
           FG+A KF    S+  T    GT  Y+APE     + +      + D+Y+ G++  E+
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 131 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 235

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 131 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 235

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 239

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 153 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 257

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 14/104 (13%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA--KFLKPDSSNWTEFA 74
           +  A  + YLH      I+HRDL S N+ L  +    + DFG+A  K     S  + + +
Sbjct: 138 RQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 194
Query: 75  GTYGYVAPELAYTMKITEK------CDVYSFGVLALEVIKGKHP 112
           G+  ++APE+   +++ +K       DVY+FG++  E++ G+ P
Sbjct: 195 GSILWMAPEV---IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 14/104 (13%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA--KFLKPDSSNWTEFA 74
           +  A  + YLH      I+HRDL S N+ L  +    + DFG+A  K     S  + + +
Sbjct: 131 RQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS 187
Query: 75  GTYGYVAPELAYTMKITEK------CDVYSFGVLALEVIKGKHP 112
           G+  ++APE+   +++ +K       DVY+FG++  E++ G+ P
Sbjct: 188 GSILWMAPEV---IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 14/104 (13%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA--KFLKPDSSNWTEFA 74
           +  A  + YLH      I+HRDL S N+ L  +    + DFG+A  K     S  + + +
Sbjct: 139 RQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS 195
Query: 75  GTYGYVAPELAYTMKITEK------CDVYSFGVLALEVIKGKHP 112
           G+  ++APE+   +++ +K       DVY+FG++  E++ G+ P
Sbjct: 196 GSILWMAPEV---IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 138 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 242

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 139 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 243

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 130 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 234

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 14/104 (13%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA--KFLKPDSSNWTEFA 74
           +  A  + YLH      I+HRDL S N+ L  +    + DFG+A  K     S  + + +
Sbjct: 139 RQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 195
Query: 75  GTYGYVAPELAYTMKITEK------CDVYSFGVLALEVIKGKHP 112
           G+  ++APE+   +++ +K       DVY+FG++  E++ G+ P
Sbjct: 196 GSILWMAPEV---IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 3/94 (3%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A AL YLH      IV+RDL  +N+LLD +    + DFG+ K     +S  + F GT  
Sbjct: 148 IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE 204
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+ +        D +  G +  E++ G  P
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 5/100 (5%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
            + +  A+ Y H      IVHRDL ++NLLLD +    +ADFG +       +    F G
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDAFCG 174
Query: 76  TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 114
              Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 14/104 (13%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA--KFLKPDSSNWTEFA 74
           +  A  + YLH      I+HRDL S N+ L  +    + DFG+A  K     S  + + +
Sbjct: 113 RQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 169
Query: 75  GTYGYVAPELAYTMKITEK------CDVYSFGVLALEVIKGKHP 112
           G+  ++APE+   +++ +K       DVY+FG++  E++ G+ P
Sbjct: 170 GSILWMAPEV---IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA- 60
           A+  + +  + ++  +  A  + YLH      I+HRDL S N+ L  +    + DFG+A 
Sbjct: 100 ASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 156
Query: 61  -KFLKPDSSNWTEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHP 112
            K     S  + + +G+  ++APE+         + + DVY+FG++  E++ G+ P
Sbjct: 157 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++++    +   +HR+L + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 114 IAEGMAFIEERNY---IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 170
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K DV+SFG+L  E++  G+ P   +         T+ E+ + L+ 
Sbjct: 171 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---------TNPEVIQNLER 221
Query: 137 --RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
             R+  P  +  E+L  ++++   C  E PE RPT 
Sbjct: 222 GYRMVRPD-NCPEELYQLMRL---CWKERPEDRPTF 253

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL---KPDS-SNWTEFA 74
           VA  + +L    F   VHRDL+++N +LD ++   VADFG+A+ +   + DS  N T   
Sbjct: 143 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAK 199
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL---KPDS-SNWTEFA 74
           VA  + +L    F   VHRDL+++N +LD ++   VADFG+A+ +   + DS  N T   
Sbjct: 143 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 199
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 62/118 (52%), Gaps = 17/118 (14%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGIAK 61
           LD    +  +  +A  L++LH + F     P I HRDL SKN+L+    +  +AD G+A 
Sbjct: 131 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA- 189
Query: 62  FLKPDSSNWTEFA-----GTYGYVAPE-LAYTMKIT-----EKCDVYSFGVLALEVIK 108
            +   S+N  +       GT  Y+APE L  T+++      ++ D+++FG++  EV +
Sbjct: 190 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 247

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 14/104 (13%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA--KFLKPDSSNWTEFA 74
           +  A  + YLH      I+HRDL S N+ L  +    + DFG+A  K     S  + + +
Sbjct: 111 RQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS 167
Query: 75  GTYGYVAPELAYTMKITEK------CDVYSFGVLALEVIKGKHP 112
           G+  ++APE+   +++ +K       DVY+FG++  E++ G+ P
Sbjct: 168 GSILWMAPEV---IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 14/104 (13%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA--KFLKPDSSNWTEFA 74
           +  A  + YLH      I+HRDL S N+ L  +    + DFG+A  K     S  + + +
Sbjct: 111 RQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 75  GTYGYVAPELAYTMKITEK------CDVYSFGVLALEVIKGKHP 112
           G+  ++APE+   +++ +K       DVY+FG++  E++ G+ P
Sbjct: 168 GSILWMAPEV---IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL---KPDS-SNWTEFA 74
           VA  + +L    F   VHRDL+++N +LD ++   VADFG+A+ +   + DS  N T   
Sbjct: 201 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 14/104 (13%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA--KFLKPDSSNWTEFA 74
           +  A  + YLH      I+HRDL S N+ L  +    + DFG+A  K     S  + + +
Sbjct: 116 RQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 75  GTYGYVAPELAYTMKITEK------CDVYSFGVLALEVIKGKHP 112
           G+  ++APE+   +++ +K       DVY+FG++  E++ G+ P
Sbjct: 173 GSILWMAPEV---IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL---KPDS-SNWTEFA 74
           VA  + +L    F   VHRDL+++N +LD ++   VADFG+A+ +   + DS  N T   
Sbjct: 140 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 196
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 8/108 (7%)
Query: 10  SQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           SQ     K   DAL+YLH +    I+HRDL + N+L  L+ +  +ADFG++         
Sbjct: 135 SQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 191
Query: 70  WTEFAGTYGYVAPELAYTMKITE-----KCDVYSFGVLALEVIKGKHP 112
              F GT  ++APE+       +     K DV+S G+  +E+ + + P
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 14/104 (13%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA--KFLKPDSSNWTEFA 74
           +  A  + YLH      I+HRDL S N+ L  +    + DFG+A  K     S  + + +
Sbjct: 111 RQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 75  GTYGYVAPELAYTMKITEK------CDVYSFGVLALEVIKGKHP 112
           G+  ++APE+   +++ +K       DVY+FG++  E++ G+ P
Sbjct: 168 GSILWMAPEV---IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 62/118 (52%), Gaps = 17/118 (14%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGIAK 61
           LD    +  +  +A  L++LH + F     P I HRDL SKN+L+    +  +AD G+A 
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA- 160
Query: 62  FLKPDSSNWTEFA-----GTYGYVAPE-LAYTMKIT-----EKCDVYSFGVLALEVIK 108
            +   S+N  +       GT  Y+APE L  T+++      ++ D+++FG++  EV +
Sbjct: 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 62/118 (52%), Gaps = 17/118 (14%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGIAK 61
           LD    +  +  +A  L++LH + F     P I HRDL SKN+L+    +  +AD G+A 
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA- 160
Query: 62  FLKPDSSNWTEFA-----GTYGYVAPE-LAYTMKIT-----EKCDVYSFGVLALEVIK 108
            +   S+N  +       GT  Y+APE L  T+++      ++ D+++FG++  EV +
Sbjct: 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 14/104 (13%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA--KFLKPDSSNWTEFA 74
           +  A  + YLH      I+HRDL S N+ L  +    + DFG+A  K     S  + + +
Sbjct: 116 RQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 75  GTYGYVAPELAYTMKITEK------CDVYSFGVLALEVIKGKHP 112
           G+  ++APE+   +++ +K       DVY+FG++  E++ G+ P
Sbjct: 173 GSILWMAPEV---IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL---KPDS-SNWTEFA 74
           VA  + +L    F   VHRDL+++N +LD ++   VADFG+A+ +   + DS  N T   
Sbjct: 142 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 8/108 (7%)
Query: 10  SQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           SQ     K   DAL+YLH +    I+HRDL + N+L  L+ +  +ADFG++         
Sbjct: 135 SQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 70  WTEFAGTYGYVAPELAYTMKITE-----KCDVYSFGVLALEVIKGKHP 112
              F GT  ++APE+       +     K DV+S G+  +E+ + + P
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA- 60
           A+  + +  + ++  +  A  + YLH      I+HRDL S N+ L  +    + DFG+A 
Sbjct: 112 ASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 168
Query: 61  -KFLKPDSSNWTEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHP 112
            K     S  + + +G+  ++APE+         + + DVY+FG++  E++ G+ P
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL---KPDS-SNWTEFA 74
           VA  + +L    F   VHRDL+++N +LD ++   VADFG+A+ +   + DS  N T   
Sbjct: 142 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 8/108 (7%)
Query: 10  SQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           SQ     K   DAL+YLH +    I+HRDL + N+L  L+ +  +ADFG++         
Sbjct: 135 SQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 70  WTEFAGTYGYVAPELAYTMKITE-----KCDVYSFGVLALEVIKGKHP 112
              F GT  ++APE+       +     K DV+S G+  +E+ + + P
Sbjct: 192 RDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL---KPDS-SNWTEFA 74
           VA  + +L    F   VHRDL+++N +LD ++   VADFG+A+ +   + DS  N T   
Sbjct: 147 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 203
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++A E   T K T K DV+SFGVL  E++    P
Sbjct: 204 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/116 (26%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA- 60
           A+  + +  + ++  +  A  + YLH      I+HRDL S N+ L  +    + DFG+A 
Sbjct: 112 ASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 168
Query: 61  -KFLKPDSSNWTEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHP 112
            K     S  + + +G+  ++APE+         + + DVY+FG++  E++ G+ P
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 48/100 (48%), Gaps = 5/100 (5%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
            + +  A+ Y H      IVHRDL ++NLLLD +    +ADFG +       +    F G
Sbjct: 119 FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEF-TFGNKLDAFCG 174
Query: 76  TYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRD 114
              Y APEL    K    + DV+S GV+   ++ G  P D
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K   + WT   GT  Y+A
Sbjct: 174 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GATWT-LCGTPEYLA 227
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 22/173 (12%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  +SYL       +VHRDL+++N+L+       + DFG+A+ L  D + +  
Sbjct: 122 LNWCMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 178
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E     + T + DV+S+GV   E++  G  P D +            E
Sbjct: 179 DGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---------E 229
Query: 130 LDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK-IVSQQLRI 179
           + ++L+   RLP P        I +  +   C     E RP  + +VS+  R+
Sbjct: 230 IPDLLEKGERLPQPPICT----IDVYMIMVKCWMIDSECRPRFRELVSEFSRM 278

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTE 72
           I+ V   ++Y+H +    IVHRDL  +NLLL+ + +     + DFG++   +  S    +
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKD 187
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y+APE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 188 KIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 10/90 (11%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           V +A+ YL  + F   VHRDL+++N+L+  +  A V+DFG+ K      ++ T+  G   
Sbjct: 111 VCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLP 162
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEV 106
             + APE     K + K DV+SFG+L  E+
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEI 192

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 10/90 (11%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           V +A+ YL  + F   VHRDL+++N+L+  +  A V+DFG+ K      ++ T+  G   
Sbjct: 126 VCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLP 177
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
             + APE     K + K DV+SFG+L  E+
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEI 207

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTE 72
           I+ V   ++Y+H +    IVHRDL  +NLLL+ + +     + DFG++   +  S    +
Sbjct: 155 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKD 210
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y+APE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 211 KIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 249

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 166 IHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 225
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 226 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPE--- 275
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 276 -MYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTE 72
           I+ V   ++Y+H +    IVHRDL  +NLLL+ + +     + DFG++   +  S    +
Sbjct: 156 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKD 211
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y+APE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 212 KIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 250

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 10/90 (11%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           V +A+ YL  + F   VHRDL+++N+L+  +  A V+DFG+ K      ++ T+  G   
Sbjct: 298 VCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLP 349
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
             + APE     K + K DV+SFG+L  E+
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEI 379

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTE 72
           I+ V   ++Y+H +    IVHRDL  +NLLL+ + +     + DFG++   +  S    +
Sbjct: 138 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKD 193
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y+APE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 194 KIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 232

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 230 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 279
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 280 -MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 57/115 (49%), Gaps = 10/115 (8%)
Query: 3   AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF 62
           A  EL  SQ ++    +A  + YL    F   VHRDL+++N L+       + DFG+++ 
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRD 182
Query: 63  LKPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
           +   S+++    G       ++ PE     K T + DV+SFGV+  E+   GK P
Sbjct: 183 VY--STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     WT   GT  Y+APE+  +    + 
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPEYLAPEIILSKGYNKA 204
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 205 VDWWALGVLIYEMAAGYPP 223

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     WT   GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPEYLAPEIILSKGYNKA 219
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 172 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 231
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 232 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 281
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 282 -MYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 161 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 220
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 221 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 270
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 271 -MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 230 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 279
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 280 -MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 10/92 (10%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 139 ISSAMEYLEKKNF---IHRDLAARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKF 193
Query: 77  -YGYVAPE-LAYTMKITEKCDVYSFGVLALEV 106
              + APE LAY    + K DV++FGVL  E+
Sbjct: 194 PIKWTAPESLAYN-TFSIKSDVWAFGVLLWEI 224

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG-TY 77
           +A+ ++Y+    +   +HRDL + N+L+       +ADFG+A+ ++ +     E A    
Sbjct: 118 IAEGMAYIERKNY---IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI 174
Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP 136
            + APE       T K +V+SFG+L  E++  GK P            N D+        
Sbjct: 175 KWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIP-------YPGRTNADVMSALSQGY 227
Query: 137 RLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           R+P    +  ++L  I+K+   C  E  E RPT
Sbjct: 228 RMPR-MENCPDELYDIMKM---CWKEKAEERPT 256

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 17/155 (10%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAG 75
           VA+ + YL    F   +HRDL+++NLLL       + DFG+ + L  +  +         
Sbjct: 120 VAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 176
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEML 134
            + + APE   T   +   D + FGV   E+   G+ P  ++       L+   +  E  
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE-- 232
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
             RLP P    Q+    I  V   C    PE RPT
Sbjct: 233 --RLPRPEDCPQD----IYNVMVQCWAHKPEDRPT 261

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 17/155 (10%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAG 75
           VA+ + YL    F   +HRDL+++NLLL       + DFG+ + L  +  +         
Sbjct: 130 VAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 186
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEML 134
            + + APE   T   +   D + FGV   E+   G+ P  ++       L+   +  E  
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGE-- 242
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
             RLP P    Q+    I  V   C    PE RPT
Sbjct: 243 --RLPRPEDCPQD----IYNVMVQCWAHKPEDRPT 271

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 21/183 (11%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           D A   L   Q +     VA  + YL    F   VHRDL+++N L+       + DFG++
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 61  KFLKPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDF 115
           + +   S+++    G       ++ PE     K T + DV+SFGV+  E+   GK P  +
Sbjct: 206 RDIY--STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--W 261
Query: 116 LXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
                   ++   +  E+  PR   P          +  +   C    P+ R ++K V  
Sbjct: 262 YQLSNTEAIDCITQGRELERPRACPP---------EVYAIMRGCWQREPQQRHSIKDVHA 312
Query: 176 QLR 178
           +L+
Sbjct: 313 RLQ 315

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W   AGT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LAGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 161 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 220
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 221 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 270
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 271 -MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 21/183 (11%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           D A   L   Q +     VA  + YL    F   VHRDL+++N L+       + DFG++
Sbjct: 126 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMS 182
Query: 61  KFLKPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDF 115
           + +   S+++    G       ++ PE     K T + DV+SFGV+  E+   GK P  +
Sbjct: 183 RDIY--STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--W 238
Query: 116 LXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
                   ++   +  E+  PR   P          +  +   C    P+ R ++K V  
Sbjct: 239 YQLSNTEAIDCITQGRELERPRACPP---------EVYAIMRGCWQREPQQRHSIKDVHA 289
Query: 176 QLR 178
           +L+
Sbjct: 290 RLQ 292

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 21/183 (11%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           D A   L   Q +     VA  + YL    F   VHRDL+++N L+       + DFG++
Sbjct: 120 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMS 176
Query: 61  KFLKPDSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDF 115
           + +   S+++    G       ++ PE     K T + DV+SFGV+  E+   GK P  +
Sbjct: 177 RDIY--STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--W 232
Query: 116 LXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
                   ++   +  E+  PR   P          +  +   C    P+ R ++K V  
Sbjct: 233 YQLSNTEAIDCITQGRELERPRACPP---------EVYAIMRGCWQREPQQRHSIKDVHA 283
Query: 176 QLR 178
           +L+
Sbjct: 284 RLQ 286

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 166 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 225
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 226 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 275
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 276 -MYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 275 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 324
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 325 -MYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 222 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 281
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 282 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 331
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 332 -MYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 266
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 267 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 316
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 317 -MYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 213 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 272
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 273 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 322
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 323 -MYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA---HVADFGIAKFLKPDSSNW 70
           + I+ + +A+ + H      +VHRDL  +NLLL  + +     +ADFG+A  ++ +   W
Sbjct: 125 HCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 181
Query: 71  TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             FAGT GY++PE+       +  D+++ GV+   ++ G  P
Sbjct: 182 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+  +  PD     +      ++APE  +    T 
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 279
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 280 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 329
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 330 -MYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLK--PDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 230 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 279
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 280 -MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLK--PDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 230 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 279
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 280 -MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLK--PDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 230 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 279
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 280 -MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLK--PDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 161 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 220
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 221 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 270
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 271 -MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA-GTYGY 79
           D++  LH+      VHRD+   N+LLD+     +ADFG    +  D +  +  A GT  Y
Sbjct: 189 DSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 242
Query: 80  VAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHP 112
           ++PE+   M     K   +CD +S GV   E++ G+ P
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLK--PDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 161 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 220
Query: 93  KCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML--DPRLPAPSRSVQEKLI 150
           + DV+SFGVL  E+         L       +  D E    L    R+ AP  +  E   
Sbjct: 221 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 270
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + +    C +  P  RPT   + + L
Sbjct: 271 -MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLD---LEYEAHVADFGIAKFLKPDSSNWTE 72
           IK V   ++Y+H      IVHRDL  +N+LL+    + +  + DFG++   + ++    +
Sbjct: 127 IKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKD 182
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y+APE+       EKCDV+S GV+   ++ G  P
Sbjct: 183 RIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V   L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  
Sbjct: 123 VLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRS 178
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE       + + D++S G+  +E+  G++P
Sbjct: 179 YMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA-GTYGY 79
           D++  LH+      VHRD+   N+L+D+     +ADFG    L  D +  +  A GT  Y
Sbjct: 189 DSVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242
Query: 80  VAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHP 112
           ++PE+   M     +   +CD +S GV   E++ G+ P
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    VADFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    VADFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    VADFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    VADFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA-GTYGY 79
           D++  LH+      VHRD+   N+LLD+     +ADFG    +  D +  +  A GT  Y
Sbjct: 205 DSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 258
Query: 80  VAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHP 112
           ++PE+   M     K   +CD +S GV   E++ G+ P
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 24/160 (15%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V   L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  
Sbjct: 132 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRS 187
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLD--- 135
           Y++PE       + + D++S G+  +E+  G++P            +  + + E+LD   
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP--------IGSGSGSMAIFELLDYIV 239
Query: 136 ----PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
               P+LP+   S++ +          CL ++P  R  +K
Sbjct: 240 NEPPPKLPSGVFSLEFQ-----DFVNKCLIKNPAERADLK 274

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 25/152 (16%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAK--FLKPDSSNWTEFAGTYGYVAPELAYTMKITE 92
           +HRDL+++N+LL       + DFG+A+  +  PD     +      ++APE  +    + 
Sbjct: 221 IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYST 280
Query: 93  KCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDPRL------PAPSRSV 145
           K DV+S+GVL  E+   G  P               +++DE    RL       AP  S 
Sbjct: 281 KSDVWSYGVLLWEIFSLGGSP------------YPGVQMDEDFCSRLREGMRMRAPEYST 328
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    I ++   C +  P+ RP    + ++L
Sbjct: 329 PE----IYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 3/84 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPELAYTMKI- 90
           I HRD+  +NLLLD      ++DFG+A   + ++      +  GT  YVAPEL    +  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 91  TEKCDVYSFGVLALEVIKGKHPRD 114
            E  DV+S G++   ++ G+ P D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT- 76
           VA  +++L   +C    +HRDL+++N+LL       + DFG+A+ +K DS+   +     
Sbjct: 177 VAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL 232
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLD 135
              ++APE  +    T + DV+S+G+   E+         L       +  D +  +M+ 
Sbjct: 233 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIK 285
Query: 136 P--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
              R+ +P  +  E +  I+K   +C +  P  RPT K + Q
Sbjct: 286 EGFRMLSPEHAPAE-MYDIMK---TCWDADPLKRPTFKQIVQ 323

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTE 72
           I+ V   ++Y H +    IVHRDL  +NLLL+ + +     + DFG++   +  S    +
Sbjct: 132 IRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKXKD 187
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y+APE+ +     EKCDV+S GV+   ++ G  P
Sbjct: 188 KIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 9/107 (8%)
Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           Q LDW  +      +  AL ++H      I+HRD+ S+N+ L  +    + DFGIA+ L 
Sbjct: 126 QILDWFVQ------ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKH 111
                     GT  Y++PE+        K D+++ G +  E+   KH
Sbjct: 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 51/100 (51%), Gaps = 8/100 (8%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTE 72
           +K V    +YLH      IVHRDL  +NLLL+ +       + DFG++   +       E
Sbjct: 110 MKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGKMKE 165
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y+APE+    K  EKCDV+S GV+   ++ G  P
Sbjct: 166 RLGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 10/90 (11%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           V +A+ YL  + F   VHRDL+++N+L+  +  A V+DFG+ K      ++ T+  G   
Sbjct: 117 VCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLP 168
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEV 106
             + APE       + K DV+SFG+L  E+
Sbjct: 169 VKWTAPEALREAAFSTKSDVWSFGILLWEI 198

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V   L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  
Sbjct: 175 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRS 230
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y++PE       + + D++S G+  +E+  G++P
Sbjct: 231 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 72/162 (44%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A+ ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 117 LNWCVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 173
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 174 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 230
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 231 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 264

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V   L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  
Sbjct: 140 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRS 195
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y++PE       + + D++S G+  +E+  G++P
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 1/76 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVIKG 109
            D++S GV+  E+IKG
Sbjct: 206 VDIWSVGVIMGEMIKG 221

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL---EYEAHVADFGIAKFLKPDSSNW 70
           + +K + +A++YLH +    IVHRDL  +NLL      +    +ADFG++K ++      
Sbjct: 152 DAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 71  TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T   GT GY APE+        + D++S G++   ++ G  P
Sbjct: 209 T-VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 51/100 (51%), Gaps = 8/100 (8%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTE 72
           +K V    +YLH      IVHRDL  +NLLL+ +       + DFG++   +       E
Sbjct: 127 MKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGKMKE 182
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y+APE+    K  EKCDV+S GV+   ++ G  P
Sbjct: 183 RLGTAYYIAPEVL-RKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 41/76 (53%), Gaps = 1/76 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVIKG 109
            D++S GV+  E+IKG
Sbjct: 206 VDIWSVGVIMGEMIKG 221

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 19/182 (10%)
Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK 61
           A A+ +D  + +     +   + YL    +   +HRDL+++N+L++ E    + DFG+ K
Sbjct: 109 AHAERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTK 165
Query: 62  FLKPDSSNWT---EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI----KGKH-PR 113
            L  D               + APE     K +   DV+SFGV+  E+     K K  P 
Sbjct: 166 VLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 225
Query: 114 DFLXXXXXXXLNTDI--ELDEML--DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           +F+           I   L E+L  + RLP P     E    I  +   C N +   RP+
Sbjct: 226 EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMIMTECWNNNVNQRPS 281
Query: 170 MK 171
            +
Sbjct: 282 FR 283

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLD---LEYEAHVADFGIAKFLKPDSSNWTE 72
           IK V   ++Y+H      IVHRDL  +N+LL+    + +  + DFG++   + ++    +
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKD 182
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y+APE+       EKCDV+S GV+   ++ G  P
Sbjct: 183 RIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V   L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  
Sbjct: 113 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRS 168
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y++PE       + + D++S G+  +E+  G++P
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V   L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  
Sbjct: 113 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRS 168
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y++PE       + + D++S G+  +E+  G++P
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLD---LEYEAHVADFGIAKFLKPDSSNWTE 72
           IK V   ++Y+H      IVHRDL  +N+LL+    + +  + DFG++   + ++    +
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKD 182
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y+APE+       EKCDV+S GV+   ++ G  P
Sbjct: 183 RIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V   L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  
Sbjct: 113 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRS 168
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y++PE       + + D++S G+  +E+  G++P
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V   L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  
Sbjct: 113 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRS 168
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y++PE       + + D++S G+  +E+  G++P
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           V   L+YL       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  
Sbjct: 113 VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRS 168
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y++PE       + + D++S G+  +E+  G++P
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 148 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 201
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 52/110 (47%), Gaps = 5/110 (4%)
Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
            LD  +     + +   + Y H      +VHRDL  +N+LLD    A +ADFG++  +  
Sbjct: 112 RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS- 167
Query: 66  DSSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
           D        G+  Y APE ++  +    + D++S GV+   ++ G  P D
Sbjct: 168 DGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LXGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 211
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 212 VDWWALGVLIYEMAAGYPP 230

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 211
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 212 VDWWALGVLIYEMAAGYPP 230

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 56/102 (54%), Gaps = 6/102 (5%)
Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA---HVADFGIAKFLKPDSSNW 70
           + I+ + +A+ + H      +VHR+L  +NLLL  + +     +ADFG+A  ++ +   W
Sbjct: 114 HCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 71  TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             FAGT GY++PE+       +  D+++ GV+   ++ G  P
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAG 75
           + + ++YLH   +   +HRDL+++N+LLD +    + DFG+AK +      +    +   
Sbjct: 143 ICEGMAYLHAQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDS 199
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVI-----KGKHPRDFLXXXXXXXLN-TDIE 129
              + APE     K     DV+SFGV   E++         P  FL          T + 
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 130 LDEMLD--PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           L E+L+   RLP P +   E    +  +  +C       RPT +
Sbjct: 260 LTELLERGERLPRPDKCPAE----VYHLMKNCWETEASFRPTFE 299

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 65/155 (41%), Gaps = 11/155 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL ++H      ++HRD+   N+ +       + D G+ +F    ++      GT  
Sbjct: 145 LCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 201
Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDPRL 138
           Y++PE  +      K D++S G L  E+   + P  +        L   IE  +      
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEQCDY----P 256
Query: 139 PAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
           P PS    E+L  +V +   C+N  PE RP +  V
Sbjct: 257 PLPSDHYSEELRQLVNM---CINPDPEKRPDVTYV 288

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 239
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 240 VDWWALGVLIYEMAAGYPP 258

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 174 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 227
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 45/98 (45%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA----HVADFGIAKFLKPDSSNWTEFA 74
           +   + YLH      +VHRDL   N+L   E        + DFG AK L+ ++       
Sbjct: 130 IGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC 186
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T  +VAPE+       E CD++S G+L   ++ G  P
Sbjct: 187 YTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           + ++Y H      ++HRDL  +NLL++ E E  +ADFG+A+        +T    T  Y 
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYR 167
Query: 81  APE-LAYTMKITEKCDVYSFGVLALEVIKG 109
           AP+ L  + K +   D++S G +  E++ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           + ++Y H      ++HRDL  +NLL++ E E  +ADFG+A+        +T    T  Y 
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYR 167
Query: 81  APE-LAYTMKITEKCDVYSFGVLALEVIKG 109
           AP+ L  + K +   D++S G +  E++ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 11  QRMNTI-KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN 69
           QR  TI + +ADAL Y H      ++HRD+  +NLLL L+ E  +ADFG +  +   S  
Sbjct: 123 QRTATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLR 177
Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                GT  Y+ PE+       EK D++  GVL  E++ G  P
Sbjct: 178 RKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 121 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 178 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 234
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 235 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 268

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 122 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 235
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 236 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 269

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 122 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 235
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 236 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 269

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 121 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 178 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 234
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 235 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 268

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 120 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 233
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 234 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 267

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 120 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 233
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 234 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 267

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT- 76
           VA  +++L   +C    +HRDL+++N+LL       + DFG+A+ +K DS+   +     
Sbjct: 154 VAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLD 135
              ++APE  +    T + DV+S+G+   E+         L       +  D +  +M+ 
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIK 262
Query: 136 P--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
              R+ +P  +  E +  I+K   +C +  P  RPT K + Q
Sbjct: 263 EGFRMLSPEHAPAE-MYDIMK---TCWDADPLKRPTFKQIVQ 300

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT- 76
           VA  +++L   +C    +HRDL+++N+LL       + DFG+A+ +K DS+   +     
Sbjct: 170 VAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 225
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLD 135
              ++APE  +    T + DV+S+G+   E+         L       +  D +  +M+ 
Sbjct: 226 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIK 278
Query: 136 P--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
              R+ +P  +  E +  I+K   +C +  P  RPT K + Q
Sbjct: 279 EGFRMLSPEHAPAE-MYDIMK---TCWDADPLKRPTFKQIVQ 316

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 24/159 (15%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL +LH      ++HRD+   N+L++   +  + DFGI+ +L  DS   T  AG   
Sbjct: 162 IVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DSVAKTIDAGCKP 218
Query: 79  YVAPEL--------AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIEL 130
           Y+APE          Y++    K D++S G+  +E+   + P D              ++
Sbjct: 219 YMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFPYD----SWGTPFQQLKQV 270
Query: 131 DEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            E   P+LPA   S +      V     CL ++ + RPT
Sbjct: 271 VEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPT 304

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT- 76
           VA  +++L   +C    +HRDL+++N+LL       + DFG+A+ +K DS+   +     
Sbjct: 177 VAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 232
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLD 135
              ++APE  +    T + DV+S+G+   E+         L       +  D +  +M+ 
Sbjct: 233 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIK 285
Query: 136 P--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
              R+ +P  +  E +  I+K   +C +  P  RPT K + Q
Sbjct: 286 EGFRMLSPEHAPAE-MYDIMK---TCWDADPLKRPTFKQIVQ 323

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NL++D +    V DFG+AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGLAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 140 TFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 193
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 123 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 180 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 236
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 237 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 270

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 127 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 240
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 241 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 274

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 120 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 233
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 234 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 267

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 126 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 182
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 183 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 239
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 240 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 273

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 123 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 180 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 236
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 237 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 270

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 127 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 240
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 241 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 274

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 124 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 180
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 181 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 237
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 238 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 271

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 154 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 210
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 211 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 267
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 268 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 301

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 127 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 240
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 241 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 274

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 123 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 180 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 236
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 237 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 270

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 114 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 171 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 227
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 228 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 261

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL--KPDSSNW--TEFAGTY 77
            L Y+H      ++HRDL   NLL++   E  + DFG+A+ L   P    +  TE+  T 
Sbjct: 171 GLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 78  GYVAPELAYTM-KITEKCDVYSFGVLALEVI 107
            Y APEL  ++ + T+  D++S G +  E++
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEML 258

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 45/98 (45%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA----HVADFGIAKFLKPDSSNWTEFA 74
           +   + YLH      +VHRDL   N+L   E        + DFG AK L+ ++       
Sbjct: 130 IGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC 186
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T  +VAPE+       E CD++S G+L   ++ G  P
Sbjct: 187 YTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT- 76
           VA  +++L   +C    +HRDL+++N+LL       + DFG+A+ +K DS+   +     
Sbjct: 172 VAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 227
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLD 135
              ++APE  +    T + DV+S+G+   E+         L       +  D +  +M+ 
Sbjct: 228 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIK 280
Query: 136 P--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
              R+ +P  +  E +  I+K   +C +  P  RPT K + Q
Sbjct: 281 EGFRMLSPEHAPAE-MYDIMK---TCWDADPLKRPTFKQIVQ 318

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITE 92
           I+HRDL  +NLL++ +    +ADFG+A+       ++T    T  Y AP+ L  + K + 
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST 199
Query: 93  KCDVYSFGVLALEVIKGK 110
             D++S G +  E+I GK
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITE 92
           I+HRDL  +NLL++ +    +ADFG+A+       ++T    T  Y AP+ L  + K + 
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYST 199
Query: 93  KCDVYSFGVLALEVIKGK 110
             D++S G +  E+I GK
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 120 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 233
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 234 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 267

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLL++   +  + DFG+A+   P+  +    TE   
Sbjct: 153 ILRGLKYIHS---ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 257

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 8/100 (8%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA--HVADFGIAKFLKPDSSNWTEFA 74
           K + + L YLH +    IVHRD+   N+L++  Y     ++DFG +K L   +     F 
Sbjct: 129 KQILEGLKYLHDN---QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFT 184
Query: 75  GTYGYVAPEL--AYTMKITEKCDVYSFGVLALEVIKGKHP 112
           GT  Y+APE+         +  D++S G   +E+  GK P
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 51/108 (47%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +     E   
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 51/108 (47%), Gaps = 13/108 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAG 75
           +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +     E   
Sbjct: 138 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 76  TYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIK------GKHPRDFL 116
           T  Y APE+    K  T+  D++S G +  E++       GKH  D L
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 242

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 145 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 201
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 202 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 258
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 259 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 292

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           + ++Y H      ++HRDL  +NLL++ E E  +ADFG+A+        +T    T  Y 
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 81  APE-LAYTMKITEKCDVYSFGVLALEVIKG 109
           AP+ L  + K +   D++S G +  E++ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  A+ Y H      +VHRDL  +N+LLD    A +ADFG++  +  D     +  G+  
Sbjct: 120 ILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRDSCGSPN 175
Query: 79  YVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
           Y APE ++  +    + D++S GV+   ++ G  P D
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL--KPDSSNW--TEFAGTY 77
            L Y+H      ++HRDL   NLL++   E  + DFG+A+ L   P    +  TE+  T 
Sbjct: 170 GLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 78  GYVAPELAYTM-KITEKCDVYSFGVLALEVI 107
            Y APEL  ++ + T+  D++S G +  E++
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NL++D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
           A+ Y H      IVHRDL  +NLLLD      +ADFG++  +  D +      G+  Y A
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAA 175
Query: 82  PE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
           PE +   +    + DV+S G++   ++ G+ P D
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NL++D +    V DFG+AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGLAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           IKG+     YLH   +  I+HRD+   NLL+  +    +ADFG++   K   +  +   G
Sbjct: 147 IKGI----EYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVG 199
Query: 76  TYGYVAPE-LAYTMKI--TEKCDVYSFGVLALEVIKGKHP 112
           T  ++APE L+ T KI   +  DV++ GV     + G+ P
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 120 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 233
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 234 KGE----RLPQPPICT----IDVYMIMRKCWMIDADSRPKFR 267

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 20/165 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA---- 74
           + + ++YLH   +   +HR L+++N+LLD +    + DFG+AK + P+   +        
Sbjct: 120 ICEGMAYLHAQHY---IHRALAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGD 175
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVI------KGKHPRDFLXXXXXXXLNTDI 128
               + APE     K     DV+SFGV   E++      +  H +            T +
Sbjct: 176 SPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVL 235
Query: 129 ELDEMLD--PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            L E+L+   RLP P R   E    I  +  +C       RPT +
Sbjct: 236 RLTELLERGERLPRPDRCPCE----IYHLMKNCWETEASFRPTFQ 276

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 130 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 186
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 187 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 243
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 244 KGE----RLPQPPICT----IDVYMIMRKCWMIDADSRPKFR 277

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/104 (25%), Positives = 50/104 (48%), Gaps = 4/104 (3%)
Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
            ++LD    +   + +   + Y+H      ++HRDL   N+ L    +  + DFG+   L
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 64  KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
           K D    T   GT  Y++PE   +    ++ D+Y+ G++  E++
Sbjct: 187 KNDGKR-TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 20/165 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA---- 74
           + + ++YLH   +   +HR L+++N+LLD +    + DFG+AK + P+   +        
Sbjct: 121 ICEGMAYLHAQHY---IHRALAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGD 176
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVI------KGKHPRDFLXXXXXXXLNTDI 128
               + APE     K     DV+SFGV   E++      +  H +            T +
Sbjct: 177 SPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVL 236
Query: 129 ELDEMLD--PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            L E+L+   RLP P R   E    I  +  +C       RPT +
Sbjct: 237 RLTELLERGERLPRPDRCPCE----IYHLMKNCWETEASFRPTFQ 277

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  ++  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  +   +  
Sbjct: 123 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 180 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 236
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 237 KGE----RLPQPPICT----IDVYMIMRKCWMIDADSRPKFR 270

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 8/100 (8%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA--HVADFGIAKFLKPDSSNWTEFA 74
           K + + L YLH +    IVHRD+   N+L++  Y     ++DFG +K L   +     F 
Sbjct: 115 KQILEGLKYLHDN---QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFT 170
Query: 75  GTYGYVAPEL--AYTMKITEKCDVYSFGVLALEVIKGKHP 112
           GT  Y+APE+         +  D++S G   +E+  GK P
Sbjct: 171 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 15/154 (9%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           VHRDL+++N+L++ E    +ADFG+AK L  D   +           + APE       +
Sbjct: 136 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 195
Query: 92  EKCDVYSFGVLALEVI----KGKHPR-DFLXXXXXXX---LNTDIELDEMLDPRLPAPSR 143
            + DV+SFGV+  E+     K   P  +FL            + +        RLPAP  
Sbjct: 196 RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPA 255
Query: 144 SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
              E +  ++K+   C   SP+ RP+   +  QL
Sbjct: 256 CPAE-VHELMKL---CWAPSPQDRPSFSALGPQL 285

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NL++D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NL++D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 8/100 (8%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLL---DLEYEAHVADFGIAKFLKPDSSNWTE 72
           I+ V  A+ YLH +    IVHRDL  +NLL    +   +  + DFG++K     +   + 
Sbjct: 112 IQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMST 166
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT GYVAPE+      ++  D +S GV+   ++ G  P
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 15/154 (9%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           VHRDL+++N+L++ E    +ADFG+AK L  D   +           + APE       +
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 208
Query: 92  EKCDVYSFGVLALEVI----KGKHPR-DFLXXXXXXX---LNTDIELDEMLDPRLPAPSR 143
            + DV+SFGV+  E+     K   P  +FL            + +        RLPAP  
Sbjct: 209 RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPA 268
Query: 144 SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
              E +  ++K+   C   SP+ RP+   +  QL
Sbjct: 269 CPAE-VHELMKL---CWAPSPQDRPSFSALGPQL 298

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NL++D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NL++D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NL++D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 218
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 219 VDWWALGVLIYEMAAGYPP 237

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+     +   T +  
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TADEMTGYVA 191
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           +++RDL  +NL++D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D ++ GVL  E+  G  P
Sbjct: 220 VDWWALGVLIYEMAAGYPP 238

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+     +   T +  
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TADEMTGYVA 191
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+    + +    F  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+     +   T +  
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TADEMTGYVA 191
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 20/165 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA---- 74
           + + ++YLH   +   +HR+L+++N+LLD +    + DFG+AK + P+   +        
Sbjct: 126 ICEGMAYLHSQHY---IHRNLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGD 181
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-----KGKHPRDFLXXXXXXXLN-TDI 128
               + APE     K     DV+SFGV   E++         P  FL          T +
Sbjct: 182 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 241
Query: 129 ELDEMLD--PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            L E+L+   RLP P +   E    +  +  +C       RPT +
Sbjct: 242 RLTELLERGERLPRPDKCPCE----VYHLMKNCWETEASFRPTFE 282

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 26/152 (17%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N   +  T        ++APE  +  
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKNTTNGRLPVKWMAPEALFDR 234
Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  P+   
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT 285
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    +  +   C +  P  RPT K + + L
Sbjct: 286 NE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVIKG 109
            D++S G +  E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVIKG 109
            D++S G +  E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+    + +    F  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 13/93 (13%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG---TYG 78
            L Y+H      I+HRDL   NL ++ + E  + DFG+A+  + DS    E  G   T  
Sbjct: 140 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADS----EMXGXVVTRW 190
Query: 79  YVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           Y APE+    M+ T+  D++S G +  E+I GK
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  A+ Y H      +VHRDL  +N+LLD    A +ADFG++  +  D        G+  
Sbjct: 120 ILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSCGSPN 175
Query: 79  YVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
           Y APE ++  +    + D++S GV+   ++ G  P D
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 65/149 (43%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D   +           + APE     K +
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS 195
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 196 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 255
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 256 GCPDE----IYMIMTECWNNNVNQRPSFR 280

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARH---TDDEMTGYVA 189
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVIKG 109
            D++S G +  E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 24/159 (15%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL +LH      ++HRD+   N+L++   +  + DFGI+ +L  D +   + AG   
Sbjct: 118 IVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-AGCKP 174
Query: 79  YVAPEL--------AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIEL 130
           Y+APE          Y++    K D++S G+  +E+   + P D              ++
Sbjct: 175 YMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFPYD----SWGTPFQQLKQV 226
Query: 131 DEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            E   P+LPA   S +      V     CL ++ + RPT
Sbjct: 227 VEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPT 260

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVIKG 109
            D++S G +  E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVIKG 109
            D++S G +  E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 43/78 (55%), Gaps = 5/78 (6%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAPELAYTMKIT 91
           I+HRDL   N+++  +    + DFG+A+     S+N+  T +  T  Y APE+   M   
Sbjct: 145 IIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYYRAPEVILGMGYK 201
Query: 92  EKCDVYSFGVLALEVIKG 109
           E  D++S G +  E++KG
Sbjct: 202 ENVDIWSVGCIMGELVKG 219

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARH---TDDEMTGYVA 189
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 142 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARH---TDDEMTGYVA 195
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 94  CDVYSFGVLALEVIKG 109
            D++S G +  E+IKG
Sbjct: 207 VDIWSVGCIMGEMIKG 222

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVIKG 109
            D++S G +  E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 20/165 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA---- 74
           + + ++YLH   +   +HR+L+++N+LLD +    + DFG+AK + P+   +        
Sbjct: 126 ICEGMAYLHAQHY---IHRNLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGD 181
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-----KGKHPRDFLXXXXXXXLN-TDI 128
               + APE     K     DV+SFGV   E++         P  FL          T +
Sbjct: 182 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 241
Query: 129 ELDEMLD--PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            L E+L+   RLP P +   E    +  +  +C       RPT +
Sbjct: 242 RLTELLERGERLPRPDKCPCE----VYHLMKNCWETEASFRPTFE 282

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 69/157 (43%), Gaps = 21/157 (13%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           VHRDL+++N+L++ E    +ADFG+AK L  D   +           + APE       +
Sbjct: 137 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 196
Query: 92  EKCDVYSFGVLALEVI----KGKHPR-DFLXXXXXXXLNTDI------ELDEMLDPRLPA 140
            + DV+SFGV+  E+     K   P  +FL          D+              RLPA
Sbjct: 197 RQSDVWSFGVVLYELFTYCDKSCSPSAEFL---RMMGCERDVPALCRLLELLEEGQRLPA 253
Query: 141 PSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           P     E +  ++K+   C   SP+ RP+   +  QL
Sbjct: 254 PPACPAE-VHELMKL---CWAPSPQDRPSFSALGPQL 286

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L Y+H      I+HRDL   N+ ++ + E  + DFG+A   +      T +  T  Y A
Sbjct: 143 GLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLA---RQADEEMTGYVATRWYRA 196
Query: 82  PELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           PE+    M   +  D++S G +  E+++GK
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+    +    T +  
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM---TGYVA 190
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L Y+H      I+HRDL   N+ ++ + E  + DFG+A   +      T +  T  Y A
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLA---RQADEEMTGYVATRWYRA 196
Query: 82  PELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           PE+    M   +  D++S G +  E+++GK
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+    + +    F  
Sbjct: 127 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVA 180
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARH---TDDEMTGYVA 186
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L Y+H      I+HRDL   N+ ++ + E  + DFG+A   +      T +  T  Y A
Sbjct: 135 GLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADEEMTGYVATRWYRA 188
Query: 82  PELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           PE+    M   +  D++S G +  E+++GK
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 26/152 (17%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N   +  T        ++APE  +  
Sbjct: 179 IHRDLAARNVLVTENNVMRIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDR 234
Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  P+   
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT 285
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    +  +   C +  P  RPT K + + L
Sbjct: 286 NE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/111 (27%), Positives = 53/111 (47%), Gaps = 16/111 (14%)
Query: 11  QRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           Q ++  +  A  + YLH      I+HRD+ S N+ L       + DFG+A       S W
Sbjct: 133 QLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATV----KSRW 185
Query: 71  T------EFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHP 112
           +      +  G+  ++APE+         + + DVYS+G++  E++ G+ P
Sbjct: 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 39/76 (51%), Gaps = 1/76 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S     F  T  Y APE+   M   E 
Sbjct: 149 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMVPFVVTRYYRAPEVILGMGYKEN 207
Query: 94  CDVYSFGVLALEVIKG 109
            D++S G +  E+IKG
Sbjct: 208 VDIWSVGCIMGEMIKG 223

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D               + APE     K +
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 213
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 214 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 273
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 274 GCPDE----IYMIMTECWNNNVNQRPSFR 298

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 26/152 (17%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N   +  T        ++APE  +  
Sbjct: 166 IHRDLTARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDR 221
Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  P+   
Sbjct: 222 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT 272
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    +  +   C +  P  RPT K + + L
Sbjct: 273 NE----LYMMMRDCWHAVPSQRPTFKQLVEDL 300

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D               + APE     K +
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 198
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 199 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 258
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 259 GCPDE----IYMIMTECWNNNVNQRPSFR 283

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D               + APE     K +
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 213
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 214 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 273
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 274 GCPDE----IYMIMTECWNNNVNQRPSFR 298

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D               + APE     K +
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 195
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 196 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 255
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 256 GCPDE----IYMIMTECWNNNVNQRPSFR 280

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D               + APE     K +
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 226
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 227 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 286
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 287 GCPDE----IYMIMTECWNNNVNQRPSFR 311

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 143 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 196
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D               + APE     K +
Sbjct: 140 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 199
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 200 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 259
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 260 GCPDE----IYMIMTECWNNNVNQRPSFR 284

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 143 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 196
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 189
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 130 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 183
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 184 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG AK L  +   +  
Sbjct: 124 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 180
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 181 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 237
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 238 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 271

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 190
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D               + APE     K +
Sbjct: 134 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 193
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 194 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 253
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 254 GCPDE----IYMIMTECWNNNVNQRPSFR 278

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D               + APE     K +
Sbjct: 143 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 202
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 203 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 262
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 263 GCPDE----IYMIMTECWNNNVNQRPSFR 287

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 143 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 196
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           ++ AL+YL    F   VHRD++++N+L+       + DFG++++++ DS+ +    G   
Sbjct: 120 LSTALAYLESKRF---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLP 175
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVI 107
             ++APE     + T   DV+ FGV   E++
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D               + APE     K +
Sbjct: 142 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 201
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 202 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 261
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 262 GCPDE----IYMIMTECWNNNVNQRPSFR 286

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG AK L  +   +  
Sbjct: 122 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 235
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 236 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 269

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG AK L  +   +  
Sbjct: 127 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 183
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 240
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 241 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 274

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D               + APE     K +
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 198
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 199 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 258
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 259 GCPDE----IYMIMTECWNNNVNQRPSFR 283

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           ++ AL+YL    F   VHRD++++N+L+       + DFG++++++ DS+ +    G   
Sbjct: 120 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 175
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVI 107
             ++APE     + T   DV+ FGV   E++
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 142 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 195
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG AK L  +   +  
Sbjct: 120 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 176
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 233
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 234 KGE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 267

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 141 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 194
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 195 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 154 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 207
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 186
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D               + APE     K +
Sbjct: 141 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 200
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 201 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 260
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 261 GCPDE----IYMIMTECWNNNVNQRPSFR 285

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D               + APE     K +
Sbjct: 135 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 194
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 195 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 254
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 255 GCPDE----IYMIMTECWNNNVNQRPSFR 279

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 191
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 26/152 (17%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N   +  T        ++APE  +  
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDR 234
Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  P+   
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT 285
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    +  +   C +  P  RPT K + + L
Sbjct: 286 NE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 128 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 181
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/106 (26%), Positives = 53/106 (50%), Gaps = 6/106 (5%)
Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
            +++  Q++     +   + YL    +   VHRDL+++N+L++ E++  + DFG+ K ++
Sbjct: 121 NKINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
Query: 65  PDSSNWT---EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
            D    T   +      + APE     K     DV+SFGV   E++
Sbjct: 178 TDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           ++ AL+YL    F   VHRD++++N+L+       + DFG++++++ DS+ +    G   
Sbjct: 120 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 175
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVI 107
             ++APE     + T   DV+ FGV   E++
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           ++ AL+YL    F   VHRD++++N+L+       + DFG++++++ DS+ +    G   
Sbjct: 122 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 177
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVI 107
             ++APE     + T   DV+ FGV   E++
Sbjct: 178 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 5/97 (5%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-EYEAHVADFGIAKFLKPDSSNWTEFAG 75
           + +   L +LH    PPI+HRDL   N+ +        + D G+A   +  +S      G
Sbjct: 136 RQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIG 192
Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  + APE  Y  K  E  DVY+FG   LE    ++P
Sbjct: 193 TPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 128 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 181
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HRDL+++N+L++ E    + DFG+ K L  D               + APE     K +
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 195
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 196 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 255
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 256 GCPDE----IYMIMTECWNNNVNQRPSFR 280

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 151 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 204
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 186
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 26/152 (17%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N   +  T        ++APE  +  
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDR 234
Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  P+   
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT 285
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    +  +   C +  P  RPT K + + L
Sbjct: 286 NE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 189
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 186
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 151 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 204
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           ++ AL+YL    F   VHRD++++N+L+       + DFG++++++ DS+ +    G   
Sbjct: 148 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 203
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVI 107
             ++APE     + T   DV+ FGV   E++
Sbjct: 204 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 150 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 203
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 26/152 (17%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N   +  T        ++APE  +  
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDR 234
Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  P+   
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT 285
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    +  +   C +  P  RPT K + + L
Sbjct: 286 NE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 26/152 (17%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N   +  T        ++APE  +  
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDR 234
Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  P+   
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT 285
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    +  +   C +  P  RPT K + + L
Sbjct: 286 NE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           ++ AL+YL    F   VHRD++++N+L+       + DFG++++++ DS+ +    G   
Sbjct: 123 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 178
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVI 107
             ++APE     + T   DV+ FGV   E++
Sbjct: 179 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/106 (26%), Positives = 53/106 (50%), Gaps = 6/106 (5%)
Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
            +++  Q++     +   + YL    +   VHRDL+++N+L++ E++  + DFG+ K ++
Sbjct: 109 NKINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIE 165
Query: 65  PDSSNWT---EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
            D    T   +      + APE     K     DV+SFGV   E++
Sbjct: 166 TDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 127 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 180
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           ++ AL+YL    F   VHRD++++N+L+       + DFG++++++ DS+ +    G   
Sbjct: 117 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 172
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVI 107
             ++APE     + T   DV+ FGV   E++
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 26/152 (17%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N   +  T        ++APE  +  
Sbjct: 171 IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDR 226
Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  P+   
Sbjct: 227 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT 277
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    +  +   C +  P  RPT K + + L
Sbjct: 278 NE----LYMMMRDCWHAVPSQRPTFKQLVEDL 305

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY---EAHVADFGIAKFLKPDSSNWTE 72
           IK + + + YLH +    IVH DL  +N+LL   Y   +  + DFG+++ +   +    E
Sbjct: 137 IKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELRE 192
Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             GT  Y+APE+     IT   D+++ G++A  ++    P
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 129 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 182
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 26/152 (17%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N   +  T        ++APE  +  
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDR 234
Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  P+   
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT 285
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    +  +   C +  P  RPT K + + L
Sbjct: 286 NE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           ++ AL+YL    F   VHRD++++N+L+       + DFG++++++ DS+ +    G   
Sbjct: 125 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 180
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVI 107
             ++APE     + T   DV+ FGV   E++
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 190
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 26/152 (17%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N   +  T        ++APE  +  
Sbjct: 168 IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDR 223
Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  P+   
Sbjct: 224 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT 274
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    +  +   C +  P  RPT K + + L
Sbjct: 275 NE----LYMMMRDCWHAVPSQRPTFKQLVEDL 302

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           P +  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 26/152 (17%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N   +  T        ++APE  +  
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNGRLPVKWMAPEALFDR 280
Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  P+   
Sbjct: 281 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT 331
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    +  +   C +  P  RPT K + + L
Sbjct: 332 NE----LYMMMRDCWHAVPSQRPTFKQLVEDL 359

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTYGYV 80
           AL +LH      I++RD+  +N+LLD      + DFG++K F+  ++    +F GT  Y+
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 81  APELAYTMKIT--EKCDVYSFGVLALEVIKGKHP 112
           AP++         +  D +S GVL  E++ G  P
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 5/83 (6%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL----AYTMK 89
           I+HRD+   N+LLD      + DFGI+  L  DS   T  AG   Y+APE     A    
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 90  ITEKCDVYSFGVLALEVIKGKHP 112
              + DV+S G+   E+  G+ P
Sbjct: 206 YDVRSDVWSLGITLYELATGRFP 228

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           ++ AL+YL    F   VHRD++++N+L+       + DFG++++++ DS+ +    G   
Sbjct: 500 LSTALAYLESKRF---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLP 555
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVI 107
             ++APE     + T   DV+ FGV   E++
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 150 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 203
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 127 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 180
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVA 190
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  A+ Y H      IVHRDL  +NLLLD      +ADFG++  +  D +      G+  
Sbjct: 112 IISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPN 167
Query: 79  YVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
           Y APE ++  +    + DV+S GV+   ++  + P D
Sbjct: 168 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           ++ AL+YL    F   VHRD++++N+L+       + DFG++++++ DS+ +    G   
Sbjct: 500 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 555
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVI 107
             ++APE     + T   DV+ FGV   E++
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 16/149 (10%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           +HR+L+++N+L++ E    + DFG+ K L  D   +           + APE     K +
Sbjct: 137 IHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS 196
Query: 92  EKCDVYSFGVLALEVI----KGKH-PRDFLXXXXXXXLNTDI--ELDEML--DPRLPAPS 142
              DV+SFGV+  E+     K K  P +F+           I   L E+L  + RLP P 
Sbjct: 197 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 256
Query: 143 RSVQEKLISIVKVAFSCLNESPESRPTMK 171
               E    I  +   C N +   RP+ +
Sbjct: 257 GCPDE----IYMIMTECWNNNVNQRPSFR 281

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 10/115 (8%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADF 57
           D A  E + S+ M   K + +A+ YLH      I HRD+  +NLL   +    +    DF
Sbjct: 109 DQAFTEREASEIM---KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 162
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G AK     +S  TE   T  YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 163 GFAKETTSHNS-LTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 56/112 (50%), Gaps = 10/112 (8%)
Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
           EL  SQ ++  + +A  + YL    F   VHRDL+++N L+       + DFG+++ +  
Sbjct: 124 ELTQSQMLHIAQQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY- 179
Query: 66  DSSNWTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
            S+++    G       ++ PE     K T + DV+S GV+  E+   GK P
Sbjct: 180 -STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 127 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVA 180
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 44/98 (44%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEY----EAHVADFGIAKFLKPDSSNWTEFA 74
           +   + YLH      +VHRDL   N+L   E        + DFG AK L+ ++       
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T  +VAPE+         CD++S GVL   ++ G  P
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 29/175 (16%)
Query: 13  MNTIKGVADALSYL--HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           ++ +  +A  + YL  HH     +VH+DL+++N+L+  +    ++D G+  F +  ++++
Sbjct: 131 VHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGL--FREVYAADY 183
Query: 71  TEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLN 125
            +  G       ++APE     K +   D++S+GV+  EV   G  P            N
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-------YCGYSN 236
Query: 126 TDIELDEMLDPR--LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
            D+   EM+  R  LP P     +    +  +   C NE P  RP  K +  +LR
Sbjct: 237 QDVV--EMIRNRQVLPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  A+ Y H      IVHRDL  +NLLLD      +ADFG++  +  D +      G+  
Sbjct: 121 IISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPN 176
Query: 79  YVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
           Y APE ++  +    + DV+S GV+   ++  + P D
Sbjct: 177 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  A+ Y H      IVHRDL  +NLLLD      +ADFG++  +  D +      G+  
Sbjct: 116 IISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPN 171
Query: 79  YVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
           Y APE ++  +    + DV+S GV+   ++  + P D
Sbjct: 172 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  A+ Y H      IVHRDL  +NLLLD      +ADFG++  +  D +      G+  
Sbjct: 122 IISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPN 177
Query: 79  YVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
           Y APE ++  +    + DV+S GV+   ++  + P D
Sbjct: 178 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 71/167 (42%), Gaps = 27/167 (16%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA-KFLKPDSSNWTEFAGT- 76
           +A  + YL +  F   +HRDL+++N +L  +    VADFG++ K    D       A   
Sbjct: 156 IALGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEV-IKGKHPRDFLXXXXXXXLNTDIELDEMLD 135
             ++A E       T K DV++FGV   E+  +G  P               ++  EM D
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY------------PGVQNHEMYD 260
Query: 136 -----PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                 RL  P   + E    + ++ +SC    P  RPT  ++  QL
Sbjct: 261 YLLHGHRLKQPEDCLDE----LYEIMYSCWRTDPLDRPTFSVLRLQL 303

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG AK L  +   +  
Sbjct: 122 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 235
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 236 KGE----RLPQPPICT----IDVYMIMRKCWMIDADSRPKFR 269

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 29/175 (16%)
Query: 13  MNTIKGVADALSYL--HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW 70
           ++ +  +A  + YL  HH     +VH+DL+++N+L+  +    ++D G+  F +  ++++
Sbjct: 148 VHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGL--FREVYAADY 200
Query: 71  TEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLN 125
            +  G       ++APE     K +   D++S+GV+  EV   G  P            N
Sbjct: 201 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-------YCGYSN 253
Query: 126 TDIELDEMLDPR--LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
            D+   EM+  R  LP P     +    +  +   C NE P  RP  K +  +LR
Sbjct: 254 QDVV--EMIRNRQVLPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 17/162 (10%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +N    +A  ++YL       +VHRDL+++N+L+       + DFG AK L  +   +  
Sbjct: 122 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 178
Query: 73  FAGTY--GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIE 129
             G     ++A E       T + DV+S+GV   E++  G  P D +       +++ +E
Sbjct: 179 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILE 235
Query: 130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             E    RLP P        I +  +   C     +SRP  +
Sbjct: 236 KGE----RLPQPPICT----IDVYMIMRKCWMIDADSRPKFR 269

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADF 57
           D A  E + S+ M   K + +A+ YLH      I HRD+  +NLL   +    +    DF
Sbjct: 116 DQAFTEREASEIM---KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 169
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G AK     +S  T     Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 170 GFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 223

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 23/122 (18%)
Query: 8   DWSQRMNTIKGVADALSYLHHDC------FPPIVHRDLSSKNLLLDLEYEAHVADFGIA- 60
           DW         V   L+YLH +        P I HRDL+S+N+L+  +    ++DFG++ 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 61  -----KFLKP---DSSNWTEFAGTYGYVAPEL---AYTMKITE----KCDVYSFGVLALE 105
                + ++P   D++  +E  GT  Y+APE+   A  ++  E    + D+Y+ G++  E
Sbjct: 169 RLTGNRLVRPGEEDNAAISE-VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227
Query: 106 VI 107
           + 
Sbjct: 228 IF 229

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT- 76
           VA  +++L   +C    +HRD++++N+LL   + A + DFG+A+ +  DS+   +     
Sbjct: 167 VAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 222
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
              ++APE  +    T + DV+S+G+L  E+ 
Sbjct: 223 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 254

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADF 57
           D A  E + S+ M   K + +A+ YLH      I HRD+  +NLL   +    +    DF
Sbjct: 115 DQAFTEREASEIM---KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 168
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G AK     +S  T     Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 169 GFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 222

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT- 76
           VA  +++L   +C    +HRD++++N+LL   + A + DFG+A+ +  DS+   +     
Sbjct: 173 VAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
              ++APE  +    T + DV+S+G+L  E+ 
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADF 57
           D A  E + S+ M   K + +A+ YLH      I HRD+  +NLL   +    +    DF
Sbjct: 117 DQAFTEREASEIM---KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 170
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G AK     +S  T     Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 171 GFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 224

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
           VA  +++L   +C    +HRD++++N+LL   + A + DFG+A+ +  DS+   +     
Sbjct: 161 VAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 78  --GYVAPELAYTMKITEKCDVYSFGVLALEVI 107
              ++APE  +    T + DV+S+G+L  E+ 
Sbjct: 217 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 248

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 69/157 (43%), Gaps = 21/157 (13%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT---EFAGTYGYVAPELAYTMKIT 91
           VHRDL+++N+L++ E    +ADFG+AK L  D               + APE       +
Sbjct: 133 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFS 192
Query: 92  EKCDVYSFGVLALEVI----KGKHPR-DFLXXXXXXXLNTDI------ELDEMLDPRLPA 140
            + DV+SFGV+  E+     K   P  +FL          D+              RLPA
Sbjct: 193 RQSDVWSFGVVLYELFTYCDKSCSPSAEFL---RMMGCERDVPALCRLLELLEEGQRLPA 249
Query: 141 PSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           P  +   ++  ++K+   C   SP+ RP+   +  QL
Sbjct: 250 PP-ACPAEVHELMKL---CWAPSPQDRPSFSALGPQL 282

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 24/159 (15%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL +LH      ++HRD+   N+L++   +    DFGI+ +L  D +   + AG   
Sbjct: 145 IVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-AGCKP 201
Query: 79  YVAPEL--------AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIEL 130
           Y APE          Y++    K D++S G+  +E+   + P D              ++
Sbjct: 202 YXAPERINPELNQKGYSV----KSDIWSLGITXIELAILRFPYD----SWGTPFQQLKQV 253
Query: 131 DEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            E   P+LPA   S +      V     CL ++ + RPT
Sbjct: 254 VEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPT 287

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT- 76
           VA  +++L   +C    +HRD++++N+LL   + A + DFG+A+ +  DS+   +     
Sbjct: 169 VAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
              ++APE  +    T + DV+S+G+L  E+ 
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 256

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT- 76
           VA  +++L   +C    +HRD++++N+LL   + A + DFG+A+ +  DS+   +     
Sbjct: 173 VAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
              ++APE  +    T + DV+S+G+L  E+ 
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 23/165 (13%)
Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
           VA  + YL    C    +HRDL+++N+L+  +    +ADFG+A+ +           G  
Sbjct: 159 VARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRL 214
Query: 78  --GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEML 134
              ++APE  +    T + DV+SFGVL  E+   G  P   +            EL ++L
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---------ELFKLL 265
Query: 135 DP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
               R+  PS    E    +  +   C +  P  RPT K + + L
Sbjct: 266 KEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 52/92 (56%), Gaps = 7/92 (7%)
Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT- 76
           VA  +++L   +C    +HRD++++N+LL   + A + DFG+A+ +  DS+   +     
Sbjct: 175 VAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 230
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
              ++APE  +    T + DV+S+G+L  E+ 
Sbjct: 231 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 262

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADF 57
           D A  E + S+ M   K + +A+ YLH      I HRD+  +NLL   +    +    DF
Sbjct: 155 DQAFTEREASEIM---KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 208
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G AK     +S  T     Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 209 GFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 38/76 (50%), Gaps = 1/76 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+          E    Y Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRY-YRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVIKG 109
            D++S G +  E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADF 57
           D A  E + S+ M   K + +A+ YLH      I HRD+  +NLL   +    +    DF
Sbjct: 109 DQAFTEREASEIM---KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 162
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G AK     +S  T     Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 163 GFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 4/87 (4%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L YLH      I+HRDL   NLLLD      +ADFG+AK     +  +     T  Y A
Sbjct: 124 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRA 180
Query: 82  PELAYTMKITE-KCDVYSFGVLALEVI 107
           PEL +  ++     D+++ G +  E++
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 19/107 (17%)
Query: 19  VADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT-- 71
            A  L++LH +       P I HRDL SKN+L+       +AD G+A  ++ DS+  T  
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTID 166
Query: 72  ----EFAGTYGYVAPEL---AYTMKITE---KCDVYSFGVLALEVIK 108
                  GT  Y+APE+   +  MK  E   + D+Y+ G++  E+ +
Sbjct: 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/121 (28%), Positives = 60/121 (49%), Gaps = 24/121 (19%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL--------DLEYEAH-----VADFGI 59
           ++ ++ +A  +++LH      I+HRDL  +N+L+        D +  A      ++DFG+
Sbjct: 136 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 60  AKFLKPDS----SNWTEFAGTYGYVAPEL---AYTMKITEKCDVYSFGVLALEVI-KGKH 111
            K L         N    +GT G+ APEL   +   ++T   D++S G +   ++ KGKH
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252
Query: 112 P 112
           P
Sbjct: 253 P 253

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADF 57
           D A  E + S+ M   K + +A+ YLH      I HRD+  +NLL   +    +    DF
Sbjct: 110 DQAFTEREASEIM---KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 163
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G AK     +S  T     Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 164 GFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           ++ AL+YL    F   VHRD++++N+L+       + DFG++++++ DS+      G   
Sbjct: 120 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLP 175
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVI 107
             ++APE     + T   DV+ FGV   E++
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 19/107 (17%)
Query: 19  VADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT-- 71
            A  L++LH +       P I HRDL SKN+L+       +AD G+A  ++ DS+  T  
Sbjct: 135 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTID 192
Query: 72  ----EFAGTYGYVAPEL---AYTMKITE---KCDVYSFGVLALEVIK 108
                  GT  Y+APE+   +  MK  E   + D+Y+ G++  E+ +
Sbjct: 193 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 239

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADF 57
           D A  E + S+ M   K + +A+ YLH      I HRD+  +NLL   +    +    DF
Sbjct: 125 DQAFTEREASEIM---KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 178
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G AK     +S  T     Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 179 GFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 232

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/121 (28%), Positives = 60/121 (49%), Gaps = 24/121 (19%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL--------DLEYEAH-----VADFGI 59
           ++ ++ +A  +++LH      I+HRDL  +N+L+        D +  A      ++DFG+
Sbjct: 136 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 60  AKFLKPDS----SNWTEFAGTYGYVAPEL---AYTMKITEKCDVYSFGVLALEVI-KGKH 111
            K L         N    +GT G+ APEL   +   ++T   D++S G +   ++ KGKH
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252
Query: 112 P 112
           P
Sbjct: 253 P 253

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADF 57
           D A  E + S+ M   K + +A+ YLH      I HRD+  +NLL   +    +    DF
Sbjct: 161 DQAFTEREASEIM---KSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF 214
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G AK     +S  T     Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 215 GFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 268

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 19/107 (17%)
Query: 19  VADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT-- 71
            A  L++LH +       P I HRDL SKN+L+       +AD G+A  ++ DS+  T  
Sbjct: 115 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTID 172
Query: 72  ----EFAGTYGYVAPEL---AYTMKITE---KCDVYSFGVLALEVIK 108
                  GT  Y+APE+   +  MK  E   + D+Y+ G++  E+ +
Sbjct: 173 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 219

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 19/107 (17%)
Query: 19  VADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT-- 71
            A  L++LH +       P I HRDL SKN+L+       +AD G+A  ++ DS+  T  
Sbjct: 112 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTID 169
Query: 72  ----EFAGTYGYVAPEL---AYTMKITE---KCDVYSFGVLALEVIK 108
                  GT  Y+APE+   +  MK  E   + D+Y+ G++  E+ +
Sbjct: 170 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 216

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+ + F   VHRDL+++N ++  ++   + DFG+ + +           G   
Sbjct: 132 IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 188
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
             +++PE       T   DV+SFGV+  E+
Sbjct: 189 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 174 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 229
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 43/98 (43%), Gaps = 7/98 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEY----EAHVADFGIAKFLKPDSSNWTEFA 74
           +   + YLH      +VHRDL   N+L   E        + DFG AK L+ ++       
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPC 181
Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            T  +VAPE+         CD++S GVL    + G  P
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 19/107 (17%)
Query: 19  VADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT-- 71
            A  L++LH +       P I HRDL SKN+L+       +AD G+A  ++ DS+  T  
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTID 205
Query: 72  ----EFAGTYGYVAPEL---AYTMKITE---KCDVYSFGVLALEVIK 108
                  GT  Y+APE+   +  MK  E   + D+Y+ G++  E+ +
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADF 57
           D A  E + S+ M   K + +A+ YLH      I HRD+  +NLL   +    +    DF
Sbjct: 111 DQAFTEREASEIM---KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G AK     +S  T     Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 165 GFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 7/90 (7%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L Y+H      +VHRDL   NL ++ + E  + DFG+A+      +  T +  T  Y A
Sbjct: 156 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRA 209
Query: 82  PELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           PE+  + M   +  D++S G +  E++ GK
Sbjct: 210 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/101 (24%), Positives = 46/101 (45%), Gaps = 15/101 (14%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA---- 74
           +A+A+ +LH      ++HRDL   N+   ++    V DFG+   +  D    T       
Sbjct: 173 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 75  --------GTYGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
                   GT  Y++PE  +    + K D++S G++  E++
Sbjct: 230 YATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 19/107 (17%)
Query: 19  VADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT-- 71
            A  L++LH +       P I HRDL SKN+L+       +AD G+A  ++ DS+  T  
Sbjct: 110 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTID 167
Query: 72  ----EFAGTYGYVAPEL---AYTMKITE---KCDVYSFGVLALEVIK 108
                  GT  Y+APE+   +  MK  E   + D+Y+ G++  E+ +
Sbjct: 168 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 214

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 42/84 (50%), Gaps = 11/84 (13%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----------SNWTEFAGTYGYVAPE 83
           ++HRDL   NLL++   +  V DFG+A+ +   +          S  TE+  T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 84  LAYT-MKITEKCDVYSFGVLALEV 106
           +  T  K +   DV+S G +  E+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 7/90 (7%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L Y+H      +VHRDL   NL ++ + E  + DFG+A+      +  T +  T  Y A
Sbjct: 138 GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRA 191
Query: 82  PELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           PE+  + M   +  D++S G +  E++ GK
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADF 57
           D A  E + S+ M   K + +A+ YLH      I HRD+  +NLL   +    +    DF
Sbjct: 111 DQAFTEREASEIM---KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G AK     +S  T     Y YVAPE+    K  + CD++S GV+   ++ G  P
Sbjct: 165 GFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + D+G+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 132 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 187
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 67/147 (45%), Gaps = 14/147 (9%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT--YGYVAPELAYTMKIT 91
           +VHRDL+++N+L+    +  ++DFG+++ +  + S      G     ++A E  +    T
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 92  EKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLI 150
            + DV+SFGVL  E++  G +P   +       L            R+  P    +E   
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT-------GHRMERPDNCSEE--- 280
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + ++   C  + P+ RP    +S+ L
Sbjct: 281 -MYRLMLQCWKQEPDKRPVFADISKDL 306

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 131 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 186
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 159 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 214
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 160 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 215
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 130 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 185
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIP 212

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 132 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 187
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L +LH +C   IVHRDL  +N+L+       +ADFG+A+      +  T    T  Y A
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVVTLWYRA 187
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGK 110
           PE+          D++S G +  E+ + K
Sbjct: 188 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 159 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 214
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 174 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 229
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 131 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 186
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIP 213

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+ + F   VHRDL+++N ++  ++   + DFG+ + +           G   
Sbjct: 141 IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 197
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
             +++PE       T   DV+SFGV+  E+
Sbjct: 198 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 67/147 (45%), Gaps = 14/147 (9%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT--YGYVAPELAYTMKIT 91
           +VHRDL+++N+L+    +  ++DFG+++ +  + S      G     ++A E  +    T
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 92  EKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLI 150
            + DV+SFGVL  E++  G +P   +       L            R+  P    +E   
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT-------GHRMERPDNCSEE--- 280
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + ++   C  + P+ RP    +S+ L
Sbjct: 281 -MYRLMLQCWKQEPDKRPVFADISKDL 306

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 160 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 215
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
              YLH      +++RDL  +NLL+D +    V DFG AK +K     W    GT   +A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEALA 206
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           PE+  +    +  D ++ GVL  E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 132 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 187
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIP 214

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 160 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 215
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 174 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 229
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIP 256

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+    +      +  
Sbjct: 154 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG---YVA 207
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 127 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 182
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 146 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 201
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIP 228

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 147 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 202
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 179 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 234
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCGDIP 261

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 166 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 221
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIP 248

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 147 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 202
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYST 183
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 159 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 214
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYST 190
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 191 AVDIWSLGCIFAEMV 205

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 31/169 (18%)
Query: 19  VADALSYL-HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK------FLKPDSSNWT 71
           VA  + YL    C    +HRDL+++N+L+  +    +ADFG+A+      + K  ++   
Sbjct: 200 VARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 255
Query: 72  EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIEL 130
                  ++APE  +    T + DV+SFGVL  E+   G  P   +            EL
Sbjct: 256 PVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---------EL 302
Query: 131 DEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            ++L    R+  PS    E    +  +   C +  P  RPT K + + L
Sbjct: 303 FKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 347

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 160 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 215
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIP 242

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+ +    +    T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM---TGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 146 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 201
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIP 228

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 159 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 214
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIP 241

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 26/152 (17%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N      T        ++APE  +  
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDXXKKTTNGRLPVKWMAPEALFDR 234
Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  P+   
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT 285
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    +  +   C +  P  RPT K + + L
Sbjct: 286 NE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 26/152 (17%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG------YVAPELAYTM 88
           +HRDL+++N+L+       +ADFG+A+    D +N      T        ++APE  +  
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDXXKKTTNGRLPVKWMAPEALFDR 234
Query: 89  KITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDP--RLPAPSRSV 145
             T + DV+SFGVL  E+   G  P   +            EL ++L    R+  P+   
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---------ELFKLLKEGHRMDKPANCT 285
Query: 146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            E    +  +   C +  P  RPT K + + L
Sbjct: 286 NE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 147 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 202
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIP 229

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD       + DFG AK L     N +     Y Y 
Sbjct: 153 SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-YR 208
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   D++S G +  E+++G+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 154 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 209
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIP 236

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 28  HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LA 85
           H+C   ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT  Y  PE + 
Sbjct: 127 HNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 182
Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y         V+S G+L  +++ G  P
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           VA  + +L    F   VHRDL+++N+L+       + DFG+A+ +  D SN+        
Sbjct: 181 VAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD-SNYVVRGNARL 236
Query: 77  -YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHP 112
              ++APE  +    T K DV+S+G+L  E+   G +P
Sbjct: 237 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 9/83 (10%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIA---KFLKPDSSNWTEFAGTYGYVAPE-LAYTMK 89
           +V+RDL   N+LLD      ++D G+A      KP +S      GT+GY+APE L   + 
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 367
Query: 90  ITEKCDVYSFGVLALEVIKGKHP 112
                D +S G +  ++++G  P
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSP 390

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/101 (24%), Positives = 46/101 (45%), Gaps = 15/101 (14%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA---- 74
           +A+A+ +LH      ++HRDL   N+   ++    V DFG+   +  D    T       
Sbjct: 127 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 75  --------GTYGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
                   GT  Y++PE  +    + K D++S G++  E++
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 187
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 188 AVDIWSLGCIFAEMV 202

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 9/98 (9%)
Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTY-- 77
           + L YLH      I+H D+ + N+LL  +   A + DFG A  L+PD    +   G Y  
Sbjct: 196 EGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP 252
Query: 78  ---GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++APE+        K DV+S   + L ++ G HP
Sbjct: 253 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 9/83 (10%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIA---KFLKPDSSNWTEFAGTYGYVAPE-LAYTMK 89
           +V+RDL   N+LLD      ++D G+A      KP +S      GT+GY+APE L   + 
Sbjct: 312 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 366
Query: 90  ITEKCDVYSFGVLALEVIKGKHP 112
                D +S G +  ++++G  P
Sbjct: 367 YDSSADWFSLGCMLFKLLRGHSP 389

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 183 AVDIWSLGCIFAEMV 197

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 183 AVDIWSLGCIFAEMV 197

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+   F   VHRDL+++N ++  ++   + DFG+ + +           G   
Sbjct: 136 IADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
             ++APE       T   D++SFGV+  E+
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 29/168 (17%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           VA  + YL        +HRDL+++N+L+  +    +ADFG+A+    D  +   +  T  
Sbjct: 144 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTN 196
Query: 79  ------YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELD 131
                 ++APE  +    T + DV+SFGVL  E+   G  P   +            EL 
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---------ELF 247
Query: 132 EMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           ++L    R+  PS    E    +  +   C +  P  RPT K + + L
Sbjct: 248 KLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 291

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T    
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGXVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+   F   VHRDL+++N ++  ++   + DFG+ + +           G   
Sbjct: 139 IADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
             ++APE       T   D++SFGV+  E+
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 60/125 (48%), Gaps = 28/125 (22%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL--------DLEYEAH-----VADFGI 59
           ++ ++ +A  +++LH      I+HRDL  +N+L+        D +  A      ++DFG+
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 60  AKFLKPDSS----NWTEFAGTYGYVAPE-------LAYTMKITEKCDVYSFGVLALEVI- 107
            K L    S    N    +GT G+ APE       L    ++T   D++S G +   ++ 
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 108 KGKHP 112
           KGKHP
Sbjct: 235 KGKHP 239

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 67/147 (45%), Gaps = 14/147 (9%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT--YGYVAPELAYTMKIT 91
           +VHRDL+++N+L+    +  ++DFG+++ +  + S      G     ++A E  +    T
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 92  EKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLI 150
            + DV+SFGVL  E++  G +P   +       L            R+  P    +E   
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT-------GHRMERPDNCSEE--- 280
Query: 151 SIVKVAFSCLNESPESRPTMKIVSQQL 177
            + ++   C  + P+ RP    +S+ L
Sbjct: 281 -MYRLMLQCWKQEPDKRPVFADISKDL 306

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 41/84 (48%), Gaps = 11/84 (13%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----------SNWTEFAGTYGYVAPE 83
           ++HRDL   NLL++   +  V DFG+A+ +   +          S   EF  T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 84  LAYT-MKITEKCDVYSFGVLALEV 106
           +  T  K +   DV+S G +  E+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 21/164 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           VA  + YL        +HRDL+++N+L+  +    +ADFG+A+ +           G   
Sbjct: 159 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 215
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLD 135
             ++APE  +    T + DV+SFGVL  E+   G  P   +            EL ++L 
Sbjct: 216 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---------ELFKLLK 266
Query: 136 P--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
              R+  PS    E    +  +   C +  P  RPT K + + L
Sbjct: 267 EGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 184
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 185 AVDIWSLGCIFAEMV 199

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 183 AVDIWSLGCIFAEMV 197

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 183 AVDIWSLGCIFAEMV 197

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 190
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 191 AVDIWSLGCIFAEMV 205

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 9/83 (10%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIA---KFLKPDSSNWTEFAGTYGYVAPE-LAYTMK 89
           +V+RDL   N+LLD      ++D G+A      KP +S      GT+GY+APE L   + 
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 367
Query: 90  ITEKCDVYSFGVLALEVIKGKHP 112
                D +S G +  ++++G  P
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 9/83 (10%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIA---KFLKPDSSNWTEFAGTYGYVAPE-LAYTMK 89
           +V+RDL   N+LLD      ++D G+A      KP +S      GT+GY+APE L   + 
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 367
Query: 90  ITEKCDVYSFGVLALEVIKGKHP 112
                D +S G +  ++++G  P
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSP 390

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+   F   VHRDL+++N ++  ++   + DFG+ + +           G   
Sbjct: 139 IADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
             ++APE       T   D++SFGV+  E+
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +T    T  Y APE+    K  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 29/168 (17%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           VA  + YL        +HRDL+++N+L+  +    +ADFG+A+    D  +   +  T  
Sbjct: 159 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTN 211
Query: 79  ------YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELD 131
                 ++APE  +    T + DV+SFGVL  E+   G  P   +            EL 
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---------ELF 262
Query: 132 EMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           ++L    R+  PS    E    +  +   C +  P  RPT K + + L
Sbjct: 263 KLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 21/164 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           VA  + YL        +HRDL+++N+L+  +    +ADFG+A+ +           G   
Sbjct: 152 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 208
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLD 135
             ++APE  +    T + DV+SFGVL  E+   G  P   +            EL ++L 
Sbjct: 209 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---------ELFKLLK 259
Query: 136 P--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
              R+  PS    E    +  +   C +  P  RPT K + + L
Sbjct: 260 EGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 299

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 21/164 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           VA  + YL        +HRDL+++N+L+  +    +ADFG+A+ +           G   
Sbjct: 148 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 204
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLD 135
             ++APE  +    T + DV+SFGVL  E+   G  P   +            EL ++L 
Sbjct: 205 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---------ELFKLLK 255
Query: 136 P--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
              R+  PS    E    +  +   C +  P  RPT K + + L
Sbjct: 256 EGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 295

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+         T +  
Sbjct: 160 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVA 213
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M      D++S G +  E++ G+
Sbjct: 214 TRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 21/164 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           VA  + YL        +HRDL+++N+L+  +    +ADFG+A+ +           G   
Sbjct: 151 VARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 207
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELDEMLD 135
             ++APE  +    T + DV+SFGVL  E+   G  P   +            EL ++L 
Sbjct: 208 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---------ELFKLLK 258
Query: 136 P--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
              R+  PS    E    +  +   C +  P  RPT K + + L
Sbjct: 259 EGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 298

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 29/168 (17%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           VA  + YL        +HRDL+++N+L+  +    +ADFG+A+    D  +   +  T  
Sbjct: 159 VARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTN 211
Query: 79  ------YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXLNTDIELD 131
                 ++APE  +    T + DV+SFGVL  E+   G  P   +            EL 
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---------ELF 262
Query: 132 EMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           ++L    R+  PS    E    +  +   C +  P  RPT K + + L
Sbjct: 263 KLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 56/107 (52%), Gaps = 13/107 (12%)
Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK----- 61
           L  ++++   + VA  ++YL    F   VHRDL+++N L+       +ADFG+++     
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 62  -FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
            + K D ++    A    ++ PE  +  + T + DV+++GV+  E+ 
Sbjct: 228 DYYKADGND----AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 4/105 (3%)
Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
           ELD  +    +  +   + +LH      I+HRDL   N+++  +    + DFG+A+    
Sbjct: 115 ELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAG 170
Query: 66  DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 110
            S   T +  T  Y APE+   M   E  D++S G +  E+++ K
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 4/105 (3%)
Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
           ELD  +    +  +   + +LH      I+HRDL   N+++  +    + DFG+A+    
Sbjct: 122 ELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAG 177
Query: 66  DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 110
            S   T +  T  Y APE+   M   E  D++S G +  E+++ K
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 48/99 (48%), Gaps = 8/99 (8%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL YL       ++HRD+   N+LLD   +  + DFGI+  L  D +     AG   
Sbjct: 133 IVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCAA 189
Query: 79  YVAPELAYTMKITE-----KCDVYSFGVLALEVIKGKHP 112
           Y+APE       T+     + DV+S G+  +E+  G+ P
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 4/105 (3%)
Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
           ELD  +    +  +   + +LH      I+HRDL   N+++  +    + DFG+A+    
Sbjct: 122 ELDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAG 177
Query: 66  DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGK 110
            S   T +  T  Y APE+   M   E  D++S G +  E+++ K
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 20/173 (11%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           ++ A  L   Q ++    VA  + YL    F   +HRDL+++N+L+   Y A +ADFG++
Sbjct: 123 NSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLS 179
Query: 61  KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXX 119
           +  +                   L Y++  T   DV+S+GVL  E++  G  P   +   
Sbjct: 180 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTPYCGM--- 235
Query: 120 XXXXLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
                 T  EL E L    RL  P     E    +  +   C  E P  RP+ 
Sbjct: 236 ------TCAELYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSF 278

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 25/111 (22%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK--------------FLKPDS 67
            + YLH      ++HRD+   N+LL+ E    VADFG+++               +  ++
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 68  SNW-------TEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGK 110
            N+       T++  T  Y APE L  + K T+  D++S G +  E++ GK
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 73/180 (40%), Gaps = 39/180 (21%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE 72
           +  +   A  + YL   C    +HRDL+++N L+  +    ++DFG+++          E
Sbjct: 216 LQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR---------EE 263
Query: 73  FAGTYG-----------YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXX 120
             G Y            + APE     + + + DV+SFG+L  E    G  P   L    
Sbjct: 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL---- 319
Query: 121 XXXLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
                ++ +  E ++   RLP P         ++ ++   C    P  RP+   + Q+L+
Sbjct: 320 -----SNQQTREFVEKGGRLPCPELCPD----AVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+++ K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 20/173 (11%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           ++ A  L   Q ++    VA  + YL    F   +HRDL+++N+L+   Y A +ADFG++
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLS 189
Query: 61  KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXX 119
           +  +                   L Y++  T   DV+S+GVL  E++  G  P   +   
Sbjct: 190 RGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGM--- 245
Query: 120 XXXXLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
                 T  EL E L    RL  P     E    +  +   C  E P  RP+ 
Sbjct: 246 ------TCAELYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSF 288

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+++ K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+++ K
Sbjct: 200 VDIWSVGCIMGEMVRHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+++ K
Sbjct: 199 VDIWSVGCIMGEMVRHK 215

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+++ K
Sbjct: 207 VDIWSVGCIMGEMVRHK 223

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTEFAGTYG 78
           A+ YLH +    I+HRDL  +N+LL  + E     + DFG +K L  ++S      GT  
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPT 181
Query: 79  YVAPEL---AYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+     T       D +S GV+    + G  P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTEFAGTYG 78
           A+ YLH +    I+HRDL  +N+LL  + E     + DFG +K L  ++S      GT  
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPT 181
Query: 79  YVAPEL---AYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+     T       D +S GV+    + G  P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 146 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 204
Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+++ K
Sbjct: 205 VDIWSVGCIMGEMVRHK 221

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+++ K
Sbjct: 200 VDIWSVGCIMGEMVRHK 216

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTEFAGTYG 78
           A+ YLH +    I+HRDL  +N+LL  + E     + DFG +K L  ++S      GT  
Sbjct: 132 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPT 187
Query: 79  YVAPEL---AYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+     T       D +S GV+    + G  P
Sbjct: 188 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+++ K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+++ K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTEFAGTYG 78
           A+ YLH +    I+HRDL  +N+LL  + E     + DFG +K L  ++S      GT  
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPT 181
Query: 79  YVAPEL---AYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+     T       D +S GV+    + G  P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTEFAGTYG 78
           A+ YLH +    I+HRDL  +N+LL  + E     + DFG +K L  ++S      GT  
Sbjct: 125 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPT 180
Query: 79  YVAPEL---AYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+     T       D +S GV+    + G  P
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+++ K
Sbjct: 207 VDIWSVGCIMGEMVRHK 223

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 47/99 (47%), Gaps = 7/99 (7%)
Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADFGIAKFLKPDSSNWTEF 73
           K + +A+ YLH      I HRD+  +NLL   +    +    DFG AK     +S  T  
Sbjct: 168 KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 224
Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
              Y YVAPE+    K  + CD +S GV+   ++ G  P
Sbjct: 225 YTPY-YVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPP 262

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 19/106 (17%)
Query: 20  ADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA 74
           A  L++LH + F     P I HRD  S+N+L+    +  +AD G+A  +    S++ +  
Sbjct: 115 ACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIG 173
Query: 75  -----GTYGYVAPELAYTMKITEKC-------DVYSFGVLALEVIK 108
                GT  Y+APE+    +I   C       D+++FG++  E+ +
Sbjct: 174 NNPRVGTKRYMAPEV-LDEQIRTDCFESYKWTDIWAFGLVLWEIAR 218

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 243
Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+++ K
Sbjct: 244 VDIWSVGCIMGEMVRHK 260

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+ + F   VHRDL+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 134 IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 188
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               +++PE       T   DV+SFGV+  E+
Sbjct: 189 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+ + F   VHRDL+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 140 IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 194
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               +++PE       T   DV+SFGV+  E+
Sbjct: 195 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  +  FG+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTY 77
           V +A+ + H+     ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT 
Sbjct: 119 VLEAVRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 173
Query: 78  GYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            Y  PE + Y         V+S G+L  +++ G  P
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+ + F   VHRDL+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 138 IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 192
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               +++PE       T   DV+SFGV+  E+
Sbjct: 193 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+ + F   VHRDL+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 147 IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 201
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               +++PE       T   DV+SFGV+  E+
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 40/77 (51%), Gaps = 1/77 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 243
Query: 94  CDVYSFGVLALEVIKGK 110
            D++S G +  E+++ K
Sbjct: 244 VDIWSVGCIMGEMVRHK 260

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+ + F   VHRDL+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 140 IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 194
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               +++PE       T   DV+SFGV+  E+
Sbjct: 195 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+ + F   VHRDL+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 147 IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 201
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               +++PE       T   DV+SFGV+  E+
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+ + F   VHRDL+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 141 IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 195
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               +++PE       T   DV+SFGV+  E+
Sbjct: 196 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+ + F   VHRDL+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 137 IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 191
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               +++PE       T   DV+SFGV+  E+
Sbjct: 192 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 9/98 (9%)
Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTY-- 77
           + L YLH      I+H D+ + N+LL  +   A + DFG A  L+PD    +   G Y  
Sbjct: 161 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 78  ---GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++APE+        K D++S   + L ++ G HP
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L++ H +    I+HRDL  +NLL++   +  + DFG+A+      + ++    T  Y A
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176
Query: 82  PE-LAYTMKITEKCDVYSFGVLALEVIKGK 110
           P+ L  +   +   D++S G +  E+I GK
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 9/98 (9%)
Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTY-- 77
           + L YLH      I+H D+ + N+LL  +   A + DFG A  L+PD        G Y  
Sbjct: 177 EGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP 233
Query: 78  ---GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++APE+        K DV+S   + L ++ G HP
Sbjct: 234 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 7/85 (8%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM----- 88
           IVHRDL  +N+LLD +    + DFG +  L P      E  GT  Y+APE+         
Sbjct: 132 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVCGTPSYLAPEIIECSMNDNH 190
Query: 89  -KITEKCDVYSFGVLALEVIKGKHP 112
               ++ D++S GV+   ++ G  P
Sbjct: 191 PGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 9/98 (9%)
Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTY-- 77
           + L YLH      I+H D+ + N+LL  +   A + DFG A  L+PD    +   G Y  
Sbjct: 177 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 233
Query: 78  ---GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++APE+        K D++S   + L ++ G HP
Sbjct: 234 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 72/155 (46%), Gaps = 19/155 (12%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+   F   VHRDL+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 139 IADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 193
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEML 134
               ++APE       T   D++SFGV+  E+         L       L+ +  L  ++
Sbjct: 194 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVM 246
Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           D        +  E++  ++++   C   +P+ RPT
Sbjct: 247 DGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPT 278

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/153 (22%), Positives = 70/153 (45%), Gaps = 15/153 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+   F   VHRDL+++N ++  ++   + DFG+ + +   +       G   
Sbjct: 139 IADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLP 195
Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLXXXXXXXLNTDIELDEMLDP 136
             ++APE       T   D++SFGV+  E+         L       L+ +  L  ++D 
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDG 248
Query: 137 RLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
                  +  E++  ++++   C   +P+ RPT
Sbjct: 249 GYLDQPDNCPERVTDLMRM---CWQFNPKMRPT 278

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 41/84 (48%), Gaps = 11/84 (13%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----------SNWTEFAGTYGYVAPE 83
           ++HRDL   NLL++   +  V DFG+A+ +   +          S  TE   T  Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 84  LAYT-MKITEKCDVYSFGVLALEV 106
           +  T  K +   DV+S G +  E+
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 42/85 (49%), Gaps = 7/85 (8%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM----- 88
           IVHRDL  +N+LLD +    + DFG +  L P      E  GT  Y+APE+         
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVCGTPSYLAPEIIECSMNDNH 203
Query: 89  -KITEKCDVYSFGVLALEVIKGKHP 112
               ++ D++S GV+   ++ G  P
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 9/98 (9%)
Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTY-- 77
           + L YLH      I+H D+ + N+LL  +   A + DFG A  L+PD    +   G Y  
Sbjct: 175 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 231
Query: 78  ---GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
               ++APE+        K D++S   + L ++ G HP
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+ + F   VHRDL+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 169 IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 223
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               +++PE       T   DV+SFGV+  E+
Sbjct: 224 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 8/86 (9%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFA-GTYGYVAPELAYTMKITE- 92
           VHRD+   N+LLD      +ADFG    L+ D +  +  A GT  Y++PE+   +     
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 93  ------KCDVYSFGVLALEVIKGKHP 112
                 +CD ++ GV A E+  G+ P
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+   F   VHRDL+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 138 IADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 192
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               ++APE       T   D++SFGV+  E+
Sbjct: 193 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTEFAGTYG 78
           A+ YLH +    I+HRDL  +N+LL  + E     + DFG +K L  ++S      GT  
Sbjct: 265 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPT 320
Query: 79  YVAPEL---AYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+     T       D +S GV+    + G  P
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTEFAGTYG 78
           A+ YLH +    I+HRDL  +N+LL  + E     + DFG +K L  ++S      GT  
Sbjct: 251 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPT 306
Query: 79  YVAPEL---AYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+     T       D +S GV+    + G  P
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 41/78 (52%), Gaps = 5/78 (6%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW--TEFAGTYGYVAPELAYTMKIT 91
           I+HRDL   N+++  +    + DFG+A   +   +N+  T +  T  Y APE+   M   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPYVVTRYYRAPEVILGMGYA 203
Query: 92  EKCDVYSFGVLALEVIKG 109
              D++S G +  E++KG
Sbjct: 204 ANVDIWSVGCIMGELVKG 221

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L +LH +C   IVHRDL  +N+L+       +ADFG+A+      + +     T  Y A
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-TLWYRA 179
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGK 110
           PE+          D++S G +  E+ + K
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 73/180 (40%), Gaps = 39/180 (21%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK----------- 61
           +  +   A  + YL   C    +HRDL+++N L+  +    ++DFG+++           
Sbjct: 216 LQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASG 272
Query: 62  FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXX 120
            L+     WT         APE     + + + DV+SFG+L  E    G  P   L    
Sbjct: 273 GLRQVPVKWT---------APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL---- 319
Query: 121 XXXLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
                ++ +  E ++   RLP P         ++ ++   C    P  RP+   + Q+L+
Sbjct: 320 -----SNQQTREFVEKGGRLPCPELCPD----AVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 223
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 48/107 (44%), Gaps = 25/107 (23%)
Query: 22  ALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW----TE 72
            L +LH + F     P I HRDL SKN+L+       +AD G+A     D++        
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 73  FAGTYGYVAPEL-----------AYTMKITEKCDVYSFGVLALEVIK 108
             GT  Y+ PE+           +Y M      D+YSFG++  EV +
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIM-----ADMYSFGLILWEVAR 247

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DFG+A+    +         
Sbjct: 151 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG---XVA 204
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + D G+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L +LH +C   IVHRDL  +N+L+       +ADFG+A+      +       T  Y A
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LAPVVVTLWYRA 179
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGK 110
           PE+          D++S G +  E+ + K
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + D G+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 146 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 201
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + D G+A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 153 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 208
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 209 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 58/117 (49%), Gaps = 25/117 (21%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-----EYEAHVADFGIAKFL---K 64
           +  ++     L++LH      IVHRDL   N+L+ +     + +A ++DFG+ K L   +
Sbjct: 121 ITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKC--------DVYSFGVLALEVI-KGKHP 112
              S  +   GT G++APE+     ++E C        D++S G +   VI +G HP
Sbjct: 178 HSFSRRSGVPGTEGWIAPEM-----LSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 32/127 (25%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL--------DLEYEAH-----VADFGI 59
           ++ ++ +A  +++LH      I+HRDL  +N+L+        D +  A      ++DFG+
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 60  AKFLKPDSS------NWTEFAGTYGYVAPE-------LAYTMKITEKCDVYSFGVLALEV 106
            K  K DS       N    +GT G+ APE       L    ++T   D++S G +   +
Sbjct: 175 CK--KLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 107 I-KGKHP 112
           + KGKHP
Sbjct: 233 LSKGKHP 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 142 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 197
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 198 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 146 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 201
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           I  +   L Y+H      I+HRDL   NL ++ + E  + DF +A+         T +  
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARH---TDDEMTGYVA 184
Query: 76  TYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           T  Y APE+    M   +  D++S G +  E++ G+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 135 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 190
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 189
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 52/107 (48%), Gaps = 4/107 (3%)
Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           ++ A  L   Q ++    VA  + YL    F   +HR+L+++N+L+   Y A +ADFG++
Sbjct: 130 NSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRNLAARNILVGENYVAKIADFGLS 186
Query: 61  KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
           +  +                   L Y++  T   DV+S+GVL  E++
Sbjct: 187 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIV 232

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 138 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 193
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 194 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 189
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/104 (23%), Positives = 49/104 (47%), Gaps = 4/104 (3%)
Query: 4   AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL 63
            ++LD    +   + +   + Y+H      +++RDL   N+ L    +  + DFG+   L
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
Query: 64  KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI 107
           K D        GT  Y++PE   +    ++ D+Y+ G++  E++
Sbjct: 173 KNDGKR-XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 189
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 187 AVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 186 AVDIWSLGCIFAEMV 200

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/106 (26%), Positives = 50/106 (47%), Gaps = 6/106 (5%)
Query: 7   LDWSQRMNTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
           LD+      +  + + + + H H+    I+HRD+  +N+L+       + DFG A+ L  
Sbjct: 121 LDYQVVQKYLFQIINGIGFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176
Query: 66  DSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK 110
               + +   T  Y APEL    +K  +  DV++ G L  E+  G+
Sbjct: 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 186 AVDIWSLGCIFAEMV 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 213 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 268
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 269 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 186 AVDIWSLGCIFAEMV 200

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 168 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 223
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 187 AVDIWSLGCIFAEMV 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 187
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 188 AVDIWSLGCIFAEMV 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 182
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 183 AVDIWSLGCIFAEMV 197

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 189
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 187 AVDIWSLGCIFAEMV 201

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 172 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 227
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 228 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 185 AVDIWSLGCIFAEMV 199

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 187 AVDIWSLGCIFAEMV 201

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 170 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 225
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 226 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 162 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 217
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 218 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 187 AVDIWSLGCIFAEMV 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 182
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 183 AVDIWSLGCIFAEMV 197

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/92 (27%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+ + F   VHRDL+++N  +  ++   + DFG+ + +    +++    G   
Sbjct: 134 IADGMAYLNANKF---VHRDLAARNCXVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 188
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               +++PE       T   DV+SFGV+  E+
Sbjct: 189 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 8/115 (6%)
Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKN-LLLDLEY---EAHVADF 57
           A  + L   +  + IK + D ++YLH      I H DL  +N +LLD         + DF
Sbjct: 107 AQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G+A  ++ D   +    GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 164 GLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L +LH +C   IVHRDL  +N+L+       +ADFG+A+      +       T  Y A
Sbjct: 124 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LDPVVVTLWYRA 179
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGK 110
           PE+          D++S G +  E+ + K
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 185 AVDIWSLGCIFAEMV 199

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 147 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 202
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 203 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/91 (28%), Positives = 47/91 (51%), Gaps = 12/91 (13%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           IK V ++ SY+H++    I HRD+   N+L+D      ++DFG ++++       +   G
Sbjct: 157 IKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--G 212
Query: 76  TYGYVAPEL-----AYTMKITEKCDVYSFGV 101
           TY ++ PE      +Y      K D++S G+
Sbjct: 213 TYEFMPPEFFSNESSYN---GAKVDIWSLGI 240

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 8/115 (6%)
Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKN-LLLDLEY---EAHVADF 57
           A  + L   +  + IK + D ++YLH      I H DL  +N +LLD         + DF
Sbjct: 107 AQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G+A  ++ D   +    GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 164 GLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 139 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 194
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 195 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 8/115 (6%)
Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKN-LLLDLEY---EAHVADF 57
           A  + L   +  + IK + D ++YLH      I H DL  +N +LLD         + DF
Sbjct: 107 AQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G+A  ++ D   +    GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 164 GLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 8/115 (6%)
Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKN-LLLDLEY---EAHVADF 57
           A  + L   +  + IK + D ++YLH      I H DL  +N +LLD         + DF
Sbjct: 107 AQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G+A  ++ D   +    GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 164 GLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 187 AVDIWSLGCIFAEMV 201

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 8/115 (6%)
Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKN-LLLDLEY---EAHVADF 57
           A  + L   +  + IK + D ++YLH      I H DL  +N +LLD         + DF
Sbjct: 107 AQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G+A  ++ D   +    GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 164 GLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 126 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 186 AVDIWSLGCIFAEMV 200

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 185 AVDIWSLGCIFAEMV 199

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 185 AVDIWSLGCIFAEMV 199

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 39/75 (52%), Gaps = 1/75 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMK-ITE 92
           ++HRDL  +NLL++ E    +ADFG+A+        +     T  Y APE+    K  + 
Sbjct: 124 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 93  KCDVYSFGVLALEVI 107
             D++S G +  E++
Sbjct: 184 AVDIWSLGCIFAEMV 198

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    ++
Sbjct: 143 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS 197
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 255
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 256 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 8/115 (6%)
Query: 2   AAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKN-LLLDLEY---EAHVADF 57
           A  + L   +  + IK + D ++YLH      I H DL  +N +LLD         + DF
Sbjct: 107 AQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 58  GIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           G+A  ++ D   +    GT  +VAPE+     +  + D++S GV+   ++ G  P
Sbjct: 164 GLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    ++
Sbjct: 143 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS 197
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 255
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 256 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 189
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 189
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA-HVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           +L+Y+H      I HRD+  +NLLLD +     + DFG AK L     N +     Y Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 189
Query: 81  APELAY-TMKITEKCDVYSFGVLALEVIKGK 110
           APEL +     T   DV+S G +  E++ G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    ++
Sbjct: 135 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS 189
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 190 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 247
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 248 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    ++
Sbjct: 150 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS 204
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 205 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 262
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 263 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 306

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    ++
Sbjct: 160 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS 214
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 215 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 272
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 273 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 316

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    ++
Sbjct: 144 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS 198
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 199 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 256
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 257 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    ++
Sbjct: 158 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS 212
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 270
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 271 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    ++
Sbjct: 144 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS 198
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 199 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 256
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 257 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    ++
Sbjct: 170 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS 224
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 225 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 282
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 283 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 326

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 69/174 (39%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    + 
Sbjct: 161 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAG 215
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 216 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 273
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 274 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 317

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    ++
Sbjct: 158 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS 212
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 270
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 271 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 69/174 (39%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    + 
Sbjct: 184 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAG 238
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 296
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 297 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 340

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    ++
Sbjct: 158 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS 212
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 270
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 271 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/92 (26%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+   F   VHR+L+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 139 IADGMAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 193
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               ++APE       T   D++SFGV+  E+
Sbjct: 194 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/92 (26%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT-- 76
           +AD ++YL+   F   VHR+L+++N ++  ++   + DFG+ + +    +++    G   
Sbjct: 140 IADGMAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGL 194
Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEV 106
               ++APE       T   D++SFGV+  E+
Sbjct: 195 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 26/174 (14%)
Query: 13  MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVA---DFGIAKFLKPDSSN 69
           ++  + +A    YL  + F   +HRD++++N LL       VA   DFG+A+ +    ++
Sbjct: 144 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIY--RAS 198
Query: 70  WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLXXXXXXXL 124
           +    G       ++ PE       T K D +SFGVL  E+   G  P  +        L
Sbjct: 199 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVL 256
Query: 125 NTDIELDEMLDPR-LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   M  P+  P P          + ++   C    PE RP   I+ +++
Sbjct: 257 EFVTSGGRMDPPKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 64/142 (45%), Gaps = 26/142 (18%)
Query: 34  IVHRDLSSKNLLLDLEYE-AHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKIT 91
           +VHRD+  +N+L+DL    A + DFG    L      +T+F GT  Y  PE ++      
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTRVYSPPEWISRHQYHA 217
Query: 92  EKCDVYSFGVLALEVIKGKHP--RDFLXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKL 149
               V+S G+L  +++ G  P  RD                 E+L+  L  P+  V    
Sbjct: 218 LPATVWSLGILLYDMVCGDIPFERD----------------QEILEAELHFPAH-VSPDC 260
Query: 150 ISIVKVAFSCLNESPESRPTMK 171
            ++++    CL   P SRP+++
Sbjct: 261 CALIR---RCLAPKPSSRPSLE 279

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 7/85 (8%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTM----- 88
           IVHRDL  +N+LLD +    + DFG +  L P         GT  Y+APE+         
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLRSVCGTPSYLAPEIIECSMNDNH 203
Query: 89  -KITEKCDVYSFGVLALEVIKGKHP 112
               ++ D++S GV+   ++ G  P
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 41/86 (47%), Gaps = 9/86 (10%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEF---AGTYGYVAPELAYTMK- 89
           ++HRD+   N+LLD      +ADFG    +K D +         GT  Y++PE+  +   
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVHCDTAVGTPDYISPEVLKSQGG 252
Query: 90  ---ITEKCDVYSFGVLALEVIKGKHP 112
                 +CD +S GV   E++ G  P
Sbjct: 253 DGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 38/74 (51%), Gaps = 1/74 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 152 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 210
Query: 94  CDVYSFGVLALEVI 107
            D++S G +  E++
Sbjct: 211 VDLWSVGCIMGEMV 224

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT--EFAGTYG 78
           D L YLH      IVH+D+   NLLL       ++  G+A+ L P +++ T     G+  
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 79  YVAPELAYTMKITE--KCDVYSFGVLALEVIKGKHP 112
           +  PE+A  +      K D++S GV    +  G +P
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 23/74 (31%), Positives = 38/74 (51%), Gaps = 1/74 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y APE+   M   E 
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 94  CDVYSFGVLALEVI 107
            D++S G +  E++
Sbjct: 200 VDLWSVGCIMGEMV 213

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 54/114 (47%), Gaps = 13/114 (11%)
Query: 5   QELDWSQRM---NTIKGVA----DALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVAD 56
            ELD  QR    + +K +      A+++ H H+C    +HRD+  +N+L+       + D
Sbjct: 90  HELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC----IHRDVKPENILITKHSVIKLCD 145
Query: 57  FGIAKFLKPDSSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKG 109
           FG A+ L   S  + +   T  Y +PEL     +     DV++ G +  E++ G
Sbjct: 146 FGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 47/110 (42%), Gaps = 25/110 (22%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLL-LDLEYEA------------------HVADFGI 59
           +  AL +LH +    + H DL  +N+L ++ E+E                    VADFG 
Sbjct: 132 LCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 60  AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG 109
           A F   D  + T    T  Y  PE+   +   + CDV+S G +  E  +G
Sbjct: 189 ATF---DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 47/110 (42%), Gaps = 25/110 (22%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLL-LDLEYEA------------------HVADFGI 59
           +  AL +LH +    + H DL  +N+L ++ E+E                    VADFG 
Sbjct: 141 LCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 197
Query: 60  AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG 109
           A F   D  + T    T  Y  PE+   +   + CDV+S G +  E  +G
Sbjct: 198 ATF---DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 244

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 43/96 (44%), Gaps = 8/96 (8%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA-KFLKPDSSNWTEFAGTYGYV 80
           AL  +H   F   +HRD+   N+LLD      +ADFG   K  K          GT  Y+
Sbjct: 180 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 81  APELAYTMK----ITEKCDVYSFGVLALEVIKGKHP 112
           +PE+  +         +CD +S GV   E++ G  P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 47/110 (42%), Gaps = 25/110 (22%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLL-LDLEYEA------------------HVADFGI 59
           +  AL +LH +    + H DL  +N+L ++ E+E                    VADFG 
Sbjct: 164 LCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 220
Query: 60  AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKG 109
           A F   D  + T    T  Y  PE+   +   + CDV+S G +  E  +G
Sbjct: 221 ATF---DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 267

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 43/96 (44%), Gaps = 8/96 (8%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA-KFLKPDSSNWTEFAGTYGYV 80
           AL  +H   F   +HRD+   N+LLD      +ADFG   K  K          GT  Y+
Sbjct: 185 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 241
Query: 81  APELAYTMK----ITEKCDVYSFGVLALEVIKGKHP 112
           +PE+  +         +CD +S GV   E++ G  P
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY- 77
           +A  + YL    F   +HRDL+++N +L  +    VADFG+++ +          A    
Sbjct: 146 IACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 78  -GYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLXXXXXXXLNTDIELDEMLD 135
             ++A E       T   DV++FGV   E++ +G+ P   +        N +I    +  
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-------NAEIYNYLIGG 255
Query: 136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            RL  P   ++E    +  + + C +  P+ RP+   +  +L
Sbjct: 256 NRLKQPPECMEE----VYDLMYQCWSADPKQRPSFTCLRMEL 293

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 6/99 (6%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY--EAHVADFGIAKFLKPDSSNWTEF 73
           ++ V   L ++H + +   VH DL  +N++   +   E  + DFG+   L P  S     
Sbjct: 261 MRQVCKGLCHMHENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT- 316
Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            GT  + APE+A    +    D++S GVL+  ++ G  P
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 76/176 (43%), Gaps = 26/176 (14%)
Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           + +D  +R +  K + +A+  +H      IVH DL   N L+ ++    + DFGIA  ++
Sbjct: 106 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQ 161
Query: 65  PDSSNWTEFA--GTYGYVAPELAYTMKITEK-----------CDVYSFGVLALEVIKGKH 111
           PD+++  + +  GT  Y+ PE    M  + +            DV+S G +   +  GK 
Sbjct: 162 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 221
Query: 112 PRDFLXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESR 167
           P   +       +N   +L  ++DP        + EK   +  V   CL   P+ R
Sbjct: 222 PFQQI-------INQISKLHAIIDPNHEIEFPDIPEK--DLQDVLKCCLKRDPKQR 268

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 43/96 (44%), Gaps = 8/96 (8%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA-KFLKPDSSNWTEFAGTYGYV 80
           AL  +H   F   +HRD+   N+LLD      +ADFG   K  K          GT  Y+
Sbjct: 185 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 241
Query: 81  APELAYTMK----ITEKCDVYSFGVLALEVIKGKHP 112
           +PE+  +         +CD +S GV   E++ G  P
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 6/99 (6%)
Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY--EAHVADFGIAKFLKPDSSNWTEF 73
           ++ V   L ++H + +   VH DL  +N++   +   E  + DFG+   L P  S     
Sbjct: 155 MRQVCKGLCHMHENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT- 210
Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            GT  + APE+A    +    D++S GVL+  ++ G  P
Sbjct: 211 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           + +D  +R +  K + +A+  +H      IVH DL   N L+ ++    + DFGIA  ++
Sbjct: 150 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQ 205
Query: 65  PDSSNWTEFA--GTYGYVAPELAYTMKITEK-----------CDVYSFGVLALEVIKGKH 111
           PD+++  + +  GT  Y+ PE    M  + +            DV+S G +   +  GK 
Sbjct: 206 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
Query: 112 PRDFLXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESR 167
           P           +N   +L  ++DP        + EK   +  V   CL   P+ R
Sbjct: 266 P-------FQQIINQISKLHAIIDPNHEIEFPDIPEK--DLQDVLKCCLKRDPKQR 312

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           + +D  +R +  K + +A+  +H      IVH DL   N L+ ++    + DFGIA  ++
Sbjct: 102 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQ 157
Query: 65  PDSSNWTEFA--GTYGYVAPELAYTMKITEK-----------CDVYSFGVLALEVIKGKH 111
           PD+++  + +  GT  Y+ PE    M  + +            DV+S G +   +  GK 
Sbjct: 158 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 217
Query: 112 PRDFLXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESR 167
           P           +N   +L  ++DP        + EK   +  V   CL   P+ R
Sbjct: 218 P-------FQQIINQISKLHAIIDPNHEIEFPDIPEK--DLQDVLKCCLKRDPKQR 264

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 26/176 (14%)
Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           + +D  +R +  K + +A+  +H      IVH DL   N L+ ++    + DFGIA  ++
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQ 177
Query: 65  PDSSNWTEFA--GTYGYVAPELAYTMKITEK-----------CDVYSFGVLALEVIKGKH 111
           PD+++  + +  GT  Y+ PE    M  + +            DV+S G +   +  GK 
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
Query: 112 PRDFLXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESR 167
           P           +N   +L  ++DP        + EK   +  V   CL   P+ R
Sbjct: 238 P-------FQQIINQISKLHAIIDPNHEIEFPDIPEK--DLQDVLKCCLKRDPKQR 284

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 40.4 bits (93), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 23/79 (29%), Positives = 37/79 (46%), Gaps = 1/79 (1%)
Query: 35  VHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS-SNWTEFAGTYGYVAPELAYTMKITEK 93
            HRD+  +N+L+  +  A++ DFGIA     +  +      GT  Y APE       T +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 94  CDVYSFGVLALEVIKGKHP 112
            D+Y+   +  E + G  P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 40.0 bits (92), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 22/80 (27%), Positives = 41/80 (51%), Gaps = 1/80 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKI-TE 92
           ++HRDL  +NLL++   E  +ADFG+A+        ++    T  Y  P++ +  K+ + 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 93  KCDVYSFGVLALEVIKGKHP 112
             D++S G +  E+     P
Sbjct: 182 SIDMWSAGCIFAELANAARP 201

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 40.0 bits (92), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L +LH      +VHRDL  +N+L+    +  +ADFG+A+      +  T    T  Y A
Sbjct: 132 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRA 187
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGK 110
           PE+          D++S G +  E+ + K
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 76/176 (43%), Gaps = 26/176 (14%)
Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           + +D  +R +  K + +A+  +H      IVH DL   N L+ ++    + DFGIA  ++
Sbjct: 103 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQ 158
Query: 65  PDSSNWTEFA--GTYGYVAPELAYTMKITEK-----------CDVYSFGVLALEVIKGKH 111
           PD+++  + +  GT  Y+ PE    M  + +            DV+S G +   +  GK 
Sbjct: 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
Query: 112 PRDFLXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESR 167
           P   +       +N   +L  ++DP        + EK   +  V   CL   P+ R
Sbjct: 219 PFQQI-------INQISKLHAIIDPNHEIEFPDIPEK--DLQDVLKCCLKRDPKQR 265

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/74 (29%), Positives = 36/74 (48%), Gaps = 1/74 (1%)
Query: 34  IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEK 93
           I+HRDL   N+++  +    + DFG+A+          E    Y Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-YRAPEVILGMGYKEN 205
Query: 94  CDVYSFGVLALEVI 107
            D++S G +  E++
Sbjct: 206 VDIWSVGCIMGEMV 219

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L +LH      +VHRDL  +N+L+    +  +ADFG+A+      +  T    T  Y A
Sbjct: 132 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRA 187
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGK 110
           PE+          D++S G +  E+ + K
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 57/113 (50%), Gaps = 18/113 (15%)
Query: 15  TIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEA---HVADFGIAKFLKPD----- 66
            ++ VA AL +LH+     I HRDL  +N+L +   +     + DFG+   +K +     
Sbjct: 116 VVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSP 172
Query: 67  --SSNWTEFAGTYGYVAPEL--AYTMKIT---EKCDVYSFGVLALEVIKGKHP 112
             +       G+  Y+APE+  A++ + +   ++CD++S GV+   ++ G  P
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 40.0 bits (92), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L +LH      +VHRDL  +N+L+    +  +ADFG+A+      +  T    T  Y A
Sbjct: 132 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRA 187
Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGK 110
           PE+          D++S G +  E+ + K
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 39.7 bits (91), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 76/176 (43%), Gaps = 26/176 (14%)
Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           + +D  +R +  K + +A+  +H      IVH DL   N L+ ++    + DFGIA  ++
Sbjct: 150 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQ 205
Query: 65  PDSSNWTEFA--GTYGYVAPELAYTMKITEK-----------CDVYSFGVLALEVIKGKH 111
           PD+++  + +  GT  Y+ PE    M  + +            DV+S G +   +  GK 
Sbjct: 206 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
Query: 112 PRDFLXXXXXXXLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESR 167
           P   +       +N   +L  ++DP        + EK   +  V   CL   P+ R
Sbjct: 266 PFQQI-------INQISKLHAIIDPNHEIEFPDIPEK--DLQDVLKCCLKRDPKQR 312

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 39.7 bits (91), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/79 (31%), Positives = 39/79 (49%), Gaps = 3/79 (3%)
Query: 34  IVHRDLSSKNLLLD-LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY-TMKIT 91
           + HRD+   N+L++  +    + DFG AK L P   N       Y Y APEL +     T
Sbjct: 152 VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-YRAPELIFGNQHYT 210
Query: 92  EKCDVYSFGVLALEVIKGK 110
              D++S G +  E++ G+
Sbjct: 211 TAVDIWSVGCIFAEMMLGE 229

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	179
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-60
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-50
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-49
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-41
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-37
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-35
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-32
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-31
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-30
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-29
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-28
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-22
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-21
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-21
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-21
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-20
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-20
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-20
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-19
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-19
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-19
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-18
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-18
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-18
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-18
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-17
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-17
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-17
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-17
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-17
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-17
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-17
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-16
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-16
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-16
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-16
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-16
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-16
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-16
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-15
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-15
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-15
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-15
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-15
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-15
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-15
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-15
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-15
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-15
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-15
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-15
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-15
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-15
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-15
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-15
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-15
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-15
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-15
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-15
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-15
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-15
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-15
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-14
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-14
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-14
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-14
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-14
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-14
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-14
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-14
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-14
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-14
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-14
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-14
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-14
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-14
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-14
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-14
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-14
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-14
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-14
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-14
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-14
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-13
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-13
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-13
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-13
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-13
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-13
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-13
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-13
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-13
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-13
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-13
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-13
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-13
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-13
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-12
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-12
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-12
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-12
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-12
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-12
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-12
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-12
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-12
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-11
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-10
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-10
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-10
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-10
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-10
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-10
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-10
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-10
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-10
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-09
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-09
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-09
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-09
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-09
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-09
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-09
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-09
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-09
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-09
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-09
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-08
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-08
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-08
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-08
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-08
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-08
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-08
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-08
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-08
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-08
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-08
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-07
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-07
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-07
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-07
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-07
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-07
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-07
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-06
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-05
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-05
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-05
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-05
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-05
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-05
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-05
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-05
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-05
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-04
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-04
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-04
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  190 bits (484), Expect = 1e-60
 Identities = 62/177 (35%), Positives = 93/177 (52%), Gaps = 12/177 (6%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           LDW +R     G A  L+YLH  C P I+HRD+ + N+LLD E+EA V DFG+AK +   
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187

Query: 67  SSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN 125
            ++  T   GT G++APE   T K +EK DV+ +GV+ LE+I G+   D     +   + 
Sbjct: 188 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247

Query: 126 ---------TDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIV 173
                     + +L+ ++D  L        E++  +++VA  C   SP  RP M  V
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  162 bits (413), Expect = 5e-50
 Identities = 59/189 (31%), Positives = 87/189 (46%), Gaps = 20/189 (10%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           D     + W QR+    G A  L YLH      I+HRD+ S N+LLD  +   + DFGI+
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186

Query: 61  KFLKPDSSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLS 117
           K    +       T   GT GY+ PE     ++TEK DVYSFGV+  EV+  +       
Sbjct: 187 K-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245

Query: 118 SISSSSL-------NTDIELDEMLDPRLPA--PSRSVQEKLISIVKVAFSCLNESPESRP 168
                +L       + + +L++++DP L       S+++        A  CL  S E RP
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK----FGDTAVKCLALSSEDRP 301

Query: 169 TMKIVSQQL 177
           +M  V  +L
Sbjct: 302 SMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  161 bits (410), Expect = 1e-49
 Identities = 55/180 (30%), Positives = 91/180 (50%), Gaps = 17/180 (9%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L W  R    +G A+ +++LH +     +HRD+ S N+LLD  + A ++DFG+A+     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEK 185

Query: 67  SSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDF------LS 117
            +     +   GT  Y+APE A   +IT K D+YSFGV+ LE+I G    D       L 
Sbjct: 186 FAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244

Query: 118 SISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            I     + +  +++ +D ++   + +    + ++  VA  CL+E    RP +K V Q L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  140 bits (354), Expect = 3e-41
 Identities = 43/197 (21%), Positives = 76/197 (38%), Gaps = 27/197 (13%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCF-------PPIVHRDLSSKNLLLDLEYEAHVADFGI 59
           + W++  +  + +A  L+YLH D         P I HRD+ SKN+LL     A +ADFG+
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177

Query: 60  AKFLKPDSSNW--TEFAGTYGYVAPELA-----YTMKITEKCDVYSFGVLALEVIKGKHP 112
           A   +   S        GT  Y+APE+      +      + D+Y+ G++  E+      
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

Query: 113 RDFLSSIS----SSSLNTDIELDEM--------LDPRLPAPSRSVQEKLISIVKVAFSCL 160
            D             +     L++M          P L          +  + +    C 
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR-DYWQKHAGMAMLCETIEECW 296

Query: 161 NESPESRPTMKIVSQQL 177
           +   E+R +   V +++
Sbjct: 297 DHDAEARLSAGCVGERI 313

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  128 bits (324), Expect = 6e-37
 Identities = 42/174 (24%), Positives = 79/174 (45%), Gaps = 13/174 (7%)

Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE-AHVADFGIAKFLK 64
               +  M+     +  ++YLH      ++HRDL   NLLL        + DFG A  ++
Sbjct: 98  YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157

Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL 124
              ++ T   G+  ++APE+      +EKCDV+S+G++  EVI  + P D +   +    
Sbjct: 158 ---THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--- 211

Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
              I        R P    ++ + + S++     C ++ P  RP+M+ + + + 
Sbjct: 212 --RIMWAVHNGTRPPLIK-NLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  124 bits (314), Expect = 9e-36
 Identities = 48/182 (26%), Positives = 82/182 (45%), Gaps = 20/182 (10%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH--------VAD 56
           + +     +N    +A  ++YLH +   PI+HRDL S N+L+  + E          + D
Sbjct: 100 KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159

Query: 57  FGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFL 116
           FG+A+     +      AG Y ++APE+      ++  DV+S+GVL  E++ G+ P   +
Sbjct: 160 FGLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

Query: 117 SSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ 176
             ++            M    LP PS +  E    +++    C N  P SRP+   +  Q
Sbjct: 218 DGLAV------AYGVAMNKLALPIPS-TCPEPFAKLME---DCWNPDPHSRPSFTNILDQ 267

Query: 177 LR 178
           L 
Sbjct: 268 LT 269

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  124 bits (314), Expect = 2e-35
 Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 23/180 (12%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           ++LD  +R++    VA  ++YLH+   PPIVHR+L S NLL+D +Y   V DFG+++   
Sbjct: 132 EQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190

Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI------KGKHPRDFLSS 118
               +    AGT  ++APE+       EK DVYSFGV+  E+          +P   +++
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 250

Query: 119 ISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           +                 RL  P  ++  ++ +I++    C    P  RP+   +   LR
Sbjct: 251 VGFKCK------------RLEIPR-NLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  123 bits (310), Expect = 5e-35
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 19/181 (10%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE-----AHVADFGI 59
             + WS ++  +  +A  + Y+ +   PPIVHRDL S N+ L    E     A VADFG+
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175

Query: 60  AKFLKPDSSNWTEFAGTYGYVAPELAYTMKI--TEKCDVYSFGVLALEVIKGKHPRDFLS 117
           ++     S   +   G + ++APE     +   TEK D YSF ++   ++ G+ P D  S
Sbjct: 176 SQQ-SVHSV--SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

Query: 118 SISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                 +N   E       R   P      +L ++++    C +  P+ RP    + ++L
Sbjct: 233 YGKIKFINMIREEGL----RPTIPE-DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284

Query: 178 R 178
            
Sbjct: 285 S 285

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  119 bits (301), Expect = 2e-33
 Identities = 49/187 (26%), Positives = 74/187 (39%), Gaps = 26/187 (13%)

Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL-- 63
           +  WSQR++  K +A  ++YLH      I+HRDL+S N L+       VADFG+A+ +  
Sbjct: 104 QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160

Query: 64  ------------KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKH 111
                       KPD        G   ++APE+       EK DV+SFG++  E+I   +
Sbjct: 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220

Query: 112 PRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
                          D  L+         P  +       I      C +  PE RP+  
Sbjct: 221 ADPDY-----LPRTMDFGLNVRGFLDRYCPP-NCPPSFFPI---TVRCCDLDPEKRPSFV 271

Query: 172 IVSQQLR 178
            +   L 
Sbjct: 272 KLEHWLE 278

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  115 bits (291), Expect = 2e-32
 Identities = 36/176 (20%), Positives = 73/176 (41%), Gaps = 19/176 (10%)

Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
            +D SQ +     +A  +++LH    P I    L+S+++++D +  A ++   +    + 
Sbjct: 107 VVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165

Query: 66  DSSNWTEFAGTYGYVAPEL---AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS 122
                        +VAPE              D++SF VL  E++  + P  F + +S+ 
Sbjct: 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP--F-ADLSNM 217

Query: 123 SLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
            +   + L+ +   R   P   +   +  ++K    C+NE P  RP   ++   L 
Sbjct: 218 EIGMKVALEGL---RPTIPP-GISPHVSKLMK---ICMNEDPAKRPKFDMIVPILE 266

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  115 bits (289), Expect = 1e-31
 Identities = 40/208 (19%), Positives = 77/208 (37%), Gaps = 35/208 (16%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHD------CFPPIVHRDLSSKNLLLDLEYEAHVADFG 58
              DW         V   L+YLH +        P I HRDL+S+N+L+  +    ++DFG
Sbjct: 106 HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165

Query: 59  IAKFLKPDSSNWTEF--------AGTYGYVAPE-------LAYTMKITEKCDVYSFGVLA 103
           ++  L  +                GT  Y+APE       L       ++ D+Y+ G++ 
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

Query: 104 LEVIKGKHPRDFLSSIS------SSSLNTDIELDEMLD--------PRLPAPSRSVQEKL 149
            E+           S+        + +      ++M          P+ P   +     +
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV 285

Query: 150 ISIVKVAFSCLNESPESRPTMKIVSQQL 177
            S+ +    C ++  E+R T +   +++
Sbjct: 286 RSLKETIEDCWDQDAEARLTAQXAEERM 313

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  110 bits (277), Expect = 4e-30
 Identities = 45/198 (22%), Positives = 81/198 (40%), Gaps = 25/198 (12%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGI 59
             LD    +  +  +A  L++LH + F     P I HRDL SKN+L+    +  +AD G+
Sbjct: 100 TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159

Query: 60  AKFLKPDSS----NWTEFAGTYGYVAPEL------AYTMKITEKCDVYSFGVLALEVIKG 109
           A      ++          GT  Y+APE+             ++ D+++FG++  EV + 
Sbjct: 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

Query: 110 KHPRDFLSSIS---SSSLNTDIELDEMLDP------RLPAPSRSVQEK-LISIVKVAFSC 159
                 +          +  D   ++M         R   P+R   +  L S+ K+   C
Sbjct: 220 MVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKEC 279

Query: 160 LNESPESRPTMKIVSQQL 177
             ++P +R T   + + L
Sbjct: 280 WYQNPSARLTALRIKKTL 297

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  110 bits (276), Expect = 5e-30
 Identities = 36/177 (20%), Positives = 78/177 (44%), Gaps = 14/177 (7%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK-- 64
            +  + ++  +  A  + YLH      I+HRDL S N+ L  +    + DFG+A      
Sbjct: 117 FEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173

Query: 65  PDSSNWTEFAGTYGYVAPEL---AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS 121
             S  + + +G+  ++APE+     +   + + DVY+FG++  E++ G+ P   +++   
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

Query: 122 SSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
                       L P L     +  +++  ++     CL +  + RP+   +  ++ 
Sbjct: 234 IIEMVG---RGSLSPDLSKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIE 284

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  109 bits (275), Expect = 2e-29
 Identities = 48/199 (24%), Positives = 77/199 (38%), Gaps = 25/199 (12%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGI 59
             LD    +         L +LH + F     P I HRDL SKN+L+       +AD G+
Sbjct: 129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188

Query: 60  AKFLKPDSSNW----TEFAGTYGYVAPE-LAYTMKI-----TEKCDVYSFGVLALEVIKG 109
           A     D++          GT  Y+ PE L  ++           D+YSFG++  EV + 
Sbjct: 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

Query: 110 KHPRDFLSSI---SSSSLNTDIELDEMLDP------RLPAPSRSVQEK-LISIVKVAFSC 159
                 +          + +D   ++M +       R   P+R   ++ L  + K+   C
Sbjct: 249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308

Query: 160 LNESPESRPTMKIVSQQLR 178
              +P SR T   V + L 
Sbjct: 309 WAHNPASRLTALRVKKTLA 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  106 bits (267), Expect = 3e-28
 Identities = 41/197 (20%), Positives = 73/197 (37%), Gaps = 25/197 (12%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGIAK 61
           +     +      A  L++LH +       P I HRDL SKN+L+       +AD G+A 
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195

Query: 62  FLKPDSS----NWTEFAGTYGYVAPEL------AYTMKITEKCDVYSFGVLALEVIKGKH 111
                +           GT  Y+APE+          +  ++ D+Y+ G++  E+ +   
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255

Query: 112 PRDFLSSIS---SSSLNTDIELDEMLDP------RLPAPSR-SVQEKLISIVKVAFSCLN 161
                          + +D  ++EM         R   P+R    E L  + K+   C  
Sbjct: 256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 315

Query: 162 ESPESRPTMKIVSQQLR 178
            +  +R T   + + L 
Sbjct: 316 ANGAARLTALRIKKTLS 332

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  106 bits (266), Expect = 3e-28
 Identities = 32/186 (17%), Positives = 66/186 (35%), Gaps = 28/186 (15%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK----- 61
           LD ++     + +   + YLH      I+H+DL SKN+  D   +  + DFG+       
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182

Query: 62  FLKPDSSNWTEFAGTYGYVAPELAYTMKI---------TEKCDVYSFGVLALEVIKGKHP 112
                        G   ++APE+   +           ++  DV++ G +  E+   + P
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

Query: 113 RDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKI 172
                +  + ++   +        +       + +++  I+     C     E RPT   
Sbjct: 243 ---FKTQPAEAIIWQMGTGM----KPNLSQIGMGKEISDILL---FCWAFEQEERPTFTK 292

Query: 173 VSQQLR 178
           +   L 
Sbjct: 293 LMDMLE 298

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 88.5 bits (220), Expect = 6e-22
 Identities = 45/150 (30%), Positives = 65/150 (43%), Gaps = 13/150 (8%)

Query: 22  ALSYLH--HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGY 79
           AL   H   D    ++HRDL   N+ LD +    + DFG+A+ L  D+S    F GT  Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 80  VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLP 139
           ++PE    M   EK D++S G L  E+     P  F +  S   L   I   +    R+P
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAF-SQKELAGKIREGKF--RRIP 237

Query: 140 APSRSVQEKLISIVKVAFSCLNESPESRPT 169
                  ++L  I+      LN     RP+
Sbjct: 238 Y---RYSDELNEIIT---RMLNLKDYHRPS 261

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 89.4 bits (222), Expect = 1e-21
 Identities = 43/169 (25%), Positives = 68/169 (40%), Gaps = 26/169 (15%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLL-----DLEYEAHVADFGIAKFLKPDSS-- 68
           ++     L++LH      IVHRDL   N+L+       + +A ++DFG+ K L       
Sbjct: 124 LQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180

Query: 69  -NWTEFAGTYGYVAPEL---AYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSS 123
              +   GT G++APE+         T   D++S G +   VI +G HP        ++ 
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI 240

Query: 124 LNTDIELDEMLDPRLPAPSRSVQEK-LISIVKVAFSCLNESPESRPTMK 171
           L         LD   P     V  + LI         +   P+ RP+ K
Sbjct: 241 LLGACS----LDCLHPEKHEDVIARELIE------KMIAMDPQKRPSAK 279

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 87.0 bits (216), Expect = 2e-21
 Identities = 30/153 (19%), Positives = 61/153 (39%), Gaps = 20/153 (13%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +   + Y+H      +++RDL   N+ L    +  + DFG+   LK D        GT  
Sbjct: 131 ITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR-SKGTLR 186

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL 138
           Y++PE   +    ++ D+Y+ G++  E++         S              ++ D  +
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF----------FTDLRDGII 236

Query: 139 PAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
                   +K  ++++     L++ PE RP   
Sbjct: 237 SD---IFDKKEKTLLQ---KLLSKKPEDRPNTS 263

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 87.0 bits (216), Expect = 3e-21
 Identities = 33/149 (22%), Positives = 61/149 (40%), Gaps = 14/149 (9%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
            L +LH    PPI+HRDL   N+ +        + D G+A   +   +      GT  ++
Sbjct: 141 GLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFM 197

Query: 81  APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPA 140
           APE+ Y  K  E  DVY+FG+  LE+   ++P     + +            +       
Sbjct: 198 APEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDK 253

Query: 141 PSRSVQEKLISIVKVAFSCLNESPESRPT 169
            +    +++I        C+ ++ + R +
Sbjct: 254 VAIPEVKEIIE------GCIRQNKDERYS 276

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 85.1 bits (211), Expect = 2e-20
 Identities = 38/179 (21%), Positives = 73/179 (40%), Gaps = 28/179 (15%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           +E + S  ++    +A+A+ +LH      ++HRDL   N+   ++    V DFG+   + 
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169

Query: 65  ------------PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
                       P  +  T   GT  Y++PE  +    + K D++S G++  E++   +P
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP 226

Query: 113 RDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             F + +      TD+   +   P L       +  ++         L+ SP  RP   
Sbjct: 227 --FSTQMERVRTLTDVRNLKF--PPLFTQKYPCEYVMVQ------DMLSPSPMERPEAI 275

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 84.9 bits (210), Expect = 3e-20
 Identities = 34/171 (19%), Positives = 63/171 (36%), Gaps = 42/171 (24%)

Query: 20  ADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS----------- 68
           A+A+ +LH      ++HRDL   N+   ++    V DFG+   +  D             
Sbjct: 174 AEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230

Query: 69  -NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD 127
              T   GT  Y++PE  +    + K D++S G++  E++   +             +T 
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YS-----------FSTQ 276

Query: 128 IELDEMLD-------PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           +E   ++        P L       +  ++         L+ SP  RP   
Sbjct: 277 MERVRIITDVRNLKFPLLFTQKYPQEHMMVQ------DMLSPSPTERPEAT 321

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 84.3 bits (209), Expect = 3e-20
 Identities = 40/154 (25%), Positives = 67/154 (43%), Gaps = 13/154 (8%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL ++H      ++HRD+   N+ +       + D G+ +F    ++      GT  
Sbjct: 145 LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 201

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS-SSLNTDIELDEMLDPR 137
           Y++PE  +      K D++S G L  E+   + P  F     +  SL   IE  +   P 
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDY--PP 257

Query: 138 LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           LP+   S  E+L  +V     C+N  PE RP + 
Sbjct: 258 LPSDHYS--EELRQLVN---MCINPDPEKRPDVT 286

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 84.4 bits (209), Expect = 6e-20
 Identities = 38/151 (25%), Positives = 62/151 (41%), Gaps = 14/151 (9%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  AL ++H      I+HRD+ S+N+ L  +    + DFGIA+ L           GT  
Sbjct: 134 ICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL 138
           Y++PE+        K D+++ G +  E+   KH   F  + S  +L   I       P +
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHA--F-EAGSMKNLVLKIISGSF--PPV 245

Query: 139 PAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
                     L S+V         +P  RP+
Sbjct: 246 SL---HYSYDLRSLVS---QLFKRNPRDRPS 270

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 82.8 bits (204), Expect = 3e-19
 Identities = 19/153 (12%), Positives = 39/153 (25%), Gaps = 11/153 (7%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +    + L       +VH   +  NL +  +    + D           +     +    
Sbjct: 203 LIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL---WKVGTRGPASSVPVT 256

Query: 79  YVAPEL--AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDP 136
           Y   E   A T   T   + +  G+    V     P   ++     S           D 
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDS 316

Query: 137 RLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
                   + + + +++      LN     R  
Sbjct: 317 LAFGSCTPLPDFVKTLIG---RFLNFDRRRRLL 346

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 81.6 bits (202), Expect = 3e-19
 Identities = 44/168 (26%), Positives = 65/168 (38%), Gaps = 28/168 (16%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW-------- 70
           + +ALSY+H      I+HRDL   N+ +D      + DFG+AK +               
Sbjct: 125 ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 71  ------TEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS 123
                 T   GT  YVA E L  T    EK D+YS G++  E+I          +I    
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKL 241

Query: 124 LNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            +  IE      P        V++K+I         ++  P  RP  +
Sbjct: 242 RSVSIE----FPPDFDDNKMKVEKKIIR------LLIDHDPNKRPGAR 279

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 81.8 bits (202), Expect = 7e-19
 Identities = 45/181 (24%), Positives = 75/181 (41%), Gaps = 35/181 (19%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH-------------VADFGIAKF 62
           ++ +A  +++LH      I+HRDL  +N+L+                    ++DFG+ K 
Sbjct: 121 LRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 63  LKPDSSNWT----EFAGTYGYVAPEL-------AYTMKITEKCDVYSFGVLALEVI-KGK 110
           L    S++       +GT G+ APEL           ++T   D++S G +   ++ KGK
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 111 HPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
           HP     S  S+ +     LDEM      +      + LIS        ++  P  RPT 
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD-LIS------QMIDHDPLKRPTA 290

Query: 171 K 171
            
Sbjct: 291 M 291

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 80.5 bits (199), Expect = 1e-18
 Identities = 37/174 (21%), Positives = 65/174 (37%), Gaps = 26/174 (14%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--------- 69
           +   L  +H        HRDL   N+LL  E +  + D G                    
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199

Query: 70  WTEFAGTYGYVAPEL----AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN 125
           W     T  Y APEL    ++ + I E+ DV+S G +   ++ G+ P  +          
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSV 256

Query: 126 TDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLRI 179
                +++  P+ P  S ++ + L++      S +   P  RP + ++  QL  
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQ-LLN------SMMTVDPHQRPHIPLLLSQLEA 303

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 79.2 bits (196), Expect = 2e-18
 Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 32/165 (19%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT 76
             +  AL +LH      ++HRD+   N+L++   +  + DFGI+ +L  D       AG 
Sbjct: 116 VSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGC 172

Query: 77  YGYVAPE--------LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDI 128
             Y+APE          Y++    K D++S G+  +E+   + P D        S  T  
Sbjct: 173 KPYMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFPYD--------SWGTPF 220

Query: 129 ELDEML----DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           +  + +     P+LPA   S   + +        CL ++ + RPT
Sbjct: 221 QQLKQVVEEPSPQLPADKFS--AEFVDFTS---QCLKKNSKERPT 260

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 80.0 bits (198), Expect = 3e-18
 Identities = 41/185 (22%), Positives = 68/185 (36%), Gaps = 35/185 (18%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
             L     +  +   A  + YL   C    +HRDL+++N L+  +    ++DFG+++   
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEA 264

Query: 65  PDSSN-----------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP 112
                           WT         APE     + + + DV+SFG+L  E    G  P
Sbjct: 265 DGVYAASGGLRQVPVKWT---------APEALNYGRYSSESDVWSFGILLWETFSLGASP 315

Query: 113 RDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKI 172
              LS       N           RLP P     + +  +++    C    P  RP+   
Sbjct: 316 YPNLS-------NQQTREFVEKGGRLPCP-ELCPDAVFRLME---QCWAYEPGQRPSFST 364

Query: 173 VSQQL 177
           + Q+L
Sbjct: 365 IYQEL 369

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 79.3 bits (196), Expect = 3e-18
 Identities = 46/162 (28%), Positives = 67/162 (41%), Gaps = 24/162 (14%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT 76
             +  AL YL       ++HRD+   N+LLD   +  + DFGI+  L  D       AG 
Sbjct: 131 VAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGC 187

Query: 77  YGYVAPELAYTMKITE-----KCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIE-L 130
             Y+APE       T+     + DV+S G+  +E+  G+ P          +  TD E L
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--------KNCKTDFEVL 239

Query: 131 DEMLD---PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
            ++L    P LP       +   S VK    CL +    RP 
Sbjct: 240 TKVLQEEPPLLPGHMGFSGD-FQSFVK---DCLTKDHRKRPK 277

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 79.2 bits (196), Expect = 3e-18
 Identities = 34/145 (23%), Positives = 60/145 (41%), Gaps = 13/145 (8%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L   + +  ++ +  AL   H        HRD+  +N+L+  +  A++ DFGIA      
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT--T 185

Query: 67  SSNWTE---FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLS---SIS 120
               T+     GT  Y+APE       T + D+Y+   +  E + G  P  +     S+ 
Sbjct: 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP--YQGDQLSVM 243

Query: 121 SSSLNTDIELDEMLDPRLPAPSRSV 145
            + +N  I     + P +P    +V
Sbjct: 244 GAHINQAIPRPSTVRPGIPVAFDAV 268

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 77.3 bits (191), Expect = 1e-17
 Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 6/109 (5%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           +   + +  I     AL++ H +    I+HRD+   N+++       V DFGIA+ +   
Sbjct: 113 MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169

Query: 67  SSNWTEFA---GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            ++ T+ A   GT  Y++PE A    +  + DVYS G +  EV+ G+ P
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.7 bits (192), Expect = 2e-17
 Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 9/95 (9%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           AL YL        I+HRD+   N+LLD     H+ DF IA  L  ++   T  AGT  Y+
Sbjct: 127 ALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYM 181

Query: 81  APELAYTMKI---TEKCDVYSFGVLALEVIKGKHP 112
           APE+  + K    +   D +S GV A E+++G+ P
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 77.8 bits (191), Expect = 2e-17
 Identities = 27/172 (15%), Positives = 49/172 (28%), Gaps = 29/172 (16%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L    R+     V   L+ LHH     +VH  L   +++LD      +  F      +  
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDG 262

Query: 67  SSNWTEFAGTYG---YVAPELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSS 118
           +S  +     +      A  +          +T   D ++ G+    +     P      
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--N--- 317

Query: 119 ISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
            +  +     E        +P P R+    L+         L    E R   
Sbjct: 318 -TDDAALGGSEWIFRSCKNIPQPVRA----LLE------GFLRYPKEDRLLP 358

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 77.0 bits (190), Expect = 2e-17
 Identities = 42/166 (25%), Positives = 64/166 (38%), Gaps = 31/166 (18%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT 76
                AL++L  +    I+HRD+   N+LLD      + DFGI+  L  DS   T  AG 
Sbjct: 132 LATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGC 188

Query: 77  YGYVAPE----LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDE 132
             Y+APE     A       + DV+S G+   E+  G+ P            N+  +   
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--------PKWNSVFDQLT 240

Query: 133 MLDPRLPAPSRSVQEKLISIVKVAFS---------CLNESPESRPT 169
            +  +   P      +L +  +  FS         CL +    RP 
Sbjct: 241 QV-VKGDPP------QLSNSEEREFSPSFINFVNLCLTKDESKRPK 279

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 76.7 bits (189), Expect = 3e-17
 Identities = 40/174 (22%), Positives = 61/174 (35%), Gaps = 30/174 (17%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--------- 69
              A+ ++H    PPI+HRDL  +NLLL  +    + DFG A  +               
Sbjct: 145 TCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203

Query: 70  ---WTEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS 123
                    T  Y  PE+        I EK D+++ G +   +   +HP  F        
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FEDGAKLRI 261

Query: 124 LNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           +N    +     P            LI       + L  +PE R ++  V  QL
Sbjct: 262 VNGKYSI-----PPHDTQYTVFH-SLIR------AMLQVNPEERLSIAEVVHQL 303

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 77.0 bits (189), Expect = 3e-17
 Identities = 29/176 (16%), Positives = 50/176 (28%), Gaps = 34/176 (19%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L    R+     V   L+ LHH     +VH  L   +++LD      +  F         
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD--- 256

Query: 67  SSNWTEFAGTYGYVAPEL-----------AYTMKITEKCDVYSFGVLALEVIKGKHPRDF 115
                  + + G+  PEL                +T   D ++ G++   +     P   
Sbjct: 257 -GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP--I 313

Query: 116 LSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
               +  +     E        +P P R+    L+         L    E R    
Sbjct: 314 ----TKDAALGGSEWIFRSCKNIPQPVRA----LLE------GFLRYPKEDRLLPL 355

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 76.2 bits (188), Expect = 4e-17
 Identities = 37/154 (24%), Positives = 54/154 (35%), Gaps = 24/154 (15%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
              AL++LH      +VH D+   N+ L       + DFG+   L    +      G   
Sbjct: 166 TLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPR 221

Query: 79  YVAPEL---AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD 135
           Y+APEL   +Y        DV+S G+  LEV                 L         L 
Sbjct: 222 YMAPELLQGSY----GTAADVFSLGLTILEVACNMELPHGGEGW--QQLRQGY-----LP 270

Query: 136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           P   A    +  +L S++      L   P+ R T
Sbjct: 271 PEFTA---GLSSELRSVLV---MMLEPDPKLRAT 298

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 75.3 bits (186), Expect = 7e-17
 Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 13/164 (7%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L     +N    + D + + H      IVHRD+  +N+L+D      + DFGIAK L   
Sbjct: 108 LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164

Query: 67  SSNWTEFA-GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN 125
           S   T    GT  Y +PE A      E  D+YS G++  E++ G+ P +  +++S     
Sbjct: 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS----- 219

Query: 126 TDIELDEMLDPRLPAPSRSVQEKL-ISIVKVAFSCLNESPESRP 168
             I +  + D  +P  +  V++ +  S+  V      +   +R 
Sbjct: 220 --IAIKHIQDS-VPNVTTDVRKDIPQSLSNVILRATEKDKANRY 260

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 76.2 bits (188), Expect = 7e-17
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 14  NTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSN 69
           + I+ + +A+ + H       +VHR+L  +NLLL  + +     +ADFG+A  ++ +   
Sbjct: 114 HCIQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169

Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 101
           W  FAGT GY++PE+       +  D+++ GV
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV 201

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 74.2 bits (183), Expect = 1e-16
 Identities = 36/94 (38%), Positives = 49/94 (52%), Gaps = 5/94 (5%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +    P S       GT  
Sbjct: 118 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTD-LCGTLD 172

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+ PE+       EK D++S GVL  E + GK P
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 75.1 bits (185), Expect = 1e-16
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 7/91 (7%)

Query: 14  NTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL-DLEYEAHV--ADFGIAKFLKPDSSNW 70
           + +K + +A++YLH +    IVHRDL  +NLL      +A +  ADFG++K ++      
Sbjct: 152 DAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-M 207

Query: 71  TEFAGTYGYVAPELAYTMKITEKCDVYSFGV 101
               GT GY APE+        + D++S G+
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 74.6 bits (184), Expect = 2e-16
 Identities = 28/92 (30%), Positives = 41/92 (44%), Gaps = 9/92 (9%)

Query: 16  IKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAH----VADFGIAKFLKPDSSNW 70
           +  +   + YLH       +VHRDL   N+L   E        + DFG AK L+ ++   
Sbjct: 122 LFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177

Query: 71  TEFAGTYGYVAPELAYTMKITEKCDVYSFGVL 102
                T  +VAPE+         CD++S GVL
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 74.1 bits (183), Expect = 2e-16
 Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 10/92 (10%)

Query: 14  NTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLL-DLEYEAHV--ADFGIAKFLKPDSSN 69
             I+ V  A+ YLH +     IVHRDL  +NLL    E  + +   DFG++K  +     
Sbjct: 110 LVIQQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GI 163

Query: 70  WTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 101
            +   GT GYVAPE+      ++  D +S GV
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 74.7 bits (183), Expect = 3e-16
 Identities = 44/174 (25%), Positives = 63/174 (36%), Gaps = 31/174 (17%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWTEFAG 75
           ++ AL YLH +    I+HRDL  +N++L    +     + D G AK L         F G
Sbjct: 130 ISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVG 185

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP----------------RDFLSSI 119
           T  Y+APEL    K T   D +SFG LA E I G  P                +     +
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245

Query: 120 SSSSLNTDIEL-DEMLDP-RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
               L   ++    +  P  L        E+ +  +      L      R T  
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM------LMWHQRQRGTDP 293

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 73.4 bits (181), Expect = 3e-16
 Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 40/189 (21%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           + +     +  +  V+  + YL    F   VHRDL+++N+LL  ++ A ++DFG++K L+
Sbjct: 112 RHVKDKNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALR 168

Query: 65  PDSSN------------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKH 111
            D +             W          APE     K + K DV+SFGVL  E    G+ 
Sbjct: 169 ADENYYKAQTHGKWPVKWY---------APECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

Query: 112 PRDFLSSISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           P   +         +++    ML+   R+  P+   +E    +  +   C     E+RP 
Sbjct: 220 PYRGMK-------GSEVT--AMLEKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPG 266

Query: 170 MKIVSQQLR 178
              V  +LR
Sbjct: 267 FAAVELRLR 275

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 74.6 bits (183), Expect = 3e-16
 Identities = 44/180 (24%), Positives = 78/180 (43%), Gaps = 22/180 (12%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           +E+  S     +  V+  + YL    F   VHR+L+++N+LL   + A ++DFG++K L 
Sbjct: 431 EEIPVSNVAELLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALG 487

Query: 65  PDSSNWTEFAGT---YGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSIS 120
            D S +T  +       + APE     K + + DV+S+GV   E +  G+ P   +    
Sbjct: 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--- 544

Query: 121 SSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
                 ++     ++   R+  P     E    +  +   C     E RP    V Q++R
Sbjct: 545 ----GPEVM--AFIEQGKRMECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 73.1 bits (180), Expect = 4e-16
 Identities = 45/189 (23%), Positives = 75/189 (39%), Gaps = 40/189 (21%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           +E+  S     +  V+  + YL    F   VHRDL+++N+LL   + A ++DFG++K L 
Sbjct: 105 EEIPVSNVAELLHQVSMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALG 161

Query: 65  PDSSN------------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKH 111
            D S             W          APE     K + + DV+S+GV   E +  G+ 
Sbjct: 162 ADDSYYTARSAGKWPLKWY---------APECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

Query: 112 PRDFLSSISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           P   +          ++     ++   R+  P     E    +  +   C     E RP 
Sbjct: 213 PYKKMK-------GPEVM--AFIEQGKRMECPPECPPE----LYALMSDCWIYKWEDRPD 259

Query: 170 MKIVSQQLR 178
              V Q++R
Sbjct: 260 FLTVEQRMR 268

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 72.7 bits (179), Expect = 6e-16
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 10/92 (10%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++ + + +  LH      IVHRDL  +N+LLD +    + DFG +  L P      E  G
Sbjct: 130 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVCG 185

Query: 76  TYGYVAPE-LAYTMKI-----TEKCDVYSFGV 101
           T  Y+APE +  +M        ++ D++S GV
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 73.7 bits (181), Expect = 6e-16
 Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 24/179 (13%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           QE+     +     ++ A+ YL    F   +HR+L+++N L+   +   VADFG+++ + 
Sbjct: 313 QEVSAVVLLYMATQISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMT 369

Query: 65  PD---SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSIS 120
            D   +    +F     + APE     K + K DV++FGVL  E+   G  P   +    
Sbjct: 370 GDTYTAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---- 423

Query: 121 SSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                   ++ E+L+   R+  P     EK+  +++   +C   +P  RP+   + Q  
Sbjct: 424 -----DLSQVYELLEKDYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAF 473

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 73.1 bits (180), Expect = 6e-16
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWTE 72
           ++ +  A+S++H      +VHRDL  +NLL   E +     + DFG A+   PD+     
Sbjct: 112 MRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168

Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVL 102
              T  Y APEL       E CD++S GV+
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVI 198

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 73.0 bits (180), Expect = 6e-16
 Identities = 40/174 (22%), Positives = 67/174 (38%), Gaps = 39/174 (22%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--------- 68
            +A  ++YL        VHRDL+++N+L+       + DFG+AK L  +           
Sbjct: 125 QIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181

Query: 69  --NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLN 125
              W          A E       T + DV+S+GV   E++  G  P D +         
Sbjct: 182 PIKWM---------ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------A 225

Query: 126 TDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           ++I    +L+   RLP P        I +  +   C     +SRP  + +  + 
Sbjct: 226 SEIS--SILEKGERLPQPPIC----TIDVYMIMRKCWMIDADSRPKFRELIIEF 273

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 72.3 bits (178), Expect = 7e-16
 Identities = 39/154 (25%), Positives = 70/154 (45%), Gaps = 24/154 (15%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
           AL +LH +    ++HRD+ S N+LL ++    + DFG    + P+ S  +   GT  ++A
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGK------HPRDFLSSISSSSLNTDIELDEMLD 135
           PE+        K D++S G++A+E+I+G+      +P   L  I+++             
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT----------- 233

Query: 136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           P L  P + +       +     CL    E R +
Sbjct: 234 PELQNPEK-LSAIFRDFLNR---CLEMDVEKRGS 263

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 73.3 bits (180), Expect = 8e-16
 Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 24/179 (13%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           + L   Q ++    +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ ++
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIE 331

Query: 65  PDSSNWTEFAGT---YGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSIS 120
            +   +T   G      + APE A   + T K DV+SFG+L  E+  KG+ P   +    
Sbjct: 332 DNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---- 385

Query: 121 SSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                 + E+ + ++   R+P P     E L  ++     C  + PE RPT + +   L
Sbjct: 386 -----VNREVLDQVERGYRMPCP-PECPESLHDLMC---QCWRKEPEERPTFEYLQAFL 435

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 72.3 bits (178), Expect = 9e-16
 Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 34/182 (18%)

Query: 7   LDWSQRMNTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFL 63
           +D  +R +  K + +A+  +H H     IVH DL   N L+    +  +   DFGIA  +
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV---DGMLKLIDFGIANQM 176

Query: 64  KPDSSNW--TEFAGTYGYVAPEL-----------AYTMKITEKCDVYSFGVLALEVIKGK 110
           +PD+++       GT  Y+ PE                KI+ K DV+S G +   +  GK
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

Query: 111 HPRDFLSSISSSSLNTDIELDEMLDPRLPAPS-RSVQEKLISIVKVAFSCLNESPESRPT 169
            P  F        +N   +L  ++DP          ++ L  ++K    CL   P+ R +
Sbjct: 237 TP--F-----QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRIS 286

Query: 170 MK 171
           + 
Sbjct: 287 IP 288

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 72.8 bits (179), Expect = 1e-15
 Identities = 43/165 (26%), Positives = 64/165 (38%), Gaps = 28/165 (16%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLL---DLEYEAHVADFGIAKFLKPDSSNWTE 72
           +K +   + YLH      IVHRD+  +N+LL   +      + DFG++ F   D     +
Sbjct: 152 MKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRD 207

Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSSISSSSLNT 126
             GT  Y+APE     K  EKCDV+S GV+   ++ G  P      +D +  +       
Sbjct: 208 RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV----EKG 262

Query: 127 DIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
               D          S   +E LI         L      R T +
Sbjct: 263 KYYFDF---NDWKNISDEAKE-LIK------LMLTYDYNKRCTAE 297

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 72.4 bits (178), Expect = 1e-15
 Identities = 36/154 (23%), Positives = 65/154 (42%), Gaps = 24/154 (15%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
           AL+YLH      ++HRD+ S ++LL L+    ++DFG    +  D        GT  ++A
Sbjct: 153 ALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 209

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGK------HPRDFLSSISSSSLNTDIELDEMLD 135
           PE+        + D++S G++ +E++ G+       P   +  +  S             
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP----------- 258

Query: 136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           P+L    + V   L   ++     L   P+ R T
Sbjct: 259 PKLKNSHK-VSPVLRDFLER---MLVRDPQERAT 288

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 72.6 bits (178), Expect = 1e-15
 Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 24/179 (13%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           + L   Q ++    +A  ++Y+    +   VHRDL + N+L+       VADFG+A+ ++
Sbjct: 358 KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIE 414

Query: 65  PDSSNWTEFAGT---YGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSIS 120
            +   +T   G      + APE A   + T K DV+SFG+L  E+  KG+ P   +    
Sbjct: 415 DNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---- 468

Query: 121 SSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                 + E+ + ++   R+P P     E L  ++     C  + PE RPT + +   L
Sbjct: 469 -----VNREVLDQVERGYRMPCP-PECPESLHDLMC---QCWRKEPEERPTFEYLQAFL 518

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 72.0 bits (177), Expect = 1e-15
 Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 34/182 (18%)

Query: 7   LDWSQRMNTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFL 63
           +D  +R +  K + +A+  +H H     IVH DL   N L+    +  +   DFGIA  +
Sbjct: 105 IDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV---DGMLKLIDFGIANQM 157

Query: 64  KPDSSNW--TEFAGTYGYVAPEL-----------AYTMKITEKCDVYSFGVLALEVIKGK 110
           +PD+++       GT  Y+ PE                KI+ K DV+S G +   +  GK
Sbjct: 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

Query: 111 HPRDFLSSISSSSLNTDIELDEMLDPRLPAP-SRSVQEKLISIVKVAFSCLNESPESRPT 169
            P  F        +N   +L  ++DP          ++ L  ++K    CL   P+ R +
Sbjct: 218 TP--F-----QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRIS 267

Query: 170 MK 171
           + 
Sbjct: 268 IP 269

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 71.5 bits (176), Expect = 1e-15
 Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 5/94 (5%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +ADAL Y H      ++HRD+  +NLL+  + E  +ADFG +    P     T   GT  
Sbjct: 123 LADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT-MCGTLD 177

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+ PE+       EK D++  GVL  E + G  P
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 71.5 bits (176), Expect = 1e-15
 Identities = 42/165 (25%), Positives = 65/165 (39%), Gaps = 19/165 (11%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT- 76
            VA+ + YL    F   +HRDL+++NLLL       + DFG+ + L  +  ++       
Sbjct: 129 QVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185

Query: 77  --YGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNTD-IELDE 132
             + + APE   T   +   D + FGV   E+   G+ P   L+        +  +   +
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKID 238

Query: 133 MLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
               RLP P          I  V   C    PE RPT   +   L
Sbjct: 239 KEGERLPRPEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 72.2 bits (177), Expect = 2e-15
 Identities = 35/156 (22%), Positives = 60/156 (38%), Gaps = 8/156 (5%)

Query: 17  KGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGT 76
             V   L+YL       I+HRD+   N+L++   E  + DFG++  L  DS   + F GT
Sbjct: 138 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-FVGT 193

Query: 77  YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP----RDFLSSISSSSLNTDIELDE 132
             Y++PE       + + D++S G+  +E+  G++P          +           + 
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253

Query: 133 MLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRP 168
              PR P    +            F  L+      P
Sbjct: 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 72.2 bits (177), Expect = 2e-15
 Identities = 28/114 (24%), Positives = 49/114 (42%), Gaps = 9/114 (7%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
            +  Q+L  ++ +  +  +  ALSYLH      +V+ DL  +N++L  E +  + D G  
Sbjct: 173 RSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLT-EEQLKLIDLGAV 228

Query: 61  KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
             +           GT G+ APE+  T   T   D+Y+ G     +      R+
Sbjct: 229 SRINSFGY----LYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRN 277

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 71.2 bits (175), Expect = 2e-15
 Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 28/155 (18%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L YLH +     +HRD+ + N+LL    E  +ADFG+A  L         F GT  ++A
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 187

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGK------HPRDFLSSISSSSLNTDIELDEMLD 135
           PE+        K D++S G+ A+E+ +G+      HP   L  I  ++            
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-----------P 236

Query: 136 PRLPAP-SRSVQEKLISIVKVAFSCLNESPESRPT 169
           P L    S+ ++E  +       +CLN+ P  RPT
Sbjct: 237 PTLEGNYSKPLKE-FVE------ACLNKEPSFRPT 264

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 71.7 bits (176), Expect = 2e-15
 Identities = 44/179 (24%), Positives = 84/179 (46%), Gaps = 24/179 (13%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
            +    + ++    +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++
Sbjct: 279 SKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIE 335

Query: 65  PDSSNWTEFAGTYGYV---APELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSIS 120
            +   +T   G    +   APE       T K DV+SFG+L +E++  G+ P   +S   
Sbjct: 336 DNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--- 390

Query: 121 SSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                 + E+   L+   R+P P  +  E+L +I+     C    PE RPT + +   L
Sbjct: 391 ------NPEVIRALERGYRMPRP-ENCPEELYNIMM---RCWKNRPEERPTFEYIQSVL 439

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 71.7 bits (176), Expect = 2e-15
 Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 28/165 (16%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWTE 72
           IK V   ++YLH      IVHRDL  +NLLL+ + +     + DFG++   +       E
Sbjct: 142 IKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKE 197

Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSSISSSSLNT 126
             GT  Y+APE+    K  EKCDV+S GV+   ++ G  P      ++ L  +       
Sbjct: 198 RLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV----EKG 252

Query: 127 DIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
               D    P     S   ++ LI         L    + R + +
Sbjct: 253 KYTFDS---PEWKNVSEGAKD-LIK------QMLQFDSQRRISAQ 287

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 70.9 bits (174), Expect = 3e-15
 Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 24/154 (15%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L YLH       +HRD+ + N+LL+ E  A +ADFG+A  L    +      GT  ++A
Sbjct: 137 GLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMA 193

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGK------HPRDFLSSISSSSLNTDIELDEMLD 135
           PE+   +      D++S G+ A+E+ +GK      HP   +  I ++             
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP----------- 242

Query: 136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           P    P     +     VK    CL +SPE R T
Sbjct: 243 PTFRKPEL-WSDNFTDFVKQ---CLVKSPEQRAT 272

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 71.3 bits (175), Expect = 3e-15
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 10/92 (10%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++ + +A+S+LH +    IVHRDL  +N+LLD   +  ++DFG +  L+P      E  G
Sbjct: 206 MRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELCG 261

Query: 76  TYGYVAPE-LAYTMKITEK-----CDVYSFGV 101
           T GY+APE L  +M  T        D+++ GV
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 71.6 bits (176), Expect = 3e-15
 Identities = 30/93 (32%), Positives = 42/93 (45%), Gaps = 10/93 (10%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWTE 72
              +  A+ YLH +    I+HRDL  +N+LL  + E     + DFG +K L   S     
Sbjct: 245 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRT 300

Query: 73  FAGTYGYVAPE-LAYTMKI--TEKCDVYSFGVL 102
             GT  Y+APE L            D +S GV+
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 71.0 bits (174), Expect = 3e-15
 Identities = 30/96 (31%), Positives = 43/96 (44%), Gaps = 11/96 (11%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKP----DSSN 69
           ++ +  AL YLH+     I HRD+  +N L        +   DFG++K        +   
Sbjct: 174 MRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230

Query: 70  WTEFAGTYGYVAPEL--AYTMKITEKCDVYSFGVLA 103
            T  AGT  +VAPE+          KCD +S GVL 
Sbjct: 231 MTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 70.3 bits (173), Expect = 3e-15
 Identities = 31/90 (34%), Positives = 53/90 (58%), Gaps = 9/90 (10%)

Query: 16  IKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYE-AHV--ADFGIAKFLKPDSSNWT 71
           I+ + ++++Y H +     IVHR+L  +NLLL  + + A V  ADFG+A  +    + W 
Sbjct: 111 IQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WH 165

Query: 72  EFAGTYGYVAPELAYTMKITEKCDVYSFGV 101
            FAGT GY++PE+      ++  D+++ GV
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 70.4 bits (173), Expect = 3e-15
 Identities = 39/193 (20%), Positives = 72/193 (37%), Gaps = 36/193 (18%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
            +++  Q++     +   + YL    +   VHRDL+++N+L++ E++  + DFG+ K ++
Sbjct: 121 NKINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIE 177

Query: 65  PDSSN------------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKH 111
            D               W          APE     K     DV+SFGV   E++     
Sbjct: 178 TDKEYYTVKDDRDSPVFWY---------APECLMQSKFYIASDVWSFGVTLHELLTYCDS 228

Query: 112 PRDFLSSISSSSLN-----TDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESP 164
               ++             T   L   L    RLP P     E    + ++   C    P
Sbjct: 229 DSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDE----VYQLMRKCWEFQP 284

Query: 165 ESRPTMKIVSQQL 177
            +R + + + +  
Sbjct: 285 SNRTSFQNLIEGF 297

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 70.8 bits (174), Expect = 4e-15
 Identities = 29/90 (32%), Positives = 52/90 (57%), Gaps = 9/90 (10%)

Query: 16  IKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWT 71
           I+ + ++++Y H +     IVHR+L  +NLLL  + +     +ADFG+A  +    + W 
Sbjct: 134 IQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WH 188

Query: 72  EFAGTYGYVAPELAYTMKITEKCDVYSFGV 101
            FAGT GY++PE+      ++  D+++ GV
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 71.2 bits (175), Expect = 4e-15
 Identities = 44/182 (24%), Positives = 76/182 (41%), Gaps = 34/182 (18%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
             L     +     V +A+ YL  + F   VHRDL+++N+L+  +  A V+DFG+ K   
Sbjct: 284 SVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340

Query: 65  PDSSN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLS 117
                      WT         APE     K + K DV+SFG+L  E+   G+ P   + 
Sbjct: 341 STQDTGKLPVKWT---------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI- 390

Query: 118 SISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
                      ++   ++   ++ AP       +  ++K   +C +    +RPT   + +
Sbjct: 391 --------PLKDVVPRVEKGYKMDAP-DGCPPAVYDVMK---NCWHLDAATRPTFLQLRE 438

Query: 176 QL 177
           QL
Sbjct: 439 QL 440

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 70.5 bits (173), Expect = 4e-15
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 30/161 (18%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            LS+LH      ++HRD+  +N+LL    E  + DFG++  L         F GT  ++A
Sbjct: 141 GLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197

Query: 82  PELAYTMKITE-----KCDVYSFGVLALEVIKGK------HPRDFLSSISSSSLNTDIEL 130
           PE+    +  +     K D++S G+ A+E+ +G       HP   L  I  +        
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP------- 250

Query: 131 DEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
                PRL +   S  +K  S ++    CL ++   RP  +
Sbjct: 251 ----APRLKSKKWS--KKFQSFIES---CLVKNHSQRPATE 282

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 70.4 bits (173), Expect = 4e-15
 Identities = 30/92 (32%), Positives = 41/92 (44%), Gaps = 10/92 (10%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWTE 72
              +  A+ YLH +    I+HRDL  +N+LL  + E     + DFG +K L   S     
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRT 175

Query: 73  FAGTYGYVAPE-LAYTMKI--TEKCDVYSFGV 101
             GT  Y+APE L            D +S GV
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 70.6 bits (173), Expect = 5e-15
 Identities = 30/188 (15%), Positives = 60/188 (31%), Gaps = 45/188 (23%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH----VADFGIAKFLKPDSSNWTEFA 74
           V   +++L  +    IVHR++   N++  +  +      + DFG A+ L+ D   +    
Sbjct: 121 VVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY 176

Query: 75  GTYGYVAPEL--------AYTMKITEKCDVYSFGVLALE--------------------- 105
           GT  Y+ P++         +  K     D++S GV                         
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

Query: 106 --VIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES 163
             +I GK          + +   D   D  +   L    + +   +++      + L   
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA------NILEAD 290

Query: 164 PESRPTMK 171
            E      
Sbjct: 291 QEKCWGFD 298

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 70.4 bits (173), Expect = 5e-15
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 9/92 (9%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWTE 72
           IK + + + YLH +    IVH DL  +N+LL   Y      + DFG+++ +        E
Sbjct: 137 IKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LRE 192

Query: 73  FAGTYGYVAPE-LAYTMKITEKCDVYSFGVLA 103
             GT  Y+APE L Y   IT   D+++ G++A
Sbjct: 193 IMGTPEYLAPEILNYD-PITTATDMWNIGIIA 223

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 70.5 bits (173), Expect = 5e-15
 Identities = 48/194 (24%), Positives = 74/194 (38%), Gaps = 36/194 (18%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
             LD S+ +     +   + YL        VHRDL+++N+L++ E    +ADFG+AK L 
Sbjct: 122 ARLDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLP 178

Query: 65  PDSS------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKH 111
            D               W          APE       + + DV+SFGV+  E+      
Sbjct: 179 LDKDYYVVREPGQSPIFWY---------APESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229

Query: 112 PRDFLSSISSSSLN-----TDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESP 164
                +                 L E+L+   RLPAP     E    + ++   C   SP
Sbjct: 230 SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAE----VHELMKLCWAPSP 285

Query: 165 ESRPTMKIVSQQLR 178
           + RP+   +  QL 
Sbjct: 286 QDRPSFSALGPQLD 299

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 70.5 bits (173), Expect = 5e-15
 Identities = 36/160 (22%), Positives = 57/160 (35%), Gaps = 30/160 (18%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTE-----FAG 75
            L YLH      I+H D+ + N+LL  +   A + DFG A  L+PD    +        G
Sbjct: 162 GLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEM-- 133
           T  ++APE+        K D++S   + L ++ G HP                +      
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW--------------TQYFRGPL 264

Query: 134 --LDPRLPAPSRSVQEKLISIVKVAF--SCLNESPESRPT 169
                  P P R +      +         L + P  R +
Sbjct: 265 CLKIASEPPPIREIPPSCAPLTA-QAIQEGLRKEPVHRAS 303

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 70.5 bits (173), Expect = 5e-15
 Identities = 27/99 (27%), Positives = 46/99 (46%), Gaps = 6/99 (6%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           IK V ++ SY+H+     I HRD+   N+L+D      ++DFG ++++  D        G
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM-VDKKIKG-SRG 212

Query: 76  TYGYVAPELAYTMKIT--EKCDVYSFGVLALEVIKGKHP 112
           TY ++ PE           K D++S G+    +     P
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 70.0 bits (172), Expect = 6e-15
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 14/92 (15%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWTE 72
           IK V   ++Y+H      IVHRDL  +N+LL+ + +     + DFG++   + ++    +
Sbjct: 127 IKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKD 182

Query: 73  FAGTYGYVAPEL---AYTMKITEKCDVYSFGV 101
             GT  Y+APE+    Y     EKCDV+S GV
Sbjct: 183 RIGTAYYIAPEVLRGTY----DEKCDVWSAGV 210

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 69.6 bits (171), Expect = 7e-15
 Identities = 41/194 (21%), Positives = 72/194 (37%), Gaps = 37/194 (19%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           + +D  + +     +   + YL    +   +HRDL+++N+L++ E    + DFG+ K L 
Sbjct: 109 ERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLP 165

Query: 65  PDSSN------------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            D               W          APE     K +   DV+SFGV+  E+      
Sbjct: 166 QDKEFFKVKEPGESPIFWY---------APESLTESKFSVASDVWSFGVVLYELFTYIEK 216

Query: 113 RDFLSSISSSSLN-------TDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNES 163
                +     +            L E+L    RLP P     E    I  +   C N +
Sbjct: 217 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMIMTECWNNN 272

Query: 164 PESRPTMKIVSQQL 177
              RP+ + ++ ++
Sbjct: 273 VNQRPSFRDLALRV 286

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 70.5 bits (173), Expect = 8e-15
 Identities = 44/165 (26%), Positives = 70/165 (42%), Gaps = 28/165 (16%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLL-DLEYEAHV--ADFGIAKFLKPDSSNWTE 72
           I+ V   ++Y+H +    IVHRDL  +NLLL     +A++   DFG++   +       +
Sbjct: 132 IRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKD 187

Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSSISSSSLNT 126
             GT  Y+APE+       EKCDV+S GV+   ++ G  P       D L  +       
Sbjct: 188 KIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV----EKG 242

Query: 127 DIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
               +    P+    S S ++ LI         L   P  R + +
Sbjct: 243 KYTFEL---PQWKKVSESAKD-LIR------KMLTYVPSMRISAR 277

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 70.0 bits (172), Expect = 8e-15
 Identities = 23/91 (25%), Positives = 42/91 (46%), Gaps = 8/91 (8%)

Query: 16  IKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWT 71
           ++ + +AL Y H ++    I+HRD+    +LL  +  +    +  FG+A  L        
Sbjct: 136 MRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191

Query: 72  EFAGTYGYVAPELAYTMKITEKCDVYSFGVL 102
              GT  ++APE+       +  DV+  GV+
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 69.6 bits (171), Expect = 9e-15
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 3/97 (3%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++ +     YLH +    ++HRDL   NL L+ + E  + DFG+A  ++ D        G
Sbjct: 147 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 203

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  Y+APE+      + + DV+S G +   ++ GK P
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 70.1 bits (172), Expect = 1e-14
 Identities = 45/165 (27%), Positives = 68/165 (41%), Gaps = 28/165 (16%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLL-DLEYEAH--VADFGIAKFLKPDSSNWTE 72
           IK V   ++Y+H      IVHRDL  +N+LL   E +    + DFG++   + ++    +
Sbjct: 127 IKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKD 182

Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSSISSSSLNT 126
             GT  Y+APE+       EKCDV+S GV+   ++ G  P       D L  +       
Sbjct: 183 RIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV----ETG 237

Query: 127 DIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
               D    P+    S   ++ LI         L   P  R T  
Sbjct: 238 KYAFDL---PQWRTISDDAKD-LIR------KMLTFHPSLRITAT 272

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 69.1 bits (170), Expect = 1e-14
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 3/97 (3%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
           ++ +     YLH +    ++HRDL   NL L+ + E  + DFG+A  ++ D        G
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 177

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  Y+APE+      + + DV+S G +   ++ GK P
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 69.3 bits (170), Expect = 1e-14
 Identities = 46/189 (24%), Positives = 76/189 (40%), Gaps = 44/189 (23%)

Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
           +    Q +  ++GV   + YL    +   VHRDL+++N+L+D      V+DFG+++ L+ 
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203

Query: 66  DSSN------------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP 112
           D               WT         APE       +   DV+SFGV+  EV+  G+ P
Sbjct: 204 DPDAAYTTTGGKIPIRWT---------APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

Query: 113 RDFLSSISSSSLNTD----IELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRP 168
              ++       N D    +E       RLPAP          + ++   C ++    RP
Sbjct: 255 YWNMT-------NRDVISSVEEGY----RLPAPMGCPHA----LHQLMLDCWHKDRAQRP 299

Query: 169 TMKIVSQQL 177
               +   L
Sbjct: 300 RFSQIVSVL 308

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 69.3 bits (170), Expect = 1e-14
 Identities = 42/172 (24%), Positives = 69/172 (40%), Gaps = 35/172 (20%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--------- 68
            +A  ++YL        VHRDL+++N+L+       + DFG+AK L  +           
Sbjct: 125 QIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181

Query: 69  --NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLN 125
              W          A E       T + DV+S+GV   E++  G  P D    I +S ++
Sbjct: 182 PIKWM---------ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD---GIPASEIS 229

Query: 126 TDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           + +E  E    RLP P        I +  +   C     +SRP  + +  + 
Sbjct: 230 SILEKGE----RLPQPPIC----TIDVYMIMVKCWMIDADSRPKFRELIIEF 273

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 68.9 bits (169), Expect = 1e-14
 Identities = 43/187 (22%), Positives = 77/187 (41%), Gaps = 22/187 (11%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
             +  +Q +   + + + ++YLH   +   +HRDL+++N+LLD +    + DFG+AK + 
Sbjct: 129 HSIGLAQLLLFAQQICEGMAYLHAQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185

Query: 65  PDSSNWTEFAGTYGYV-----APELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSS 118
                +       G       APE     K     DV+SFGV   E++      +   + 
Sbjct: 186 EGHEYYR--VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 243

Query: 119 ISSSSLN-----TDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
                       T + L E+L+   RLP P +   E    +  +  +C       RPT +
Sbjct: 244 FLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAE----VYHLMKNCWETEASFRPTFE 299

Query: 172 IVSQQLR 178
            +   L+
Sbjct: 300 NLIPILK 306

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 69.5 bits (170), Expect = 1e-14
 Identities = 30/188 (15%), Positives = 60/188 (31%), Gaps = 45/188 (23%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH----VADFGIAKFLKPDSSNWTEFA 74
           V   +++L  +    IVHR++   N++  +  +      + DFG A+ L+ D   +    
Sbjct: 121 VVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY 176

Query: 75  GTYGYVAPEL--------AYTMKITEKCDVYSFGVLALE--------------------- 105
           GT  Y+ P++         +  K     D++S GV                         
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

Query: 106 --VIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES 163
             +I GK          + +   D   D  +   L    + +   +++      + L   
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA------NILEAD 290

Query: 164 PESRPTMK 171
            E      
Sbjct: 291 QEKCWGFD 298

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 68.9 bits (169), Expect = 2e-14
 Identities = 41/194 (21%), Positives = 72/194 (37%), Gaps = 37/194 (19%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           + +D  + +     +   + YL    +   +HRDL+++N+L++ E    + DFG+ K L 
Sbjct: 140 ERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLP 196

Query: 65  PDSSN------------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            D               W          APE     K +   DV+SFGV+  E+      
Sbjct: 197 QDKEYYKVKEPGESPIFWY---------APESLTESKFSVASDVWSFGVVLYELFTYIEK 247

Query: 113 RDFLSSISSSSLN-------TDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNES 163
                +     +            L E+L    RLP P     E    I  +   C N +
Sbjct: 248 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMIMTECWNNN 303

Query: 164 PESRPTMKIVSQQL 177
              RP+ + ++ ++
Sbjct: 304 VNQRPSFRDLALRV 317

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 69.1 bits (169), Expect = 2e-14
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 30/180 (16%)

Query: 7   LDWSQRMNTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
           +D  +R +  K + +A+  +H H     IVH DL   N L+  +    + DFGIA  ++P
Sbjct: 152 IDPWERKSYWKNMLEAVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206

Query: 66  DSSNWTE--FAGTYGYVAPEL-----------AYTMKITEKCDVYSFGVLALEVIKGKHP 112
           D+++  +    G   Y+ PE                KI+ K DV+S G +   +  GK P
Sbjct: 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

Query: 113 RDFLSSISSSSLNTDIELDEMLDPRLPAP-SRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             F        +N   +L  ++DP          ++ L  ++K    CL   P+ R ++ 
Sbjct: 267 --F-----QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIP 316

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 69.1 bits (169), Expect = 2e-14
 Identities = 40/151 (26%), Positives = 62/151 (41%), Gaps = 22/151 (14%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSNWTEFAGTYGY 79
            L  LH +    IV+RDL  +N+LLD     H+  +D G+A  +    +      GT GY
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLD--DHGHIRISDLGLAVHVPEGQTIKG-RVGTVGY 351

Query: 80  VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLP 139
           +APE+    + T   D ++ G L  E+I G+ P  F            I+ +E+      
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP--FQQR------KKKIKREEVERLVKE 403

Query: 140 AP---SRSVQEKLISIVKVAFSCLNESPESR 167
            P   S     +  S+       L + P  R
Sbjct: 404 VPEEYSERFSPQARSLCS---QLLCKDPAER 431

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 68.4 bits (168), Expect = 2e-14
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 13/100 (13%)

Query: 19  VADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSN---WTE 72
           +  AL YLH       I+HRDL  +N+LL+   + H+   DFG AK L P+S      + 
Sbjct: 139 IVSALEYLHGKG----IIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANS- 191

Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           F GT  YV+PEL       +  D+++ G +  +++ G  P
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 68.1 bits (167), Expect = 3e-14
 Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 40/187 (21%)

Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
           E    Q +  ++G+A  + YL +  +   VHRDL+++N+L++      V+DFG+++ L+ 
Sbjct: 143 EFSVLQLVGMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLED 199

Query: 66  DSSN------------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP 112
           D               WT         APE     K T   DV+SFG++  EV+  G+ P
Sbjct: 200 DPEATYTTSGGKIPIRWT---------APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

Query: 113 RDFLSSISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
              LS       N ++   + ++   RLP P       +  ++     C  +    RP  
Sbjct: 251 YWELS-------NHEVM--KAINDGFRLPTP-MDCPSAIYQLMM---QCWQQERARRPKF 297

Query: 171 KIVSQQL 177
             +   L
Sbjct: 298 ADIVSIL 304

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 67.6 bits (166), Expect = 3e-14
 Identities = 28/93 (30%), Positives = 42/93 (45%), Gaps = 16/93 (17%)

Query: 16  IKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWT 71
           +K V  A++Y H  +    + HRDL  +N L   +       + DFG+A   KP      
Sbjct: 112 MKDVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMR 166

Query: 72  EFAGTYGYVAPEL---AYTMKITEKCDVYSFGV 101
              GT  YV+P++    Y      +CD +S GV
Sbjct: 167 TKVGTPYYVSPQVLEGLY----GPECDEWSAGV 195

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 68.1 bits (166), Expect = 4e-14
 Identities = 16/121 (13%), Positives = 39/121 (32%), Gaps = 16/121 (13%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH----------- 53
           + +     ++    +   +  +H      I+H D+   N +L   +              
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223

Query: 54  VADFGIAKFLK--PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKH 111
           + D G +  +K  P  + +T    T G+   E+        + D +        ++ G +
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283

Query: 112 P 112
            
Sbjct: 284 M 284

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 67.2 bits (165), Expect = 4e-14
 Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 3/94 (3%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +   + YLH      I+HRDL+  NLLL       +ADFG+A  LK          GT  
Sbjct: 121 IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y++PE+A       + DV+S G +   ++ G+ P
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 67.2 bits (165), Expect = 4e-14
 Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 10/93 (10%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLL-DLEYEAH---VADFGIAKFLKPDSSNWT 71
           +K + D + YLH      I H DL  +N++L D         + DFGIA  ++  +  + 
Sbjct: 114 LKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FK 169

Query: 72  EFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLA 103
              GT  +VAPE + Y   +  + D++S GV+ 
Sbjct: 170 NIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 201

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 67.3 bits (165), Expect = 5e-14
 Identities = 35/190 (18%), Positives = 71/190 (37%), Gaps = 44/190 (23%)

Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH--------VADF 57
            ++   ++   K +A A+ +L  +     +H ++ +KN+LL  E +          ++D 
Sbjct: 109 CINILWKLEVAKQLAAAMHFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165

Query: 58  GIAKFLKPDSS-----NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI-KGK 110
           GI+  + P         W           PE +     +    D +SFG    E+   G 
Sbjct: 166 GISITVLPKDILQERIPWV---------PPECIENPKNLNLATDKWSFGTTLWEICSGGD 216

Query: 111 HPRDFLSSISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRP 168
            P   L        +      +  +   +LPAP      K   +  +  +C++  P+ RP
Sbjct: 217 KPLSALD-------SQRKL--QFYEDRHQLPAP------KAAELANLINNCMDYEPDHRP 261

Query: 169 TMKIVSQQLR 178
           + + + + L 
Sbjct: 262 SFRAIIRDLN 271

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 66.8 bits (164), Expect = 5e-14
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 38/173 (21%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD----SSN---- 69
            V + ++YL   C    +HRDL+++N L+       V+DFG+ +F+  D    S+     
Sbjct: 112 DVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 168

Query: 70  --WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
             W          +PE+    + + K DV+SFGVL  EV  +GK P +  S       N+
Sbjct: 169 VKWA---------SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NS 212

Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           ++   E +    RL  P R     +  I+     C  E PE RP    + +QL
Sbjct: 213 EVV--EDISTGFRLYKP-RLASTHVYQIMN---HCWRERPEDRPAFSRLLRQL 259

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 67.4 bits (165), Expect = 5e-14
 Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 8/90 (8%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWTE 72
           ++ +  A+ +LH      I HRD+  +NLL   + +     + DFG AK    ++     
Sbjct: 134 MRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT 188

Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVL 102
              T  YVAPE+    K  + CD++S GV+
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 66.9 bits (164), Expect = 6e-14
 Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 12/91 (13%)

Query: 16  IKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWT 71
           +K + +AL+Y H       +VH+DL  +N+L           + DFG+A+  K D    T
Sbjct: 130 MKQMMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-ST 184

Query: 72  EFAGTYGYVAPE-LAYTMKITEKCDVYSFGV 101
             AGT  Y+APE       +T KCD++S GV
Sbjct: 185 NAAGTALYMAPEVFKR--DVTFKCDIWSAGV 213

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 67.4 bits (165), Expect = 6e-14
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 32/157 (20%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L+YLH      ++HRD+ + N+LL       + DFG A  + P +S    F GT  ++A
Sbjct: 166 GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMA 218

Query: 82  PELAYTMKITE---KCDVYSFGVLALEVIKGK------HPRDFLSSISSSSLNTDIELDE 132
           PE+   M   +   K DV+S G+  +E+ + K      +    L  I+ +          
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--------- 269

Query: 133 MLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
              P L +   S  E   + V     CL + P+ RPT
Sbjct: 270 --SPALQSGHWS--EYFRNFVDS---CLQKIPQDRPT 299

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 66.4 bits (163), Expect = 7e-14
 Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 38/186 (20%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           + L+ SQ +     V + +++L    F   +HRDL+++N L+D +    V+DFG+ +++ 
Sbjct: 99  KGLEPSQLLEMCYDVCEGMAFLESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155

Query: 65  PD----SSN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPR 113
            D    S        W+         APE+ +  K + K DV++FG+L  EV   GK P 
Sbjct: 156 DDQYVSSVGTKFPVKWS---------APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

Query: 114 DFLSSISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           D  +       N+++     +    RL  P     + +  I+    SC +E PE RPT +
Sbjct: 207 DLYT-------NSEVV--LKVSQGHRLYRP-HLASDTIYQIMY---SCWHELPEKRPTFQ 253

Query: 172 IVSQQL 177
            +   +
Sbjct: 254 QLLSSI 259

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 67.4 bits (165), Expect = 7e-14
 Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 10/93 (10%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH----VADFGIAKFLKPDSSNWT 71
           IK + D ++YLH      I H DL  +N++L  +        + DFG+A  ++     + 
Sbjct: 121 IKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FK 176

Query: 72  EFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLA 103
              GT  +VAPE + Y   +  + D++S GV+ 
Sbjct: 177 NIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 208

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 67.0 bits (164), Expect = 8e-14
 Identities = 43/165 (26%), Positives = 78/165 (47%), Gaps = 29/165 (17%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAG 75
            + + +AL++LH      I+HRDL + N+L+ LE +  +ADFG++            F G
Sbjct: 123 CRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG 179

Query: 76  TYGYVAPELAYTMKITE-----KCDVYSFGVLALEVIKGK------HPRDFLSSISSSSL 124
           T  ++APE+     + +     K D++S G+  +E+ + +      +P   L  I+ S  
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD- 238

Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
                      P L  PS+   E     +K+    L+++PE+RP+
Sbjct: 239 ----------PPTLLTPSKWSVE-FRDFLKI---ALDKNPETRPS 269

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 67.1 bits (164), Expect = 9e-14
 Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 7/90 (7%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWTE 72
           +K + +A+ YLH      I HRD+  +NLL   +       + DFG AK     +S  T 
Sbjct: 167 MKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTT 222

Query: 73  FAGTYGYVAPELAYTMKITEKCDVYSFGVL 102
              T  YVAPE+    K  + CD++S GV+
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 66.6 bits (163), Expect = 1e-13
 Identities = 44/172 (25%), Positives = 67/172 (38%), Gaps = 35/172 (20%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--------- 68
            +A  + YL        VHR+L+++N+LL    +  VADFG+A  L PD           
Sbjct: 123 QIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179

Query: 69  --NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLN 125
              W          A E  +  K T + DV+S+GV   E++  G  P      +  + + 
Sbjct: 180 PIKWM---------ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA---GLRLAEVP 227

Query: 126 TDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             +E  E    RL  P        I +  V   C       RPT K ++ + 
Sbjct: 228 DLLEKGE----RLAQPQIC----TIDVYMVMVKCWMIDENIRPTFKELANEF 271

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 66.5 bits (163), Expect = 1e-13
 Identities = 43/186 (23%), Positives = 78/186 (41%), Gaps = 38/186 (20%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           QE+     +     ++ A+ YL    F   +HRDL+++N L+   +   VADFG+++ + 
Sbjct: 106 QEVSAVVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMT 162

Query: 65  PD----SSN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPR 113
            D     +       WT         APE     K + K DV++FGVL  E+   G  P 
Sbjct: 163 GDTYTAHAGAKFPIKWT---------APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

Query: 114 DFLSSISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             +         + +   E+L+   R+  P    ++    + ++  +C   +P  RP+  
Sbjct: 214 PGID-------LSQVY--ELLEKDYRMERPEGCPEK----VYELMRACWQWNPSDRPSFA 260

Query: 172 IVSQQL 177
            + Q  
Sbjct: 261 EIHQAF 266

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 66.6 bits (163), Expect = 1e-13
 Identities = 44/189 (23%), Positives = 77/189 (40%), Gaps = 44/189 (23%)

Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
           +    Q +  ++G+A  + YL    +   VHRDL+++N+L++      V+DFG+ + L+ 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLED 199

Query: 66  DSSN------------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHP 112
           D               WT         +PE     K T   DV+S+G++  EV+  G+ P
Sbjct: 200 DPEAAYTTRGGKIPIRWT---------SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

Query: 113 RDFLSSISSSSLNTD----IELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRP 168
              +S       N D    ++       RLP P       L  ++     C  +   +RP
Sbjct: 251 YWEMS-------NQDVIKAVDEGY----RLPPP-MDCPAALYQLML---DCWQKDRNNRP 295

Query: 169 TMKIVSQQL 177
             + +   L
Sbjct: 296 KFEQIVSIL 304

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 66.7 bits (163), Expect = 1e-13
 Identities = 25/95 (26%), Positives = 45/95 (47%), Gaps = 10/95 (10%)

Query: 13  MNTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSN 69
           +N ++   + L ++H H     IVH D+  +N++ + +  + V   DFG+A  L PD   
Sbjct: 152 INYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207

Query: 70  WTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLA 103
                 T  + APE +     +    D+++ GVL 
Sbjct: 208 KVTT-ATAEFAAPEIVDREP-VGFYTDMWAIGVLG 240

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 66.5 bits (163), Expect = 1e-13
 Identities = 26/94 (27%), Positives = 45/94 (47%), Gaps = 12/94 (12%)

Query: 16  IKGVADALSYLH-HDCFPPIVHRDLSSKNLLL-DLEYEAH---VADFGIAKFLKPDSSNW 70
           +K + + + YLH       I H DL  +N++L D         + DFG+A  +   +  +
Sbjct: 120 LKQILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-F 174

Query: 71  TEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLA 103
               GT  +VAPE + Y   +  + D++S GV+ 
Sbjct: 175 KNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 207

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 66.6 bits (163), Expect = 1e-13
 Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 8/91 (8%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSNWTEF 73
           +K + + + ++H      I+H DL  +N+L        +   DFG+A+  KP       F
Sbjct: 193 MKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249

Query: 74  AGTYGYVAPE-LAYTMKITEKCDVYSFGVLA 103
            GT  ++APE + Y   ++   D++S GV+A
Sbjct: 250 -GTPEFLAPEVVNYD-FVSFPTDMWSVGVIA 278

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 65.7 bits (161), Expect = 1e-13
 Identities = 43/182 (23%), Positives = 75/182 (41%), Gaps = 34/182 (18%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
             L     +     V +A+ YL  + F   VHRDL+++N+L+  +  A V+DFG+ K   
Sbjct: 112 SVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168

Query: 65  PDSSN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLS 117
                      WT         APE     K + K DV+SFG+L  E+   G+ P   + 
Sbjct: 169 STQDTGKLPVKWT---------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219

Query: 118 SISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQ 175
                      ++   ++   ++ AP       +  ++K   +C +     RP+   + +
Sbjct: 220 -------LK--DVVPRVEKGYKMDAP-DGCPPAVYEVMK---NCWHLDAAMRPSFLQLRE 266

Query: 176 QL 177
           QL
Sbjct: 267 QL 268

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 66.8 bits (163), Expect = 2e-13
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 10/94 (10%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSNWTEFAGTYGY 79
            L ++H+     +V+RDL   N+LLD     HV  +D G+A        +     GT+GY
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLD--EHGHVRISDLGLACDFSKKKPH--ASVGTHGY 356

Query: 80  VAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           +APE L   +      D +S G +  ++++G  P
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 66.7 bits (163), Expect = 2e-13
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 7/93 (7%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSNWTEFAGTYGY 79
            L +LH      I++RDL  +N+LLD   + +V  +D G+A  LK   +    +AGT G+
Sbjct: 301 GLEHLHQRN---IIYRDLKPENVLLD--DDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355

Query: 80  VAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           +APEL    +     D ++ GV   E+I  + P
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 66.1 bits (162), Expect = 2e-13
 Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 10/93 (10%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH----VADFGIAKFLKPDSSNWT 71
           IK + D ++YLH      I H DL  +N++L  +        + DFG+A  ++     + 
Sbjct: 121 IKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FK 176

Query: 72  EFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLA 103
              GT  +VAPE + Y   +  + D++S GV+ 
Sbjct: 177 NIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 208

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 65.3 bits (160), Expect = 2e-13
 Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 38/173 (21%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD----SSN---- 69
            V +A+ YL    F   +HRDL+++N L++ +    V+DFG+++++  D    S      
Sbjct: 128 DVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 184

Query: 70  --WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
             W+          PE+    K + K D+++FGVL  E+   GK P +  +       N+
Sbjct: 185 VRWS---------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NS 228

Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           +    E +    RL  P     EK+ +I+    SC +E  + RPT KI+   +
Sbjct: 229 ETA--EHIAQGLRLYRP-HLASEKVYTIMY---SCWHEKADERPTFKILLSNI 275

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 65.9 bits (161), Expect = 2e-13
 Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 15/100 (15%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSNWTE-FAGTY 77
           A+  +H        VHRD+   N+L+D     H+  ADFG    L  D +  +    GT 
Sbjct: 187 AIDSVHQLH----YVHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240

Query: 78  GYVAPELAYTMKITEK-----CDVYSFGVLALEVIKGKHP 112
            Y++PE+   M+  +      CD +S GV   E++ G+ P
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 65.0 bits (159), Expect = 3e-13
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 8/94 (8%)

Query: 23  LSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSNWTEFAGTYGYV 80
           L YLH +    IVHRD+   N+L++  Y   +  +DFG +K L   +     F GT  Y+
Sbjct: 135 LKYLHDNQ---IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM 190

Query: 81  APELAYTMKI--TEKCDVYSFGVLALEVIKGKHP 112
           APE+         +  D++S G   +E+  GK P
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 64.9 bits (159), Expect = 3e-13
 Identities = 43/186 (23%), Positives = 83/186 (44%), Gaps = 38/186 (20%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
            +L  ++ ++    +A+ ++++    +   +HRDL + N+L+       +ADFG+A+ ++
Sbjct: 104 IKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIE 160

Query: 65  PD----SSN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPR 113
            +             WT         APE       T K DV+SFG+L  E++  G+ P 
Sbjct: 161 DNEYTAREGAKFPIKWT---------APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

Query: 114 DFLSSISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             ++         + E+ + L+   R+  P  +  E+L  +++    C  E PE RPT  
Sbjct: 212 PGMT---------NPEVIQNLERGYRMVRP-DNCPEELYQLMR---LCWKERPEDRPTFD 258

Query: 172 IVSQQL 177
            +   L
Sbjct: 259 YLRSVL 264

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 64.9 bits (159), Expect = 4e-13
 Identities = 25/92 (27%), Positives = 44/92 (47%), Gaps = 10/92 (10%)

Query: 16  IKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSNWTE 72
           +  V +AL +LH H+    I H D+  +N++      + +   +FG A+ LKP  +    
Sbjct: 108 VHQVCEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163

Query: 73  FAGTYGYVAPE-LAYTMKITEKCDVYSFGVLA 103
           F     Y APE   + + ++   D++S G L 
Sbjct: 164 F-TAPEYYAPEVHQHDV-VSTATDMWSLGTLV 193

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 65.2 bits (159), Expect = 5e-13
 Identities = 24/90 (26%), Positives = 42/90 (46%), Gaps = 6/90 (6%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSNWTEF 73
           ++ V   L ++H +     VH DL  +N++   +    +   DFG+   L P   +    
Sbjct: 261 MRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVT 316

Query: 74  AGTYGYVAPELAYTMKITEKCDVYSFGVLA 103
            GT  + APE+A    +    D++S GVL+
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 63.9 bits (156), Expect = 9e-13
 Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 31/164 (18%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTE-----FAGT 76
            L YLH +     +HRD+ + N+LL  +    +ADFG++ FL              F GT
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 77  YGYVAPEL-----AYTMKITEKCDVYSFGVLALEVIKGK------HPRDFLSSISSSSLN 125
             ++APE+      Y      K D++SFG+ A+E+  G        P   L     +   
Sbjct: 190 PCWMAPEVMEQVRGYD----FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245

Query: 126 TDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
           + +E        L    +S ++ +IS       CL + PE RPT
Sbjct: 246 S-LETGVQDKEMLKKYGKSFRK-MIS------LCLQKDPEKRPT 281

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 64.0 bits (156), Expect = 1e-12
 Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 15/101 (14%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSNWTE-FAGTYG 78
           A+  +H       VHRD+   N+LLD     H+  ADFG    L+ D +  +    GT  
Sbjct: 174 AIDSVHRLG---YVHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228

Query: 79  YVAPELAYTMKITEK-------CDVYSFGVLALEVIKGKHP 112
           Y++PE+   +            CD ++ GV A E+  G+ P
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 63.4 bits (155), Expect = 1e-12
 Identities = 37/174 (21%), Positives = 66/174 (37%), Gaps = 38/174 (21%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-------- 69
            +  A++YL        VHRD++ +N+L+       + DFG++++++ +           
Sbjct: 121 QICKAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP 177

Query: 70  --WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
             W          +PE     + T   DV+ F V   E++  GK P  +L        N 
Sbjct: 178 IKWM---------SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------NK 221

Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           D+    +L+   RLP P          +  +   C +  P  RP    +   L 
Sbjct: 222 DVI--GVLEKGDRLPKPDLCPPV----LYTLMTRCWDYDPSDRPRFTELVCSLS 269

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 63.6 bits (155), Expect = 2e-12
 Identities = 28/99 (28%), Positives = 43/99 (43%), Gaps = 14/99 (14%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSNWTE-FAGTY 77
           AL  +H        +HRD+   N+LLD     H+  ADFG    +  +     +   GT 
Sbjct: 180 ALDAIHSMG----FIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233

Query: 78  GYVAPEL----AYTMKITEKCDVYSFGVLALEVIKGKHP 112
            Y++PE+            +CD +S GV   E++ G  P
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 63.1 bits (154), Expect = 2e-12
 Identities = 31/86 (36%), Positives = 40/86 (46%), Gaps = 11/86 (12%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
            A+ Y H      IVHRDL ++NLLLD +    +ADFG +            F G   Y 
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYA 180

Query: 81  APEL----AYTMKITEKCDVYSFGVL 102
           APEL     Y      + DV+S GV+
Sbjct: 181 APELFQGKKYDGP---EVDVWSLGVI 203

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 63.0 bits (153), Expect = 2e-12
 Identities = 30/181 (16%), Positives = 59/181 (32%), Gaps = 21/181 (11%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL-------KPDSS 68
           ++GV  AL Y+HH      VHR + + ++L+ ++ + +++       +       +    
Sbjct: 134 LQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 69  NWTEFAGTYGYVAPELAYTMKI--TEKCDVYSFGVLALEVIKGK------HPRDFLSSIS 120
                     +++PE+          K D+YS G+ A E+  G            L    
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250

Query: 121 SS---SLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           +     L     +        P+ S +      S+        N    S P  +  S   
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310

Query: 178 R 178
            
Sbjct: 311 H 311

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 62.6 bits (153), Expect = 3e-12
 Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 26/156 (16%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAK-FLKPDSSNWTEFAGTY 77
           AL+YLH       I++RDL   N+LLD   E H+   D+G+ K  L+P  +  T F GT 
Sbjct: 122 ALNYLHERG----IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTST-FCGTP 174

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD-- 135
            Y+APE+          D ++ GVL  E++ G+ P  F    SS + + + E D +    
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP--FDIVGSSDNPDQNTE-DYLFQVI 231

Query: 136 ----PRLPAPSRSVQEKLISIVKVAFSCLNESPESR 167
                R+P   RS+  K  S++K   S LN+ P+ R
Sbjct: 232 LEKQIRIP---RSLSVKAASVLK---SFLNKDPKER 261

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 62.3 bits (152), Expect = 3e-12
 Identities = 43/159 (27%), Positives = 63/159 (39%), Gaps = 33/159 (20%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTY 77
           V  A+ + H      +VHRD+  +N+L+DL    A + DFG    L      +T+F GT 
Sbjct: 148 VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTR 202

Query: 78  GYVAPEL----AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEM 133
            Y  PE      Y         V+S G+L  +++ G  P +    I  + L         
Sbjct: 203 VYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFERDQEILEAEL--------- 250

Query: 134 LDPRLPAP-SRSVQEKLISIVKVAFSCLNESPESRPTMK 171
                PA  S      LI        CL   P SRP+++
Sbjct: 251 ---HFPAHVSPDCC-ALIR------RCLAPKPSSRPSLE 279

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 61.9 bits (151), Expect = 3e-12
 Identities = 44/186 (23%), Positives = 75/186 (40%), Gaps = 38/186 (20%)

Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
            LD +  +     ++ AL+YL    F   VHRD++++N+L+       + DFG++++++ 
Sbjct: 112 SLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168

Query: 66  D----SSN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRD 114
                +S       W          APE     + T   DV+ FGV   E++  G  P  
Sbjct: 169 STYYKASKGKLPIKWM---------APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219

Query: 115 FLSSISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKI 172
            +        N D+     ++   RLP P  +    L S++     C    P  RP    
Sbjct: 220 GVK-------NNDVI--GRIENGERLPMP-PNCPPTLYSLMT---KCWAYDPSRRPRFTE 266

Query: 173 VSQQLR 178
           +  QL 
Sbjct: 267 LKAQLS 272

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 62.4 bits (152), Expect = 4e-12
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 8/94 (8%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAK-FLKPDSSNWTEFAGTYG 78
           AL YLH +    +V+RDL  +NL+LD   + H+   DFG+ K  +K  ++  T F GT  
Sbjct: 260 ALDYLHSEK--NVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMKT-FCGTPE 314

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+          D +  GV+  E++ G+ P
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 61.9 bits (151), Expect = 4e-12
 Identities = 26/102 (25%), Positives = 44/102 (43%), Gaps = 18/102 (17%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSS---- 68
           ++ VA AL +LH      I HRDL  +N+L +   +     + DF +   +K +      
Sbjct: 117 VQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173

Query: 69  ---NWTEFAGTYGYVAPE-----LAYTMKITEKCDVYSFGVL 102
                    G+  Y+APE             ++CD++S GV+
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 62.4 bits (152), Expect = 4e-12
 Identities = 51/153 (33%), Positives = 76/153 (49%), Gaps = 20/153 (13%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAK-FLKPDSSNWTEFAGTY 77
           AL+YLH       I++RDL   N+LLD   E H+   D+G+ K  L+P  +  T F GT 
Sbjct: 165 ALNYLHERG----IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTST-FCGTP 217

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPR 137
            Y+APE+          D ++ GVL  E++ G+ P  F    SS + + + E D +    
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP--FDIVGSSDNPDQNTE-DYLFQVI 274

Query: 138 LPAP---SRSVQEKLISIVKVAFSCLNESPESR 167
           L       RS+  K  S++K   S LN+ P+ R
Sbjct: 275 LEKQIRIPRSLSVKAASVLK---SFLNKDPKER 304

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 62.0 bits (151), Expect = 5e-12
 Identities = 40/158 (25%), Positives = 66/158 (41%), Gaps = 31/158 (19%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTY 77
           V +A+ + H+     ++HRD+  +N+L+DL   E  + DFG    LK   + +T+F GT 
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTR 212

Query: 78  GYVAPEL----AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEM 133
            Y  PE      Y  +      V+S G+L  +++ G  P +    I    +         
Sbjct: 213 VYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF-------- 261

Query: 134 LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
              R+ +  +     LI        CL   P  RPT +
Sbjct: 262 FRQRVSSECQH----LIR------WCLALRPSDRPTFE 289

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 61.9 bits (151), Expect = 5e-12
 Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 11/98 (11%)

Query: 19  VADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAK-FLKPDSSNWTEFA 74
           +A AL YLH  +    IV+RDL  +N+LLD   + H+   DFG+ K  ++ +S+  T F 
Sbjct: 148 IASALGYLHSLN----IVYRDLKPENILLD--SQGHIVLTDFGLCKENIEHNSTTST-FC 200

Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           GT  Y+APE+ +        D +  G +  E++ G  P
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 62.2 bits (151), Expect = 6e-12
 Identities = 41/181 (22%), Positives = 74/181 (40%), Gaps = 28/181 (15%)

Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKP 65
            LD +  +     ++ AL+YL    F   VHRD++++N+L+       + DFG++++++ 
Sbjct: 487 SLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543

Query: 66  DSSNWTEFAGTYGYV-----APELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSI 119
            +     +  + G +     APE     + T   DV+ FGV   E++  G  P   +   
Sbjct: 544 ST----YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-- 597

Query: 120 SSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                N D+     ++   RLP P          +  +   C    P  RP    +  QL
Sbjct: 598 -----NNDVI--GRIENGERLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQL 646

Query: 178 R 178
            
Sbjct: 647 S 647

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 61.7 bits (150), Expect = 7e-12
 Identities = 25/88 (28%), Positives = 44/88 (50%), Gaps = 11/88 (12%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           +  A+ YL       I+HRD+  +N+++  ++   + DFG A +L+     +T F GT  
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIE 194

Query: 79  YVAPEL----AYTMKITEKCDVYSFGVL 102
           Y APE+     Y      + +++S GV 
Sbjct: 195 YCAPEVLMGNPYRGP---ELEMWSLGVT 219

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 61.5 bits (150), Expect = 7e-12
 Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 11/95 (11%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAK-FLKPDSSNWTEFAGTY 77
            L +LH       IV+RDL   N+LLD   + H+  ADFG+ K  +  D+   T F GT 
Sbjct: 130 GLQFLHSKG----IVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTNT-FCGTP 182

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            Y+APE+    K     D +SFGVL  E++ G+ P
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 61.4 bits (150), Expect = 7e-12
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 11/95 (11%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAK-FLKPDSSNWTEFAGTY 77
           AL +LH       I++RDL  +N+LLD   E H+   DFG++K  +  +   ++ F GT 
Sbjct: 138 ALDHLHSLG----IIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYS-FCGTV 190

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            Y+APE+      T+  D +SFGVL  E++ G  P
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 61.1 bits (149), Expect = 8e-12
 Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 12/97 (12%)

Query: 19  VADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSNWTEFAG 75
           +     YLH  D    +++RDL  +NLL+D   + ++   DFG AK  +     WT   G
Sbjct: 150 IVLTFEYLHSLD----LIYRDLKPENLLID--QQGYIQVTDFGFAK--RVKGRTWT-LCG 200

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T   +APE+  +    +  D ++ GVL  E+  G  P
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 61.6 bits (149), Expect = 9e-12
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 9/97 (9%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAK-FLKPDSSNWTEFAG 75
           +A  L +L       I++RDL   N++LD   E H+  ADFG+ K  +    +  T F G
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKT-FCG 504

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  Y+APE+       +  D ++FGVL  E++ G+ P
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 60.4 bits (147), Expect = 1e-11
 Identities = 24/84 (28%), Positives = 41/84 (48%), Gaps = 6/84 (7%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
             + YLH+     I+HRD+   NLL+  +    +ADFG++   K   +  +   GT  ++
Sbjct: 148 KGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFM 204

Query: 81  APELAYTMKIT---EKCDVYSFGV 101
           APE     +     +  DV++ GV
Sbjct: 205 APESLSETRKIFSGKALDVWAMGV 228

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 60.2 bits (147), Expect = 2e-11
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 11/95 (11%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAK-FLKPDSSNWTEFAGTY 77
           AL +LH       I++RDL  +N++L+  ++ HV   DFG+ K  +   +   T F GT 
Sbjct: 133 ALGHLHQKG----IIYRDLKPENIMLN--HQGHVKLTDFGLCKESIHDGTVTHT-FCGTI 185

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            Y+APE+          D +S G L  +++ G  P
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 60.3 bits (147), Expect = 2e-11
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 11/95 (11%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAK-FLKPDSSNWTEFAGTY 77
           AL YLH  D    +V+RD+  +NL+LD   + H+   DFG+ K  +   ++  T F GT 
Sbjct: 117 ALEYLHSRD----VVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKT-FCGTP 169

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            Y+APE+          D +  GV+  E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 59.9 bits (146), Expect = 3e-11
 Identities = 35/95 (36%), Positives = 49/95 (51%), Gaps = 11/95 (11%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAK-FLKPDSSNWTEFAGTY 77
           AL +LH       I++RDL   N+LLD  +E H   ADFG+ K  +    +  T F GT 
Sbjct: 136 ALMFLHDKG----IIYRDLKLDNVLLD--HEGHCKLADFGMCKEGICNGVTTAT-FCGTP 188

Query: 78  GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            Y+APE+   M      D ++ GVL  E++ G  P
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 58.9 bits (143), Expect = 4e-11
 Identities = 29/175 (16%), Positives = 52/175 (29%), Gaps = 49/175 (28%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLD-------------------LEYEAHVADFGI 59
           V   L Y+H      +VH D+   N+ +                     +    + D G 
Sbjct: 124 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 60  AKFLKPDSSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSS 118
              +    S+     G   ++A E L        K D+++  +  +     +        
Sbjct: 181 VTRI----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236

Query: 119 ---ISSSSLNTDIELDEMLDPRLPAP-SRSVQEKLISIVKVAFSCLNESPESRPT 169
              I    L           PR+P   S+   E L+         ++  PE RP+
Sbjct: 237 WHEIRQGRL-----------PRIPQVLSQEFTE-LLK------VMIHPDPERRPS 273

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 58.8 bits (143), Expect = 6e-11
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 9/94 (9%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAK-FLKPDSSNWTEFAGTYG 78
            L +L       I++RDL   N++LD   E H+  ADFG+ K  +    +  T F GT  
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKT-FCGTPD 186

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           Y+APE+       +  D ++FGVL  E++ G+ P
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 58.7 bits (143), Expect = 7e-11
 Identities = 37/97 (38%), Positives = 50/97 (51%), Gaps = 12/97 (12%)

Query: 19  VADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSNWTEFAG 75
           V  AL YLH  D    I++RDL  +N+LLD     H+   DFG AK        +T   G
Sbjct: 115 VCLALEYLHSKD----IIYRDLKPENILLD--KNGHIKITDFGFAK--YVPDVTYT-LCG 165

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
           T  Y+APE+  T    +  D +SFG+L  E++ G  P
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 58.5 bits (142), Expect = 8e-11
 Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 12/97 (12%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSNWTE-FAGTY 77
           AL +LH       I++RD+  +N+LLD     HV   DFG++K    D +     F GT 
Sbjct: 171 ALEHLHKLG----IIYRDIKLENILLD--SNGHVVLTDFGLSKEFVADETERAYDFCGTI 224

Query: 78  GYVAPELAYTMKI--TEKCDVYSFGVLALEVIKGKHP 112
            Y+AP++         +  D +S GVL  E++ G  P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.0 bits (140), Expect = 1e-10
 Identities = 43/173 (24%), Positives = 67/173 (38%), Gaps = 38/173 (21%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--------- 69
           VA  + +L        +HRDL+++N+LL  +    + DFG+A+ +  D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 70  --WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNT 126
             W          APE  +    T + DV+SFGVL  E+   G  P           +  
Sbjct: 259 LKWM---------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--------YPGVKI 301

Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           D E    L    R+ AP  +  E    + +    C +  P  RPT   + + L
Sbjct: 302 DEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 350

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 57.3 bits (139), Expect = 2e-10
 Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 7/85 (8%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT--EFAGTYG 78
           D L YLH      IVH+D+   NLLL       ++  G+A+ L P +++ T     G+  
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 79  YVAPELAYTMKITE--KCDVYSFGV 101
           +  PE+A  +      K D++S GV
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGV 201

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 57.5 bits (139), Expect = 2e-10
 Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 25/168 (14%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
            VA  + +L    F   VHRDL+++N +LD ++   VADFG+A+ +     +      T 
Sbjct: 200 QVAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTG 255

Query: 78  GYV-----APELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNTDIELD 131
             +     A E   T K T K DV+SFGVL  E++ +G  P   +++          ++ 
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---------FDIT 306

Query: 132 EMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             L    RL  P     + L  ++     C +   E RP+   +  ++
Sbjct: 307 VYLLQGRRLLQP-EYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 350

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 57.3 bits (139), Expect = 2e-10
 Identities = 28/96 (29%), Positives = 45/96 (46%), Gaps = 14/96 (14%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           ++  LH      + HRD+   N+L++       + DFG AK L P   N   +  +  Y 
Sbjct: 141 SIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYICSRYYR 198

Query: 81  APEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 110
           APEL      YT  +    D++S G + A E++ G+
Sbjct: 199 APELIFGNQHYTTAV----DIWSVGCIFA-EMMLGE 229

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 56.8 bits (137), Expect = 3e-10
 Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 4/89 (4%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            + +LH      I+HRDL   N+++  +    + DFG+A+     S   T +  T  Y A
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRA 231

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGK 110
           PE+   M   E  D++S G +  E+++ K
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 56.6 bits (137), Expect = 4e-10
 Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 4/89 (4%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            + +LH      I+HRDL   N+++  +    + DFG+A+         T +  T  Y A
Sbjct: 139 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRA 194

Query: 82  PELAYTMKITEKCDVYSFGVLALEVIKGK 110
           PE+   M   E  D++S G +  E+IKG 
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 56.1 bits (136), Expect = 4e-10
 Identities = 28/86 (32%), Positives = 42/86 (48%), Gaps = 11/86 (12%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
            A+ Y H      +VHRDL  +N+LLD    A +ADFG++  +       T   G+  Y 
Sbjct: 122 SAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYA 177

Query: 81  APEL----AYTMKITEKCDVYSFGVL 102
           APE+     Y      + D++S GV+
Sbjct: 178 APEVISGRLYA---GPEVDIWSCGVI 200

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 55.8 bits (135), Expect = 6e-10
 Identities = 30/87 (34%), Positives = 38/87 (43%), Gaps = 13/87 (14%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH--VADFGIAKFLKPDSSNWTEFAGTYG 78
             +SY H      I HRDL  +N LLD        + DFG +K     S   +   GT  
Sbjct: 127 SGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPA 182

Query: 79  YVAPEL----AYTMKITEKCDVYSFGV 101
           Y+APE+     Y  K     DV+S GV
Sbjct: 183 YIAPEVLLRQEYDGK---IADVWSCGV 206

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 55.4 bits (134), Expect = 9e-10
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 25/167 (14%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
           VA  + YL    F   VHRDL+++N +LD  +   VADFG+A+ +  D   ++     + 
Sbjct: 133 VARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHRHA 188

Query: 79  YV-----APELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNTDIELDE 132
            +     A E   T + T K DV+SFGVL  E++ +G  P   +            +L  
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---------FDLTH 239

Query: 133 MLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            L    RLP P     + L  +++    C    P  RPT +++  ++
Sbjct: 240 FLAQGRRLPQP-EYCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEV 282

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 55.4 bits (134), Expect = 9e-10
 Identities = 29/86 (33%), Positives = 42/86 (48%), Gaps = 11/86 (12%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
            A+ Y H      IVHRDL  +NLLLD      +ADFG++  +   +   T   G+  Y 
Sbjct: 119 CAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYA 174

Query: 81  APEL----AYTMKITEKCDVYSFGVL 102
           APE+     Y      + DV+S G++
Sbjct: 175 APEVINGKLYA---GPEVDVWSCGIV 197

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 54.6 bits (132), Expect = 1e-09
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 25/168 (14%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTY 77
            VA  + YL    F   VHRDL+++N +LD ++   VADFG+A+ +  D   ++    T 
Sbjct: 136 QVAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTG 191

Query: 78  GYV-----APELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNTDIELD 131
             +     A E   T K T K DV+SFGVL  E++ +G  P   +++          ++ 
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---------FDIT 242

Query: 132 EMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             L    RL  P     + L  ++     C +   E RP+   +  ++
Sbjct: 243 VYLLQGRRLLQP-EYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 286

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 54.7 bits (132), Expect = 2e-09
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 16/96 (16%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           A+ ++H      I HRD+  +NLL++ +     + DFG AK L P   +   +  +  Y 
Sbjct: 153 AVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-VAYICSRFYR 208

Query: 81  APEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 110
           APEL      YT  I    D++S G V   E+I GK
Sbjct: 209 APELMLGATEYTPSI----DLWSIGCVFG-ELILGK 239

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 54.3 bits (131), Expect = 2e-09
 Identities = 38/173 (21%), Positives = 68/173 (39%), Gaps = 39/173 (22%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---------- 68
           +A  + YL    F   +HRDL+++N +L  +    VADFG+++ +               
Sbjct: 146 IACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202

Query: 69  -NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
             W          A E       T   DV++FGV   E++ +G+ P   + +        
Sbjct: 203 VKWL---------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-------- 245

Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             E+   L    RL  P     E++  ++     C +  P+ RP+   +  +L
Sbjct: 246 -AEIYNYLIGGNRLKQP-PECMEEVYDLMY---QCWSADPKQRPSFTCLRMEL 293

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 54.2 bits (131), Expect = 3e-09
 Identities = 39/173 (22%), Positives = 75/173 (43%), Gaps = 38/173 (21%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS-----SN---- 69
           VA  +++L        +HRD++++N+LL   + A + DFG+A+ +  DS      N    
Sbjct: 173 VAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229

Query: 70  --WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
             W          APE  +    T + DV+S+G+L  E+   G +P           +  
Sbjct: 230 VKWM---------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--------YPGILV 272

Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           + +  +++    ++  P     + + SI++   +C    P  RPT + +   L
Sbjct: 273 NSKFYKLVKDGYQMAQP-AFAPKNIYSIMQ---ACWALEPTHRPTFQQICSFL 321

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 53.4 bits (129), Expect = 4e-09
 Identities = 44/173 (25%), Positives = 69/173 (39%), Gaps = 39/173 (22%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---------- 68
           +A  + YL +  F   +HRDL+++N +L  +    VADFG++K +               
Sbjct: 156 IALGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212

Query: 69  -NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
             W          A E       T K DV++FGV   E+  +G  P   + +        
Sbjct: 213 VKWI---------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-------- 255

Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             E+ + L    RL  P     ++L  I+    SC    P  RPT  ++  QL
Sbjct: 256 -HEMYDYLLHGHRLKQP-EDCLDELYEIMY---SCWRTDPLDRPTFSVLRLQL 303

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 53.4 bits (129), Expect = 4e-09
 Identities = 41/173 (23%), Positives = 72/173 (41%), Gaps = 38/173 (21%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-----SSN---- 69
           VA  +++L        +HRDL+++N+LL       + DFG+A+ +K D       N    
Sbjct: 154 VAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210

Query: 70  --WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
             W          APE  +    T + DV+S+G+   E+   G  P           +  
Sbjct: 211 VKWM---------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP--------YPGMPV 253

Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           D +  +M+    R+ +P  +  E    +  +  +C +  P  RPT K + Q +
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLI 302

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 54.0 bits (130), Expect = 4e-09
 Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 11/86 (12%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
             + Y H      +VHRDL  +N+LLD    A +ADFG++  +       T   G+  Y 
Sbjct: 127 SGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYA 182

Query: 81  APEL----AYTMKITEKCDVYSFGVL 102
           APE+     Y      + D++S GV+
Sbjct: 183 APEVISGRLYA---GPEVDIWSSGVI 205

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 53.1 bits (128), Expect = 6e-09
 Identities = 49/187 (26%), Positives = 83/187 (44%), Gaps = 29/187 (15%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           D A   L   Q +     VA  + YL    F   VHRDL+++N L+       + DFG++
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMS 205

Query: 61  KFLKPDSSNWTEFAGTYGYV-----APE-LAYTMKITEKCDVYSFGVLALEVI-KGKHPR 113
           + +   S+++    G    +      PE + Y  K T + DV+SFGV+  E+   GK P 
Sbjct: 206 RDI--YSTDYYR-VGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPW 261

Query: 114 DFLSSISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             LS         + E  + +     L  P R+   ++ +I++    C    P+ R ++K
Sbjct: 262 YQLS---------NTEAIDCITQGRELERP-RACPPEVYAIMR---GCWQREPQQRHSIK 308

Query: 172 IVSQQLR 178
            V  +L+
Sbjct: 309 DVHARLQ 315

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 52.7 bits (127), Expect = 8e-09
 Identities = 42/171 (24%), Positives = 69/171 (40%), Gaps = 32/171 (18%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADFGIAKFLKPDSSNWTEFAG 75
           +A    YL  + F   +HRD++++N LL       V    DFG+A+ +    +++    G
Sbjct: 149 IACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYR-KG 202

Query: 76  TYGYV-----APE-LAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNTDI 128
               +      PE        T K D +SFGVL  E+   G  P    S       N   
Sbjct: 203 GCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQ-- 252

Query: 129 ELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           E+ E +    R+  P ++    +  I+     C    PE RP   I+ +++
Sbjct: 253 EVLEFVTSGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERI 299

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 52.7 bits (127), Expect = 8e-09
 Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 7/90 (7%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L Y+H      I+HRDL   NL ++ + E  + DFG+A   +  +   T +  T  Y A
Sbjct: 144 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRA 197

Query: 82  PELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           PE+    M   +  D++S G +  E++ G+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 52.6 bits (127), Expect = 8e-09
 Identities = 29/88 (32%), Positives = 41/88 (46%), Gaps = 14/88 (15%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW---TEFAGTY 77
             + YLH      I HRD+  +NLLLD      ++DFG+A   + ++          GT 
Sbjct: 116 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTL 171

Query: 78  GYVAPEL----AYTMKITEKCDVYSFGV 101
            YVAPEL     +     E  DV+S G+
Sbjct: 172 PYVAPELLKRREFH---AEPVDVWSCGI 196

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 52.7 bits (127), Expect = 9e-09
 Identities = 42/173 (24%), Positives = 66/173 (38%), Gaps = 38/173 (21%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---------- 68
           VA  + +L        +HRDL+++N+LL  +    + DFG+A+ +  D            
Sbjct: 157 VAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213

Query: 69  -NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
             W          APE  +    T + DV+SFGVL  E+   G  P           +  
Sbjct: 214 LKWM---------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--------YPGVKI 256

Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           D E    L    R+ AP      ++   +     C +  P  RPT   + + L
Sbjct: 257 DEEFCRRLKEGTRMRAP-DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 305

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 52.4 bits (126), Expect = 1e-08
 Identities = 36/97 (37%), Positives = 49/97 (50%), Gaps = 18/97 (18%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTYGY 79
           +L+Y+H       I HRD+  +NLLLD +     + DFG AK L     N   +  +  Y
Sbjct: 168 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYY 222

Query: 80  VAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 110
            APEL      YT  I    DV+S G VLA E++ G+
Sbjct: 223 RAPELIFGATDYTSSI----DVWSAGCVLA-ELLLGQ 254

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 52.3 bits (126), Expect = 1e-08
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 18/97 (18%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTYGY 79
           +L+Y+H       I HRD+  +NLLLD       + DFG AK L     N   +  +  Y
Sbjct: 153 SLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYICSRYY 207

Query: 80  VAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 110
            APEL      YT  I    D++S G V+A E+++G+
Sbjct: 208 RAPELIFGATNYTTNI----DIWSTGCVMA-ELMQGQ 239

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 52.3 bits (126), Expect = 1e-08
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 7/90 (7%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L Y+H      +VHRDL   NL ++ + E  + DFG+A   +   +  T +  T  Y A
Sbjct: 138 GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRA 191

Query: 82  PELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           PE+  + M   +  D++S G +  E++ GK
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 52.0 bits (125), Expect = 1e-08
 Identities = 41/171 (23%), Positives = 68/171 (39%), Gaps = 32/171 (18%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV---ADFGIAKFLKPDSSNWTEFAG 75
           +A    YL  + F   +HRD++++N LL       V    DFG+A+ +    + +    G
Sbjct: 190 IACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYR-KG 243

Query: 76  TYGYV-----APE-LAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNTDI 128
               +      PE        T K D +SFGVL  E+   G  P    S         + 
Sbjct: 244 GCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---------NQ 293

Query: 129 ELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           E+ E +    R+  P ++    +  I+     C    PE RP   I+ +++
Sbjct: 294 EVLEFVTSGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERI 340

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 51.9 bits (125), Expect = 1e-08
 Identities = 29/88 (32%), Positives = 41/88 (46%), Gaps = 14/88 (15%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNW---TEFAGTY 77
             + YLH      I HRD+  +NLLLD      ++DFG+A   + ++          GT 
Sbjct: 116 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTL 171

Query: 78  GYVAPEL----AYTMKITEKCDVYSFGV 101
            YVAPEL     +     E  DV+S G+
Sbjct: 172 PYVAPELLKRREFH---AEPVDVWSCGI 196

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 51.8 bits (125), Expect = 2e-08
 Identities = 41/174 (23%), Positives = 69/174 (39%), Gaps = 39/174 (22%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL------KPDSSN--- 69
           +A  + YL    F   VHRDL+++N L+       + DFG+++ +      +        
Sbjct: 142 IASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198

Query: 70  --WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
             W           PE     K T + DV+SFGV+  E+   GK P   LS         
Sbjct: 199 IRWM---------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS--------- 240

Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           + E+ E +     L  P R   +++  ++     C    P+ R  +K + + L 
Sbjct: 241 NTEVIECITQGRVLERP-RVCPKEVYDVML---GCWQREPQQRLNIKEIYKILH 290

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 51.9 bits (125), Expect = 2e-08
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 7/90 (7%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L Y+H      I+HRDL   NL ++ + E  + DFG+A   +   S  T +  T  Y A
Sbjct: 140 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRWYRA 193

Query: 82  PELAYT-MKITEKCDVYSFGVLALEVIKGK 110
           PE+    M+ T+  D++S G +  E+I GK
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 51.9 bits (125), Expect = 2e-08
 Identities = 39/175 (22%), Positives = 69/175 (39%), Gaps = 42/175 (24%)

Query: 19  VADALSYL--HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-----SSN-- 69
           VA  + +L          VHRDL+++N+L+       + DFG+A+ +  D       N  
Sbjct: 181 VAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR 235

Query: 70  ----WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSL 124
               W          APE  +    T K DV+S+G+L  E+   G +P           +
Sbjct: 236 LPVKWM---------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--------YPGI 278

Query: 125 NTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             D    +++    ++  P     E++  I++   SC       RP+   ++  L
Sbjct: 279 PVDANFYKLIQNGFKMDQP-FYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFL 329

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 51.5 bits (124), Expect = 2e-08
 Identities = 26/98 (26%), Positives = 45/98 (45%), Gaps = 16/98 (16%)

Query: 22  ALSYLH-HDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGY 79
           AL Y H       I+HRD+   N+++D E+ +  + D+G+A+F  P    +     +  +
Sbjct: 142 ALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYF 196

Query: 80  VAPEL-----AYTMKITEKCDVYSFGVLALEVIKGKHP 112
             PEL      Y   +    D++S G +   +I  K P
Sbjct: 197 KGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 51.5 bits (124), Expect = 2e-08
 Identities = 35/174 (20%), Positives = 72/174 (41%), Gaps = 39/174 (22%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL------KPDSSN--- 69
           +AD ++YL+ + F   VHRDL+++N ++  ++   + DFG+ + +      +        
Sbjct: 147 IADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203

Query: 70  --WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
             W          +PE       T   DV+SFGV+  E+    + P   LS         
Sbjct: 204 VRWM---------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------- 245

Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           + ++   +     L  P  +  + L  +++    C   +P+ RP+   +   ++
Sbjct: 246 NEQVLRFVMEGGLLDKP-DNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 295

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 51.5 bits (124), Expect = 2e-08
 Identities = 46/176 (26%), Positives = 69/176 (39%), Gaps = 46/176 (26%)

Query: 18  GVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-------- 69
            VA  + YL    F   +HRDL+++N+L+   Y A +ADFG+++                
Sbjct: 150 DVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 202

Query: 70  ----WTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSS 123
               W          A E L Y+   T   DV+S+GVL  E++  G  P      ++ + 
Sbjct: 203 LPVRWM---------AIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP---YCGMTCA- 248

Query: 124 LNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                EL E L    RL  P     E    +  +   C  E P  RP+   +   L
Sbjct: 249 -----ELYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSL 295

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 51.2 bits (123), Expect = 3e-08
 Identities = 28/94 (29%), Positives = 42/94 (44%), Gaps = 13/94 (13%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L  LH      +VHRDL   N+LL    +  + DF +A+    D +N T +     Y A
Sbjct: 146 GLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRA 201

Query: 82  PEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
           PEL      +T  +    D++S G +  E+   K
Sbjct: 202 PELVMQFKGFTKLV----DMWSAGCVMAEMFNRK 231

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 51.1 bits (123), Expect = 3e-08
 Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 17/98 (17%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYG 78
            L Y+H      ++HRDL   NLLL+   +  + DFG+A+   PD  +    TE+  T  
Sbjct: 140 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196

Query: 79  YVAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 110
           Y APE+      YT  I    D++S G +LA E++  +
Sbjct: 197 YRAPEIMLNSKGYTKSI----DIWSVGCILA-EMLSNR 229

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 50.3 bits (121), Expect = 5e-08
 Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 16/98 (16%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSN---WTEFAGTY 77
            L Y+H      ++HRDL   NL ++ E     + DFG+A+ + P  S+    +E   T 
Sbjct: 132 GLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 78  GYVAPEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
            Y +P L      YT  I    D+++ G +  E++ GK
Sbjct: 189 WYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 49.6 bits (119), Expect = 1e-07
 Identities = 43/173 (24%), Positives = 73/173 (42%), Gaps = 39/173 (22%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-----SSN---- 69
           +A  + YL        +HRDL+++N+L+       +ADFG+A+ +        ++N    
Sbjct: 166 LARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222

Query: 70  --WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
             W          APE  +    T + DV+SFGVL  E+   G  P   +          
Sbjct: 223 VKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-------- 265

Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             EL ++L    R+  P  +   +L  +++    C +  P  RPT K + + L
Sbjct: 266 -EELFKLLKEGHRMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 49.7 bits (119), Expect = 1e-07
 Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 39/173 (22%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-----SSN---- 69
           VA  + YL        +HRDL+++N+L+  +    +ADFG+A+ +        ++N    
Sbjct: 200 VARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 256

Query: 70  --WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSLNT 126
             W          APE  +    T + DV+SFGVL  E+   G  P   +          
Sbjct: 257 VKWM---------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-------- 299

Query: 127 DIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             EL ++L    R+  P  +   +L  +++    C +  P  RPT K + + L
Sbjct: 300 -EELFKLLKEGHRMDKP-SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 347

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 49.0 bits (117), Expect = 1e-07
 Identities = 15/168 (8%), Positives = 40/168 (23%), Gaps = 35/168 (20%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           + A         +  ++ +A A    H      +         + + ++ +  +A     
Sbjct: 120 EVADTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-- 174

Query: 61  KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS 120
                              +            + D+   G     ++  + P     +  
Sbjct: 175 ------------------TMPDA-------NPQDDIRGIGASLYALLVNRWP--LPEAGV 207

Query: 121 SSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRP 168
            S L      +     +   P+   ++    I  VA   +      R 
Sbjct: 208 RSGLAP---AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRS 252

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 49.3 bits (118), Expect = 1e-07
 Identities = 44/175 (25%), Positives = 73/175 (41%), Gaps = 43/175 (24%)

Query: 19  VADALSYL--HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-----SSN-- 69
           +A  + YL          +HRDL+++N+L+       +ADFG+A+ +        ++N  
Sbjct: 212 LARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266

Query: 70  ----WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSL 124
               W          APE  +    T + DV+SFGVL  E+   G  P      I     
Sbjct: 267 LPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP---YPGIPVE-- 312

Query: 125 NTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
               EL ++L    R+  P  +   +L  +++    C +  P  RPT K + + L
Sbjct: 313 ----ELFKLLKEGHRMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 359

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 48.9 bits (117), Expect = 2e-07
 Identities = 24/96 (25%), Positives = 41/96 (42%), Gaps = 11/96 (11%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH------VADFGIAKFLKPDSSNWTEFAG 75
            L Y+H  C   I+H D+  +N+L+++           +AD G A +      ++T    
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYTNSIQ 197

Query: 76  TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKH 111
           T  Y +PE+          D++S   L  E+I G  
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 48.4 bits (116), Expect = 3e-07
 Identities = 43/190 (22%), Positives = 79/190 (41%), Gaps = 43/190 (22%)

Query: 5   QELDWSQRMNTIKGVADALSYL--HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF 62
             L+    ++ +  +A  + YL  HH     +VH+DL+++N+L+  +    ++D G+ + 
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFRE 177

Query: 63  L------KPDSSN-----WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGK 110
           +      K   ++     W          APE     K +   D++S+GV+  EV   G 
Sbjct: 178 VYAADYYKLLGNSLLPIRWM---------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 228

Query: 111 HPRDFLSSISSSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRP 168
            P    S         + ++ EM+     LP P       + +++     C NE P  RP
Sbjct: 229 QPYCGYS---------NQDVVEMIRNRQVLPCP-DDCPAWVYALMI---ECWNEFPSRRP 275

Query: 169 TMKIVSQQLR 178
             K +  +LR
Sbjct: 276 RFKDIHSRLR 285

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 46.9 bits (112), Expect = 7e-07
 Identities = 38/177 (21%), Positives = 75/177 (42%), Gaps = 45/177 (25%)

Query: 19  VADALSYL--HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL------KPDSSN- 69
           VA  ++YL          VHRDL+++N L+       +ADFG+++ +      K D ++ 
Sbjct: 183 VAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDA 237

Query: 70  ----WTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSS 123
               W           PE + Y  + T + DV+++GV+  E+   G  P   ++      
Sbjct: 238 IPIRWM---------PPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMA------ 281

Query: 124 LNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
                E+   +     L  P  +   +L ++++    C ++ P  RP+   + + L+
Sbjct: 282 ---HEEVIYYVRDGNILACP-ENCPLELYNLMR---LCWSKLPADRPSFCSIHRILQ 331

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 47.2 bits (113), Expect = 7e-07
 Identities = 28/104 (26%), Positives = 47/104 (45%), Gaps = 22/104 (21%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN----------WT 71
           A+  LH      ++HRDL   NLL++   +  V DFG+A+ +   +++            
Sbjct: 124 AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 72  EFAGTYGYVAPEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
           EF  T  Y APE+      Y+  +    DV+S G +  E+   +
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 46.5 bits (111), Expect = 9e-07
 Identities = 39/175 (22%), Positives = 73/175 (41%), Gaps = 43/175 (24%)

Query: 19  VADALSYL--HHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-----SSN-- 69
           ++  + YL         +VHRDL+++N+L+    +  ++DFG+++ +  +      S   
Sbjct: 159 ISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGR 213

Query: 70  ----WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSL 124
               W          A E  +    T + DV+SFGVL  E++  G +P      I     
Sbjct: 214 IPVKWM---------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP---YPGIPPE-- 259

Query: 125 NTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                L  +L    R+  P  +  E++  ++     C  + P+ RP    +S+ L
Sbjct: 260 ----RLFNLLKTGHRMERP-DNCSEEMYRLML---QCWKQEPDKRPVFADISKDL 306

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 43.8 bits (104), Expect = 9e-06
 Identities = 22/100 (22%), Positives = 42/100 (42%), Gaps = 17/100 (17%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH-----VADFGIAKFLKPDSSNWTEFAG 75
           + +++ H       +HRDL  +NLLL +   +      + DFG+A+        +T    
Sbjct: 143 NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199

Query: 76  TYGYVAPEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
           T  Y  PE+      Y+  +    D++S   +  E++   
Sbjct: 200 TLWYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 43.4 bits (103), Expect = 1e-05
 Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 12/95 (12%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
           + + + H      I+HRD+  +N+L+       + DFG A+ L      + +   T  Y 
Sbjct: 135 NGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191

Query: 81  APEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
           APEL      Y   +    DV++ G L  E+  G+
Sbjct: 192 APELLVGDVKYGKAV----DVWAIGCLVTEMFMGE 222

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 42.9 bits (102), Expect = 2e-05
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 12/94 (12%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            ++Y H      ++HRDL  +NLL++ E E  +ADFG+A+        +T    T  Y A
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168

Query: 82  PEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
           P++      Y+  I    D++S G +  E++ G 
Sbjct: 169 PDVLMGSKKYSTTI----DIWSVGCIFAEMVNGT 198

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 42.9 bits (101), Expect = 2e-05
 Identities = 26/92 (28%), Positives = 39/92 (42%), Gaps = 19/92 (20%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH----VADFGIAKFLKPDSSNWTEFAG- 75
           D + YLH +    ++HRDL   N+L+  E        +AD G A+          +    
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 76  --TYGYVAPEL-----AYTMKITEKCDVYSFG 100
             T+ Y APEL      YT  I    D+++ G
Sbjct: 196 VVTFWYRAPELLLGARHYTKAI----DIWAIG 223

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 42.5 bits (101), Expect = 2e-05
 Identities = 24/96 (25%), Positives = 43/96 (44%), Gaps = 12/96 (12%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L + H      ++HRDL  +NLL++   E  +A+FG+A+        ++    T  Y  
Sbjct: 113 GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169

Query: 82  PEL-----AYTMKITEKCDVYSFGVLALEVIKGKHP 112
           P++      Y+  I    D++S G +  E+     P
Sbjct: 170 PDVLFGAKLYSTSI----DMWSAGCIFAELANAGRP 201

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 42.5 bits (101), Expect = 2e-05
 Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 12/94 (12%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            +++ H      I+HRDL  +NLL++ +    +ADFG+A+       ++T    T  Y A
Sbjct: 131 GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187

Query: 82  PEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
           P++      Y+  +    D++S G +  E+I GK
Sbjct: 188 PDVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 42.6 bits (101), Expect = 2e-05
 Identities = 24/95 (25%), Positives = 43/95 (45%), Gaps = 12/95 (12%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV 80
            A+++ H       +HRD+  +N+L+       + DFG A+ L   S  + +   T  Y 
Sbjct: 113 QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169

Query: 81  APEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
           +PEL      Y   +    DV++ G +  E++ G 
Sbjct: 170 SPELLVGDTQYGPPV----DVWAIGCVFAELLSGV 200

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 42.2 bits (100), Expect = 3e-05
 Identities = 27/100 (27%), Positives = 45/100 (45%), Gaps = 18/100 (18%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA-KFLKPDSSNWTEFAG---T 76
           + L Y+H +    I+HRD+ + N+L+  +    +ADFG+A  F    +S    +     T
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191

Query: 77  YGYVAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 110
             Y  PEL      Y   I    D++  G ++A E+    
Sbjct: 192 LWYRPPELLLGERDYGPPI----DLWGAGCIMA-EMWTRS 226

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 41.9 bits (99), Expect = 4e-05
 Identities = 23/91 (25%), Positives = 36/91 (39%), Gaps = 30/91 (32%)

Query: 16  IKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAH---VADFGIAKFLKPDSSNWT 71
           +K + +A+ YLH  +    I HRD+  +NLL   +       + DFG AK          
Sbjct: 123 MKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-------- 170

Query: 72  EFAGTYGYVAPELAYTMKITEKCDVYSFGVL 102
                Y              + CD++S GV+
Sbjct: 171 -TGEKYD-------------KSCDMWSLGVI 187

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 41.4 bits (98), Expect = 5e-05
 Identities = 25/94 (26%), Positives = 45/94 (47%), Gaps = 12/94 (12%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L+Y H      ++HRDL  +NLL++   E  +ADFG+A+     +  +     T  Y  
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168

Query: 82  PEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
           P++      Y+ +I    D++  G +  E+  G+
Sbjct: 169 PDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 41.0 bits (97), Expect = 8e-05
 Identities = 17/42 (40%), Positives = 25/42 (59%), Gaps = 3/42 (7%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF 62
             L +LH +C   IVHRDL  +N+L+       +ADFG+A+ 
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 12/94 (12%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA 81
            L++ H +    I+HRDL  +NLL++   +  + DFG+A+      + ++    T  Y A
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176

Query: 82  PEL-----AYTMKITEKCDVYSFGVLALEVIKGK 110
           P++      Y+  I    D++S G +  E+I GK
Sbjct: 177 PDVLMGSRTYSTSI----DIWSCGCILAEMITGK 206

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 40.7 bits (96), Expect = 1e-04
 Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 14/95 (14%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK-FLKPDSSNWTEFAGTYGY 79
             L +LH      +VHRDL  +N+L+    +  +ADFG+A+ +        T    T  Y
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWY 185

Query: 80  VAPEL----AYTMKITEKCDVYSFGVLALEVIKGK 110
            APE+    +Y   +    D++S G +  E+ + K
Sbjct: 186 RAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 40.3 bits (94), Expect = 1e-04
 Identities = 27/147 (18%), Positives = 44/147 (29%), Gaps = 54/147 (36%)

Query: 15  TIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE------------------------- 49
            I+ V   L YLH  C   I+H D+  +N+LL +                          
Sbjct: 151 IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208

Query: 50  ------------------------YEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA 85
                                    +  +AD G A ++       TE   T  Y + E+ 
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVL 265

Query: 86  YTMKITEKCDVYSFGVLALEVIKGKHP 112
                    D++S   +A E+  G + 
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYL 292

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 40.4 bits (95), Expect = 1e-04
 Identities = 31/116 (26%), Positives = 48/116 (41%), Gaps = 35/116 (30%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN------------ 69
            + YLH      ++HRD+   N+LL+ E    VADFG+++                    
Sbjct: 121 VIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 70  ---------WTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 110
                     T++  T  Y APE+      YT  I    D++S G +L  E++ GK
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILG-EILCGK 228

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 39.5 bits (93), Expect = 2e-04
 Identities = 32/103 (31%), Positives = 45/103 (43%), Gaps = 30/103 (29%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF----LKPDSSN----WTEF 73
            L YLH      I+HRDL   NLLLD      +ADFG+AK      +  +      W   
Sbjct: 124 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRW--- 177

Query: 74  AGTYGYVAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGK 110
                Y APEL      Y + +    D+++ G +LA E++   
Sbjct: 178 -----YRAPELLFGARMYGVGV----DMWAVGCILA-ELLLRV 210

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 39.3 bits (92), Expect = 3e-04
 Identities = 15/51 (29%), Positives = 29/51 (56%), Gaps = 5/51 (9%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYE--AHVADFGIAKFLKPDSSN 69
           D L Y+H + +   VH D+ + NLLL  +     ++AD+G++    P+ ++
Sbjct: 162 DVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 39.0 bits (91), Expect = 4e-04
 Identities = 16/51 (31%), Positives = 26/51 (50%), Gaps = 5/51 (9%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPDSSN 69
           D L Y+H   +   VH D+ + NLLL+ +    V   D+G+A    P+  +
Sbjct: 163 DILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 38.7 bits (89), Expect = 5e-04
 Identities = 16/111 (14%), Positives = 32/111 (28%), Gaps = 13/111 (11%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
              +   + +  +  +L+           HRDL   N+LL       +      K     
Sbjct: 158 SSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI- 214

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEK--CDVYSFGVLALEVIKGKHPRDF 115
                    + G     + YT+   E+    V+    +  ++  G     F
Sbjct: 215 --------PSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQF 257

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 38.2 bits (89), Expect = 7e-04
 Identities = 15/48 (31%), Positives = 28/48 (58%), Gaps = 5/48 (10%)

Query: 21  DALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLKPD 66
           DAL +LH + +   VH +++++N+ +D E ++ V  A +G A    P 
Sbjct: 170 DALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 38.2 bits (89), Expect = 8e-04
 Identities = 29/119 (24%), Positives = 44/119 (36%), Gaps = 36/119 (30%)

Query: 22  ALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN------------ 69
             +++H      I+HRDL   N LL+ +    V DFG+A+ +  +               
Sbjct: 141 GENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 70  ----------WTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFG-VLALEVIKGKHP 112
                      T    T  Y APEL      YT  I    D++S G + A E++     
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFA-ELLNMLQS 251

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	179
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.98
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.98
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.98
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.98
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.98
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.98
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.98
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.98
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.98
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.98
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.98
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.98
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.98
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.98
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.98
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.98
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.98
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.98
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.98
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.98
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.98
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.98
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.98
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.98
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.98
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.98
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.98
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.98
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.98
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.98
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.98
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.98
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.98
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.98
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.97
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.97
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.97
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.97
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.97
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.97
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.97
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.97
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.97
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.97
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.97
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.97
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.97
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.97
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.96
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.96
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.95
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.94
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.93
3uqc_A	286	Probable conserved transmembrane protein; structur	99.93
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.81
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.55
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.33
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.13
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.67
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.84
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.61
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	97.56
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.54
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	96.9
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	96.62
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.33
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	95.78
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.32
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	94.99
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	94.72
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	94.25
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	94.11
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	93.64
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	93.58
3ats_A	357	Putative uncharacterized protein; hypothetical pro	93.31
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	93.2
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	92.88
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	92.52
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	92.23
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	91.59
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	91.24
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	91.05
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	90.45
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	89.23
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.65
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.54
3mes_A	424	Choline kinase; malaria, structural genomics, stru	83.01

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.4e-41  Score=245.33  Aligned_cols=166  Identities=21%  Similarity=0.380  Sum_probs=124.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~   81 (179)
                      ..++++.+++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|........  ......|++.|+|
T Consensus       126 ~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymA  202 (307)
T 3omv_A          126 ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA  202 (307)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccC
Confidence            45799999999999999999999999   999999999999999999999999999976543221  2344679999999


Q ss_pred             CcccccC---CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           82 PELAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        82 pe~~~~~---~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      ||.+.+.   .++.++|||||||++|+|++|+.||...+....   ...........+..+....   .....+.+||.+
T Consensus       203 PE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~---~~~~~l~~li~~  276 (307)
T 3omv_A          203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---IIFMVGRGYASPDLSKLYK---NCPKAMKRLVAD  276 (307)
T ss_dssp             HHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHTTCCCCCSTTSCT---TSCHHHHHHHHH
T ss_pred             HHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCCCCCcccccc---cchHHHHHHHHH
Confidence            9998643   478999999999999999999999975432111   0011111112222221111   122347889999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||+.||++|||++|++++|+
T Consensus       277 cl~~dP~~RPs~~ei~~~Le  296 (307)
T 3omv_A          277 CVKKVKEERPLFPQILSSIE  296 (307)
T ss_dssp             HTCSSSTTSCCHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHHH
Confidence            99999999999999998875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-40  Score=247.25  Aligned_cols=160  Identities=23%  Similarity=0.361  Sum_probs=129.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..............|++.|+|||+
T Consensus       165 ~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEv  241 (346)
T 4fih_A          165 TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEL  241 (346)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHH
Confidence            4689999999999999999999999   9999999999999999999999999999877655444556789999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+|||||++|+|++|..||...+....     .........+..+.    ......++.+||.+||+.||
T Consensus       242 l~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-----~~~i~~~~~~~~~~----~~~~s~~~~dli~~~L~~dP  312 (346)
T 4fih_A          242 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-----MKMIRDNLPPRLKN----LHKVSPSLKGFLDRLLVRDP  312 (346)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSSCCCCSC----GGGSCHHHHHHHHHHSCSST
T ss_pred             HCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-----HHHHHcCCCCCCCc----cccCCHHHHHHHHHHcCCCh
Confidence            9999999999999999999999999999975432111     11111122222222    12223347889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      ++|||++|+++|
T Consensus       313 ~~R~ta~e~l~H  324 (346)
T 4fih_A          313 AQRATAAELLKH  324 (346)
T ss_dssp             TTSCCHHHHTTC
T ss_pred             hHCcCHHHHhcC
Confidence            999999999886

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.1e-40  Score=243.50  Aligned_cols=159  Identities=23%  Similarity=0.398  Sum_probs=128.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC--CCcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.||++||+|||+.   +++||||||+|||++.++.+||+|||+++......  .......+++.|+||
T Consensus       140 ~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  216 (308)
T 4gt4_A          140 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP  216 (308)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCH
Confidence            4689999999999999999999999   99999999999999999999999999997654322  123345788999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCC-CCCCCCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLD-PRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |.+.+..++.++|||||||++|||+| |..||.+......        ...+.. .+.+.+..+..    .+.+||.+||
T Consensus       217 E~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~--------~~~i~~~~~~~~p~~~~~----~~~~li~~C~  284 (308)
T 4gt4_A          217 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV--------VEMIRNRQVLPCPDDCPA----WVYALMIECW  284 (308)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH--------HHHHHTTCCCCCCTTCCH----HHHHHHHHHT
T ss_pred             HHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHHcCCCCCCcccchH----HHHHHHHHHc
Confidence            99999999999999999999999998 8999976542211        111111 12222223333    4888999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||++|||+++|+++|+
T Consensus       285 ~~dP~~RPs~~ei~~~L~  302 (308)
T 4gt4_A          285 NEFPSRRPRFKDIHSRLR  302 (308)
T ss_dssp             CSSGGGSCCHHHHHHHHH
T ss_pred             CCChhHCcCHHHHHHHHH
Confidence            999999999999999997

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.7e-40  Score=243.20  Aligned_cols=160  Identities=25%  Similarity=0.371  Sum_probs=121.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      .++++.+++.++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  ......+++.|+||
T Consensus       153 ~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  229 (329)
T 4aoj_A          153 GPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  229 (329)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccCh
Confidence            5699999999999999999999999   999999999999999999999999999986543322  12345688999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|||||||++|||++ |+.||.........     .....  ..+.+.+..+..    ++.+||.+||+
T Consensus       230 E~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~-----~~i~~--g~~~~~p~~~~~----~~~~li~~cl~  298 (329)
T 4aoj_A          230 ESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-----DCITQ--GRELERPRACPP----EVYAIMRGCWQ  298 (329)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH-----HHHHH--TCCCCCCTTCCH----HHHHHHHHHCC
T ss_pred             hhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH-----HHHHc--CCCCCCcccccH----HHHHHHHHHcC
Confidence            99999999999999999999999998 89999765422111     01111  112222223333    48889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++|||++||+++|+
T Consensus       299 ~dP~~RPs~~ei~~~L~  315 (329)
T 4aoj_A          299 REPQQRHSIKDVHARLQ  315 (329)
T ss_dssp             SSTTTSCCHHHHHHHHH
T ss_pred             cChhHCcCHHHHHHHHH
Confidence            99999999999999886

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.1e-40  Score=245.33  Aligned_cols=162  Identities=25%  Similarity=0.384  Sum_probs=128.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   81 (179)
                      ...+++.+++.++.||++||.|||++   +++||||||+|||++.++.+||+|||+++........  .....+++.|+|
T Consensus       179 ~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymA  255 (353)
T 4ase_A          179 KDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  255 (353)
T ss_dssp             TTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCC
T ss_pred             cccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccC
Confidence            34589999999999999999999999   9999999999999999999999999999866543322  234567889999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..++.++|||||||++|||+| |..||.+.+....    .........  +.+.+..+..    ++.++|.+||
T Consensus       256 PE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~----~~~~i~~g~--~~~~p~~~~~----~~~~li~~c~  325 (353)
T 4ase_A          256 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLKEGT--RMRAPDYTTP----EMYQTMLDCW  325 (353)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----HHHHHHHTC--CCCCCTTCCH----HHHHHHHHHT
T ss_pred             HHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH----HHHHHHcCC--CCCCCccCCH----HHHHHHHHHc
Confidence            999999999999999999999999998 8999976432110    001111111  2222223333    4888999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||++|||+++++++|+
T Consensus       326 ~~dP~~RPt~~eil~~L~  343 (353)
T 4ase_A          326 HGEPSQRPTFSELVEHLG  343 (353)
T ss_dssp             CSSGGGSCCHHHHHHHHH
T ss_pred             CcChhHCcCHHHHHHHHH
Confidence            999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=247.25  Aligned_cols=160  Identities=23%  Similarity=0.354  Sum_probs=129.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..............|++.|+|||+
T Consensus       242 ~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEv  318 (423)
T 4fie_A          242 TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEL  318 (423)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHH
Confidence            4689999999999999999999999   9999999999999999999999999999877655444556789999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+|||||++|+|++|..||...+....     .........+.++.....    ..++.+||.+||..||
T Consensus       319 l~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-----~~~i~~~~~~~~~~~~~~----s~~~~dli~~~L~~dP  389 (423)
T 4fie_A          319 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-----MKMIRDNLPPRLKNLHKV----SPSLKGFLDRLLVRDP  389 (423)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCCCCCSCTTSS----CHHHHHHHHHHSCSST
T ss_pred             HCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-----HHHHHcCCCCCCcccccC----CHHHHHHHHHHcCCCh
Confidence            9999999999999999999999999999965432111     111112222222222222    2347889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      ++|||++|+++|
T Consensus       390 ~~R~ta~ell~H  401 (423)
T 4fie_A          390 AQRATAAELLKH  401 (423)
T ss_dssp             TTSCCHHHHTTC
T ss_pred             hHCcCHHHHhcC
Confidence            999999999886

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.1e-40  Score=241.71  Aligned_cols=160  Identities=25%  Similarity=0.394  Sum_probs=127.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   81 (179)
                      ...+++.+++.++.||++||.|||++   +++||||||+|||++.++.+||+|||+++........  .....+++.|+|
T Consensus       122 ~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymA  198 (299)
T 4asz_A          122 PTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP  198 (299)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcC
Confidence            45799999999999999999999999   9999999999999999999999999999765433221  223457899999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcC-CCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEML-DPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      ||.+.+..++.++|||||||++|||+| |+.||...+....        ...+. ..+.+.+..+..    ++.+||.+|
T Consensus       199 PE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~--------~~~i~~~~~~~~p~~~~~----~~~~li~~c  266 (299)
T 4asz_A          199 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV--------IECITQGRVLQRPRTCPQ----EVYELMLGC  266 (299)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--------HHHHHHTCCCCCCTTCCH----HHHHHHHHH
T ss_pred             HHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--------HHHHHcCCCCCCCccchH----HHHHHHHHH
Confidence            999999999999999999999999998 8999976542211        11111 111222222322    488899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||++|||++++.+.|+
T Consensus       267 l~~dP~~RPs~~~i~~~L~  285 (299)
T 4asz_A          267 WQREPHMRKNIKGIHTLLQ  285 (299)
T ss_dssp             TCSSGGGSCCHHHHHHHHH
T ss_pred             cCCChhHCcCHHHHHHHHH
Confidence            9999999999999998875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.3e-40  Score=246.08  Aligned_cols=158  Identities=22%  Similarity=0.330  Sum_probs=125.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.............|++.|+|||.
T Consensus       120 ~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~  196 (350)
T 4b9d_A          120 VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI  196 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHH
Confidence            4578999999999999999999999   9999999999999999999999999999765432222334579999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+|||||++|+|++|+.||...+...        ....+.....+......   ..++.+||.+||+.||
T Consensus       197 l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~~~~~~~~---s~~~~~li~~~L~~dP  265 (350)
T 4b9d_A          197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--------LVLKIISGSFPPVSLHY---SYDLRSLVSQLFKRNP  265 (350)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCCCCCTTS---CHHHHHHHHHHTCSSG
T ss_pred             HCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcCCCCCCCccC---CHHHHHHHHHHccCCh
Confidence            999999999999999999999999999997543211        11111111222211111   2247889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      ++|||++|+++|
T Consensus       266 ~~R~s~~e~l~h  277 (350)
T 4b9d_A          266 RDRPSVNSILEK  277 (350)
T ss_dssp             GGSCCHHHHHTS
T ss_pred             hHCcCHHHHhcC
Confidence            999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3e-39  Score=233.48  Aligned_cols=157  Identities=23%  Similarity=0.308  Sum_probs=116.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..++++.+++.+++||+.||+|||++   +++||||||+||+++.++.+||+|||+++...... ......|++.|+|||
T Consensus       106 ~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~~~~~~GT~~Y~APE  181 (275)
T 3hyh_A          106 RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPE  181 (275)
T ss_dssp             SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----------------CTTSCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC-ccCCeeECcccCChh
Confidence            45799999999999999999999999   99999999999999999999999999997665433 234468999999999


Q ss_pred             ccccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..+ +.++|+||+||++|+|++|+.||...+...        ....+.....+.+...    ..++.+|+.+||+.
T Consensus       182 ~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~--------~~~~i~~~~~~~p~~~----s~~~~~li~~~L~~  249 (275)
T 3hyh_A          182 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV--------LFKNISNGVYTLPKFL----SPGAAGLIKRMLIV  249 (275)
T ss_dssp             HHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCCTTS----CHHHHHHHHHHSCS
T ss_pred             hhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCCCCCCCC----CHHHHHHHHHHccC
Confidence            9988876 579999999999999999999997543211        1111111111111111    22478899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 042876          163 SPESRPTMKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rps~~~~~~~  176 (179)
                      ||++|||++|+++|
T Consensus       250 dP~~R~s~~eil~h  263 (275)
T 3hyh_A          250 NPLNRISIHEIMQD  263 (275)
T ss_dssp             SGGGSCCHHHHHHC
T ss_pred             ChhHCcCHHHHHcC
Confidence            99999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.4e-39  Score=239.58  Aligned_cols=162  Identities=22%  Similarity=0.278  Sum_probs=124.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-ceeEccccCccccCCCCCC-----cccccCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSN-----WTEFAGTYG   78 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~   78 (179)
                      +.+++.+++.++.||+.||.|||++   +|+||||||+|||++.++ .+||+|||++.........     .....|++.
T Consensus       145 ~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~  221 (336)
T 4g3f_A          145 GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET  221 (336)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCcc
Confidence            5799999999999999999999999   999999999999999887 5999999999876543221     223579999


Q ss_pred             CCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           79 YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        79 ~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      |+|||.+.+..++.++|+|||||++|+|++|..||.........   ............+++  .    ....+.++|.+
T Consensus       222 YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i~~~~~~~~~~~~--~----~s~~~~~li~~  292 (336)
T 4g3f_A          222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKIASEPPPIREIPP--S----CAPLTAQAIQE  292 (336)
T ss_dssp             GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HHHHHSCCGGGGSCT--T----SCHHHHHHHHH
T ss_pred             ccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHHHcCCCCchhcCc--c----CCHHHHHHHHH
Confidence            99999999999999999999999999999999999764432211   111111000001111  1    12247889999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||+.||.+|||+.|++++|.
T Consensus       293 ~L~~dP~~R~sa~el~~~l~  312 (336)
T 4g3f_A          293 GLRKEPVHRASAMELRRKVG  312 (336)
T ss_dssp             HTCSSGGGSCCHHHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHHHH
Confidence            99999999999999998874

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.9e-39  Score=237.46  Aligned_cols=157  Identities=25%  Similarity=0.319  Sum_probs=123.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.............|++.|+|||.
T Consensus       121 ~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~  197 (304)
T 3ubd_A          121 VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV  197 (304)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHH
Confidence            5789999999999999999999999   9999999999999999999999999999876544444455789999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+||++|+|++|..||...+...        ....+.....+.+...    ..++.+||.+||+.||
T Consensus       198 ~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~~~p~~~----s~~~~~li~~~L~~dP  265 (304)
T 3ubd_A          198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--------TMTMILKAKLGMPQFL----SPEAQSLLRMLFKRNP  265 (304)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTTS----CHHHHHHHHHHTCSSG
T ss_pred             hccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--------HHHHHHcCCCCCCCcC----CHHHHHHHHHHcccCH
Confidence            999999999999999999999999999997543211        1111111111111122    2247889999999999


Q ss_pred             CCCCC-----HHHHHHH
Q 042876          165 ESRPT-----MKIVSQQ  176 (179)
Q Consensus       165 ~~Rps-----~~~~~~~  176 (179)
                      ++|||     ++|+++|
T Consensus       266 ~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          266 ANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             GGSTTCSTTTHHHHHTS
T ss_pred             HHCCCCCcCCHHHHHcC
Confidence            99998     5788775

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.2e-39  Score=233.20  Aligned_cols=157  Identities=21%  Similarity=0.338  Sum_probs=121.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCC--cccCCCCCCCeeecC-CCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPP--IVHRDLSSKNLLLDL-EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.||++||+|||++   +  |+||||||+|||++. ++.+||+|||+|+....  .......|++.|+|
T Consensus       124 ~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--~~~~~~~GTp~YmA  198 (290)
T 3fpq_A          124 KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMA  198 (290)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--CccCCcccCccccC
Confidence            5789999999999999999999998   6  999999999999974 78999999999975432  22345689999999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+ +++.++|+|||||++|+|++|+.||.......       .....+.....+..  .......++.+||.+||+
T Consensus       199 PE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-------~~~~~i~~~~~~~~--~~~~~~~~~~~li~~~L~  268 (290)
T 3fpq_A          199 PEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKPAS--FDKVAIPEVKEIIEGCIR  268 (290)
T ss_dssp             GGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCCGG--GGGCCCHHHHHHHHHHSC
T ss_pred             HHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-------HHHHHHHcCCCCCC--CCccCCHHHHHHHHHHcc
Confidence            998865 69999999999999999999999996543211       11111111111110  001111247889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||++|||++|+++|
T Consensus       269 ~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          269 QNKDERYSIKDLLNH  283 (290)
T ss_dssp             SSGGGSCCHHHHHTS
T ss_pred             CChhHCcCHHHHhcC
Confidence            999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.4e-39  Score=236.35  Aligned_cols=155  Identities=24%  Similarity=0.357  Sum_probs=124.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      +.+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......  ......|++.|+||
T Consensus       127 ~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAP  203 (311)
T 4aw0_A          127 GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP  203 (311)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCH
Confidence            5799999999999999999999999   999999999999999999999999999987654322  23456899999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |++.+..++.++|+||+||++|+|++|..||...+...        ....+.......+....    .++.+||.+||+.
T Consensus       204 Evl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--------~~~~i~~~~~~~p~~~s----~~~~dli~~lL~~  271 (311)
T 4aw0_A          204 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL--------IFAKIIKLEYDFPEKFF----PKARDLVEKLLVL  271 (311)
T ss_dssp             HHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCCTTCC----HHHHHHHHHHSCS
T ss_pred             HHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCCCcccC----HHHHHHHHHHccC
Confidence            99999999999999999999999999999997543211        11111111111111222    2478899999999


Q ss_pred             CCCCCCCHHHHH
Q 042876          163 SPESRPTMKIVS  174 (179)
Q Consensus       163 ~p~~Rps~~~~~  174 (179)
                      ||.+|||++|++
T Consensus       272 dp~~R~t~~e~~  283 (311)
T 4aw0_A          272 DATKRLGCEEME  283 (311)
T ss_dssp             SGGGSTTSGGGT
T ss_pred             CHhHCcChHHHc
Confidence            999999999863

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.2e-37  Score=228.86  Aligned_cols=173  Identities=22%  Similarity=0.290  Sum_probs=125.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC----CcccccC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDC-----FPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS----NWTEFAG   75 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~-----~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~   75 (179)
                      ++++++.+..++.|++.||+|||+++     ..+|+||||||+|||++.++.+||+|||++........    ......|
T Consensus        95 ~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~G  174 (303)
T 3hmm_A           95 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG  174 (303)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----C
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccc
Confidence            46899999999999999999999752     23899999999999999999999999999976543322    1233578


Q ss_pred             CCCCCCCcccccC------CCCcchhhHHHHHHHHHHHhCCCCCcccccccccc-------cchhhhhh----hcCCCCC
Q 042876           76 TYGYVAPELAYTM------KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS-------LNTDIELD----EMLDPRL  138 (179)
Q Consensus        76 ~~~~~~pe~~~~~------~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~-------~~~~~~~~----~~~~~~~  138 (179)
                      ++.|+|||.+.+.      .++.++|||||||++|||++|..|+..........       ........    ...++.+
T Consensus       175 T~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~  254 (303)
T 3hmm_A          175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI  254 (303)
T ss_dssp             CGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC
T ss_pred             cccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCC
Confidence            9999999998754      35678999999999999999988775433221110       01111111    1222222


Q ss_pred             CCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          139 PAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       139 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +... ...+....+.+|+.+||+.||++|||++|+++.|+
T Consensus       255 p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  293 (303)
T 3hmm_A          255 PNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             CGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             Cccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence            2211 12234556889999999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=230.51  Aligned_cols=170  Identities=24%  Similarity=0.300  Sum_probs=124.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC----CCcccccCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----SNWTEFAGTYGY   79 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~   79 (179)
                      .+.+++.+++.+++||+.||.|||++   ||+||||||+|||++.++.+|++|||++.......    .......|++.|
T Consensus       152 ~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y  228 (398)
T 4b99_A          152 SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY  228 (398)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHh
Confidence            46799999999999999999999999   99999999999999999999999999998654321    123456899999


Q ss_pred             CCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc------------------hhhhhhhcCCCCCCC
Q 042876           80 VAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN------------------TDIELDEMLDPRLPA  140 (179)
Q Consensus        80 ~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~  140 (179)
                      +|||++.+. .++.++|+||+||++|+|++|..||.+.+........                  .............+.
T Consensus       229 ~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (398)
T 4b99_A          229 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPV  308 (398)
T ss_dssp             CCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCC
T ss_pred             cCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCC
Confidence            999998775 4689999999999999999999999754321100000                  000000011111111


Q ss_pred             CCc-cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          141 PSR-SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       141 ~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ... .......++.+||.+||..||.+|||++|+++|
T Consensus       309 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          309 PWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            100 000112347889999999999999999999886

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-36  Score=222.82  Aligned_cols=154  Identities=23%  Similarity=0.384  Sum_probs=112.6

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC------------ccccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN------------WTEFA   74 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~------------~~~~~   74 (179)
                      .++..++.++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++........            .....
T Consensus       115 ~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (299)
T 4g31_A          115 RERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV  191 (299)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------
T ss_pred             hHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcc
Confidence            45567899999999999999999   9999999999999999999999999999876433211            12346


Q ss_pred             CCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHH
Q 042876           75 GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVK  154 (179)
Q Consensus        75 ~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (179)
                      |++.|+|||.+.+..++.++|+|||||++|+|++   ||....       ..............+   ...........+
T Consensus       192 GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-------~~~~~~~~~~~~~~p---~~~~~~~~~~~~  258 (299)
T 4g31_A          192 GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-------ERVRTLTDVRNLKFP---PLFTQKYPCEYV  258 (299)
T ss_dssp             CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-------HHHHHHHHHHTTCCC---HHHHHHCHHHHH
T ss_pred             cCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-------HHHHHHHHHhcCCCC---CCCcccCHHHHH
Confidence            9999999999999999999999999999999995   664321       001111111222222   222333345678


Q ss_pred             HHhcccCcCCCCCCCHHHHHHH
Q 042876          155 VAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       155 li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ||.+||+.||.+|||+.|+++|
T Consensus       259 li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          259 MVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHcCCChhHCcCHHHHhcC
Confidence            9999999999999999999985

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6e-36  Score=224.35  Aligned_cols=109  Identities=28%  Similarity=0.380  Sum_probs=92.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC-CceeEccccCccccCCCCC---------------
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSS---------------   68 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~---------------   68 (179)
                      +++++.+++.+++||+.||+|||++   ||+||||||+|||++.+ +.+||+|||+|+.......               
T Consensus       112 ~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~  188 (361)
T 4f9c_A          112 NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERC  188 (361)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC---------
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccc
Confidence            3689999999999999999999999   99999999999999876 7899999999975432211               


Q ss_pred             -------------CcccccCCCCCCCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCccc
Q 042876           69 -------------NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFL  116 (179)
Q Consensus        69 -------------~~~~~~~~~~~~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~  116 (179)
                                   ......|++.|+|||.+.+. .++.++|+||+||++|+|++|+.||...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          189 SQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             -----------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence                         11234689999999998775 4889999999999999999999999543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.1e-35  Score=231.33  Aligned_cols=161  Identities=20%  Similarity=0.275  Sum_probs=127.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC--CceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE--YEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ...|++.+++.+++||++||.|||++   +|+||||||+||+++.+  +.+||+|||++..+.... ......|++.|+|
T Consensus       249 ~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-~~~~~~GT~~y~A  324 (573)
T 3uto_A          249 HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTTGTAEFAA  324 (573)
T ss_dssp             TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-EEEEECSSGGGCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-ceeeeEECccccC
Confidence            35789999999999999999999999   99999999999999754  789999999998776433 2344578999999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||++.+..++.++|+||+||++|+|++|..||.+.+...        ....+...........+.....++.+||.+||+
T Consensus       325 PEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~  396 (573)
T 3uto_A          325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--------TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL  396 (573)
T ss_dssp             HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSC
T ss_pred             HHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence            999999999999999999999999999999997543211        111111111111112222223357889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||.+|||+.|+++|
T Consensus       397 ~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          397 ADPNTRMTIHQALEH  411 (573)
T ss_dssp             SSGGGSCCHHHHHHS
T ss_pred             CChhHCcCHHHHhcC
Confidence            999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.6e-35  Score=230.66  Aligned_cols=158  Identities=19%  Similarity=0.248  Sum_probs=123.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..|++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+|.......  .....|++.|+|||+
T Consensus       287 ~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~--~~t~~GTp~YmAPEv  361 (689)
T 3v5w_A          287 GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEV  361 (689)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC--CCSCCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCCC--CCCccCCcCccCHHH
Confidence            5799999999999999999999999   99999999999999999999999999998765433  234689999999999


Q ss_pred             cc-cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AY-TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~-~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +. +..++.++|+|||||++|+|++|..||...+.......   ..........++.  ..    ..++.+||.+||+.|
T Consensus       362 l~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~~i~~~~~~~p~--~~----S~~a~dLI~~lL~~d  432 (689)
T 3v5w_A          362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTMAVELPD--SF----SPELRSLLEGLLQRD  432 (689)
T ss_dssp             HSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HHHHHHCCCCCCT--TS----CHHHHHHHHHHTCSC
T ss_pred             HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhhcCCCCCCCc--cC----CHHHHHHHHHHccCC
Confidence            86 46789999999999999999999999975432211111   0111111112221  11    224788999999999


Q ss_pred             CCCCCC-----HHHHHHH
Q 042876          164 PESRPT-----MKIVSQQ  176 (179)
Q Consensus       164 p~~Rps-----~~~~~~~  176 (179)
                      |.+|++     ++|+++|
T Consensus       433 P~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          433 VNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             GGGCTTCSSSTHHHHTTS
T ss_pred             HhHCCCCCCCCHHHHhcC
Confidence            999998     7888776

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.8e-34  Score=209.21  Aligned_cols=160  Identities=26%  Similarity=0.423  Sum_probs=126.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..............+++.|+|||.
T Consensus       111 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  187 (297)
T 3fxz_A          111 TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV  187 (297)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhh
Confidence            3588999999999999999999999   9999999999999999999999999999876655444455678999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|++++|..||.........     ........+.......    ....+.+++.+||+.||
T Consensus       188 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp  258 (297)
T 3fxz_A          188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGTPELQNPEK----LSAIFRDFLNRCLEMDV  258 (297)
T ss_dssp             HHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHHCSCCCSCGGG----SCHHHHHHHHHHSCSST
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhCCCCCCCCccc----cCHHHHHHHHHHccCCh
Confidence            99989999999999999999999999999654321110     0111111111111111    22347889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+|||++++++|
T Consensus       259 ~~Rps~~ell~h  270 (297)
T 3fxz_A          259 EKRGSAKELLQH  270 (297)
T ss_dssp             TTSCCHHHHTTC
T ss_pred             hHCcCHHHHhhC
Confidence            999999999886

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3e-34  Score=210.07  Aligned_cols=171  Identities=25%  Similarity=0.370  Sum_probs=125.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC----cc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLH--------HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN----WT   71 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh--------~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~   71 (179)
                      ...+++..++.++.|++.||.|||        +.   +++|+||||+||+++.++.++|+|||++.........    ..
T Consensus        99 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  175 (301)
T 3q4u_A           99 LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN  175 (301)
T ss_dssp             TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCC
T ss_pred             hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccc
Confidence            356899999999999999999999        77   9999999999999999999999999999765433221    22


Q ss_pred             cccCCCCCCCCcccccC------CCCcchhhHHHHHHHHHHHhC----------CCCCcccccccccccch-hhhhhhcC
Q 042876           72 EFAGTYGYVAPELAYTM------KITEKCDVYSFGVLALEVIKG----------KHPRDFLSSISSSSLNT-DIELDEML  134 (179)
Q Consensus        72 ~~~~~~~~~~pe~~~~~------~~~~~~D~~slg~~~~~l~~~----------~~p~~~~~~~~~~~~~~-~~~~~~~~  134 (179)
                      ...+++.|+|||.+.+.      .++.++|+||||+++|++++|          ..||............. ........
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~  255 (301)
T 3q4u_A          176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ  255 (301)
T ss_dssp             CCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC
T ss_pred             ccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCC
Confidence            34688999999998776      445789999999999999999          66765432211111000 00111111


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      .+..+. ..........+.+++.+||+.||.+|||++++++.|+
T Consensus       256 ~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  298 (301)
T 3q4u_A          256 RPNIPN-RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT  298 (301)
T ss_dssp             CCCCCG-GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCh-hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence            111111 1122334566899999999999999999999999885

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.7e-34  Score=208.50  Aligned_cols=168  Identities=17%  Similarity=0.263  Sum_probs=128.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee---cCCCceeEccccCccccCCCCC-------Ccccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL---DLEYEAHVADFGIAKFLKPDSS-------NWTEF   73 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~-------~~~~~   73 (179)
                      .+.+++.+++.++.|++.||.|||+.   +++|+||||+||++   +.++.++|+|||++........       .....
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~  175 (296)
T 4hgt_A           99 SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL  175 (296)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCccccc
Confidence            45799999999999999999999999   99999999999999   7888999999999986654322       12345


Q ss_pred             cCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHH
Q 042876           74 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIV  153 (179)
Q Consensus        74 ~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (179)
                      .+++.|+|||.+.+..++.++|+||||+++|++++|..||......................+ .+   .........+.
T Consensus       176 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~l~  251 (296)
T 4hgt_A          176 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IE---VLCKGYPSEFA  251 (296)
T ss_dssp             CSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-HH---HHTTTSCHHHH
T ss_pred             CCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-hh---hhhccCCHHHH
Confidence            788999999999998999999999999999999999999976554332222211111111100 00   00000123488


Q ss_pred             HHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          154 KVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       154 ~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +++.+||+.||++|||++++++.|+
T Consensus       252 ~li~~~l~~~p~~Rpt~~~l~~~l~  276 (296)
T 4hgt_A          252 TYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             HHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCHHHHHHHHH
Confidence            8999999999999999999999875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-33  Score=207.87  Aligned_cols=160  Identities=31%  Similarity=0.480  Sum_probs=116.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCC--cccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPP--IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+++..++.++.|++.||+|||+.   +  ++|+||||+||+++.++.++|+|||++..............+++.|+|||
T Consensus       133 ~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE  209 (309)
T 3p86_A          133 QLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE  209 (309)
T ss_dssp             HSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChh
Confidence            388999999999999999999999   8  99999999999999999999999999976544333334457889999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||||+++|++++|..||........      ..................    ..+.+++.+||+.|
T Consensus       210 ~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~------~~~~~~~~~~~~~~~~~~----~~l~~li~~~l~~d  279 (309)
T 3p86_A          210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV------VAAVGFKCKRLEIPRNLN----PQVAAIIEGCWTNE  279 (309)
T ss_dssp             HHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHHSCCCCCCCTTSC----HHHHHHHHHHTCSS
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcCCCCCCCccCC----HHHHHHHHHHccCC
Confidence            99998899999999999999999999999975432110      011111111111111222    24788999999999


Q ss_pred             CCCCCCHHHHHHHhh
Q 042876          164 PESRPTMKIVSQQLR  178 (179)
Q Consensus       164 p~~Rps~~~~~~~l~  178 (179)
                      |.+|||++++++.|+
T Consensus       280 P~~Rps~~~ll~~L~  294 (309)
T 3p86_A          280 PWKRPSFATIMDLLR  294 (309)
T ss_dssp             GGGSCCHHHHHHHHH
T ss_pred             hhhCcCHHHHHHHHH
Confidence            999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.3e-34  Score=207.01  Aligned_cols=168  Identities=17%  Similarity=0.263  Sum_probs=128.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee---cCCCceeEccccCccccCCCCC-------Ccccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL---DLEYEAHVADFGIAKFLKPDSS-------NWTEF   73 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~-------~~~~~   73 (179)
                      .+.+++.+++.++.|++.||.|||+.   +++|+||+|+||++   +.++.++|+|||.+........       .....
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  175 (296)
T 3uzp_A           99 SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL  175 (296)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccc
Confidence            45799999999999999999999999   99999999999999   4788999999999976654322       12345


Q ss_pred             cCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHH
Q 042876           74 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIV  153 (179)
Q Consensus        74 ~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (179)
                      .+++.|+|||.+.+..++.++|+||||+++|++++|..||......................+ .+   .........+.
T Consensus       176 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~l~  251 (296)
T 3uzp_A          176 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IE---VLCKGYPSEFA  251 (296)
T ss_dssp             CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-HH---HHTTTSCHHHH
T ss_pred             ccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-hH---HHHhhCCHHHH
Confidence            788999999999998899999999999999999999999986543332222211111111100 00   00001123488


Q ss_pred             HHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          154 KVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       154 ~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +++.+||+.||.+|||++++++.|+
T Consensus       252 ~li~~~l~~dp~~Rps~~~l~~~l~  276 (296)
T 3uzp_A          252 TYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             HHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHhcCcCcCCCHHHHHHHHH
Confidence            8999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.8e-33  Score=208.33  Aligned_cols=172  Identities=37%  Similarity=0.612  Sum_probs=132.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||+|||+.+..+++|+||+|+||+++.++.++|+|||++......... .....+++.|+|||
T Consensus       126 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE  205 (326)
T 3uim_A          126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE  205 (326)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHH
Confidence            45899999999999999999999975458999999999999999999999999999866533322 23345889999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh---------hhhhhcCCCCCCCCCccHHHHHHHHHH
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD---------IELDEMLDPRLPAPSRSVQEKLISIVK  154 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (179)
                      .+.+..++.++|+||||+++|++++|..||+.............         .......+....  ..........+.+
T Consensus       206 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~  283 (326)
T 3uim_A          206 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ--GNYKDEEVEQLIQ  283 (326)
T ss_dssp             HHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCT--TSCCHHHHHHHHH
T ss_pred             HhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhc--cccCHHHHHHHHH
Confidence            99888899999999999999999999999964322111111111         111112222222  1234556677999


Q ss_pred             HHhcccCcCCCCCCCHHHHHHHhh
Q 042876          155 VAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       155 li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ++.+||+.||.+|||+++++++|+
T Consensus       284 li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          284 VALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             HHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             HHHHHhCcCCccCCCHHHHHHHhc
Confidence            999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.5e-33  Score=207.24  Aligned_cols=169  Identities=35%  Similarity=0.526  Sum_probs=130.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++........  ......+++.|+||
T Consensus       134 ~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  210 (321)
T 2qkw_B          134 MSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDP  210 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCH
Confidence            4689999999999999999999999   999999999999999999999999999976543221  12334578899999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-------hhhhhhcCCCCCCCCCccHHHHHHHHHHH
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-------DIELDEMLDPRLPAPSRSVQEKLISIVKV  155 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  155 (179)
                      |.+.+..++.++|+||||+++|++++|+.||.............       .......+++....  .........+.++
T Consensus       211 E~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l  288 (321)
T 2qkw_B          211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD--KIRPESLRKFGDT  288 (321)
T ss_dssp             HHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT--CSCHHHHHHHHHH
T ss_pred             HHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc--ccCHHHHHHHHHH
Confidence            99988889999999999999999999999997544322111100       00111122222221  2335566779999


Q ss_pred             HhcccCcCCCCCCCHHHHHHHhh
Q 042876          156 AFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       156 i~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +.+||+.||++|||+++++++|+
T Consensus       289 i~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          289 AVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHcCCCcccCcCHHHHHHHHH
Confidence            99999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.5e-34  Score=208.40  Aligned_cols=168  Identities=16%  Similarity=0.229  Sum_probs=126.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc-----eeEccccCccccCCCCC-------Ccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE-----AHVADFGIAKFLKPDSS-------NWT   71 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~-------~~~   71 (179)
                      .+++++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.     ++|+|||++........       ...
T Consensus       100 ~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  176 (298)
T 1csn_A          100 GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK  176 (298)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCcc
Confidence            35699999999999999999999999   9999999999999977765     99999999986654322       123


Q ss_pred             cccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHH
Q 042876           72 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLIS  151 (179)
Q Consensus        72 ~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (179)
                      ...+++.|+|||.+.+..++.++|+||||+++|++++|..||......................+ .+   .........
T Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~  252 (298)
T 1csn_A          177 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-LR---ELCAGFPEE  252 (298)
T ss_dssp             CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-HH---HHTTTSCHH
T ss_pred             CCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-HH---HHHhhCcHH
Confidence            45688999999999988899999999999999999999999976543221111111111000000 00   000011234


Q ss_pred             HHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          152 IVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       152 ~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +.+++.+||+.||++|||++++++.|+
T Consensus       253 l~~li~~~l~~dp~~RP~~~~l~~~l~  279 (298)
T 1csn_A          253 FYKYMHYARNLAFDATPDYDYLQGLFS  279 (298)
T ss_dssp             HHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            888999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-33  Score=206.72  Aligned_cols=170  Identities=21%  Similarity=0.203  Sum_probs=123.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..............+++.|+|||
T Consensus       113 ~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE  189 (311)
T 3niz_A          113 KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPD  189 (311)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHH
Confidence            34689999999999999999999999   999999999999999999999999999987664444445567889999999


Q ss_pred             cccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh-------------hhhhhcCCCCCCCCCc-cH---
Q 042876           84 LAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD-------------IELDEMLDPRLPAPSR-SV---  145 (179)
Q Consensus        84 ~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~-~~---  145 (179)
                      .+.+ ..++.++|+||+|+++|++++|..||..............             ................ ..   
T Consensus       190 ~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (311)
T 3niz_A          190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSI  269 (311)
T ss_dssp             HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHH
T ss_pred             HhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHh
Confidence            9876 4578999999999999999999999975443211000000             0000000000000000 00   


Q ss_pred             -HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 -QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 -~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                       .....++.+|+.+||+.||.+|||++|+++|
T Consensus       270 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          270 IPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             STTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence             0112347889999999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.8e-33  Score=216.27  Aligned_cols=163  Identities=22%  Similarity=0.277  Sum_probs=126.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec---CCCceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD---LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      ...+++.++..++.||++||.|||+.   +++||||||+||+++   .++.++|+|||++..............+++.|+
T Consensus       104 ~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~  180 (444)
T 3soa_A          104 REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL  180 (444)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccC
Confidence            35689999999999999999999999   999999999999998   457899999999977665544445567899999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |||.+.+..++.++|+||+|+++|+|++|..||.......        ....+...........+.....++.+++.+||
T Consensus       181 APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  252 (444)
T 3soa_A          181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--------LYQQIKAGAYDFPSPEWDTVTPEAKDLINKML  252 (444)
T ss_dssp             CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHS
T ss_pred             CHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHhCCCCCCccccccCCHHHHHHHHHHc
Confidence            9999998889999999999999999999999996543211        11111111111111111112234788999999


Q ss_pred             CcCCCCCCCHHHHHHHh
Q 042876          161 NESPESRPTMKIVSQQL  177 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l  177 (179)
                      +.||.+|||+.|+++|=
T Consensus       253 ~~dP~~Rpta~e~L~hp  269 (444)
T 3soa_A          253 TINPSKRITAAEALKHP  269 (444)
T ss_dssp             CSSTTTSCCHHHHHHSC
T ss_pred             CCChhHCCCHHHHhcCc
Confidence            99999999999999873

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.9e-33  Score=204.28  Aligned_cols=162  Identities=30%  Similarity=0.486  Sum_probs=126.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--------------
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--------------   69 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--------------   69 (179)
                      ...+++.+++.++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++.........              
T Consensus       102 ~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~  178 (310)
T 3s95_A          102 DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK  178 (310)
T ss_dssp             CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccccccccccc
Confidence            45789999999999999999999999   9999999999999999999999999999765433221              


Q ss_pred             cccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccc-cchhhhhhhcCCCCCCCCCccHHHH
Q 042876           70 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS-LNTDIELDEMLDPRLPAPSRSVQEK  148 (179)
Q Consensus        70 ~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  148 (179)
                      .....+++.|+|||.+.+..++.++|+||||+++|++++|..|+.......... ............+.++.        
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  250 (310)
T 3s95_A          179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP--------  250 (310)
T ss_dssp             -CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCT--------
T ss_pred             ccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCH--------
Confidence            113568899999999999899999999999999999999999987544322211 11112222222222222        


Q ss_pred             HHHHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          149 LISIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       149 ~~~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                        .+.+++.+||+.||++|||++++++.|+
T Consensus       251 --~l~~li~~~l~~dP~~Rps~~~l~~~L~  278 (310)
T 3s95_A          251 --SFFPITVRCCDLDPEKRPSFVKLEHWLE  278 (310)
T ss_dssp             --THHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --HHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence              3788999999999999999999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.9e-33  Score=211.51  Aligned_cols=165  Identities=24%  Similarity=0.277  Sum_probs=120.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC---CCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL---EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.||+.||.|||+.   +++||||||+||+++.   ++.+||+|||++....... ......+++.|++
T Consensus       156 ~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~a  231 (400)
T 1nxk_A          156 QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVA  231 (400)
T ss_dssp             -CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC------------CTTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC-ccccCCCCCCccC
Confidence            4699999999999999999999999   9999999999999987   7889999999997654322 2234567899999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+|||||++|+|++|..||.....................  ..+.  ..+.....++.+||.+||+
T Consensus       232 PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~--~~~~--~~~~~~s~~~~~li~~~L~  307 (400)
T 1nxk_A          232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY--EFPN--PEWSEVSEEVKMLIRNLLK  307 (400)
T ss_dssp             GGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC--CCCT--TTTTTSCHHHHHHHHTTSC
T ss_pred             HhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc--cCCC--cccccCCHHHHHHHHHHCC
Confidence            99998889999999999999999999999999765433221111111111111  1111  1111122347889999999


Q ss_pred             cCCCCCCCHHHHHHHh
Q 042876          162 ESPESRPTMKIVSQQL  177 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l  177 (179)
                      .||.+|||++++++|-
T Consensus       308 ~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          308 TEPTQRMTITEFMNHP  323 (400)
T ss_dssp             SSGGGSCCHHHHHHSH
T ss_pred             CChhHCcCHHHHhcCc
Confidence            9999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.2e-33  Score=212.43  Aligned_cols=167  Identities=18%  Similarity=0.243  Sum_probs=126.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec--CCCceeEccccCccccCCCCC-------Cccccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD--LEYEAHVADFGIAKFLKPDSS-------NWTEFA   74 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~--~~~~~~l~d~~~~~~~~~~~~-------~~~~~~   74 (179)
                      ...+++.+++.++.||+.||+|||+.   +++||||||+||+++  .++.++|+|||++........       ......
T Consensus       146 ~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~  222 (364)
T 3op5_A          146 AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHD  222 (364)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccC
Confidence            36799999999999999999999999   999999999999998  889999999999976543211       113345


Q ss_pred             CCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhh----hhhhcCCCCCCCCCccHHHHHH
Q 042876           75 GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDI----ELDEMLDPRLPAPSRSVQEKLI  150 (179)
Q Consensus        75 ~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  150 (179)
                      +++.|+|||.+.+..++.++|+||||+++|+|++|..||...............    ......++.++. ...    ..
T Consensus       223 gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~  297 (364)
T 3op5_A          223 GTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPA-ANA----PG  297 (364)
T ss_dssp             CCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCT-TCC----CH
T ss_pred             CCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhccc-ccC----HH
Confidence            899999999999988999999999999999999999999754322111110110    111111111110 011    22


Q ss_pred             HHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          151 SIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       151 ~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      .+.+++..||+.||.+||+++++++.|+
T Consensus       298 ~~~~li~~cl~~~p~~RP~~~~l~~~l~  325 (364)
T 3op5_A          298 EIAKYMETVKLLDYTEKPLYENLRDILL  325 (364)
T ss_dssp             HHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence            4888999999999999999999999874

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.2e-33  Score=206.26  Aligned_cols=161  Identities=24%  Similarity=0.381  Sum_probs=127.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............+++.|+|||.
T Consensus       136 ~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  212 (321)
T 2c30_A          136 VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV  212 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhh
Confidence            4689999999999999999999999   9999999999999999999999999998776544333445678899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|++++|..||.......     ..........+.......    ....+.+++.+||+.||
T Consensus       213 ~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp  283 (321)
T 2c30_A          213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----AMKRLRDSPPPKLKNSHK----VSPVLRDFLERMLVRDP  283 (321)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSSCCCCTTGGG----SCHHHHHHHHHHSCSST
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhcCCCCCcCcccc----CCHHHHHHHHHHccCCh
Confidence            988889999999999999999999999996543211     111111122222221111    22347889999999999


Q ss_pred             CCCCCHHHHHHHh
Q 042876          165 ESRPTMKIVSQQL  177 (179)
Q Consensus       165 ~~Rps~~~~~~~l  177 (179)
                      ++|||++++++|-
T Consensus       284 ~~Rps~~ell~hp  296 (321)
T 2c30_A          284 QERATAQELLDHP  296 (321)
T ss_dssp             TTSCCHHHHHTSG
T ss_pred             hhCcCHHHHhcCh
Confidence            9999999999863

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7e-33  Score=206.31  Aligned_cols=157  Identities=24%  Similarity=0.290  Sum_probs=124.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++..............+++.|+|||.
T Consensus       100 ~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~  176 (337)
T 1o6l_A          100 RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV  176 (337)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhh
Confidence            4689999999999999999999999   9999999999999999999999999999765443333445678999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|+|++|..||........   ..... .  ....++.  ..    ..++.++|.+||+.||
T Consensus       177 ~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~-~--~~~~~p~--~~----s~~~~~li~~lL~~dP  244 (337)
T 1o6l_A          177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELIL-M--EEIRFPR--TL----SPEAKSLLAGLLKKDP  244 (337)
T ss_dssp             GSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH-H--CCCCCCT--TS----CHHHHHHHHHHTCSST
T ss_pred             hcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH---HHHHH-c--CCCCCCC--CC----CHHHHHHHHHHhhcCH
Confidence            9988899999999999999999999999965321110   00000 0  1111221  11    2247889999999999


Q ss_pred             CCCC-----CHHHHHHH
Q 042876          165 ESRP-----TMKIVSQQ  176 (179)
Q Consensus       165 ~~Rp-----s~~~~~~~  176 (179)
                      .+||     +++++++|
T Consensus       245 ~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          245 KQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             TTSTTCSTTTHHHHHTS
T ss_pred             HHhcCCCCCCHHHHHcC
Confidence            9999     89999886

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.4e-33  Score=208.57  Aligned_cols=160  Identities=25%  Similarity=0.385  Sum_probs=125.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||++.........  .....+++.|+||
T Consensus       198 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  274 (370)
T 2psq_A          198 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  274 (370)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECH
Confidence            4689999999999999999999999   9999999999999999999999999999765543221  2234556789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|+|++ |..||........     ........  +........    ..+.+++.+||+
T Consensus       275 E~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-----~~~~~~~~--~~~~~~~~~----~~l~~li~~~l~  343 (370)
T 2psq_A          275 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-----FKLLKEGH--RMDKPANCT----NELYMMMRDCWH  343 (370)
T ss_dssp             HHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----HHHHHTTC--CCCCCTTSC----HHHHHHHHHHTC
T ss_pred             hHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHhcCC--CCCCCCCCC----HHHHHHHHHHcC
Confidence            99998889999999999999999998 9999975432111     01111111  111111222    248889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+.+++++|+
T Consensus       344 ~dP~~Rpt~~ell~~L~  360 (370)
T 2psq_A          344 AVPSQRPTFKQLVEDLD  360 (370)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHH
Confidence            99999999999999885

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7e-33  Score=202.85  Aligned_cols=160  Identities=21%  Similarity=0.313  Sum_probs=123.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++.+++.++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++..............+++.|+|||
T Consensus       131 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE  207 (298)
T 2zv2_A          131 LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPE  207 (298)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChh
Confidence            35789999999999999999999999   999999999999999999999999999987654433334457899999999


Q ss_pred             ccccCC---CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           84 LAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        84 ~~~~~~---~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      .+.+..   .+.++|+||||+++|++++|..||........     ....... ....+.....    ..++.+++.+||
T Consensus       208 ~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~-~~~~~~~~~~----~~~l~~li~~~l  277 (298)
T 2zv2_A          208 SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL-----HSKIKSQ-ALEFPDQPDI----AEDLKDLITRML  277 (298)
T ss_dssp             GCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHC-CCCCCSSSCC----CHHHHHHHHHHT
T ss_pred             hhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH-----HHHHhcc-cCCCCCcccc----CHHHHHHHHHHh
Confidence            987655   36789999999999999999999965321110     0011110 1111111112    224788999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.||++|||++++++|
T Consensus       278 ~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          278 DKNPESRIVVPEIKLH  293 (298)
T ss_dssp             CSCTTTSCCHHHHTTC
T ss_pred             hcChhhCCCHHHHhcC
Confidence            9999999999999876

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.1e-33  Score=210.07  Aligned_cols=165  Identities=27%  Similarity=0.380  Sum_probs=125.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++..............+++.|+|||.
T Consensus       148 ~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~  224 (396)
T 4dc2_A          148 RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI  224 (396)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchh
Confidence            5689999999999999999999999   9999999999999999999999999999764443334455688999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-hhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-TDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +.+..++.++|+||||+++|+|++|..||............ .......+.......+...    ..++.++|.+||+.|
T Consensus       225 l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~----s~~~~~li~~lL~~d  300 (396)
T 4dc2_A          225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL----SVKAASVLKSFLNKD  300 (396)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTS----CHHHHHHHHHHTCSC
T ss_pred             hcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcC----CHHHHHHHHHHhcCC
Confidence            99999999999999999999999999999654322211111 1111111111121111122    224788999999999


Q ss_pred             CCCCCCH------HHHHHH
Q 042876          164 PESRPTM------KIVSQQ  176 (179)
Q Consensus       164 p~~Rps~------~~~~~~  176 (179)
                      |.+||++      +++++|
T Consensus       301 P~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          301 PKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             TTTSTTCSTTTHHHHHHHS
T ss_pred             HhHcCCCCCCCCHHHHhcC
Confidence            9999984      677765

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-33  Score=208.71  Aligned_cols=160  Identities=28%  Similarity=0.392  Sum_probs=123.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++........  ......++..|++|
T Consensus       110 ~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  186 (325)
T 3kex_A          110 GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL  186 (325)
T ss_dssp             GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccCh
Confidence            4688999999999999999999999   999999999999999999999999999987654332  22344667789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||.........     .......  ..........    ++.+++.+||+
T Consensus       187 E~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----~~~~~~~--~~~~~~~~~~----~~~~li~~~l~  255 (325)
T 3kex_A          187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-----DLLEKGE--RLAQPQICTI----DVYMVMVKCWM  255 (325)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-----HHHHTTC--BCCCCTTBCT----TTTHHHHHHTC
T ss_pred             HHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-----HHHHcCC--CCCCCCcCcH----HHHHHHHHHcC
Confidence            99998899999999999999999999 99999764321110     1111111  1111111111    37789999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+.+++++|+
T Consensus       256 ~dp~~Rps~~el~~~l~  272 (325)
T 3kex_A          256 IDENIRPTFKELANEFT  272 (325)
T ss_dssp             SCTTTSCCHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHH
Confidence            99999999999999885

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.7e-33  Score=206.98  Aligned_cols=161  Identities=24%  Similarity=0.404  Sum_probs=125.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   81 (179)
                      ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.........  .....++..|++
T Consensus       111 ~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a  187 (327)
T 3poz_A          111 KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA  187 (327)
T ss_dssp             TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccC
Confidence            45689999999999999999999999   9999999999999999999999999999876543322  222345678999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..++.++|+||||+++|++++ |..||........     .......  ...+......    .++.+++.+||
T Consensus       188 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~~~~~~--~~~~~~~~~~----~~~~~li~~~l  256 (327)
T 3poz_A          188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILEKG--ERLPQPPICT----IDVYMIMVKCW  256 (327)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----HHHHHTT--CCCCCCTTBC----HHHHHHHHHHT
T ss_pred             hHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-----HHHHHcC--CCCCCCccCC----HHHHHHHHHHc
Confidence            999999899999999999999999999 9999975432211     1111111  1112222222    24888999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||.+|||+++++++|+
T Consensus       257 ~~~p~~Rps~~ell~~l~  274 (327)
T 3poz_A          257 MIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             CSCGGGSCCHHHHHHHHH
T ss_pred             CCChhhCCCHHHHHHHHH
Confidence            999999999999999874

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.3e-33  Score=206.77  Aligned_cols=156  Identities=26%  Similarity=0.386  Sum_probs=124.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++....... ......+++.|+|||.
T Consensus       109 ~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~  184 (328)
T 3fe3_A          109 GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFCGAPPYAAPEL  184 (328)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-GGGTTSSSGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-ccccccCCcceeCccc
Confidence            5689999999999999999999999   99999999999999999999999999997665433 2344678999999999


Q ss_pred             cccCCCC-cchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYTMKIT-EKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~~~~~-~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +.+..+. .++|+||+|+++|+|++|..||...+...        ....+.......+...    ..++.+++.+||+.|
T Consensus       185 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~p~~~----s~~~~~li~~~L~~d  252 (328)
T 3fe3_A          185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--------LRERVLRGKYRIPFYM----STDCENLLKRFLVLN  252 (328)
T ss_dssp             HHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTTS----CHHHHHHHHHHCCSS
T ss_pred             ccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCCCC----CHHHHHHHHHHCCCC
Confidence            9887764 78999999999999999999997543211        1111111111111122    224788999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |.+|||++|+++|
T Consensus       253 P~~R~t~~eil~h  265 (328)
T 3fe3_A          253 PIKRGTLEQIMKD  265 (328)
T ss_dssp             TTTSCCHHHHTTC
T ss_pred             hhHCcCHHHHhcC
Confidence            9999999999886

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.4e-33  Score=209.84  Aligned_cols=160  Identities=19%  Similarity=0.226  Sum_probs=125.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc---eeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.||++||.|||+.   +++|+||||+||+++.++.   ++++|||++..............+++.|+|
T Consensus       125 ~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~a  201 (351)
T 3c0i_A          125 FVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA  201 (351)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccC
Confidence            4589999999999999999999999   9999999999999976554   999999999877654433445678999999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+||||+++|+|++|..||.....         .....+...........+......+.++|.+||+
T Consensus       202 PE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  272 (351)
T 3c0i_A          202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLM  272 (351)
T ss_dssp             HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTC
T ss_pred             HHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCC
Confidence            9999988899999999999999999999999965321         1111111111111111112223458889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||++|||+.++++|
T Consensus       273 ~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          273 LDPAERITVYEALNH  287 (351)
T ss_dssp             SSTTTSCCHHHHHTS
T ss_pred             CChhHCcCHHHHhcC
Confidence            999999999999876

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2e-33  Score=208.58  Aligned_cols=167  Identities=13%  Similarity=0.200  Sum_probs=127.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc-----eeEccccCccccCCCCCC-------cc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE-----AHVADFGIAKFLKPDSSN-------WT   71 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~~-------~~   71 (179)
                      .+.+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.     ++|+|||++.........       ..
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~  175 (330)
T 2izr_A           99 DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK  175 (330)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccC
Confidence            46799999999999999999999999   9999999999999998877     999999999865433221       23


Q ss_pred             cccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHH
Q 042876           72 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLIS  151 (179)
Q Consensus        72 ~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (179)
                      ...+++.|+|||.+.+..++.++|+||||+++|++++|..||......................+ ........   . .
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~---p-~  250 (330)
T 2izr_A          176 SLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-IEVLCENF---P-E  250 (330)
T ss_dssp             CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-HHHHTTTC---H-H
T ss_pred             CcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-HHHHhccC---h-H
Confidence            45789999999999998999999999999999999999999976543221111111111100000 00000001   1 4


Q ss_pred             HHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          152 IVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       152 ~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +.+++..||+.||.+||+++++.+.|+
T Consensus       251 ~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          251 MATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             HHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence            888999999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-33  Score=209.17  Aligned_cols=169  Identities=22%  Similarity=0.314  Sum_probs=111.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC---ceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY---EAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      .+.+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++   .++|+|||++..............+++.|+
T Consensus       100 ~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~  176 (325)
T 3kn6_A          100 KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA  176 (325)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCcc
Confidence            35689999999999999999999999   999999999999997665   799999999986655444444556789999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |||.+.+..++.++|+||||+++|++++|..||........ ..........+...........+.....++.+++.+||
T Consensus       177 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  255 (325)
T 3kn6_A          177 APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLL  255 (325)
T ss_dssp             -------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHH
T ss_pred             CHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHC
Confidence            99999988999999999999999999999999975432211 11111222233333333333333344556889999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.||.+|||++++++|
T Consensus       256 ~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          256 TVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             CCCTTTCCCTTTSTTC
T ss_pred             CCChhHCCCHHHHhcC
Confidence            9999999999999876

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.8e-33  Score=208.92  Aligned_cols=162  Identities=20%  Similarity=0.263  Sum_probs=126.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC----ceeEccccCccccCCCCCCcccccCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY----EAHVADFGIAKFLKPDSSNWTEFAGTYGY   79 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   79 (179)
                      ...+++.+++.++.||+.||.|||+.   |++|+||||+||+++.++    .++|+|||++....... ......+++.|
T Consensus       109 ~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~-~~~~~~gt~~y  184 (361)
T 2yab_A          109 KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEF  184 (361)
T ss_dssp             CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC-CCCCCCSCGGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC-ccccCCCCccE
Confidence            45789999999999999999999999   999999999999998776    79999999998765432 23445789999


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +|||.+.+..++.++|+||||+++|+|++|..||......        .....+...........+......+.++|.+|
T Consensus       185 ~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  256 (361)
T 2yab_A          185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITAVSYDFDEEFFSQTSELAKDFIRKL  256 (361)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHH
T ss_pred             ECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcCCCCCchhccCCCHHHHHHHHHH
Confidence            9999999888999999999999999999999999654321        11111111111111111122234578899999


Q ss_pred             cCcCCCCCCCHHHHHHHh
Q 042876          160 LNESPESRPTMKIVSQQL  177 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l  177 (179)
                      |..||.+|||+.++++|=
T Consensus       257 L~~dP~~R~t~~e~l~hp  274 (361)
T 2yab_A          257 LVKETRKRLTIQEALRHP  274 (361)
T ss_dssp             SCSSTTTSCCHHHHHTST
T ss_pred             CCCChhHCcCHHHHhcCc
Confidence            999999999999999863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.2e-33  Score=210.26  Aligned_cols=157  Identities=25%  Similarity=0.344  Sum_probs=120.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++.+++.++.||+.||+|||+.   +++||||||+||+++.++.++|+|||++..............+++.|+|||.
T Consensus       119 ~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~  195 (353)
T 3txo_A          119 RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI  195 (353)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhh
Confidence            5689999999999999999999999   9999999999999999999999999999765444333445678999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|+|++|..||...+...        ....+.......+...    ..++.+++.+||+.||
T Consensus       196 ~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~----~~~~~~li~~lL~~dP  263 (353)
T 3txo_A          196 LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAILNDEVVYPTWL----HEDATGILKSFMTKNP  263 (353)
T ss_dssp             HHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTTS----CHHHHHHHHHHTCSSG
T ss_pred             cCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCCCCCC----CHHHHHHHHHHhhhCH
Confidence            998889999999999999999999999997543211        1111111111111111    2247889999999999


Q ss_pred             CCCCCH------HHHHHH
Q 042876          165 ESRPTM------KIVSQQ  176 (179)
Q Consensus       165 ~~Rps~------~~~~~~  176 (179)
                      .+||++      +++++|
T Consensus       264 ~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          264 TMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             GGSTTSGGGTCTHHHHTS
T ss_pred             HHccCCcccCCHHHHhhC
Confidence            999998      778765

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4e-33  Score=208.16  Aligned_cols=167  Identities=18%  Similarity=0.268  Sum_probs=125.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC--ceeEccccCccccCCCC-------CCcccccC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY--EAHVADFGIAKFLKPDS-------SNWTEFAG   75 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~~-------~~~~~~~~   75 (179)
                      ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++  .++|+|||++.......       .......+
T Consensus       146 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~g  222 (345)
T 2v62_A          146 GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNG  222 (345)
T ss_dssp             GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCC
Confidence            3789999999999999999999999   999999999999998777  99999999997653221       11234578


Q ss_pred             CCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCC---CCCCccHHHHHHHH
Q 042876           76 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL---PAPSRSVQEKLISI  152 (179)
Q Consensus        76 ~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  152 (179)
                      ++.|+|||.+.+..++.++|+||||+++|++++|..||....................++...   ....    .....+
T Consensus       223 t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l  298 (345)
T 2v62_A          223 TIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSG----SSCCEI  298 (345)
T ss_dssp             CTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTT----SCCHHH
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhcccc----ccHHHH
Confidence            899999999998889999999999999999999999996432211111111111111110000   0000    112248


Q ss_pred             HHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          153 VKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       153 ~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      .+++.+||+.||++|||++++++.|+
T Consensus       299 ~~li~~~l~~dp~~Rps~~~l~~~L~  324 (345)
T 2v62_A          299 AQFLVCAHSLAYDEKPNYQALKKILN  324 (345)
T ss_dssp             HHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred             HHHHHHHhhcCcccCCCHHHHHHHHh
Confidence            88999999999999999999999886

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.8e-33  Score=203.21  Aligned_cols=170  Identities=19%  Similarity=0.222  Sum_probs=123.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.+..............+++.|+|||
T Consensus        95 ~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE  171 (292)
T 3o0g_A           95 NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD  171 (292)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChH
Confidence            46799999999999999999999999   999999999999999999999999999987665444445567889999999


Q ss_pred             ccccCC-CCcchhhHHHHHHHHHHHhCCCCCcccccccccc-------------cc-hhhhhhhcCC-CC---CCCCCcc
Q 042876           84 LAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS-------------LN-TDIELDEMLD-PR---LPAPSRS  144 (179)
Q Consensus        84 ~~~~~~-~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~-------------~~-~~~~~~~~~~-~~---~~~~~~~  144 (179)
                      .+.+.. ++.++|+||+|++++++++|..|+-.........             .. .......... +.   .......
T Consensus       172 ~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (292)
T 3o0g_A          172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV  251 (292)
T ss_dssp             HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTT
T ss_pred             HHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhc
Confidence            987765 7999999999999999999888853222110000             00 0000000000 00   0000001


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.+++.+||+.||++|||++|+++|
T Consensus       252 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            11122347889999999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.6e-33  Score=210.98  Aligned_cols=161  Identities=25%  Similarity=0.366  Sum_probs=124.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.........  .....+++.|+||
T Consensus       188 ~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP  264 (359)
T 3vhe_A          188 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  264 (359)
T ss_dssp             TCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeECh
Confidence            3489999999999999999999999   9999999999999999999999999999765433221  2334567889999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||........    .............+  ....    ..+.+++.+||+
T Consensus       265 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----~~~~~~~~~~~~~~--~~~~----~~l~~li~~~l~  334 (359)
T 3vhe_A          265 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLKEGTRMRAP--DYTT----PEMYQTMLDCWH  334 (359)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----HHHHHHHTCCCCCC--TTCC----HHHHHHHHHHTC
T ss_pred             hhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH----HHHHHHcCCCCCCC--CCCC----HHHHHHHHHHcc
Confidence            99988899999999999999999998 9999975432110    00111111111111  1222    237889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+++++++|+
T Consensus       335 ~dP~~Rps~~ell~~L~  351 (359)
T 3vhe_A          335 GEPSQRPTFSELVEHLG  351 (359)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CChhhCCCHHHHHHHHH
Confidence            99999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-33  Score=205.97  Aligned_cols=167  Identities=25%  Similarity=0.270  Sum_probs=124.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++....... ......+++.|+|||.
T Consensus       115 ~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~  190 (308)
T 3g33_A          115 PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPEV  190 (308)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC-CSGGGGCCCSSCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCccccccCCCc-ccCCccccccccCchH
Confidence            3489999999999999999999999   99999999999999999999999999997665332 2344578999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhh----------------hcCCCCCCCC-CccHHH
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELD----------------EMLDPRLPAP-SRSVQE  147 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~-~~~~~~  147 (179)
                      +.+..++.++|+||||+++|++++|..||............  ....                .......+.. ......
T Consensus       191 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (308)
T 3g33_A          191 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI--FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPE  268 (308)
T ss_dssp             HHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH--HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCS
T ss_pred             HcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCChhhccchhhccccccCCCCCCcHHHhCcc
Confidence            98889999999999999999999999999654321110000  0000                0000000000 000011


Q ss_pred             HHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          148 KLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       148 ~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      ....+.+++.+||+.||.+|||+.|+++|=
T Consensus       269 ~~~~~~~li~~~L~~dP~~R~t~~e~l~h~  298 (308)
T 3g33_A          269 MEESGAQLLLEMLTFNPHKRISAFRALQHS  298 (308)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred             ccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence            223478899999999999999999999873

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.1e-32  Score=205.10  Aligned_cols=156  Identities=22%  Similarity=0.282  Sum_probs=123.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++.+++.++.|+++||.|||+.   |++||||||+||+++.++.++|+|||++........ .....+++.|+|||.
T Consensus       103 ~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~-~~~~~gt~~y~aPE~  178 (336)
T 3h4j_B          103 KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPEV  178 (336)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT-TCCCTTSTTTSCGGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc-cccccCCcCcCCHHH
Confidence            5689999999999999999999999   999999999999999999999999999976654332 234578999999999


Q ss_pred             cccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +.+..+ ++++|+||+|+++|++++|..||............        .......+...    ...+.+++.+||+.|
T Consensus       179 ~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------~~~~~~~p~~~----s~~~~~li~~~L~~d  246 (336)
T 3h4j_B          179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--------NSCVYVMPDFL----SPGAQSLIRRMIVAD  246 (336)
T ss_dssp             SCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--------CSSCCCCCTTS----CHHHHHHHHTTSCSS
T ss_pred             HcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--------HcCCCCCcccC----CHHHHHHHHHHcCCC
Confidence            988775 68999999999999999999999754322211110        11111111111    223788999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |.+|||++|+++|
T Consensus       247 P~~Rpt~~eil~h  259 (336)
T 3h4j_B          247 PMQRITIQEIRRD  259 (336)
T ss_dssp             GGGSCCHHHHTTC
T ss_pred             hhHCcCHHHHHhC
Confidence            9999999999876

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-33  Score=207.73  Aligned_cols=161  Identities=22%  Similarity=0.313  Sum_probs=126.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC--CCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL--EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.  ++.++++|||++....... ......+++.|+||
T Consensus        97 ~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aP  172 (321)
T 1tki_A           97 FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAP  172 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-EEEEEESCGGGSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-ccccccCChhhcCc
Confidence            4689999999999999999999999   9999999999999987  7889999999997765432 23445688999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |.+.+..++.++|+||+|+++|+|++|..||......        .....+...........+.....++.+++.+||..
T Consensus       173 E~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  244 (321)
T 1tki_A          173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK  244 (321)
T ss_dssp             HHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCS
T ss_pred             HHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCC
Confidence            9998888899999999999999999999999654321        11111111111111111222334588999999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 042876          163 SPESRPTMKIVSQQL  177 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l  177 (179)
                      ||.+|||+.|+++|-
T Consensus       245 dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          245 ERKSRMTASEALQHP  259 (321)
T ss_dssp             SGGGSCCHHHHHHSH
T ss_pred             ChhHCcCHHHHhcCh
Confidence            999999999999863

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-32  Score=202.46  Aligned_cols=168  Identities=18%  Similarity=0.232  Sum_probs=127.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee----cCCCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL----DLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      .+++.+++.++.|+++||.|||+.   +++|+||||+||++    +.++.++|+|||++........ .....+++.|+|
T Consensus       108 ~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~gt~~y~a  183 (319)
T 4euu_A          108 GLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLYGTEEYLH  183 (319)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC-BCCCCSCGGGCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc-eeecccCCCccC
Confidence            489999999999999999999999   99999999999998    7777899999999987654332 234568899999


Q ss_pred             Ccccc--------cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhc-----------------CCC
Q 042876           82 PELAY--------TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEM-----------------LDP  136 (179)
Q Consensus        82 pe~~~--------~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-----------------~~~  136 (179)
                      ||.+.        +..++.++|+||||+++|++++|..||....................                 ...
T Consensus       184 PE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  263 (319)
T 4euu_A          184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG  263 (319)
T ss_dssp             HHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEES
T ss_pred             HHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCc
Confidence            99876        46788999999999999999999999965432211111100011100                 011


Q ss_pred             CCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          137 RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      ..+............+.+++.+||+.||++|||++|++++.
T Consensus       264 ~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          264 DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            22333333455566788999999999999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-32  Score=206.37  Aligned_cols=160  Identities=27%  Similarity=0.382  Sum_probs=125.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........  ......+++.|+||
T Consensus       186 ~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  262 (382)
T 3tt0_A          186 EQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  262 (382)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCH
Confidence            4699999999999999999999999   999999999999999999999999999976654322  12334556789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||++++++++ |..||........     ........  .........    .++.+++.+||+
T Consensus       263 E~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~-----~~~~~~~~--~~~~~~~~~----~~l~~li~~~l~  331 (382)
T 3tt0_A          263 EALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-----FKLLKEGH--RMDKPSNCT----NELYMMMRDCWH  331 (382)
T ss_dssp             HHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-----HHHHHTTC--CCCCCSSCC----HHHHHHHHHHTC
T ss_pred             HHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHcCC--CCCCCccCC----HHHHHHHHHHcC
Confidence            99999899999999999999999999 9999965432110     01111111  111111222    248889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++|||+++++++|+
T Consensus       332 ~dP~~Rps~~ell~~L~  348 (382)
T 3tt0_A          332 AVPSQRPTFKQLVEDLD  348 (382)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHH
Confidence            99999999999999985

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-32  Score=204.19  Aligned_cols=161  Identities=24%  Similarity=0.385  Sum_probs=119.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   81 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.........  .....+++.|++
T Consensus       111 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~a  187 (327)
T 3lzb_A          111 KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA  187 (327)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccC
Confidence            35689999999999999999999999   9999999999999999999999999999776443222  222345678999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..++.++|+||||+++|++++ |..||........     .......  ...+.......    ++.+++.+||
T Consensus       188 PE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-----~~~~~~~--~~~~~~~~~~~----~l~~li~~~l  256 (327)
T 3lzb_A          188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILEKG--ERLPQPPICTI----DVYMIMRKCW  256 (327)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----HHHHHTT--CCCCCCTTBCH----HHHHHHHHHT
T ss_pred             HHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHcC--CCCCCCccCCH----HHHHHHHHHc
Confidence            999999899999999999999999999 9999975432211     1111111  11222222222    4788999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||.+|||+.++++.|+
T Consensus       257 ~~dp~~Rps~~ell~~L~  274 (327)
T 3lzb_A          257 MIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             CSSGGGSCCHHHHHHHHH
T ss_pred             CCChhHCcCHHHHHHHHH
Confidence            999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.6e-33  Score=202.24  Aligned_cols=166  Identities=22%  Similarity=0.429  Sum_probs=116.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC--CCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~   81 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......  .......+++.|++
T Consensus       114 ~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  190 (289)
T 3og7_A          114 ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA  190 (289)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccC
Confidence            45789999999999999999999999   99999999999999999999999999987654322  12234568899999


Q ss_pred             Ccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           82 PELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        82 pe~~~---~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      ||.+.   +..++.++|+||||++++++++|..||........   ...........+.....   .......+.+++.+
T Consensus       191 PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~  264 (289)
T 3og7_A          191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLSKV---RSNCPKRMKRLMAE  264 (289)
T ss_dssp             HHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH---HHHHHHHTSCCCCTTSS---CTTSCHHHHHHHHH
T ss_pred             chhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH---HHHHhcccccCcchhhc---cccCCHHHHHHHHH
Confidence            99886   55678899999999999999999999975432110   00011111111111111   11122348889999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||+.||.+|||+.++++.|+
T Consensus       265 ~l~~~p~~Rps~~ell~~L~  284 (289)
T 3og7_A          265 CLKKKRDERPSFPRILAEIE  284 (289)
T ss_dssp             HTCSSGGGSCCHHHHHHHHH
T ss_pred             HccCChhhCCCHHHHHHHHH
Confidence            99999999999999999885

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.4e-32  Score=211.19  Aligned_cols=168  Identities=23%  Similarity=0.267  Sum_probs=121.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.||+.||+|||+.   +++||||||+||+++.++.+||+|||++....... ......+++.|+|||.
T Consensus       159 ~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~  234 (464)
T 3ttj_A          159 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEV  234 (464)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----CC-CC----CCCTTCCHHH
T ss_pred             hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc-ccCCCcccccccCHHH
Confidence            3588999999999999999999999   99999999999999999999999999997665432 2344578999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCccccccccccc--------------chhhhhhhcCCCC-------------
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL--------------NTDIELDEMLDPR-------------  137 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~--------------~~~~~~~~~~~~~-------------  137 (179)
                      +.+..++.++|+||+||++++|++|+.||.+.........              .........+...             
T Consensus       235 ~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (464)
T 3ttj_A          235 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP  314 (464)
T ss_dssp             HTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSC
T ss_pred             HcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCc
Confidence            9999999999999999999999999999976432110000              0000000011000             


Q ss_pred             ---CCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          138 ---LPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       138 ---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                         .+...........++.+|+.+||+.||.+|||++|+++|
T Consensus       315 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          315 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             GGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               111111122224568899999999999999999999987

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.6e-32  Score=204.98  Aligned_cols=165  Identities=26%  Similarity=0.370  Sum_probs=124.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++..............+++.|+|||.
T Consensus       105 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~  181 (345)
T 3a8x_A          105 RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI  181 (345)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccc
Confidence            4689999999999999999999999   9999999999999999999999999999764433333445678999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccc-cchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS-LNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +.+..++.++|+|||||++|+|++|..||.......... .........+.......+...    ...+.+++.+||+.|
T Consensus       182 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~----s~~~~~li~~lL~~d  257 (345)
T 3a8x_A          182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL----SVKAASVLKSFLNKD  257 (345)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS----CHHHHHHHHHHTCSS
T ss_pred             cCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHHhcCC
Confidence            999899999999999999999999999996533211111 011111111111111111112    224788999999999


Q ss_pred             CCCCCCH------HHHHHH
Q 042876          164 PESRPTM------KIVSQQ  176 (179)
Q Consensus       164 p~~Rps~------~~~~~~  176 (179)
                      |.+||++      +++++|
T Consensus       258 P~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          258 PKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             TTTSTTCCTTTHHHHHHTS
T ss_pred             HhHCCCCCCcCCHHHHhcC
Confidence            9999985      677765

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.7e-32  Score=205.34  Aligned_cols=157  Identities=23%  Similarity=0.320  Sum_probs=124.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.||+.||.|||+.   |++||||||+||+++.++.++|+|||++..............+++.|+|||.
T Consensus       116 ~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~  192 (353)
T 2i0e_A          116 GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI  192 (353)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhh
Confidence            4689999999999999999999999   9999999999999999999999999999765433333455678999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|+|++|..||...+..        .....+.......+...    ..++.++|.+||+.||
T Consensus       193 ~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~p~~~----s~~~~~li~~lL~~dP  260 (353)
T 2i0e_A          193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHNVAYPKSM----SKEAVAICKGLMTKHP  260 (353)
T ss_dssp             HTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCTTS----CHHHHHHHHHHTCSCT
T ss_pred             hcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhCCCCCCCCC----CHHHHHHHHHHhhcCH
Confidence            99889999999999999999999999999754321        11111111111111111    2247889999999999


Q ss_pred             CCCCC-----HHHHHHH
Q 042876          165 ESRPT-----MKIVSQQ  176 (179)
Q Consensus       165 ~~Rps-----~~~~~~~  176 (179)
                      .+||+     ++++++|
T Consensus       261 ~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          261 GKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             TSCTTCSTTHHHHHHTS
T ss_pred             HHcCCCCCCCHHHHhcC
Confidence            99994     6888776

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.1e-33  Score=201.97  Aligned_cols=170  Identities=22%  Similarity=0.267  Sum_probs=120.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++..............+++.|+|||
T Consensus        94 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE  170 (288)
T 1ob3_A           94 EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD  170 (288)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCch
Confidence            35689999999999999999999999   999999999999999999999999999977654333334456789999999


Q ss_pred             ccccC-CCCcchhhHHHHHHHHHHHhCCCCCccccccccccc------------chhhhhhhcCCCCCCCCC-----ccH
Q 042876           84 LAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL------------NTDIELDEMLDPRLPAPS-----RSV  145 (179)
Q Consensus        84 ~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~-----~~~  145 (179)
                      .+.+. .++.++|+||||+++|++++|..||...........            ..........++......     ...
T Consensus       171 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (288)
T 1ob3_A          171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL  250 (288)
T ss_dssp             HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTC
T ss_pred             heeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHh
Confidence            98764 578999999999999999999999975432110000            000000000011110000     000


Q ss_pred             HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .....++.+++.+||+.||++|||++++++|
T Consensus       251 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          251 KGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1112347889999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-32  Score=207.00  Aligned_cols=161  Identities=24%  Similarity=0.330  Sum_probs=123.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC---ceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY---EAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      ...+++.+++.++.||++||.|||+.   +++|+||||+||+++.++   .++|+|||++....... ......+++.|+
T Consensus       122 ~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~  197 (362)
T 2bdw_A          122 REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPGYL  197 (362)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-SCCCSCSCTTTC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-ccccCCCCcccc
Confidence            35689999999999999999999999   999999999999997654   59999999997665332 233457899999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |||.+.+..++.++|+||||+++|+|++|..||.......        ....+...........+......+.++|.+||
T Consensus       198 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L  269 (362)
T 2bdw_A          198 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML  269 (362)
T ss_dssp             CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHS
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCCCCcccccCCCHHHHHHHHHHc
Confidence            9999998889999999999999999999999996543211        11111111111111112222335788999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.||.+|||+.++++|
T Consensus       270 ~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          270 TVNPKKRITADQALKV  285 (362)
T ss_dssp             CSSGGGSCCHHHHTTS
T ss_pred             CCChhhCcCHHHHhcC
Confidence            9999999999999876

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4e-33  Score=208.01  Aligned_cols=165  Identities=22%  Similarity=0.308  Sum_probs=124.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC----CceeEccccCccccCCCCCCcccccCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE----YEAHVADFGIAKFLKPDSSNWTEFAGTYGY   79 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   79 (179)
                      .+.+++.+++.++.||+.||.|||+.   |++||||||+||++..+    +.++++|||++..............+++.|
T Consensus       110 ~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y  186 (342)
T 2qr7_A          110 QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF  186 (342)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccc
Confidence            35689999999999999999999999   99999999999998433    349999999998765544344456788999


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +|||.+.+..++.++|+||||+++|+|++|..||...........     ...+...........+......+.+++.+|
T Consensus       187 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  261 (342)
T 2qr7_A          187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI-----LARIGSGKFSLSGGYWNSVSDTAKDLVSKM  261 (342)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH-----HHHHHHCCCCCCSTTTTTSCHHHHHHHHHH
T ss_pred             cCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH-----HHHHccCCcccCccccccCCHHHHHHHHHH
Confidence            999999887888999999999999999999999975432111111     111111111111111112233478899999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 042876          160 LNESPESRPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~  176 (179)
                      |+.||.+|||+.++++|
T Consensus       262 L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          262 LHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             TCSSTTTSCCHHHHTTS
T ss_pred             CCCChhHCcCHHHHhcC
Confidence            99999999999999876

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-32  Score=204.45  Aligned_cols=162  Identities=20%  Similarity=0.262  Sum_probs=125.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC----ceeEccccCccccCCCCCCcccccCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY----EAHVADFGIAKFLKPDSSNWTEFAGTYGY   79 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   79 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++    .++|+|||++....... ......+++.|
T Consensus       108 ~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y  183 (326)
T 2y0a_A          108 KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEF  183 (326)
T ss_dssp             SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS-CCCCCCSCTTT
T ss_pred             cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC-ccccccCCcCc
Confidence            45689999999999999999999999   999999999999998877    79999999997765332 22345789999


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +|||.+.+..++.++|+||||+++|+|++|..||.......        .......................+.+++.+|
T Consensus       184 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  255 (326)
T 2y0a_A          184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANVSAVNYEFEDEYFSNTSALAKDFIRRL  255 (326)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHH
T ss_pred             CCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHHhcCCCcCccccccCCHHHHHHHHHH
Confidence            99999988889999999999999999999999996532111        1111110111111111112233478899999


Q ss_pred             cCcCCCCCCCHHHHHHHh
Q 042876          160 LNESPESRPTMKIVSQQL  177 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l  177 (179)
                      |+.||.+|||++++++|-
T Consensus       256 L~~dP~~Rpt~~e~l~hp  273 (326)
T 2y0a_A          256 LVKDPKKRMTIQDSLQHP  273 (326)
T ss_dssp             SCSSGGGSCCHHHHHHST
T ss_pred             ccCChhhCCCHHHHhcCC
Confidence            999999999999999873

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.1e-32  Score=199.64  Aligned_cols=169  Identities=20%  Similarity=0.270  Sum_probs=124.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..............+++.|+|||.
T Consensus       103 ~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~  179 (317)
T 2pmi_A          103 RGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV  179 (317)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchH
Confidence            4689999999999999999999999   9999999999999999999999999999876544433445578899999999


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccc------------cchhhhhhhcCCCCCCCC-CccH-----
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS------------LNTDIELDEMLDPRLPAP-SRSV-----  145 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~-~~~~-----  145 (179)
                      +.+. .++.++|+||||+++|+|++|..||..........            ............+..... ....     
T Consensus       180 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (317)
T 2pmi_A          180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQ  259 (317)
T ss_dssp             HTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHG
T ss_pred             hhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhc
Confidence            8764 57899999999999999999999997543211000            000000000000000000 0000     


Q ss_pred             ----HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 ----QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ----~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                          .....++.+++.+||+.||++|||++|+++|
T Consensus       260 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          260 PHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                0112358899999999999999999999876

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.6e-33  Score=203.65  Aligned_cols=161  Identities=25%  Similarity=0.377  Sum_probs=125.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++.........  .....+++.|+||
T Consensus       140 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  216 (313)
T 1t46_A          140 LALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (313)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeCh
Confidence            3589999999999999999999999   9999999999999999999999999999776544321  2233456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||++++++++ |..||........    .............+  ...    ...+.+++.+||+
T Consensus       217 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----~~~~~~~~~~~~~~--~~~----~~~l~~li~~~l~  286 (313)
T 1t46_A          217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----FYKMIKEGFRMLSP--EHA----PAEMYDIMKTCWD  286 (313)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH----HHHHHHHTCCCCCC--TTS----CHHHHHHHHHHTC
T ss_pred             HHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH----HHHHhccCCCCCCc--ccC----CHHHHHHHHHHcC
Confidence            99988889999999999999999998 9999875432111    01111111111111  111    2247889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+++++++|+
T Consensus       287 ~dp~~Rps~~ell~~L~  303 (313)
T 1t46_A          287 ADPLKRPTFKQIVQLIE  303 (313)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CCchhCcCHHHHHHHHH
Confidence            99999999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-32  Score=202.06  Aligned_cols=173  Identities=29%  Similarity=0.369  Sum_probs=122.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC----cccccC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDC-----FPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN----WTEFAG   75 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~-----~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~   75 (179)
                      +.+++..++.++.|++.||.|||+.+     ..+++|+||||+||+++.++.++|+|||++.........    .....+
T Consensus       129 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g  208 (337)
T 3mdy_A          129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG  208 (337)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCS
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCcc
Confidence            46889999999999999999999751     127999999999999999999999999999765433221    124578


Q ss_pred             CCCCCCCcccccCCCCcc------hhhHHHHHHHHHHHhC----------CCCCcccccccccccchh-hhhhhcCCCCC
Q 042876           76 TYGYVAPELAYTMKITEK------CDVYSFGVLALEVIKG----------KHPRDFLSSISSSSLNTD-IELDEMLDPRL  138 (179)
Q Consensus        76 ~~~~~~pe~~~~~~~~~~------~D~~slg~~~~~l~~~----------~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~  138 (179)
                      ++.|+|||.+.+......      +|+||||+++|+|++|          ..||.............. ........+..
T Consensus       209 t~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (337)
T 3mdy_A          209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF  288 (337)
T ss_dssp             CGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC
T ss_pred             CcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccc
Confidence            899999999987665554      8999999999999999          555543322111110000 01111111112


Q ss_pred             CCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          139 PAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       139 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +. ..........+.+++.+||+.||.+|||+++++++|+
T Consensus       289 ~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  327 (337)
T 3mdy_A          289 PN-RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA  327 (337)
T ss_dssp             CG-GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             cc-cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence            11 1112345566899999999999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.1e-33  Score=206.27  Aligned_cols=157  Identities=28%  Similarity=0.372  Sum_probs=123.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++..............+++.|+|||.
T Consensus       113 ~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~  189 (345)
T 1xjd_A          113 HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI  189 (345)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhh
Confidence            4689999999999999999999999   9999999999999999999999999999765433333445678999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|+|++|..||........   .....   .....++.  ..    ..++.+++.+||..||
T Consensus       190 ~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~---~~~~~~p~--~~----s~~~~~li~~lL~~dp  257 (345)
T 1xjd_A          190 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSIR---MDNPFYPR--WL----EKEAKDLLVKLFVREP  257 (345)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH---HCCCCCCT--TS----CHHHHHHHHHHSCSSG
T ss_pred             hcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHH---hCCCCCCc--cc----CHHHHHHHHHHhcCCH
Confidence            9998899999999999999999999999975432110   00010   11112221  11    2247889999999999


Q ss_pred             CCCCCHH-HHHHH
Q 042876          165 ESRPTMK-IVSQQ  176 (179)
Q Consensus       165 ~~Rps~~-~~~~~  176 (179)
                      .+||++. ++++|
T Consensus       258 ~~R~~~~~~i~~h  270 (345)
T 1xjd_A          258 EKRLGVRGDIRQH  270 (345)
T ss_dssp             GGSBTTBSCGGGS
T ss_pred             hHcCCChHHHHcC
Confidence            9999997 77654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-32  Score=196.93  Aligned_cols=163  Identities=28%  Similarity=0.466  Sum_probs=118.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC--------CCceeEccccCccccCCCCCCcccccC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL--------EYEAHVADFGIAKFLKPDSSNWTEFAG   75 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~--------~~~~~l~d~~~~~~~~~~~~~~~~~~~   75 (179)
                      .+.+++..++.++.|++.||.|||+.+..+++|+||+|+||+++.        ++.++++|||.+........  ....+
T Consensus        99 ~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~  176 (271)
T 3dtc_A           99 GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAG  176 (271)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------------C
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc--cCCCC
Confidence            457899999999999999999999992112899999999999985        67799999999976543322  23467


Q ss_pred             CCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHH
Q 042876           76 TYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKV  155 (179)
Q Consensus        76 ~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  155 (179)
                      ++.|+|||.+.+..++.++|+||||++++++++|..||..........    .....  ....+......    ..+.++
T Consensus       177 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~--~~~~~~~~~~~----~~~~~l  246 (271)
T 3dtc_A          177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY----GVAMN--KLALPIPSTCP----EPFAKL  246 (271)
T ss_dssp             CGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----HHHTS--CCCCCCCTTCC----HHHHHH
T ss_pred             ccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----hhhcC--CCCCCCCcccC----HHHHHH
Confidence            889999999998889999999999999999999999997543211000    00001  11111111222    248889


Q ss_pred             HhcccCcCCCCCCCHHHHHHHhh
Q 042876          156 AFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       156 i~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +.+||+.||.+|||+++++++|+
T Consensus       247 i~~~l~~~p~~Rps~~e~l~~L~  269 (271)
T 3dtc_A          247 MEDCWNPDPHSRPSFTNILDQLT  269 (271)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhcCCcccCcCHHHHHHHHh
Confidence            99999999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.2e-32  Score=210.57  Aligned_cols=157  Identities=26%  Similarity=0.323  Sum_probs=123.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +.+++..++.++.||+.||+|||+ .   +++||||||+||+++.++.++|+|||++..............+++.|+|||
T Consensus       243 ~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE  319 (446)
T 4ejn_A          243 RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE  319 (446)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHh
Confidence            568999999999999999999998 7   999999999999999999999999999976544433345567899999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||||+++|+|++|..||........      ..........++.  ..    ..++.++|.+||+.|
T Consensus       320 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~p~--~~----~~~~~~li~~~L~~d  387 (446)
T 4ejn_A          320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILMEEIRFPR--TL----GPEAKSLLSGLLKKD  387 (446)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCCCCT--TS----CHHHHHHHHHHTCSS
T ss_pred             hcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHHHHhCCCCCCc--cC----CHHHHHHHHHHcccC
Confidence            99998999999999999999999999999965432110      0000011111221  11    124788999999999


Q ss_pred             CCCCC-----CHHHHHHH
Q 042876          164 PESRP-----TMKIVSQQ  176 (179)
Q Consensus       164 p~~Rp-----s~~~~~~~  176 (179)
                      |.+||     +++++++|
T Consensus       388 P~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          388 PKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             TTTSTTCSTTTHHHHHTS
T ss_pred             HHHhCCCCCCCHHHHHhC
Confidence            99999     99999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.7e-32  Score=201.70  Aligned_cols=158  Identities=22%  Similarity=0.389  Sum_probs=117.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe   83 (179)
                      .+++.+++.++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++.........  .....+++.|++||
T Consensus       133 ~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  209 (323)
T 3qup_A          133 NLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE  209 (323)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence            689999999999999999999999   9999999999999999999999999999765433221  22334567899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      .+.+..++.++|+||||+++|++++ |..||........        ....... ..+.....    ...+.+++.+||+
T Consensus       210 ~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~----~~~l~~li~~~l~  277 (323)
T 3qup_A          210 SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--------YNYLIGGNRLKQPPEC----MEEVYDLMYQCWS  277 (323)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------HHHHHTTCCCCCCTTC----CHHHHHHHHHTTC
T ss_pred             hhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--------HHHHhcCCCCCCCCcc----CHHHHHHHHHHcc
Confidence            9998889999999999999999999 8999975432211        1111111 11111122    2248889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||++++++.|+
T Consensus       278 ~dp~~Rps~~~l~~~l~  294 (323)
T 3qup_A          278 ADPKQRPSFTCLRMELE  294 (323)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHH
Confidence            99999999999888775

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.9e-32  Score=196.48  Aligned_cols=161  Identities=29%  Similarity=0.480  Sum_probs=122.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--cccCCCCCCCeeecCCCc-----eeEccccCccccCCCCCCcccccCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPP--IVHRDLSSKNLLLDLEYE-----AHVADFGIAKFLKPDSSNWTEFAGT   76 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~dl~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~~~~~~~~~   76 (179)
                      ...+++..++.++.|++.||+|||+.   +  ++|+||+|+||+++.++.     ++++|||++.....   ......++
T Consensus       116 ~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~g~  189 (287)
T 4f0f_A          116 AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGN  189 (287)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS---CEECCCCC
T ss_pred             cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc---cccccCCC
Confidence            45789999999999999999999999   8  999999999999987776     99999999875433   23445788


Q ss_pred             CCCCCCcccc--cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHH
Q 042876           77 YGYVAPELAY--TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVK  154 (179)
Q Consensus        77 ~~~~~pe~~~--~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (179)
                      +.|+|||.+.  ...++.++|+||||+++|++++|..||..........  .............+.  ..    ...+.+
T Consensus       190 ~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~--~~----~~~l~~  261 (287)
T 4f0f_A          190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMIREEGLRPTIPE--DC----PPRLRN  261 (287)
T ss_dssp             CTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHHHHSCCCCCCCT--TS----CHHHHH
T ss_pred             ccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHHhccCCCCCCCc--cc----CHHHHH
Confidence            9999999984  4456889999999999999999999997543221100  001111111111221  12    224888


Q ss_pred             HHhcccCcCCCCCCCHHHHHHHhh
Q 042876          155 VAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       155 li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ++.+||+.||.+|||++++++.|+
T Consensus       262 li~~~l~~dp~~Rps~~~ll~~L~  285 (287)
T 4f0f_A          262 VIELCWSGDPKKRPHFSYIVKELS  285 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHhcCChhhCcCHHHHHHHHH
Confidence            999999999999999999999885

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-33  Score=207.80  Aligned_cols=161  Identities=23%  Similarity=0.321  Sum_probs=124.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.........  .....+++.|+||
T Consensus       167 ~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  243 (344)
T 1rjb_A          167 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  243 (344)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCH
Confidence            3589999999999999999999999   9999999999999999999999999999765433221  2233556789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|+|++ |..||........    .............+  ...    ...+.+++.+||+
T Consensus       244 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~----~~~~~~~~~~~~~~--~~~----~~~l~~li~~~l~  313 (344)
T 1rjb_A          244 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN----FYKLIQNGFKMDQP--FYA----TEEIYIIMQSCWA  313 (344)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----HHHHHHTTCCCCCC--TTC----CHHHHHHHHHHTC
T ss_pred             HHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH----HHHHHhcCCCCCCC--CCC----CHHHHHHHHHHcC
Confidence            99988889999999999999999998 9999975432110    00111111111111  112    2248889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+++++++|+
T Consensus       314 ~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          314 FDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CCchhCcCHHHHHHHHH
Confidence            99999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.98  E-value=1.8e-32  Score=197.79  Aligned_cols=160  Identities=28%  Similarity=0.488  Sum_probs=123.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++.+++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+......... .....+++.|+|||
T Consensus        99 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  175 (268)
T 3sxs_A           99 KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPE  175 (268)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHH
Confidence            4589999999999999999999999   9999999999999999999999999999765543221 12234456799999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||++++++++ |..||........     .......  ..........    ..+.+++.+||+.
T Consensus       176 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~~~~~--~~~~~~~~~~----~~l~~li~~~l~~  244 (268)
T 3sxs_A          176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-----VLKVSQG--HRLYRPHLAS----DTIYQIMYSCWHE  244 (268)
T ss_dssp             HHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----HHHHHTT--CCCCCCTTSC----HHHHHHHHHTTCS
T ss_pred             HHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-----HHHHHcC--CCCCCCCcCh----HHHHHHHHHHcCC
Confidence            9988889999999999999999998 9999965432110     0111111  1111111111    2478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||.+|||+.+++++|+
T Consensus       245 ~p~~Rps~~~ll~~L~  260 (268)
T 3sxs_A          245 LPEKRPTFQQLLSSIE  260 (268)
T ss_dssp             SGGGSCCHHHHHHHHG
T ss_pred             ChhhCcCHHHHHHHHH
Confidence            9999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.98  E-value=7.8e-33  Score=214.53  Aligned_cols=168  Identities=15%  Similarity=0.286  Sum_probs=128.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee---cCCCceeEccccCccccCCCCCC-------cccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL---DLEYEAHVADFGIAKFLKPDSSN-------WTEF   73 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~-------~~~~   73 (179)
                      .+.+++.+++.++.||+.||.|||+.   +++|+||||+||++   +.++.++|+|||++.........       ....
T Consensus        97 ~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~  173 (483)
T 3sv0_A           97 SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL  173 (483)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccccccccccc
Confidence            45799999999999999999999999   99999999999999   57889999999999876543221       2245


Q ss_pred             cCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHH
Q 042876           74 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIV  153 (179)
Q Consensus        74 ~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (179)
                      .++..|++||.+.+..++.++|+||||+++|+|++|..||...................... ...   ........++.
T Consensus       174 ~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-~~~---~l~~~~p~~l~  249 (483)
T 3sv0_A          174 TGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT-SIE---ALCRGYPTEFA  249 (483)
T ss_dssp             CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS-CHH---HHHTTSCHHHH
T ss_pred             CCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc-cHH---HHhcCCcHHHH
Confidence            78899999999999999999999999999999999999997654322111111111111100 000   00001123488


Q ss_pred             HHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          154 KVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       154 ~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +++..||+.||.+||++++|++.|+
T Consensus       250 ~li~~cl~~dP~~RPs~~el~~~L~  274 (483)
T 3sv0_A          250 SYFHYCRSLRFDDKPDYSYLKRLFR  274 (483)
T ss_dssp             HHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHhcCChhhCcCHHHHHHHHH
Confidence            9999999999999999999998875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.98  E-value=1.4e-32  Score=205.65  Aligned_cols=171  Identities=16%  Similarity=0.240  Sum_probs=127.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC--ceeEccccCccccCCCCC-------Cccccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY--EAHVADFGIAKFLKPDSS-------NWTEFA   74 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~~~-------~~~~~~   74 (179)
                      ...+++.+++.++.||+.||.|||+.   +++|+||||+||+++.++  .++|+|||++........       ......
T Consensus       153 ~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~  229 (352)
T 2jii_A          153 KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHE  229 (352)
T ss_dssp             GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccccccccccc
Confidence            36799999999999999999999999   999999999999999988  899999999976543211       123347


Q ss_pred             CCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHH
Q 042876           75 GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVK  154 (179)
Q Consensus        75 ~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (179)
                      +++.|+|||.+.+..++.++|+||||+++|++++|..||..................... ..+.............+.+
T Consensus       230 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~  308 (352)
T 2jii_A          230 GDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKP-GPFVGPCGHWIRPSETLQK  308 (352)
T ss_dssp             SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSC-CCEECTTSCEECCCHHHHH
T ss_pred             CCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCCh-hhhhhhccccCCCcHHHHH
Confidence            889999999999888999999999999999999999999765321111111111111111 1111100000011234888


Q ss_pred             HHhcccCcCCCCCCCHHHHHHHhh
Q 042876          155 VAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       155 li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ++.+||+.||.+|||++++++.|+
T Consensus       309 li~~~l~~dp~~Rps~~~l~~~L~  332 (352)
T 2jii_A          309 YLKVVMALTYEEKPPYAMLRNNLE  332 (352)
T ss_dssp             HHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHhCChhhCCCHHHHHHHHH
Confidence            999999999999999999999875

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.98  E-value=2.5e-32  Score=197.97  Aligned_cols=158  Identities=25%  Similarity=0.383  Sum_probs=103.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++.+++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+..............+++.|+|||
T Consensus       106 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE  182 (278)
T 3cok_A          106 VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE  182 (278)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-------------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcc
Confidence            35789999999999999999999999   999999999999999999999999999977654333333456788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||||++++++++|..||.........        ..........+...    ..++.+++.+||+.|
T Consensus       183 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~----~~~~~~li~~~l~~d  250 (278)
T 3cok_A          183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL--------NKVVLADYEMPSFL----SIEAKDLIHQLLRRN  250 (278)
T ss_dssp             ---------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCCCCCTTS----CHHHHHHHHHHSCSS
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH--------HHHhhcccCCcccc----CHHHHHHHHHHcccC
Confidence            998888899999999999999999999999754321110        11111111111111    224788999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |++|||++++++|
T Consensus       251 p~~Rps~~~~l~h  263 (278)
T 3cok_A          251 PADRLSLSSVLDH  263 (278)
T ss_dssp             GGGSCCHHHHTTS
T ss_pred             HhhCCCHHHHhcC
Confidence            9999999999876

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.98  E-value=2.7e-32  Score=198.18  Aligned_cols=160  Identities=23%  Similarity=0.381  Sum_probs=114.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++++|||++......... .....+++.|+|||
T Consensus       111 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  187 (281)
T 1mp8_A          111 YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE  187 (281)
T ss_dssp             TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChh
Confidence            4689999999999999999999999   9999999999999999999999999999766433221 22234567899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||+++|++++ |..||........     .......  ...+.....    ...+.+++.+||+.
T Consensus       188 ~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-----~~~i~~~--~~~~~~~~~----~~~l~~li~~~l~~  256 (281)
T 1mp8_A          188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIENG--ERLPMPPNC----PPTLYSLMTKCWAY  256 (281)
T ss_dssp             HHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----HHHHHTT--CCCCCCTTC----CHHHHHHHHHHTCS
T ss_pred             hcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-----HHHHHcC--CCCCCCCCC----CHHHHHHHHHHccC
Confidence            9988889999999999999999996 9999975432211     0111111  111111122    22478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||++|||+.+++++|+
T Consensus       257 ~p~~Rps~~~l~~~l~  272 (281)
T 1mp8_A          257 DPSRRPRFTELKAQLS  272 (281)
T ss_dssp             SGGGSCCHHHHHHHHH
T ss_pred             ChhhCcCHHHHHHHHH
Confidence            9999999999999885

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.98  E-value=6.9e-33  Score=208.72  Aligned_cols=153  Identities=11%  Similarity=0.007  Sum_probs=115.2

Q ss_pred             HHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccccc--CCC
Q 042876           13 MNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYT--MKI   90 (179)
Q Consensus        13 ~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~   90 (179)
                      +.++.||++||+|||+.   +++||||||+||+++.++.+||+|||++.......   ....+++.|+|||.+.+  ..+
T Consensus       197 ~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~  270 (371)
T 3q60_A          197 HILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATF  270 (371)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEEC
T ss_pred             HHHHHHHHHHHHHHHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCc
Confidence            67789999999999999   99999999999999999999999999997654322   13455699999999987  678


Q ss_pred             CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC--CCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCC
Q 042876           91 TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRP  168 (179)
Q Consensus        91 ~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp  168 (179)
                      +.++|+||||+++|+|++|..||............. .......  ....+....    ....+.++|.+||+.||++||
T Consensus       271 ~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rp  345 (371)
T 3q60_A          271 THALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR-PSLRVPGTDSLAFGSCTP----LPDFVKTLIGRFLNFDRRRRL  345 (371)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCB-CCTTSCCCCSCCCTTSSC----CCHHHHHHHHHHTCSSTTTCC
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCCcCcccccchhh-hhhhhccccccchhhccC----CCHHHHHHHHHHcCCChhhCC
Confidence            999999999999999999999997654322111110 0001111  111111111    123488899999999999999


Q ss_pred             CHHHHHHH
Q 042876          169 TMKIVSQQ  176 (179)
Q Consensus       169 s~~~~~~~  176 (179)
                      |+.++++|
T Consensus       346 t~~e~l~h  353 (371)
T 3q60_A          346 LPLEAMET  353 (371)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.98  E-value=1.1e-32  Score=203.03  Aligned_cols=161  Identities=25%  Similarity=0.354  Sum_probs=119.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~   81 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++........  ......+++.|++
T Consensus       141 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  217 (313)
T 3brb_A          141 PKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA  217 (313)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSC
T ss_pred             CccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccC
Confidence            45799999999999999999999999   999999999999999999999999999976543321  1223456778999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..++.++|+||||+++|++++ |..||.........     .......  ........    ...+.+++.+||
T Consensus       218 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-----~~~~~~~--~~~~~~~~----~~~l~~li~~~l  286 (313)
T 3brb_A          218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY-----DYLLHGH--RLKQPEDC----LDELYEIMYSCW  286 (313)
T ss_dssp             HHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-----HHHHTTC--CCCCBTTC----CHHHHHHHHHTT
T ss_pred             chhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-----HHHHcCC--CCCCCccc----cHHHHHHHHHHc
Confidence            999998889999999999999999999 88898654322110     1111111  11111112    224888999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||.+|||+++++++|+
T Consensus       287 ~~dp~~Rps~~~l~~~L~  304 (313)
T 3brb_A          287 RTDPLDRPTFSVLRLQLE  304 (313)
T ss_dssp             CSSGGGSCCHHHHHHHHH
T ss_pred             CCChhhCcCHHHHHHHHH
Confidence            999999999999999985

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.98  E-value=3.5e-32  Score=201.62  Aligned_cols=161  Identities=27%  Similarity=0.430  Sum_probs=122.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~   80 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.........   .....+++.|+
T Consensus       145 ~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~  221 (325)
T 3kul_A          145 DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT  221 (325)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGS
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCccccc
Confidence            35789999999999999999999999   9999999999999999999999999999876543222   12223456799


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      |||.+.+..++.++|+||||+++|++++ |..||........     .......  ...+......    ..+.+++.+|
T Consensus       222 aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-----~~~~~~~--~~~~~~~~~~----~~l~~li~~~  290 (325)
T 3kul_A          222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----ISSVEEG--YRLPAPMGCP----HALHQLMLDC  290 (325)
T ss_dssp             CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-----HHHHHTT--CCCCCCTTCC----HHHHHHHHHH
T ss_pred             CHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-----HHHHHcC--CCCCCCCCcC----HHHHHHHHHH
Confidence            9999988889999999999999999998 9999965432110     0111111  1112122222    2488899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||.+|||++++++.|+
T Consensus       291 l~~dp~~Rps~~eil~~L~  309 (325)
T 3kul_A          291 WHKDRAQRPRFSQIVSVLD  309 (325)
T ss_dssp             TCSSGGGSCCHHHHHHHHH
T ss_pred             ccCChhhCcCHHHHHHHHH
Confidence            9999999999999999885

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.98  E-value=5.1e-32  Score=201.52  Aligned_cols=152  Identities=22%  Similarity=0.384  Sum_probs=123.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........ .....+++.|+|||
T Consensus       124 ~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE  199 (335)
T 3dls_A          124 HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL-FYTFCGTIEYCAPE  199 (335)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC-BCEECSCGGGCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc-eeccCCCccccChh
Confidence            34689999999999999999999999   999999999999999999999999999977654332 33456889999999


Q ss_pred             ccccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..+ +.++|+||||+++|++++|..||......              ...........    ..++.+++.+||+.
T Consensus       200 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------~~~~~~~~~~~----~~~l~~li~~~L~~  261 (335)
T 3dls_A          200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------VEAAIHPPYLV----SKELMSLVSGLLQP  261 (335)
T ss_dssp             HHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------TTTCCCCSSCC----CHHHHHHHHHHTCS
T ss_pred             hhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------HhhccCCCccc----CHHHHHHHHHHccC
Confidence            9988776 78999999999999999999999653211              11111111111    12478899999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 042876          163 SPESRPTMKIVSQQL  177 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l  177 (179)
                      ||.+|||+++++++-
T Consensus       262 dP~~Rps~~ell~hp  276 (335)
T 3dls_A          262 VPERRTTLEKLVTDP  276 (335)
T ss_dssp             SGGGSCCHHHHHHCT
T ss_pred             ChhhCcCHHHHhcCc
Confidence            999999999999873

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.98  E-value=2.4e-32  Score=204.86  Aligned_cols=166  Identities=22%  Similarity=0.291  Sum_probs=121.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-------------------------CCceeEccccC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-------------------------EYEAHVADFGI   59 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-------------------------~~~~~l~d~~~   59 (179)
                      ..+++.+++.++.||+.||.|||+.   +++||||||+||+++.                         ++.++|+|||+
T Consensus       132 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~  208 (360)
T 3llt_A          132 NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC  208 (360)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccC
Confidence            4589999999999999999999999   9999999999999975                         78899999999


Q ss_pred             ccccCCCCCCcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh-------hhh--
Q 042876           60 AKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD-------IEL--  130 (179)
Q Consensus        60 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~-------~~~--  130 (179)
                      +.......   ....+++.|+|||.+.+..++.++|+|||||++|+|++|..||..............       ...  
T Consensus       209 a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~  285 (360)
T 3llt_A          209 ATFKSDYH---GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYE  285 (360)
T ss_dssp             CEETTSCC---CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHH
T ss_pred             ceecCCCC---cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhh
Confidence            97654322   345678999999999998999999999999999999999999965432110000000       000  


Q ss_pred             ------hh-----cCCCCCCCCCccHHH--------------HHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          131 ------DE-----MLDPRLPAPSRSVQE--------------KLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       131 ------~~-----~~~~~~~~~~~~~~~--------------~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                            ..     .....++........              ....+.+|+.+||+.||.+|||++|+++|
T Consensus       286 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          286 ATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             hhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                  00     000001111110000              01347799999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.98  E-value=1.3e-31  Score=196.70  Aligned_cols=167  Identities=31%  Similarity=0.527  Sum_probs=129.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........  .....+++.|+||
T Consensus       128 ~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aP  204 (307)
T 2nru_A          128 PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAP  204 (307)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCCh
Confidence            4689999999999999999999999   9999999999999999999999999998765533221  2234678899999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh------hhhhhcCCCCCCCCCccHHHHHHHHHHHH
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD------IELDEMLDPRLPAPSRSVQEKLISIVKVA  156 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li  156 (179)
                      |.+.+ .++.++|+||||+++|++++|..||..............      ......+++.++.   ........+.+++
T Consensus       205 E~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li  280 (307)
T 2nru_A          205 EALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVA  280 (307)
T ss_dssp             HHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC---CCHHHHHHHHHHH
T ss_pred             HHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc---cchHHHHHHHHHH
Confidence            98865 578899999999999999999999976543221111100      0112223333322   2344556688999


Q ss_pred             hcccCcCCCCCCCHHHHHHHhh
Q 042876          157 FSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       157 ~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      .+||+.||.+|||+++++++|+
T Consensus       281 ~~cl~~~p~~Rps~~~l~~~L~  302 (307)
T 2nru_A          281 SQCLHEKKNKRPDIKKVQQLLQ  302 (307)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHH
T ss_pred             HHHcCCCcccCcCHHHHHHHHH
Confidence            9999999999999999999985

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.98  E-value=4.7e-32  Score=202.21  Aligned_cols=159  Identities=27%  Similarity=0.424  Sum_probs=117.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   81 (179)
                      .+.+++.+++.++.|++.||.|||+.   +++||||||+||+++ ++.++|+|||++.........  .....+++.|+|
T Consensus       102 ~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a  177 (343)
T 3dbq_A          102 KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP  177 (343)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCC
Confidence            35789999999999999999999999   999999999999997 678999999999776543321  234578999999


Q ss_pred             Cccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCC--CCccHHHH
Q 042876           82 PELAYT-----------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPA--PSRSVQEK  148 (179)
Q Consensus        82 pe~~~~-----------~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  148 (179)
                      ||.+.+           ..++.++|+||||+++|+|++|..||.....       ........+++....  ....    
T Consensus       178 PE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~----  246 (343)
T 3dbq_A          178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLHAIIDPNHEIEFPDIP----  246 (343)
T ss_dssp             HHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHHHHCTTSCCCCCCCS----
T ss_pred             HHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------HHHHHHHHhcCCcccCCcccC----
Confidence            999865           5678899999999999999999999964321       111112222111111  1111    


Q ss_pred             HHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          149 LISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       149 ~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      ..++.+++.+||+.||.+|||+.++++|-
T Consensus       247 ~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          247 EKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            12478899999999999999999999874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.98  E-value=6.7e-32  Score=200.27  Aligned_cols=157  Identities=23%  Similarity=0.297  Sum_probs=119.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++..............+++.|+|||.
T Consensus       116 ~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  192 (327)
T 3a62_A          116 GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI  192 (327)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhh
Confidence            4688999999999999999999999   9999999999999999999999999998765433333344578999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|+|++|..||.......        ....+.......+...    ...+.+++.+||+.||
T Consensus       193 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~~~~p~~~----~~~~~~li~~~L~~dp  260 (327)
T 3a62_A          193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--------TIDKILKCKLNLPPYL----TQEARDLLKKLLKRNA  260 (327)
T ss_dssp             HTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCCCCTTS----CHHHHHHHHHHSCSCG
T ss_pred             CcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCCCCCCC----CHHHHHHHHHHHhcCH
Confidence            988889999999999999999999999997543211        1111111111111111    2247889999999999


Q ss_pred             CCCC-----CHHHHHHH
Q 042876          165 ESRP-----TMKIVSQQ  176 (179)
Q Consensus       165 ~~Rp-----s~~~~~~~  176 (179)
                      .+||     ++.++++|
T Consensus       261 ~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          261 ASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             GGSTTSSTTTHHHHHHS
T ss_pred             hhccCCCCCCHHHHHcC
Confidence            9999     78888876

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.98  E-value=2.5e-32  Score=202.24  Aligned_cols=162  Identities=25%  Similarity=0.351  Sum_probs=123.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC--CCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~   81 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......  .......+++.|+|
T Consensus        99 ~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  175 (323)
T 3tki_A           99 DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA  175 (323)
T ss_dssp             TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccC
Confidence            34689999999999999999999999   99999999999999999999999999997653222  12234578899999


Q ss_pred             CcccccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..+ +.++|+||||+++|+|++|..||........    ........ ....+.    .......+.+++.+||
T Consensus       176 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~~~~~~-~~~~~~----~~~~~~~~~~li~~~L  246 (323)
T 3tki_A          176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----EYSDWKEK-KTYLNP----WKKIDSAPLALLHKIL  246 (323)
T ss_dssp             HHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH----HHHHHHTT-CTTSTT----GGGSCHHHHHHHHHHS
T ss_pred             cHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH----HHHHHhcc-cccCCc----cccCCHHHHHHHHHHc
Confidence            999987765 7789999999999999999999975432111    00011110 111111    1112234778999999


Q ss_pred             CcCCCCCCCHHHHHHHh
Q 042876          161 NESPESRPTMKIVSQQL  177 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l  177 (179)
                      +.||.+|||++|++++-
T Consensus       247 ~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          247 VENPSARITIPDIKKDR  263 (323)
T ss_dssp             CSSTTTSCCHHHHTTCT
T ss_pred             cCChhhCcCHHHHhhCh
Confidence            99999999999998864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.98  E-value=1.7e-32  Score=206.37  Aligned_cols=159  Identities=24%  Similarity=0.383  Sum_probs=122.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC---ceeEccccCccccCCCC--CCcccccCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY---EAHVADFGIAKFLKPDS--SNWTEFAGTYGY   79 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~---~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~   79 (179)
                      ..+++.+++.++.|++.||.|||+.   +++||||||+||+++.++   .++|+|||++.......  .......+++.|
T Consensus       176 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y  252 (367)
T 3l9p_A          176 SSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW  252 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGG
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccE
Confidence            4689999999999999999999999   999999999999998554   59999999997542211  122334567889


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCC-CCCCCCCccHHHHHHHHHHHHh
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLD-PRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      +|||.+.+..++.++|+|||||++|+|++ |..||.......        ....+.. ..........    ..+.+++.
T Consensus       253 ~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~----~~l~~li~  320 (367)
T 3l9p_A          253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--------VLEFVTSGGRMDPPKNCP----GPVYRIMT  320 (367)
T ss_dssp             CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHTTCCCCCCTTCC----HHHHHHHH
T ss_pred             ECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCCccCC----HHHHHHHH
Confidence            99999988899999999999999999998 999996543211        1111111 1111111222    23788999


Q ss_pred             cccCcCCCCCCCHHHHHHHhh
Q 042876          158 SCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +||+.||.+|||+++++++|+
T Consensus       321 ~~l~~dP~~Rps~~eil~~l~  341 (367)
T 3l9p_A          321 QCWQHQPEDRPNFAIILERIE  341 (367)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHHH
Confidence            999999999999999999985

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.98  E-value=2.7e-32  Score=201.02  Aligned_cols=155  Identities=23%  Similarity=0.243  Sum_probs=118.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++....... ......+++.|+|||
T Consensus       151 ~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE  226 (311)
T 3p1a_A          151 GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-AGEVQEGDPRYMAPE  226 (311)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-------CCCCCGGGCCGG
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC-CCcccCCCccccCHh
Confidence            34699999999999999999999999   99999999999999999999999999987665432 223456889999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+ .++.++|+||||++++++++|..|+.....           .........+.  .........+.+++.+||+.|
T Consensus       227 ~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~d  292 (311)
T 3p1a_A          227 LLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQGYLPP--EFTAGLSSELRSVLVMMLEPD  292 (311)
T ss_dssp             GGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHHTTTCCCH--HHHTTSCHHHHHHHHHHSCSS
T ss_pred             HhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHhccCCCc--ccccCCCHHHHHHHHHHcCCC
Confidence            8876 789999999999999999999666532211           11111111111  111112335889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |++|||+++++++
T Consensus       293 P~~Rpt~~ell~h  305 (311)
T 3p1a_A          293 PKLRATAEALLAL  305 (311)
T ss_dssp             TTTSCCHHHHHTS
T ss_pred             hhhCcCHHHHHhC
Confidence            9999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.98  E-value=3.1e-32  Score=203.70  Aligned_cols=162  Identities=23%  Similarity=0.308  Sum_probs=115.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC---CCceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL---EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.   ++.++|+|||++....... ......+++.|+
T Consensus       142 ~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~  217 (349)
T 2w4o_A          142 KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-LMKTVCGTPGYC  217 (349)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----------------CGGGS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-ccccccCCCCcc
Confidence            34689999999999999999999999   9999999999999975   7889999999987654322 223456789999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |||.+.+..++.++|+||||+++|++++|..||.......       .....+.................++.+++.+||
T Consensus       218 aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L  290 (349)
T 2w4o_A          218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-------FMFRRILNCEYYFISPWWDEVSLNAKDLVRKLI  290 (349)
T ss_dssp             CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-------HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTS
T ss_pred             CHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-------HHHHHHHhCCCccCCchhhhCCHHHHHHHHHHc
Confidence            9999998889999999999999999999999996433211       111111111111111111122334788999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.||++|||+.++++|
T Consensus       291 ~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          291 VLDPKKRLTTFQALQH  306 (349)
T ss_dssp             CSSGGGSCCHHHHHHS
T ss_pred             cCChhhCcCHHHHhcC
Confidence            9999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.98  E-value=2.5e-32  Score=202.83  Aligned_cols=174  Identities=22%  Similarity=0.356  Sum_probs=125.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC------CCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--------Cc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDC------FPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--------NW   70 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~------~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--------~~   70 (179)
                      ..+++..++.++.|++.||.|||+..      ..+++|+||||+||+++.++.++|+|||++........        ..
T Consensus       106 ~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~  185 (336)
T 3g2f_A          106 HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA  185 (336)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------
T ss_pred             cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCcccccccc
Confidence            34578899999999999999999862      12799999999999999999999999999976543211        12


Q ss_pred             ccccCCCCCCCCccccc-------CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh--------------hh
Q 042876           71 TEFAGTYGYVAPELAYT-------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD--------------IE  129 (179)
Q Consensus        71 ~~~~~~~~~~~pe~~~~-------~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~--------------~~  129 (179)
                      ....+++.|+|||.+.+       ..++.++|+||||+++|+|++|..||..............              ..
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (336)
T 3g2f_A          186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV  265 (336)
T ss_dssp             CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHH
T ss_pred             ccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhh
Confidence            23468899999999876       3456789999999999999999777643332221111100              01


Q ss_pred             hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ......+.++............+.++|.+||+.||++|||++++++.|+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          266 SREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             TTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             cccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            1111222333333333344556899999999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.98  E-value=2.6e-32  Score=197.11  Aligned_cols=161  Identities=25%  Similarity=0.387  Sum_probs=124.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~p   82 (179)
                      ...+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++........ ......+++.|+||
T Consensus       100 ~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP  176 (269)
T 4hcu_A          100 RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP  176 (269)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCH
T ss_pred             CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCH
Confidence            34689999999999999999999999   999999999999999999999999999976543211 12223456679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||+|++++++++ |..||........     ............+  ...    ...+.+++.+||+
T Consensus       177 E~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~--~~~----~~~~~~li~~~l~  245 (269)
T 4hcu_A          177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYKP--RLA----STHVYQIMNHCWR  245 (269)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HHHHHTTCCCCCC--TTS----CHHHHHHHHHHTC
T ss_pred             HHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-----HHHHhcCccCCCC--CcC----CHHHHHHHHHHcc
Confidence            99998899999999999999999999 9999965432110     0111111111111  111    2247889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+++++++|+
T Consensus       246 ~~p~~Rps~~~ll~~l~  262 (269)
T 4hcu_A          246 ERPEDRPAFSRLLRQLA  262 (269)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CCcccCcCHHHHHHHHH
Confidence            99999999999999985

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.98  E-value=5.3e-32  Score=196.62  Aligned_cols=160  Identities=22%  Similarity=0.344  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+......... .....+++.|+|||
T Consensus       108 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  184 (281)
T 3cc6_A          108 NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE  184 (281)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCch
Confidence            4689999999999999999999999   9999999999999999999999999999765543221 22345567899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||+++|++++ |..||.........     ......  ...+......    ..+.+++.+||+.
T Consensus       185 ~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~-----~~~~~~--~~~~~~~~~~----~~l~~li~~~l~~  253 (281)
T 3cc6_A          185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-----GVLEKG--DRLPKPDLCP----PVLYTLMTRCWDY  253 (281)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH-----HHHHHT--CCCCCCTTCC----HHHHHHHHHHTCS
T ss_pred             hhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH-----HHHhcC--CCCCCCCCCC----HHHHHHHHHHccC
Confidence            9988889999999999999999998 99999654322111     111111  1111111222    2378899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||++|||+++++++|+
T Consensus       254 ~p~~Rps~~ell~~L~  269 (281)
T 3cc6_A          254 DPSDRPRFTELVCSLS  269 (281)
T ss_dssp             SGGGSCCHHHHHHHHH
T ss_pred             CchhCcCHHHHHHHHH
Confidence            9999999999999885

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.98  E-value=7.2e-32  Score=216.58  Aligned_cols=157  Identities=24%  Similarity=0.340  Sum_probs=126.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.++|+|||++..............+++.|+|||.
T Consensus       437 ~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~  513 (674)
T 3pfq_A          437 GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI  513 (674)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhh
Confidence            4689999999999999999999999   9999999999999999999999999999865444444455689999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|+|++|..||...+.        ......+.......+...    ..++.+||.+||+.||
T Consensus       514 l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~----s~~~~~li~~lL~~dP  581 (674)
T 3pfq_A          514 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPKSM----SKEAVAICKGLMTKHP  581 (674)
T ss_dssp             HTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSSCCCCCTTS----CHHHHHHHHHHSCSSS
T ss_pred             hcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCCCCCCccC----CHHHHHHHHHHccCCH
Confidence            9999999999999999999999999999975432        111222222222211122    2347889999999999


Q ss_pred             CCCCCH-----HHHHHH
Q 042876          165 ESRPTM-----KIVSQQ  176 (179)
Q Consensus       165 ~~Rps~-----~~~~~~  176 (179)
                      .+||++     ++|++|
T Consensus       582 ~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          582 GKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             TTCTTCSTTHHHHHHSS
T ss_pred             HHCCCCCCCcHHHHhcC
Confidence            999997     788765

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.98  E-value=2e-32  Score=207.21  Aligned_cols=168  Identities=24%  Similarity=0.309  Sum_probs=125.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC----------------------------------
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY----------------------------------   50 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~----------------------------------   50 (179)
                      +.+++..++.++.||+.||.|||+++  +++||||||+||+++.++                                  
T Consensus       141 ~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (397)
T 1wak_A          141 QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG  218 (397)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccc
Confidence            56999999999999999999999963  899999999999998775                                  


Q ss_pred             ---------------ceeEccccCccccCCCCCCcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcc
Q 042876           51 ---------------EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDF  115 (179)
Q Consensus        51 ---------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~  115 (179)
                                     .++|+|||.+......   .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||..
T Consensus       219 ~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  295 (397)
T 1wak_A          219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEP  295 (397)
T ss_dssp             TTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCC
Confidence                           7999999999765432   2334678999999999998899999999999999999999999975


Q ss_pred             cccccccccchhh-hhhhc------------------CCC--------CCCC---------CCccHHHHHHHHHHHHhcc
Q 042876          116 LSSISSSSLNTDI-ELDEM------------------LDP--------RLPA---------PSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus       116 ~~~~~~~~~~~~~-~~~~~------------------~~~--------~~~~---------~~~~~~~~~~~~~~li~~c  159 (179)
                      ............. .....                  ...        ....         ...........+.+|+.+|
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  375 (397)
T 1wak_A          296 HSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPM  375 (397)
T ss_dssp             CCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGG
T ss_pred             CcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHH
Confidence            4432211000000 00000                  000        0000         0011244456788999999


Q ss_pred             cCcCCCCCCCHHHHHHHh
Q 042876          160 LNESPESRPTMKIVSQQL  177 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l  177 (179)
                      |+.||++|||++|+++|=
T Consensus       376 L~~dP~~Rpt~~e~l~hp  393 (397)
T 1wak_A          376 LELIPEKRATAAECLRHP  393 (397)
T ss_dssp             GCSSGGGSCCHHHHHTSG
T ss_pred             hccChhhcCCHHHHhhCc
Confidence            999999999999999873

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.98  E-value=3.2e-32  Score=199.00  Aligned_cols=167  Identities=22%  Similarity=0.344  Sum_probs=120.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.........   .....++..|+|
T Consensus       109 ~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  185 (295)
T 3ugc_A          109 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA  185 (295)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCC
T ss_pred             cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeC
Confidence            3589999999999999999999999   9999999999999999999999999999766433211   222345667999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccc-------cccccchh-hhhhhcC-CCCCCCCCccHHHHHHHH
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSI-------SSSSLNTD-IELDEML-DPRLPAPSRSVQEKLISI  152 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~-------~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~  152 (179)
                      ||.+.+..++.++|+||||+++|++++|..|+......       ........ ....... ..+.+......    ..+
T Consensus       186 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~l  261 (295)
T 3ugc_A          186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCP----DEI  261 (295)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCC----HHH
T ss_pred             cHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcC----HHH
Confidence            99999889999999999999999999999988543211       00000000 0111111 11222222222    248


Q ss_pred             HHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          153 VKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       153 ~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      .+++.+||+.||++|||++++++.|+
T Consensus       262 ~~li~~~l~~dp~~Rps~~el~~~L~  287 (295)
T 3ugc_A          262 YMIMTECWNNNVNQRPSFRDLALRVD  287 (295)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            88999999999999999999999885

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.98  E-value=2.2e-32  Score=202.45  Aligned_cols=174  Identities=23%  Similarity=0.364  Sum_probs=126.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC-------CCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDC-------FPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAG   75 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~-------~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~   75 (179)
                      +.+++.+++.++.|++.||.|||+..       ..+++|+||||+||+++.++.+||+|||++.........  .....+
T Consensus       116 ~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~g  195 (322)
T 3soc_A          116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG  195 (322)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCcc
Confidence            45899999999999999999999851       127999999999999999999999999999766543321  233568


Q ss_pred             CCCCCCCcccccC-----CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-------hhhhh-hhcCCCCC-CCC
Q 042876           76 TYGYVAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-------TDIEL-DEMLDPRL-PAP  141 (179)
Q Consensus        76 ~~~~~~pe~~~~~-----~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-------~~~~~-~~~~~~~~-~~~  141 (179)
                      ++.|+|||.+.+.     .++.++|+||||+++|+|++|..||............       ..... ........ +..
T Consensus       196 t~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (322)
T 3soc_A          196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVL  275 (322)
T ss_dssp             CGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCC
T ss_pred             CccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCc
Confidence            8999999998763     4566889999999999999999999754432211110       01111 11111111 111


Q ss_pred             Cc--cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          142 SR--SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       142 ~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ..  ........+.+++.+||+.||++|||++++++.|+
T Consensus       276 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  314 (322)
T 3soc_A          276 RDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT  314 (322)
T ss_dssp             CGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11  11223455889999999999999999999999885

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.98  E-value=6.6e-33  Score=204.05  Aligned_cols=160  Identities=23%  Similarity=0.382  Sum_probs=124.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++.........  .....+++.|++|
T Consensus       145 ~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  221 (314)
T 2ivs_A          145 RALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI  221 (314)
T ss_dssp             CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH
T ss_pred             cCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccCh
Confidence            3489999999999999999999999   9999999999999999999999999999766443221  2233556789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|+|++ |..||........     ........  ........    ...+.+++.+||+
T Consensus       222 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-----~~~~~~~~--~~~~~~~~----~~~~~~li~~~l~  290 (314)
T 2ivs_A          222 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL-----FNLLKTGH--RMERPDNC----SEEMYRLMLQCWK  290 (314)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----HHHHHTTC--CCCCCTTC----CHHHHHHHHHHTC
T ss_pred             hhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHhhcCC--cCCCCccC----CHHHHHHHHHHcc
Confidence            99988889999999999999999999 9999975432111     01111111  11111122    2248889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+++++++|+
T Consensus       291 ~dp~~Rps~~~l~~~l~  307 (314)
T 2ivs_A          291 QEPDKRPVFADISKDLE  307 (314)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHH
Confidence            99999999999999885

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.98  E-value=1.4e-32  Score=203.59  Aligned_cols=170  Identities=16%  Similarity=0.202  Sum_probs=118.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++..............+++.|+|||
T Consensus        94 ~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE  170 (324)
T 3mtl_A           94 GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPD  170 (324)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChh
Confidence            34689999999999999999999999   999999999999999999999999999976654443444557789999999


Q ss_pred             cccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccc----------------cchhhhhhhcCCCCCCCC--Ccc
Q 042876           84 LAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS----------------LNTDIELDEMLDPRLPAP--SRS  144 (179)
Q Consensus        84 ~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~--~~~  144 (179)
                      .+.+ ..++.++|+||+|+++|+|++|..||..........                ............+.....  ...
T Consensus       171 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (324)
T 3mtl_A          171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH  250 (324)
T ss_dssp             HHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHH
T ss_pred             hhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhh
Confidence            9876 567899999999999999999999997543211000                000000000000000000  000


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ......++.+|+.+||+.||.+|||++|+++|
T Consensus       251 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          251 APRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            01112347889999999999999999999886

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.98  E-value=3.4e-32  Score=202.50  Aligned_cols=170  Identities=24%  Similarity=0.309  Sum_probs=124.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC----Cccc
Q 042876            5 QELDWSQRMNTIKGVADALSYLH--------HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS----NWTE   72 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh--------~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~   72 (179)
                      ..+++.+++.++.|++.||.|||        +.   +++|+||||+||+++.++.++|+|||++........    ....
T Consensus       134 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~  210 (342)
T 1b6c_B          134 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH  210 (342)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCS
T ss_pred             cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCceecccccccccccccc
Confidence            36889999999999999999999        77   999999999999999999999999999976554332    1233


Q ss_pred             ccCCCCCCCCcccccCC------CCcchhhHHHHHHHHHHHhC----------CCCCccccccccccc-chhhhhhhcCC
Q 042876           73 FAGTYGYVAPELAYTMK------ITEKCDVYSFGVLALEVIKG----------KHPRDFLSSISSSSL-NTDIELDEMLD  135 (179)
Q Consensus        73 ~~~~~~~~~pe~~~~~~------~~~~~D~~slg~~~~~l~~~----------~~p~~~~~~~~~~~~-~~~~~~~~~~~  135 (179)
                      ..+++.|+|||.+.+..      ++.++|+||||+++|+|++|          ..||........... ...........
T Consensus       211 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  290 (342)
T 1b6c_B          211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR  290 (342)
T ss_dssp             CCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC
T ss_pred             CCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhC
Confidence            46888999999987652      33689999999999999999          667654322111110 00111111122


Q ss_pred             CCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +.++... ........+.+++.+||+.||++|||+.+++++|+
T Consensus       291 ~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          291 PNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             CCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             CCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            2222111 12244556889999999999999999999999985

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.98  E-value=2.3e-32  Score=199.95  Aligned_cols=163  Identities=25%  Similarity=0.360  Sum_probs=120.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      .++++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++++|||++......... .....+++.|+|||
T Consensus       106 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE  182 (294)
T 4eqm_A          106 GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE  182 (294)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHh
Confidence            4689999999999999999999999   9999999999999999999999999999766543221 23356889999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCC-CccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAP-SRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||+++|++++|..||........        ....+....+.. ..........+.+++.+||+.
T Consensus       183 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  254 (294)
T 4eqm_A          183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--------AIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEK  254 (294)
T ss_dssp             HHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--------HHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCS
T ss_pred             HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--------HHHHhhccCCCcchhcccCCCHHHHHHHHHHhcC
Confidence            99998899999999999999999999999975432110        011111111110 000011123478899999999


Q ss_pred             CCCCCC-CHHHHHHHhh
Q 042876          163 SPESRP-TMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rp-s~~~~~~~l~  178 (179)
                      ||.+|| +++++.+.|+
T Consensus       255 dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          255 DKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             SGGGSCSSHHHHHHHHH
T ss_pred             CHhHccccHHHHHHHHH
Confidence            999998 8888888764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.98  E-value=3.6e-32  Score=201.73  Aligned_cols=158  Identities=22%  Similarity=0.300  Sum_probs=107.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC--cccCCCCCCCeeecCCCceeEccccCccccCCCCCC------------
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPP--IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN------------   69 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~------------   69 (179)
                      ...+++.+++.++.||+.||.|||+.   +  ++|+||||+||+++.++.++|+|||++.........            
T Consensus       130 ~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  206 (337)
T 3ll6_A          130 RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE  206 (337)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC--------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchh
Confidence            35699999999999999999999998   8  999999999999999999999999999776543221            


Q ss_pred             cccccCCCCCCCCccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHH
Q 042876           70 WTEFAGTYGYVAPELA---YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQ  146 (179)
Q Consensus        70 ~~~~~~~~~~~~pe~~---~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (179)
                      .....+++.|++||.+   .+..++.++|+||||+++|++++|..||........        .....  ..+...... 
T Consensus       207 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--------~~~~~--~~~~~~~~~-  275 (337)
T 3ll6_A          207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--------VNGKY--SIPPHDTQY-  275 (337)
T ss_dssp             -----------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------------C--CCCTTCCSS-
T ss_pred             hccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--------hcCcc--cCCcccccc-
Confidence            1134578899999988   456688999999999999999999999965432110        00001  011111111 


Q ss_pred             HHHHHHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          147 EKLISIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       147 ~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                         ..+.+++.+||+.||.+|||+++++++|+
T Consensus       276 ---~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          276 ---TVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ---GGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             ---hHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence               12778899999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=3.6e-32  Score=203.04  Aligned_cols=171  Identities=22%  Similarity=0.213  Sum_probs=125.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++.+++.++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++..............+++.|+|||
T Consensus       106 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE  182 (346)
T 1ua2_A          106 SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE  182 (346)
T ss_dssp             CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHH
T ss_pred             CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCch
Confidence            34689999999999999999999999   999999999999999999999999999987654444444567889999999


Q ss_pred             ccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhh-------------hhhhcCC-CCCCCCC--ccHH
Q 042876           84 LAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDI-------------ELDEMLD-PRLPAPS--RSVQ  146 (179)
Q Consensus        84 ~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~-------------~~~~~~~-~~~~~~~--~~~~  146 (179)
                      .+.+. .++.++|+||||+++|+|++|..||...............             .....+. ...+...  ....
T Consensus       183 ~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (346)
T 1ua2_A          183 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS  262 (346)
T ss_dssp             HHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCT
T ss_pred             HhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhc
Confidence            98654 4788999999999999999999998654321100000000             0000000 0000000  0001


Q ss_pred             HHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          147 EKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       147 ~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      ....++.+++.+||+.||.+|||++|+++|-
T Consensus       263 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          263 AAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             TCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             cCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            1123588999999999999999999999874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.98  E-value=2.8e-32  Score=206.45  Aligned_cols=161  Identities=19%  Similarity=0.273  Sum_probs=123.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC--CCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL--EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.||+.||+|||+.   +++|+||||+||+++.  ++.++|+|||++....... ......+++.|+||
T Consensus       144 ~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y~aP  219 (387)
T 1kob_A          144 YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-IVKVTTATAEFAAP  219 (387)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-CEEEECSSGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc-ceeeeccCCCccCc
Confidence            4689999999999999999999999   9999999999999974  4679999999998765433 22345688999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |.+.+..++.++|+||||+++|+|++|..||.......        ....+.................++.++|.+||+.
T Consensus       220 E~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  291 (387)
T 1kob_A          220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK  291 (387)
T ss_dssp             HHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCS
T ss_pred             hhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCC
Confidence            99998889999999999999999999999997543211        1111110111111111111223478899999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 042876          163 SPESRPTMKIVSQQL  177 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l  177 (179)
                      ||.+|||++++++|-
T Consensus       292 dP~~Rpt~~ell~hp  306 (387)
T 1kob_A          292 EPRKRLTVHDALEHP  306 (387)
T ss_dssp             SGGGSCCHHHHHTST
T ss_pred             ChhHCcCHHHHhhCc
Confidence            999999999999873

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.98  E-value=4.6e-32  Score=205.55  Aligned_cols=158  Identities=27%  Similarity=0.417  Sum_probs=118.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.||+.||.|||+.   +++||||||+||+++ ++.+||+|||++........  ......+++.|+||
T Consensus       150 ~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP  225 (390)
T 2zmd_A          150 KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP  225 (390)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccCh
Confidence            4688999999999999999999999   999999999999996 57899999999987654322  12345789999999


Q ss_pred             ccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCC--CCccHHHHH
Q 042876           83 ELAYT-----------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPA--PSRSVQEKL  149 (179)
Q Consensus        83 e~~~~-----------~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  149 (179)
                      |.+.+           ..++.++|+|||||++|+|++|..||.....       ........+++....  ....    .
T Consensus       226 E~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~----~  294 (390)
T 2zmd_A          226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLHAIIDPNHEIEFPDIP----E  294 (390)
T ss_dssp             HHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHHHCTTSCCCCCCCS----C
T ss_pred             HHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHHHHHHHhCccccCCCCccc----h
Confidence            99865           3578899999999999999999999964321       111122222221111  1111    1


Q ss_pred             HHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          150 ISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       150 ~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      .++.++|.+||+.||.+|||++++++|-
T Consensus       295 ~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          295 KDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence            2478899999999999999999999863

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.98  E-value=1.4e-32  Score=202.54  Aligned_cols=160  Identities=25%  Similarity=0.366  Sum_probs=124.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCCc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAPE   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe   83 (179)
                      .+++.+++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||++.........  .....+++.|+|||
T Consensus       144 ~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  220 (316)
T 2xir_A          144 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  220 (316)
T ss_dssp             CEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCch
Confidence            389999999999999999999999   9999999999999999999999999999766543321  22345677899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||+++|++++ |..||........    .............+  ....    ..+.+++.+||+.
T Consensus       221 ~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~----~~~~~~~~~~~~~~--~~~~----~~l~~li~~~l~~  290 (316)
T 2xir_A          221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLKEGTRMRAP--DYTT----PEMYQTMLDCWHG  290 (316)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH----HHHHHHHTCCCCCC--TTCC----HHHHHHHHHHTCS
T ss_pred             hhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH----HHHHhccCccCCCC--CCCC----HHHHHHHHHHcCC
Confidence            9988889999999999999999998 9999965432110    00111111111111  1122    2378899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||.+|||+.+++++|+
T Consensus       291 dp~~Rps~~ell~~L~  306 (316)
T 2xir_A          291 EPSQRPTFSELVEHLG  306 (316)
T ss_dssp             SGGGSCCHHHHHHHHH
T ss_pred             ChhhCcCHHHHHHHHH
Confidence            9999999999999985

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=2e-32  Score=207.27  Aligned_cols=169  Identities=21%  Similarity=0.271  Sum_probs=120.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCC------------------
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD------------------   66 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~------------------   66 (179)
                      +.+++..+..++.|++.||+|||+.   |++||||||+||+++.++.++|+|||++......                  
T Consensus       104 ~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~  180 (388)
T 3oz6_A          104 NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF  180 (388)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccc
Confidence            4688999999999999999999999   9999999999999999999999999999765321                  


Q ss_pred             ---CCCcccccCCCCCCCCccccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-------hh-------
Q 042876           67 ---SSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-------DI-------  128 (179)
Q Consensus        67 ---~~~~~~~~~~~~~~~pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-------~~-------  128 (179)
                         ........+++.|+|||.+.+ ..++.++|+||+||++++|++|..||.+...........       ..       
T Consensus       181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~  260 (388)
T 3oz6_A          181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQS  260 (388)
T ss_dssp             ---------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCC
T ss_pred             ccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccC
Confidence               111233578899999999876 578999999999999999999999997543211000000       00       


Q ss_pred             --------hhhhcC---CCCCCCCCccHH----------HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          129 --------ELDEML---DPRLPAPSRSVQ----------EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       129 --------~~~~~~---~~~~~~~~~~~~----------~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                              ......   ..........+.          ....++.+|+.+||+.||.+|||++|+++|
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          261 PFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             SSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence                    000000   000000000000          112347899999999999999999999987

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=3.9e-32  Score=204.81  Aligned_cols=160  Identities=21%  Similarity=0.237  Sum_probs=124.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee--cCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL--DLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.||+.||.|||+.   +++|+||||+||++  +.++.++|+|||++........ .....+++.|+||
T Consensus       182 ~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~gt~~y~aP  257 (373)
T 2x4f_A          182 YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNFGTPEFLAP  257 (373)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-CCCCCSSCTTCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-cccccCCCcEeCh
Confidence            4589999999999999999999999   99999999999999  5667899999999987654332 2334688999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |.+.+..++.++|+||||+++|+|++|..||.......        ....+..................+.+||.+||+.
T Consensus       258 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~  329 (373)
T 2x4f_A          258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--------TLNNILACRWDLEDEEFQDISEEAKEFISKLLIK  329 (373)
T ss_dssp             HHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCS
T ss_pred             hhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhccCCCChhhhccCCHHHHHHHHHHcCC
Confidence            99988889999999999999999999999996543211        1111111111111111222233588899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 042876          163 SPESRPTMKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rps~~~~~~~  176 (179)
                      ||.+|||+.++++|
T Consensus       330 dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          330 EKSWRISASEALKH  343 (373)
T ss_dssp             SGGGSCCHHHHHHS
T ss_pred             ChhhCCCHHHHhcC
Confidence            99999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.97  E-value=5e-32  Score=207.62  Aligned_cols=107  Identities=22%  Similarity=0.309  Sum_probs=95.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc--eeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE--AHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.||+.||+|||+.   +++||||||+||+++.++.  ++|+|||++.......   ....+++.|+||
T Consensus       195 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~---~~~~gt~~y~aP  268 (429)
T 3kvw_A          195 QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTYIQSRFYRAP  268 (429)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCC---CSSCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCCcc---cccCCCCCccCh
Confidence            4589999999999999999999999   9999999999999998887  9999999996644322   335778899999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLS  117 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~  117 (179)
                      |.+.+..++.++|+|||||++|+|++|..||....
T Consensus       269 E~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          269 EVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             HHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999899999999999999999999999996543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=1.9e-32  Score=206.77  Aligned_cols=160  Identities=23%  Similarity=0.376  Sum_probs=123.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|+++||+|||+.   +++||||+|+||+++.++.+||+|||++.........  .....+++.|+||
T Consensus       208 ~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aP  284 (377)
T 3cbl_A          208 ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP  284 (377)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCH
Confidence            3589999999999999999999999   9999999999999999999999999998754322111  1112346679999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||........     ......  ..+.+.+..+..    .+.++|.+||+
T Consensus       285 E~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-----~~~~~~--~~~~~~~~~~~~----~l~~li~~cl~  353 (377)
T 3cbl_A          285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-----REFVEK--GGRLPCPELCPD----AVFRLMEQCWA  353 (377)
T ss_dssp             HHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-----HHHHHT--TCCCCCCTTCCH----HHHHHHHHHTC
T ss_pred             hHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHc--CCCCCCCCCCCH----HHHHHHHHHcC
Confidence            99988889999999999999999998 9999975432111     001111  112222222222    47889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++|||++++++.|+
T Consensus       354 ~dP~~Rps~~~i~~~L~  370 (377)
T 3cbl_A          354 YEPGQRPSFSTIYQELQ  370 (377)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CCchhCcCHHHHHHHHH
Confidence            99999999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.97  E-value=8.5e-32  Score=202.90  Aligned_cols=157  Identities=24%  Similarity=0.274  Sum_probs=122.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++..++.++.||+.||+|||+.   +++||||||+||+++.++.++|+|||++..............+++.|+|||.
T Consensus       134 ~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~  210 (373)
T 2r5t_A          134 RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV  210 (373)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHH
Confidence            4688999999999999999999999   9999999999999999999999999999765443333455678999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|+|++|..||...+...        ....+...........    ...+.++|.+||+.||
T Consensus       211 ~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~----~~~~~~li~~lL~~dp  278 (373)
T 2r5t_A          211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--------MYDNILNKPLQLKPNI----TNSARHLLEGLLQKDR  278 (373)
T ss_dssp             HTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH--------HHHHHHHSCCCCCSSS----CHHHHHHHHHHTCSSG
T ss_pred             hCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHhcccCCCCCC----CHHHHHHHHHHcccCH
Confidence            999899999999999999999999999996543211        1111111111111111    1237889999999999


Q ss_pred             CCCCCH----HHHHHH
Q 042876          165 ESRPTM----KIVSQQ  176 (179)
Q Consensus       165 ~~Rps~----~~~~~~  176 (179)
                      .+||++    .++++|
T Consensus       279 ~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          279 TKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             GGSTTTTTTHHHHHTS
T ss_pred             HhCCCCCCCHHHHhCC
Confidence            999987    455544

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.3e-31  Score=194.50  Aligned_cols=161  Identities=27%  Similarity=0.410  Sum_probs=122.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC----CCcccccCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----SNWTEFAGTYGY   79 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~   79 (179)
                      ...+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.++++|||++.......    .......+++.|
T Consensus       118 ~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y  194 (298)
T 3pls_A          118 QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKW  194 (298)
T ss_dssp             TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccc
Confidence            45789999999999999999999999   99999999999999999999999999997553321    112334567889


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHhCCCC-CcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-RDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      ++||.+.+..++.++|+||||+++|++++|..| |.......     .........  ..+......    ..+.+++.+
T Consensus       195 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-----~~~~~~~~~--~~~~~~~~~----~~l~~li~~  263 (298)
T 3pls_A          195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-----LTHFLAQGR--RLPQPEYCP----DSLYQVMQQ  263 (298)
T ss_dssp             SCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-----HHHHHHTTC--CCCCCTTCC----HHHHHHHHH
T ss_pred             cChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-----HHHHhhcCC--CCCCCccch----HHHHHHHHH
Confidence            999999988999999999999999999996555 43222111     011111111  111111222    247889999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||+.||.+|||++++++.|+
T Consensus       264 ~l~~~p~~Rps~~~ll~~l~  283 (298)
T 3pls_A          264 CWEADPAVRPTFRVLVGEVE  283 (298)
T ss_dssp             HTCSSGGGSCCHHHHHHHHH
T ss_pred             HccCChhhCcCHHHHHHHHH
Confidence            99999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.97  E-value=1e-31  Score=198.64  Aligned_cols=155  Identities=26%  Similarity=0.354  Sum_probs=123.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++......   .....+++.|+|||
T Consensus       100 ~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---~~~~~gt~~y~aPE  173 (318)
T 1fot_A          100 SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPE  173 (318)
T ss_dssp             TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc---cccccCCccccCHh
Confidence            35689999999999999999999999   9999999999999999999999999999765432   23357889999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||||+++|+|++|..||...+...        ....+.......+...    ..++.+++.+||..|
T Consensus       174 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~p~~~----~~~~~~li~~lL~~d  241 (318)
T 1fot_A          174 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAELRFPPFF----NEDVKDLLSRLITRD  241 (318)
T ss_dssp             HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHCCCCCCTTS----CHHHHHHHHHHTCSC
T ss_pred             HhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCCCC----CHHHHHHHHHHhccC
Confidence            9998889999999999999999999999996543211        1111111111111111    124788999999999


Q ss_pred             CCCCC-----CHHHHHHH
Q 042876          164 PESRP-----TMKIVSQQ  176 (179)
Q Consensus       164 p~~Rp-----s~~~~~~~  176 (179)
                      |.+||     +++++++|
T Consensus       242 p~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          242 LSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             TTTCTTSSTTTTHHHHTS
T ss_pred             HHHcCCCcCCCHHHHhcC
Confidence            99999     89999876

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=3.7e-32  Score=202.38  Aligned_cols=159  Identities=21%  Similarity=0.383  Sum_probs=123.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.||++||.|||+.   +++|+||||+||+++.++.++|+|||++........  ......+++.|+||
T Consensus       169 ~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  245 (343)
T 1luf_A          169 PPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  245 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence            6799999999999999999999999   999999999999999999999999999876543221  12234567889999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCC-CCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLP-APSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |.+.+..++.++|+||||+++|++++ |..||.......        ....+.....+ .....    ...+.+++.+||
T Consensus       246 E~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~----~~~l~~li~~~l  313 (343)
T 1luf_A          246 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--------VIYYVRDGNILACPENC----PLELYNLMRLCW  313 (343)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHTTCCCCCCTTC----CHHHHHHHHHHT
T ss_pred             hhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH--------HHHHHhCCCcCCCCCCC----CHHHHHHHHHHc
Confidence            99988889999999999999999998 999996543211        11111111111 11122    224888999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||.+|||+.+++++|+
T Consensus       314 ~~~p~~Rps~~~~~~~L~  331 (343)
T 1luf_A          314 SKLPADRPSFCSIHRILQ  331 (343)
T ss_dssp             CSSGGGSCCHHHHHHHHH
T ss_pred             ccCcccCCCHHHHHHHHH
Confidence            999999999999999885

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=1.2e-32  Score=204.39  Aligned_cols=162  Identities=23%  Similarity=0.335  Sum_probs=124.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   81 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.........  .....+++.|+|
T Consensus       158 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  234 (333)
T 2i1m_A          158 NSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA  234 (333)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSC
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccC
Confidence            34689999999999999999999999   9999999999999999999999999999765433221  223345678999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..++.++|+||||+++|+|++ |..||........    .............+.  ..    ...+.+++.+||
T Consensus       235 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~--~~----~~~l~~li~~~l  304 (333)
T 2i1m_A          235 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK----FYKLVKDGYQMAQPA--FA----PKNIYSIMQACW  304 (333)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH----HHHHHHHTCCCCCCT--TC----CHHHHHHHHHHT
T ss_pred             HHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH----HHHHHhcCCCCCCCC--CC----CHHHHHHHHHHh
Confidence            999988889999999999999999998 8999875432110    001111111111111  11    224788999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||.+|||+++++++|+
T Consensus       305 ~~~p~~Rps~~~l~~~L~  322 (333)
T 2i1m_A          305 ALEPTHRPTFQQICSFLQ  322 (333)
T ss_dssp             CSSGGGSCCHHHHHHHHH
T ss_pred             ccChhhCcCHHHHHHHHH
Confidence            999999999999999885

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=9.3e-33  Score=208.45  Aligned_cols=147  Identities=17%  Similarity=0.146  Sum_probs=114.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY   86 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   86 (179)
                      +++..++.++.||+.||+|||+.   +++||||||+||+++.++.+||+|||++.....   ......+ +.|+|||.+.
T Consensus       203 l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~  275 (377)
T 3byv_A          203 LVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEA  275 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHH
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhc
Confidence            44578889999999999999999   999999999999999999999999999975432   2233456 8999999998


Q ss_pred             cC-----------CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHH
Q 042876           87 TM-----------KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKV  155 (179)
Q Consensus        87 ~~-----------~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  155 (179)
                      +.           .++.++|+||||+++|+|++|..||...........        ... ..+   ..    ..++.++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~--------~~~-~~~---~~----~~~~~~l  339 (377)
T 3byv_A          276 RRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW--------IFR-SCK---NI----PQPVRAL  339 (377)
T ss_dssp             HHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGG--------GGS-SCC---CC----CHHHHHH
T ss_pred             ccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhh--------hhh-hcc---CC----CHHHHHH
Confidence            87           789999999999999999999999965432221111        010 111   11    1247889


Q ss_pred             HhcccCcCCCCCCCHHHHHHH
Q 042876          156 AFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       156 i~~cl~~~p~~Rps~~~~~~~  176 (179)
                      |.+||+.||++|||+.++++|
T Consensus       340 i~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          340 LEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHcCCCchhCCCHHHHhhC
Confidence            999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=4.6e-32  Score=197.02  Aligned_cols=161  Identities=25%  Similarity=0.448  Sum_probs=124.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~p   82 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+........ ......+++.|++|
T Consensus       114 ~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP  190 (283)
T 3gen_A          114 RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP  190 (283)
T ss_dssp             GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCH
Confidence            35689999999999999999999999   999999999999999999999999999976543211 11223456779999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||+|+++|++++ |..||.......     .............+  ....    ..+.+++.+||+
T Consensus       191 E~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~~~~~~~~~--~~~~----~~l~~li~~~l~  259 (283)
T 3gen_A          191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHIAQGLRLYRP--HLAS----EKVYTIMYSCWH  259 (283)
T ss_dssp             HHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHHTTCCCCCC--TTCC----HHHHHHHHHTTC
T ss_pred             HHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-----HHHHHhcccCCCCC--CcCC----HHHHHHHHHHcc
Confidence            99998889999999999999999998 999997543211     11111111111111  1111    247889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+++++++|+
T Consensus       260 ~~p~~Rps~~~ll~~L~  276 (283)
T 3gen_A          260 EKADERPTFKILLSNIL  276 (283)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CChhHCcCHHHHHHHHH
Confidence            99999999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=1.3e-31  Score=206.45  Aligned_cols=156  Identities=26%  Similarity=0.395  Sum_probs=122.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      .+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++.......   ....+++.|+|||.+
T Consensus       285 ~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~y~aPE~~  358 (450)
T 1k9a_A          285 VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEAL  358 (450)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---cCCCCCcceeCHHHh
Confidence            478999999999999999999999   99999999999999999999999999997543322   223567889999999


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           86 YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      .+..++.++|+||||+++|++++ |..||........     ........  +.+.+..+..    .+.++|.+||+.||
T Consensus       359 ~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-----~~~i~~~~--~~~~p~~~~~----~l~~li~~cl~~dp  427 (450)
T 1k9a_A          359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGY--KMDAPDGCPP----AVYDVMKNCWHLDA  427 (450)
T ss_dssp             HSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-----HHHHHTTC--CCCCCTTCCH----HHHHHHHHHTCSSG
T ss_pred             cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHcCC--CCCCCCcCCH----HHHHHHHHHcCCCh
Confidence            98899999999999999999998 9999976532211     11111111  1222222222    48889999999999


Q ss_pred             CCCCCHHHHHHHhh
Q 042876          165 ESRPTMKIVSQQLR  178 (179)
Q Consensus       165 ~~Rps~~~~~~~l~  178 (179)
                      .+|||+.++++.|+
T Consensus       428 ~~Rpt~~~l~~~L~  441 (450)
T 1k9a_A          428 ATRPTFLQLREQLE  441 (450)
T ss_dssp             GGSCCHHHHHHHHH
T ss_pred             hHCcCHHHHHHHHH
Confidence            99999999998875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=8.8e-33  Score=203.29  Aligned_cols=170  Identities=19%  Similarity=0.286  Sum_probs=119.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+..............++..|+|||
T Consensus        96 ~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE  172 (311)
T 4agu_A           96 QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPE  172 (311)
T ss_dssp             SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHH
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChH
Confidence            45689999999999999999999999   999999999999999999999999999987664443344557888999999


Q ss_pred             cccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh------------hhhhhc-CCCCCCCCCc------
Q 042876           84 LAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD------------IELDEM-LDPRLPAPSR------  143 (179)
Q Consensus        84 ~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~------------~~~~~~-~~~~~~~~~~------  143 (179)
                      .+.+ ..++.++|+||+|++++++++|..||..............            ...... .....+....      
T Consensus       173 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (311)
T 4agu_A          173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLEL  252 (311)
T ss_dssp             HHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHH
T ss_pred             HHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhh
Confidence            9876 5678999999999999999999999975432211000000            000000 0001111000      


Q ss_pred             cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          144 SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       144 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ........+.+++.+||+.||.+|||++++++|
T Consensus       253 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          253 KFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             hcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            001123347889999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=7.9e-32  Score=203.16  Aligned_cols=161  Identities=27%  Similarity=0.381  Sum_probs=115.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC----cccccCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN----WTEFAGTYGY   79 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~   79 (179)
                      ...+++.+++.++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++.........    .....+++.|
T Consensus       186 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y  262 (373)
T 3c1x_A          186 THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW  262 (373)
T ss_dssp             TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccc
Confidence            35688999999999999999999999   9999999999999999999999999999765432211    1223556789


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      ++||.+.+..++.++|+||||+++|++++ |..||.........     ......  .+...+....    ..+.+++.+
T Consensus       263 ~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~-----~~~~~~--~~~~~p~~~~----~~l~~li~~  331 (373)
T 3c1x_A          263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-----VYLLQG--RRLLQPEYCP----DPLYEVMLK  331 (373)
T ss_dssp             SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH-----HHHHTT--CCCCCCTTCC----HHHHHHHHH
T ss_pred             cChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH-----HHHHcC--CCCCCCCCCC----HHHHHHHHH
Confidence            99999998899999999999999999999 67777654322111     111111  1111111222    247889999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||+.||++|||+++++++|+
T Consensus       332 cl~~dp~~RPs~~ell~~L~  351 (373)
T 3c1x_A          332 CWHPKAEMRPSFSELVSRIS  351 (373)
T ss_dssp             HTCSSGGGSCCHHHHHHHHH
T ss_pred             HcCCChhhCcCHHHHHHHHH
Confidence            99999999999999999885

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=9.8e-32  Score=195.80  Aligned_cols=161  Identities=25%  Similarity=0.357  Sum_probs=125.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~   80 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........   .....+++.|+
T Consensus       104 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  180 (287)
T 1u59_A          104 REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY  180 (287)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGC
T ss_pred             CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccccccccccc
Confidence            45689999999999999999999999   9999999999999999999999999999876543221   12234567899


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      |||.+.+..++.++|+||||+++|++++ |..||........     ............+  ...    ...+.+++.+|
T Consensus       181 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~~i~~~~~~~~~--~~~----~~~l~~li~~~  249 (287)
T 1u59_A          181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-----MAFIEQGKRMECP--PEC----PPELYALMSDC  249 (287)
T ss_dssp             CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-----HHHHHTTCCCCCC--TTC----CHHHHHHHHHT
T ss_pred             CHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-----HHHHhcCCcCCCC--CCc----CHHHHHHHHHH
Confidence            9999988888999999999999999998 9999965432110     0111111111111  122    22488899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||.+|||+.+++++|+
T Consensus       250 l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          250 WIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             TCSSGGGSCCHHHHHHHHH
T ss_pred             cCCChhhCcCHHHHHHHHH
Confidence            9999999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.97  E-value=9.1e-32  Score=207.68  Aligned_cols=103  Identities=28%  Similarity=0.379  Sum_probs=86.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---------------
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---------------   68 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------------   68 (179)
                      ...+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||++........               
T Consensus       150 ~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~  226 (458)
T 3rp9_A          150 PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN  226 (458)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccc
Confidence            35689999999999999999999999   999999999999999999999999999976542211               


Q ss_pred             ------------CcccccCCCCCCCCccc-ccCCCCcchhhHHHHHHHHHHHhC
Q 042876           69 ------------NWTEFAGTYGYVAPELA-YTMKITEKCDVYSFGVLALEVIKG  109 (179)
Q Consensus        69 ------------~~~~~~~~~~~~~pe~~-~~~~~~~~~D~~slg~~~~~l~~~  109 (179)
                                  ......+++.|+|||.+ .+..++.++|+|||||++|+|++|
T Consensus       227 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             ------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence                        12334678999999975 456789999999999999999984

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=1.1e-31  Score=202.29  Aligned_cols=168  Identities=23%  Similarity=0.251  Sum_probs=117.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++....... ......+++.|+|||.
T Consensus       122 ~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~  197 (371)
T 2xrw_A          122 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEV  197 (371)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----------------CTTCCHHH
T ss_pred             hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccccc-ccCCceecCCccCHHH
Confidence            3588999999999999999999999   99999999999999999999999999997654322 2233567889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc--------------hhhhhh---------------hcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN--------------TDIELD---------------EMLD  135 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~--------------~~~~~~---------------~~~~  135 (179)
                      +.+..++.++|+||||+++|+|++|..||............              ......               ....
T Consensus       198 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (371)
T 2xrw_A          198 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP  277 (371)
T ss_dssp             HTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSC
T ss_pred             hcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcc
Confidence            99888999999999999999999999999754321100000              000000               0000


Q ss_pred             C-CCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          136 P-RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       136 ~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      . ..+...........++.+|+.+||..||.+|||++++++|
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          278 DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             GGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            0 0111111222335568899999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=1e-31  Score=196.21  Aligned_cols=157  Identities=23%  Similarity=0.367  Sum_probs=125.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+..............+++.|++||.
T Consensus       110 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  186 (294)
T 2rku_A          110 KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV  186 (294)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcch
Confidence            4689999999999999999999999   9999999999999999999999999999876544433444578889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||++++++++|..||.......        .................    ..+.+++.+||+.||
T Consensus       187 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~li~~~l~~~p  254 (294)
T 2rku_A          187 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDP  254 (294)
T ss_dssp             HTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCCCCCTTSC----HHHHHHHHHHTCSSG
T ss_pred             hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhhccCCCccccC----HHHHHHHHHHcccCh
Confidence            988889999999999999999999999996543211        11111111111111111    237889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      ++|||+++++++
T Consensus       255 ~~Rps~~~ll~~  266 (294)
T 2rku_A          255 TARPTINELLND  266 (294)
T ss_dssp             GGSCCGGGGGGS
T ss_pred             hhCcCHHHHhhC
Confidence            999999999876

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.97  E-value=1.7e-31  Score=201.78  Aligned_cols=160  Identities=29%  Similarity=0.395  Sum_probs=123.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.||+.||.|||+.   |++||||||+||+++.++.++|+|||++....... ......+++.|+|||
T Consensus       109 ~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~gt~~Y~aPE  184 (384)
T 4fr4_A          109 NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-QITTMAGTKPYMAPE  184 (384)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-CBCCCCSCGGGCCGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC-ceeccCCCccccCCe
Confidence            35789999999999999999999999   99999999999999999999999999998665332 234467899999999


Q ss_pred             cccc---CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           84 LAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        84 ~~~~---~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      .+.+   ..++.++|+|||||++|+|++|..||................   ......+.  ..    ...+.++|.+||
T Consensus       185 ~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~~~~~~p~--~~----s~~~~~li~~lL  255 (384)
T 4fr4_A          185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---TTVVTYPS--AW----SQEMVSLLKKLL  255 (384)
T ss_dssp             GTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---HCCCCCCT--TS----CHHHHHHHHHHS
T ss_pred             eeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---hcccCCCC--cC----CHHHHHHHHHHh
Confidence            9864   357889999999999999999999997543222111111111   11111111  11    224788999999


Q ss_pred             CcCCCCCCC-HHHHHHH
Q 042876          161 NESPESRPT-MKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps-~~~~~~~  176 (179)
                      +.||.+||+ ++++++|
T Consensus       256 ~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          256 EPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             CSSGGGSCCSHHHHHTS
T ss_pred             cCCHhHhcccHHHHHcC
Confidence            999999998 8888764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=1.2e-31  Score=197.50  Aligned_cols=161  Identities=26%  Similarity=0.387  Sum_probs=126.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+..............+++.|++||
T Consensus       119 ~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE  195 (314)
T 3com_A          119 NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE  195 (314)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChh
Confidence            45789999999999999999999999   999999999999999999999999999976654433334457888999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||||+++|++++|..||.......     ..................    ....+.+++.+||+.|
T Consensus       196 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~d  266 (314)
T 3com_A          196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----AIFMIPTNPPPTFRKPEL----WSDNFTDFVKQCLVKS  266 (314)
T ss_dssp             HHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCCCCSSGGG----SCHHHHHHHHHHTCSC
T ss_pred             hcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCCCcccCCccc----CCHHHHHHHHHHccCC
Confidence            9988889999999999999999999999997543211     001111111111111111    1234788999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |.+|||+.++++|
T Consensus       267 p~~Rpt~~~ll~~  279 (314)
T 3com_A          267 PEQRATATQLLQH  279 (314)
T ss_dssp             TTTSCCHHHHTTS
T ss_pred             hhhCcCHHHHHhC
Confidence            9999999999875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=7e-32  Score=201.71  Aligned_cols=169  Identities=20%  Similarity=0.258  Sum_probs=122.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC----CCcccccCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS----SNWTEFAGTYGY   79 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~   79 (179)
                      ...+++.+++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++.......    .......+++.|
T Consensus       118 ~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y  194 (351)
T 3mi9_A          118 LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY  194 (351)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCc
Confidence            35689999999999999999999999   99999999999999999999999999997654322    122345678899


Q ss_pred             CCCccccc-CCCCcchhhHHHHHHHHHHHhCCCCCccccccccccc------------chhh---hhhhcCCCCCCCCCc
Q 042876           80 VAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL------------NTDI---ELDEMLDPRLPAPSR  143 (179)
Q Consensus        80 ~~pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~------------~~~~---~~~~~~~~~~~~~~~  143 (179)
                      +|||.+.+ ..++.++|+||||+++++|++|..||...........            ....   ....... .......
T Consensus       195 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  273 (351)
T 3mi9_A          195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE-LVKGQKR  273 (351)
T ss_dssp             CCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSC-CCSSCCC
T ss_pred             cCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccc-ccccccc
Confidence            99998876 4578999999999999999999999975432110000            0000   0000000 0000001


Q ss_pred             cHHHH------HHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          144 SVQEK------LISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       144 ~~~~~------~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .....      ...+.+|+.+||+.||++|||++|+++|
T Consensus       274 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          274 KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            11111      2247889999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=7.2e-32  Score=199.48  Aligned_cols=162  Identities=20%  Similarity=0.262  Sum_probs=124.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC----ceeEccccCccccCCCCCCcccccCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY----EAHVADFGIAKFLKPDSSNWTEFAGTYGY   79 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   79 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++    .++++|||++....... ......+++.|
T Consensus       109 ~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y  184 (321)
T 2a2a_A          109 KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTPEF  184 (321)
T ss_dssp             CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC-CCCCCCSCGGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc-cccccCCCCCc
Confidence            34688999999999999999999999   999999999999998887    79999999997665432 22345688999


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +|||.+.+..++.++|+||||+++|++++|..||......        .....+..................+.+++.+|
T Consensus       185 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  256 (321)
T 2a2a_A          185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITSVSYDFDEEFFSHTSELAKDFIRKL  256 (321)
T ss_dssp             CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTT
T ss_pred             cCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcccccChhhhcccCHHHHHHHHHH
Confidence            9999998888999999999999999999999999653211        11111111111111111111223478899999


Q ss_pred             cCcCCCCCCCHHHHHHHh
Q 042876          160 LNESPESRPTMKIVSQQL  177 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l  177 (179)
                      |+.||.+|||++++++|-
T Consensus       257 l~~dp~~Rps~~e~l~hp  274 (321)
T 2a2a_A          257 LVKETRKRLTIQEALRHP  274 (321)
T ss_dssp             SCSSTTTSCCHHHHHHST
T ss_pred             cCCChhhCcCHHHHhcCc
Confidence            999999999999999863

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=3e-32  Score=202.07  Aligned_cols=162  Identities=23%  Similarity=0.350  Sum_probs=121.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC---CCceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL---EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      ...+++.+++.++.|++.||+|||+.   +++|+||+|+||+++.   ++.++|+|||++........ .....+++.|+
T Consensus       125 ~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~-~~~~~gt~~y~  200 (327)
T 3lm5_A          125 AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYL  200 (327)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----------CCCGGGC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc-cccccCCcCcc
Confidence            35789999999999999999999999   9999999999999987   78999999999987654322 23356889999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |||.+.+..++.++|+||||+++|+|++|..||........     ........ ...+.  .........+.+++.+||
T Consensus       201 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~i~~~~-~~~~~--~~~~~~~~~~~~li~~~L  272 (327)
T 3lm5_A          201 APEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-----YLNISQVN-VDYSE--ETFSSVSQLATDFIQSLL  272 (327)
T ss_dssp             CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHTC-CCCCT--TTTTTSCHHHHHHHHHHS
T ss_pred             CCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----HHHHHhcc-cccCc--hhhcccCHHHHHHHHHHc
Confidence            99999988999999999999999999999999965432111     00111111 11111  111112234788999999


Q ss_pred             CcCCCCCCCHHHHHHHh
Q 042876          161 NESPESRPTMKIVSQQL  177 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l  177 (179)
                      +.||.+|||++++++|-
T Consensus       273 ~~dP~~Rpt~~~ll~h~  289 (327)
T 3lm5_A          273 VKNPEKRPTAEICLSHS  289 (327)
T ss_dssp             CSSGGGSCCHHHHTTCG
T ss_pred             CCChhhCcCHHHHhCCH
Confidence            99999999999998863

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.97  E-value=2e-31  Score=206.29  Aligned_cols=157  Identities=24%  Similarity=0.364  Sum_probs=124.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++.+++.++.||+.||+|||+.   +++||||||+||+++.++.++|+|||++....... ......+++.|+|||
T Consensus       110 ~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~gt~~y~aPE  185 (476)
T 2y94_A          110 NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPNYAAPE  185 (476)
T ss_dssp             SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-CBCCCCSCSTTCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc-cccccCCCcCeEChh
Confidence            45789999999999999999999999   99999999999999999999999999998765432 233457899999999


Q ss_pred             ccccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..+ +.++|+||+|+++|+|++|..||......        .....+.......+....    .++.+++.+||+.
T Consensus       186 ~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~p~~~s----~~~~~Li~~~L~~  253 (476)
T 2y94_A          186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------TLFKKICDGIFYTPQYLN----PSVISLLKHMLQV  253 (476)
T ss_dssp             HHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--------HHHHHHHTTCCCCCTTCC----HHHHHHHHHHTCS
T ss_pred             hccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcCCcCCCccCC----HHHHHHHHHHcCC
Confidence            9988765 68999999999999999999999754321        111111111111111122    2378899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 042876          163 SPESRPTMKIVSQQ  176 (179)
Q Consensus       163 ~p~~Rps~~~~~~~  176 (179)
                      ||.+|||++++++|
T Consensus       254 dP~~Rpt~~eil~h  267 (476)
T 2y94_A          254 DPMKRATIKDIREH  267 (476)
T ss_dssp             STTTSCCHHHHHTC
T ss_pred             CchhCcCHHHHHhC
Confidence            99999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.97  E-value=8.1e-32  Score=201.53  Aligned_cols=154  Identities=22%  Similarity=0.276  Sum_probs=123.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++.......   ....+++.|+|||.
T Consensus       136 ~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~---~~~~gt~~y~aPE~  209 (350)
T 1rdq_E          136 GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEI  209 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---CCCEECGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc---ccccCCccccCHHH
Confidence            4689999999999999999999999   99999999999999999999999999998664322   33568899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|+|++|..||...+...        ....+.......+...    ..++.++|.+||+.||
T Consensus       210 ~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~----~~~~~~li~~lL~~dp  277 (350)
T 1rdq_E          210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKVRFPSHF----SSDLKDLLRNLLQVDL  277 (350)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTTC----CHHHHHHHHHHSCSCT
T ss_pred             hcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--------HHHHHHcCCCCCCCCC----CHHHHHHHHHHhhcCH
Confidence            998889999999999999999999999996543211        1111111111111112    2247889999999999


Q ss_pred             CCCCC-----HHHHHHH
Q 042876          165 ESRPT-----MKIVSQQ  176 (179)
Q Consensus       165 ~~Rps-----~~~~~~~  176 (179)
                      .+||+     ++++++|
T Consensus       278 ~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          278 TKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             TTCTTSSTTTTHHHHTS
T ss_pred             HhccCCccCCHHHHHhC
Confidence            99998     8988876

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=1.3e-31  Score=194.36  Aligned_cols=156  Identities=28%  Similarity=0.408  Sum_probs=120.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.......  .....+++.|+|||.
T Consensus       104 ~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~  178 (279)
T 3fdn_A          104 SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTDLCGTLDYLPPEM  178 (279)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----------CCCCTTCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc--ccccCCCCCccCHhH
Confidence            4689999999999999999999999   99999999999999999999999999885543322  234567899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||++++++++|..||.......      ............+.  ..    ...+.+++.+||+.||
T Consensus       179 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~--~~----~~~~~~li~~~l~~~p  246 (279)
T 3fdn_A          179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVEFTFPD--FV----TEGARDLISRLLKHNP  246 (279)
T ss_dssp             HTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCCCCT--TS----CHHHHHHHHHHCCSSG
T ss_pred             hccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HHHHHHhCCCCCCC--cC----CHHHHHHHHHHhccCh
Confidence            998888999999999999999999999996432111      00111111111111  11    2247889999999999


Q ss_pred             CCCCCHHHHHHHh
Q 042876          165 ESRPTMKIVSQQL  177 (179)
Q Consensus       165 ~~Rps~~~~~~~l  177 (179)
                      .+|||++++++|-
T Consensus       247 ~~Rps~~e~l~h~  259 (279)
T 3fdn_A          247 SQRPMLREVLEHP  259 (279)
T ss_dssp             GGSCCHHHHHHCH
T ss_pred             hhCCCHHHHhhCc
Confidence            9999999999874

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=7e-32  Score=196.09  Aligned_cols=160  Identities=24%  Similarity=0.319  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc---eeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.   ++++|||.+....... ......+++.|+|
T Consensus       100 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~a  175 (284)
T 3kk8_A          100 EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPGYLS  175 (284)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-BCCCSCSCGGGCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-cccCCCCCcCCcC
Confidence            4689999999999999999999999   9999999999999976655   9999999997655332 2234578899999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+||||++++++++|..||.........   . ...........+.    .......+.+++.+||+
T Consensus       176 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~-~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~  247 (284)
T 3kk8_A          176 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---A-QIKAGAYDYPSPE----WDTVTPEAKSLIDSMLT  247 (284)
T ss_dssp             HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H-HHHHTCCCCCTTT----TTTSCHHHHHHHHHHSC
T ss_pred             chhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH---H-HHHhccccCCchh----hcccCHHHHHHHHHHcc
Confidence            99999888999999999999999999999999654321100   0 0011111111111    11112347889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||++|||++++++|
T Consensus       248 ~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          248 VNPKKRITADQALKV  262 (284)
T ss_dssp             SSTTTSCCHHHHTTS
T ss_pred             cChhhCCCHHHHhcC
Confidence            999999999999886

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=1e-31  Score=199.26  Aligned_cols=165  Identities=19%  Similarity=0.281  Sum_probs=122.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-------------------CCceeEccccCccccCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-------------------EYEAHVADFGIAKFLKP   65 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-------------------~~~~~l~d~~~~~~~~~   65 (179)
                      ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.                   ++.++++|||.+.....
T Consensus       113 ~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  189 (339)
T 1z57_A          113 LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE  189 (339)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc
Confidence            4689999999999999999999999   9999999999999987                   66799999999976543


Q ss_pred             CCCCcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhh-------h---------
Q 042876           66 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDI-------E---------  129 (179)
Q Consensus        66 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~-------~---------  129 (179)
                      ..   ....+++.|+|||.+.+..++.++|+||||+++|++++|..||...............       .         
T Consensus       190 ~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  266 (339)
T 1z57_A          190 HH---STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKY  266 (339)
T ss_dssp             CC---CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGG
T ss_pred             cc---ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhH
Confidence            22   3356789999999999889999999999999999999999999754321100000000       0         


Q ss_pred             -----------------hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          130 -----------------LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       130 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                                       ..... ................+.+++.+||+.||.+|||++|+++|
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          267 FHHDRLDWDEHSSAGRYVSRAC-KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             EETTEECCCTTSHHHHHHHHHC-CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HhhccccccccccccchhhhcC-cchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence                             00000 00000001112234568899999999999999999999876

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.97  E-value=2.2e-31  Score=195.83  Aligned_cols=161  Identities=25%  Similarity=0.377  Sum_probs=116.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc-eeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE-AHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .+++..++.++.|++.||.|||+....+++|+||||+||+++.++. ++++|||++.......   ....+++.|+|||.
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~  174 (307)
T 2eva_A           98 YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGSAAWMAPEV  174 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------CCTTSSCHHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc---ccCCCCCceEChhh
Confidence            4788999999999999999999921118999999999999988876 7999999987554322   23467899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|++++|..||..........   .......  ...+.....    ...+.+++.+||+.||
T Consensus       175 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~--~~~~~~~~~----~~~l~~li~~~l~~dp  245 (307)
T 2eva_A          175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI---MWAVHNG--TRPPLIKNL----PKPIESLMTRCWSKDP  245 (307)
T ss_dssp             HTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH---HHHHHTT--CCCCCBTTC----CHHHHHHHHHHTCSSG
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH---HHHHhcC--CCCCccccc----CHHHHHHHHHHhcCCh
Confidence            998889999999999999999999999997543211000   0001111  111111111    2247889999999999


Q ss_pred             CCCCCHHHHHHHhh
Q 042876          165 ESRPTMKIVSQQLR  178 (179)
Q Consensus       165 ~~Rps~~~~~~~l~  178 (179)
                      .+|||++++++.|+
T Consensus       246 ~~Rps~~ell~~L~  259 (307)
T 2eva_A          246 SQRPSMEEIVKIMT  259 (307)
T ss_dssp             GGSCCHHHHHHHHH
T ss_pred             hhCcCHHHHHHHHH
Confidence            99999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=4.9e-32  Score=209.02  Aligned_cols=159  Identities=24%  Similarity=0.443  Sum_probs=123.9

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCcc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPEL   84 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~   84 (179)
                      .+++..++.++.||+.||+|||+.   +++||||||+||+++.++.+||+|||++........ ......++..|+|||.
T Consensus       280 ~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~  356 (454)
T 1qcf_A          280 KQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA  356 (454)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHH
Confidence            678899999999999999999999   999999999999999999999999999976543211 1122345678999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +.+..++.++|+||||+++|++++ |..||.........     ......  .+.+.+..+.    ..+.++|.+||+.|
T Consensus       357 ~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~-----~~i~~~--~~~~~~~~~~----~~l~~li~~cl~~d  425 (454)
T 1qcf_A          357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-----RALERG--YRMPRPENCP----EELYNIMMRCWKNR  425 (454)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-----HHHHHT--CCCCCCTTSC----HHHHHHHHHHTCSS
T ss_pred             hccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHHcC--CCCCCCCCCC----HHHHHHHHHHccCC
Confidence            988889999999999999999999 99999754321110     111111  1222222222    24888999999999


Q ss_pred             CCCCCCHHHHHHHhh
Q 042876          164 PESRPTMKIVSQQLR  178 (179)
Q Consensus       164 p~~Rps~~~~~~~l~  178 (179)
                      |++|||++++++.|+
T Consensus       426 p~~RPt~~~i~~~L~  440 (454)
T 1qcf_A          426 PEERPTFEYIQSVLD  440 (454)
T ss_dssp             GGGSCCHHHHHHHHH
T ss_pred             hhHCcCHHHHHHHHH
Confidence            999999999999885

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=6.8e-32  Score=197.73  Aligned_cols=167  Identities=22%  Similarity=0.361  Sum_probs=125.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---CcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---NWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++........   ......++..|+|
T Consensus       121 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  197 (302)
T 4e5w_A          121 NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA  197 (302)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCC
T ss_pred             ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccC
Confidence            5689999999999999999999999   999999999999999999999999999987654432   1233456777999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccc------cccccchhhhhhhcC--CCCCCCCCccHHHHHHHHH
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSI------SSSSLNTDIELDEML--DPRLPAPSRSVQEKLISIV  153 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  153 (179)
                      ||.+.+..++.++|+||||++++++++|..|+......      ..............+  ....+.....    ...+.
T Consensus       198 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~  273 (302)
T 4e5w_A          198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNC----PDEVY  273 (302)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTC----CHHHH
T ss_pred             CeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCC----CHHHH
Confidence            99998888899999999999999999999886432110      001111111111111  1111111122    22488


Q ss_pred             HHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          154 KVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       154 ~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +++.+||+.||.+|||++++++.|+
T Consensus       274 ~li~~~l~~dp~~Rps~~~ll~~L~  298 (302)
T 4e5w_A          274 QLMRKCWEFQPSNRTSFQNLIEGFE  298 (302)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            8999999999999999999999885

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=2.1e-31  Score=195.99  Aligned_cols=164  Identities=18%  Similarity=0.259  Sum_probs=114.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............++..|++||
T Consensus       130 ~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE  206 (310)
T 2wqm_A          130 KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE  206 (310)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChH
Confidence            45689999999999999999999999   999999999999999999999999999876654333333456788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||||+++|++++|..||.......      ............+....  ......+.+++.+||+.|
T Consensus       207 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~d  278 (310)
T 2wqm_A          207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIEQCDYPPLPS--DHYSEELRQLVNMCINPD  278 (310)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH------HHHHHHHHTTCSCCCCT--TTSCHHHHHHHHHHTCSS
T ss_pred             HhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH------HHHHHHhhcccCCCCcc--cccCHHHHHHHHHHcCCC
Confidence            9988889999999999999999999999986432110      00111111111111100  011224788999999999


Q ss_pred             CCCCCCHHHHHHHhh
Q 042876          164 PESRPTMKIVSQQLR  178 (179)
Q Consensus       164 p~~Rps~~~~~~~l~  178 (179)
                      |.+|||++++++.|+
T Consensus       279 p~~Rps~~~il~~l~  293 (310)
T 2wqm_A          279 PEKRPDVTYVYDVAK  293 (310)
T ss_dssp             GGGSCCHHHHHHHHH
T ss_pred             hhhCCCHHHHHHHHH
Confidence            999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=9.9e-32  Score=199.90  Aligned_cols=157  Identities=23%  Similarity=0.389  Sum_probs=124.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..............++..|++||.
T Consensus       136 ~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  212 (335)
T 2owb_A          136 KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV  212 (335)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHH
Confidence            4689999999999999999999999   9999999999999999999999999999876544433445678899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|+|++|..||........   .  ..... ....++.  ...    ..+.+++.+||+.||
T Consensus       213 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~--~~~~~-~~~~~~~--~~~----~~~~~li~~~l~~dp  280 (335)
T 2owb_A          213 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET---Y--LRIKK-NEYSIPK--HIN----PVAASLIQKMLQTDP  280 (335)
T ss_dssp             HHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H--HHHHH-TCCCCCT--TSC----HHHHHHHHHHTCSSG
T ss_pred             hccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH---H--HHHhc-CCCCCCc--cCC----HHHHHHHHHHccCCh
Confidence            9888899999999999999999999999965431110   0  00000 0111111  111    237789999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      ++|||+++++++
T Consensus       281 ~~Rps~~ell~~  292 (335)
T 2owb_A          281 TARPTINELLND  292 (335)
T ss_dssp             GGSCCGGGGGGS
T ss_pred             hHCcCHHHHhcC
Confidence            999999999876

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=1.4e-31  Score=199.79  Aligned_cols=165  Identities=22%  Similarity=0.286  Sum_probs=122.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee-------------------cCCCceeEccccCccccCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL-------------------DLEYEAHVADFGIAKFLKP   65 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~-------------------~~~~~~~l~d~~~~~~~~~   65 (179)
                      ..+++.+++.++.||+.||.|||+.   +++|+||||+||++                   +.++.++|+|||++.....
T Consensus       118 ~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  194 (355)
T 2eu9_A          118 QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE  194 (355)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc
Confidence            4689999999999999999999999   99999999999999                   5678899999999976443


Q ss_pred             CCCCcccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhh-----------------
Q 042876           66 DSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDI-----------------  128 (179)
Q Consensus        66 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~-----------------  128 (179)
                      ..   ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...............                 
T Consensus       195 ~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  271 (355)
T 2eu9_A          195 HH---TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKY  271 (355)
T ss_dssp             CC---CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGG
T ss_pred             cc---cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhh
Confidence            22   3357889999999999889999999999999999999999999754321100000000                 


Q ss_pred             ----------------hhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          129 ----------------ELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       129 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                                      ....... ...............+.+|+.+||+.||.+|||+.++++|
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          272 FYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             EETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             hcccccccccccchhccccccCC-cccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                            0000000 0000000111223458899999999999999999999876

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=3.3e-32  Score=203.49  Aligned_cols=157  Identities=26%  Similarity=0.424  Sum_probs=121.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......    ....+++.|+|||
T Consensus       148 ~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----~~~~gt~~y~aPE  220 (348)
T 1u5q_A          148 KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPE  220 (348)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----CCCCSCGGGCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----CcccCCcceeCHh
Confidence            45789999999999999999999999   9999999999999999999999999999765432    2346889999999


Q ss_pred             ccc---cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           84 LAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        84 ~~~---~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      .+.   +..++.++|+||||+++++|++|..||........     .........+....  ...   ...+.+++.+||
T Consensus       221 ~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~--~~~---~~~l~~li~~~l  290 (348)
T 1u5q_A          221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNESPALQS--GHW---SEYFRNFVDSCL  290 (348)
T ss_dssp             HHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCCCCCCC--TTS---CHHHHHHHHHHT
T ss_pred             hhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcCCCCCCC--CCC---CHHHHHHHHHHc
Confidence            884   45678899999999999999999999865432110     00111111111111  111   223778899999


Q ss_pred             CcCCCCCCCHHHHHHHh
Q 042876          161 NESPESRPTMKIVSQQL  177 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l  177 (179)
                      +.||++|||+++++++-
T Consensus       291 ~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          291 QKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             CSSGGGSCCHHHHTTCH
T ss_pred             ccChhhCcCHHHHhhCh
Confidence            99999999999998764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=9.8e-32  Score=199.47  Aligned_cols=169  Identities=17%  Similarity=0.166  Sum_probs=115.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec-----CCCceeEccccCccccCCCCCCcccccCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD-----LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGY   79 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~-----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   79 (179)
                      ..+++..++.++.||+.||.|||+.   +++|+||||+||+++     .++.++|+|||++..............+++.|
T Consensus       127 ~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y  203 (329)
T 3gbz_A          127 PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY  203 (329)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccc
Confidence            4689999999999999999999999   999999999999994     44559999999998765444334445678999


Q ss_pred             CCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch------------hhhhhhcCCCCCCCCC-ccH
Q 042876           80 VAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT------------DIELDEMLDPRLPAPS-RSV  145 (179)
Q Consensus        80 ~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~-~~~  145 (179)
                      +|||.+.+. .++.++|+||||+++|++++|..||.............            ............+... ...
T Consensus       204 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (329)
T 3gbz_A          204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTL  283 (329)
T ss_dssp             CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCH
T ss_pred             cCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccH
Confidence            999998774 47999999999999999999999996543211000000            0000000000111100 000


Q ss_pred             HH-----HHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 QE-----KLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ~~-----~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ..     ...++.+|+.+||+.||.+|||++|+++|
T Consensus       284 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          284 KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             HHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            00     12357899999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=2.4e-31  Score=194.56  Aligned_cols=161  Identities=28%  Similarity=0.386  Sum_probs=121.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC----CcccccCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS----NWTEFAGTYGY   79 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~   79 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++++|||++........    ......+++.|
T Consensus       122 ~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y  198 (298)
T 3f66_A          122 THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW  198 (298)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccc
Confidence            45689999999999999999999999   999999999999999999999999999976543221    12234566789


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      ++||.+.+..++.++|+||||++++++++ +..||........     ........  .........    ..+.+++.+
T Consensus       199 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-----~~~~~~~~--~~~~~~~~~----~~l~~li~~  267 (298)
T 3f66_A          199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TVYLLQGR--RLLQPEYCP----DPLYEVMLK  267 (298)
T ss_dssp             SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-----HHHHHTTC--CCCCCTTCC----HHHHHHHHH
T ss_pred             cChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-----HHHHhcCC--CCCCCccCC----HHHHHHHHH
Confidence            99999998899999999999999999999 5556654332111     11111111  111111111    247889999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||+.||.+|||++++++.|+
T Consensus       268 ~l~~~p~~Rps~~ell~~L~  287 (298)
T 3f66_A          268 CWHPKAEMRPSFSELVSRIS  287 (298)
T ss_dssp             HTCSSGGGSCCHHHHHHHHH
T ss_pred             HcCCChhhCcCHHHHHHHHH
Confidence            99999999999999999885

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=6.6e-32  Score=204.48  Aligned_cols=169  Identities=17%  Similarity=0.248  Sum_probs=120.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC-------CCcccccCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS-------SNWTEFAGTY   77 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~   77 (179)
                      ..+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++++|||.+.......       .......+++
T Consensus       123 ~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~  199 (389)
T 3gni_B          123 DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL  199 (389)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTG
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccc
Confidence            5689999999999999999999999   99999999999999999999999999875432111       1112246778


Q ss_pred             CCCCCccccc--CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCC-------------------
Q 042876           78 GYVAPELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDP-------------------  136 (179)
Q Consensus        78 ~~~~pe~~~~--~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------  136 (179)
                      .|+|||.+.+  ..++.++|+|||||++|+|++|..||.....................+.                   
T Consensus       200 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (389)
T 3gni_B          200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANS  279 (389)
T ss_dssp             GGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------------------------
T ss_pred             cccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccccc
Confidence            8999999987  5788999999999999999999999975433221110000000000000                   


Q ss_pred             ---------------CCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          137 ---------------RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       137 ---------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                                     ...............+.+||.+||+.||++|||++|+++|
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          280 GLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             --------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                           0000000111223458889999999999999999999876

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.97  E-value=2e-31  Score=200.14  Aligned_cols=160  Identities=23%  Similarity=0.278  Sum_probs=112.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc--eeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE--AHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      +.+++.+++.++.|++.||+|||+.   |++||||||+||+++.++.  ++|+|||++....... ......+++.|+||
T Consensus       111 ~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aP  186 (361)
T 3uc3_A          111 GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAP  186 (361)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------------CTTSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-CCCCCcCCCCcCCh
Confidence            4689999999999999999999999   9999999999999987665  9999999987443222 22335689999999


Q ss_pred             cccccCCCCcc-hhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCC--CCCCCCCccHHHHHHHHHHHHhcc
Q 042876           83 ELAYTMKITEK-CDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD--PRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        83 e~~~~~~~~~~-~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      |.+.+..++.+ +|+||||+++|++++|..||.........    .........  ...+......    ..+.+||.+|
T Consensus       187 E~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~s----~~~~~li~~~  258 (361)
T 3uc3_A          187 EVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY----RKTIQRILSVKYSIPDDIRIS----PECCHLISRI  258 (361)
T ss_dssp             HHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH----HHHHHHHHTTCCCCCTTSCCC----HHHHHHHHHH
T ss_pred             hhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH----HHHHHHHhcCCCCCCCcCCCC----HHHHHHHHHH
Confidence            99988777554 89999999999999999999754322111    111111111  1222221222    2378899999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 042876          160 LNESPESRPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~  176 (179)
                      |+.||.+|||++++++|
T Consensus       259 L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          259 FVADPATRISIPEIKTH  275 (361)
T ss_dssp             SCSCTTTSCCHHHHHTS
T ss_pred             ccCChhHCcCHHHHHhC
Confidence            99999999999999987

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.97  E-value=1.7e-31  Score=209.19  Aligned_cols=162  Identities=22%  Similarity=0.313  Sum_probs=125.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++..............+++.|+|||
T Consensus       283 ~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE  359 (543)
T 3c4z_A          283 NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE  359 (543)
T ss_dssp             SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHH
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChh
Confidence            34699999999999999999999999   999999999999999999999999999987655443334457899999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+|||||++|+|++|..||.........    ......+.......+...    ...+.++|.+||+.|
T Consensus       360 ~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~----~~~~~~i~~~~~~~p~~~----s~~~~~li~~lL~~d  431 (543)
T 3c4z_A          360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRVLEQAVTYPDKF----SPASKDFCEALLQKD  431 (543)
T ss_dssp             HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH----HHHHHHHHHCCCCCCTTS----CHHHHHHHHHHSCSS
T ss_pred             hhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH----HHHHHHHhhcccCCCccc----CHHHHHHHHHhccCC
Confidence            999989999999999999999999999999754321110    111111111111111111    224788999999999


Q ss_pred             CCCCCCH-----HHHHHH
Q 042876          164 PESRPTM-----KIVSQQ  176 (179)
Q Consensus       164 p~~Rps~-----~~~~~~  176 (179)
                      |.+||++     +++++|
T Consensus       432 P~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          432 PEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             GGGSCCCBTTBSHHHHTS
T ss_pred             HhHCCCCcccCHHHHHcC
Confidence            9999964     677764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=1.2e-31  Score=202.13  Aligned_cols=159  Identities=25%  Similarity=0.452  Sum_probs=113.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.........   .....+++.|++
T Consensus       142 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~a  218 (373)
T 2qol_A          142 AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS  218 (373)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccC
Confidence            4689999999999999999999999   9999999999999999999999999999766543221   112234568999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      ||.+.+..++.++|+||||+++|++++ |..||.......        ....+... +.+.....    ...+.+++.+|
T Consensus       219 PE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--------~~~~i~~~~~~~~~~~~----~~~l~~li~~c  286 (373)
T 2qol_A          219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDEGYRLPPPMDC----PAALYQLMLDC  286 (373)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--------HHHHHHTTEECCCCTTC----BHHHHHHHHHH
T ss_pred             hhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCCccc----cHHHHHHHHHH
Confidence            999998899999999999999999997 999986543211        11111110 11111122    22488899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||.+||+++++++.|+
T Consensus       287 l~~dp~~RPs~~~i~~~L~  305 (373)
T 2qol_A          287 WQKDRNNRPKFEQIVSILD  305 (373)
T ss_dssp             TCSSGGGSCCHHHHHHHHH
T ss_pred             hCcChhhCcCHHHHHHHHH
Confidence            9999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.97  E-value=2.5e-31  Score=211.58  Aligned_cols=161  Identities=25%  Similarity=0.390  Sum_probs=122.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~   80 (179)
                      ...+++..++.++.||+.||+|||+.   +++||||||+||+++.++.+||+|||++.........   .....+++.|+
T Consensus       430 ~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~  506 (613)
T 2ozo_A          430 REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY  506 (613)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCcccee
Confidence            45689999999999999999999999   9999999999999999999999999999766433221   12233457899


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      |||.+.+..++.++|+||||+++|+|++ |..||.........     .....  ..+.+....+.    ..+.++|.+|
T Consensus       507 APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-----~~i~~--~~~~~~p~~~~----~~l~~li~~c  575 (613)
T 2ozo_A          507 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-----AFIEQ--GKRMECPPECP----PELYALMSDC  575 (613)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-----HHHHT--TCCCCCCTTCC----HHHHHHHHHT
T ss_pred             CHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----HHHHc--CCCCCCCCcCC----HHHHHHHHHH
Confidence            9999988899999999999999999998 99999764422110     11111  11122222222    2488899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||++||+++++++.|+
T Consensus       576 l~~dP~~RPs~~~l~~~L~  594 (613)
T 2ozo_A          576 WIYKWEDRPDFLTVEQRMR  594 (613)
T ss_dssp             TCSSTTTSCCHHHHHHHHH
T ss_pred             cCCChhHCcCHHHHHHHHH
Confidence            9999999999999998875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=1.8e-31  Score=197.21  Aligned_cols=159  Identities=21%  Similarity=0.355  Sum_probs=123.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........  .....+++.|+||
T Consensus       133 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (322)
T 1p4o_A          133 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP  209 (322)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccCh
Confidence            4678999999999999999999999   9999999999999999999999999998765432211  1223456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCC-CCCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRL-PAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |.+.+..++.++|+||||+++|++++ |..||.......        .......... ......    ...+.+++.+||
T Consensus       210 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~----~~~l~~li~~~l  277 (322)
T 1p4o_A          210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--------VLRFVMEGGLLDKPDNC----PDMLFELMRMCW  277 (322)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--------HHHHHHTTCCCCCCTTC----CHHHHHHHHHHT
T ss_pred             hhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--------HHHHHHcCCcCCCCCCC----CHHHHHHHHHHc
Confidence            99988889999999999999999999 899986543211        1111111111 111122    224788999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||.+|||+.+++++|+
T Consensus       278 ~~dp~~Rps~~e~l~~L~  295 (322)
T 1p4o_A          278 QYNPKMRPSFLEIISSIK  295 (322)
T ss_dssp             CSSGGGSCCHHHHHHHHG
T ss_pred             CCCcccCcCHHHHHHHHH
Confidence            999999999999999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=2.3e-32  Score=208.62  Aligned_cols=149  Identities=17%  Similarity=0.141  Sum_probs=117.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++......   .....+ +.|+|||.
T Consensus       206 ~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~  278 (413)
T 3dzo_A          206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPET  278 (413)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchh
Confidence            3467788999999999999999999   9999999999999999999999999998765433   233456 89999999


Q ss_pred             c----------ccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHH
Q 042876           85 A----------YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVK  154 (179)
Q Consensus        85 ~----------~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (179)
                      +          .+..++.++|+|||||++|+|++|+.||..........        .... ...   ..    ...+.+
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~--------~~~~-~~~---~~----~~~~~~  342 (413)
T 3dzo_A          279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE--------WIFR-SCK---NI----PQPVRA  342 (413)
T ss_dssp             HHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG--------GGGS-SCC---CC----CHHHHH
T ss_pred             hhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH--------HHHh-hcc---cC----CHHHHH
Confidence            8          45557889999999999999999999997544322111        1111 011   11    124888


Q ss_pred             HHhcccCcCCCCCCCHHHHHHH
Q 042876          155 VAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       155 li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      +|.+||+.||++||++.+++++
T Consensus       343 li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          343 LLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHccCChhhCcCHHHHHhC
Confidence            9999999999999999888764

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=7.2e-32  Score=200.76  Aligned_cols=164  Identities=23%  Similarity=0.258  Sum_probs=102.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC---CCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL---EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.   ++.++|+|||++.......  .....+++.|++
T Consensus       123 ~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~t~~y~a  197 (336)
T 3fhr_A          123 QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVA  197 (336)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc--cccCCCCcCccC
Confidence            4799999999999999999999999   9999999999999976   4459999999997655322  233467889999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+||||+++|++++|..||.....................  ..+.  .........+.+++.+||+
T Consensus       198 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~li~~~L~  273 (336)
T 3fhr_A          198 PEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY--GFPN--PEWSEVSEDAKQLIRLLLK  273 (336)
T ss_dssp             ------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------CCCT--TTSTTCCHHHHHHHHHHSC
T ss_pred             hhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc--ccCc--hhhccCCHHHHHHHHHHCC
Confidence            99998888899999999999999999999999654432211111100000000  0111  1111122347889999999


Q ss_pred             cCCCCCCCHHHHHHHh
Q 042876          162 ESPESRPTMKIVSQQL  177 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l  177 (179)
                      .||.+|||++++++|-
T Consensus       274 ~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          274 TDPTERLTITQFMNHP  289 (336)
T ss_dssp             SSGGGSCCHHHHHHSH
T ss_pred             CChhHCcCHHHHhcCc
Confidence            9999999999999863

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.5e-31  Score=196.81  Aligned_cols=160  Identities=28%  Similarity=0.461  Sum_probs=118.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~   80 (179)
                      ...+++.+++.++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++.........   .....++..|+
T Consensus       141 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  217 (333)
T 1mqb_A          141 DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT  217 (333)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGS
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCcccccc
Confidence            35689999999999999999999999   9999999999999999999999999999766543211   11223466799


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      +||.+.+..++.++|+||||+++|++++ |..||.......        ....+... +.+.....    ...+.+++.+
T Consensus       218 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~----~~~l~~li~~  285 (333)
T 1mqb_A          218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------VMKAINDGFRLPTPMDC----PSAIYQLMMQ  285 (333)
T ss_dssp             CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCCCTTC----BHHHHHHHHH
T ss_pred             CchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHCCCcCCCcccC----CHHHHHHHHH
Confidence            9999988889999999999999999998 999996543211        11111111 12222222    2247889999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||+.||.+||++.++++.|+
T Consensus       286 ~l~~~p~~Rps~~~l~~~L~  305 (333)
T 1mqb_A          286 CWQQERARRPKFADIVSILD  305 (333)
T ss_dssp             HTCSSTTTSCCHHHHHHHHH
T ss_pred             HcCCChhhCcCHHHHHHHHH
Confidence            99999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=7.5e-33  Score=200.75  Aligned_cols=160  Identities=28%  Similarity=0.343  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCC-----cccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPP-----IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGY   79 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~-----~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~   79 (179)
                      ..+++..++.++.|++.||+|||+.   +     ++|+||+|+||+++.++.++++|||.+..............++..|
T Consensus       106 ~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y  182 (279)
T 2w5a_A          106 QYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY  182 (279)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccc
Confidence            4589999999999999999999998   7     9999999999999999999999999987655432222334678899


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +|||.+.+..++.++|+||||+++|++++|..||........     ...........++.  ..    ...+.+++.+|
T Consensus       183 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~i~~~~~~~~~~--~~----~~~l~~li~~~  251 (279)
T 2w5a_A          183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-----AGKIREGKFRRIPY--RY----SDELNEIITRM  251 (279)
T ss_dssp             CCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHTCCCCCCT--TS----CHHHHHHHHHH
T ss_pred             cChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH-----HHHHhhcccccCCc--cc----CHHHHHHHHHH
Confidence            999999888899999999999999999999999975432110     01111111111111  11    22478899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||.+|||++++++++.
T Consensus       252 l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          252 LNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             TCSSGGGSCCHHHHHTSTT
T ss_pred             cCCCcccCCCHHHHHhChh
Confidence            9999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.97  E-value=9.2e-32  Score=193.99  Aligned_cols=156  Identities=23%  Similarity=0.311  Sum_probs=119.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCC--cccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPP--IVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|+++||.|||+.   +  ++|+||+|+||+++.++.+++.+|++......     ....+++.|+||
T Consensus       106 ~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-----~~~~~t~~y~aP  177 (271)
T 3kmu_A          106 FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAP  177 (271)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-----TTCBSCGGGSCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc-----cCccCCccccCh
Confidence            3589999999999999999999998   8  99999999999999999999998887654332     224678899999


Q ss_pred             cccccCCCCc---chhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           83 ELAYTMKITE---KCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        83 e~~~~~~~~~---~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      |.+.+...+.   ++|+||||+++|++++|..||.........    .........+..+.  ..    ...+.+++.+|
T Consensus       178 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~--~~----~~~~~~li~~~  247 (271)
T 3kmu_A          178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG----MKVALEGLRPTIPP--GI----SPHVSKLMKIC  247 (271)
T ss_dssp             HHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH----HHHHHSCCCCCCCT--TC----CHHHHHHHHHH
T ss_pred             hhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH----HHHHhcCCCCCCCC--CC----CHHHHHHHHHH
Confidence            9988765443   799999999999999999999754321110    00111111111111  12    22478899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||.+|||++++++.|+
T Consensus       248 l~~~p~~Rps~~~il~~L~  266 (271)
T 3kmu_A          248 MNEDPAKRPKFDMIVPILE  266 (271)
T ss_dssp             TCSSGGGSCCHHHHHHHHH
T ss_pred             cCCChhhCcCHHHHHHHHH
Confidence            9999999999999999885

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.97  E-value=1.7e-31  Score=194.85  Aligned_cols=160  Identities=27%  Similarity=0.383  Sum_probs=123.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........   .....+++.|+|
T Consensus       112 ~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  188 (291)
T 1xbb_A          112 RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA  188 (291)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeC
Confidence            4689999999999999999999999   9999999999999999999999999999766543321   122344678999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..++.++|+||||+++|++++ |..||........     ............+  ...    ...+.+++.+||
T Consensus       189 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~--~~~----~~~l~~li~~~l  257 (291)
T 1xbb_A          189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----TAMLEKGERMGCP--AGC----PREMYDLMNLCW  257 (291)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----HHHHHTTCCCCCC--TTC----CHHHHHHHHHHT
T ss_pred             hHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-----HHHHHcCCCCCCC--CCC----CHHHHHHHHHHc
Confidence            999988888999999999999999999 9999975432111     0111111111111  112    224888999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||.+|||+.++++.|+
T Consensus       258 ~~dp~~Rps~~~l~~~L~  275 (291)
T 1xbb_A          258 TYDVENRPGFAAVELRLR  275 (291)
T ss_dssp             CSSTTTSCCHHHHHHHHH
T ss_pred             CCChhhCcCHHHHHHHHH
Confidence            999999999999999885

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=1.3e-31  Score=206.51  Aligned_cols=160  Identities=27%  Similarity=0.425  Sum_probs=120.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      ..+++.+++.++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++........ ......++..|+|||
T Consensus       275 ~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE  351 (452)
T 1fmk_A          275 KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE  351 (452)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHh
Confidence            4589999999999999999999999   999999999999999999999999999976543221 122334567899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||+++|++++ |..||........     .......  .+.+.+..+.    ..+.++|.+||+.
T Consensus       352 ~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-----~~~i~~~--~~~~~~~~~~----~~l~~li~~cl~~  420 (452)
T 1fmk_A          352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQVERG--YRMPCPPECP----ESLHDLMCQCWRK  420 (452)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----HHHHHTT--CCCCCCTTSC----HHHHHHHHHHTCS
T ss_pred             HHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHcC--CCCCCCCCCC----HHHHHHHHHHccC
Confidence            9988889999999999999999999 9999975432110     0011111  1122222222    2478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||++|||++++++.|+
T Consensus       421 dP~~Rpt~~~l~~~L~  436 (452)
T 1fmk_A          421 EPEERPTFEYLQAFLE  436 (452)
T ss_dssp             SGGGSCCHHHHHHHHH
T ss_pred             ChhhCcCHHHHHHHHH
Confidence            9999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=1.2e-31  Score=194.28  Aligned_cols=159  Identities=23%  Similarity=0.308  Sum_probs=122.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee---cCCCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL---DLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||++   +.++.++++|||.+....... ......+++.|+|
T Consensus       101 ~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~t~~y~a  176 (277)
T 3f3z_A          101 RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMRTKVGTPYYVS  176 (277)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-CBCCCCSCTTTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-chhccCCCCCccC
Confidence            4689999999999999999999999   99999999999999   778899999999997665433 2334568899999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+. ++.++|+||||++++++++|..||......        ........................+.+++.+||+
T Consensus       177 PE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  247 (277)
T 3f3z_A          177 PQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLT  247 (277)
T ss_dssp             HHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTC
T ss_pred             hHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHcc
Confidence            9998664 889999999999999999999999654321        1111111111111111111223458889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||.+|||+.++++|
T Consensus       248 ~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          248 KSPKQRITSLQALEH  262 (277)
T ss_dssp             SSTTTSCCHHHHTTS
T ss_pred             CChhhCcCHHHHhcC
Confidence            999999999999876

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=3.9e-32  Score=206.80  Aligned_cols=109  Identities=23%  Similarity=0.383  Sum_probs=88.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee----cCCCceeEccccCccccCCCCC---CcccccCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL----DLEYEAHVADFGIAKFLKPDSS---NWTEFAGTYG   78 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~----~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~   78 (179)
                      .+++..++.++.||+.||.|||+.   +++||||||+||++    +.++.++|+|||++........   ......+++.
T Consensus       124 ~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  200 (405)
T 3rgf_A          124 QLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW  200 (405)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCc
Confidence            589999999999999999999999   99999999999999    6778999999999976653221   1234577899


Q ss_pred             CCCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccc
Q 042876           79 YVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLS  117 (179)
Q Consensus        79 ~~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~  117 (179)
                      |+|||.+.+. .++.++|+|||||++|+|++|..||....
T Consensus       201 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             TCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            9999998774 58999999999999999999999996543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=3.9e-32  Score=199.27  Aligned_cols=159  Identities=28%  Similarity=0.448  Sum_probs=126.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .++++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+..............+++.|++||.
T Consensus       114 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  190 (303)
T 3a7i_A          114 GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV  190 (303)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHH
Confidence            5789999999999999999999999   9999999999999999999999999999776554433444578889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||++++++++|..||........     .........+..+.  ..    ...+.+++.+||+.||
T Consensus       191 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~--~~----~~~l~~li~~~l~~dp  259 (303)
T 3a7i_A          191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV-----LFLIPKNNPPTLEG--NY----SKPLKEFVEACLNKEP  259 (303)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCCCCCCS--SC----CHHHHHHHHHHCCSSG
T ss_pred             HhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH-----HHHhhcCCCCCCcc--cc----CHHHHHHHHHHcCCCh
Confidence            9988899999999999999999999999865432110     01111111111111  11    1237889999999999


Q ss_pred             CCCCCHHHHHHHh
Q 042876          165 ESRPTMKIVSQQL  177 (179)
Q Consensus       165 ~~Rps~~~~~~~l  177 (179)
                      .+|||+++++++.
T Consensus       260 ~~Rps~~~ll~~~  272 (303)
T 3a7i_A          260 SFRPTAKELLKHK  272 (303)
T ss_dssp             GGSCCHHHHTTCH
T ss_pred             hhCcCHHHHhhCh
Confidence            9999999998864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=1.3e-31  Score=201.74  Aligned_cols=166  Identities=20%  Similarity=0.257  Sum_probs=119.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......   .....+++.|+|||.
T Consensus       139 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE~  212 (371)
T 4exu_A          139 MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEV  212 (371)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC---cCCcccCccccCHHH
Confidence            4589999999999999999999999   9999999999999999999999999999765432   233567889999999


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc------------------hhhhhhhcCCCCCCCC-Ccc
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN------------------TDIELDEMLDPRLPAP-SRS  144 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~-~~~  144 (179)
                      +.+ ..++.++|+||||++++++++|..||............                  ................ ...
T Consensus       213 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (371)
T 4exu_A          213 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQL  292 (371)
T ss_dssp             HSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHH
T ss_pred             hcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHh
Confidence            876 67899999999999999999999999754321100000                  0000000010000000 000


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.+|+.+||+.||.+|||++|+++|
T Consensus       293 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          293 FPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             STTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            01113358899999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.2e-31  Score=200.35  Aligned_cols=166  Identities=22%  Similarity=0.252  Sum_probs=122.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......   .....++..|+|||.
T Consensus       123 ~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~  196 (367)
T 1cm8_A          123 EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWYRAPEV  196 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS---CCSSCSCGGGCCTHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccccc---cCcCcCCCCcCCHHH
Confidence            4689999999999999999999999   9999999999999999999999999999765432   233567889999998


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc------------------hhhhhhhcCCCCCCCC-Ccc
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN------------------TDIELDEMLDPRLPAP-SRS  144 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~-~~~  144 (179)
                      +.+ ..++.++|+||+||++++|++|+.||.+..........                  ................ ...
T Consensus       197 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (367)
T 1cm8_A          197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI  276 (367)
T ss_dssp             HHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGT
T ss_pred             HhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHH
Confidence            877 67899999999999999999999999754321100000                  0000000010000000 000


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.+|+.+||+.||.+|||++++++|
T Consensus       277 ~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          277 LTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            01112347889999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=1.5e-31  Score=201.10  Aligned_cols=168  Identities=19%  Similarity=0.245  Sum_probs=120.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec------CCCceeEccccCccccCCCCCCcccccCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD------LEYEAHVADFGIAKFLKPDSSNWTEFAGTY   77 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~   77 (179)
                      ...+++..++.++.||+.||.|||++.  +++|+||||+||+++      ..+.++|+|||++.......   ....+++
T Consensus       125 ~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~t~  199 (373)
T 1q8y_A          125 HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TNSIQTR  199 (373)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC---CSCCSCG
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCC---CCCCCCc
Confidence            356899999999999999999999953  899999999999994      33479999999997654322   3346789


Q ss_pred             CCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-hhhhhhcCCC--------------------
Q 042876           78 GYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-DIELDEMLDP--------------------  136 (179)
Q Consensus        78 ~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~--------------------  136 (179)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||............. ..........                    
T Consensus       200 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  279 (373)
T 1q8y_A          200 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG  279 (373)
T ss_dssp             GGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--
T ss_pred             cccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcc
Confidence            9999999999889999999999999999999999997543211100000 0000000000                    


Q ss_pred             ---CCCC------------CCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          137 ---RLPA------------PSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       137 ---~~~~------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                         ....            ...........+.+||.+||+.||.+|||++|+++|
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          280 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             hhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence               0000            001123455678899999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.97  E-value=4e-31  Score=191.68  Aligned_cols=155  Identities=26%  Similarity=0.384  Sum_probs=116.2

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY   86 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   86 (179)
                      +++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.......   ....+++.|+|||.+.
T Consensus       114 ~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~y~aPE~~~  187 (278)
T 1byg_A          114 LGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALR  187 (278)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc---cCCCccccccCHHHhC
Confidence            78889999999999999999999   99999999999999999999999999987554322   2235677899999998


Q ss_pred             cCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCC
Q 042876           87 TMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPE  165 (179)
Q Consensus        87 ~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  165 (179)
                      +..++.++|+||||++++++++ |..||........     .........  .......    ...+.+++.+||+.||.
T Consensus       188 ~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-----~~~~~~~~~--~~~~~~~----~~~l~~li~~~l~~~p~  256 (278)
T 1byg_A          188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGYK--MDAPDGC----PPAVYEVMKNCWHLDAA  256 (278)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-----HHHHTTTCC--CCCCTTC----CHHHHHHHHHHTCSSGG
T ss_pred             CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHhcCCC--CCCcccC----CHHHHHHHHHHhcCChh
Confidence            8889999999999999999998 9999865432110     011111111  1111112    22478899999999999


Q ss_pred             CCCCHHHHHHHhh
Q 042876          166 SRPTMKIVSQQLR  178 (179)
Q Consensus       166 ~Rps~~~~~~~l~  178 (179)
                      +|||+.++++.|+
T Consensus       257 ~Rps~~~l~~~L~  269 (278)
T 1byg_A          257 MRPSFLQLREQLE  269 (278)
T ss_dssp             GSCCHHHHHHHHH
T ss_pred             hCCCHHHHHHHHH
Confidence            9999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.97  E-value=1.7e-31  Score=204.91  Aligned_cols=108  Identities=25%  Similarity=0.360  Sum_probs=89.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---------------
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---------------   68 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------------   68 (179)
                      ...+++..++.++.||+.||+|||+.   +++||||||+||+++.++.+||+|||++........               
T Consensus       123 ~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~  199 (432)
T 3n9x_A          123 PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP  199 (432)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC--------------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccc
Confidence            35689999999999999999999999   999999999999999999999999999986543221               


Q ss_pred             -------CcccccCCCCCCCCccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCc
Q 042876           69 -------NWTEFAGTYGYVAPELA-YTMKITEKCDVYSFGVLALEVIKGKHPRD  114 (179)
Q Consensus        69 -------~~~~~~~~~~~~~pe~~-~~~~~~~~~D~~slg~~~~~l~~~~~p~~  114 (179)
                             ......+++.|+|||.+ .+..++.++|+||+||++|+|++|..||.
T Consensus       200 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -----------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence                   12445789999999985 55678999999999999999998766653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=9e-32  Score=200.50  Aligned_cols=159  Identities=26%  Similarity=0.312  Sum_probs=118.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC--ceeEccccCccccCCCCC----CcccccCCCCCC
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY--EAHVADFGIAKFLKPDSS----NWTEFAGTYGYV   80 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~   80 (179)
                      +++..++.++.|++.||.|||+.   +++|+||+|+||+++.++  .++|+|||++........    ......+++.|+
T Consensus       165 ~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~  241 (345)
T 3hko_A          165 QREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV  241 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGC
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCcccc
Confidence            35678899999999999999999   999999999999998666  899999999976533211    123456889999


Q ss_pred             CCccccc--CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           81 APELAYT--MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        81 ~pe~~~~--~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      |||.+.+  ..++.++|+||||+++|++++|..||.......        .......................+.+++.+
T Consensus       242 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  313 (345)
T 3hko_A          242 APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD--------TISQVLNKKLCFENPNYNVLSPLARDLLSN  313 (345)
T ss_dssp             CHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCTTSGGGGGSCHHHHHHHHH
T ss_pred             CchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH--------HHHHHHhcccccCCcccccCCHHHHHHHHH
Confidence            9999875  567899999999999999999999996543211        111111111111112222223358889999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||+.||.+|||+.++++|
T Consensus       314 ~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHS
T ss_pred             HcCCChhHCCCHHHHhcC
Confidence            999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.97  E-value=4e-32  Score=200.04  Aligned_cols=161  Identities=25%  Similarity=0.414  Sum_probs=115.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.........   .....+++.|+|
T Consensus       111 ~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  187 (311)
T 3ork_A          111 GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS  187 (311)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCC
Confidence            4689999999999999999999999   9999999999999999999999999999765433221   223467899999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+||||+++|+|++|..||........       ..........+ ..........++.+++.+||+
T Consensus       188 PE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~  259 (311)
T 3ork_A          188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-------AYQHVREDPIP-PSARHEGLSADLDAVVLKALA  259 (311)
T ss_dssp             HHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCCCCC-HHHHSTTCCHHHHHHHHHHTC
T ss_pred             HHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhcCCCCC-cccccCCCCHHHHHHHHHHHh
Confidence            9999988999999999999999999999999965432110       00001111111 000001122348889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||.+||+..+++++
T Consensus       260 ~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          260 KNPENRYQTAAEMRA  274 (311)
T ss_dssp             SSGGGSCSSHHHHHH
T ss_pred             cCHhhChhhHHHHHH
Confidence            999999977776654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.97  E-value=2.1e-31  Score=197.43  Aligned_cols=160  Identities=26%  Similarity=0.355  Sum_probs=122.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....... ......+++.|++||
T Consensus       136 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE  211 (327)
T 1fvr_A          136 ASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIE  211 (327)
T ss_dssp             SCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC-CC----CCTTTCCHH
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEcccCcCccccccc-cccCCCCCccccChh
Confidence            35789999999999999999999999   99999999999999999999999999986433221 122335577899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||+++|++++ |..||........     ........  .........    ..+.+++.+||+.
T Consensus       212 ~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-----~~~~~~~~--~~~~~~~~~----~~l~~li~~~l~~  280 (327)
T 1fvr_A          212 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-----YEKLPQGY--RLEKPLNCD----DEVYDLMRQCWRE  280 (327)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HHHGGGTC--CCCCCTTBC----HHHHHHHHHHTCS
T ss_pred             hhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-----HHHhhcCC--CCCCCCCCC----HHHHHHHHHHccC
Confidence            9988888999999999999999998 9999965432110     00111111  111111222    2478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||.+|||+++++++|+
T Consensus       281 dp~~Rps~~ell~~L~  296 (327)
T 1fvr_A          281 KPYERPSFAQILVSLN  296 (327)
T ss_dssp             SGGGSCCHHHHHHHHH
T ss_pred             ChhhCcCHHHHHHHHH
Confidence            9999999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.97  E-value=9.1e-32  Score=202.44  Aligned_cols=166  Identities=22%  Similarity=0.310  Sum_probs=113.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++..++.++.||+.||.|||+.   |++||||||+||+++.++.++|+|||++......   .....++..|+|||.
T Consensus       127 ~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~  200 (367)
T 2fst_X          127 QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEI  200 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC------------------CCCTTCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc---CCCcCcCcCccChHH
Confidence            5689999999999999999999999   9999999999999999999999999999765432   233578899999999


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc---------------hhhhhhhcCC--CCCCCCC--cc
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN---------------TDIELDEMLD--PRLPAPS--RS  144 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~---------------~~~~~~~~~~--~~~~~~~--~~  144 (179)
                      +.+ ..++.++|+||+||++++|++|..||.+..........               ........+.  +..+...  ..
T Consensus       201 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (367)
T 2fst_X          201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV  280 (367)
T ss_dssp             HTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred             HcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHH
Confidence            876 67889999999999999999999999764421100000               0000000000  0000000  00


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.+|+.+||..||.+|||+.++++|
T Consensus       281 ~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          281 FIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00112347889999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=5.3e-32  Score=200.32  Aligned_cols=159  Identities=24%  Similarity=0.364  Sum_probs=115.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..............+++.|+|||.
T Consensus       124 ~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  200 (326)
T 2x7f_A          124 NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV  200 (326)
T ss_dssp             GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhh
Confidence            5689999999999999999999999   9999999999999999999999999998765543323344568889999999


Q ss_pred             cc-----cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           85 AY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        85 ~~-----~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      +.     +..++.++|+||||+++|++++|..||........     .........+.... ...    ...+.+++.+|
T Consensus       201 ~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~-~~~----~~~l~~li~~~  270 (326)
T 2x7f_A          201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIPRNPAPRLKS-KKW----SKKFQSFIESC  270 (326)
T ss_dssp             HC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCCCCCSC-SCS----CHHHHHHHHHH
T ss_pred             hccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-----HHHhhcCccccCCc-ccc----CHHHHHHHHHH
Confidence            86     45678899999999999999999999965432110     00111111111111 111    12478899999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 042876          160 LNESPESRPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~  176 (179)
                      |..||.+|||++++++|
T Consensus       271 l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          271 LVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             CCSSGGGSCCHHHHHTS
T ss_pred             hccChhhCCCHHHHhhC
Confidence            99999999999999886

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.97  E-value=2.2e-31  Score=197.86  Aligned_cols=160  Identities=24%  Similarity=0.358  Sum_probs=123.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++.........  .....+++.|+||
T Consensus       152 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  228 (334)
T 2pvf_A          152 EQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  228 (334)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeCh
Confidence            3589999999999999999999999   9999999999999999999999999999765543221  1223456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|++++ |..||........     ............+  ...    ...+.+++.+||+
T Consensus       229 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~~~~~~~~~~~~--~~~----~~~l~~li~~~l~  297 (334)
T 2pvf_A          229 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-----FKLLKEGHRMDKP--ANC----TNELYMMMRDCWH  297 (334)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-----HHHHHHTCCCCCC--TTC----CHHHHHHHHHHTC
T ss_pred             HHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-----HHHHhcCCCCCCC--ccC----CHHHHHHHHHHcc
Confidence            99988888999999999999999999 9999965432110     0011111111111  122    2247889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+.+++++|+
T Consensus       298 ~dp~~Rps~~ell~~L~  314 (334)
T 2pvf_A          298 AVPSQRPTFKQLVEDLD  314 (334)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHH
Confidence            99999999999999885

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.97  E-value=2.3e-31  Score=193.71  Aligned_cols=161  Identities=24%  Similarity=0.351  Sum_probs=125.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~p   82 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+......... .....+++.|+||
T Consensus       105 ~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP  181 (288)
T 3kfa_A          105 RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP  181 (288)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCH
T ss_pred             cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCCh
Confidence            45689999999999999999999999   9999999999999999999999999999766543321 2223456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||++++++++ |..||........     ............  ....    ...+.+++.+||+
T Consensus       182 E~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-----~~~~~~~~~~~~--~~~~----~~~l~~li~~~l~  250 (288)
T 3kfa_A          182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELLEKDYRMER--PEGC----PEKVYELMRACWQ  250 (288)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----HHHHHTTCCCCC--CTTC----CHHHHHHHHHHTC
T ss_pred             hhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHhccCCCCC--CCCC----CHHHHHHHHHHhC
Confidence            99998899999999999999999999 9999875432111     111111111111  1122    2248889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||++++++.|+
T Consensus       251 ~dp~~Rps~~~~~~~l~  267 (288)
T 3kfa_A          251 WNPSDRPSFAEIHQAFE  267 (288)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHH
Confidence            99999999999999875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=4.4e-31  Score=192.03  Aligned_cols=155  Identities=26%  Similarity=0.365  Sum_probs=122.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+.......  .....+++.|++||.
T Consensus       109 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~  183 (284)
T 2vgo_A          109 GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--RRTMCGTLDYLPPEM  183 (284)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--BCCCCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc--cccccCCCCcCCHHH
Confidence            4689999999999999999999999   99999999999999999999999999986554322  233567889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||++++++++|..||.......        ................    ...+.+++.+||+.||
T Consensus       184 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p  251 (284)
T 2vgo_A          184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--------THRRIVNVDLKFPPFL----SDGSKDLISKLLRYHP  251 (284)
T ss_dssp             HTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCCCCCTTS----CHHHHHHHHHHSCSSG
T ss_pred             hccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--------HHHHHhccccCCCCcC----CHHHHHHHHHHhhcCH
Confidence            998889999999999999999999999996543211        1111111111111111    2247889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+|||++++++|
T Consensus       252 ~~Rps~~~ll~h  263 (284)
T 2vgo_A          252 PQRLPLKGVMEH  263 (284)
T ss_dssp             GGSCCHHHHHTC
T ss_pred             hhCCCHHHHhhC
Confidence            999999999876

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.97  E-value=1.6e-31  Score=194.78  Aligned_cols=159  Identities=26%  Similarity=0.414  Sum_probs=122.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........   .....++..|+|
T Consensus       116 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  192 (291)
T 1u46_A          116 GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA  192 (291)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCC
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeC
Confidence            4588999999999999999999999   9999999999999999999999999999776543321   122345668999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcC--CCCCCCCCccHHHHHHHHHHHHhc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      ||.+.+..++.++|+||||++++++++ |..||.......        ......  ....+.....    ...+.+++.+
T Consensus       193 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~l~~li~~  260 (291)
T 1u46_A          193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEGERLPRPEDC----PQDIYNVMVQ  260 (291)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSCCCCCCCTTC----CHHHHHHHHH
T ss_pred             chhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--------HHHHHHccCCCCCCCcCc----CHHHHHHHHH
Confidence            999988888999999999999999999 999996543211        111111  1111211122    2348889999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||+.||.+|||+.+++++|+
T Consensus       261 ~l~~~p~~Rps~~~l~~~l~  280 (291)
T 1u46_A          261 CWAHKPEDRPTFVALRDFLL  280 (291)
T ss_dssp             HTCSSGGGSCCHHHHHHHHH
T ss_pred             HccCCcccCcCHHHHHHHHH
Confidence            99999999999999999885

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.97  E-value=7.3e-32  Score=198.81  Aligned_cols=170  Identities=19%  Similarity=0.307  Sum_probs=118.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc---eeEccccCccccCCCCC-------Cccccc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSS-------NWTEFA   74 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~---~~l~d~~~~~~~~~~~~-------~~~~~~   74 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.   ++++|||++........       ......
T Consensus       106 ~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  182 (316)
T 2ac3_A          106 RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC  182 (316)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------C
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccccccccccc
Confidence            4689999999999999999999999   9999999999999987765   99999999875542211       122345


Q ss_pred             CCCCCCCCccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-------hhhhhhhcCCCCCCCCC
Q 042876           75 GTYGYVAPELAYT-----MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-------TDIELDEMLDPRLPAPS  142 (179)
Q Consensus        75 ~~~~~~~pe~~~~-----~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~  142 (179)
                      +++.|+|||.+.+     ..++.++|+||||+++|+|++|..||............       .......+.........
T Consensus       183 gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  262 (316)
T 2ac3_A          183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD  262 (316)
T ss_dssp             CSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCH
T ss_pred             CCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCc
Confidence            8899999999875     45788999999999999999999999764322110000       00111111111111111


Q ss_pred             ccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          143 RSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       143 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      .........+.+++.+||+.||.+|||++++++|-
T Consensus       263 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  297 (316)
T 2ac3_A          263 KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP  297 (316)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred             hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence            11111233588999999999999999999999873

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=2.7e-31  Score=201.60  Aligned_cols=169  Identities=22%  Similarity=0.242  Sum_probs=123.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec-CCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD-LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      .+.+++..++.++.|++.||+|||+.   +++||||||+||+++ .++.+||+|||++........ .....+++.|+||
T Consensus       135 ~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~t~~y~aP  210 (394)
T 4e7w_A          135 KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP-NVSYICSRYYRAP  210 (394)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-CCSSCSCGGGCCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC-CcccccCcCccCH
Confidence            46789999999999999999999999   999999999999998 789999999999976643322 2345678899999


Q ss_pred             cccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-------hh----hhhhcCCCCCCCCCc-cHH---
Q 042876           83 ELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-------DI----ELDEMLDPRLPAPSR-SVQ---  146 (179)
Q Consensus        83 e~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-------~~----~~~~~~~~~~~~~~~-~~~---  146 (179)
                      |.+.+. .++.++|+||+||++|+|++|+.||.+...........       ..    .........++.... ...   
T Consensus       211 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (394)
T 4e7w_A          211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVF  290 (394)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHS
T ss_pred             HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhc
Confidence            988764 58999999999999999999999997643211000000       00    000011111111100 000   


Q ss_pred             --HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          147 --EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       147 --~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                        ....++.+|+.+||+.||.+|||+.++++|
T Consensus       291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          291 RPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence              012358899999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=1.8e-31  Score=207.83  Aligned_cols=161  Identities=24%  Similarity=0.368  Sum_probs=125.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~p   82 (179)
                      ...+++..++.++.||+.||+|||+.   +++||||||+||+++.++.+||+|||++........ ......++..|+||
T Consensus       312 ~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aP  388 (495)
T 1opk_A          312 RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP  388 (495)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCH
Confidence            35689999999999999999999999   999999999999999999999999999976543221 12223456789999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|+|++ |..||........     ........  +.+....+.    ..+.++|.+||+
T Consensus       389 E~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-----~~~~~~~~--~~~~~~~~~----~~l~~li~~cl~  457 (495)
T 1opk_A          389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELLEKDY--RMERPEGCP----EKVYELMRACWQ  457 (495)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----HHHHHTTC--CCCCCTTCC----HHHHHHHHHHTC
T ss_pred             hHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHcCC--CCCCCCCCC----HHHHHHHHHHcC
Confidence            99988889999999999999999998 9999976432211     11111111  122222222    247889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||+.++++.|+
T Consensus       458 ~dP~~RPs~~el~~~L~  474 (495)
T 1opk_A          458 WNPSDRPSFAEIHQAFE  474 (495)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             cChhHCcCHHHHHHHHH
Confidence            99999999999999885

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=3.6e-31  Score=202.38  Aligned_cols=170  Identities=24%  Similarity=0.252  Sum_probs=123.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC-CceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ...+++..++.++.||+.||.|||+.   +++||||||+||+++.+ +.+||+|||++........ .....+++.|+||
T Consensus       150 ~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~t~~y~aP  225 (420)
T 1j1b_A          150 KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRYYRAP  225 (420)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-CCSCCSCTTSCCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC-ceeeeeCCCcCCH
Confidence            46789999999999999999999999   99999999999999865 5689999999986543322 2335678999999


Q ss_pred             cccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-------hhhhhhhc----CCCCCCCCC-ccHH---
Q 042876           83 ELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-------TDIELDEM----LDPRLPAPS-RSVQ---  146 (179)
Q Consensus        83 e~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-------~~~~~~~~----~~~~~~~~~-~~~~---  146 (179)
                      |.+.+. .++.++|+|||||++|+|++|+.||.+..........       ........    ..-.++... ..+.   
T Consensus       226 E~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  305 (420)
T 1j1b_A          226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF  305 (420)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHS
T ss_pred             HHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhc
Confidence            998764 6899999999999999999999999764321100000       00000000    000111110 0011   


Q ss_pred             --HHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          147 --EKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       147 --~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                        ....++.+|+.+||+.||.+|||+.|+++|-
T Consensus       306 ~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp  338 (420)
T 1j1b_A          306 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  338 (420)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence              1123588999999999999999999999763

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=1.8e-31  Score=203.96  Aligned_cols=163  Identities=23%  Similarity=0.268  Sum_probs=116.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC---ceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY---EAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      .+.+++.+++.++.|++.||+|||+.   +++||||||+||+++.++   .++|+|||++....... ......+++.|+
T Consensus       233 ~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~  308 (419)
T 3i6u_A          233 NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYL  308 (419)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC------------CTTC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccceecCCCc-cccccCCCCCcc
Confidence            45789999999999999999999999   999999999999996544   49999999998765432 223457899999


Q ss_pred             CCccccc---CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHh
Q 042876           81 APELAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        81 ~pe~~~~---~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      |||.+.+   ..++.++|+||||+++|+|++|..||........    .....   ...........+......+.+++.
T Consensus       309 aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~----~~~~i---~~~~~~~~~~~~~~~~~~~~~li~  381 (419)
T 3i6u_A          309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----LKDQI---TSGKYNFIPEVWAEVSEKALDLVK  381 (419)
T ss_dssp             CTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC----HHHHH---HTTCCCCCHHHHTTSCHHHHHHHH
T ss_pred             CceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH----HHHHH---hcCCCCCCchhhcccCHHHHHHHH
Confidence            9998853   4677899999999999999999999975432110    00011   111111111111222345889999


Q ss_pred             cccCcCCCCCCCHHHHHHHh
Q 042876          158 SCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~l  177 (179)
                      +||+.||.+|||++++++|=
T Consensus       382 ~~L~~dP~~Rps~~e~l~hp  401 (419)
T 3i6u_A          382 KLLVVDPKARFTTEEALRHP  401 (419)
T ss_dssp             HHSCSSTTTSCCHHHHHHSG
T ss_pred             HHccCChhHCcCHHHHhCCc
Confidence            99999999999999999873

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=8.8e-32  Score=199.42  Aligned_cols=167  Identities=28%  Similarity=0.385  Sum_probs=125.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---CcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---NWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.++++|||.+........   ......++..|++
T Consensus       122 ~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  198 (327)
T 3lxl_A          122 ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA  198 (327)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccC
Confidence            3589999999999999999999999   999999999999999999999999999987654332   1223456777999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccc------cccchhhhhhhcC-C-CCCCCCCccHHHHHHHHH
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------SSLNTDIELDEML-D-PRLPAPSRSVQEKLISIV  153 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~------~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~  153 (179)
                      ||.+.+..++.++|+||||++++++++|..||........      ............+ . ...+.....    ...+.
T Consensus       199 PE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~  274 (327)
T 3lxl_A          199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPAC----PAEVH  274 (327)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTC----CHHHH
T ss_pred             HHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcc----cHHHH
Confidence            9999888889999999999999999999999854322100      0000001111111 1 111111122    23488


Q ss_pred             HHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          154 KVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       154 ~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +++.+||+.||.+|||+++++++|+
T Consensus       275 ~li~~~l~~dP~~Rps~~ell~~L~  299 (327)
T 3lxl_A          275 ELMKLCWAPSPQDRPSFSALGPQLD  299 (327)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHH
Confidence            8999999999999999999999886

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=3.6e-31  Score=200.05  Aligned_cols=109  Identities=21%  Similarity=0.275  Sum_probs=93.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec--CCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD--LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      +.+++..++.++.|++.||.|||.+. .+++||||||+||+++  .++.++|+|||++.......   ....+++.|+||
T Consensus       152 ~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aP  227 (382)
T 2vx3_A          152 RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQSRFYRSP  227 (382)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCC---CSSCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCceeccccc---ccccCCccccCh
Confidence            46899999999999999999999521 1899999999999994  46789999999997765322   335678899999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLS  117 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~  117 (179)
                      |.+.+..++.++|+|||||++|+|++|..||....
T Consensus       228 E~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999899999999999999999999999997543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=3.3e-31  Score=205.93  Aligned_cols=159  Identities=24%  Similarity=0.352  Sum_probs=121.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec---CCCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD---LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.||+.||.|||+.   +++||||||+||+++   .++.++|+|||++....... ......+++.|+|
T Consensus       116 ~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~a  191 (486)
T 3mwu_A          116 KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIA  191 (486)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-ccCCCcCCCCCCC
Confidence            5689999999999999999999999   999999999999995   45679999999997665432 2334578899999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+ .++.++|+||+|+++|++++|..||.......        ....+...........+.....++.++|.+||+
T Consensus       192 PE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  262 (486)
T 3mwu_A          192 PEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--------ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT  262 (486)
T ss_dssp             GGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTC
T ss_pred             HHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcC
Confidence            999876 58899999999999999999999996543211        111111111111112222233458889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||.+|||+.++++|
T Consensus       263 ~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          263 FHPSLRITATQCLEH  277 (486)
T ss_dssp             SSTTTSCCHHHHHHC
T ss_pred             CChhhCcCHHHHhcC
Confidence            999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=1.6e-31  Score=201.04  Aligned_cols=160  Identities=26%  Similarity=0.436  Sum_probs=122.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   |++|+||+|.||+++.++.++++|||++....... ......+++.|+|||.
T Consensus       195 ~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~  270 (365)
T 2y7j_A          195 VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRELCGTPGYLAPEI  270 (365)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccCCCc-ccccCCCCCCccChhh
Confidence            4689999999999999999999999   99999999999999999999999999987765433 2234578899999998


Q ss_pred             cccC------CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           85 AYTM------KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        85 ~~~~------~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      +.+.      .++.++|+||||+++|+|++|..||.......        ....+...........+......+.+++.+
T Consensus       271 ~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  342 (365)
T 2y7j_A          271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--------MLRMIMEGQYQFSSPEWDDRSSTVKDLISR  342 (365)
T ss_dssp             HHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCCHHHHSSSCHHHHHHHHH
T ss_pred             ccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCCCCCcccccCCHHHHHHHHH
Confidence            8642      47889999999999999999999996532111        111111111111111111123348889999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||+.||++|||++++++|
T Consensus       343 ~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          343 LLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HSCSSTTTSCCHHHHHHS
T ss_pred             HcCCChhHCcCHHHHhcC
Confidence            999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=4e-31  Score=191.72  Aligned_cols=159  Identities=23%  Similarity=0.416  Sum_probs=123.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCcc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPEL   84 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~   84 (179)
                      .+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+......... .....++..|++||.
T Consensus       105 ~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  181 (279)
T 1qpc_A          105 KLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA  181 (279)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhh
Confidence            689999999999999999999999   9999999999999999999999999999776543211 222345678999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +.+..++.++|+||||++++++++ |..||........     .........  .......    ...+.+++.+||+.|
T Consensus       182 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-----~~~~~~~~~--~~~~~~~----~~~l~~li~~~l~~~  250 (279)
T 1qpc_A          182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----IQNLERGYR--MVRPDNC----PEELYQLMRLCWKER  250 (279)
T ss_dssp             HHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----HHHHHTTCC--CCCCTTC----CHHHHHHHHHHTCSS
T ss_pred             hccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH-----HHHHhcccC--CCCcccc----cHHHHHHHHHHhccC
Confidence            988888999999999999999999 8999865432110     001111111  1111111    224788999999999


Q ss_pred             CCCCCCHHHHHHHhh
Q 042876          164 PESRPTMKIVSQQLR  178 (179)
Q Consensus       164 p~~Rps~~~~~~~l~  178 (179)
                      |++|||++++++.|+
T Consensus       251 p~~Rps~~~l~~~l~  265 (279)
T 1qpc_A          251 PEDRPTFDYLRSVLE  265 (279)
T ss_dssp             GGGSCCHHHHHHHHH
T ss_pred             hhhCCCHHHHHHHHH
Confidence            999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=8.9e-32  Score=208.99  Aligned_cols=161  Identities=24%  Similarity=0.349  Sum_probs=124.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee---cCCCceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL---DLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      ...+++.+++.++.||+.||.|||+.   +++||||||+||++   +.++.++|+|||++....... ......+++.|+
T Consensus       120 ~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~  195 (484)
T 3nyv_A          120 RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-KMKDKIGTAYYI  195 (484)
T ss_dssp             CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC-SHHHHTTGGGTC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc-ccccCCCCcccc
Confidence            45789999999999999999999999   99999999999999   567889999999997765433 233457889999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |||.+.+ .++.++|+||+|+++|++++|..||.......        ....+...........+......+.++|.+||
T Consensus       196 aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  266 (484)
T 3nyv_A          196 APEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--------ILKKVEKGKYTFELPQWKKVSESAKDLIRKML  266 (484)
T ss_dssp             CHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHT
T ss_pred             CceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCCCCCCcccccCCHHHHHHHHHHC
Confidence            9999876 68899999999999999999999997543211        11111111111111222223345888999999


Q ss_pred             CcCCCCCCCHHHHHHHh
Q 042876          161 NESPESRPTMKIVSQQL  177 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l  177 (179)
                      +.||.+|||+.++++|-
T Consensus       267 ~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          267 TYVPSMRISARDALDHE  283 (484)
T ss_dssp             CSSGGGSCCHHHHHTSH
T ss_pred             CCChhHCcCHHHHhhCh
Confidence            99999999999999863

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=2.1e-31  Score=191.88  Aligned_cols=160  Identities=26%  Similarity=0.391  Sum_probs=123.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+........ ......++..|+|||
T Consensus        99 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  175 (267)
T 3t9t_A           99 GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE  175 (267)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHH
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChh
Confidence            4689999999999999999999999   999999999999999999999999999876543211 112234567899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||+++|++++ |..||........     ............+  ...    ...+.+++.+||+.
T Consensus       176 ~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~i~~~~~~~~~--~~~----~~~l~~li~~~l~~  244 (267)
T 3t9t_A          176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYKP--RLA----STHVYQIMNHCWRE  244 (267)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----HHHHHTTCCCCCC--TTS----CHHHHHHHHHHTCS
T ss_pred             hhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH-----HHHHhcCCcCCCC--ccC----cHHHHHHHHHHccC
Confidence            9988889999999999999999999 8999865432110     0111111111111  111    22478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||++|||+++++++|+
T Consensus       245 ~p~~Rps~~~ll~~L~  260 (267)
T 3t9t_A          245 RPEDRPAFSRLLRQLA  260 (267)
T ss_dssp             SGGGSCCHHHHHHHHH
T ss_pred             ChhhCcCHHHHHHHHH
Confidence            9999999999999885

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.97  E-value=6.7e-31  Score=190.11  Aligned_cols=162  Identities=25%  Similarity=0.351  Sum_probs=122.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC--CCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~   81 (179)
                      ...+++.+++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+.......  .......+++.|++
T Consensus        99 ~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  175 (276)
T 2yex_A           99 DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA  175 (276)
T ss_dssp             TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccC
Confidence            34689999999999999999999999   99999999999999999999999999987653221  11234567889999


Q ss_pred             CcccccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..+ +.++|+||||++++++++|..||........    ........ ....+.    .......+.+++.+||
T Consensus       176 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~-~~~~~~----~~~~~~~~~~li~~~l  246 (276)
T 2yex_A          176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----EYSDWKEK-KTYLNP----WKKIDSAPLALLHKIL  246 (276)
T ss_dssp             GGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH----HHHHHHTT-CTTSTT----GGGSCHHHHHHHHHHS
T ss_pred             hHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH----HHHHhhhc-ccccCc----hhhcCHHHHHHHHHHC
Confidence            999987665 6789999999999999999999975432111    00011110 011111    1112234788999999


Q ss_pred             CcCCCCCCCHHHHHHHh
Q 042876          161 NESPESRPTMKIVSQQL  177 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l  177 (179)
                      +.||.+|||++++++|-
T Consensus       247 ~~~p~~Rps~~~il~~~  263 (276)
T 2yex_A          247 VENPSARITIPDIKKDR  263 (276)
T ss_dssp             CSSTTTSCCHHHHTTCT
T ss_pred             CCCchhCCCHHHHhcCc
Confidence            99999999999998864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=1.8e-31  Score=198.12  Aligned_cols=170  Identities=22%  Similarity=0.317  Sum_probs=119.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+..............++..|++||
T Consensus       118 ~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE  194 (331)
T 4aaa_A          118 PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE  194 (331)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcc
Confidence            35689999999999999999999999   999999999999999999999999999976654443344557889999999


Q ss_pred             ccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch----------------hhhhhhcCCCCCCCCC---c
Q 042876           84 LAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT----------------DIELDEMLDPRLPAPS---R  143 (179)
Q Consensus        84 ~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~---~  143 (179)
                      .+.+. .++.++|+||||+++|++++|..||.............                .........+......   .
T Consensus       195 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (331)
T 4aaa_A          195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLER  274 (331)
T ss_dssp             HHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHH
T ss_pred             cccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhh
Confidence            98765 67899999999999999999999997543211100000                0000000000000000   0


Q ss_pred             cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          144 SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       144 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ........+.+++.+||+.||.+|||++|+++|
T Consensus       275 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          275 RYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            011123458899999999999999999999876

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.97  E-value=2.7e-31  Score=196.61  Aligned_cols=155  Identities=21%  Similarity=0.361  Sum_probs=119.8

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC------------Ccccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS------------NWTEF   73 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~------------~~~~~   73 (179)
                      ..++..++.++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........            .....
T Consensus       160 ~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T 3qd2_B          160 DREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ  236 (332)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred             chhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence            345667899999999999999999   999999999999999999999999999987654321            12334


Q ss_pred             cCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHH
Q 042876           74 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIV  153 (179)
Q Consensus        74 ~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (179)
                      .+++.|+|||.+.+..++.++|+||||+++|++++|..|+....          ...........+   .........+.
T Consensus       237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----------~~~~~~~~~~~~---~~~~~~~~~~~  303 (332)
T 3qd2_B          237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----------RIITDVRNLKFP---LLFTQKYPQEH  303 (332)
T ss_dssp             C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----------HHHHHHHTTCCC---HHHHHHCHHHH
T ss_pred             CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----------HHHHHhhccCCC---cccccCChhHH
Confidence            68899999999999899999999999999999999877653211          011111111111   22333445578


Q ss_pred             HHHhcccCcCCCCCCCHHHHHHH
Q 042876          154 KVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       154 ~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      +++.+||+.||.+|||++++++|
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHccCCCCcCCCHHHHhhc
Confidence            89999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=1.1e-31  Score=201.78  Aligned_cols=169  Identities=21%  Similarity=0.279  Sum_probs=122.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---CcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---NWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~   81 (179)
                      +.+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........   ......+++.|+|
T Consensus       123 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a  199 (364)
T 3qyz_A          123 QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA  199 (364)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCC
Confidence            4689999999999999999999999   999999999999999999999999999976543221   1234578899999


Q ss_pred             Cccccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-------hh-----------h-hhhcCCCCCCCC
Q 042876           82 PELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-------DI-----------E-LDEMLDPRLPAP  141 (179)
Q Consensus        82 pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-------~~-----------~-~~~~~~~~~~~~  141 (179)
                      ||.+.+ ..++.++|+||||+++|++++|..||.............       ..           . ......+.....
T Consensus       200 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (364)
T 3qyz_A          200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW  279 (364)
T ss_dssp             HHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCH
T ss_pred             CHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCH
Confidence            998654 458899999999999999999999997543221100000       00           0 000000000000


Q ss_pred             CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          142 SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       142 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .........++.+|+.+||+.||.+|||++++++|
T Consensus       280 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          280 NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00001112357899999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=3.1e-31  Score=193.15  Aligned_cols=161  Identities=25%  Similarity=0.363  Sum_probs=112.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.|||+..  +++|+||||+||+++.++.++|+|||++....... ......+++.|+|||
T Consensus       103 ~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE  179 (290)
T 3fme_A          103 GQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-AKDIDAGCKPYMAPE  179 (290)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC----------------CCCCCCSCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccccc-cccccCCCccccChh
Confidence            467999999999999999999999852  89999999999999999999999999997655432 223346888999999


Q ss_pred             cc----ccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           84 LA----YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        84 ~~----~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      .+    .+..++.++|+||+|++++++++|..||.......    ...........+..+. ...    ..++.+++.+|
T Consensus       180 ~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~-~~~----~~~~~~li~~~  250 (290)
T 3fme_A          180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF----QQLKQVVEEPSPQLPA-DKF----SAEFVDFTSQC  250 (290)
T ss_dssp             HHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH----HHHHHHHHSCCCCCCT-TTS----CHHHHHHHHHH
T ss_pred             hcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH----HHHHHHhccCCCCccc-ccC----CHHHHHHHHHH
Confidence            96    45567899999999999999999999996432110    0000111111111111 111    22478899999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 042876          160 LNESPESRPTMKIVSQQ  176 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~  176 (179)
                      |+.||.+|||++++++|
T Consensus       251 l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          251 LKKNSKERPTYPELMQH  267 (290)
T ss_dssp             TCSSGGGSCCHHHHTTS
T ss_pred             hhcChhhCcCHHHHHhC
Confidence            99999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.97  E-value=2.6e-31  Score=212.08  Aligned_cols=161  Identities=27%  Similarity=0.404  Sum_probs=122.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~   80 (179)
                      .+.+++.+++.++.||+.||+|||+.   +++||||||+||+++.++.+||+|||++.........   .....+++.|+
T Consensus       463 ~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~  539 (635)
T 4fl3_A          463 NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY  539 (635)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGS
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeee
Confidence            35689999999999999999999999   9999999999999999999999999999766543221   22234567899


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      |||.+.+..++.++|+||||+++|+|++ |..||........     ........  +.+.....    ..++.++|.+|
T Consensus       540 APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-----~~~i~~~~--~~~~p~~~----~~~l~~li~~c  608 (635)
T 4fl3_A          540 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----TAMLEKGE--RMGCPAGC----PREMYDLMNLC  608 (635)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----HHHHHTTC--CCCCCTTC----CHHHHHHHHHH
T ss_pred             ChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHcCC--CCCCCCCC----CHHHHHHHHHH
Confidence            9999998899999999999999999998 9999975432111     01111111  11111122    23488899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||++|||++++++.|+
T Consensus       609 l~~dP~~RPs~~~l~~~L~  627 (635)
T 4fl3_A          609 WTYDVENRPGFAAVELRLR  627 (635)
T ss_dssp             TCSSTTTSCCHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHHH
Confidence            9999999999999999885

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.97  E-value=3.6e-31  Score=195.25  Aligned_cols=160  Identities=21%  Similarity=0.316  Sum_probs=116.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC-----CCcccccCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS-----SNWTEFAGTYGY   79 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~   79 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++ ++.++++|||++.......     .......+++.|
T Consensus       125 ~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y  200 (319)
T 2y4i_B          125 IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH  200 (319)
T ss_dssp             CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccc
Confidence            4689999999999999999999999   999999999999998 6799999999976543211     112334577889


Q ss_pred             CCCccccc---------CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHH
Q 042876           80 VAPELAYT---------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLI  150 (179)
Q Consensus        80 ~~pe~~~~---------~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (179)
                      +|||.+.+         ..++.++|+||||+++|++++|..||........     .........+..... ..    ..
T Consensus       201 ~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~-~~----~~  270 (319)
T 2y4i_B          201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-----IWQMGTGMKPNLSQI-GM----GK  270 (319)
T ss_dssp             SCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-----HHHHHTTCCCCCCCS-SC----CT
T ss_pred             cChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHhccCCCCCCCcC-CC----CH
Confidence            99999874         3468899999999999999999999965432110     001111111111110 11    11


Q ss_pred             HHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          151 SIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       151 ~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      .+.+++.+||+.||.+|||++++++.|+
T Consensus       271 ~l~~li~~~l~~~p~~Rpt~~~l~~~l~  298 (319)
T 2y4i_B          271 EISDILLFCWAFEQEERPTFTKLMDMLE  298 (319)
T ss_dssp             THHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            3788999999999999999999999886

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=8.8e-31  Score=192.07  Aligned_cols=159  Identities=21%  Similarity=0.308  Sum_probs=122.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~   81 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+........  ......+++.|++
T Consensus       103 ~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  179 (305)
T 2wtk_C          103 EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP  179 (305)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCC
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcC
Confidence            45789999999999999999999999   999999999999999999999999999976543221  1234567889999


Q ss_pred             CcccccCCC--CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           82 PELAYTMKI--TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        82 pe~~~~~~~--~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      ||.+.+...  +.++|+||||+++|++++|..||.......        ....+............    ..+.+++.+|
T Consensus       180 PE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~i~~~~~~~~~~~~----~~l~~li~~~  247 (305)
T 2wtk_C          180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--------LFENIGKGSYAIPGDCG----PPLSDLLKGM  247 (305)
T ss_dssp             HHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCCCCCCSSSC----HHHHHHHHHH
T ss_pred             hhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--------HHHHHhcCCCCCCCccC----HHHHHHHHHH
Confidence            999876543  679999999999999999999997532111        11111111111111222    2378899999


Q ss_pred             cCcCCCCCCCHHHHHHHh
Q 042876          160 LNESPESRPTMKIVSQQL  177 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l  177 (179)
                      |+.||.+|||++++++|-
T Consensus       248 l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          248 LEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             TCSSTTTSCCHHHHHHSH
T ss_pred             ccCChhhCCCHHHHhcCc
Confidence            999999999999999863

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=6.4e-31  Score=198.76  Aligned_cols=169  Identities=23%  Similarity=0.257  Sum_probs=122.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec-CCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD-LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ...+++..++.++.||+.||.|||+.   |++||||||+||+++ .++.++|+|||++........ .....++..|+||
T Consensus       135 ~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aP  210 (383)
T 3eb0_A          135 GRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAP  210 (383)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCH
Confidence            46789999999999999999999999   999999999999997 678999999999986644332 2345678899999


Q ss_pred             cccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-------hhhhhhhc----CCCCCCCC-CccHH---
Q 042876           83 ELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-------TDIELDEM----LDPRLPAP-SRSVQ---  146 (179)
Q Consensus        83 e~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-------~~~~~~~~----~~~~~~~~-~~~~~---  146 (179)
                      |.+.+. .++.++|+||+||++|+|++|..||............       ........    ....++.. ...+.   
T Consensus       211 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (383)
T 3eb0_A          211 ELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL  290 (383)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHS
T ss_pred             HHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhC
Confidence            988765 4899999999999999999999999754321100000       00000000    00001100 00000   


Q ss_pred             --HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          147 --EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       147 --~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                        ....++.+|+.+||+.||.+|||+.|+++|
T Consensus       291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              012347899999999999999999999876

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=4.2e-31  Score=195.41  Aligned_cols=168  Identities=20%  Similarity=0.237  Sum_probs=122.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   |++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.
T Consensus       115 ~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  190 (326)
T 1blx_A          115 PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEV  190 (326)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG-GGCCCCCCCTTCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccccccCCC-CccccccccceeCHHH
Confidence            4589999999999999999999999   99999999999999999999999999987654322 2233567889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh-------hhhh-------hcCC-CCCCCCCccHHHHH
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD-------IELD-------EMLD-PRLPAPSRSVQEKL  149 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~-------~~~~-------~~~~-~~~~~~~~~~~~~~  149 (179)
                      +.+..++.++|+||||+++|++++|..||..............       ....       .... ..............
T Consensus       191 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (326)
T 1blx_A          191 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID  270 (326)
T ss_dssp             HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC
T ss_pred             HhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCC
Confidence            9888899999999999999999999999975432110000000       0000       0000 00000000011122


Q ss_pred             HHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          150 ISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       150 ~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ..+.+++.+||+.||.+|||+.++++|
T Consensus       271 ~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          271 ELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            347889999999999999999999976

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.97  E-value=2.1e-31  Score=196.81  Aligned_cols=167  Identities=25%  Similarity=0.392  Sum_probs=124.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.........   .....++..|++
T Consensus       129 ~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~a  205 (318)
T 3lxp_A          129 HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA  205 (318)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeC
Confidence            4589999999999999999999999   9999999999999999999999999999876543321   223456777999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCccccccc------ccccchhhhhhhcCCC--CCCCCCccHHHHHHHHH
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS------SSSLNTDIELDEMLDP--RLPAPSRSVQEKLISIV  153 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  153 (179)
                      ||.+.+..++.++|+||||++++++++|..||.......      .............+..  ..+.....    ...+.
T Consensus       206 PE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~  281 (318)
T 3lxp_A          206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKC----PAEVY  281 (318)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTC----CHHHH
T ss_pred             hHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccc----cHHHH
Confidence            999998888999999999999999999999986432110      0000011111111111  11111122    23488


Q ss_pred             HHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          154 KVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       154 ~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +++.+||+.||.+|||++++++.|+
T Consensus       282 ~li~~~l~~dP~~Rps~~ell~~L~  306 (318)
T 3lxp_A          282 HLMKNCWETEASFRPTFENLIPILK  306 (318)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHcCCCcccCcCHHHHHHHHH
Confidence            8999999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=3.2e-31  Score=192.51  Aligned_cols=160  Identities=21%  Similarity=0.290  Sum_probs=120.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC----ceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY----EAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++    .++++|||.+....... ......+++.|+
T Consensus       103 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~  178 (283)
T 3bhy_A          103 ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-EFKNIFGTPEFV  178 (283)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---------CCCGGGC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC-cccccCCCcCcc
Confidence            4689999999999999999999999   999999999999998776    79999999997654332 223346788999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      +||.+.+..++.++|+||||++++++++|..||......        ........................+.+++.+||
T Consensus       179 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  250 (283)
T 3bhy_A          179 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--------ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLL  250 (283)
T ss_dssp             CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTS
T ss_pred             CcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--------HHHHHhHhcccCCcchhcccCCHHHHHHHHHHc
Confidence            999998888999999999999999999999999654321        111111111111111111122334788999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.||.+|||+.++++|
T Consensus       251 ~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          251 VKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             CSSGGGSCCHHHHHHC
T ss_pred             cCCHhHCcCHHHHHhC
Confidence            9999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=2.2e-31  Score=195.99  Aligned_cols=162  Identities=22%  Similarity=0.293  Sum_probs=114.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++........ ......+++.|++||
T Consensus       129 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE  205 (309)
T 2h34_A          129 GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE  205 (309)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHH
Confidence            4689999999999999999999999   999999999999999999999999999876543321 123456788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||||+++|++++|..||.......     .........    +............+.+++.+||+.|
T Consensus       206 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~d  276 (309)
T 2h34_A          206 RFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-----MGAHINQAI----PRPSTVRPGIPVAFDAVIARGMAKN  276 (309)
T ss_dssp             GTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-----HHHHHHSCC----CCGGGTSTTCCTHHHHHHHHHTCSS
T ss_pred             HHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-----HHHHhccCC----CCccccCCCCCHHHHHHHHHhccCC
Confidence            9988888999999999999999999999997543210     000111111    0000001111224788999999999


Q ss_pred             CCCCC-CHHHHHHHhh
Q 042876          164 PESRP-TMKIVSQQLR  178 (179)
Q Consensus       164 p~~Rp-s~~~~~~~l~  178 (179)
                      |++|| +++++++.|+
T Consensus       277 P~~Rp~s~~~l~~~l~  292 (309)
T 2h34_A          277 PEDRYVTCGDLSAAAH  292 (309)
T ss_dssp             GGGSCSSHHHHHHHHH
T ss_pred             HHHHHHhHHHHHHHHH
Confidence            99999 9999998875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.97  E-value=3.3e-31  Score=194.46  Aligned_cols=159  Identities=25%  Similarity=0.308  Sum_probs=121.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee---cCCCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL---DLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||++   +.++.++++|||.+......  ......+++.|+|
T Consensus       101 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~a  175 (304)
T 2jam_A          101 GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYVA  175 (304)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--TTHHHHSCCCBCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--ccccccCCCCccC
Confidence            4689999999999999999999999   99999999999999   77889999999998654322  1233467889999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+||||+++|++++|..||.......        ....+..................+.+++.+||+
T Consensus       176 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  247 (304)
T 2jam_A          176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--------LFEKIKEGYYEFESPFWDDISESAKDFICHLLE  247 (304)
T ss_dssp             TTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHC
T ss_pred             hHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCCCCCccccccCCHHHHHHHHHHcC
Confidence            999998889999999999999999999999996543211        011111111110001111122348889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||.+|||++++++|
T Consensus       248 ~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          248 KDPNERYTCEKALSH  262 (304)
T ss_dssp             SSTTTSCCHHHHHTS
T ss_pred             CChhHCcCHHHHhcC
Confidence            999999999999876

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=5.8e-31  Score=196.94  Aligned_cols=166  Identities=20%  Similarity=0.259  Sum_probs=119.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......   .....+++.|+|||.
T Consensus       121 ~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~  194 (353)
T 3coi_A          121 LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEV  194 (353)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC---ccccccCcCcCCHHH
Confidence            4689999999999999999999999   9999999999999999999999999998765432   233467889999998


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCccccccccccc----------------chh--hhhhhcCCCC-CCCCCcc
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL----------------NTD--IELDEMLDPR-LPAPSRS  144 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~----------------~~~--~~~~~~~~~~-~~~~~~~  144 (179)
                      +.+ ..++.++|+||||++++++++|..||...........                ...  ......+... .+.....
T Consensus       195 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (353)
T 3coi_A          195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQL  274 (353)
T ss_dssp             HSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTT
T ss_pred             HhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHh
Confidence            876 6788999999999999999999999975432110000                000  0000000000 0000001


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.+++.+||+.||++|||++++++|
T Consensus       275 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          275 FPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            11123348889999999999999999999976

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.9e-31  Score=198.15  Aligned_cols=163  Identities=23%  Similarity=0.310  Sum_probs=121.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........ ......+++.|+|||
T Consensus       154 ~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE  230 (355)
T 1vzo_A          154 ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD  230 (355)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChh
Confidence            4689999999999999999999999   999999999999999999999999999876543221 123356899999999


Q ss_pred             ccccC--CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTM--KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~--~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      .+.+.  .++.++|+||||+++|+|++|..||.........    ............+.....    ...+.++|.+||+
T Consensus       231 ~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~  302 (355)
T 1vzo_A          231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKSEPPYPQEM----SALAKDLIQRLLM  302 (355)
T ss_dssp             HHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHHCCCCCCTTS----CHHHHHHHHHHTC
T ss_pred             hhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH----HHHHHHHhccCCCCCccc----CHHHHHHHHHHhh
Confidence            98753  4678999999999999999999999654322111    111111111111111111    2237789999999


Q ss_pred             cCCCCCC-----CHHHHHHHhh
Q 042876          162 ESPESRP-----TMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rp-----s~~~~~~~l~  178 (179)
                      .||.+||     +++++++|..
T Consensus       303 ~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          303 KDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             SSGGGSTTSSTTTHHHHHTSGG
T ss_pred             hCHHHhcCCCCCCHHHHHcCcc
Confidence            9999999     9999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=6.7e-31  Score=191.78  Aligned_cols=160  Identities=23%  Similarity=0.331  Sum_probs=119.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-CCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++. ++.++++|||.+..............+++.|++||
T Consensus       117 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE  193 (295)
T 2clq_A          117 LKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE  193 (295)
T ss_dssp             CTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHH
T ss_pred             CCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChh
Confidence            3567889999999999999999999   9999999999999987 88999999999977654333334456888999999


Q ss_pred             ccccCC--CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTMK--ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~~--~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      .+.+..  ++.++|+||||+++|++++|..||..........  .. .......+..+.  ..    ...+.+++.+||+
T Consensus       194 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~-~~~~~~~~~~~~--~~----~~~~~~li~~~l~  264 (295)
T 2clq_A          194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM--FK-VGMFKVHPEIPE--SM----SAEAKAFILKCFE  264 (295)
T ss_dssp             HHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH--HH-HHHHCCCCCCCT--TS----CHHHHHHHHHTTC
T ss_pred             hhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH--Hh-hccccccccccc--cC----CHHHHHHHHHHcc
Confidence            987643  7889999999999999999999996543211100  00 001111112221  11    2247889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||++|||+++++++
T Consensus       265 ~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          265 PDPDKRACANDLLVD  279 (295)
T ss_dssp             SSTTTSCCHHHHHTS
T ss_pred             CChhhCCCHHHHhcC
Confidence            999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=3.4e-31  Score=201.10  Aligned_cols=169  Identities=18%  Similarity=0.231  Sum_probs=126.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee----cCCCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL----DLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      .+++.+++.++.|++.||+|||+.   +++|+||||+||++    +.++.++|+|||++....... ......+++.|+|
T Consensus       108 ~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~-~~~~~~gt~~y~a  183 (396)
T 4eut_A          108 GLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLH  183 (396)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG-GSSCSSSCCTTCC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC-ccccccCCccccC
Confidence            489999999999999999999999   99999999999999    777789999999997665432 2234568899999


Q ss_pred             Cccccc--------CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhc-----------------CCC
Q 042876           82 PELAYT--------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEM-----------------LDP  136 (179)
Q Consensus        82 pe~~~~--------~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-----------------~~~  136 (179)
                      ||.+.+        ..++.++|+||||+++|++++|..||....................                 ...
T Consensus       184 PE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  263 (396)
T 4eut_A          184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG  263 (396)
T ss_dssp             HHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEES
T ss_pred             HHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCc
Confidence            998864        4567899999999999999999999965432111100000000000                 011


Q ss_pred             CCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          137 RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ..+............+.+++.+||+.||++||+++++++.++
T Consensus       264 ~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~  305 (396)
T 4eut_A          264 DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (396)
T ss_dssp             SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence            222223333555667889999999999999999999988764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.97  E-value=4e-31  Score=191.91  Aligned_cols=154  Identities=21%  Similarity=0.345  Sum_probs=123.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+........ .....+++.|+|||.
T Consensus       117 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~  192 (284)
T 2a19_B          117 EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQ  192 (284)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC-CCCCCSCCTTSCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcchhheecccccc-ccccCCcccccChhh
Confidence            5789999999999999999999999   999999999999999999999999999877654332 233468899999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|++++|..|+.....          ..........+.  ..    ...+.+++.+||+.||
T Consensus       193 ~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----------~~~~~~~~~~~~--~~----~~~~~~li~~~l~~dp  256 (284)
T 2a19_B          193 ISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----------FFTDLRDGIISD--IF----DKKEKTLLQKLLSKKP  256 (284)
T ss_dssp             HHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH----------HHHHHHTTCCCT--TS----CHHHHHHHHHHTCSSG
T ss_pred             hccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH----------HHHHhhcccccc--cC----CHHHHHHHHHHccCCh
Confidence            9988899999999999999999999988643210          011111111111  11    1237789999999999


Q ss_pred             CCCCCHHHHHHHhh
Q 042876          165 ESRPTMKIVSQQLR  178 (179)
Q Consensus       165 ~~Rps~~~~~~~l~  178 (179)
                      .+|||+.+++++|+
T Consensus       257 ~~Rps~~e~l~~l~  270 (284)
T 2a19_B          257 EDRPNTSEILRTLT  270 (284)
T ss_dssp             GGSCCHHHHHHHHH
T ss_pred             hhCcCHHHHHHHHH
Confidence            99999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.97  E-value=2.1e-31  Score=196.44  Aligned_cols=163  Identities=25%  Similarity=0.372  Sum_probs=122.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---------ccccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---------WTEFA   74 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---------~~~~~   74 (179)
                      ...+++.+++.++.|+++||.|||+.   +++|+||+|+||+++.++.++++|||.+.........         .....
T Consensus       128 ~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  204 (317)
T 2buj_A          128 GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR  204 (317)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccccccccccccccccccccc
Confidence            46789999999999999999999999   9999999999999999999999999988654321111         11234


Q ss_pred             CCCCCCCCcccccCC---CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHH
Q 042876           75 GTYGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLIS  151 (179)
Q Consensus        75 ~~~~~~~pe~~~~~~---~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (179)
                      +++.|+|||.+.+..   ++.++|+||||+++|++++|..||.........   ........  ...+.....    ...
T Consensus       205 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~--~~~~~~~~~----~~~  275 (317)
T 2buj_A          205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS---VALAVQNQ--LSIPQSPRH----SSA  275 (317)
T ss_dssp             SCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---HHHHHHCC----CCCCTTS----CHH
T ss_pred             CCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---hhHHhhcc--CCCCccccC----CHH
Confidence            688899999987554   688999999999999999999999643211110   00111111  111111112    224


Q ss_pred             HHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          152 IVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       152 ~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +.+++.+||+.||.+|||+++++++|+
T Consensus       276 l~~li~~~l~~dp~~Rps~~~ll~~L~  302 (317)
T 2buj_A          276 LWQLLNSMMTVDPHQRPHIPLLLSQLE  302 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence            888999999999999999999999985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=8.8e-31  Score=190.70  Aligned_cols=159  Identities=28%  Similarity=0.416  Sum_probs=116.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeee---cCCCceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLL---DLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      ...+++..++.++.|++.||+|||+.   +++|+||+|+||++   +.++.++|+|||++....... ......+++.|+
T Consensus       118 ~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~  193 (285)
T 3is5_A          118 GKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HSTNAAGTALYM  193 (285)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----------CTTGGGC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc-cCcCcccccCcC
Confidence            36789999999999999999999999   99999999999999   456789999999997654332 223456788999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |||.+. ..++.++|+||||++++++++|..||........      .................   ....+.+++.+||
T Consensus       194 aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L  263 (285)
T 3is5_A          194 APEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV------QQKATYKEPNYAVECRP---LTPQAVDLLKQML  263 (285)
T ss_dssp             CHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCCCCC--CC---CCHHHHHHHHHHT
T ss_pred             ChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH------HhhhccCCcccccccCc---CCHHHHHHHHHHc
Confidence            999875 4688999999999999999999999975431110      01111111111111110   1224778999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.||.+|||+.|+++|
T Consensus       264 ~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          264 TKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CSCTTTSCCHHHHHTS
T ss_pred             cCChhhCcCHHHHhcC
Confidence            9999999999999976

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=2.6e-31  Score=203.80  Aligned_cols=163  Identities=20%  Similarity=0.248  Sum_probs=123.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~p   82 (179)
                      ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......... .....+++.|+||
T Consensus       169 ~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~AP  245 (437)
T 4aw2_A          169 EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP  245 (437)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeCh
Confidence            45799999999999999999999999   9999999999999999999999999999765543322 2335789999999


Q ss_pred             cccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHh
Q 042876           83 ELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        83 e~~~-----~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      |.+.     ...++.++|+||||+++|+|++|..||...+.........  .....  ..++.....   ...++.+||.
T Consensus       246 E~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~--~~~p~~~~~---~s~~~~dLi~  318 (437)
T 4aw2_A          246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--NHKER--FQFPTQVTD---VSENAKDLIR  318 (437)
T ss_dssp             HHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--THHHH--CCCCSSCCC---SCHHHHHHHH
T ss_pred             HHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh--hcccc--ccCCccccc---CCHHHHHHHH
Confidence            9986     4567899999999999999999999997543221111100  00000  111211111   1223788899


Q ss_pred             cccCcCCCC--CCCHHHHHHH
Q 042876          158 SCLNESPES--RPTMKIVSQQ  176 (179)
Q Consensus       158 ~cl~~~p~~--Rps~~~~~~~  176 (179)
                      +||..+|++  ||+++++++|
T Consensus       319 ~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          319 RLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             TTSSCGGGCTTTTTTHHHHTS
T ss_pred             HHhcccccccCCCCHHHHhCC
Confidence            999888888  9999999886

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=1e-30  Score=190.58  Aligned_cols=158  Identities=20%  Similarity=0.333  Sum_probs=120.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCC--cccCCCCCCCeeec-CCCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPP--IVHRDLSSKNLLLD-LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.|++.||.|||+.   +  ++|+||+|+||+++ .++.++|+|||++......  ......+++.|+|
T Consensus       124 ~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~a  198 (290)
T 1t4h_A          124 KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMA  198 (290)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc--ccccccCCcCcCC
Confidence            5689999999999999999999998   7  99999999999997 7889999999999654432  2234568899999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+ .++.++|+||||++++++++|..||.......       ...........+.  .........+.+++.+||+
T Consensus       199 PE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~  268 (290)
T 1t4h_A          199 PEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKPA--SFDKVAIPEVKEIIEGCIR  268 (290)
T ss_dssp             GGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCCG--GGGGCCCHHHHHHHHHHSC
T ss_pred             HHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-------HHHHHHhccCCcc--ccCCCCCHHHHHHHHHHcc
Confidence            998864 58899999999999999999999996533211       1111111111110  0001111248889999999


Q ss_pred             cCCCCCCCHHHHHHHh
Q 042876          162 ESPESRPTMKIVSQQL  177 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l  177 (179)
                      .||.+|||++++++|-
T Consensus       269 ~dp~~Rps~~ell~h~  284 (290)
T 1t4h_A          269 QNKDERYSIKDLLNHA  284 (290)
T ss_dssp             SSGGGSCCHHHHHTSG
T ss_pred             CChhhCCCHHHHhhCc
Confidence            9999999999999863

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=7.3e-31  Score=204.37  Aligned_cols=159  Identities=26%  Similarity=0.355  Sum_probs=121.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC---CceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE---YEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      .++++..++.++.||+.||.|||+.   +++||||||+||+++.+   +.++|+|||++....... ......+++.|+|
T Consensus       131 ~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~a  206 (494)
T 3lij_A          131 MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-KMKERLGTAYYIA  206 (494)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-CBCCCCSCTTTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-cccccCCCcCeeC
Confidence            4689999999999999999999999   99999999999999754   459999999997765432 2334578999999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+. ..++.++|+||+|+++|++++|..||.......        ....+...........+......+.+++.+||+
T Consensus       207 PE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  277 (494)
T 3lij_A          207 PEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--------ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQ  277 (494)
T ss_dssp             HHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTC
T ss_pred             HHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCchhcccCCHHHHHHHHHHCC
Confidence            99886 468999999999999999999999997543211        111111111111112222223357889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||.+|||+.++++|
T Consensus       278 ~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          278 FDSQRRISAQQALEH  292 (494)
T ss_dssp             SSTTTSCCHHHHHTC
T ss_pred             CChhhCccHHHHhcC
Confidence            999999999999976

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=1.7e-31  Score=195.67  Aligned_cols=161  Identities=25%  Similarity=0.407  Sum_probs=118.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++..............+++.|+|||
T Consensus       111 ~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE  187 (302)
T 2j7t_A          111 DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE  187 (302)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCe
Confidence            35689999999999999999999999   999999999999999999999999998753221111122346788999999


Q ss_pred             ccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           84 LAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        84 ~~~-----~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      .+.     +..++.++|+||||+++|++++|..||........     .........+.......    ....+.+++.+
T Consensus       188 ~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~----~~~~l~~li~~  258 (302)
T 2j7t_A          188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKSDPPTLLTPSK----WSVEFRDFLKI  258 (302)
T ss_dssp             HHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCCCCCSSGGG----SCHHHHHHHHH
T ss_pred             eeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----HHHHhccCCcccCCccc----cCHHHHHHHHH
Confidence            873     55678899999999999999999999975432110     01111111111111111    12347889999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||+.||.+|||++++++|
T Consensus       259 ~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          259 ALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             HSCSCTTTSCCHHHHTTS
T ss_pred             HcccChhhCCCHHHHhcC
Confidence            999999999999999876

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=8.1e-32  Score=197.22  Aligned_cols=165  Identities=28%  Similarity=0.456  Sum_probs=118.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-----CcccccCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-----NWTEFAGTYG   78 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~   78 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+........     ......+++.
T Consensus       115 ~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  191 (303)
T 2vwi_A          115 SGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC  191 (303)
T ss_dssp             TCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCcc
Confidence            35689999999999999999999999   999999999999999999999999999876543211     1233467889


Q ss_pred             CCCCccccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCC---CCccHHHHHHHHHH
Q 042876           79 YVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPA---PSRSVQEKLISIVK  154 (179)
Q Consensus        79 ~~~pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  154 (179)
                      |+|||.+.+ ..++.++|+||||+++|++++|..||..........    ..... ..+....   ...........+.+
T Consensus       192 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  266 (303)
T 2vwi_A          192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM----LTLQN-DPPSLETGVQDKEMLKKYGKSFRK  266 (303)
T ss_dssp             TCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH----HHHTS-SCCCTTC-----CCCCCCCHHHHH
T ss_pred             ccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH----HHhcc-CCCccccccccchhhhhhhHHHHH
Confidence            999998875 467899999999999999999999997643221100    00000 0000000   00000011224788


Q ss_pred             HHhcccCcCCCCCCCHHHHHHH
Q 042876          155 VAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       155 li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ++.+||+.||.+|||+.++++|
T Consensus       267 li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          267 MISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHccCChhhCcCHHHHhhC
Confidence            9999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=8.9e-31  Score=196.14  Aligned_cols=169  Identities=18%  Similarity=0.157  Sum_probs=122.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCcccCCCCCCCeeecC-CCceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLH--HDCFPPIVHRDLSSKNLLLDL-EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh--~~~~~~~~h~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      ...+++..++.++.|++.||.|||  +.   +++|+||||+||+++. ++.++|+|||++........ .....+++.|+
T Consensus       123 ~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~  198 (360)
T 3e3p_A          123 QVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP-NVAYICSRYYR  198 (360)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC-CCSTTSCGGGC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC-cccccCCccee
Confidence            456889999999999999999999  87   9999999999999986 88999999999977654332 23456788999


Q ss_pred             CCcccccCC-CCcchhhHHHHHHHHHHHhCCCCCcccccccccccch-------hhhhhhcCCCCC-----CCCCccHH-
Q 042876           81 APELAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT-------DIELDEMLDPRL-----PAPSRSVQ-  146 (179)
Q Consensus        81 ~pe~~~~~~-~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~-----~~~~~~~~-  146 (179)
                      |||.+.+.. ++.++|+||||+++|++++|..||.............       ............     ......+. 
T Consensus       199 aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (360)
T 3e3p_A          199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSN  278 (360)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHH
T ss_pred             CHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCccc
Confidence            999886554 7999999999999999999999997543211100000       000000000000     00000000 


Q ss_pred             -------HHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          147 -------EKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       147 -------~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                             .....+.+|+.+||+.||.+|||+.|+++|
T Consensus       279 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          279 VFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                   123458899999999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.97  E-value=1.1e-31  Score=204.47  Aligned_cols=162  Identities=21%  Similarity=0.271  Sum_probs=123.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++........ ......+++.|+|||
T Consensus       163 ~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE  239 (410)
T 3v8s_A          163 YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE  239 (410)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHH
Confidence            4689999999999999999999999   999999999999999999999999999976654332 123467899999999


Q ss_pred             ccccCC----CCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           84 LAYTMK----ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        84 ~~~~~~----~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      .+.+..    ++.++|+||||+++|+|++|..||...+.........  .....  ..++.....    ..++.+||.+|
T Consensus       240 ~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~--~~~p~~~~~----s~~~~~li~~l  311 (410)
T 3v8s_A          240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM--NHKNS--LTFPDDNDI----SKEAKNLICAF  311 (410)
T ss_dssp             HHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--THHHH--CCCCTTCCC----CHHHHHHHHHH
T ss_pred             HhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH--hcccc--ccCCCcccc----cHHHHHHHHHH
Confidence            988665    7789999999999999999999997543211111000  00000  112211111    12378899999


Q ss_pred             cCcCCCC--CCCHHHHHHHh
Q 042876          160 LNESPES--RPTMKIVSQQL  177 (179)
Q Consensus       160 l~~~p~~--Rps~~~~~~~l  177 (179)
                      |..+|.+  ||+++++++|-
T Consensus       312 L~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          312 LTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             SSCGGGCTTSSCHHHHHTSG
T ss_pred             ccChhhhCCCCCHHHHhcCc
Confidence            9999988  99999999873

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.97  E-value=4.8e-31  Score=207.14  Aligned_cols=160  Identities=27%  Similarity=0.425  Sum_probs=123.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      +.+++.+++.++.||+.||+|||++   +++||||+|+||+++.++.+||+|||++........ ......++..|++||
T Consensus       358 ~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE  434 (535)
T 2h8h_A          358 KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE  434 (535)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHH
Confidence            4589999999999999999999999   999999999999999999999999999976542211 112234567899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||+++|+|++ |..||........     .......  .+.+....+.    ..+.+||.+||+.
T Consensus       435 ~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~-----~~~i~~~--~~~~~~~~~~----~~l~~li~~cl~~  503 (535)
T 2h8h_A          435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQVERG--YRMPCPPECP----ESLHDLMCQCWRK  503 (535)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH-----HHHHHTT--CCCCCCTTCC----HHHHHHHHHHTCS
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHcC--CCCCCCCCCC----HHHHHHHHHHcCC
Confidence            9988889999999999999999999 8999975432111     0011111  1122222222    2478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||++|||+++|++.|+
T Consensus       504 dP~~RPt~~~l~~~L~  519 (535)
T 2h8h_A          504 EPEERPTFEYLQAFLE  519 (535)
T ss_dssp             SGGGSCCHHHHHHHHH
T ss_pred             ChhHCcCHHHHHHHHH
Confidence            9999999999999885

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.97  E-value=9.2e-31  Score=205.87  Aligned_cols=160  Identities=23%  Similarity=0.278  Sum_probs=124.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++....... ......+++.|+|||.
T Consensus       281 ~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APEv  356 (576)
T 2acx_A          281 AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEV  356 (576)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-CEECCCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc-cccccCCCccccCHHH
Confidence            4599999999999999999999999   99999999999999999999999999997765432 2234578999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||||+++|+|++|..||..........  ............++.  ..    ..++.+||.+||+.||
T Consensus       357 l~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i~~~i~~~~~~~p~--~~----s~~~~dLI~~lL~~dP  428 (576)
T 2acx_A          357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVERLVKEVPEEYSE--RF----SPQARSLCSQLLCKDP  428 (576)
T ss_dssp             HTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HHHHHHHHCCCCCCT--TS----CHHHHHHHHHHTCSSG
T ss_pred             HcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HHHHHhhcccccCCc--cC----CHHHHHHHHHhccCCH
Confidence            998889999999999999999999999997543211100  001111111112221  11    2247889999999999


Q ss_pred             CCCC-----CHHHHHHH
Q 042876          165 ESRP-----TMKIVSQQ  176 (179)
Q Consensus       165 ~~Rp-----s~~~~~~~  176 (179)
                      .+||     +++++++|
T Consensus       429 ~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          429 AERLGCRGGSAREVKEH  445 (576)
T ss_dssp             GGSTTCSSSHHHHHHTS
T ss_pred             HHcCCCCCCCHHHHHhC
Confidence            9999     78999876

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=9.5e-31  Score=204.18  Aligned_cols=160  Identities=24%  Similarity=0.344  Sum_probs=123.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC---ceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY---EAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.||+.||.|||+.   +++||||||+||+++.++   .++|+|||++....... ......+++.|+|
T Consensus       141 ~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~a  216 (504)
T 3q5i_A          141 HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLGTAYYIA  216 (504)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS-CBCCCCSCTTTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC-ccccccCCcCCCC
Confidence            5689999999999999999999999   999999999999998775   69999999997765432 2344578999999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+ .++.++|+||+|+++|++++|..||.......        ....+...........+......+.+++.+||+
T Consensus       217 PE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  287 (504)
T 3q5i_A          217 PEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--------IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLT  287 (504)
T ss_dssp             HHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTC
T ss_pred             HHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCCCccccCCCCHHHHHHHHHHcC
Confidence            999864 68899999999999999999999997543211        111111111111111112223458889999999


Q ss_pred             cCCCCCCCHHHHHHHh
Q 042876          162 ESPESRPTMKIVSQQL  177 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l  177 (179)
                      .||.+|||++|+++|=
T Consensus       288 ~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          288 YDYNKRCTAEEALNSR  303 (504)
T ss_dssp             SSTTTSCCHHHHHTSH
T ss_pred             CChhHCCCHHHHhcCH
Confidence            9999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=5.3e-31  Score=196.91  Aligned_cols=170  Identities=23%  Similarity=0.223  Sum_probs=120.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC----------ccccc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN----------WTEFA   74 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----------~~~~~   74 (179)
                      +.+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.........          .....
T Consensus       107 ~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~  183 (353)
T 2b9h_A          107 QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV  183 (353)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhcc
Confidence            4689999999999999999999999   9999999999999999999999999999765432211          12246


Q ss_pred             CCCCCCCCccccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccc----------------cchhhhhhh---cC
Q 042876           75 GTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS----------------LNTDIELDE---ML  134 (179)
Q Consensus        75 ~~~~~~~pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~----------------~~~~~~~~~---~~  134 (179)
                      +++.|+|||.+.+ ..++.++|+||||++++++++|..||..........                .........   ..
T Consensus       184 gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (353)
T 2b9h_A          184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSL  263 (353)
T ss_dssp             CCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTS
T ss_pred             ccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcc
Confidence            7889999998754 678899999999999999999999997543211000                000000000   00


Q ss_pred             CCCC-CCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          135 DPRL-PAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       135 ~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      .... ............++.+++.+||+.||.+|||++++++|-
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (353)
T 2b9h_A          264 PMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP  307 (353)
T ss_dssp             CCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             cCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence            0000 000000011233578899999999999999999999863

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=1.7e-30  Score=188.06  Aligned_cols=156  Identities=23%  Similarity=0.357  Sum_probs=113.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+....... ......+++.|++||.
T Consensus       106 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  181 (276)
T 2h6d_A          106 GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSCGSPNYAAPEV  181 (276)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------------CCTGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc-ceecccCCccccCHHH
Confidence            4688999999999999999999999   99999999999999999999999999987655432 1233467889999999


Q ss_pred             cccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +.+..+ +.++|+||||++++++++|..||.......        ............+...    ...+.+++.+||+.|
T Consensus       182 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~  249 (276)
T 2h6d_A          182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--------LFKKIRGGVFYIPEYL----NRSVATLLMHMLQVD  249 (276)
T ss_dssp             GTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTTS----CHHHHHHHHHHTCSS
T ss_pred             HcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--------HHHHhhcCcccCchhc----CHHHHHHHHHHccCC
Confidence            987665 689999999999999999999996532111        0111111111111111    123788999999999


Q ss_pred             CCCCCCHHHHHHH
Q 042876          164 PESRPTMKIVSQQ  176 (179)
Q Consensus       164 p~~Rps~~~~~~~  176 (179)
                      |.+|||++++++|
T Consensus       250 p~~Rps~~~~l~h  262 (276)
T 2h6d_A          250 PLKRATIKDIREH  262 (276)
T ss_dssp             GGGSCCHHHHHHS
T ss_pred             hhhCCCHHHHHhC
Confidence            9999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.97  E-value=1.2e-30  Score=193.25  Aligned_cols=159  Identities=25%  Similarity=0.387  Sum_probs=120.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC---CCceeEccccCccccCCCCC--CcccccCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL---EYEAHVADFGIAKFLKPDSS--NWTEFAGTYGY   79 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~---~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~   79 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.   +..++++|||++........  ......+++.|
T Consensus       135 ~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y  211 (327)
T 2yfx_A          135 SSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW  211 (327)
T ss_dssp             TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGG
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcce
Confidence            4589999999999999999999999   9999999999999984   44699999999875433221  12334567889


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCC-CCCCCCCccHHHHHHHHHHHHh
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLD-PRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      +|||.+.+..++.++|+||||+++|++++ |..||.......        ....... ..........    ..+.+++.
T Consensus       212 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~----~~l~~li~  279 (327)
T 2yfx_A          212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--------VLEFVTSGGRMDPPKNCP----GPVYRIMT  279 (327)
T ss_dssp             CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHTTCCCCCCTTCC----HHHHHHHH
T ss_pred             eCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--------HHHHHhcCCCCCCCCCCC----HHHHHHHH
Confidence            99999988889999999999999999998 999986543211        0111111 1111111222    24788999


Q ss_pred             cccCcCCCCCCCHHHHHHHhh
Q 042876          158 SCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +||+.||.+|||+++++++|+
T Consensus       280 ~~l~~dp~~Rps~~~ll~~l~  300 (327)
T 2yfx_A          280 QCWQHQPEDRPNFAIILERIE  300 (327)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhcCChhhCcCHHHHHHHHH
Confidence            999999999999999999885

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.97  E-value=2.8e-30  Score=192.64  Aligned_cols=161  Identities=20%  Similarity=0.288  Sum_probs=122.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ...+++..++.++.|++.||.|||+ .   |++|+||+|+||+++.++.++|+|||.+......  ......++..|+||
T Consensus       145 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aP  219 (348)
T 2pml_X          145 TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPP  219 (348)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCG
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCc
Confidence            4678999999999999999999999 8   9999999999999999999999999999765433  22345678899999


Q ss_pred             cccccC-CCCc-chhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCC--CCCC-------------CccH
Q 042876           83 ELAYTM-KITE-KCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPR--LPAP-------------SRSV  145 (179)
Q Consensus        83 e~~~~~-~~~~-~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-------------~~~~  145 (179)
                      |.+.+. .++. ++|+||||++++++++|..||......       ......+....  .+..             ....
T Consensus       220 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (348)
T 2pml_X          220 EFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSN  292 (348)
T ss_dssp             GGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-------HHHHHHHTSCCCCCCCSSSSSTTTTCC-------
T ss_pred             hhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHhccCcCCccchhhhhccccccccccch
Confidence            999876 5555 899999999999999999999754321       00011111110  1100             0000


Q ss_pred             HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ......+.+++.+||+.||.+|||++++++|
T Consensus       293 ~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          293 NFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             -CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1123358889999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=3.6e-31  Score=192.80  Aligned_cols=153  Identities=24%  Similarity=0.435  Sum_probs=116.5

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc--------eeEccccCccccCCCCCCcccccCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE--------AHVADFGIAKFLKPDSSNWTEFAGTY   77 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~   77 (179)
                      .+++..++.++.|+++||.|||+.   +++|+||||+||+++.++.        ++++|||.+......    ....+++
T Consensus       109 ~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~  181 (289)
T 4fvq_A          109 CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----DILQERI  181 (289)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH----HHHHHTT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc----cccCCcC
Confidence            489999999999999999999999   9999999999999988877        999999998654322    2345678


Q ss_pred             CCCCCccccc-CCCCcchhhHHHHHHHHHHHhCC-CCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHH
Q 042876           78 GYVAPELAYT-MKITEKCDVYSFGVLALEVIKGK-HPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKV  155 (179)
Q Consensus        78 ~~~~pe~~~~-~~~~~~~D~~slg~~~~~l~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  155 (179)
                      .|+|||.+.+ ..++.++|+||||+++|++++|. .|+.......      ...... .....+...      ...+.++
T Consensus       182 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~------~~~~~~-~~~~~~~~~------~~~l~~l  248 (289)
T 4fvq_A          182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR------KLQFYE-DRHQLPAPK------AAELANL  248 (289)
T ss_dssp             TTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHH-TTCCCCCCS------SCTTHHH
T ss_pred             cccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH------HHHHhh-ccCCCCCCC------CHHHHHH
Confidence            8999999887 66899999999999999999954 4443322110      000000 011111111      1137789


Q ss_pred             HhcccCcCCCCCCCHHHHHHHhh
Q 042876          156 AFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       156 i~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +.+||+.||.+|||+++++++|+
T Consensus       249 i~~~l~~dp~~Rps~~~ll~~l~  271 (289)
T 4fvq_A          249 INNCMDYEPDHRPSFRAIIRDLN  271 (289)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHHHH
Confidence            99999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.97  E-value=8e-31  Score=199.81  Aligned_cols=161  Identities=24%  Similarity=0.285  Sum_probs=120.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||++......... .....+++.|+|||
T Consensus       157 ~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE  233 (412)
T 2vd5_A          157 ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE  233 (412)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHH
Confidence            4789999999999999999999999   9999999999999999999999999999776543322 23357899999999


Q ss_pred             ccc-------cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHH
Q 042876           84 LAY-------TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVA  156 (179)
Q Consensus        84 ~~~-------~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  156 (179)
                      .+.       +..++.++|+|||||++|+|++|..||...+........  .......  .++.....   ...++.++|
T Consensus       234 ~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i--~~~~~~~--~~p~~~~~---~s~~~~dli  306 (412)
T 2vd5_A          234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI--VHYKEHL--SLPLVDEG---VPEEARDFI  306 (412)
T ss_dssp             HHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HTHHHHC--CCC----C---CCHHHHHHH
T ss_pred             HHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH--HhcccCc--CCCccccC---CCHHHHHHH
Confidence            987       346789999999999999999999999654321111000  0000111  11111011   122478899


Q ss_pred             hcccCcCCCCC---CCHHHHHHH
Q 042876          157 FSCLNESPESR---PTMKIVSQQ  176 (179)
Q Consensus       157 ~~cl~~~p~~R---ps~~~~~~~  176 (179)
                      .+||. +|.+|   |+++++++|
T Consensus       307 ~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          307 QRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHcC-ChhhcCCCCCHHHHhcC
Confidence            99999 99998   599999876

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=6.1e-31  Score=194.94  Aligned_cols=167  Identities=19%  Similarity=0.230  Sum_probs=120.2

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-ceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++ .++|+|||++....... ......++..|++||.
T Consensus       126 ~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~  201 (330)
T 3nsz_A          126 TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRYFKGPEL  201 (330)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CCCSCCSCGGGCCHHH
T ss_pred             hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-ccccccccccccChhh
Confidence            578899999999999999999999   999999999999999776 79999999997655433 2334567888999999


Q ss_pred             ccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-----hhhh---------------hhhcCCCCCCCC--
Q 042876           85 AYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-----TDIE---------------LDEMLDPRLPAP--  141 (179)
Q Consensus        85 ~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-----~~~~---------------~~~~~~~~~~~~--  141 (179)
                      +.+ ..++.++|+||||+++++|++|..||............     ....               ............  
T Consensus       202 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (330)
T 3nsz_A          202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE  281 (330)
T ss_dssp             HTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGG
T ss_pred             hcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchh
Confidence            876 56889999999999999999999998432211000000     0000               000000000000  


Q ss_pred             ----CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          142 ----SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       142 ----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                          .........++.+|+.+||+.||.+|||++|+++|
T Consensus       282 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          282 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             GGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                00001123358889999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=2.9e-31  Score=199.10  Aligned_cols=169  Identities=21%  Similarity=0.217  Sum_probs=116.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||
T Consensus       128 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE  203 (362)
T 3pg1_A          128 RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPE  203 (362)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCTTC----------------CGGGCCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEecCccccccccc-ccceecccceecCcH
Confidence            34689999999999999999999999   99999999999999999999999999997544322 223356788899999


Q ss_pred             cccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc---------------hhhhhhhcCCCCCCC-CCccH-
Q 042876           84 LAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN---------------TDIELDEMLDPRLPA-PSRSV-  145 (179)
Q Consensus        84 ~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~-~~~~~-  145 (179)
                      .+.+ ..++.++|+||||+++|++++|..||............               ............... ..... 
T Consensus       204 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (362)
T 3pg1_A          204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT  283 (362)
T ss_dssp             HHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHH
T ss_pred             HhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHH
Confidence            8876 66889999999999999999999999754321100000               000000111110000 00011 


Q ss_pred             ---HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 ---QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ---~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                         ......+.+++.+||+.||.+|||++++++|
T Consensus       284 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          284 AVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence               1112347889999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=9.6e-31  Score=193.82  Aligned_cols=167  Identities=23%  Similarity=0.373  Sum_probs=123.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++.........   .....++..|+|
T Consensus       140 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  216 (326)
T 2w1i_A          140 ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA  216 (326)
T ss_dssp             TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEEC
Confidence            4589999999999999999999999   9999999999999999999999999999876543321   122345667999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccc-------cccccchhhhhhhcC--CCCCCCCCccHHHHHHHH
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSI-------SSSSLNTDIELDEML--DPRLPAPSRSVQEKLISI  152 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  152 (179)
                      ||.+.+..++.++|+||||++++++++|..|+......       ..............+  ..+.+.....    ...+
T Consensus       217 PE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l  292 (326)
T 2w1i_A          217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC----PDEI  292 (326)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTC----CHHH
T ss_pred             chhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcc----cHHH
Confidence            99998888899999999999999999999987532100       000000000111111  1112222222    2248


Q ss_pred             HHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          153 VKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       153 ~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      .++|.+||+.||++|||+.++++.|+
T Consensus       293 ~~li~~cl~~dP~~Rps~~el~~~L~  318 (326)
T 2w1i_A          293 YMIMTECWNNNVNQRPSFRDLALRVD  318 (326)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            88999999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=1.2e-30  Score=190.73  Aligned_cols=160  Identities=23%  Similarity=0.329  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||.+....... ......+++.|++||.
T Consensus       119 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  194 (298)
T 1phk_A          119 VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEI  194 (298)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhcCCCc-ccccccCCccccCHHH
Confidence            4689999999999999999999999   99999999999999999999999999997665432 2234567889999998


Q ss_pred             cc------cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           85 AY------TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        85 ~~------~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      +.      ...++.++|+||||++++++++|..||.......        .......................+.+++.+
T Consensus       195 ~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  266 (298)
T 1phk_A          195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSR  266 (298)
T ss_dssp             HHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCCTTTGGGSCHHHHHHHHH
T ss_pred             hccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--------HHHHHhcCCcccCcccccccCHHHHHHHHH
Confidence            75      3457889999999999999999999996543211        111111111111111112223358889999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||+.||.+|||+.++++|
T Consensus       267 ~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          267 FLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HCCSSGGGSCCHHHHTTS
T ss_pred             HccCCcccCCCHHHHHhC
Confidence            999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.97  E-value=3.5e-30  Score=193.52  Aligned_cols=156  Identities=13%  Similarity=0.099  Sum_probs=121.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-----------CCceeEccccCccccCCC--CCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-----------EYEAHVADFGIAKFLKPD--SSNW   70 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-----------~~~~~l~d~~~~~~~~~~--~~~~   70 (179)
                      ...+++.+++.++.||+.||+|||+.   +++||||||+||+++.           ++.++|+|||++......  ....
T Consensus       166 ~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~  242 (365)
T 3e7e_A          166 EKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF  242 (365)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEE
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCcee
Confidence            46799999999999999999999999   9999999999999988           899999999999754422  2223


Q ss_pred             ccccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHH
Q 042876           71 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLI  150 (179)
Q Consensus        71 ~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (179)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.........           ....+....  ..   .
T Consensus       243 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-----------~~~~~~~~~--~~---~  306 (365)
T 3e7e_A          243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-----------PEGLFRRLP--HL---D  306 (365)
T ss_dssp             CCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----------ECSCCTTCS--SH---H
T ss_pred             eeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-----------echhccccC--cH---H
Confidence            4457899999999999988999999999999999999999998543321100           111111111  12   2


Q ss_pred             HHHHHHhcccCcCCCCC-CCHHHHHHHhh
Q 042876          151 SIVKVAFSCLNESPESR-PTMKIVSQQLR  178 (179)
Q Consensus       151 ~~~~li~~cl~~~p~~R-ps~~~~~~~l~  178 (179)
                      .+.+++..|++.+|.+| |++.++.+.|+
T Consensus       307 ~~~~~~~~~l~~~p~~r~~~~~~l~~~l~  335 (365)
T 3e7e_A          307 MWNEFFHVMLNIPDCHHLPSLDLLRQKLK  335 (365)
T ss_dssp             HHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence            35677889999999999 57777776653

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.97  E-value=4.3e-31  Score=194.64  Aligned_cols=169  Identities=20%  Similarity=0.243  Sum_probs=119.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec-CCCceeEccccCccccCCCC---CCcccccCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD-LEYEAHVADFGIAKFLKPDS---SNWTEFAGTYGYV   80 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~   80 (179)
                      .++++..++.++.|++.||+|||+.   +++|+||+|+||+++ .++.++|+|||++.......   .......++..|+
T Consensus       115 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~  191 (320)
T 2i6l_A          115 GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR  191 (320)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTC
T ss_pred             CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCccccccccccccccccc
Confidence            5689999999999999999999999   999999999999997 56689999999997654321   1123345688899


Q ss_pred             CCccccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-------hhhhhhh-----------cCCCCCCCC
Q 042876           81 APELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-------TDIELDE-----------MLDPRLPAP  141 (179)
Q Consensus        81 ~pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-------~~~~~~~-----------~~~~~~~~~  141 (179)
                      +||.+.+ ..++.++|+||||+++|++++|..||............       .......           .........
T Consensus       192 aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (320)
T 2i6l_A          192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL  271 (320)
T ss_dssp             CHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCH
T ss_pred             CcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCCh
Confidence            9998765 67889999999999999999999999754321100000       0000000           000000000


Q ss_pred             CccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          142 SRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       142 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .........++.+++.+||+.||.+|||++++++|
T Consensus       272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          272 TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            00001123358899999999999999999999886

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=3.2e-30  Score=189.88  Aligned_cols=159  Identities=27%  Similarity=0.410  Sum_probs=115.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~   81 (179)
                      .+.+++.+++.++.|+++||.|||+.   +++|+||+|+||+++ ++.++|+|||++........  ......+++.|+|
T Consensus       121 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  196 (313)
T 3cek_A          121 KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP  196 (313)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCC
Confidence            35689999999999999999999999   999999999999996 47899999999976643322  1233467899999


Q ss_pred             Cccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCC--CCCCccHHHH
Q 042876           82 PELAYT-----------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL--PAPSRSVQEK  148 (179)
Q Consensus        82 pe~~~~-----------~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  148 (179)
                      ||.+.+           ..++.++|+||||+++|++++|..||......       .........+..  ......    
T Consensus       197 PE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~----  265 (313)
T 3cek_A          197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISKLHAIIDPNHEIEFPDIP----  265 (313)
T ss_dssp             HHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHHHHCTTSCCCCCCCS----
T ss_pred             HHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-------HHHHHHHHhcccccCCcccc----
Confidence            999875           35788999999999999999999999643211       111111111111  111111    


Q ss_pred             HHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          149 LISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       149 ~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      ...+.+++.+||+.||.+|||+++++++-
T Consensus       266 ~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          266 EKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             hHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            12478899999999999999999999863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=8.6e-31  Score=193.71  Aligned_cols=150  Identities=25%  Similarity=0.377  Sum_probs=119.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec-CCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD-LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|+++||+|||+.   +++|+||+|+||+++ .++.++|+|||++.......  .....+++.|+|||
T Consensus       144 ~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~--~~~~~gt~~y~aPE  218 (320)
T 3a99_A          144 GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPE  218 (320)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC--BCCCCSCGGGSCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc--ccCCCCCccCCChH
Confidence            4689999999999999999999999   999999999999998 67899999999997665322  23356888999999


Q ss_pred             ccccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..+ +.++|+||||+++|++++|..||......          .....  ..+  ...    ..++.+++.+||+.
T Consensus       219 ~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----------~~~~~--~~~--~~~----~~~~~~li~~~l~~  280 (320)
T 3a99_A          219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQV--FFR--QRV----SSECQHLIRWCLAL  280 (320)
T ss_dssp             HHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----------HHCCC--CCS--SCC----CHHHHHHHHHHTCS
T ss_pred             HhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh----------hcccc--ccc--ccC----CHHHHHHHHHHccC
Confidence            9877665 67899999999999999999999643210          00000  011  111    12478899999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 042876          163 SPESRPTMKIVSQQL  177 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l  177 (179)
                      ||++|||+++++++-
T Consensus       281 dp~~Rps~~~ll~hp  295 (320)
T 3a99_A          281 RPSDRPTFEEIQNHP  295 (320)
T ss_dssp             SGGGSCCHHHHHTSG
T ss_pred             ChhhCcCHHHHhcCH
Confidence            999999999999863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=2.5e-30  Score=190.59  Aligned_cols=161  Identities=23%  Similarity=0.308  Sum_probs=113.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ...+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|||++....... ......+++.|++|
T Consensus       118 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aP  193 (318)
T 2dyl_A          118 QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-AKDRSAGCAAYMAP  193 (318)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---------------CCTTCCH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-cccccCCCccccCh
Confidence            3578999999999999999999998 6   89999999999999999999999999987654332 22334678899999


Q ss_pred             cccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHh
Q 042876           83 ELAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        83 e~~~-----~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      |.+.     +..++.++|+||||+++|++++|..||.......    ...........+..+......    .++.+++.
T Consensus       194 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~----~~l~~li~  265 (318)
T 2dyl_A          194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF----EVLTKVLQEEPPLLPGHMGFS----GDFQSFVK  265 (318)
T ss_dssp             HHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HHHHHHHHSCCCCCCSSSCCC----HHHHHHHH
T ss_pred             hhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH----HHHHHHhccCCCCCCccCCCC----HHHHHHHH
Confidence            9984     4457889999999999999999999997532110    000111111111222111122    23788999


Q ss_pred             cccCcCCCCCCCHHHHHHH
Q 042876          158 SCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~  176 (179)
                      +||+.||.+|||++++++|
T Consensus       266 ~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          266 DCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HHTCSCTTTSCCHHHHTTS
T ss_pred             HHccCChhHCcCHHHHhhC
Confidence            9999999999999999876

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=7.7e-31  Score=193.98  Aligned_cols=162  Identities=25%  Similarity=0.303  Sum_probs=121.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc---eeEccccCccccCCCCCCcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      ...+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.++.   ++|+|||++....... ......+++.|+
T Consensus       108 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~  183 (322)
T 2ycf_A          108 NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYL  183 (322)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH-HHHHHHSCCTTC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccceeccccc-ccccccCCcCcc
Confidence            45789999999999999999999999   9999999999999987654   9999999997654321 122346788999


Q ss_pred             CCcccc---cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHh
Q 042876           81 APELAY---TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAF  157 (179)
Q Consensus        81 ~pe~~~---~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  157 (179)
                      |||.+.   +..++.++|+||||+++|++++|..||........  ..  .....   ................+.+++.
T Consensus       184 aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~--~~~~~---~~~~~~~~~~~~~~~~~~~li~  256 (322)
T 2ycf_A          184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK--DQITS---GKYNFIPEVWAEVSEKALDLVK  256 (322)
T ss_dssp             CHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HH--HHHHH---TCCCCCHHHHTTSCHHHHHHHH
T ss_pred             CchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HH--HHHHh---CccccCchhhhhcCHHHHHHHH
Confidence            999874   45678899999999999999999999975432111  00  01111   0111111111122345889999


Q ss_pred             cccCcCCCCCCCHHHHHHH
Q 042876          158 SCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       158 ~cl~~~p~~Rps~~~~~~~  176 (179)
                      +||+.||.+|||+.++++|
T Consensus       257 ~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          257 KLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHSCSSTTTSCCHHHHHTS
T ss_pred             HHcccCHhhCCCHHHHhhC
Confidence            9999999999999999876

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=1.9e-30  Score=199.13  Aligned_cols=156  Identities=24%  Similarity=0.392  Sum_probs=112.5

Q ss_pred             HHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC-------------CceeEccccCccccCCCCCC----ccc
Q 042876           10 SQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-------------YEAHVADFGIAKFLKPDSSN----WTE   72 (179)
Q Consensus        10 ~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~-------------~~~~l~d~~~~~~~~~~~~~----~~~   72 (179)
                      ..++.++.||+.||.|||+.   +++||||||+||+++.+             ..++|+|||++.........    ...
T Consensus       115 ~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~  191 (434)
T 2rio_A          115 YNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN  191 (434)
T ss_dssp             CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC-----------
T ss_pred             hhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecC
Confidence            35678999999999999999   99999999999999654             47999999999876543221    223


Q ss_pred             ccCCCCCCCCccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCC-CCCCCCCc
Q 042876           73 FAGTYGYVAPELAYT-------MKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLD-PRLPAPSR  143 (179)
Q Consensus        73 ~~~~~~~~~pe~~~~-------~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  143 (179)
                      ..+++.|+|||.+.+       ..++.++|+|||||++|++++ |..||.......      ......... +..+  ..
T Consensus       192 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------~~i~~~~~~~~~~~--~~  263 (434)
T 2rio_A          192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------SNIIRGIFSLDEMK--CL  263 (434)
T ss_dssp             ---CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH------HHHHHTCCCCCCCT--TC
T ss_pred             CCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH------HHHhcCCCCccccc--cc
Confidence            578999999999875       567899999999999999998 999996432111      011111111 1111  11


Q ss_pred             cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          144 SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       144 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......++.+++.+||+.||.+|||+.++++|
T Consensus       264 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          264 HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            123344568899999999999999999999876

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=2e-30  Score=194.44  Aligned_cols=163  Identities=23%  Similarity=0.335  Sum_probs=120.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..+++..+..++.|++.||.|||+ +   +++|+||+|+||+++.++.++|+|||++.......  .....+++.|+|||
T Consensus       126 ~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~gt~~y~aPE  200 (360)
T 3eqc_A          126 GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPE  200 (360)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC------CCCCTTCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccccc--ccCCCCCCCeECHH
Confidence            468899999999999999999998 5   89999999999999999999999999986543221  22346788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCccccccccccc----------------------------------chhhh
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL----------------------------------NTDIE  129 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~----------------------------------~~~~~  129 (179)
                      .+.+..++.++|+||||+++|++++|..||...........                                  .....
T Consensus       201 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (360)
T 3eqc_A          201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL  280 (360)
T ss_dssp             HHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHH
T ss_pred             HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhh
Confidence            99998999999999999999999999999965332110000                                  00000


Q ss_pred             hhhc---CCCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          130 LDEM---LDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       130 ~~~~---~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      ....   ..+..+.  .   ....++.+|+.+||+.||++|||++++++|-
T Consensus       281 ~~~~~~~~~~~~~~--~---~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          281 LDYIVNEPPPKLPS--G---VFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             HHHHHHSCCCCCCT--T---TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             hhHHhccCCCCCCc--c---cccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence            0000   0111111  1   1122488899999999999999999999863

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=3.7e-30  Score=197.34  Aligned_cols=159  Identities=25%  Similarity=0.340  Sum_probs=111.3

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-----CCceeEccccCccccCCCCC---CcccccCCC
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-----EYEAHVADFGIAKFLKPDSS---NWTEFAGTY   77 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-----~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~   77 (179)
                      .++..+++.++.||+.||.|||+.   +++||||||+||+++.     ...++|+|||++........   ......+++
T Consensus       114 ~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~  190 (432)
T 3p23_A          114 AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE  190 (432)
T ss_dssp             CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCT
T ss_pred             CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCc
Confidence            455567789999999999999999   9999999999999943     23578999999976653321   123456899


Q ss_pred             CCCCCcccc---cCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHH
Q 042876           78 GYVAPELAY---TMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIV  153 (179)
Q Consensus        78 ~~~~pe~~~---~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (179)
                      .|+|||.+.   +..++.++|+|||||+++++++ |..||.......     .. ...............   .....+.
T Consensus       191 ~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-----~~-~~~~~~~~~~~~~~~---~~~~~~~  261 (432)
T 3p23_A          191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----AN-ILLGACSLDCLHPEK---HEDVIAR  261 (432)
T ss_dssp             TSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-----HH-HHTTCCCCTTSCTTC---HHHHHHH
T ss_pred             CccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-----HH-HHhccCCccccCccc---cccHHHH
Confidence            999999987   3456789999999999999999 899985332110     00 011111111111111   2233467


Q ss_pred             HHHhcccCcCCCCCCCHHHHHHH
Q 042876          154 KVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       154 ~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ++|.+||+.||.+|||++++++|
T Consensus       262 ~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          262 ELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHhCCHhhCCCHHHHHhC
Confidence            89999999999999999999976

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=3.1e-30  Score=206.61  Aligned_cols=160  Identities=23%  Similarity=0.380  Sum_probs=121.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......... .....+++.|+|||
T Consensus       486 ~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE  562 (656)
T 2j0j_A          486 FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE  562 (656)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHH
Confidence            4689999999999999999999999   9999999999999999999999999999766433221 12234567899999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++|+||||+++|++++ |..||.........     .......  ..+......    ..+.+++.+||+.
T Consensus       563 ~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~-----~~i~~~~--~~~~~~~~~----~~l~~li~~~l~~  631 (656)
T 2j0j_A          563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-----GRIENGE--RLPMPPNCP----PTLYSLMTKCWAY  631 (656)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-----HHHHHTC--CCCCCTTCC----HHHHHHHHHHTCS
T ss_pred             HhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH-----HHHHcCC--CCCCCcccc----HHHHHHHHHHcCC
Confidence            9988889999999999999999997 99999754321110     0111111  111111222    2478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||.+|||+.++++.|+
T Consensus       632 dP~~RPs~~el~~~L~  647 (656)
T 2j0j_A          632 DPSRRPRFTELKAQLS  647 (656)
T ss_dssp             SGGGSCCHHHHHHHHH
T ss_pred             ChhHCcCHHHHHHHHH
Confidence            9999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=3.8e-30  Score=186.90  Aligned_cols=152  Identities=15%  Similarity=0.212  Sum_probs=115.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC-------------------CceeEccccCccccCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-------------------YEAHVADFGIAKFLKP   65 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~-------------------~~~~l~d~~~~~~~~~   65 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.+                   ..++++|||.+.....
T Consensus       110 ~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~  186 (289)
T 1x8b_A          110 SYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS  186 (289)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCC
Confidence            5689999999999999999999999   99999999999999844                   4789999999877654


Q ss_pred             CCCCcccccCCCCCCCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCcc
Q 042876           66 DSSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRS  144 (179)
Q Consensus        66 ~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (179)
                      ..    ...+++.|+|||.+.+. .++.++|+||||++++++++|..++.....        .........+..+.  ..
T Consensus       187 ~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--------~~~~~~~~~~~~~~--~~  252 (289)
T 1x8b_A          187 PQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--------WHEIRQGRLPRIPQ--VL  252 (289)
T ss_dssp             SC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--------HHHHHTTCCCCCSS--CC
T ss_pred             cc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--------HHHHHcCCCCCCCc--cc
Confidence            32    23578899999998765 556899999999999999998876532210        11111111111111  11


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                          ...+.+++.+||+.||++|||+.++++|-
T Consensus       253 ----~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          253 ----SQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             ----CHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             ----CHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence                12478899999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=2.1e-30  Score=191.99  Aligned_cols=161  Identities=25%  Similarity=0.357  Sum_probs=104.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..+..++.|++.||.|||+..  +++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||
T Consensus       119 ~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE  195 (327)
T 3aln_A          119 DDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPE  195 (327)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------
T ss_pred             cccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-ccccCCCCccccCce
Confidence            467899999999999999999999952  79999999999999999999999999997654332 223346788999999


Q ss_pred             cc----ccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCC---CCCCCCCccHHHHHHHHHHHH
Q 042876           84 LA----YTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD---PRLPAPSRSVQEKLISIVKVA  156 (179)
Q Consensus        84 ~~----~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li  156 (179)
                      .+    .+..++.++|+||||+++|++++|..||.........       ......   +.++..  ........+.+++
T Consensus       196 ~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~~~~~~~--~~~~~~~~l~~li  266 (327)
T 3aln_A          196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-------LTQVVKGDPPQLSNS--EEREFSPSFINFV  266 (327)
T ss_dssp             ----------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCCCCCCCC--SSCCCCHHHHHHH
T ss_pred             eeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-------HHHHhcCCCCCCCCc--ccccCCHHHHHHH
Confidence            98    4556889999999999999999999999754321100       011111   111110  0001122488899


Q ss_pred             hcccCcCCCCCCCHHHHHHH
Q 042876          157 FSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       157 ~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .+||+.||.+|||+++++++
T Consensus       267 ~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          267 NLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             HHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHhhCChhhCcCHHHHHhC
Confidence            99999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.96  E-value=4.2e-30  Score=187.15  Aligned_cols=159  Identities=24%  Similarity=0.348  Sum_probs=119.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC---CceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE---YEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.+   ..++++|||++........ .....+++.|++
T Consensus       116 ~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~y~a  191 (287)
T 2wei_A          116 KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIA  191 (287)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS-CSCHHHHHTTCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc-cccccCcccccC
Confidence            4689999999999999999999999   99999999999999654   4699999999876554322 223457788999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+ .++.++|+||||++++++++|..||.......        .......................+.+++.+||+
T Consensus       192 PE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  262 (287)
T 2wei_A          192 PEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--------ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT  262 (287)
T ss_dssp             HHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTC
T ss_pred             hHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcc
Confidence            998876 48899999999999999999999996543211        111111111111111111223348889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||.+|||+++++++
T Consensus       263 ~dp~~Rps~~ell~h  277 (287)
T 2wei_A          263 FHPSLRITATQCLEH  277 (287)
T ss_dssp             SSGGGSCCHHHHHHS
T ss_pred             cChhhCcCHHHHhcC
Confidence            999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.96  E-value=4.9e-30  Score=187.57  Aligned_cols=160  Identities=26%  Similarity=0.373  Sum_probs=112.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC--------------CCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--------------SNW   70 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--------------~~~   70 (179)
                      ..+++..++.++.|+++||+|||+.   +++|+||+|+||+++.++.++++|||.+.......              ...
T Consensus       111 ~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (303)
T 1zy4_A          111 LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL  187 (303)
T ss_dssp             GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------
T ss_pred             cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccccccccccc
Confidence            3567889999999999999999999   99999999999999999999999999987654221              112


Q ss_pred             ccccCCCCCCCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHH
Q 042876           71 TEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKL  149 (179)
Q Consensus        71 ~~~~~~~~~~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (179)
                      ....++..|+|||.+.+. .++.++|+||||+++|++++   ||.......    ........ ....++..  ......
T Consensus       188 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~----~~~~~~~~-~~~~~~~~--~~~~~~  257 (303)
T 1zy4_A          188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV----NILKKLRS-VSIEFPPD--FDDNKM  257 (303)
T ss_dssp             ------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH----HHHHHHHS-TTCCCCTT--CCTTTS
T ss_pred             ccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH----HHHHhccc-cccccCcc--ccccch
Confidence            334678899999998765 68899999999999999998   443211100    00001111 11111111  111122


Q ss_pred             HHHHHHHhcccCcCCCCCCCHHHHHHHh
Q 042876          150 ISIVKVAFSCLNESPESRPTMKIVSQQL  177 (179)
Q Consensus       150 ~~~~~li~~cl~~~p~~Rps~~~~~~~l  177 (179)
                      ..+.+++.+||+.||.+|||+.++++|-
T Consensus       258 ~~~~~li~~~l~~dp~~Rps~~~ll~h~  285 (303)
T 1zy4_A          258 KVEKKIIRLLIDHDPNKRPGARTLLNSG  285 (303)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred             HHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence            3478899999999999999999999863

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=9.2e-30  Score=187.32  Aligned_cols=150  Identities=25%  Similarity=0.386  Sum_probs=119.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec-CCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD-LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++ .++.++++|||++.......  .....++..|++||
T Consensus       134 ~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE  208 (312)
T 2iwi_A          134 GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDFDGTRVYSPPE  208 (312)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC--BCCCCSCTTTSCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc--ccccCCcccccCce
Confidence            4689999999999999999999999   999999999999998 78899999999987665432  23456888999999


Q ss_pred             ccccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..+ +.++|+||||+++|++++|..||.....          .....  ..++.  ..    ...+.+++.+||+.
T Consensus       209 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~~~~--~~~~~--~~----~~~~~~li~~~l~~  270 (312)
T 2iwi_A          209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------ILEAE--LHFPA--HV----SPDCCALIRRCLAP  270 (312)
T ss_dssp             HHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HHHTC--CCCCT--TS----CHHHHHHHHHHTCS
T ss_pred             eeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------Hhhhc--cCCcc--cC----CHHHHHHHHHHccC
Confidence            9876665 4589999999999999999999864321          00110  01111  11    22478899999999


Q ss_pred             CCCCCCCHHHHHHHh
Q 042876          163 SPESRPTMKIVSQQL  177 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l  177 (179)
                      ||++|||+++++++-
T Consensus       271 ~p~~Rps~~e~l~~~  285 (312)
T 2iwi_A          271 KPSSRPSLEEILLDP  285 (312)
T ss_dssp             STTTSCCHHHHHHST
T ss_pred             ChhhCcCHHHHhcCh
Confidence            999999999999864

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.96  E-value=2.8e-29  Score=199.71  Aligned_cols=167  Identities=28%  Similarity=0.316  Sum_probs=119.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCc---eeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++..++.++.|++.||+|||+.   |++|+||+|+||+++.++.   ++++|||.+........ .....+++.|+|
T Consensus       116 ~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~-~~~~~gt~~Y~A  191 (676)
T 3qa8_A          116 CGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEFVGTLQYLA  191 (676)
T ss_dssp             TCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC-CCCCCSCCTTCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccccccccccc-cccccCCcccCC
Confidence            3689999999999999999999999   9999999999999986654   89999999987654332 244578899999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccc--c----------ccchhhhhhhcCCCCCCCCCccHHHHH
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS--S----------SLNTDIELDEMLDPRLPAPSRSVQEKL  149 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~--~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (179)
                      ||.+.+..++.++|+||+|+++|++++|..||........  .          ................+..........
T Consensus       192 PE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls  271 (676)
T 3qa8_A          192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILA  271 (676)
T ss_dssp             SCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGH
T ss_pred             hHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhh
Confidence            9999988999999999999999999999999964311000  0          000000000001111222222223344


Q ss_pred             HHHHHHHhcccCcCCCCCCCHHHHHH
Q 042876          150 ISIVKVAFSCLNESPESRPTMKIVSQ  175 (179)
Q Consensus       150 ~~~~~li~~cl~~~p~~Rps~~~~~~  175 (179)
                      ..+.+++.+||..||++|||++++++
T Consensus       272 ~~L~dLI~~mL~~DP~kRPTa~elL~  297 (676)
T 3qa8_A          272 GKLERWLQCMLMWHQRQRGTDPQNPN  297 (676)
T ss_dssp             HHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred             HHHHHHHHHHccCCHhhCcCHHHHhc
Confidence            56889999999999999999987553

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.95  E-value=1.5e-28  Score=180.01  Aligned_cols=144  Identities=23%  Similarity=0.296  Sum_probs=105.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC---CCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL---EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.|++.||.|||+.   +++|+||+|+||+++.   ++.++++|||++....                 
T Consensus       112 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------------  171 (299)
T 3m2w_A          112 QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------------  171 (299)
T ss_dssp             CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-----------------
Confidence            4689999999999999999999999   9999999999999988   7889999999885432                 


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                           +..++.++|+||||+++|+|++|..||.............    .....................+.+++.+||+
T Consensus       172 -----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  242 (299)
T 3m2w_A          172 -----GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK  242 (299)
T ss_dssp             -----TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC----CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTC
T ss_pred             -----cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH----HHHhhccccCCchhcccCCHHHHHHHHHHcc
Confidence                 2346788999999999999999999996543222111000    0000011111111111223458889999999


Q ss_pred             cCCCCCCCHHHHHHHh
Q 042876          162 ESPESRPTMKIVSQQL  177 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l  177 (179)
                      .||.+|||++++++|-
T Consensus       243 ~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          243 TEPTQRMTITEFMNHP  258 (299)
T ss_dssp             SSTTTSCCHHHHHTSH
T ss_pred             cChhhCCCHHHHhcCh
Confidence            9999999999999863

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.94  E-value=4.9e-27  Score=189.05  Aligned_cols=145  Identities=26%  Similarity=0.301  Sum_probs=113.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++.+++.++.||++||.|||+.   +++||||||+||+++.+ .++|+|||++......    ....+++.|++||.
T Consensus       177 ~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~  248 (681)
T 2pzi_A          177 QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEI  248 (681)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHH
Confidence            3689999999999999999999999   99999999999999875 8999999999776543    33568899999998


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+. ++.++|+||||+++++|++|..||.......                 .+. ..........+.++|.+||+.||
T Consensus       249 ~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------~~~-~~~~~~~~~~l~~li~~~l~~dP  309 (681)
T 2pzi_A          249 VRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------LPE-DDPVLKTYDSYGRLLRRAIDPDP  309 (681)
T ss_dssp             HHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------CCT-TCHHHHHCHHHHHHHHHHTCSSG
T ss_pred             HcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----------------ccc-cccccccCHHHHHHHhhhccCCh
Confidence            8764 4889999999999999999988875421110                 000 01112223458889999999999


Q ss_pred             CCCCC-HHHHHHH
Q 042876          165 ESRPT-MKIVSQQ  176 (179)
Q Consensus       165 ~~Rps-~~~~~~~  176 (179)
                      .+||+ ++++...
T Consensus       310 ~~R~~~~~~l~~~  322 (681)
T 2pzi_A          310 RQRFTTAEEMSAQ  322 (681)
T ss_dssp             GGSCSSHHHHHHH
T ss_pred             hhCCCHHHHHHHH
Confidence            99995 4444443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.93  E-value=5.7e-26  Score=168.82  Aligned_cols=154  Identities=12%  Similarity=0.068  Sum_probs=114.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHh-hCCCCCcccCCCCCCCeeecCCC--------------------ceeEccccCcccc
Q 042876            5 QELDWSQRMNTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEY--------------------EAHVADFGIAKFL   63 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh-~~~~~~~~h~dl~~~nil~~~~~--------------------~~~l~d~~~~~~~   63 (179)
                      +.+++.+++.++.||+.||.||| +.   +++||||||+||+++.++                    .+||+|||++...
T Consensus       156 ~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~  232 (336)
T 2vuw_A          156 KLSSLATAKSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE  232 (336)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEE
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEec
Confidence            46799999999999999999999 88   999999999999999887                    8999999999866


Q ss_pred             CCCCCCcccccCCCCCCCCcccccCCCCcchhhHHHHHH-HHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCC
Q 042876           64 KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVL-ALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPS  142 (179)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~-~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (179)
                      ...     ...+++.|+|||.+.+.. +.++|+||++++ .+++++|..||......    ...................
T Consensus       233 ~~~-----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~  302 (336)
T 2vuw_A          233 RDG-----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL----HYLTDKMLKQMTFKTKCNT  302 (336)
T ss_dssp             ETT-----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH----HHHHHHHHHTCCCSSCCCS
T ss_pred             CCC-----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh----hHHHHhhhhhhccCcccch
Confidence            532     247889999999998766 889999998777 66677898888532100    0000011111111111122


Q ss_pred             ccHHHHHHHHHHHHhcccCcCCCCCCCHHHHH-HH
Q 042876          143 RSVQEKLISIVKVAFSCLNESPESRPTMKIVS-QQ  176 (179)
Q Consensus       143 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~-~~  176 (179)
                      ........++.+||.+||+.|     |++|++ +|
T Consensus       303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          303 PAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             hhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            334556677999999999876     999999 65

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.93  E-value=5.8e-26  Score=165.50  Aligned_cols=136  Identities=10%  Similarity=0.049  Sum_probs=98.9

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcccc
Q 042876            7 LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY   86 (179)
Q Consensus         7 l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~   86 (179)
                      ....++..++.|+++||.|||+.   |++|+||||+||+++.++.+++++++.                    ++     
T Consensus       126 ~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~--------------------~~-----  177 (286)
T 3uqc_A          126 PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPAT--------------------MP-----  177 (286)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCC--------------------CT-----
T ss_pred             CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccc--------------------cC-----
Confidence            45667899999999999999999   999999999999999999999874432                    22     


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCCC
Q 042876           87 TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPES  166 (179)
Q Consensus        87 ~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~  166 (179)
                        .++.++|+||||+++|+|++|..||..............     ......+............+.+++.+||+.||++
T Consensus       178 --~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~  250 (286)
T 3uqc_A          178 --DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-----DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGI  250 (286)
T ss_dssp             --TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB-----CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSC
T ss_pred             --CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH-----HhccCCCChhhcccCCCHHHHHHHHHHcccCCcc
Confidence              357899999999999999999999976543221100000     0000000000000112234888999999999999


Q ss_pred             CCCHHHHHHHhh
Q 042876          167 RPTMKIVSQQLR  178 (179)
Q Consensus       167 Rps~~~~~~~l~  178 (179)
                      | |+.++++.|+
T Consensus       251 R-s~~el~~~L~  261 (286)
T 3uqc_A          251 R-SASTLLNLMQ  261 (286)
T ss_dssp             C-CHHHHHHHHH
T ss_pred             C-CHHHHHHHHH
Confidence            9 9999999875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.81  E-value=1.6e-21  Score=154.01  Aligned_cols=101  Identities=19%  Similarity=0.155  Sum_probs=67.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..+++..   ++++||++||+|+|++   ||+||||||+|||++.++.+||+|||+++.............+++.|++||
T Consensus       336 ~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE  409 (569)
T 4azs_A          336 GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNE  409 (569)
T ss_dssp             TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHH
T ss_pred             CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHH
Confidence            3456554   5789999999999999   999999999999999999999999999987665544445567899999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKH  111 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~  111 (179)
                      .+.+ .+..++|+|++|++.+.+.++..
T Consensus       410 ~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          410 LFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             HC------------------CCCCTTHH
T ss_pred             HhCC-CCCCcccccccccchhhhccccc
Confidence            9876 45678999999998776654433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.55  E-value=3.4e-16  Score=123.01  Aligned_cols=97  Identities=15%  Similarity=0.251  Sum_probs=80.0

Q ss_pred             HHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-------cccccCCCCCCCCcc
Q 042876           12 RMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-------WTEFAGTYGYVAPEL   84 (179)
Q Consensus        12 ~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~~~~pe~   84 (179)
                      ++.++.|+++||.|||++   +++||||||+||+++.  .+||+|||++.........       .....+++.|++||+
T Consensus       433 ~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv  507 (540)
T 3en9_A          433 NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEI  507 (540)
T ss_dssp             CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHH
T ss_pred             HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHH
Confidence            458899999999999999   9999999999999998  9999999999876543211       124578899999999


Q ss_pred             ccc--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 042876           85 AYT--MKITEKCDVYSFGVLALEVIKGKHPR  113 (179)
Q Consensus        85 ~~~--~~~~~~~D~~slg~~~~~l~~~~~p~  113 (179)
                      +.+  ..|+...|.|+..+-..+-..++.+|
T Consensus       508 ~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          508 WERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             HHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            986  55777889999888888777666655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.33  E-value=6.1e-13  Score=96.51  Aligned_cols=49  Identities=24%  Similarity=0.306  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccc
Q 042876           10 SQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF   62 (179)
Q Consensus        10 ~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~   62 (179)
                      .+...++.|++.||.|||+.   |++|+||||+||+++ ++.++|+|||++..
T Consensus       193 ~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          193 ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence            45668999999999999999   999999999999999 99999999999854

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.13  E-value=4.2e-11  Score=85.68  Aligned_cols=50  Identities=24%  Similarity=0.227  Sum_probs=45.3

Q ss_pred             HHHHHHHHHHHHHHHHHHh-hCCCCCcccCCCCCCCeeecCCCceeEccccCcccc
Q 042876            9 WSQRMNTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFL   63 (179)
Q Consensus         9 ~~~~~~~~~qi~~~l~~lh-~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~   63 (179)
                      +..+..++.|++.||.+|| +.   |++||||||.||+++.  .++|+|||++...
T Consensus       169 ~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          169 ELDVEGIFNDVVENVKRLYQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             GSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             hHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            3467889999999999999 88   9999999999999987  8999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.67  E-value=1.9e-08  Score=75.73  Aligned_cols=52  Identities=13%  Similarity=0.187  Sum_probs=44.6

Q ss_pred             HHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC----------ceeEccccCccccC
Q 042876           10 SQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY----------EAHVADFGIAKFLK   64 (179)
Q Consensus        10 ~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~----------~~~l~d~~~~~~~~   64 (179)
                      .....+..|++.+|.+||+.   |+|||||||.|||++.++          .+.|+||+.+....
T Consensus       205 ~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          205 PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            45677899999999999998   999999999999998766          37899999876543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.84  E-value=0.00061  Score=47.07  Aligned_cols=94  Identities=17%  Similarity=0.095  Sum_probs=59.3

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      .+.+|+++++|.++.|.+.+|.-+-...  .-..+-+.+..+++..+|.+.+.+ +.+.            .....+.+|
T Consensus        42 ~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~~~~~~p  106 (229)
T 2yle_A           42 YNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGEPPPVAG  106 (229)
T ss_dssp             HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------------------
T ss_pred             cCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------------ccccCCCCh
Confidence            3578999999999999999988763221  112334556888999898887754 1110            111234577


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHP  112 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p  112 (179)
                      |... ...+.+.-|||||+++|..+-...|
T Consensus       107 e~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          107 KLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             hhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            7653 3445677899999999998764444

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.61  E-value=9.3e-05  Score=55.00  Aligned_cols=57  Identities=18%  Similarity=0.274  Sum_probs=46.7

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------------------------
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDC-------------------------------------------------------   30 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~-------------------------------------------------------   30 (179)
                      .++..++..++.+++..|+.||+..                                                       
T Consensus       135 ~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  214 (359)
T 3dxp_A          135 GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDAD  214 (359)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSS
T ss_pred             cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCC
Confidence            4567888999999999999999720                                                       


Q ss_pred             CCCcccCCCCCCCeeecCCCc--eeEccccCccc
Q 042876           31 FPPIVHRDLSSKNLLLDLEYE--AHVADFGIAKF   62 (179)
Q Consensus        31 ~~~~~h~dl~~~nil~~~~~~--~~l~d~~~~~~   62 (179)
                      ...++|+|+++.||+++.++.  +.++||+.+..
T Consensus       215 ~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          215 LTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            137999999999999987653  68999998753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=97.56  E-value=4.7e-05  Score=54.00  Aligned_cols=28  Identities=21%  Similarity=0.311  Sum_probs=23.9

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~   60 (179)
                      .++|+|+++.||+++.+..+.|+||+.+
T Consensus       184 ~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          184 VFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             EEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             eEECCCCCcCcEEEECCcEEEEEEchhc
Confidence            5899999999999986655679999865

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.54  E-value=7.4e-05  Score=52.64  Aligned_cols=27  Identities=19%  Similarity=0.240  Sum_probs=23.9

Q ss_pred             cccCCCCCCCeeecCCCceeEccccCc
Q 042876           34 IVHRDLSSKNLLLDLEYEAHVADFGIA   60 (179)
Q Consensus        34 ~~h~dl~~~nil~~~~~~~~l~d~~~~   60 (179)
                      ++|+|++|.||+++.+..+.++||+.+
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhc
Confidence            999999999999987655679999976

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=96.90  E-value=0.0012  Score=47.77  Aligned_cols=80  Identities=21%  Similarity=0.270  Sum_probs=46.7

Q ss_pred             CcccCCCCCCCeeecC--CCceeEccccCccccCCCCCCcccccCCCCCCCCcccc----cC-C---------CCcchhh
Q 042876           33 PIVHRDLSSKNLLLDL--EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELAY----TM-K---------ITEKCDV   96 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~----~~-~---------~~~~~D~   96 (179)
                      .++|+|+++.|++++.  ...+.++||+.+..-.+. ...........-..|+...    .. .         ...-.+.
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~  270 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKY  270 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHH
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHH
Confidence            5799999999999987  455789999987542211 0000000000001222111    00 0         0112578


Q ss_pred             HHHHHHHHHHHhCCCCC
Q 042876           97 YSFGVLALEVIKGKHPR  113 (179)
Q Consensus        97 ~slg~~~~~l~~~~~p~  113 (179)
                      |+++.++|.+.+|..+|
T Consensus       271 ~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          271 WSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHcCCHHH
Confidence            99999999999998775

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.33  E-value=0.0067  Score=44.31  Aligned_cols=29  Identities=24%  Similarity=0.346  Sum_probs=26.2

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      .++|+|+.+.|++++.++.+.++||+.+.
T Consensus       223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          223 NLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             ceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            89999999999999877889999999763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=95.78  E-value=0.022  Score=41.28  Aligned_cols=30  Identities=33%  Similarity=0.581  Sum_probs=24.6

Q ss_pred             CcccCCCCCCCeeecC---CCc-eeEccccCccc
Q 042876           33 PIVHRDLSSKNLLLDL---EYE-AHVADFGIAKF   62 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~---~~~-~~l~d~~~~~~   62 (179)
                      .++|+|+.+.|++++.   ++. +.|+||+.+..
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            6799999999999987   345 48999997743

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.32  E-value=0.021  Score=43.29  Aligned_cols=29  Identities=17%  Similarity=0.403  Sum_probs=25.8

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCccc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAKF   62 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~~   62 (179)
                      .++|+|+.+.||+++.++ +.++||+.+..
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            899999999999998776 99999988753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=94.99  E-value=0.045  Score=37.65  Aligned_cols=89  Identities=10%  Similarity=0.114  Sum_probs=64.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.++..++++++.+|+....+++..     +|--+.|+|++++.++.+++.-.|+...+.                 |. 
T Consensus        76 k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~~~~~p~i~~RGik~~l~-----------------P~-  132 (215)
T 4ann_A           76 KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFTRDGLPIAKTRGLQNVVD-----------------PL-  132 (215)
T ss_dssp             GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEECTTSCEEESCCEETTTBS-----------------CC-
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEcCCCCEEEEEccCccCCC-----------------CC-
Confidence            4678889999999999877666655     889999999999999999998877543222                 21 


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCccccccc
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS  120 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~  120 (179)
                          ..+...-.-.+-+++..++.++..|.......
T Consensus       133 ----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~  164 (215)
T 4ann_A          133 ----PVSEAEFLTRYKALVICAFNEKQSFDALVEGN  164 (215)
T ss_dssp             ----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSC
T ss_pred             ----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcCh
Confidence                11122223357788889999999987654433

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=94.72  E-value=0.05  Score=37.52  Aligned_cols=85  Identities=12%  Similarity=0.148  Sum_probs=61.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHH-HHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALS-YLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~-~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +.++..++++++.+|+.... +++..     +|--+.|+|++++.++.+++.-.|+-..+                 +|.
T Consensus        80 ~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL~f~~~~~p~i~hRGi~~~l-----------------pP~  137 (219)
T 4ano_A           80 RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENLMFNRALEPFFLHVGVKESL-----------------PPD  137 (219)
T ss_dssp             HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGEEECTTCCEEESCCEETTTB-----------------SSC
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceEEEeCCCcEEEEEcCCcccC-----------------CCC
Confidence            35788899999999998776 56555     88899999999999999999887754222                 221


Q ss_pred             ccccCCCCcchhh-HHHHHHHHHHHhCCCCCcccc
Q 042876           84 LAYTMKITEKCDV-YSFGVLALEVIKGKHPRDFLS  117 (179)
Q Consensus        84 ~~~~~~~~~~~D~-~slg~~~~~l~~~~~p~~~~~  117 (179)
                           ..+ ..|. -++=+++..++.++..|+...
T Consensus       138 -----e~~-ee~fl~qyKali~all~~K~~Fe~l~  166 (219)
T 4ano_A          138 -----EWD-DERLLREVKATVLALTEGEYRFDEYL  166 (219)
T ss_dssp             -----SCC-HHHHHHHHHHHHHHHTTCSSCHHHHH
T ss_pred             -----CCC-HHHHHHHHHHHHHHHHcCCCCHHHHH
Confidence                 111 1233 357788888888888886543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=94.25  E-value=0.023  Score=40.12  Aligned_cols=29  Identities=28%  Similarity=0.316  Sum_probs=24.9

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      .++|+|+.+.|++++.++.+-|+||+.+.
T Consensus       194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence            48999999999999977667799999763

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=94.11  E-value=0.082  Score=38.57  Aligned_cols=30  Identities=43%  Similarity=0.499  Sum_probs=26.1

Q ss_pred             CcccCCCCCCCeeecCC----CceeEccccCccc
Q 042876           33 PIVHRDLSSKNLLLDLE----YEAHVADFGIAKF   62 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~----~~~~l~d~~~~~~   62 (179)
                      .++|+|+.+.||+++.+    +.+.++||+.+..
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            79999999999999864    6789999998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=93.64  E-value=0.022  Score=41.32  Aligned_cols=29  Identities=24%  Similarity=0.277  Sum_probs=25.0

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      +++|+|+.+.|++++.+..+.++||+.+.
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            79999999999999877556899998763

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=93.58  E-value=0.093  Score=38.08  Aligned_cols=27  Identities=22%  Similarity=0.297  Sum_probs=24.0

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      .++|+|+.+.||+++ + .+.++||+.+.
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            689999999999998 4 88999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=93.31  E-value=0.043  Score=40.44  Aligned_cols=29  Identities=17%  Similarity=0.147  Sum_probs=24.8

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      .++|+|+.+.||+++.+..+.|+||+.+.
T Consensus       223 ~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          223 VLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             EEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             eEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            79999999999999854456899999774

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=92.88  E-value=0.13  Score=39.69  Aligned_cols=15  Identities=33%  Similarity=0.448  Sum_probs=14.3

Q ss_pred             CcccCCCCCCCeeec
Q 042876           33 PIVHRDLSSKNLLLD   47 (179)
Q Consensus        33 ~~~h~dl~~~nil~~   47 (179)
                      .++|+|+.+.||+++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            699999999999998

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=92.52  E-value=0.12  Score=37.94  Aligned_cols=30  Identities=20%  Similarity=0.330  Sum_probs=26.5

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCccc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAKF   62 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~~   62 (179)
                      .++|+|+.+.|++++.++.+.++||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            799999999999998777899999987643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=92.23  E-value=0.19  Score=36.15  Aligned_cols=29  Identities=21%  Similarity=0.290  Sum_probs=24.5

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCccc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAKF   62 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~~   62 (179)
                      .++|+|+.+.|++ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            6999999999999 5566789999998743

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=91.59  E-value=0.12  Score=39.36  Aligned_cols=17  Identities=35%  Similarity=0.534  Sum_probs=15.0

Q ss_pred             CcccCCCCCCCeeecCC
Q 042876           33 PIVHRDLSSKNLLLDLE   49 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~   49 (179)
                      .++|+|+.+.||+++.+
T Consensus       250 v~~H~Dl~~gNiL~~~~  266 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKA  266 (429)
T ss_dssp             EEECSCCCGGGEEEEC-
T ss_pred             EEEeCCCCCCeEEeeCC
Confidence            69999999999999875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=91.24  E-value=0.089  Score=39.01  Aligned_cols=28  Identities=21%  Similarity=0.330  Sum_probs=23.7

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      .++|+|+.+.||+++.+ .+.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~-~~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNK-CLRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC--CEEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCC-cEEEEEecCCC
Confidence            69999999999999855 48999998774

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=90.45  E-value=0.36  Score=36.06  Aligned_cols=28  Identities=25%  Similarity=0.360  Sum_probs=24.4

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      .++|+|+.+.||+++.+ .+.++||..+.
T Consensus       228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          228 TLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             EEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             ceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            89999999999999865 48899998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=89.23  E-value=0.21  Score=37.50  Aligned_cols=29  Identities=28%  Similarity=0.376  Sum_probs=25.9

Q ss_pred             CcccCCCCCCCeeecCC----CceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLE----YEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~----~~~~l~d~~~~~   61 (179)
                      .++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            79999999999999876    688999999875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.54  E-value=0.31  Score=36.67  Aligned_cols=30  Identities=23%  Similarity=0.401  Sum_probs=24.8

Q ss_pred             CcccCCCCCCCeee------cCCCceeEccccCccc
Q 042876           33 PIVHRDLSSKNLLL------DLEYEAHVADFGIAKF   62 (179)
Q Consensus        33 ~~~h~dl~~~nil~------~~~~~~~l~d~~~~~~   62 (179)
                      .++|+|+.+.||++      +.+..+.++||.++..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      3456789999998853

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=83.01  E-value=0.59  Score=35.60  Aligned_cols=28  Identities=25%  Similarity=0.450  Sum_probs=25.2

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      .++|+|+.+.|++ ..++.+.++||..+.
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCC
Confidence            6899999999999 777889999999885

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	179
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-36
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-32
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-32
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-32
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-32
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-31
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-31
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-30
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-30
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-30
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-30
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-30
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-29
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-29
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-29
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-29
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-28
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-28
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-28
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-28
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-28
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-28
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-28
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-27
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-27
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-26
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-25
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-25
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-25
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-24
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-24
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-24
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-23
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-23
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-23
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-23
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-22
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-22
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-22
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-22
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-21
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-21
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-21
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-21
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-20
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-20
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-19
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-19
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-19
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-18
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-18
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-18
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-17
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-17
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-17
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-14
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-13
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-13
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-12
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-12
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-07

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 9e-39
 Identities = 38/177 (21%), Positives = 78/177 (44%), Gaps = 14/177 (7%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
            +  + ++  +  A  + YLH      I+HRDL S N+ L  +    + DFG+A      
Sbjct: 101 FEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157

Query: 67  SSN--WTEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLALEVIKGKHPRDFLSSISS 121
           S +  + + +G+  ++APE+         + + DVY+FG++  E++ G+ P    S+I++
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINN 214

Query: 122 SSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
                 +     L P L     +  + +  ++     CL +  + RP    +   + 
Sbjct: 215 RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIE 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (311), Expect = 6e-36
 Identities = 42/169 (24%), Positives = 70/169 (41%), Gaps = 13/169 (7%)

Query: 5   QELDWSQRMNTIKGVADALSYLH--HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKF 62
           Q LD    +  +  +  AL   H   D    ++HRDL   N+ LD +    + DFG+A+ 
Sbjct: 104 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163

Query: 63  LKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS 122
           L  D+S    F GT  Y++PE    M   EK D++S G L  E+     P          
Sbjct: 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------- 215

Query: 123 SLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           + +      ++ + +         ++L  I+      LN     RP+++
Sbjct: 216 AFSQKELAGKIREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVE 261

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (289), Expect = 2e-32
 Identities = 33/174 (18%), Positives = 77/174 (44%), Gaps = 15/174 (8%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L  ++++   + VA  ++YL        VHRDL+++N L+       +ADFG+++ +   
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 67  SSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL 124
                    A    ++ PE  +  + T + DV+++GV+  E+        +        +
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY-------GM 246

Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
             +  +  + D  + A   +   +L ++++    C ++ P  RP+   + + L+
Sbjct: 247 AHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFCSIHRILQ 297

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-32
 Identities = 42/198 (21%), Positives = 75/198 (37%), Gaps = 27/198 (13%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCF-----PPIVHRDLSSKNLLLDLEYEAHVADFGIAK 61
           +     +      A  L++LH +       P I HRDL SKN+L+       +AD G+A 
Sbjct: 97  VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156

Query: 62  FLKPDSSNW----TEFAGTYGYVAPELAYTM------KITEKCDVYSFGVLALEVIKGKH 111
                +           GT  Y+APE+          +  ++ D+Y+ G++  E+ +   
Sbjct: 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216

Query: 112 P-----------RDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL 160
                        D + S  S      +  ++ L P +P   +S  E L  + K+   C 
Sbjct: 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECW 275

Query: 161 NESPESRPTMKIVSQQLR 178
             +  +R T   + + L 
Sbjct: 276 YANGAARLTALRIKKTLS 293

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 6e-32
 Identities = 37/174 (21%), Positives = 73/174 (41%), Gaps = 14/174 (8%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
            +L  ++ ++    +A+ ++++        +HRDL + N+L+       +ADFG+A+ ++
Sbjct: 104 IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160

Query: 65  PDSSNW-TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS 123
            +             + APE       T K DV+SFG+L  E++          +     
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----- 215

Query: 124 LNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
            N ++  +     R+  P    +E    + ++   C  E PE RPT   +   L
Sbjct: 216 -NPEVIQNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 8e-32
 Identities = 34/168 (20%), Positives = 74/168 (44%), Gaps = 14/168 (8%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFL 63
           + +      +  + +   L +LH    PPI+HRDL   N+ +        + D G+A   
Sbjct: 107 KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165

Query: 64  KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS 123
           +   +      GT  ++APE+ Y  K  E  DVY+FG+  LE+   ++P  +    +++ 
Sbjct: 166 RASFA--KAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQ 220

Query: 124 LNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           +   +        +  +  +    ++  I++    C+ ++ + R ++K
Sbjct: 221 IYRRV----TSGVKPASFDKVAIPEVKEIIE---GCIRQNKDERYSIK 261

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 5e-31
 Identities = 39/176 (22%), Positives = 73/176 (41%), Gaps = 20/176 (11%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L +   +     VA  + +L        VHRDL+++N+L+       + DFG+A+ +  D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 67  SSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSS 123
           S+            ++APE  +    T K DV+S+G+L  E+   G +P           
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP--------G 269

Query: 124 LNTDIELDEMLD--PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           +  D    +++    ++  P  + +E    I  +  SC       RP+   ++  L
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATEE----IYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 7e-31
 Identities = 46/165 (27%), Positives = 71/165 (43%), Gaps = 17/165 (10%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
            D  +    I  +A+ALSY H      ++HRD+  +NLLL    E  +ADFG +      
Sbjct: 103 FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--P 157

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT 126
           SS  T   GT  Y+ PE+       EK D++S GVL  E + GK P        +++   
Sbjct: 158 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP------FEANTYQE 211

Query: 127 DIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             +    ++   P     V E    ++      L  +P  RP ++
Sbjct: 212 TYKRISRVEFTFP---DFVTEGARDLIS---RLLKHNPSQRPMLR 250

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-30
 Identities = 45/180 (25%), Positives = 76/180 (42%), Gaps = 22/180 (12%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           +E+  S     +  V+  + YL        VHRDL+++N+LL   + A ++DFG++K L 
Sbjct: 104 EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160

Query: 65  PDSSNWTE---FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSIS 120
            D S +T          + APE     K + + DV+S+GV   E +  G+ P   +    
Sbjct: 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--- 217

Query: 121 SSSLNTDIELDEMLD--PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
                   E+   ++   R+  P     E    +  +   C     E RP    V Q++R
Sbjct: 218 ------GPEVMAFIEQGKRMECPPECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 2e-30
 Identities = 39/197 (19%), Positives = 71/197 (36%), Gaps = 36/197 (18%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           +           V   L+YL       I+HRD+   N+L++   E  + DFG++  L   
Sbjct: 101 IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-------------- 112
            +    F GT  Y++PE       + + D++S G+  +E+  G++P              
Sbjct: 159 MA--NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFG 216

Query: 113 ----------------RDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVA 156
                                S         + + E+LD  +  P   +   + S+    
Sbjct: 217 CQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 276

Query: 157 F--SCLNESPESRPTMK 171
           F   CL ++P  R  +K
Sbjct: 277 FVNKCLIKNPAERADLK 293

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 2e-30
 Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 14/172 (8%)

Query: 8   DWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS 67
                +     V + +    +     ++HRDL+++N L+       V+DFG+ +F+  D 
Sbjct: 99  AAETLLGMCLDVCEGM---AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155

Query: 68  SNWTE-FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT 126
              +        + +PE+    + + K DV+SFGVL  EV           S      N+
Sbjct: 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NS 209

Query: 127 DIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           ++  D     RL  P  +       + ++   C  E PE RP    + +QL 
Sbjct: 210 EVVEDISTGFRLYKPRLASTH----VYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 3e-30
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 22/180 (12%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           + +     +  +  V+  + YL        VHRDL+++N+LL  ++ A ++DFG++K L+
Sbjct: 102 RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158

Query: 65  PDSSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSIS 120
            D + +   T       + APE     K + K DV+SFGVL  E    G+ P   +    
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---- 214

Query: 121 SSSLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
                   E+  ML    R+  P+   +E    +  +   C     E+RP    V  +LR
Sbjct: 215 -----KGSEVTAMLEKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 7e-30
 Identities = 40/170 (23%), Positives = 71/170 (41%), Gaps = 14/170 (8%)

Query: 9   WSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD-S 67
             Q ++    +A  ++Y+        VHRDL + N+L+       VADFG+A+ ++ +  
Sbjct: 112 LPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168

Query: 68  SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD 127
           +          + APE A   + T K DV+SFG+L  E+            + +  +   
Sbjct: 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQ 226

Query: 128 IELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           +E       R+P P    +     +  +   C  + PE RPT + +   L
Sbjct: 227 VERGY----RMPCPPECPES----LHDLMCQCWRKEPEERPTFEYLQAFL 268

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 1e-29
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 17/170 (10%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L  SQ     K   DAL+YLH      I+HRDL + N+L  L+ +  +ADFG++      
Sbjct: 107 LTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163

Query: 67  SSNWTEFAGTYGYVAPELAYTM-----KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS 121
                 F GT  ++APE+             K DV+S G+  +E+ + + P         
Sbjct: 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-----EL 218

Query: 122 SSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           + +   +++ +   P L  PSR         +K    CL ++ ++R T  
Sbjct: 219 NPMRVLLKIAKSEPPTLAQPSR-WSSNFKDFLK---KCLEKNVDARWTTS 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 3e-29
 Identities = 39/177 (22%), Positives = 73/177 (41%), Gaps = 20/177 (11%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
               Q +  ++G+A   + + +      VHRDL+++N+L++      V+DFG+++ L+ D
Sbjct: 107 FSVLQLVGMLRGIA---AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163

Query: 67  SSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS 123
                  +       + APE     K T   DV+SFG++  EV+       +  S     
Sbjct: 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----- 218

Query: 124 LNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
              + E+ + ++   RLP P          I ++   C  +    RP    +   L 
Sbjct: 219 ---NHEVMKAINDGFRLPTPMDCPSA----IYQLMMQCWQQERARRPKFADIVSILD 268

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  106 bits (266), Expect = 4e-29
 Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 20/177 (11%)

Query: 8   DWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS 67
              Q +  ++G+A  + YL        VHRDL+++N+L++      V+DFG+++FL+ D+
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 68  SNWTE-----FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISS 121
           S+ T            + APE     K T   DV+S+G++  EV+  G+ P   ++    
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---- 238

Query: 122 SSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
              N D+      D RLP P          + ++   C  +    RP    +   L 
Sbjct: 239 ---NQDVINAIEQDYRLPPPMDCPSA----LHQLMLDCWQKDRNHRPKFGQIVNTLD 288

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 7e-29
 Identities = 42/174 (24%), Positives = 81/174 (46%), Gaps = 16/174 (9%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
               Q +   K V +A+ YL        +HRDL+++N L++ +    V+DFG+++++  D
Sbjct: 97  FQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153

Query: 67  -SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSL 124
             ++         +  PE+    K + K D+++FGVL  E+   GK P +  +       
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------- 206

Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           N++         RL  P  + ++    +  + +SC +E  + RPT KI+   + 
Sbjct: 207 NSETAEHIAQGLRLYRPHLASEK----VYTIMYSCWHEKADERPTFKILLSNIL 256

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 2e-28
 Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 12/164 (7%)

Query: 8   DWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS 67
           D  Q     +    AL +LH +    ++HRD+ S N+LL ++    + DFG    + P+ 
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

Query: 68  SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD 127
           S  +   GT  ++APE+        K D++S G++A+E+I+G+ P       + + L   
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-----NENPLRAL 225

Query: 128 IELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             +     P L  P + +       +     CL+   E R + K
Sbjct: 226 YLIATNGTPELQNPEK-LSAIFRDFLN---RCLDMDVEKRGSAK 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 2e-28
 Identities = 42/172 (24%), Positives = 69/172 (40%), Gaps = 16/172 (9%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L     +     V +A+ YL        VHRDL+++N+L+  +  A V+DFG+ K     
Sbjct: 100 LGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--- 153

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT 126
           SS          + APE     K + K DV+SFG+L  E+            I    +  
Sbjct: 154 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVP 211

Query: 127 DIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
            +E       ++ AP          + +V  +C +     RP+   + +QL 
Sbjct: 212 RVEKGY----KMDAPDGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 2e-28
 Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 15/168 (8%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           +           +   + YLH      I HRD+  +NLLLD      ++DFG+A   + +
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156

Query: 67  SSN--WTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS 123
           +      +  GT  YVAPEL    +   E  DV+S G++   ++ G+ P D        S
Sbjct: 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD------QPS 210

Query: 124 LNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
            +     D         P + +    ++++      L E+P +R T+ 
Sbjct: 211 DSCQEYSDWKEKKTYLNPWKKIDSAPLALLH---KILVENPSARITIP 255

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 2e-28
 Identities = 43/177 (24%), Positives = 69/177 (38%), Gaps = 17/177 (9%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
                   +     VA  +           VHRDL+++N +LD ++   VADFG+A+ + 
Sbjct: 125 HNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181

Query: 65  PDS----SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS 120
                   N T       ++A E   T K T K DV+SFGVL  E++    P     +  
Sbjct: 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-- 239

Query: 121 SSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                 DI +  +   RL  P          + +V   C +   E RP+   +  ++
Sbjct: 240 ----TFDITVYLLQGRRLLQPEYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRI 288

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  104 bits (260), Expect = 3e-28
 Identities = 39/177 (22%), Positives = 75/177 (42%), Gaps = 18/177 (10%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           QE+     +     ++ A+ YL        +HRDL+++N L+   +   VADFG+++ + 
Sbjct: 110 QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166

Query: 65  PDSSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS 123
            D+            + APE     K + K DV++FGVL  E+            +S   
Sbjct: 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--- 223

Query: 124 LNTDIELDEMLDP--RLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
                ++ E+L+   R+  P    ++    + ++  +C   +P  RP+   + Q   
Sbjct: 224 -----QVYELLEKDYRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 3e-28
 Identities = 43/180 (23%), Positives = 71/180 (39%), Gaps = 18/180 (10%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           ++ A  L   Q ++    VA  + YL        +HRDL+++N+L+   Y A +ADFG++
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS 174

Query: 61  KFLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS 120
           +  +              ++A E       T   DV+S+GVL  E++          + +
Sbjct: 175 RGQEVYVKKTM-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 233

Query: 121 SSSLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
                   EL E L    RL  P     E    +  +   C  E P  RP+   +   L 
Sbjct: 234 --------ELYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSLN 281

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 4e-28
 Identities = 40/175 (22%), Positives = 76/175 (43%), Gaps = 18/175 (10%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           LD    ++    VA  +++L        +HRDL+++N+LL       + DFG+A+ +K D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 67  SSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL 124
           S+            ++APE  +    T + DV+S+G+   E+                 +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-------GM 251

Query: 125 NTDIELDEMLD--PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
             D +  +M+    R+ +P  +  E    +  +  +C +  P  RPT K + Q +
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 3e-27
 Identities = 38/172 (22%), Positives = 71/172 (41%), Gaps = 15/172 (8%)

Query: 8   DWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS 67
                +N    +A  ++YL       +VHRDL+++N+L+       + DFG+AK L  + 
Sbjct: 109 GSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165

Query: 68  SNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN 125
             +          ++A E       T + DV+S+GV   E++           I +S ++
Sbjct: 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEIS 223

Query: 126 TDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
           + +E  E    RLP P     +    +  +   C     +SRP  + +  + 
Sbjct: 224 SILEKGE----RLPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEF 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  100 bits (251), Expect = 9e-27
 Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 20/168 (11%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L   +      G    L+YLH      ++HRD+ + N+LL       + DFG A  + P 
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168

Query: 67  SSNWTEFAGTYGYVAPELAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS 123
           +S    F GT  ++APE+   M   +   K DV+S G+  +E+ + K P   ++++    
Sbjct: 169 NS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---- 220

Query: 124 LNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
                      +      S    E   + V    SCL + P+ RPT +
Sbjct: 221 ---SALYHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSE 262

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 1e-26
 Identities = 41/176 (23%), Positives = 65/176 (36%), Gaps = 17/176 (9%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
                       VA+ + YL        +HRDL+++NLLL       + DFG+ + L  +
Sbjct: 108 FLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164

Query: 67  SSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSS 122
             ++         + + APE   T   +   D + FGV   E+   G+ P          
Sbjct: 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP------WIGL 218

Query: 123 SLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           + +  +   +    RLP P    Q+    I  V   C    PE RPT   +   L 
Sbjct: 219 NGSQILHKIDKEGERLPRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 1e-25
 Identities = 42/182 (23%), Positives = 70/182 (38%), Gaps = 18/182 (9%)

Query: 1   DAAAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIA 60
           D     L     +     VA  + +L        +HRDL+++N+LL  +    + DFG+A
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA 181

Query: 61  KFLKPDSSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSS 118
           + +  D       +      ++APE  +    T + DV+SFGVL  E+            
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---- 237

Query: 119 ISSSSLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ 176
                +  D E    L    R+ AP  +  E    + +    C +  P  RPT   + + 
Sbjct: 238 ---PGVKIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEH 290

Query: 177 LR 178
           L 
Sbjct: 291 LG 292

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.1 bits (241), Expect = 2e-25
 Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 15/167 (8%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
            + D S+       +   L +LH      IV+RDL   N+LLD +    +ADFG+ K   
Sbjct: 98  HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154

Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL 124
              +    F GT  Y+APE+    K     D +SFGVL  E++ G+ P            
Sbjct: 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--------- 205

Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             + EL   +    P   R ++++   ++          PE R  ++
Sbjct: 206 QDEEELFHSIRMDNPFYPRWLEKEAKDLLV---KLFVREPEKRLGVR 249

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.0 bits (238), Expect = 3e-25
 Identities = 41/174 (23%), Positives = 74/174 (42%), Gaps = 16/174 (9%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           LD +  +     ++ AL+YL        VHRD++++N+L+       + DFG++++++  
Sbjct: 105 LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161

Query: 67  SS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVI-KGKHPRDFLSSISSSSL 124
           +    ++      ++APE     + T   DV+ FGV   E++  G  P   +        
Sbjct: 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK------- 214

Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
           N D+        RLP P  +    L S++     C    P  RP    +  QL 
Sbjct: 215 NNDVIGRIENGERLPMPP-NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLS 264

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 9e-25
 Identities = 42/177 (23%), Positives = 73/177 (41%), Gaps = 19/177 (10%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           ++L     ++    VA  + YL        +HRDL+++N+L+  +    +ADFG+A+ + 
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186

Query: 65  PDSSNWT--EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS 122
                           ++APE  +    T + DV+SFGVL  E+            +   
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 244

Query: 123 SLNTDIELDEML--DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQL 177
                 EL ++L    R+  PS    E    +  +   C +  P  RPT K + + L
Sbjct: 245 ------ELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 95.9 bits (238), Expect = 1e-24
 Identities = 36/167 (21%), Positives = 66/167 (39%), Gaps = 14/167 (8%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLK 64
           +   + +  ++ V   L ++H +     VH DL  +N++   +    +   DFG+   L 
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177

Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL 124
           P  S      GT  + APE+A    +    D++S GVL+  ++ G  P  F       +L
Sbjct: 178 PKQSVKV-TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETL 234

Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
                 D  +D    +    + E     ++     L   P +R T+ 
Sbjct: 235 RNVKSCDWNMDDSAFS---GISEDGKDFIR---KLLLADPNTRMTIH 275

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.7 bits (235), Expect = 1e-24
 Identities = 40/167 (23%), Positives = 67/167 (40%), Gaps = 17/167 (10%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
            D +        +  AL YLH      I+HRDL  +N+LL+ +    + DFG AK L P+
Sbjct: 105 FDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161

Query: 67  SSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL 124
           S       F GT  YV+PEL       +  D+++ G +  +++ G  P          + 
Sbjct: 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR--------AG 213

Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           N  +   +++      P +    K   +V+     L      R   +
Sbjct: 214 NEYLIFQKIIKLEYDFPEK-FFPKARDLVE---KLLVLDATKRLGCE 256

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 93.4 bits (231), Expect = 5e-24
 Identities = 28/184 (15%), Positives = 62/184 (33%), Gaps = 17/184 (9%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLL---LDLEYEAHVADFGIAK 61
           ++      +     +   + Y+H       +HRD+   N L          ++ DFG+AK
Sbjct: 98  RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154

Query: 62  FLKPDSSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRD 114
             +   ++            GT  Y +      ++ + + D+ S G + +    G  P  
Sbjct: 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214

Query: 115 FLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVS 174
            L + +       I   +M  P +    +    +  + +     C +   + +P    + 
Sbjct: 215 GLKAATKRQKYERISEKKMSTP-IEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLR 270

Query: 175 QQLR 178
           Q  R
Sbjct: 271 QLFR 274

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.2 bits (228), Expect = 1e-23
 Identities = 32/176 (18%), Positives = 72/176 (40%), Gaps = 15/176 (8%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
                S+ +     +AD ++YL+       VHRDL+++N ++  ++   + DFG+ + + 
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184

Query: 65  PDSS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS 122
                    +      +++PE       T   DV+SFGV+  E+                
Sbjct: 185 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-------PYQ 237

Query: 123 SLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR 178
            L+ +  L  +++  L     +  + L  +++    C   +P+ RP+   +   ++
Sbjct: 238 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 290

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 92.8 bits (230), Expect = 2e-23
 Identities = 35/169 (20%), Positives = 68/169 (40%), Gaps = 18/169 (10%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFLK 64
           +  ++ +N ++   + L ++H      IVH D+  +N++ + +  + V   DFG+A  L 
Sbjct: 124 MSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180

Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSIS--SS 122
           PD         T  + APE+     +    D+++ GVL   ++ G  P      +    +
Sbjct: 181 PDEIVKV-TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN 239

Query: 123 SLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
               D E DE     +   ++      I       + L + P  R T+ 
Sbjct: 240 VKRCDWEFDEDAFSSVSPEAKD----FIK------NLLQKEPRKRLTVH 278

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.4 bits (229), Expect = 2e-23
 Identities = 36/170 (21%), Positives = 69/170 (40%), Gaps = 18/170 (10%)

Query: 6   ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHV--ADFGIAKFL 63
           EL+  + ++ +  V +AL +LH      I H D+  +N++      + +   +FG A+ L
Sbjct: 98  ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154

Query: 64  KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISS 121
           KP  +          Y APE+     ++   D++S G L   ++ G +P   +    I  
Sbjct: 155 KPGDNFRL-LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE 213

Query: 122 SSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           + +N +   DE     +         + +  V      L +  +SR T  
Sbjct: 214 NIMNAEYTFDEEAFKEIS-------IEAMDFVD---RLLVKERKSRMTAS 253

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 91.8 bits (227), Expect = 2e-23
 Identities = 27/186 (14%), Positives = 62/186 (33%), Gaps = 19/186 (10%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH-----VADFGI 59
           ++          K +   +  +H      +V+RD+   N L+      +     V DFG+
Sbjct: 96  RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152

Query: 60  AKFLKPDSSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
            KF +   +            +GT  Y++       + + + D+ + G + +  ++G  P
Sbjct: 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 212

Query: 113 RDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKI 172
              L + ++      I   +   P L        E+    +       N + ++ P    
Sbjct: 213 WQGLKAATNKQKYERIGEKKQSTP-LRELCAGFPEEFYKYMH---YARNLAFDATPDYDY 268

Query: 173 VSQQLR 178
           +     
Sbjct: 269 LQGLFS 274

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.8 bits (222), Expect = 2e-22
 Identities = 46/171 (26%), Positives = 72/171 (42%), Gaps = 13/171 (7%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAK 61
           Q     +    +K + +A+ YLH      I HRD+  +NLL   +       + DFG AK
Sbjct: 106 QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162

Query: 62  FLKPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISS 121
                +S  T    T  YVAPE+    K  + CD++S GV+   ++ G  P  F S+   
Sbjct: 163 ETTSHNSLTT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGL 219

Query: 122 SSLNTDIELDEMLDPRLPAPSRS-VQEKLISIVKVAFSCLNESPESRPTMK 171
           +          M     P P  S V E++  +++   + L   P  R T+ 
Sbjct: 220 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTIT 267

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.2 bits (220), Expect = 2e-22
 Identities = 34/180 (18%), Positives = 60/180 (33%), Gaps = 19/180 (10%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           +      + +  +   L +LH      +VHRDL  +N+L+    +  +ADFG+A+     
Sbjct: 113 VPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 169

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP-------------R 113
            +  +    T  Y APE+          D++S G +  E+ + K                
Sbjct: 170 MALTS-VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228

Query: 114 DFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAF--SCLNESPESRPTMK 171
           D +          D+ L         A         I  +       CL  +P  R +  
Sbjct: 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.6 bits (219), Expect = 2e-22
 Identities = 40/167 (23%), Positives = 72/167 (43%), Gaps = 25/167 (14%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKP 65
           L      +    V +A+ + H+     ++HRD+  +N+L+DL   E  + DFG    LK 
Sbjct: 107 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163

Query: 66  DSSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL 124
             + +T+F GT  Y  PE + Y         V+S G+L  +++ G  P +          
Sbjct: 164 --TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE---------- 211

Query: 125 NTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
                 +E++  ++    R V  +   +++    CL   P  RPT +
Sbjct: 212 ----HDEEIIRGQVFFRQR-VSSECQHLIR---WCLALRPSDRPTFE 250

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 87.5 bits (216), Expect = 7e-22
 Identities = 43/176 (24%), Positives = 76/176 (43%), Gaps = 15/176 (8%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           +   + +  I     AL++ H      I+HRD+   N+++       V DFGIA+ +   
Sbjct: 108 MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164

Query: 67  SSNWTE---FAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS 123
            ++ T+     GT  Y++PE A    +  + DVYS G +  EV+ G+ P    +  S  S
Sbjct: 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVS 221

Query: 124 LNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRP-TMKIVSQQLR 178
           +      ++ + P       S    L ++V      L ++PE+R  T   +   L 
Sbjct: 222 VAYQHVREDPIPPSARHEGLS--ADLDAVVL---KALAKNPENRYQTAAEMRADLV 272

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 86.7 bits (214), Expect = 1e-21
 Identities = 37/172 (21%), Positives = 67/172 (38%), Gaps = 20/172 (11%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L   +    ++ + + +  LH      IVHRDL  +N+LLD +    + DFG +  L P 
Sbjct: 107 LSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 163

Query: 67  SSNWTEFAGTYGYVAPELAYTM------KITEKCDVYSFGVLALEVIKGKHPRDFLSSIS 120
                E  GT  Y+APE+             ++ D++S GV+   ++ G  P        
Sbjct: 164 EKL-REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------FW 216

Query: 121 SSSLNTDIELDEMLDPRLPAPSR-SVQEKLISIVKVAFSCLNESPESRPTMK 171
                  + +    + +  +P      + +  +V      L   P+ R T +
Sbjct: 217 HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAE 265

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 86.6 bits (214), Expect = 2e-21
 Identities = 46/170 (27%), Positives = 70/170 (41%), Gaps = 19/170 (11%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYE---AHVADFGIAKFL 63
                    I  V DA+ YLH      IVHRDL  +NLL     E     ++DFG++K  
Sbjct: 104 YTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160

Query: 64  KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP--RDFLSSISS 121
            P S   T   GT GYVAPE+      ++  D +S GV+A  ++ G  P   +  + +  
Sbjct: 161 DPGSVLST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 219

Query: 122 SSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             L  + E D      +        +     ++     + + PE R T +
Sbjct: 220 QILKAEYEFDSPYWDDIS-------DSAKDFIR---HLMEKDPEKRFTCE 259

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 86.3 bits (213), Expect = 2e-21
 Identities = 37/151 (24%), Positives = 61/151 (40%), Gaps = 15/151 (9%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
            A+    L +     I++RDL  +N+LLD      + DFG AK++           GT  
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPD 166

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL 138
           Y+APE+  T    +  D +SFG+L  E++ G  P            NT    +++L+  L
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY--------DSNTMKTYEKILNAEL 218

Query: 139 PAPSRSVQEKLISIVKVAFSCLNESPESRPT 169
             P     E +  ++      +      R  
Sbjct: 219 RFPP-FFNEDVKDLLS---RLITRDLSQRLG 245

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 86.7 bits (214), Expect = 4e-21
 Identities = 34/163 (20%), Positives = 61/163 (37%), Gaps = 15/163 (9%)

Query: 9   WSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS 68
            +        +   L ++H+     +V+RDL   N+LLD      ++D G+A        
Sbjct: 106 EADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162

Query: 69  NWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD 127
           + +   GT+GY+APE L   +      D +S G +  ++++G  P               
Sbjct: 163 HASV--GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR------QHKTKDK 214

Query: 128 IELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
            E+D M          S   +L S+++     L      R   
Sbjct: 215 HEIDRMTLTMAVELPDSFSPELRSLLE---GLLQRDVNRRLGC 254

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.4 bits (205), Expect = 3e-20
 Identities = 42/185 (22%), Positives = 66/185 (35%), Gaps = 26/185 (14%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L  S     +      L YLH      I+HRDL   NLLLD      +ADFG+AK     
Sbjct: 97  LTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153

Query: 67  SSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIKGKHP------RDFLSSI 119
           +  +T    T  Y APEL +  +      D+++ G +  E++            D L+ I
Sbjct: 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213

Query: 120 -------------SSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPES 166
                           SL   +         L     +  + L+ +++        +P +
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCA 270

Query: 167 RPTMK 171
           R T  
Sbjct: 271 RITAT 275

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 83.0 bits (204), Expect = 4e-20
 Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 21/183 (11%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
           L+     + +  + + ++Y H      ++HRDL  +NLL++ E E  +ADFG+A+     
Sbjct: 97  LESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153

Query: 67  SSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSSI 119
              +T    T  Y AP+ L  + K +   D++S G +  E++ G          D L  I
Sbjct: 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213

Query: 120 ------SSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAF-----SCLNESPESRP 168
                  +S    ++      DP          E  +  +  +        L   P  R 
Sbjct: 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273

Query: 169 TMK 171
           T K
Sbjct: 274 TAK 276

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.8 bits (201), Expect = 1e-19
 Identities = 35/153 (22%), Positives = 67/153 (43%), Gaps = 12/153 (7%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYG 78
            A+ +S L +     +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170

Query: 79  YVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRL 138
           Y+APE+          D +  GV+  E++ G+ P          + + +   + +L   +
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY--------NQDHERLFELILMEEI 222

Query: 139 PAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
             P R++  +  S++      L + P+ R    
Sbjct: 223 RFP-RTLSPEAKSLLA---GLLKKDPKQRLGGG 251

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (197), Expect = 3e-19
 Identities = 30/157 (19%), Positives = 64/157 (40%), Gaps = 13/157 (8%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLE----YEAHVADFGIAKFLKPDSSNWTEFA 74
           +   L+ +++     I H DL  +N++L           + DFG+A  +   +  +    
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 177

Query: 75  GTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML 134
           GT  +VAPE+     +  + D++S GV+   ++ G  P  FL      +L     ++   
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEF 235

Query: 135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMK 171
           +    +   +        ++     L + P+ R T++
Sbjct: 236 EDEYFS---NTSALAKDFIR---RLLVKDPKKRMTIQ 266

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.3 bits (197), Expect = 3e-19
 Identities = 38/185 (20%), Positives = 68/185 (36%), Gaps = 21/185 (11%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
             +      + +  +   L++ H      ++HRDL  +NLL++ E    +ADFG+A+   
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

Query: 65  PDSSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLS 117
                +T    T  Y APE L      +   D++S G +  E++  +         D L 
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213

Query: 118 SISSSSLNTDIELDE------MLDPRLPAPSRSVQEKLISIVKVAF-----SCLNESPES 166
            I  +    D  +           P  P  +R    K++  +           L+  P  
Sbjct: 214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273

Query: 167 RPTMK 171
           R + K
Sbjct: 274 RISAK 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 1e-18
 Identities = 39/193 (20%), Positives = 69/193 (35%), Gaps = 32/193 (16%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           Q L        +  +   L Y+H      ++HRDL   NLLL+   +  + DFG+A+   
Sbjct: 104 QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160

Query: 65  PDSSN---WTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLALEVIKGKHP-------- 112
           PD  +    TE+  T  Y APE+       T+  D++S G +  E++  +          
Sbjct: 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220

Query: 113 --------------RDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS 158
                          D    I+  + N  + L             +   K + ++     
Sbjct: 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---K 277

Query: 159 CLNESPESRPTMK 171
            L  +P  R  ++
Sbjct: 278 MLTFNPHKRIEVE 290

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.3 bits (192), Expect = 3e-18
 Identities = 41/185 (22%), Positives = 62/185 (33%), Gaps = 21/185 (11%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAH-VADFGIAKFL 63
           Q L        +  +  +L+Y+H      I HRD+  +NLLLD +     + DFG AK L
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

Query: 64  KPDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLS 117
                N +     Y      +      T   DV+S G +  E++ G+         D L 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233

Query: 118 SISSSSLNTDIELDEMLDPRL---------PAPSRSVQEKLISIVKVAF--SCLNESPES 166
            I         E    ++P             P   V         +A     L  +P +
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293

Query: 167 RPTMK 171
           R T  
Sbjct: 294 RLTPL 298

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.7 bits (190), Expect = 3e-18
 Identities = 29/182 (15%), Positives = 63/182 (34%), Gaps = 19/182 (10%)

Query: 9   WSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS 68
                     +   L  L       ++HRDL  +NLL++   E  +A+FG+A+       
Sbjct: 97  DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156

Query: 69  NWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLALEVIKGKHP--------------R 113
            ++    T  Y  P++ +  K+ +   D++S G +  E+     P               
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216

Query: 114 DFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS----CLNESPESRPT 169
             L + +     +  +L +     +   + S+   +  +           L  +P  R +
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276

Query: 170 MK 171
            +
Sbjct: 277 AE 278

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.5 bits (187), Expect = 1e-17
 Identities = 28/181 (15%), Positives = 60/181 (33%), Gaps = 31/181 (17%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS----NWTEFA 74
           +   L+ L++     I+HRD+ + N+L+  +    +ADFG+A+      +     +T   
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 75  GTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIKGKHP--------------------- 112
            T  Y  PEL    +      D++  G +  E+                           
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 113 RDFLSSISSSSLNTDIELDEMLDPRLPA--PSRSVQEKLISIVKVAFSCLNESPESRPTM 170
            +   ++ +  L   +EL +    ++     +       + ++      L   P  R   
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDS 299

Query: 171 K 171
            
Sbjct: 300 D 300

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 76.4 bits (187), Expect = 2e-17
 Identities = 33/162 (20%), Positives = 55/162 (33%), Gaps = 18/162 (11%)

Query: 7   LDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPD 66
                       +     YLH      +++RDL  +NLL+D +    V DFG AK     
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR---V 191

Query: 67  SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT 126
                   GT   +APE+  +    +  D ++ GVL  E+  G  P            + 
Sbjct: 192 KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---------DQ 242

Query: 127 DIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRP 168
            I++ E +              L  +++   + L      R 
Sbjct: 243 PIQIYEKIVSGKVRFPSHFSSDLKDLLR---NLLQVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.6 bits (185), Expect = 2e-17
 Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 11/155 (7%)

Query: 19  VADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWT-EFAGTY 77
           V + +  L H     I++RD+  +N+LLD      + DFG++K    D +    +F GT 
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 78  GYVAPELAYTMK--ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLD 135
            Y+AP++         +  D +S GVL  E++ G  P  F      +S           +
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSE 252

Query: 136 PRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTM 170
           P  P   + +      +++     L + P+ R   
Sbjct: 253 PPYP---QEMSALAKDLIQ---RLLMKDPKKRLGC 281

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 66.4 bits (161), Expect = 5e-14
 Identities = 42/195 (21%), Positives = 69/195 (35%), Gaps = 32/195 (16%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFL 63
           Q L        +  +  AL Y H      I+HRD+   N+++D E  +  + D+G+A+F 
Sbjct: 124 QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180

Query: 64  KPDSSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLALEVIKGKHP-------RDF 115
            P    +     +  +  PEL    +      D++S G +   +I  K P        D 
Sbjct: 181 HPGQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239

Query: 116 LSSISSS---------SLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAF--------- 157
           L  I+               +IELD   +  L   SR   E+ +                
Sbjct: 240 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 299

Query: 158 -SCLNESPESRPTMK 171
              L    +SR T +
Sbjct: 300 DKLLRYDHQSRLTAR 314

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.8 bits (157), Expect = 2e-13
 Identities = 34/189 (17%), Positives = 67/189 (35%), Gaps = 30/189 (15%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           ++L   +    +  +   L Y+H        HRDL   NL ++ + E  + DFG+A+   
Sbjct: 116 EKLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQ-- 170

Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------------ 112
            DS         +      +   M+ T+  D++S G +  E+I GK              
Sbjct: 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230

Query: 113 ---------RDFLSSISSSSLNTDIE-LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE 162
                     +F+  + S      ++ L E+      +   +     +++++     L  
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVL 287

Query: 163 SPESRPTMK 171
             E R T  
Sbjct: 288 DAEQRVTAG 296

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.4 bits (153), Expect = 5e-13
 Identities = 28/108 (25%), Positives = 49/108 (45%), Gaps = 4/108 (3%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
            ELD  +    +  +   + +LH       +HRDL   N+++  +    + DFG+A+   
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART-A 169

Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP 112
             S   T +  T  Y APE+   M   E  D++S G +  E+++ K  
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.7 bits (146), Expect = 6e-12
 Identities = 36/186 (19%), Positives = 59/186 (31%), Gaps = 24/186 (12%)

Query: 5   QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLK 64
           Q+L        I  +   L Y+H        HRDL   NL ++ + E  + DFG+A+   
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH-- 170

Query: 65  PDSSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHP------RDFLSS 118
            D       A  +      +   M   +  D++S G +  E++ G+         D L  
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

Query: 119 ISSSSLNTDIELDE---------MLDPRLPAPSRSVQEKLISIVKVAF----SCLNESPE 165
           I         EL +          +      P  +     I    +A       L    +
Sbjct: 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290

Query: 166 SRPTMK 171
            R T  
Sbjct: 291 KRITAA 296

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 60.0 bits (144), Expect = 8e-12
 Identities = 28/143 (19%), Positives = 53/143 (37%), Gaps = 7/143 (4%)

Query: 8   DWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPD 66
                    K +   L Y+H  C   I+H D+  +N+L+++     ++    IA      
Sbjct: 123 PLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

Query: 67  SS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL 124
               ++T    T  Y +PE+          D++S   L  E+I G     F      S  
Sbjct: 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYT 238

Query: 125 NTDIELDEMLDPRLPAPSRSVQE 147
             D  + ++++     PS  ++ 
Sbjct: 239 KDDDHIAQIIELLGELPSYLLRN 261

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 45.9 bits (108), Expect = 3e-07
 Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 14/76 (18%)

Query: 16  IKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK---------FLKPD 66
           +  + + ++  +H     IVH DLS  N+L+  E    + DF  +           L+ D
Sbjct: 109 LDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERD 164

Query: 67  SSNWTE-FAGTYGYVA 81
             N    F+ TY    
Sbjct: 165 VRNIITYFSRTYRTEK 180

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	179
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.43
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.28
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	93.84
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	93.26
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	90.88
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	90.85
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	83.33

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-40  Score=236.41  Aligned_cols=166  Identities=22%  Similarity=0.424  Sum_probs=123.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~   81 (179)
                      +..+++.+++.++.||++||+|||++   +++||||||+||+++.++.+||+|||++........  ......+++.|+|
T Consensus        98 ~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A  174 (276)
T d1uwha_          98 ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA  174 (276)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCC
Confidence            45699999999999999999999999   999999999999999999999999999976653322  2344578999999


Q ss_pred             CcccccC---CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           82 PELAYTM---KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        82 pe~~~~~---~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      ||.+.+.   .++.++|||||||++|+|++|+.||........   ...........+..+....   ....++.++|.+
T Consensus       175 PE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~---~~~~~~~~~~~p~~~~~~~---~~~~~l~~li~~  248 (276)
T d1uwha_         175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLSPDLSKVRS---NCPKAMKRLMAE  248 (276)
T ss_dssp             HHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHHTSCCCCGGGSCT---TCCHHHHHHHHH
T ss_pred             HHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCCCCcchhccc---cchHHHHHHHHH
Confidence            9998653   478899999999999999999999975432111   0011111111121111111   112348889999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||+.||++|||+++++++|+
T Consensus       249 cl~~dp~~RPt~~~il~~Le  268 (276)
T d1uwha_         249 CLKKKRDERPLFPQILASIE  268 (276)
T ss_dssp             HTCSSGGGSCCHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHHH
Confidence            99999999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-39  Score=235.01  Aligned_cols=160  Identities=26%  Similarity=0.426  Sum_probs=127.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++.+++.++.||++||.|||++   |++||||||+||+++.++.+||+|||++..............|++.|+|||.
T Consensus       111 ~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~  187 (293)
T d1yhwa1         111 TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV  187 (293)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhh
Confidence            4689999999999999999999999   9999999999999999999999999999877655444556679999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+||++|+|++|..||...+.....     ........+..+..    ......+.+||.+||+.||
T Consensus       188 ~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~----~~~s~~~~~li~~~L~~dP  258 (293)
T d1yhwa1         188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGTPELQNP----EKLSAIFRDFLNRCLDMDV  258 (293)
T ss_dssp             HSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHHCSCCCSSG----GGSCHHHHHHHHHHTCSST
T ss_pred             hcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH-----HHHHhCCCCCCCCc----ccCCHHHHHHHHHHccCCh
Confidence            99989999999999999999999999999654321110     00111111111111    1122347889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      .+|||++|+++|
T Consensus       259 ~~R~s~~eil~H  270 (293)
T d1yhwa1         259 EKRGSAKELLQH  270 (293)
T ss_dssp             TTSCCHHHHTTC
T ss_pred             hHCcCHHHHhcC
Confidence            999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-39  Score=230.05  Aligned_cols=155  Identities=28%  Similarity=0.420  Sum_probs=125.0

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.||++||+|||++   +++||||||+||+++.++.+|++|||++.......  .....|++.|+|||.
T Consensus       101 ~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~Gt~~Y~APE~  175 (263)
T d2j4za1         101 SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTTLCGTLDYLPPEM  175 (263)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--CEETTEEGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc--ccccCCCCcccCHHH
Confidence            5789999999999999999999999   99999999999999999999999999997655332  244578999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+|||||++|+|++|+.||...+...        ....+.......+...    ..++.+|+.+||+.||
T Consensus       176 ~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~----s~~~~~li~~~L~~dp  243 (263)
T d2j4za1         176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVEFTFPDFV----TEGARDLISRLLKHNP  243 (263)
T ss_dssp             HTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCCCCCTTS----CHHHHHHHHHHTCSSG
T ss_pred             HcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCCCccC----CHHHHHHHHHHccCCH
Confidence            999899999999999999999999999996543211        1111111111111112    2247889999999999


Q ss_pred             CCCCCHHHHHHH
Q 042876          165 ESRPTMKIVSQQ  176 (179)
Q Consensus       165 ~~Rps~~~~~~~  176 (179)
                      ++|||++|+++|
T Consensus       244 ~~R~t~~eil~h  255 (263)
T d2j4za1         244 SQRPMLREVLEH  255 (263)
T ss_dssp             GGSCCHHHHHTC
T ss_pred             hHCcCHHHHHcC
Confidence            999999999986

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-39  Score=229.91  Aligned_cols=161  Identities=24%  Similarity=0.351  Sum_probs=124.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCC--CCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDS--SNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~   81 (179)
                      ...+++.+++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.......  .......|++.|+|
T Consensus        97 ~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~A  173 (271)
T d1nvra_          97 DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA  173 (271)
T ss_dssp             TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccC
Confidence            45799999999999999999999999   99999999999999999999999999998764332  22344678999999


Q ss_pred             CcccccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..+ +.++|+||+||++|+|++|+.||........    ......  ...........   ...++.+|+.+||
T Consensus       174 PE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~----~~~~~~--~~~~~~~~~~~---~s~~~~~li~~~L  244 (271)
T d1nvra_         174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----EYSDWK--EKKTYLNPWKK---IDSAPLALLHKIL  244 (271)
T ss_dssp             THHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH----HHHHHH--TTCTTSTTGGG---SCHHHHHHHHHHS
T ss_pred             HhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH----HHHHHh--cCCCCCCcccc---CCHHHHHHHHHHc
Confidence            999988776 5789999999999999999999965432110    000010  11111111111   1234778899999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.||++|||++|+++|
T Consensus       245 ~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         245 VENPSARITIPDIKKD  260 (271)
T ss_dssp             CSSTTTSCCHHHHTTC
T ss_pred             CCChhHCcCHHHHhcC
Confidence            9999999999999876

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-39  Score=235.85  Aligned_cols=161  Identities=23%  Similarity=0.350  Sum_probs=126.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.||++||+|||++   +++||||||+||+++.++.+||+|||+++........  .....+++.|+||
T Consensus       159 ~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  235 (325)
T d1rjba_         159 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  235 (325)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence            4689999999999999999999999   9999999999999999999999999999765543322  2234578899999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+|||||++|+|++ |..||.+.+....  .  ........  +++.+....    .++.+||.+||+
T Consensus       236 E~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~--~--~~~~~~~~--~~~~p~~~~----~~l~~li~~cl~  305 (325)
T d1rjba_         236 ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN--F--YKLIQNGF--KMDQPFYAT----EEIYIIMQSCWA  305 (325)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--H--HHHHHTTC--CCCCCTTCC----HHHHHHHHHHTC
T ss_pred             HHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH--H--HHHHhcCC--CCCCCCcCC----HHHHHHHHHHcC
Confidence            99999999999999999999999997 8999976432211  0  01111111  122222222    248889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++|||++||+++|.
T Consensus       306 ~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         306 FDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CChhHCcCHHHHHHHHh
Confidence            99999999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-39  Score=232.08  Aligned_cols=161  Identities=29%  Similarity=0.412  Sum_probs=123.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++.+++.++.||++||.|||++   +++||||||+||+++.++.+||+|||++..............|++.|+|||
T Consensus       104 ~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE  180 (288)
T d2jfla1         104 ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE  180 (288)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHH
Confidence            35799999999999999999999999   999999999999999999999999999865432221223457899999999


Q ss_pred             ccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           84 LAY-----TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        84 ~~~-----~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      .+.     +..++.++|+||+||++|+|++|..||...+.....     ........+.......    ...++.+||.+
T Consensus       181 ~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~-----~~i~~~~~~~~~~~~~----~s~~~~~li~~  251 (288)
T d2jfla1         181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL-----LKIAKSEPPTLAQPSR----WSSNFKDFLKK  251 (288)
T ss_dssp             HHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-----HHHHHSCCCCCSSGGG----SCHHHHHHHHH
T ss_pred             HHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH-----HHHHcCCCCCCCcccc----CCHHHHHHHHH
Confidence            874     445788999999999999999999999765422110     1111111112221111    22347889999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||+.||.+|||++|+++|
T Consensus       252 ~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         252 CLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             HSCSSTTTSCCHHHHTTS
T ss_pred             HccCChhHCcCHHHHhcC
Confidence            999999999999999885

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-38  Score=230.75  Aligned_cols=162  Identities=24%  Similarity=0.348  Sum_probs=119.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~   81 (179)
                      +..+++.+++.++.||++||.|||++   +++||||||+||+++.++.+||+|||+++.......  ......+++.|+|
T Consensus       128 ~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A  204 (299)
T d1ywna1         128 KDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  204 (299)
T ss_dssp             --CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCC
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccc
Confidence            34689999999999999999999999   999999999999999999999999999976543322  2334578899999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhC-CCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKG-KHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..++.++||||+||++|+|+++ ..||........    .............+  .....    ++.++|.+||
T Consensus       205 PE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~----~~~~~~~~~~~~~~--~~~~~----~l~~li~~cl  274 (299)
T d1ywna1         205 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLKEGTRMRAP--DYTTP----EMYQTMLDCW  274 (299)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH----HHHHHHHTCCCCCC--TTCCH----HHHHHHHHHT
T ss_pred             hhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH----HHHHHhcCCCCCCC--ccCCH----HHHHHHHHHc
Confidence            9999999999999999999999999986 557764432110    01111111111222  12222    4888999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||++|||++|++++|+
T Consensus       275 ~~dP~~Rpt~~eil~~L~  292 (299)
T d1ywna1         275 HGEPSQRPTFSELVEHLG  292 (299)
T ss_dssp             CSSGGGSCCHHHHHHHHH
T ss_pred             CCChhHCcCHHHHHHHHH
Confidence            999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-39  Score=229.97  Aligned_cols=162  Identities=27%  Similarity=0.335  Sum_probs=115.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCC--CCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCF--PPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~--~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ++.+++.+++.++.|+++||.|||+.+.  .+++||||||+||+++.++.+||+|||++..............+++.|+|
T Consensus       103 ~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~A  182 (269)
T d2java1         103 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS  182 (269)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCC
Confidence            4579999999999999999999998610  03999999999999999999999999999876654433445678999999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+|||||++|+|++|+.||...+....   .  ........+.++.  ..    ..++.+|+.+||+
T Consensus       183 PE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~---~--~~i~~~~~~~~~~--~~----s~~l~~li~~~L~  251 (269)
T d2java1         183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---A--GKIREGKFRRIPY--RY----SDELNEIITRMLN  251 (269)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H--HHHHHTCCCCCCT--TS----CHHHHHHHHHHTC
T ss_pred             HHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH---H--HHHHcCCCCCCCc--cc----CHHHHHHHHHHcC
Confidence            9999998999999999999999999999999975432110   0  1111111111211  12    2247889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||.+|||++|+++|
T Consensus       252 ~dp~~Rps~~ell~h  266 (269)
T d2java1         252 LKDYHRPSVEEILEN  266 (269)
T ss_dssp             SSGGGSCCHHHHHTS
T ss_pred             CChhHCcCHHHHHhC
Confidence            999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.7e-38  Score=228.82  Aligned_cols=160  Identities=26%  Similarity=0.474  Sum_probs=117.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-----cccccCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-----WTEFAGTYG   78 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~   78 (179)
                      ...+++.+++.++.||++||+|||++   +++||||||+||+++.++.+||+|||++.........     .....+++.
T Consensus       122 ~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~  198 (299)
T d1jpaa_         122 DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR  198 (299)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------------------CGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCcc
Confidence            35689999999999999999999999   9999999999999999999999999999866533221     112356788


Q ss_pred             CCCCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcC-CCCCCCCCccHHHHHHHHHHHH
Q 042876           79 YVAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEML-DPRLPAPSRSVQEKLISIVKVA  156 (179)
Q Consensus        79 ~~~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li  156 (179)
                      |+|||.+.+..++.++|||||||++|+|++ |..||.......        ....+. ..+.+.+....    ..+.+|+
T Consensus       199 y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~----~~l~~li  266 (299)
T d1jpaa_         199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--------VINAIEQDYRLPPPMDCP----SALHQLM  266 (299)
T ss_dssp             GSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCCCCCTTCC----HHHHHHH
T ss_pred             ccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCCccch----HHHHHHH
Confidence            999999998899999999999999999998 899997543211        111111 11222222222    2478899


Q ss_pred             hcccCcCCCCCCCHHHHHHHhh
Q 042876          157 FSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       157 ~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      .+||+.||++|||++|+++.|+
T Consensus       267 ~~cl~~~P~~RPs~~ei~~~L~  288 (299)
T d1jpaa_         267 LDCWQKDRNHRPKFGQIVNTLD  288 (299)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHHH
Confidence            9999999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-38  Score=228.09  Aligned_cols=162  Identities=26%  Similarity=0.378  Sum_probs=128.1

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGY   79 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~   79 (179)
                      .+..+++.+++.++.||++||+|||++   +++||||||+||+++.++.+||+|||++.........   .....+++.|
T Consensus       102 ~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y  178 (285)
T d1u59a_         102 KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW  178 (285)
T ss_dssp             CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGG
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccc
Confidence            346799999999999999999999999   9999999999999999999999999999876543321   2334578899


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      +|||.+.+..++.++|||||||++|++++ |..||...+....     ........  +.+.+....    .++.+||.+
T Consensus       179 ~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~-----~~~i~~~~--~~~~p~~~~----~~l~~li~~  247 (285)
T d1u59a_         179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-----MAFIEQGK--RMECPPECP----PELYALMSD  247 (285)
T ss_dssp             CCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-----HHHHHTTC--CCCCCTTCC----HHHHHHHHH
T ss_pred             cChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH-----HHHHHcCC--CCCCCCcCC----HHHHHHHHH
Confidence            99999988899999999999999999998 8999976432211     01111111  122222222    247889999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||+.||++|||+.++.+.|+
T Consensus       248 cl~~~p~~RPs~~~i~~~L~  267 (285)
T d1u59a_         248 CWIYKWEDRPDFLTVEQRMR  267 (285)
T ss_dssp             TTCSSGGGSCCHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHHH
Confidence            99999999999999998875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-38  Score=226.50  Aligned_cols=161  Identities=27%  Similarity=0.417  Sum_probs=125.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~   80 (179)
                      .+.+++.+++.++.||+.||+|||++   +++||||||+||+++.++.++++|||+++........   .....+++.|+
T Consensus       101 ~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~  177 (277)
T d1xbba_         101 NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY  177 (277)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGC
T ss_pred             ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceec
Confidence            45799999999999999999999999   9999999999999999999999999999876543322   23346788999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      |||.+.+..++.++|+||||+++|++++ |+.||...+....     ......  ..+.+.+....    .++.+||.+|
T Consensus       178 APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~-----~~~i~~--~~~~~~p~~~~----~~~~~li~~c  246 (277)
T d1xbba_         178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----TAMLEK--GERMGCPAGCP----REMYDLMNLC  246 (277)
T ss_dssp             CHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----HHHHHT--TCCCCCCTTCC----HHHHHHHHHH
T ss_pred             CchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH-----HHHHHc--CCCCCCCcccC----HHHHHHHHHH
Confidence            9999998889999999999999999997 8999975432111     011111  11222222222    2478899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||++|||++++.+.|+
T Consensus       247 l~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         247 WTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             TCSSTTTSCCHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHhh
Confidence            9999999999999988764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-38  Score=227.00  Aligned_cols=161  Identities=25%  Similarity=0.395  Sum_probs=115.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~p   82 (179)
                      ...++++.++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++........ .....+++.|+||
T Consensus        95 ~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aP  171 (263)
T d1sm2a_          95 RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP  171 (263)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCCh
Confidence            45689999999999999999999999   9999999999999999999999999999766543322 2335678899999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhC-CCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKG-KHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|+++++ ..|+.......   ..  ........  ...+..+.    .++.+++.+||+
T Consensus       172 E~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~--~~i~~~~~--~~~p~~~~----~~l~~li~~cl~  240 (263)
T d1sm2a_         172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV--EDISTGFR--LYKPRLAS----THVYQIMNHCWK  240 (263)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HH--HHHHHTCC--CCCCTTSC----HHHHHHHHHHTC
T ss_pred             HHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HH--HHHHhcCC--CCCccccC----HHHHHHHHHHcc
Confidence            999999999999999999999999995 55554322111   00  11111111  11111222    247889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++|||+++++++|+
T Consensus       241 ~~p~~Rps~~~il~~L~  257 (263)
T d1sm2a_         241 ERPEDRPAFSRLLRQLA  257 (263)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CCHhHCcCHHHHHHHHH
Confidence            99999999999999985

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-37  Score=224.13  Aligned_cols=161  Identities=26%  Similarity=0.411  Sum_probs=118.2

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---CcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---NWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~   80 (179)
                      ...+++.+++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++.......   ......+++.|+
T Consensus       104 ~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~  180 (283)
T d1mqba_         104 DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT  180 (283)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGS
T ss_pred             cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCcccc
Confidence            45789999999999999999999999   999999999999999999999999999986543322   122345788999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCC-CCCCCCccHHHHHHHHHHHHhcc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDP-RLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      |||.+.+..++.++|+||||+++|+|+++..|+......       ......+... +.+.+....    ..+.+||.+|
T Consensus       181 APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~~~~~~~~~~~----~~l~~li~~c  249 (283)
T d1mqba_         181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRLPTPMDCP----SAIYQLMMQC  249 (283)
T ss_dssp             CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCCCCCTTCB----HHHHHHHHHH
T ss_pred             CHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-------HHHHHHHhccCCCCCchhhH----HHHHHHHHHH
Confidence            999999999999999999999999999976665332111       1111111111 122222222    3488899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||++|||++++++.|+
T Consensus       250 l~~~p~~RPt~~eil~~L~  268 (283)
T d1mqba_         250 WQQERARRPKFADIVSILD  268 (283)
T ss_dssp             TCSSTTTSCCHHHHHHHHH
T ss_pred             CcCCHhHCcCHHHHHHHHH
Confidence            9999999999999998874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-37  Score=224.14  Aligned_cols=161  Identities=22%  Similarity=0.362  Sum_probs=123.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      .++++.+++.++.||++||.|||+.   +++||||||+||+++.++.+||+|||++........ ......+++.|+|||
T Consensus       104 ~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE  180 (272)
T d1qpca_         104 IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE  180 (272)
T ss_dssp             HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChH
Confidence            3689999999999999999999999   999999999999999999999999999987654332 233456788999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|||||||++|+|++|..|+.......    ..........  +.+.+....    .++.+|+.+||+.|
T Consensus       181 ~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~----~~~~~i~~~~--~~~~p~~~~----~~l~~li~~cl~~~  250 (272)
T d1qpca_         181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVIQNLERGY--RMVRPDNCP----EELYQLMRLCWKER  250 (272)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHHHTTC--CCCCCTTCC----HHHHHHHHHHTCSS
T ss_pred             HHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH----HHHHHHHhcC--CCCCcccCh----HHHHHHHHHHcCCC
Confidence            9988889999999999999999999655543221110    0001111111  111112222    24788999999999


Q ss_pred             CCCCCCHHHHHHHhh
Q 042876          164 PESRPTMKIVSQQLR  178 (179)
Q Consensus       164 p~~Rps~~~~~~~l~  178 (179)
                      |++|||++++++.|+
T Consensus       251 P~~Rpt~~ei~~~L~  265 (272)
T d1qpca_         251 PEDRPTFDYLRSVLE  265 (272)
T ss_dssp             GGGSCCHHHHHHHHH
T ss_pred             HhHCcCHHHHHHHhh
Confidence            999999999998875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-37  Score=220.51  Aligned_cols=161  Identities=26%  Similarity=0.473  Sum_probs=128.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~p   82 (179)
                      ...+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++........ ......+++.|+||
T Consensus        94 ~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aP  170 (258)
T d1k2pa_          94 RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP  170 (258)
T ss_dssp             GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCH
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCc
Confidence            45789999999999999999999999   999999999999999999999999999976554332 23345678899999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|+|++ |+.||.........     .......  +.+.+....    ..+.+||.+||+
T Consensus       171 E~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~-----~~i~~~~--~~~~p~~~~----~~l~~li~~cl~  239 (258)
T d1k2pa_         171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-----EHIAQGL--RLYRPHLAS----EKVYTIMYSCWH  239 (258)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-----HHHHTTC--CCCCCTTCC----HHHHHHHHHTTC
T ss_pred             HHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH-----HHHHhCC--CCCCccccc----HHHHHHHHHHcc
Confidence            99999999999999999999999998 89999765422111     1111111  222222222    247889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++|||+++++++|.
T Consensus       240 ~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         240 EKADERPTFKILLSNIL  256 (258)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CCHhHCcCHHHHHHHhh
Confidence            99999999999999984

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-38  Score=230.91  Aligned_cols=156  Identities=26%  Similarity=0.436  Sum_probs=121.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ++++++.+++.++.||++||.|||++   |++||||||+|||++.++.+||+|||++......    ....|++.|+|||
T Consensus       109 ~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~----~~~~GT~~Y~APE  181 (309)
T d1u5ra_         109 KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPE  181 (309)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----CCCCSCGGGCCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC----CccccCccccCHH
Confidence            46799999999999999999999999   9999999999999999999999999999765432    3357899999999


Q ss_pred             cccc---CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           84 LAYT---MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        84 ~~~~---~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      .+.+   ..++.++|+|||||++|+|++|..||........     .........+.... ...    ...+.+||.+||
T Consensus       182 ~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-----~~~i~~~~~~~~~~-~~~----s~~~~~li~~~L  251 (309)
T d1u5ra_         182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNESPALQS-GHW----SEYFRNFVDSCL  251 (309)
T ss_dssp             HHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCCCCCSC-TTS----CHHHHHHHHHHT
T ss_pred             HHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHhCCCCCCCC-CCC----CHHHHHHHHHHC
Confidence            9864   3478899999999999999999999965432110     00111111111111 111    224788999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.||.+|||++|+++|
T Consensus       252 ~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         252 QKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             CSSGGGSCCHHHHTTC
T ss_pred             cCChhHCcCHHHHHhC
Confidence            9999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-37  Score=222.95  Aligned_cols=157  Identities=20%  Similarity=0.339  Sum_probs=120.5

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCC--cccCCCCCCCeeec-CCCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPP--IVHRDLSSKNLLLD-LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~--~~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..+++.+++.++.||++||+|||++   +  ++||||||+||+++ .++.+||+|||++......  ......|++.|+|
T Consensus       107 ~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--~~~~~~GT~~Y~a  181 (270)
T d1t4ha_         107 KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMA  181 (270)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCC
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--ccCCcccCccccC
Confidence            5789999999999999999999998   6  99999999999996 4789999999999754332  2345679999999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+ +++.++|+||+||++|+|++|+.||.......       .....+.....+..  .......++.++|.+||+
T Consensus       182 PE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-------~~~~~i~~~~~~~~--~~~~~~~~~~~li~~~l~  251 (270)
T d1t4ha_         182 PEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKPAS--FDKVAIPEVKEIIEGCIR  251 (270)
T ss_dssp             GGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCCGG--GGGCCCHHHHHHHHHHSC
T ss_pred             HHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-------HHHHHHHcCCCCcc--cCccCCHHHHHHHHHHcc
Confidence            998865 68999999999999999999999996432211       11111111111110  001112237889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||++|||++|+++|
T Consensus       252 ~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         252 QNKDERYSIKDLLNH  266 (270)
T ss_dssp             SSGGGSCCHHHHHTS
T ss_pred             CCHhHCcCHHHHhCC
Confidence            999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-38  Score=227.16  Aligned_cols=157  Identities=24%  Similarity=0.363  Sum_probs=122.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~   81 (179)
                      .+.+++.+++.++.|++.||.|||+.   +++||||||+||+++.++.++++|||++........  ......|++.|+|
T Consensus       102 ~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~A  178 (288)
T d1uu3a_         102 IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS  178 (288)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccC
Confidence            35789999999999999999999999   999999999999999999999999999987654322  2334578999999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+||+||++|+|++|..||...+...        ....+.......+...    ..++.+||.+||+
T Consensus       179 PE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~----s~~~~~li~~~L~  246 (288)
T d1uu3a_         179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKF----FPKARDLVEKLLV  246 (288)
T ss_dssp             HHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHTTCCCCCTTC----CHHHHHHHHTTSC
T ss_pred             ceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--------HHHHHHcCCCCCCccC----CHHHHHHHHHHcc
Confidence            999999999999999999999999999999997543211        1111111111111122    2247889999999


Q ss_pred             cCCCCCCCHHHHHH
Q 042876          162 ESPESRPTMKIVSQ  175 (179)
Q Consensus       162 ~~p~~Rps~~~~~~  175 (179)
                      .||.+|||++|+++
T Consensus       247 ~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         247 LDATKRLGCEEMEG  260 (288)
T ss_dssp             SSGGGSTTSGGGTC
T ss_pred             CCHhHCcCHHHHcC
Confidence            99999999998644

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-38  Score=227.81  Aligned_cols=161  Identities=28%  Similarity=0.326  Sum_probs=114.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec---CCCceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD---LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      ...+++.++..++.||+.||+|||+.   +++||||||+||++.   .++.+|++|||++....... ......|++.|+
T Consensus       101 ~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-~~~~~~GT~~y~  176 (307)
T d1a06a_         101 KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-VLSTACGTPGYV  176 (307)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------------------CTTS
T ss_pred             ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC-eeeeeeeCcccc
Confidence            45799999999999999999999999   999999999999994   46789999999997655332 233457899999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |||.+.+..++.++|+||+||++|+|++|..||.......        ....+.................++.+|+.+||
T Consensus       177 APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  248 (307)
T d1a06a_         177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--------LFEQILKAEYEFDSPYWDDISDSAKDFIRHLM  248 (307)
T ss_dssp             CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHS
T ss_pred             CcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCCCCCCccccCCCHHHHHHHHHHc
Confidence            9999999999999999999999999999999997543211        11111111111111111112234788999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.||++|||++|+++|
T Consensus       249 ~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         249 EKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CSSGGGSCCHHHHHHS
T ss_pred             cCCHhHCcCHHHHhcC
Confidence            9999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.6e-38  Score=227.22  Aligned_cols=162  Identities=23%  Similarity=0.340  Sum_probs=124.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC-cccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN-WTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~p   82 (179)
                      ...+++..++.++.||++||+|||++   +++||||||+|||++.++.+||+|||++......... .....+++.|+||
T Consensus       109 ~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aP  185 (287)
T d1opja_         109 RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP  185 (287)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCH
T ss_pred             ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccCh
Confidence            46789999999999999999999999   9999999999999999999999999999876543322 2233567889999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      |.+.+..++.++|+|||||++|+|++|..|+.......  ..  ........  +.+.+....    .++.+||.+||+.
T Consensus       186 E~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~--~~~i~~~~--~~~~~~~~~----~~l~~li~~cl~~  255 (287)
T d1opja_         186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QV--YELLEKDY--RMERPEGCP----EKVYELMRACWQW  255 (287)
T ss_dssp             HHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH--HHHHHTTC--CCCCCTTCC----HHHHHHHHHHTCS
T ss_pred             HHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HH--HHHHhcCC--CCCCCccch----HHHHHHHHHHcCC
Confidence            99999999999999999999999999777653322111  00  00111111  111111222    2488899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||++|||++++++.|+
T Consensus       256 dP~~Rps~~ei~~~L~  271 (287)
T d1opja_         256 NPSDRPSFAEIHQAFE  271 (287)
T ss_dssp             SGGGSCCHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHHH
Confidence            9999999999998774

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-37  Score=228.58  Aligned_cols=161  Identities=24%  Similarity=0.400  Sum_probs=125.5

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~   81 (179)
                      ...+++..++.++.||+.||.|||++   +++||||||+||+++.++.+||+|||++.........  .....+++.|+|
T Consensus       105 ~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A  181 (317)
T d1xkka_         105 KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA  181 (317)
T ss_dssp             SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccC
Confidence            46789999999999999999999999   9999999999999999999999999999876543322  233467899999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..++.++|+||||+++|+|++ |..||........   .  .....  ..+.+.+..+..    .+.+++.+||
T Consensus       182 PE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~--~~i~~--~~~~~~p~~~~~----~~~~li~~cl  250 (317)
T d1xkka_         182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S--SILEK--GERLPQPPICTI----DVYMIMVKCW  250 (317)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---H--HHHHH--TCCCCCCTTBCH----HHHHHHHHHT
T ss_pred             hHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---H--HHHHc--CCCCCCCcccCH----HHHHHHHHhC
Confidence            999999899999999999999999998 7889875432211   1  11111  112222223323    3788999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||.+|||+.+++++|+
T Consensus       251 ~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         251 MIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             CSSGGGSCCHHHHHHHHH
T ss_pred             CCChhhCcCHHHHHHHHH
Confidence            999999999999998874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-37  Score=227.75  Aligned_cols=165  Identities=21%  Similarity=0.298  Sum_probs=122.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ..+++.+++.++.|+++||.|||+ +   +|+||||||+||+++.++.+||+|||+|.......  .....|++.|+|||
T Consensus        99 ~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~~~~~GT~~Y~APE  173 (322)
T d1s9ja_          99 GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPE  173 (322)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--C---CCSSCCCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--cccccCCccccCch
Confidence            468999999999999999999996 6   89999999999999999999999999998654322  23458999999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccch----------------------------------hhh
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNT----------------------------------DIE  129 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~----------------------------------~~~  129 (179)
                      .+.+..++.++|+||+||++|+|++|+.||...+.........                                  ...
T Consensus       174 vl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (322)
T d1s9ja_         174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFEL  253 (322)
T ss_dssp             HHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHH
T ss_pred             HHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHH
Confidence            9999999999999999999999999999996543211000000                                  000


Q ss_pred             hhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          130 LDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .........+....  .....++.+|+.+||..||.+|||++|+++|
T Consensus       254 ~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         254 LDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             HHHHHTSCCCCCCB--TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhhhhccCCccCcc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            00000000000000  0012347889999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-37  Score=225.61  Aligned_cols=158  Identities=23%  Similarity=0.310  Sum_probs=126.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++..++.++.||+.||+|||++   +++||||||+||+++.++.+||+|||++..............|++.|+|||
T Consensus        99 ~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE  175 (337)
T d1o6la_          99 ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE  175 (337)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGG
T ss_pred             ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhh
Confidence            35789999999999999999999999   999999999999999999999999999987655444445568899999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+||++|+|++|+.||...+....        ...........+....    .++.+||.+||+.|
T Consensus       176 ~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--------~~~i~~~~~~~p~~~s----~~~~dli~~~L~~d  243 (337)
T d1o6la_         176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--------FELILMEEIRFPRTLS----PEAKSLLAGLLKKD  243 (337)
T ss_dssp             GGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHHCCCCCCTTSC----HHHHHHHHHHTCSS
T ss_pred             hccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH--------HHHHhcCCCCCCccCC----HHHHHHHHhhccCC
Confidence            99999999999999999999999999999975432111        1111111111111222    23788999999999


Q ss_pred             CCCCCC-----HHHHHHH
Q 042876          164 PESRPT-----MKIVSQQ  176 (179)
Q Consensus       164 p~~Rps-----~~~~~~~  176 (179)
                      |.+|++     ++++++|
T Consensus       244 P~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         244 PKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             TTTSTTCSTTTHHHHHTS
T ss_pred             chhhcccccccHHHHHcC
Confidence            999995     8888876

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-37  Score=221.95  Aligned_cols=161  Identities=23%  Similarity=0.395  Sum_probs=117.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~p   82 (179)
                      ..++++..++.++.||++||.|||+.   +++||||||+||+++.++.+|++|||++........ ......+++.|+||
T Consensus       102 ~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~ap  178 (273)
T d1mp8a_         102 KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP  178 (273)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCH
T ss_pred             CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchh
Confidence            45789999999999999999999999   999999999999999999999999999987654322 22345678899999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+|||||++|+|++ |..||.........   .  .....  .+.+.+....    ..+.+||.+||+
T Consensus       179 E~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~--~i~~~--~~~~~~~~~~----~~~~~li~~cl~  247 (273)
T d1mp8a_         179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G--RIENG--ERLPMPPNCP----PTLYSLMTKCWA  247 (273)
T ss_dssp             HHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H--HHHTT--CCCCCCTTCC----HHHHHHHHHHTC
T ss_pred             hHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---H--HHHcC--CCCCCCCCCC----HHHHHHHHHHcC
Confidence            99998899999999999999999998 89998765432211   1  11111  1112222222    248889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||++|||+++|+++|+
T Consensus       248 ~dp~~Rps~~ei~~~L~  264 (273)
T d1mp8a_         248 YDPSRRPRFTELKAQLS  264 (273)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CCHhHCcCHHHHHHHHH
Confidence            99999999999999885

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.6e-37  Score=229.05  Aligned_cols=161  Identities=20%  Similarity=0.271  Sum_probs=126.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec--CCCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD--LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..++++.+++.++.||+.||.|||++   |++||||||+||+++  .++.+||+|||++....... ......+++.|+|
T Consensus       118 ~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~gT~~Y~a  193 (350)
T d1koaa2         118 HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKVTTGTAEFAA  193 (350)
T ss_dssp             TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-CEEEECSCTTTCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc-ccceecCcccccC
Confidence            45799999999999999999999999   999999999999995  45789999999998765433 2344678999999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+|||||++|+|++|..||.+.+...        ....+.................++.+||.+||+
T Consensus       194 PEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  265 (350)
T d1koaa2         194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--------TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL  265 (350)
T ss_dssp             HHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCC
T ss_pred             HHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence            999999999999999999999999999999996543211        111111111111112222223357889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||++|||++|+++|
T Consensus       266 ~dP~~R~t~~eil~h  280 (350)
T d1koaa2         266 ADPNTRMTIHQALEH  280 (350)
T ss_dssp             SSGGGSCCHHHHHHS
T ss_pred             CChhHCcCHHHHhcC
Confidence            999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-37  Score=225.13  Aligned_cols=165  Identities=24%  Similarity=0.288  Sum_probs=127.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC---CCceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL---EYEAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      .+.|++.+++.++.||+.||+|||+.   +++||||||+||+++.   ++.+|++|||++....... ......|++.|+
T Consensus       105 ~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~-~~~~~~gt~~y~  180 (335)
T d2ozaa1         105 DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYV  180 (335)
T ss_dssp             CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC-CCCCCSCCCSSC
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCC-ccccccCCcccC
Confidence            35799999999999999999999999   9999999999999975   4569999999998765433 234467899999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |||.+.+..++.++|+|||||++|+|++|+.||.+..........    ...........+.........++.+||.+||
T Consensus       181 aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  256 (335)
T d2ozaa1         181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLL  256 (335)
T ss_dssp             CCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHS
T ss_pred             CcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----HHHHhcCCCCCCCcccccCCHHHHHHHHHHc
Confidence            999999999999999999999999999999999765432211110    0011111111122223344556889999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.||++|||+.|+++|
T Consensus       257 ~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         257 KTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CSSTTTSCCHHHHHHS
T ss_pred             cCChhHCcCHHHHHcC
Confidence            9999999999999886

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.2e-37  Score=228.76  Aligned_cols=161  Identities=19%  Similarity=0.276  Sum_probs=126.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec--CCCceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD--LEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..++++.+++.++.||+.||.|||+.   |++||||||+|||++  .++.+||+|||++....... ......+++.|+|
T Consensus       121 ~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-~~~~~~gt~~y~a  196 (352)
T d1koba_         121 DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-IVKVTTATAEFAA  196 (352)
T ss_dssp             TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-CEEEECSSGGGCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC-ceeeccCcccccC
Confidence            34699999999999999999999999   999999999999997  56889999999998776543 2344678899999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||.+.+..++.++|+|||||++|+|++|..||.+.....        ....+.................++.+||.+||+
T Consensus       197 PE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  268 (352)
T d1koba_         197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ  268 (352)
T ss_dssp             HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSC
T ss_pred             HHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCcccccCCCHHHHHHHHHHcc
Confidence            999999999999999999999999999999997543211        111111111111111111122347889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||.+|||++|+++|
T Consensus       269 ~dp~~R~s~~eil~H  283 (352)
T d1koba_         269 KEPRKRLTVHDALEH  283 (352)
T ss_dssp             SSGGGSCCHHHHHTS
T ss_pred             CChhHCcCHHHHhcC
Confidence            999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-37  Score=220.25  Aligned_cols=159  Identities=26%  Similarity=0.416  Sum_probs=124.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC---cccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN---WTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~   81 (179)
                      .++++..++.++.|++.||.|||++   +++||||||+||+++.++.+|++|||++.........   .....++..|+|
T Consensus       106 ~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~a  182 (273)
T d1u46a_         106 GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA  182 (273)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCC
Confidence            4689999999999999999999999   9999999999999999999999999999876544322   223456788999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCC--CCCCCCCccHHHHHHHHHHHHhc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLD--PRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      ||.+.+..++.++|+||||+++|+|++ |..||...+...        ....+..  .+.+......    ..+.+||.+
T Consensus       183 PE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~----~~l~~li~~  250 (273)
T d1u46a_         183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEGERLPRPEDCP----QDIYNVMVQ  250 (273)
T ss_dssp             HHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSCCCCCCCTTCC----HHHHHHHHH
T ss_pred             HHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--------HHHHHHhCCCCCCCccccc----HHHHHHHHH
Confidence            999999899999999999999999998 899997543221        1111111  1122222222    247889999


Q ss_pred             ccCcCCCCCCCHHHHHHHhh
Q 042876          159 CLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~l~  178 (179)
                      ||+.||++|||+++|.+.|+
T Consensus       251 cl~~dp~~RPt~~ei~~~L~  270 (273)
T d1u46a_         251 CWAHKPEDRPTFVALRDFLL  270 (273)
T ss_dssp             HTCSSGGGSCCHHHHHHHHH
T ss_pred             HcCCChhHCcCHHHHHHHHH
Confidence            99999999999999998875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-37  Score=223.45  Aligned_cols=159  Identities=21%  Similarity=0.368  Sum_probs=123.6

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........  ......+++.|+||
T Consensus       135 ~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aP  211 (301)
T d1lufa_         135 PPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  211 (301)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCH
Confidence            4689999999999999999999999   999999999999999999999999999975543222  12345677889999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCC-CCCcccccccccccchhhhhhhcCCCCCCC-CCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGK-HPRDFLSSISSSSLNTDIELDEMLDPRLPA-PSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl  160 (179)
                      |.+.+..++.++|||||||++|+|++|. .||.......        ....+.....+. +....    .++.+|+.+||
T Consensus       212 E~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e--------~~~~v~~~~~~~~p~~~~----~~~~~li~~cl  279 (301)
T d1lufa_         212 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--------VIYYVRDGNILACPENCP----LELYNLMRLCW  279 (301)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHTTCCCCCCTTCC----HHHHHHHHHHT
T ss_pred             HHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH--------HHHHHHcCCCCCCCccch----HHHHHHHHHHc
Confidence            9999999999999999999999999985 5675443211        111112222211 11222    24888999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||++|||+.||++.|+
T Consensus       280 ~~~P~~RPt~~ev~~~L~  297 (301)
T d1lufa_         280 SKLPADRPSFCSIHRILQ  297 (301)
T ss_dssp             CSSGGGSCCHHHHHHHHH
T ss_pred             CCChhHCcCHHHHHHHHH
Confidence            999999999999999886

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-37  Score=222.78  Aligned_cols=171  Identities=22%  Similarity=0.204  Sum_probs=126.2

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ....+++.+++.+++||+.||+|||++   +++||||||+||+++.++.+||+|||.+..............+++.|+||
T Consensus        93 ~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aP  169 (299)
T d1ua2a_          93 NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP  169 (299)
T ss_dssp             CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCH
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccH
Confidence            346789999999999999999999999   99999999999999999999999999998776554444556789999999


Q ss_pred             cccccC-CCCcchhhHHHHHHHHHHHhCCCCCccccccccccc-------------chhhhhhhcC-CCCCCCCC--ccH
Q 042876           83 ELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL-------------NTDIELDEML-DPRLPAPS--RSV  145 (179)
Q Consensus        83 e~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~-------------~~~~~~~~~~-~~~~~~~~--~~~  145 (179)
                      |.+.+. .++.++|+||+||++|+|++|..||...........             .......... ....+...  ...
T Consensus       170 E~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (299)
T d1ua2a_         170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF  249 (299)
T ss_dssp             HHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHC
T ss_pred             HHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhc
Confidence            988654 578999999999999999999999965432110000             0000000000 00001000  000


Q ss_pred             HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .....++.+|+.+||+.||++|||++|+++|
T Consensus       250 ~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         250 SAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            1112358899999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=221.90  Aligned_cols=169  Identities=20%  Similarity=0.247  Sum_probs=124.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.|++.||+|||++   +++||||||+|||++.++.++++|||.+....... ......|++.|+|||
T Consensus       110 ~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~-~~~~~~gT~~Y~APE  185 (305)
T d1blxa_         110 EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPE  185 (305)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG-GGCCCCCCCTTCCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhhhcccc-cCCCcccChhhcCcc
Confidence            45689999999999999999999999   99999999999999999999999999986543322 234567899999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-------------hhhh-hhhcCCCCC-CCCCccHHHH
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-------------TDIE-LDEMLDPRL-PAPSRSVQEK  148 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-------------~~~~-~~~~~~~~~-~~~~~~~~~~  148 (179)
                      .+.+..++.++|+||+||++|+|++|+.||...+........             .... ......... ..........
T Consensus       186 ~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (305)
T d1blxa_         186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI  265 (305)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSC
T ss_pred             hhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccC
Confidence            999999999999999999999999999999754321100000             0000 000000000 0000001111


Q ss_pred             HHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          149 LISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       149 ~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ...+.+|+.+||+.||++|||++|+++|
T Consensus       266 s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         266 DELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            2247788999999999999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-36  Score=225.37  Aligned_cols=154  Identities=22%  Similarity=0.276  Sum_probs=123.9

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++.+++.++.||+.||.|||++   +++||||||+|||++.++.+||+|||++.......   ....|++.|+|||.
T Consensus       136 ~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~---~~~~Gt~~Y~APE~  209 (350)
T d1rdqe_         136 GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEI  209 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---CCCEECGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc---ccccCccccCCHHH
Confidence            4789999999999999999999999   99999999999999999999999999998765332   34578999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+|||||++|+|++|..||...+...        ....+.......+...    ..++.++|.+||+.||
T Consensus       210 ~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~----s~~~~~li~~~L~~dP  277 (350)
T d1rdqe_         210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKVRFPSHF----SSDLKDLLRNLLQVDL  277 (350)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCCCTTC----CHHHHHHHHHHSCSCT
T ss_pred             HcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH--------HHHHHhcCCCCCCccC----CHHHHHHHHHHhhhCH
Confidence            999999999999999999999999999996543211        1111111111111122    2247889999999999


Q ss_pred             CCCC-----CHHHHHHH
Q 042876          165 ESRP-----TMKIVSQQ  176 (179)
Q Consensus       165 ~~Rp-----s~~~~~~~  176 (179)
                      .+|+     |++++++|
T Consensus       278 ~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         278 TKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             TTCTTSSTTTTHHHHTS
T ss_pred             HhccccccccHHHHHcC
Confidence            9994     89999876

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.2e-36  Score=222.78  Aligned_cols=158  Identities=19%  Similarity=0.226  Sum_probs=124.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++.......  .....|++.|+|||.
T Consensus       102 ~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~--~~~~~GT~~y~APE~  176 (364)
T d1omwa3         102 GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEV  176 (364)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC--CCSCCSCGGGCCHHH
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCc--ccccccccccchhHH
Confidence            4688999999999999999999999   99999999999999999999999999998765433  234578999999999


Q ss_pred             cc-cCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           85 AY-TMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        85 ~~-~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      +. +..++.++|+|||||++|+|++|..||.......     ...............+.....    ++.+||.+||+.|
T Consensus       177 ~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~s~----~~~~li~~~L~~d  247 (364)
T d1omwa3         177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTMAVELPDSFSP----ELRSLLEGLLQRD  247 (364)
T ss_dssp             HSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHHSSSCCCCCCSSSCH----HHHHHHHHHTCSS
T ss_pred             hhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcccCCCCCCCCCCH----HHHHHHHHHcccC
Confidence            86 4568999999999999999999999997543211     111111222222222222222    3788999999999


Q ss_pred             CCCCCC-----HHHHHHH
Q 042876          164 PESRPT-----MKIVSQQ  176 (179)
Q Consensus       164 p~~Rps-----~~~~~~~  176 (179)
                      |.+|||     ++++++|
T Consensus       248 P~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         248 VNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             TTTSTTTSSSTHHHHHTS
T ss_pred             HHHhCCCcccCHHHHHcC
Confidence            999999     7999876

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-36  Score=217.97  Aligned_cols=160  Identities=27%  Similarity=0.387  Sum_probs=118.4

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      +.+++.+++.++.||+.||+|||++   +++||||||+||+++.++.+||+|||++........ ......+++.|+|||
T Consensus       108 ~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE  184 (285)
T d1fmka3         108 KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE  184 (285)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHH
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChH
Confidence            4689999999999999999999999   999999999999999999999999999976543332 223356789999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcC-CCCCCCCCccHHHHHHHHHHHHhcccCc
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEML-DPRLPAPSRSVQEKLISIVKVAFSCLNE  162 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~  162 (179)
                      .+.+..++.++||||||+++|+|++|..|+......       ......+. ..+.+......    ..+.++|.+||+.
T Consensus       185 ~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-------~~~~~~i~~~~~~~~~~~~~----~~l~~li~~cl~~  253 (285)
T d1fmka3         185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMPCPPECP----ESLHDLMCQCWRK  253 (285)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCCCTTSC----HHHHHHHHHHTCS
T ss_pred             HHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCCCcccC----HHHHHHHHHHccc
Confidence            999999999999999999999999976665332211       11111111 11122222222    2478899999999


Q ss_pred             CCCCCCCHHHHHHHhh
Q 042876          163 SPESRPTMKIVSQQLR  178 (179)
Q Consensus       163 ~p~~Rps~~~~~~~l~  178 (179)
                      ||++|||+++|++.|+
T Consensus       254 dP~~Rps~~~i~~~L~  269 (285)
T d1fmka3         254 EPEERPTFEYLQAFLE  269 (285)
T ss_dssp             SGGGSCCHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHHh
Confidence            9999999999998774

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-36  Score=217.78  Aligned_cols=161  Identities=27%  Similarity=0.387  Sum_probs=126.8

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC--CcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS--NWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~   81 (179)
                      .+.+++.+++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||++........  ......+++.|+|
T Consensus       129 ~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  205 (299)
T d1fgka_         129 EEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA  205 (299)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSC
T ss_pred             cccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhh
Confidence            46799999999999999999999999   999999999999999999999999999986644322  2334567889999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      ||.+.+..++.++|+||||+++|+|++ |..||........     ........  +.+.+.....    ++.+||.+||
T Consensus       206 PE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~-----~~~i~~~~--~~~~p~~~~~----~l~~li~~cl  274 (299)
T d1fgka_         206 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-----FKLLKEGH--RMDKPSNCTN----ELYMMMRDCW  274 (299)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-----HHHHHTTC--CCCCCSSCCH----HHHHHHHHHT
T ss_pred             hhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH-----HHHHHcCC--CCCCCccchH----HHHHHHHHHc
Confidence            999999999999999999999999998 6888865432111     01111111  1122222222    4788999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||++|||++|+++.|+
T Consensus       275 ~~dP~~Rps~~eil~~L~  292 (299)
T d1fgka_         275 HAVPSQRPTFKQLVEDLD  292 (299)
T ss_dssp             CSSGGGSCCHHHHHHHHH
T ss_pred             cCCHhHCcCHHHHHHHHH
Confidence            999999999999999885

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-35  Score=216.06  Aligned_cols=170  Identities=21%  Similarity=0.248  Sum_probs=126.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++.+++.++.|++.||.|||+.   +++||||||+||+++.++.+|++|||.+..............+++.|+|||
T Consensus        96 ~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE  172 (298)
T d1gz8a_          96 LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE  172 (298)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehh
Confidence            45699999999999999999999999   999999999999999999999999999987765554455568899999999


Q ss_pred             ccccCC-CCcchhhHHHHHHHHHHHhCCCCCcccccccc------------cccchhhhhhhcCCCCCCCC-Ccc----H
Q 042876           84 LAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------------SSLNTDIELDEMLDPRLPAP-SRS----V  145 (179)
Q Consensus        84 ~~~~~~-~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~-~~~----~  145 (179)
                      .+.... ++.++|+||+||++|+|++|+.||...+....            .................+.. ...    .
T Consensus       173 ~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (298)
T d1gz8a_         173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV  252 (298)
T ss_dssp             HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHS
T ss_pred             hhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhc
Confidence            877655 57899999999999999999999975432110            00000000000000011110 000    0


Q ss_pred             HHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          146 QEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       146 ~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .....++.+|+.+||+.||++|||++|+++|
T Consensus       253 ~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         253 PPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1112357889999999999999999999987

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.3e-36  Score=219.38  Aligned_cols=155  Identities=26%  Similarity=0.367  Sum_probs=123.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      ...+++..++.++.||+.||.|||++   +++||||||+||+++.++.+||+|||++.......   ....|++.|+|||
T Consensus        98 ~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~---~~~~Gt~~Y~APE  171 (316)
T d1fota_          98 SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPE  171 (316)
T ss_dssp             TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB---CCCCSCTTTCCHH
T ss_pred             cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc---ccccCcccccCHH
Confidence            45678899999999999999999999   99999999999999999999999999998765432   3467899999999


Q ss_pred             ccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcC
Q 042876           84 LAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNES  163 (179)
Q Consensus        84 ~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~  163 (179)
                      .+.+..++.++|+||+||++|+|++|+.||...+...        ....+.......+....    .++.+++.+||..|
T Consensus       172 ~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~~~p~~~s----~~~~~li~~~L~~d  239 (316)
T d1fota_         172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAELRFPPFFN----EDVKDLLSRLITRD  239 (316)
T ss_dssp             HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHCCCCCCTTSC----HHHHHHHHHHTCSC
T ss_pred             HHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH--------HHHHHHcCCCCCCCCCC----HHHHHHHHHHhhhC
Confidence            9999899999999999999999999999997543211        11111111111111111    24788999999999


Q ss_pred             CCCCC-----CHHHHHHH
Q 042876          164 PESRP-----TMKIVSQQ  176 (179)
Q Consensus       164 p~~Rp-----s~~~~~~~  176 (179)
                      |.+|+     |++++++|
T Consensus       240 p~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         240 LSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             TTTCTTSSTTTTHHHHTS
T ss_pred             HHhccccchhhHHHHHcC
Confidence            99996     89999876

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-36  Score=218.71  Aligned_cols=160  Identities=21%  Similarity=0.271  Sum_probs=124.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC----ceeEccccCccccCCCCCCcccccCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY----EAHVADFGIAKFLKPDSSNWTEFAGTYGYV   80 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~   80 (179)
                      +.+++.+++.++.|+++||+|||+.   +++||||||+||+++.++    .+|++|||++....... ......+++.|+
T Consensus       108 ~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~-~~~~~~~t~~y~  183 (293)
T d1jksa_         108 ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFV  183 (293)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC-BCSCCCCCGGGC
T ss_pred             cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhhcCCCc-cccccCCCCccc
Confidence            5799999999999999999999999   999999999999998766    48999999997765433 234457888999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |||.+.+..++.++|+||+||++|+|++|..||.+.+...        ....+..................+.+||.+||
T Consensus       184 APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L  255 (293)
T d1jksa_         184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANVSAVNYEFEDEYFSNTSALAKDFIRRLL  255 (293)
T ss_dssp             CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTS
T ss_pred             CHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--------HHHHHHhcCCCCCchhcCCCCHHHHHHHHHHc
Confidence            9999999889999999999999999999999997543211        11111111111111111122335788999999


Q ss_pred             CcCCCCCCCHHHHHHH
Q 042876          161 NESPESRPTMKIVSQQ  176 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~  176 (179)
                      +.||.+|||++|+++|
T Consensus       256 ~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         256 VKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             CSSGGGSCCHHHHHHS
T ss_pred             cCChhHCcCHHHHhcC
Confidence            9999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-36  Score=220.71  Aligned_cols=157  Identities=28%  Similarity=0.372  Sum_probs=126.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++.+++.++.||+.||.|||++   +++||||||+||+++.++.+|++|||++..............|++.|+|||.
T Consensus        98 ~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~  174 (320)
T d1xjda_          98 HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI  174 (320)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHH
Confidence            5689999999999999999999999   9999999999999999999999999999876655555555688999999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      +.+..++.++|+||+||++|+|++|+.||.+.+....   .....   .....++.  ..    ..++.+||.+||+.||
T Consensus       175 ~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i~---~~~~~~p~--~~----s~~~~dli~~~L~~dP  242 (320)
T d1xjda_         175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSIR---MDNPFYPR--WL----EKEAKDLLVKLFVREP  242 (320)
T ss_dssp             HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH---HCCCCCCT--TS----CHHHHHHHHHHSCSSG
T ss_pred             HcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHH---cCCCCCCc--cC----CHHHHHHHHHhcccCC
Confidence            9999999999999999999999999999975432111   11111   11122221  11    2247889999999999


Q ss_pred             CCCCCHH-HHHHH
Q 042876          165 ESRPTMK-IVSQQ  176 (179)
Q Consensus       165 ~~Rps~~-~~~~~  176 (179)
                      .+|||+. ++++|
T Consensus       243 ~~R~s~~~~l~~h  255 (320)
T d1xjda_         243 EKRLGVRGDIRQH  255 (320)
T ss_dssp             GGSBTTBSCGGGS
T ss_pred             CCCcCHHHHHHhC
Confidence            9999985 67654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.5e-36  Score=217.66  Aligned_cols=163  Identities=25%  Similarity=0.386  Sum_probs=118.4

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---CcccccCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---NWTEFAGTYGYV   80 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~   80 (179)
                      .+++++.+++.++.||+.||+|||+.   |++||||||+||+++.++..+++|||.+........   ......|++.|+
T Consensus       105 ~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~  181 (277)
T d1o6ya_         105 EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL  181 (277)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhccccccccccccccCccccc
Confidence            35789999999999999999999999   999999999999999999999999999875543322   233457899999


Q ss_pred             CCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhccc
Q 042876           81 APELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        81 ~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |||.+.+..++.++|+||+||++|+|++|..||...+....        ....+..............+..+.++|.+||
T Consensus       182 aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--------~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L  253 (277)
T d1o6ya_         182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--------AYQHVREDPIPPSARHEGLSADLDAVVLKAL  253 (277)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------HHHHHHCCCCCGGGTSSSCCHHHHHHHHHHT
T ss_pred             CHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH--------HHHHHhcCCCCCchhccCCCHHHHHHHHHHc
Confidence            99999998999999999999999999999999975432111        1111100000000111111234788999999


Q ss_pred             CcCCCCCC-CHHHHHHHh
Q 042876          161 NESPESRP-TMKIVSQQL  177 (179)
Q Consensus       161 ~~~p~~Rp-s~~~~~~~l  177 (179)
                      +.||.+|| |+++++..|
T Consensus       254 ~~dp~~R~~sa~~l~~~l  271 (277)
T d1o6ya_         254 AKNPENRYQTAAEMRADL  271 (277)
T ss_dssp             CSSGGGSCSSHHHHHHHH
T ss_pred             cCCHhHCHhHHHHHHHHH
Confidence            99999999 899988765

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-36  Score=216.83  Aligned_cols=150  Identities=25%  Similarity=0.394  Sum_probs=120.0

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC-CceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE-YEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ...+++.+++.++.||++||.|||+.   +++||||||+||+++.+ +.+|++|||++......  ......|++.|+||
T Consensus       104 ~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~--~~~~~~GT~~y~aP  178 (273)
T d1xwsa_         104 RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPP  178 (273)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceecccc--cccccccCCCcCCH
Confidence            35789999999999999999999999   99999999999999855 78999999999765432  23446789999999


Q ss_pred             cccccCCC-CcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKI-TEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~-~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..+ +.++|+||+||++|+|++|+.||...+..          .....  .++.  ..    ..++.+||.+||+
T Consensus       179 E~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i----------~~~~~--~~~~--~~----s~~~~~li~~~L~  240 (273)
T d1xwsa_         179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------IRGQV--FFRQ--RV----SSECQHLIRWCLA  240 (273)
T ss_dssp             HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----------HHCCC--CCSS--CC----CHHHHHHHHHHTC
T ss_pred             HHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH----------hhccc--CCCC--CC----CHHHHHHHHHHcc
Confidence            99887665 57789999999999999999999653210          00000  1111  11    1247889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||++|||++|+++|
T Consensus       241 ~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         241 LRPSDRPTFEEIQNH  255 (273)
T ss_dssp             SSGGGSCCHHHHHTS
T ss_pred             CCHhHCcCHHHHhcC
Confidence            999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.7e-36  Score=217.53  Aligned_cols=168  Identities=17%  Similarity=0.263  Sum_probs=124.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeec---CCCceeEccccCccccCCCCC-------Ccccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLD---LEYEAHVADFGIAKFLKPDSS-------NWTEF   73 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~~~-------~~~~~   73 (179)
                      .+.+++..++.++.|++.||+|||++   +++||||||+||+++   .+..++++|||++........       .....
T Consensus        97 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~  173 (299)
T d1ckia_          97 SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL  173 (299)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSC
T ss_pred             cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCc
Confidence            46799999999999999999999999   999999999999875   345699999999987654321       12345


Q ss_pred             cCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHH
Q 042876           74 AGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIV  153 (179)
Q Consensus        74 ~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (179)
                      .|++.|+|||.+.+..++.++|+|||||++|+|++|..||......................+ .+   ......+.++.
T Consensus       174 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~p~~~~  249 (299)
T d1ckia_         174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IE---VLCKGYPSEFA  249 (299)
T ss_dssp             CCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-HH---HHTTTSCHHHH
T ss_pred             CCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-hh---HhccCCCHHHH
Confidence            789999999999999999999999999999999999999976554332222111111111000 00   00001123478


Q ss_pred             HHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          154 KVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       154 ~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +++..||+.||++||+++++.+.|+
T Consensus       250 ~li~~cl~~~p~~RP~~~~i~~~l~  274 (299)
T d1ckia_         250 TYLNFCRSLRFDDKPDYSYLRQLFR  274 (299)
T ss_dssp             HHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHHHHH
Confidence            8999999999999999998887664

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-35  Score=210.75  Aligned_cols=156  Identities=25%  Similarity=0.361  Sum_probs=117.4

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCccc
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPELA   85 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~   85 (179)
                      .+++..++.++.||++||.|||+.   +++||||+|+||+++.++.++++|||++.......   ....++..|+|||.+
T Consensus        99 ~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---~~~~~~~~y~aPE~l  172 (262)
T d1byga_          99 VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEAL  172 (262)
T ss_dssp             HCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHH
T ss_pred             CCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---ccccccccCCChHHH
Confidence            489999999999999999999999   99999999999999999999999999997654332   334567889999999


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHh-CCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccCcCC
Q 042876           86 YTMKITEKCDVYSFGVLALEVIK-GKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLNESP  164 (179)
Q Consensus        86 ~~~~~~~~~D~~slg~~~~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p  164 (179)
                      .+..++.++||||||+++|+|++ |..||........     .........+..+  ....    ..+.+|+.+||+.||
T Consensus       173 ~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~-----~~~i~~~~~~~~~--~~~~----~~~~~li~~cl~~dP  241 (262)
T d1byga_         173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGYKMDAP--DGCP----PAVYEVMKNCWHLDA  241 (262)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-----HHHHTTTCCCCCC--TTCC----HHHHHHHHHHTCSSG
T ss_pred             hCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHcCCCCCCC--ccCC----HHHHHHHHHHcccCH
Confidence            98899999999999999999998 6777765432111     1111111111222  1222    247889999999999


Q ss_pred             CCCCCHHHHHHHhh
Q 042876          165 ESRPTMKIVSQQLR  178 (179)
Q Consensus       165 ~~Rps~~~~~~~l~  178 (179)
                      .+|||+.+++++|+
T Consensus       242 ~~Rps~~~l~~~L~  255 (262)
T d1byga_         242 AMRPSFLQLREQLE  255 (262)
T ss_dssp             GGSCCHHHHHHHHH
T ss_pred             hHCcCHHHHHHHHH
Confidence            99999999999985

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.1e-36  Score=214.99  Aligned_cols=160  Identities=23%  Similarity=0.328  Sum_probs=123.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      .++++.+++.++.||+.||+|||++   |++||||||+||+++.++.+||+|||++....... ......+++.|++||.
T Consensus       105 ~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~~PE~  180 (277)
T d1phka_         105 VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEI  180 (277)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEccCCC-ceeeeeccCCCCCHHH
Confidence            5789999999999999999999999   99999999999999999999999999998766433 2344678999999998


Q ss_pred             ccc------CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhc
Q 042876           85 AYT------MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFS  158 (179)
Q Consensus        85 ~~~------~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  158 (179)
                      +.+      ..++.++|+||+||++|+|++|+.||...+...        ....+.................++.+|+.+
T Consensus       181 ~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  252 (277)
T d1phka_         181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSR  252 (277)
T ss_dssp             HHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCCCTTTGGGSCHHHHHHHHH
T ss_pred             hhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--------HHHHHHhCCCCCCCcccccCCHHHHHHHHH
Confidence            864      235789999999999999999999997543211        111111111111111111122348889999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 042876          159 CLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       159 cl~~~p~~Rps~~~~~~~  176 (179)
                      ||+.||.+|||++|+++|
T Consensus       253 ~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         253 FLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HCCSSGGGSCCHHHHTTS
T ss_pred             HccCChhHCcCHHHHHcC
Confidence            999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-35  Score=217.09  Aligned_cols=162  Identities=26%  Similarity=0.336  Sum_probs=123.9

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC----cccccCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN----WTEFAGTYGY   79 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~   79 (179)
                      ...+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.........    .....++..|
T Consensus       124 ~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y  200 (311)
T d1r0pa_         124 THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW  200 (311)
T ss_dssp             TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGG
T ss_pred             cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccc
Confidence            44678889999999999999999999   9999999999999999999999999999876543221    2234678899


Q ss_pred             CCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcc
Q 042876           80 VAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSC  159 (179)
Q Consensus        80 ~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  159 (179)
                      ++||.+.+..++.++||||||+++|++++|..||.......  ....  .....  .+...+....    ..+.+||.+|
T Consensus       201 ~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~--~i~~g--~~~~~p~~~~----~~l~~li~~c  270 (311)
T d1r0pa_         201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITV--YLLQG--RRLLQPEYCP----DPLYEVMLKC  270 (311)
T ss_dssp             SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH--HHHTT--CCCCCCTTCC----HHHHHHHHHH
T ss_pred             cChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHH--HHHcC--CCCCCcccCc----HHHHHHHHHH
Confidence            99999998899999999999999999999888875432111  1111  11111  1111112222    2378899999


Q ss_pred             cCcCCCCCCCHHHHHHHhh
Q 042876          160 LNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       160 l~~~p~~Rps~~~~~~~l~  178 (179)
                      |+.||++|||+.|++++|+
T Consensus       271 l~~dP~~RPs~~ei~~~L~  289 (311)
T d1r0pa_         271 WHPKAEMRPSFSELVSRIS  289 (311)
T ss_dssp             TCSSGGGSCCHHHHHHHHH
T ss_pred             cCCCHhHCcCHHHHHHHHH
Confidence            9999999999999999985

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.1e-35  Score=215.12  Aligned_cols=171  Identities=23%  Similarity=0.288  Sum_probs=121.2

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ..+.+++.+++.++.||+.||+|||+.   +++||||||+||+++.++.+|++|||.+..............+++.|.+|
T Consensus        93 ~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~p  169 (286)
T d1ob3a_          93 CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP  169 (286)
T ss_dssp             STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCH
T ss_pred             hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhH
Confidence            356799999999999999999999999   99999999999999999999999999998766544444455788899999


Q ss_pred             cccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccc------------cccch-hhhhhhc---CCCCCCCC-Ccc
Q 042876           83 ELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISS------------SSLNT-DIELDEM---LDPRLPAP-SRS  144 (179)
Q Consensus        83 e~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~------------~~~~~-~~~~~~~---~~~~~~~~-~~~  144 (179)
                      |.+.+. .++.++|+||+||++++|++|+.||...+....            ..... .......   .....+.. ...
T Consensus       170 E~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (286)
T d1ob3a_         170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESF  249 (286)
T ss_dssp             HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGT
T ss_pred             HHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhh
Confidence            998765 468999999999999999999999965432110            00000 0000000   00000000 000


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ......++.+|+.+||+.||++|||++|+++|
T Consensus       250 ~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11112347889999999999999999999976

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-35  Score=216.42  Aligned_cols=161  Identities=24%  Similarity=0.354  Sum_probs=124.1

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++.+++.++.||+.||+|||++   +++||||||+||+++.++.++++|||.+.........  .....+++.|+||
T Consensus       140 ~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP  216 (311)
T d1t46a_         140 LALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (311)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCH
Confidence            4689999999999999999999999   9999999999999999999999999999876543322  2335678999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhC-CCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKG-KHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      |.+.+..++.++|+||||+++|+|+++ ..||...+....    .............+  ...    ...+.+||.+||+
T Consensus       217 E~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~----~~~~i~~~~~~~~~--~~~----~~~l~~Li~~cl~  286 (311)
T d1t46a_         217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----FYKMIKEGFRMLSP--EHA----PAEMYDIMKTCWD  286 (311)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH----HHHHHHHTCCCCCC--TTS----CHHHHHHHHHHTC
T ss_pred             HHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH----HHHHHhcCCCCCCc--ccc----cHHHHHHHHHHcC
Confidence            999988999999999999999999995 444543322111    00111111111111  112    2248889999999


Q ss_pred             cCCCCCCCHHHHHHHhh
Q 042876          162 ESPESRPTMKIVSQQLR  178 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~l~  178 (179)
                      .||.+|||++++++.|+
T Consensus       287 ~dP~~RPs~~~il~~L~  303 (311)
T d1t46a_         287 ADPLKRPTFKQIVQLIE  303 (311)
T ss_dssp             SSGGGSCCHHHHHHHHH
T ss_pred             CChhHCcCHHHHHHHHH
Confidence            99999999999999885

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-35  Score=217.52  Aligned_cols=161  Identities=22%  Similarity=0.327  Sum_probs=125.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCC--CceeEccccCccccCCCCCCcccccCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLE--YEAHVADFGIAKFLKPDSSNWTEFAGTYGYVA   81 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~   81 (179)
                      ..++++.+++.++.||++||+|||+.   |++||||||+||+++.+  ..++++|||++....... ......+++.|++
T Consensus        96 ~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-~~~~~~~t~~y~a  171 (321)
T d1tkia_          96 AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYA  171 (321)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-EEEEEESCGGGSC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC-ccccccccccccc
Confidence            34799999999999999999999999   99999999999999744  579999999997765433 2344577889999


Q ss_pred             CcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           82 PELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        82 pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      ||...+..++.++|+||+||++|+|++|..||.......        ....+.................++.+|+.+||.
T Consensus       172 pe~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~  243 (321)
T d1tkia_         172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--------IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV  243 (321)
T ss_dssp             HHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSC
T ss_pred             chhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCChhhccCCCHHHHHHHHHHcc
Confidence            999998889999999999999999999999997543211        111111111211111112223457889999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 042876          162 ESPESRPTMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rps~~~~~~~  176 (179)
                      .||.+|||++|+++|
T Consensus       244 ~dp~~R~s~~eil~h  258 (321)
T d1tkia_         244 KERKSRMTASEALQH  258 (321)
T ss_dssp             SSGGGSCCHHHHHHS
T ss_pred             CChhHCcCHHHHhcC
Confidence            999999999999985

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-35  Score=212.69  Aligned_cols=173  Identities=21%  Similarity=0.270  Sum_probs=125.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC----CcccccC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDC-----FPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS----NWTEFAG   75 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~-----~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~   75 (179)
                      .++++..++.++.|++.||.|||+.+     ..+++||||||+||+++.++.+||+|||++........    ......+
T Consensus        95 ~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~g  174 (303)
T d1vjya_          95 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG  174 (303)
T ss_dssp             CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceec
Confidence            46899999999999999999999731     02899999999999999999999999999987644322    1234578


Q ss_pred             CCCCCCCcccccCC------CCcchhhHHHHHHHHHHHhCCCCCcccccccccc-------cchhhhhhhcCCCC----C
Q 042876           76 TYGYVAPELAYTMK------ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS-------LNTDIELDEMLDPR----L  138 (179)
Q Consensus        76 ~~~~~~pe~~~~~~------~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~-------~~~~~~~~~~~~~~----~  138 (179)
                      ++.|+|||.+.+..      ++.++|+|||||++|+|++|..|+..........       ..............    +
T Consensus       175 t~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~  254 (303)
T d1vjya_         175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI  254 (303)
T ss_dssp             CGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC
T ss_pred             ccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCC
Confidence            99999999987643      4678999999999999999988875433221111       11111111222222    2


Q ss_pred             CCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          139 PAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       139 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +.. ....+....+.+++.+||+.||++|||+.|+++.|+
T Consensus       255 ~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~  293 (303)
T d1vjya_         255 PNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             CGG-GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             Ccc-cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence            221 112334556889999999999999999999999885

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-35  Score=213.67  Aligned_cols=160  Identities=25%  Similarity=0.353  Sum_probs=123.3

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ....+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++....... ......++..|++|
T Consensus       120 ~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aP  195 (309)
T d1fvra_         120 TASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAI  195 (309)
T ss_dssp             BSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC-CC----CCTTTCCH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEccccccccccccc-cccceecCCcccch
Confidence            346799999999999999999999999   99999999999999999999999999997554322 22345678899999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhCC-CCCcccccccccccchhhhhhhcCC-CCCCCCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKGK-HPRDFLSSISSSSLNTDIELDEMLD-PRLPAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |.+.+..++.++|+||||+++|+|++|. .||...+...        ....+.. .+.+.......    ++.+||.+||
T Consensus       196 E~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--------~~~~i~~~~~~~~~~~~~~----~~~~li~~cl  263 (309)
T d1fvra_         196 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQGYRLEKPLNCDD----EVYDLMRQCW  263 (309)
T ss_dssp             HHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHGGGTCCCCCCTTBCH----HHHHHHHHHT
T ss_pred             HHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHhcCCCCCCccCCH----HHHHHHHHHc
Confidence            9999989999999999999999999965 4665432211        1111111 12222222222    4888999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||++|||+++++++|+
T Consensus       264 ~~dP~~RPs~~eil~~L~  281 (309)
T d1fvra_         264 REKPYERPSFAQILVSLN  281 (309)
T ss_dssp             CSSGGGSCCHHHHHHHHH
T ss_pred             CCChhHCcCHHHHHHHHH
Confidence            999999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-35  Score=212.15  Aligned_cols=159  Identities=21%  Similarity=0.342  Sum_probs=124.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCC--cccccCCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSN--WTEFAGTYGYVAP   82 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~p   82 (179)
                      ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.........  .....+++.|++|
T Consensus       128 ~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aP  204 (308)
T d1p4oa_         128 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP  204 (308)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCH
Confidence            4578999999999999999999999   9999999999999999999999999999765443322  2334678999999


Q ss_pred             cccccCCCCcchhhHHHHHHHHHHHhC-CCCCcccccccccccchhhhhhhcCCCCC-CCCCccHHHHHHHHHHHHhccc
Q 042876           83 ELAYTMKITEKCDVYSFGVLALEVIKG-KHPRDFLSSISSSSLNTDIELDEMLDPRL-PAPSRSVQEKLISIVKVAFSCL  160 (179)
Q Consensus        83 e~~~~~~~~~~~D~~slg~~~~~l~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl  160 (179)
                      |.+.+..++.++|+||||+++|+|++| ..||...+..        .....+..... +.+....    ..+.++|.+||
T Consensus       205 e~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~--------~~~~~i~~~~~~~~p~~~~----~~l~~li~~cl  272 (308)
T d1p4oa_         205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--------QVLRFVMEGGLLDKPDNCP----DMLFELMRMCW  272 (308)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--------HHHHHHHTTCCCCCCTTCC----HHHHHHHHHHT
T ss_pred             HHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhCCCCCCcccch----HHHHHHHHHHc
Confidence            999999999999999999999999997 5677543221        11111222222 2122222    24888999999


Q ss_pred             CcCCCCCCCHHHHHHHhh
Q 042876          161 NESPESRPTMKIVSQQLR  178 (179)
Q Consensus       161 ~~~p~~Rps~~~~~~~l~  178 (179)
                      +.||++|||+++++++|+
T Consensus       273 ~~~P~~RPs~~~il~~L~  290 (308)
T d1p4oa_         273 QYNPKMRPSFLEIISSIK  290 (308)
T ss_dssp             CSSGGGSCCHHHHHHHHG
T ss_pred             CCChhHCcCHHHHHHHHH
Confidence            999999999999999886

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-34  Score=214.03  Aligned_cols=169  Identities=22%  Similarity=0.288  Sum_probs=122.2

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC---CcccccCCCCCCC
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS---NWTEFAGTYGYVA   81 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~   81 (179)
                      +.+++.+++.++.|++.||+|||++   |++||||||+||+++.++.+||+|||++........   ......+++.|+|
T Consensus       104 ~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~a  180 (345)
T d1pmea_         104 QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA  180 (345)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceech
Confidence            4789999999999999999999999   999999999999999999999999999976543221   2344568899999


Q ss_pred             Cccccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc------------------hhhhhhhcCCCCCCCCC
Q 042876           82 PELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN------------------TDIELDEMLDPRLPAPS  142 (179)
Q Consensus        82 pe~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~  142 (179)
                      ||.+.. ..++.++|+||+||++++|++|..||............                  .................
T Consensus       181 PE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (345)
T d1pmea_         181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW  260 (345)
T ss_dssp             GGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCH
T ss_pred             HHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCH
Confidence            998854 45788999999999999999999999654321100000                  00000000111100000


Q ss_pred             -ccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          143 -RSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       143 -~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                       .........+.+|+.+||+.||.+|||++|+++|
T Consensus       261 ~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         261 NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0001112247889999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-34  Score=210.19  Aligned_cols=170  Identities=20%  Similarity=0.250  Sum_probs=122.5

Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC----CcccccCCCC
Q 042876            3 AAQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS----NWTEFAGTYG   78 (179)
Q Consensus         3 ~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~   78 (179)
                      ..+.+++..++.+++|+++||.|||+.   +++||||||+||+++.++.++++|||++........    ......+++.
T Consensus       110 ~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~  186 (318)
T d3blha1         110 VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW  186 (318)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGG
T ss_pred             cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHH
Confidence            346789999999999999999999999   999999999999999999999999999976543221    1233468899


Q ss_pred             CCCCcccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh---------------hhhhhcCCCCCCCCC
Q 042876           79 YVAPELAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD---------------IELDEMLDPRLPAPS  142 (179)
Q Consensus        79 ~~~pe~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~  142 (179)
                      |+|||.+.+. .++.++|+||+||++++|++|+.||..............               ........ ......
T Consensus       187 Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  265 (318)
T d3blha1         187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE-LVKGQK  265 (318)
T ss_dssp             GCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC--------CCSSCC
T ss_pred             HhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhc-cccccc
Confidence            9999998765 678999999999999999999999964332110000000               00000000 011111


Q ss_pred             ccHHHH------HHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          143 RSVQEK------LISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       143 ~~~~~~------~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ....+.      ...+.+||.+||+.||++|||++|+++|
T Consensus       266 ~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         266 RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             BCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            111111      2246789999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-34  Score=211.99  Aligned_cols=166  Identities=22%  Similarity=0.252  Sum_probs=122.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      ..+++..++.++.||+.||+|||++   |++||||||+||+++.++.++++|||.+.......   ....+++.|+|||.
T Consensus       116 ~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~---~~~~~t~~y~aPE~  189 (346)
T d1cm8a_         116 EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEV  189 (346)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC---CSSCSCGGGCCTHH
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCCcc---ccccccccccCHHH
Confidence            4799999999999999999999999   99999999999999999999999999997765432   44678899999998


Q ss_pred             cccC-CCCcchhhHHHHHHHHHHHhCCCCCccccccccc------------------ccchhhhhhhcCCCCCCCC-Ccc
Q 042876           85 AYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSS------------------SLNTDIELDEMLDPRLPAP-SRS  144 (179)
Q Consensus        85 ~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~-~~~  144 (179)
                      +.+. .++.++|+||+||++++|++|..||...+.....                  ................... ...
T Consensus       190 ~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (346)
T d1cm8a_         190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI  269 (346)
T ss_dssp             HHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGT
T ss_pred             HcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHh
Confidence            8764 5688999999999999999999999654321100                  0000000001111100000 000


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ......++.+||.+||..||.+|||++|+++|
T Consensus       270 ~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         270 LTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            01112247789999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.6e-34  Score=207.20  Aligned_cols=168  Identities=16%  Similarity=0.226  Sum_probs=125.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecC-----CCceeEccccCccccCCCCC-------Ccc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDL-----EYEAHVADFGIAKFLKPDSS-------NWT   71 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~-----~~~~~l~d~~~~~~~~~~~~-------~~~   71 (179)
                      .+.++..++..++.|++.||.|||+.   |++||||||+||+++.     ++.++++|||+++.......       ...
T Consensus        95 ~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~  171 (293)
T d1csna_          95 GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK  171 (293)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccC
Confidence            45799999999999999999999999   9999999999999964     56799999999987643221       123


Q ss_pred             cccCCCCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHH
Q 042876           72 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLIS  151 (179)
Q Consensus        72 ~~~~~~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (179)
                      ...|++.|+|||.+.+..++.++|+||||+++|+|++|..||......................+ .+   ......+.+
T Consensus       172 ~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~---~l~~~~p~~  247 (293)
T d1csna_         172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-LR---ELCAGFPEE  247 (293)
T ss_dssp             CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-HH---HHTTTSCHH
T ss_pred             ceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC-hH---HhcCCCCHH
Confidence            45789999999999999999999999999999999999999975543222111111110000000 00   000001124


Q ss_pred             HHHHHhcccCcCCCCCCCHHHHHHHhh
Q 042876          152 IVKVAFSCLNESPESRPTMKIVSQQLR  178 (179)
Q Consensus       152 ~~~li~~cl~~~p~~Rps~~~~~~~l~  178 (179)
                      +.+++..|+..+|++||+++.+.+.|+
T Consensus       248 l~~ii~~~~~~~~~~rP~y~~l~~~l~  274 (293)
T d1csna_         248 FYKYMHYARNLAFDATPDYDYLQGLFS  274 (293)
T ss_dssp             HHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             HHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence            788889999999999999999887664

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-33  Score=204.54  Aligned_cols=170  Identities=19%  Similarity=0.232  Sum_probs=123.7

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+.+++..++.++.|+++||+|||++   +++||||||+||+++.++.++++|||.+..............++..|.+||
T Consensus        95 ~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe  171 (292)
T d1unla_          95 NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD  171 (292)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHH
T ss_pred             ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhh
Confidence            46789999999999999999999999   999999999999999999999999999987765554455556778899999


Q ss_pred             ccccCC-CCcchhhHHHHHHHHHHHhCCCCCcccccccccc--------------cchhhhhhhcCC----CCCCCCCcc
Q 042876           84 LAYTMK-ITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS--------------LNTDIELDEMLD----PRLPAPSRS  144 (179)
Q Consensus        84 ~~~~~~-~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~--------------~~~~~~~~~~~~----~~~~~~~~~  144 (179)
                      .+.+.. ++.++|+||+||++++|++|..||....+.....              ............    .........
T Consensus       172 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (292)
T d1unla_         172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV  251 (292)
T ss_dssp             HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTT
T ss_pred             HhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhc
Confidence            887655 6899999999999999999999973322111000              000000000000    000001111


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......+.+|+.+||+.||.+|||++|+++|
T Consensus       252 ~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11122347788999999999999999999886

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-33  Score=207.74  Aligned_cols=169  Identities=23%  Similarity=0.233  Sum_probs=122.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-ceeEccccCccccCCCCCCcccccCCCCCCCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP   82 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p   82 (179)
                      ...+++.+++.++.||+.||+|||++   ||+||||||+||+++.++ .+||+|||++........ .....++..|++|
T Consensus       116 ~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~-~~~~~gt~~y~aP  191 (350)
T d1q5ka_         116 KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRYYRAP  191 (350)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC-CCSCCSCTTSCCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCcc-cccccccccccCh
Confidence            45799999999999999999999999   999999999999998775 789999999987654332 3345788999999


Q ss_pred             ccccc-CCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc-------hhhhhh----hcCCCCCCCCC------cc
Q 042876           83 ELAYT-MKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN-------TDIELD----EMLDPRLPAPS------RS  144 (179)
Q Consensus        83 e~~~~-~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~-------~~~~~~----~~~~~~~~~~~------~~  144 (179)
                      |.+.+ ..++.++|+||+||++|+|++|..||............       ......    ......++...      ..
T Consensus       192 E~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (350)
T d1q5ka_         192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF  271 (350)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTS
T ss_pred             HHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhc
Confidence            98765 46899999999999999999999999654321100000       000000    00011111100      00


Q ss_pred             HHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          145 VQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       145 ~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ......++.+|+.+||+.||++|||+.|+++|
T Consensus       272 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         272 RPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            01112247889999999999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-32  Score=204.78  Aligned_cols=168  Identities=23%  Similarity=0.260  Sum_probs=119.7

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCcc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPEL   84 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~   84 (179)
                      +.+++..++.++.||+.||.|||+.   |++||||||+||+++.++.++++|||++....... ......+++.|+|||.
T Consensus       114 ~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~-~~~~~~~t~~y~aPE~  189 (355)
T d2b1pa1         114 MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEV  189 (355)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------------CCTTCCHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccccc-ccccccccccccChhh
Confidence            4689999999999999999999999   99999999999999999999999999987655432 2334567889999999


Q ss_pred             cccCCCCcchhhHHHHHHHHHHHhCCCCCccccccccccc------------c--hhhhhh----h-----------cC-
Q 042876           85 AYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSL------------N--TDIELD----E-----------ML-  134 (179)
Q Consensus        85 ~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~------------~--~~~~~~----~-----------~~-  134 (179)
                      +.+..+++++|+||+||+++++++|..||.+.+.......            .  ......    .           .. 
T Consensus       190 l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (355)
T d2b1pa1         190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP  269 (355)
T ss_dssp             HTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSC
T ss_pred             hcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccc
Confidence            9999999999999999999999999999964431110000            0  000000    0           00 


Q ss_pred             CCCCCCCCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          135 DPRLPAPSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      ....+...........++.+|+.+||+.||++|||++|+++|
T Consensus       270 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         270 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             GGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            001111222333445678999999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.1e-33  Score=205.12  Aligned_cols=168  Identities=20%  Similarity=0.242  Sum_probs=121.3

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCC-ceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEY-EAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      +.+++.+++.+++||+.||.|||++   ||+||||||+|||++.++ .++++|||++........ .....+++.|+|||
T Consensus       124 ~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~-~~~~~~t~~y~aPE  199 (328)
T d3bqca1         124 QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPE  199 (328)
T ss_dssp             TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC-CCSCCSCGGGCCHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc-ccccccCccccCcc
Confidence            5789999999999999999999999   999999999999998655 589999999987654332 34457788999999


Q ss_pred             ccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccc--------------------cchhhhhhhcCCCCCCC--
Q 042876           84 LAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSS--------------------LNTDIELDEMLDPRLPA--  140 (179)
Q Consensus        84 ~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~--  140 (179)
                      .+.+. .++.++|+||+||+++++++|..||..........                    .................  
T Consensus       200 ~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (328)
T d3bqca1         200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW  279 (328)
T ss_dssp             HHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCG
T ss_pred             cccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccch
Confidence            98765 47899999999999999999999986443211000                    00000000000000000  


Q ss_pred             ----CCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          141 ----PSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       141 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                          ..........++.+||.+||+.||.+|||++|+++|
T Consensus       280 ~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         280 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             GGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                000111122347889999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-33  Score=203.12  Aligned_cols=161  Identities=23%  Similarity=0.305  Sum_probs=121.8

Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCC-CcccccCCCCCCCCc
Q 042876            5 QELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSS-NWTEFAGTYGYVAPE   83 (179)
Q Consensus         5 ~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe   83 (179)
                      +.+++..++.++.||+.||.|+|+.   +++||||||+||+++.++.++|+|||++........ ......+++.|++||
T Consensus       124 ~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe  200 (322)
T d1vzoa_         124 ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD  200 (322)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHH
T ss_pred             ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhH
Confidence            4678899999999999999999999   999999999999999999999999999976543322 233457889999999


Q ss_pred             ccccC--CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchhhhhhhcCCCCCCCCCccHHHHHHHHHHHHhcccC
Q 042876           84 LAYTM--KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTDIELDEMLDPRLPAPSRSVQEKLISIVKVAFSCLN  161 (179)
Q Consensus        84 ~~~~~--~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  161 (179)
                      .+.+.  .++.++|||||||++|+|++|..||................    .....+.+...    ...+.+++.+||+
T Consensus       201 ~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~----~~~~~~~~~~~----s~~~~~li~~~l~  272 (322)
T d1vzoa_         201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI----LKSEPPYPQEM----SALAKDLIQRLLM  272 (322)
T ss_dssp             HHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH----HHCCCCCCTTS----CHHHHHHHHHHTC
T ss_pred             HhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc----ccCCCCCcccC----CHHHHHHHHHHcc
Confidence            88754  36789999999999999999999997654332211111111    11111111122    2248889999999


Q ss_pred             cCCCCCC-----CHHHHHHH
Q 042876          162 ESPESRP-----TMKIVSQQ  176 (179)
Q Consensus       162 ~~p~~Rp-----s~~~~~~~  176 (179)
                      .||.+||     |++|+++|
T Consensus       273 ~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         273 KDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             SSGGGSTTSSTTTHHHHHTS
T ss_pred             cCHHHcCCCCcccHHHHHcC
Confidence            9999999     48899875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-32  Score=204.52  Aligned_cols=167  Identities=22%  Similarity=0.300  Sum_probs=117.6

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCCc
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAPE   83 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe   83 (179)
                      .+++++.+++.++.||+.||+|||++   |++||||||+||+++.++.++++|||.+......   .....++..|++||
T Consensus       115 ~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~---~~~~~g~~~y~apE  188 (348)
T d2gfsa1         115 CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPE  188 (348)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTGG---GSSSCHHHHTSCHH
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCcc---cccccccccccCch
Confidence            35799999999999999999999999   9999999999999999999999999998654432   23456788899999


Q ss_pred             ccccC-CCCcchhhHHHHHHHHHHHhCCCCCcccccccccccc---------------hhhhhhhcCC--CCCCCCC--c
Q 042876           84 LAYTM-KITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLN---------------TDIELDEMLD--PRLPAPS--R  143 (179)
Q Consensus        84 ~~~~~-~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~---------------~~~~~~~~~~--~~~~~~~--~  143 (179)
                      ...+. .++.++|+||+||++|+|++|..||.+.+........               ..........  ...+...  .
T Consensus       189 ~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (348)
T d2gfsa1         189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN  268 (348)
T ss_dssp             HHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHH
T ss_pred             hhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhh
Confidence            87665 4588999999999999999999999654321100000               0000000000  0011000  0


Q ss_pred             cHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          144 SVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       144 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                      .......++.+||.+||+.||.+|||++|+++|
T Consensus       269 ~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         269 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            000112347889999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=1.5e-31  Score=198.92  Aligned_cols=167  Identities=19%  Similarity=0.214  Sum_probs=121.1

Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCcccCCCCCCCeeecCCCc------eeEccccCccccCCCCCCcccccCC
Q 042876            4 AQELDWSQRMNTIKGVADALSYLHH-DCFPPIVHRDLSSKNLLLDLEYE------AHVADFGIAKFLKPDSSNWTEFAGT   76 (179)
Q Consensus         4 ~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~~~~h~dl~~~nil~~~~~~------~~l~d~~~~~~~~~~~~~~~~~~~~   76 (179)
                      ...+++..++.++.|++.||.|||+ .   ||+||||||+||+++.++.      ++++|||.+.......   ....++
T Consensus       119 ~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~---~~~~gt  192 (362)
T d1q8ya_         119 HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TNSIQT  192 (362)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC---CSCCSC
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccceeeEeeccccccccccc---cccccc
Confidence            4578899999999999999999998 5   9999999999999976543      8999999987654332   345788


Q ss_pred             CCCCCCcccccCCCCcchhhHHHHHHHHHHHhCCCCCcccccccccccchh-------------hhh------hhc----
Q 042876           77 YGYVAPELAYTMKITEKCDVYSFGVLALEVIKGKHPRDFLSSISSSSLNTD-------------IEL------DEM----  133 (179)
Q Consensus        77 ~~~~~pe~~~~~~~~~~~D~~slg~~~~~l~~~~~p~~~~~~~~~~~~~~~-------------~~~------~~~----  133 (179)
                      +.|+|||.+.+..++.++|+||+||++++|++|+.||..............             ...      ...    
T Consensus       193 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~  272 (362)
T d1q8ya_         193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR  272 (362)
T ss_dssp             GGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC-
T ss_pred             ccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccc
Confidence            899999999998999999999999999999999999964432111000000             000      000    


Q ss_pred             -CCCCCCC------------CCccHHHHHHHHHHHHhcccCcCCCCCCCHHHHHHH
Q 042876          134 -LDPRLPA------------PSRSVQEKLISIVKVAFSCLNESPESRPTMKIVSQQ  176 (179)
Q Consensus       134 -~~~~~~~------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~~~~~  176 (179)
                       .......            ...........+.+|+.+||+.||.+|||++|+++|
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         273 GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             -CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             hhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0000000            111223455678999999999999999999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.43  E-value=2e-14  Score=96.96  Aligned_cols=84  Identities=17%  Similarity=0.171  Sum_probs=60.6

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCCCCcccCCCCCCCeeecCCCceeEccccCccccCCCCCCcccccCCCCCCCC--c
Q 042876            6 ELDWSQRMNTIKGVADALSYLHHDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAKFLKPDSSNWTEFAGTYGYVAP--E   83 (179)
Q Consensus         6 ~l~~~~~~~~~~qi~~~l~~lh~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p--e   83 (179)
                      .++...+..++.|++.+|.|||+.   |++||||||+||+++.+ .++++|||.+.....+... .       |...  +
T Consensus        99 ~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~-~-------~l~rd~~  166 (191)
T d1zara2          99 RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR-E-------ILERDVR  166 (191)
T ss_dssp             GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH-H-------HHHHHHH
T ss_pred             chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcH-H-------HHHHHHH
Confidence            356667788999999999999999   99999999999999855 5889999998765432210 0       1000  0


Q ss_pred             ---ccccCCCCcchhhHHHHH
Q 042876           84 ---LAYTMKITEKCDVYSFGV  101 (179)
Q Consensus        84 ---~~~~~~~~~~~D~~slg~  101 (179)
                         ......++..+|+||+.-
T Consensus       167 ~~~~~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         167 NIITYFSRTYRTEKDINSAID  187 (191)
T ss_dssp             HHHHHHHHHHCCCCCHHHHHH
T ss_pred             HHHHHHcCCCCCcccHHHHHH
Confidence               011345678889999643

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.28  E-value=0.0026  Score=44.52  Aligned_cols=29  Identities=24%  Similarity=0.277  Sum_probs=26.2

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      |+||+|+.+.|++++.+....+.||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            89999999999999988777899999773

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=93.84  E-value=0.014  Score=39.23  Aligned_cols=28  Identities=21%  Similarity=0.311  Sum_probs=24.3

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~   60 (179)
                      .++|+|+.+.|++++.++.+.++||+.+
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a  211 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             EEEEeeccCcceeecCCceEEEeechhc
Confidence            4899999999999997766679999876

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=93.26  E-value=0.015  Score=38.90  Aligned_cols=28  Identities=18%  Similarity=0.210  Sum_probs=24.5

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIA   60 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~   60 (179)
                      .++|+|+.+.|++++.+..+.|+||+.+
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~  203 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRL  203 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhc
Confidence            5899999999999997766789999876

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=90.88  E-value=0.18  Score=35.00  Aligned_cols=46  Identities=17%  Similarity=0.143  Sum_probs=29.4

Q ss_pred             HHHHHHHHHHHHHh-hCCCCCcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           14 NTIKGVADALSYLH-HDCFPPIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        14 ~~~~qi~~~l~~lh-~~~~~~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      ..+.++...+...- .....+++|+|+.+.|++++.+  ..++||+-+.
T Consensus       173 ~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         173 KATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             HHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             HHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhcc
Confidence            33444444444332 2222379999999999999743  4578999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=90.85  E-value=0.058  Score=38.82  Aligned_cols=28  Identities=25%  Similarity=0.360  Sum_probs=24.6

Q ss_pred             CcccCCCCCCCeeecCCCceeEccccCcc
Q 042876           33 PIVHRDLSSKNLLLDLEYEAHVADFGIAK   61 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~~~~~~l~d~~~~~   61 (179)
                      .++|+|+.+.||+++.+ .++++||..+.
T Consensus       224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~  251 (392)
T d2pula1         224 TLIHGDLHTGSIFASEH-ETKVIDPEFAF  251 (392)
T ss_dssp             EEECSCCCGGGEEECSS-CEEECCCTTCE
T ss_pred             ceeccCCcCCceeEcCC-ceEEechhhcc
Confidence            69999999999999866 48999998774

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=83.33  E-value=0.23  Score=35.44  Aligned_cols=16  Identities=38%  Similarity=0.567  Sum_probs=13.6

Q ss_pred             CcccCCCCCCCeeecC
Q 042876           33 PIVHRDLSSKNLLLDL   48 (179)
Q Consensus        33 ~~~h~dl~~~nil~~~   48 (179)
                      .++|+|+.+.||++..
T Consensus       219 v~CHnDL~~~NiL~~~  234 (395)
T d1nw1a_         219 TFCHNDLQEGNILLPK  234 (395)
T ss_dssp             EEECSCCCGGGEEEEC
T ss_pred             eEEecCCCcccEeecc
Confidence            3689999999999853